Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" ABCC3 "cMOAT2, EST90757, MLP2, MOAT-D, MRP3" ENSG00000108846 "ATP binding cassette subfamily C member 3" O15438 17 50634777-50692252 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 53.5;liver: 66.2" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 262.4;Enterocytes: 161.4;Hepatocytes: 155.5;Paneth cells: 153.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "intermediate monocyte: 6.2;non-classical monocyte: 7.6" "Lineage enriched" "Detected in many" 5 "monocytes: 7.6" "Cell line enhanced" "Detected in many" "A549: 31.4;CAPAN-2: 24.0;OE19: 34.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB037136, HPA048483" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB037136: AB_477165, HPA048483: AB_2680414" "unprognostic (1.57e-2)" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (1.65e-2)" "unprognostic (9.67e-3)" "unprognostic (6.19e-3)" "unprognostic (7.44e-3)" "unprognostic (8.20e-2)" "unprognostic (3.18e-1)" "unprognostic (5.13e-2)" "prognostic unfavorable (9.57e-4)" "unprognostic (1.60e-3)" "prognostic unfavorable (4.68e-6)" "unprognostic (3.42e-1)" "unprognostic (4.77e-2)" "unprognostic (4.44e-2)" "unprognostic (1.57e-3)" 3.5 36.0 0.4 17.0 0.4 0.5 7.7 0.3 0.4 1.9 23.9 0.8 14.1 10.3 1.6 4.6 5.3 1.0 53.5 0.8 0.4 0.4 13.5 66.2 9.0 10.3 0.6 0.0 1.0 22.2 1.7 0.8 3.5 1.5 5.4 7.7 0.8 4.7 23.6 0.4 4.8 37.0 2.5 4.6 4.9 12.8 1.0 0.0 0.8 4.5 7.0 7.9 7.1 3.5 0.0 1.6 1.3 7.6 0.3 0.5 7.4 2.2 31.4 0.0 0.1 1.8 2.8 0.0 4.2 5.2 0.3 0.3 1.7 24.0 0.0 3.3 8.2 5.9 5.7 0.0 0.4 0.4 0.0 0.0 0.6 13.2 9.5 7.1 0.0 0.0 3.1 2.3 1.2 2.5 3.5 0.5 0.0 0.0 0.0 3.3 7.3 0.0 0.0 0.0 34.9 4.1 0.0 0.0 0.1 13.7 13.6 0.0 0.2 7.6 1.3 0.0 0.0 1.0 0.0 6.9 0.2 1.4 0.1 3.3 0.0 0.0 0.0 3.4 0.0 0.3 0.3 2.8 0.0 0.0 6.2 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 1.3 0.3 7.6 0.2 0.5 7.4 0.4 0.4 0.3 0.4 0.4 0.4 0.6 0.0 1.5 0.0 17.9 5.6 2.4 103.4 8.4 1.2 2.5 262.4 0.0 23.9 14.0 0.0 0.3 5.0 84.3 55.0 1.4 161.4 0.0 92.3 3.0 3.5 62.4 0.0 155.5 27.5 1.6 22.7 4.9 18.2 59.8 8.3 13.8 3.3 4.6 85.5 3.7 82.4 153.0 2.8 7.9 0.1 0.0 5.2 0.7 0.6 9.3 0.8 2.5 66.2 81.6 ABI1 "ABI-1, E3B1, SSH3BP1" ENSG00000136754 "Abl interactor 1" Q8IZP0 10 26746593-26861087 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 218.7;Suprabasal keratinocytes: 236.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008375, HPA068407" Approved Approved "Plasma membrane" NA NA 400000 "Plasma membrane" "CAB008375: AB_592744, HPA068407: AB_2685983" "unprognostic (2.83e-3)" "unprognostic (8.69e-2)" "unprognostic (1.12e-1)" "unprognostic (3.96e-1)" "unprognostic (2.51e-2)" "unprognostic (9.24e-3)" "unprognostic (1.88e-3)" "unprognostic (2.03e-1)" "unprognostic (6.04e-2)" "unprognostic (4.38e-1)" "unprognostic (2.40e-2)" "unprognostic (5.48e-2)" "unprognostic (1.98e-1)" "unprognostic (1.07e-1)" "unprognostic (1.79e-1)" "unprognostic (1.37e-1)" "unprognostic (1.18e-1)" 24.0 14.0 32.0 28.1 32.6 54.1 21.4 28.2 35.5 22.5 22.7 19.8 14.8 24.8 23.9 15.4 45.1 20.3 21.6 14.1 47.3 23.1 21.9 17.8 22.5 32.1 25.0 26.4 25.3 17.0 19.1 14.4 22.7 20.9 19.1 24.8 26.7 30.9 17.0 16.6 33.0 26.0 21.6 27.5 25.5 23.9 12.4 20.5 43.5 18.8 27.3 40.9 25.2 30.3 36.1 26.8 51.5 28.0 20.5 44.5 31.5 23.7 13.3 10.9 10.7 16.6 20.4 16.4 24.1 16.4 17.8 20.8 15.6 28.1 43.6 12.4 25.5 11.4 26.7 13.1 15.6 19.9 29.1 11.7 19.1 9.1 11.0 11.3 9.2 19.4 13.9 19.9 17.4 10.4 20.8 21.5 14.6 14.1 27.9 18.2 10.2 21.7 8.8 9.0 14.8 6.4 23.6 20.3 28.1 18.9 11.0 9.1 9.7 20.0 19.6 20.1 14.6 12.6 14.8 26.7 13.7 16.8 17.3 12.3 6.3 10.0 51.9 19.7 23.8 9.8 35.5 23.8 51.5 27.0 28.0 25.8 36.1 25.9 30.0 26.8 28.6 24.4 26.5 37.9 20.5 26.7 22.3 44.5 31.5 32.0 32.6 28.2 31.9 47.3 23.1 25.0 26.4 20.9 20.5 38.7 33.6 47.0 115.9 218.7 9.0 20.7 33.1 77.6 58.0 24.4 2.0 30.2 11.6 46.6 9.9 39.4 52.3 0.0 46.0 39.6 47.2 106.9 56.6 23.6 68.6 15.9 43.1 35.0 76.6 4.2 20.4 67.7 87.7 83.8 48.7 42.6 61.4 46.3 20.8 31.5 9.7 32.3 49.1 12.1 8.5 236.6 64.5 62.5 39.1 163.3 AC004691.2 ENSG00000250424 7 30852273-30923812 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.3;ASC diff: 1.1;SH-SY5Y: 1.9;SK-BR-3: 1.3" "HPA019206, HPA030130" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA019206: AB_1844965, HPA030130: AB_10601565" "unprognostic (2.15e-1)" "unprognostic (3.12e-1)" "unprognostic (1.83e-1)" "unprognostic (1.66e-1)" "unprognostic (2.72e-4)" "unprognostic (5.13e-2)" "unprognostic (3.44e-2)" "unprognostic (2.15e-1)" "unprognostic (2.88e-2)" "unprognostic (3.76e-1)" "unprognostic (2.49e-1)" "unprognostic (3.71e-2)" 0.8 0.2 0.0 0.0 0.4 0.2 0.6 0.0 0.3 1.1 1.3 1.4 1.4 1.5 0.7 2.4 3.1 0.8 0.0 0.1 0.5 0.0 1.1 0.0 0.0 0.6 2.2 0.0 0.3 0.0 0.7 0.2 0.7 1.2 0.4 0.3 0.4 2.3 0.0 0.0 0.9 0.1 0.7 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.3 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.6 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADAM12 "MCMPMltna, MLTN" ENSG00000148848 "ADAM metallopeptidase domain 12" O43184 10 126012381-126388455 "Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 50 "placenta: 487.4" "Cell type enhanced" "Detected in many" 24 "Cone photoreceptor cells: 96.2;Extravillous trophoblasts: 348.4;Syncytiotrophoblasts: 108.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 5 "MAIT T-cell: 9.8" "Lineage enriched" "Detected in single" 98 "T-cells: 9.8" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 47.3;hTEC/SVTERT24-B: 29.7;U-2197: 29.3;U-251 MG: 26.2;U-87 MG: 22.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA030866, HPA030867, HPA030868" Enhanced Supported "Plasma membrane" "Secreted in female reproductive system" NA NA "Plasma membrane" "HPA030866: AB_2673636, HPA030867: AB_10602428, HPA030868: AB_2673638" "unprognostic (3.35e-1)" "unprognostic (1.05e-3)" "unprognostic (3.52e-2)" "unprognostic (2.47e-2)" "unprognostic (3.34e-2)" "unprognostic (2.16e-1)" "unprognostic (2.91e-6)" "unprognostic (2.17e-2)" "unprognostic (4.85e-2)" "unprognostic (1.30e-2)" "unprognostic (2.53e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.39e-14)" "unprognostic (3.11e-3)" "unprognostic (9.06e-3)" "unprognostic (4.70e-3)" "unprognostic (3.47e-3)" 6.0 0.0 0.6 2.1 2.8 0.0 5.9 0.6 0.6 8.0 0.5 0.5 0.4 0.0 2.6 0.5 0.5 0.1 4.6 0.7 0.6 0.7 1.0 0.4 1.1 1.0 0.8 0.5 8.2 0.6 0.0 1.1 487.4 0.8 0.7 0.1 0.9 1.1 0.4 0.5 0.3 0.4 1.5 0.7 0.5 0.1 0.7 0.6 0.5 0.4 0.5 1.2 4.5 0.8 0.0 0.0 0.0 0.0 0.0 9.8 0.1 5.0 0.7 2.0 0.0 6.0 12.4 0.0 13.2 1.1 4.5 11.3 0.0 0.0 0.0 0.0 47.3 9.5 0.0 0.0 0.4 4.9 0.5 0.1 0.0 8.0 0.0 0.9 0.0 10.5 15.2 0.0 29.7 0.9 8.6 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.5 1.3 0.1 13.5 0.1 9.0 1.5 0.0 0.2 0.8 0.0 0.0 0.0 16.3 5.4 29.3 26.2 0.0 0.1 0.0 22.5 0.0 10.0 0.0 0.0 0.0 0.5 0.0 9.8 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.6 2.8 0.6 0.6 0.6 0.7 0.8 0.5 0.8 0.6 0.0 3.4 0.0 0.4 1.3 0.8 1.4 0.0 1.4 0.0 0.0 96.2 12.1 0.0 7.6 6.3 1.1 0.4 0.0 1.0 348.4 2.0 0.6 49.5 0.0 14.2 6.4 0.0 2.5 0.3 1.1 15.5 0.7 1.7 15.4 0.2 5.5 1.9 0.0 0.7 0.0 31.5 0.0 1.2 5.1 5.5 0.5 108.0 3.1 0.7 0.5 ADAMTS1 "C3-C5, KIAA1346, METH1" ENSG00000154734 "ADAM metallopeptidase with thrombospondin type 1 motif 1" Q9UHI8 21 26835747-26845409 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Heparin-binding, Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 112.8" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 211.3;Sertoli cells: 207.0;Smooth muscle cells: 366.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "gdT-cell: 8.0;NK-cell: 9.0" "Group enriched" "Detected in many" 85 "NK-cells: 9.0;T-cells: 8.0" "Cell line enhanced" "Detected in many" "ASC diff: 62.1;BJ: 72.4;hTEC/SVTERT24-B: 49.9;hTERT-HME1: 45.5;RPTEC TERT1: 42.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB016394, HPA031498" Approved Approved "Plasma membrane" "Secreted to extracellular matrix" NA NA 1900000 "Plasma membrane" "CAB016394: AB_626637, HPA031498: AB_2673907" "unprognostic (6.82e-2)" "unprognostic (1.35e-1)" "unprognostic (1.21e-1)" "unprognostic (1.64e-1)" "unprognostic (1.18e-2)" "prognostic unfavorable (5.13e-4)" "unprognostic (1.03e-1)" "unprognostic (3.28e-1)" "unprognostic (2.37e-2)" "unprognostic (5.39e-2)" "unprognostic (1.75e-1)" "unprognostic (4.55e-2)" "unprognostic (9.70e-3)" "unprognostic (8.27e-3)" "unprognostic (1.12e-1)" "unprognostic (6.76e-2)" "unprognostic (1.57e-1)" 70.6 13.4 8.2 18.7 14.0 0.7 29.0 6.3 9.2 22.0 18.2 9.5 4.8 3.3 27.7 25.8 30.0 45.8 62.3 40.9 7.6 4.8 15.4 22.8 25.0 10.9 12.7 3.7 112.8 9.3 6.3 7.6 56.8 13.2 23.3 16.5 7.8 5.8 8.1 25.7 6.1 16.2 46.4 10.2 7.2 16.8 12.8 11.4 0.0 14.3 18.1 2.7 32.7 45.3 0.0 0.0 0.0 0.0 9.0 8.0 1.4 0.0 0.0 1.1 0.0 62.1 15.4 3.8 72.4 25.3 12.5 8.3 0.0 0.0 0.0 5.0 22.9 0.3 1.3 0.8 3.7 22.1 0.0 23.0 0.0 7.5 0.0 11.9 2.9 0.0 17.2 0.0 49.9 45.5 3.0 5.1 0.7 1.2 0.0 37.1 0.0 0.3 0.0 4.1 0.0 2.9 0.0 28.6 0.2 42.4 4.0 0.0 5.6 3.4 0.0 0.4 2.7 0.1 0.7 5.2 17.8 0.9 27.8 10.7 0.1 0.0 0.0 14.7 0.0 5.4 0.0 0.0 0.0 8.0 0.0 0.8 0.0 0.3 0.6 0.0 0.0 0.0 1.5 0.0 9.0 0.0 0.0 0.0 1.4 8.2 14.0 6.3 9.2 7.6 4.8 12.7 3.7 13.2 11.4 6.0 31.4 0.0 31.2 107.6 0.5 151.1 7.6 5.3 14.8 54.1 0.0 44.4 1.7 29.9 1.3 165.7 0.0 0.0 18.6 211.3 148.2 23.5 2.3 1.3 14.7 0.0 0.0 124.0 6.0 2.2 100.9 4.8 50.6 1.0 0.0 31.7 24.2 0.0 39.3 2.2 2.2 207.0 366.0 0.5 1.0 36.4 45.9 5.0 0.0 13.3 ADGRB2 BAI2 ENSG00000121753 "Adhesion G protein-coupled receptor B2" O60241 1 31727117-31764893 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 52.0" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 18.3;Horizontal cells: 7.9;Late spermatids: 10.3;Muller glia cells: 10.1" "Cancer enhanced" "Detected in many" "glioma: 20.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 20.7;SH-SY5Y: 15.2;T-47d: 17.5;U-2 OS: 17.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069175 Supported "Plasma membrane" NA NA 49000 "Plasma membrane" "HPA069175: " "prognostic favorable (6.46e-4)" "unprognostic (1.74e-1)" "unprognostic (7.98e-2)" "unprognostic (4.34e-2)" "unprognostic (1.90e-1)" "unprognostic (2.40e-1)" "unprognostic (8.17e-4)" "prognostic unfavorable (4.02e-5)" "unprognostic (2.31e-2)" "unprognostic (1.54e-2)" "unprognostic (1.48e-2)" "unprognostic (1.65e-1)" "unprognostic (1.80e-3)" "unprognostic (1.63e-1)" "unprognostic (1.23e-1)" "unprognostic (1.75e-3)" "unprognostic (7.98e-2)" 2.2 5.4 15.9 1.3 26.8 1.1 1.4 7.9 52.0 2.4 1.4 7.3 0.0 5.2 2.4 1.2 1.6 2.2 2.1 2.8 18.9 8.0 1.4 0.9 1.3 1.3 7.4 16.5 1.8 1.4 1.3 2.7 3.8 8.4 2.4 1.1 1.3 1.4 3.1 1.1 1.5 5.0 2.4 2.9 1.8 1.8 3.2 6.3 1.5 3.2 0.0 1.1 2.0 0.5 0.4 0.0 0.0 0.0 0.0 0.9 0.3 0.6 4.4 4.2 12.0 1.2 0.7 2.0 2.8 4.5 2.8 4.9 0.2 1.3 0.0 2.8 1.2 4.6 0.4 1.8 0.2 0.4 3.1 1.9 0.0 20.7 0.0 0.1 0.0 1.6 0.7 0.3 3.8 0.0 8.8 0.4 8.8 0.4 0.1 3.1 0.4 7.9 0.1 5.2 0.1 1.3 12.1 0.4 0.4 0.0 5.7 3.2 15.2 6.5 0.4 0.5 1.5 17.5 0.0 0.1 2.1 17.0 0.3 0.7 0.0 0.0 0.4 6.7 0.0 5.1 0.0 0.0 0.0 0.9 0.0 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 15.9 26.8 7.9 37.6 18.9 8.0 7.4 16.5 8.4 6.3 0.0 0.0 0.0 0.5 0.0 18.3 4.1 0.0 0.0 0.0 0.0 5.9 0.7 0.0 0.1 2.9 0.0 0.0 0.0 0.0 1.1 0.4 0.5 0.0 0.0 0.4 7.9 1.2 0.0 0.0 10.3 1.1 0.0 0.0 0.0 0.0 10.1 0.1 0.0 1.8 1.9 4.1 0.0 0.3 0.7 4.5 0.0 0.2 0.0 0.1 0.9 ADGRG7 "FLJ14454, GPR128" ENSG00000144820 "Adhesion G protein-coupled receptor G7" Q96K78 3 100609589-100695479 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 31 "intestine: 58.4;liver: 26.9" "Cell type enhanced" "Detected in some" 25 "Collecting duct cells: 1.8;Enterocytes: 2.6;Hepatocytes: 10.4;Paneth cells: 4.0" "Cancer enhanced" "Detected in some" "stomach cancer: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BEWO: 2.9;CACO-2: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA056451 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA056451: " "unprognostic (1.65e-1)" "unprognostic (1.10e-1)" "unprognostic (2.79e-1)" "unprognostic (8.46e-3)" "unprognostic (1.26e-1)" "unprognostic (6.71e-2)" "unprognostic (9.37e-3)" "unprognostic (2.84e-5)" "unprognostic (1.17e-1)" "unprognostic (2.16e-1)" "unprognostic (6.77e-2)" 0.1 0.2 0.1 0.5 0.1 1.2 0.1 0.1 0.1 0.9 17.1 0.1 0.1 25.7 0.3 0.1 0.2 0.9 0.3 0.2 0.1 0.1 0.1 26.9 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.2 0.4 1.7 0.1 0.1 0.1 0.1 0.2 58.4 0.8 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 ADORA1 RDC7 ENSG00000163485 "Adenosine A1 receptor" P30542 1 203090654-203167405 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.7" "Group enriched" "Detected in some" 4 "granulocytes: 23.0;Muller glia cells: 40.0" "Cancer enhanced" "Detected in many" "glioma: 24.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 19.7;MCF7: 11.9;RH-30: 32.7;RPTEC TERT1: 15.9;SK-BR-3: 17.7;U-138 MG: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044383 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA044383: AB_2678921" "unprognostic (3.93e-3)" "unprognostic (8.16e-2)" "unprognostic (6.16e-2)" "unprognostic (2.38e-3)" "unprognostic (2.25e-2)" "unprognostic (2.34e-1)" "unprognostic (4.64e-2)" "unprognostic (4.17e-2)" "unprognostic (3.04e-1)" "unprognostic (4.80e-3)" "unprognostic (1.42e-1)" "unprognostic (2.98e-1)" "unprognostic (2.96e-3)" "unprognostic (1.54e-1)" "unprognostic (1.27e-1)" "unprognostic (4.13e-2)" "unprognostic (5.76e-4)" 4.5 1.0 19.7 2.6 21.7 0.8 6.1 9.7 38.7 1.1 1.6 27.4 0.0 2.0 2.0 1.6 1.6 2.0 1.8 13.8 19.8 12.1 4.2 1.0 2.8 1.4 22.8 13.4 0.8 15.5 15.5 0.9 8.9 25.0 1.2 1.6 1.8 8.9 1.3 2.0 1.9 1.8 1.3 20.7 7.4 1.6 16.3 15.9 0.0 3.2 0.0 1.4 3.4 0.3 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.1 1.4 0.3 0.1 0.1 0.8 0.1 1.0 1.5 0.4 0.2 19.7 0.3 0.0 4.5 3.6 2.4 0.0 0.3 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.3 0.0 0.0 0.4 0.0 0.4 0.0 3.2 0.0 3.2 0.0 0.0 3.1 11.9 0.0 0.0 5.1 0.0 0.0 0.0 32.7 1.0 15.9 0.0 0.3 0.4 2.1 17.7 0.2 1.9 1.0 0.4 0.0 10.6 5.4 0.0 5.7 0.0 0.1 0.0 5.3 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 19.7 21.7 9.7 25.7 19.8 12.1 22.8 13.4 25.0 15.9 0.0 0.0 0.0 0.0 0.0 0.5 2.5 5.1 0.0 0.0 3.5 0.0 0.0 0.0 7.2 0.1 0.0 0.0 0.0 3.0 1.0 0.7 0.0 23.0 0.0 0.9 0.0 0.0 0.0 1.3 0.0 0.0 0.4 1.7 0.0 0.0 40.0 0.5 0.0 0.7 1.0 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 ADRA1B ENSG00000170214 "Adrenoceptor alpha 1B" P35368 5 159865080-159972544 "Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.6;liver: 20.3;lymphoid tissue: 17.4" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 13.2;HaCaT: 6.7;TIME: 11.1;U-2 OS: 9.3;U-251 MG: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074416 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA074416: AB_2686688" "unprognostic (4.93e-3)" "unprognostic (2.94e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (6.00e-5)" "prognostic unfavorable (6.98e-4)" "unprognostic (4.08e-3)" "unprognostic (1.67e-3)" "unprognostic (1.68e-1)" "unprognostic (6.12e-2)" "prognostic favorable (2.67e-4)" "unprognostic (2.28e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (1.40e-6)" "unprognostic (5.24e-4)" "unprognostic (2.54e-1)" "prognostic favorable (3.19e-5)" "unprognostic (1.59e-2)" 5.3 2.9 5.3 0.9 9.0 0.4 2.3 1.3 21.6 0.9 1.2 0.7 0.8 1.2 1.5 3.6 1.1 3.6 1.3 3.3 6.2 5.8 7.4 20.3 4.7 2.3 1.2 13.9 6.2 0.8 1.0 0.8 1.1 5.2 1.6 1.1 0.9 1.0 1.9 1.6 1.3 1.7 1.2 0.9 17.4 0.9 0.8 0.5 0.0 2.0 0.0 1.1 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.7 0.3 0.0 2.4 0.9 0.1 0.5 0.2 0.6 0.3 0.0 4.3 0.0 13.2 3.9 5.2 6.7 0.0 0.6 0.3 0.0 0.3 0.0 1.7 0.0 5.1 0.0 0.0 2.8 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.7 0.0 4.5 0.0 0.4 0.0 0.0 0.3 0.4 2.3 0.1 0.0 11.1 0.1 9.3 0.0 7.1 0.0 0.0 0.0 3.4 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 9.0 1.3 21.6 6.2 5.8 1.2 13.9 5.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL355315.1 ENSG00000249967 10 97584374-97673910 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 22.2;liver: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Lineage enhanced" "Detected in single" "NK-cells: 1.0" "Cell line enhanced" "Detected in some" "AN3-CA: 3.2;EFO-21: 3.4;GAMG: 2.8;HBEC3-KT: 2.6;hTERT-RPE1: 5.1" HPA076857 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA076857: AB_2686817" 2.4 1.1 1.9 0.3 2.3 0.3 1.0 4.6 3.3 1.9 0.9 5.5 0.6 0.3 1.1 2.5 0.8 2.7 2.3 4.9 2.6 1.0 22.2 15.1 0.8 0.3 6.4 3.3 0.8 2.4 5.7 0.9 0.6 4.8 0.8 0.3 2.1 0.8 3.9 2.2 0.9 0.8 0.8 5.5 0.9 0.9 0.9 4.6 0.0 0.8 2.5 0.4 1.0 0.9 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.5 3.2 0.0 1.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 3.4 0.5 2.8 1.7 0.0 2.6 1.8 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.0 0.0 0.6 0.0 1.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.9 2.3 4.6 2.3 2.6 1.0 6.4 3.3 4.8 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALK CD246 ENSG00000171094 "ALK receptor tyrosine kinase" Q9UM73 2 29192774-29921566 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.1;pituitary gland: 17.9" "Group enriched" "Detected in some" 12 "Early spermatids: 36.6;Late spermatids: 30.9" "Group enriched" "Detected in some" 5 "glioma: 1.0;melanoma: 1.5;ovarian cancer: 0.7;thyroid cancer: 1.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 27.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010694 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA010694: AB_1078133" "unprognostic (4.96e-2)" "unprognostic (1.11e-2)" "unprognostic (1.45e-1)" "unprognostic (4.56e-7)" "unprognostic (7.17e-2)" "unprognostic (1.71e-1)" "unprognostic (9.07e-3)" "unprognostic (6.29e-3)" "unprognostic (1.18e-1)" "unprognostic (1.01e-1)" "unprognostic (2.67e-4)" "unprognostic (3.70e-2)" "unprognostic (2.06e-2)" "unprognostic (7.15e-2)" "unprognostic (1.98e-1)" "unprognostic (1.38e-1)" "unprognostic (3.61e-2)" 1.8 3.1 3.6 1.2 4.4 0.3 1.1 0.5 8.1 0.7 2.1 2.0 0.0 0.7 0.5 0.5 0.6 0.5 1.2 0.4 3.4 4.9 0.4 0.5 1.1 0.5 2.7 4.2 0.6 0.4 0.4 17.9 0.5 5.5 0.5 1.2 2.4 0.9 0.8 0.3 0.9 1.5 0.9 2.1 0.5 0.8 4.9 0.9 0.0 1.6 0.0 0.3 0.6 1.2 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 3.6 0.0 0.0 0.1 0.3 27.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 3.2 0.0 4.1 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 4.4 0.5 5.9 3.4 4.9 2.7 4.2 5.5 0.9 0.0 0.0 0.0 0.0 0.0 1.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 30.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 ALPI ENSG00000163295 "Alkaline phosphatase, intestinal" P09923 2 232456123-232460032 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 406 "intestine: 133.2" "Group enriched" "Detected in some" 6 "Enterocytes: 45.5;Paneth cells: 17.5" "Cancer enhanced" "Detected in many" "liver cancer: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "CACO-2: 12.7" "HPA038764, HPA038765, HPA051699" Supported Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577" "unprognostic (1.01e-1)" "unprognostic (7.71e-2)" "unprognostic (4.14e-2)" "unprognostic (1.47e-1)" "unprognostic (9.57e-4)" "unprognostic (8.07e-2)" "unprognostic (1.71e-1)" "unprognostic (9.99e-2)" 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 63.0 0.0 0.0 57.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 1.3 0.0 0.1 0.0 0.1 0.1 133.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 17.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 ALPP ENSG00000163283 "Alkaline phosphatase, placental" P05187 2 232378534-232382889 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "placenta: 240.2" "Group enriched" "Detected in some" 19 "Alveolar cells type 1: 11.9;Club cells: 3.4;Syncytiotrophoblasts: 5.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 15.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HaCaT: 88.1;SiHa: 24.3" "CAB026327, HPA038764, HPA038765, HPA051699" Enhanced Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "CAB026327: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577" "unprognostic (4.86e-2)" "unprognostic (5.19e-3)" "unprognostic (6.67e-3)" "unprognostic (2.60e-1)" "unprognostic (2.44e-3)" "unprognostic (1.26e-2)" "prognostic unfavorable (4.33e-4)" "unprognostic (1.44e-1)" "unprognostic (4.09e-1)" "unprognostic (2.12e-1)" "unprognostic (1.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 240.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.5 1.6 0.5 1.1 0.5 0.3 0.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 9.9 0.0 0.0 0.0 0.0 88.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 24.3 8.6 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.7 0.5 0.2 0.5 0.3 0.3 0.3 0.1 1.0 0.4 0.4 1.6 1.1 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 5.6 0.0 0.0 0.0 ALPPL2 ENSG00000163286 "Alkaline phosphatase, placental like 2" P10696 2 232406843-232410714 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 4.2;lung: 9.4" "Cell type enhanced" "Detected in some" 28 "Alveolar cells type 1: 6.0;Ciliated cells: 1.4;Club cells: 2.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 49.1;testis cancer: 64.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 21.4;HaCaT: 15.7;SuSa: 25.7" "CAB020698, HPA038764, HPA038765, HPA051699" Approved Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "CAB020698: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577" "unprognostic (1.39e-1)" "unprognostic (6.63e-3)" "unprognostic (1.27e-2)" "unprognostic (2.89e-1)" "unprognostic (1.46e-1)" "unprognostic (1.26e-1)" "unprognostic (1.69e-3)" "unprognostic (1.65e-1)" "unprognostic (2.67e-1)" "unprognostic (6.72e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.0 0.0 0.0 0.2 1.5 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.4 21.4 0.0 0.0 0.0 0.0 15.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 AMER2 "FAM123A, FLJ25477" ENSG00000165566 "APC membrane recruitment protein 2" Q8N7J2 13 25161684-25172288 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 26 "brain: 57.0" "Cell type enhanced" "Detected in some" 24 "Bipolar cells: 86.8;Cone photoreceptor cells: 76.6;Horizontal cells: 144.6;Muller glia cells: 354.7;Rod photoreceptor cells: 96.7" "Cancer enriched" "Detected in single" 24 "glioma: 4.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "AF22: 5.9;SCLC-21H: 5.0;SuSa: 4.3;U-266/70: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039458 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA039458: AB_10795677" "unprognostic (1.69e-2)" "unprognostic (4.13e-2)" "unprognostic (7.43e-3)" "unprognostic (2.32e-1)" "unprognostic (3.00e-3)" "unprognostic (5.00e-3)" "unprognostic (7.28e-2)" "unprognostic (2.34e-2)" "unprognostic (5.90e-4)" "unprognostic (1.60e-2)" "unprognostic (1.20e-2)" "unprognostic (1.52e-1)" "unprognostic (1.13e-1)" "unprognostic (1.34e-1)" 1.2 1.4 15.5 1.2 33.5 1.2 1.2 11.7 57.0 1.2 1.2 24.7 0.0 1.2 1.2 1.2 1.2 2.2 1.2 1.2 19.9 9.7 1.2 1.2 1.2 1.2 41.9 9.2 1.2 1.2 1.1 1.6 1.2 15.8 1.4 1.2 0.0 1.2 1.5 1.4 1.3 1.2 1.2 15.9 1.2 1.2 2.0 47.8 0.0 1.2 0.0 1.2 1.2 0.0 0.4 0.4 1.1 0.4 0.7 0.3 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.0 0.0 4.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.4 0.0 0.2 0.0 0.1 1.1 0.3 0.2 0.2 0.3 0.3 0.3 0.2 0.2 0.1 0.4 0.3 0.3 0.9 0.7 0.4 0.4 0.3 0.0 15.5 33.5 11.7 20.9 19.9 9.7 41.9 9.2 15.8 47.8 0.0 0.0 0.0 0.0 0.1 86.8 0.8 0.0 0.0 0.0 0.0 76.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 144.6 0.0 0.0 0.0 1.0 0.0 0.0 1.7 0.0 0.0 354.7 0.0 0.0 0.0 0.0 96.7 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.1 ANK2 LQT4 ENSG00000145362 "Ankyrin 2" Q01484 4 112818109-113383740 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport" "Disease mutation, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.5;heart muscle: 56.7;kidney: 59.8;skeletal muscle: 66.9" "Cell type enhanced" "Detected in many" 21 "Bipolar cells: 313.8;Cone photoreceptor cells: 451.6;Horizontal cells: 1352.3;Rod photoreceptor cells: 483.8" "Cancer enhanced" "Detected in many" "glioma: 10.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 16.5;ASC TERT1: 22.9;RH-30: 31.5;SH-SY5Y: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008007, CAB015178, HPA035970" Enhanced Approved Supported "Plasma membrane" NA NA "Plasma membrane" "CAB015178: AB_2242828, HPA008007: AB_2667965, HPA035970: AB_2674893" "unprognostic (8.33e-2)" "unprognostic (9.47e-2)" "unprognostic (1.33e-2)" "unprognostic (7.63e-2)" "unprognostic (2.73e-1)" "unprognostic (1.71e-1)" "unprognostic (1.54e-1)" "unprognostic (2.15e-2)" "unprognostic (1.23e-1)" "unprognostic (1.63e-1)" "unprognostic (1.79e-3)" "unprognostic (2.94e-2)" "prognostic unfavorable (2.41e-6)" "unprognostic (1.18e-2)" "unprognostic (3.16e-1)" "unprognostic (1.51e-3)" "unprognostic (2.04e-3)" 17.3 8.7 34.0 6.3 42.1 0.8 10.7 43.7 58.5 20.9 9.5 24.5 0.6 4.3 10.5 4.3 8.3 5.8 13.0 56.7 29.4 30.3 59.8 2.0 4.6 5.1 28.7 38.7 19.0 2.4 1.6 8.6 2.0 42.1 5.4 7.2 7.8 2.6 8.7 66.9 3.5 4.7 15.2 19.0 15.1 3.8 5.8 24.2 0.0 5.6 4.4 4.5 4.5 4.8 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 10.4 4.2 16.5 22.9 0.0 1.1 1.9 0.7 2.1 4.1 0.0 4.3 1.4 3.7 2.5 0.0 7.6 0.4 0.6 1.9 6.3 2.5 0.0 1.7 1.0 1.0 0.7 9.8 1.7 0.9 4.0 2.7 0.0 0.2 0.0 7.0 3.5 0.1 0.2 0.0 5.4 0.0 1.8 0.5 31.5 0.0 0.1 0.0 8.4 15.8 0.1 0.3 5.4 7.4 0.1 0.6 0.0 3.2 1.8 0.2 1.9 4.2 1.2 0.6 12.9 0.4 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.0 42.1 43.7 54.3 29.4 30.3 28.7 38.7 42.1 24.2 0.0 3.8 0.0 0.0 9.3 313.8 152.3 0.0 1.4 2.3 19.2 451.6 0.1 13.3 0.0 92.0 11.6 0.0 0.0 1.5 0.1 44.2 0.4 1.1 0.4 0.8 1352.3 63.4 0.0 0.0 26.4 33.6 1.0 16.9 1.0 0.0 40.0 0.1 0.0 28.3 129.2 483.8 6.5 20.5 1.1 1.5 8.3 0.0 0.0 0.1 0.1 ANK3 ENSG00000151150 "Ankyrin 3" Q12955 10 60026298-60733490 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Autism spectrum disorder, Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 95.4;parathyroid gland: 74.4" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 464.8;Cone photoreceptor cells: 212.1;Rod photoreceptor cells: 219.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 24.0;SK-BR-3: 24.1" "CAB013249, CAB015179, HPA038455" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB013249: AB_2533145, CAB015179: AB_633909, HPA038455: AB_2676020" "unprognostic (1.91e-1)" "unprognostic (5.33e-3)" "unprognostic (6.76e-3)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" "unprognostic (3.70e-3)" "unprognostic (3.47e-1)" "unprognostic (1.62e-1)" "unprognostic (1.89e-1)" "unprognostic (1.21e-2)" "unprognostic (3.83e-1)" "unprognostic (2.28e-2)" "prognostic favorable (8.88e-16)" "unprognostic (5.75e-2)" "unprognostic (2.59e-1)" "unprognostic (1.00e-1)" "unprognostic (2.83e-2)" 2.7 3.1 21.1 3.1 24.8 1.1 9.1 95.4 29.1 5.5 10.5 21.5 19.4 15.7 9.7 52.9 7.1 8.2 8.9 31.2 24.4 16.4 38.9 6.6 10.1 2.5 26.8 19.8 5.2 5.0 74.4 10.5 31.9 31.9 8.6 8.8 6.5 16.1 19.4 29.2 16.0 10.6 5.9 16.5 5.9 6.3 3.4 30.0 0.6 17.2 4.6 3.4 5.6 6.6 6.2 3.5 1.7 0.4 2.1 7.7 1.3 4.1 2.3 14.8 0.2 0.0 0.9 11.4 0.3 0.2 0.0 0.2 10.6 8.0 0.2 4.8 0.3 0.4 5.8 7.9 7.1 0.2 0.2 5.3 0.1 4.5 0.0 3.1 0.0 0.2 7.3 4.6 3.8 0.2 12.9 1.7 0.0 2.0 10.0 3.3 13.6 0.0 0.4 6.7 11.0 12.8 0.0 10.6 2.0 2.6 24.0 7.7 1.4 0.3 24.1 0.0 17.3 14.0 0.0 4.8 0.4 1.5 6.5 0.7 0.4 0.0 0.0 2.7 0.1 9.1 1.7 0.4 0.6 4.1 0.3 3.7 6.2 7.0 2.2 0.2 1.9 7.7 1.9 1.1 2.1 0.4 3.5 1.0 1.3 21.1 24.8 95.4 29.1 24.4 16.4 26.8 19.8 31.9 30.0 41.7 132.9 8.9 17.9 16.9 464.8 156.4 15.3 72.3 58.0 50.6 212.1 34.4 16.6 7.2 18.5 2.1 50.2 0.0 7.4 8.8 4.0 13.1 11.6 0.8 3.9 41.3 29.4 12.9 3.2 8.5 25.9 2.9 8.5 7.2 10.6 35.7 5.0 39.0 5.3 48.8 219.9 0.0 0.4 1.1 0.6 15.8 20.9 5.3 16.0 19.2 ANKRD13A "ANKRD13, NY-REN-25" ENSG00000076513 "Ankyrin repeat domain 13A" Q8IZ07 12 109999186-110039763 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 116.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "fHDF/TERT166: 49.6;HBF TERT88: 50.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039488, HPA043218" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA039488: AB_10673612, HPA043218: AB_2678367" "unprognostic (1.54e-1)" "unprognostic (3.94e-3)" "unprognostic (5.81e-1)" "unprognostic (1.62e-2)" "unprognostic (1.05e-1)" "prognostic favorable (7.70e-6)" "unprognostic (5.68e-2)" "unprognostic (1.31e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (6.77e-4)" "unprognostic (9.71e-3)" "unprognostic (1.67e-1)" "unprognostic (2.67e-2)" "unprognostic (2.57e-1)" "unprognostic (2.13e-2)" "unprognostic (1.08e-1)" "unprognostic (5.29e-2)" 11.1 12.3 7.0 19.8 12.6 18.3 10.2 6.8 12.8 10.6 13.8 23.3 8.6 7.9 12.0 6.9 19.9 9.8 13.1 9.1 9.2 6.4 12.8 14.0 15.1 28.7 13.1 8.3 11.1 10.6 6.5 5.3 39.4 9.5 12.6 13.0 17.1 21.7 15.1 6.2 21.1 16.8 31.0 12.3 24.2 12.7 45.8 13.8 13.3 19.1 8.0 36.5 21.5 13.0 3.9 2.5 8.9 4.2 1.4 2.9 1.3 38.1 1.7 4.2 3.8 6.5 6.4 5.1 38.4 36.8 37.2 19.9 5.1 2.5 25.4 3.0 49.6 4.7 4.6 5.3 5.8 50.2 28.4 4.3 9.4 3.9 4.2 5.7 10.9 11.3 5.6 6.2 15.8 9.2 9.4 5.6 6.2 7.2 4.2 16.5 1.3 9.6 4.8 2.2 2.8 7.9 8.3 11.7 10.1 5.4 5.0 8.7 4.1 7.1 14.2 4.9 3.0 6.4 9.3 7.0 27.9 4.9 15.3 20.6 9.0 5.3 34.0 13.7 7.7 4.0 2.6 1.9 8.9 0.9 4.2 2.9 3.9 2.4 1.1 2.5 1.9 1.4 1.8 6.0 1.4 2.0 1.9 1.0 1.3 7.0 12.6 6.8 12.8 9.2 6.4 13.1 8.3 9.5 13.8 44.7 33.3 22.3 16.2 26.1 20.0 11.7 25.5 25.4 31.8 54.1 13.7 13.2 18.3 25.5 73.7 14.6 14.0 0.0 15.1 17.2 15.3 13.6 12.7 14.9 13.2 23.8 18.0 15.4 34.8 116.0 10.9 19.7 13.5 19.8 10.0 10.5 21.6 8.6 20.5 6.8 13.3 32.3 15.0 43.4 13.5 33.1 31.5 17.8 14.4 20.1 ANPEP "CD13, gp150, LAP1, p150, PEPN" ENSG00000166825 "Alanyl aminopeptidase, membrane" P15144 15 89784889-89815401 "CD markers, Enzymes, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Differentiation, Host-virus interaction" "Aminopeptidase, Developmental protein, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 195.3;kidney: 78.7;pancreas: 93.9" "Cell type enhanced" "Detected in many" 16 "Cholangiocytes: 372.0;Enterocytes: 993.7;Exocrine glandular cells: 328.5;Proximal tubular cells: 388.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in many" 5 "neutrophil: 59.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 59.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 78.5;BJ: 78.2;BJ hTERT+: 111.8;fHDF/TERT166: 67.0;HMC-1: 71.1;HSkMC: 68.7;HUVEC TERT2: 87.5;TIME: 87.4;U-2197: 95.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB002417, HPA004625" Enhanced Supported "Plasma membrane" NA NA 1500000000 "Plasma membrane" "CAB002417: AB_563491, HPA004625: AB_2667199" "unprognostic (6.31e-2)" "unprognostic (7.94e-3)" "unprognostic (6.91e-2)" "unprognostic (2.16e-1)" "unprognostic (2.50e-1)" "unprognostic (1.13e-1)" "unprognostic (2.23e-2)" "unprognostic (1.89e-1)" "unprognostic (2.50e-1)" "unprognostic (7.73e-2)" "unprognostic (5.28e-3)" "unprognostic (3.96e-1)" "unprognostic (4.04e-3)" "unprognostic (3.20e-2)" "unprognostic (2.01e-2)" "unprognostic (4.61e-3)" "unprognostic (1.99e-2)" 21.3 1.1 0.6 2.9 0.8 9.5 17.0 1.0 1.3 8.2 21.2 0.8 0.5 195.3 1.4 8.4 3.6 1.4 27.7 3.7 0.4 0.3 78.7 37.7 9.7 9.3 0.9 0.9 1.8 93.9 0.0 0.7 14.7 1.3 8.6 4.7 4.0 6.6 1.8 1.6 4.9 155.8 4.3 1.2 7.2 0.8 4.7 0.2 5.6 1.5 4.2 3.8 4.7 3.0 0.0 6.9 59.4 12.8 0.0 0.0 5.5 0.0 5.0 0.0 0.0 61.3 78.5 0.5 78.2 111.8 9.6 8.5 0.5 0.0 0.0 0.9 67.0 0.0 0.0 0.6 0.0 3.8 0.0 0.0 14.7 0.4 11.7 36.1 1.0 71.1 68.7 0.1 30.2 0.0 0.4 87.5 0.0 0.4 0.1 3.7 0.0 0.0 34.7 0.2 0.0 5.3 0.0 0.0 0.8 43.7 0.0 0.1 0.7 0.0 0.1 0.0 0.1 0.0 6.8 87.4 42.2 0.0 95.3 0.0 0.0 0.0 0.0 0.1 0.0 2.2 5.7 12.8 10.4 0.0 7.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 59.4 0.0 12.0 0.1 0.0 5.5 0.6 0.8 1.0 1.3 0.4 0.3 0.9 0.9 1.3 0.2 0.0 4.8 8.2 3.1 8.9 0.0 0.8 372.0 2.7 20.5 19.2 0.0 9.7 36.5 10.6 0.1 1.8 993.7 0.0 328.5 12.0 36.3 18.0 24.2 144.7 39.4 0.0 2.9 101.9 51.7 0.0 2.6 46.4 3.3 39.7 10.5 0.0 120.5 201.5 1.4 388.5 0.0 25.8 5.0 0.4 0.1 5.1 5.4 1.0 18.3 1.3 ANXA3 ANX3 ENSG00000138772 "Annexin A3" P12429 4 78551519-78610451 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Phospholipase A2 inhibitor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 83.0" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 547.9;Ductal cells: 468.5;Exocrine glandular cells: 274.5;Pancreatic endocrine cells: 473.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 319 "neutrophil: 51.3" "Lineage enriched" "Detected in single" 319 "granulocytes: 51.3" "Cell line enhanced" "Detected in many" "A-431: 51.5;CACO-2: 52.8;CAPAN-2: 71.5;EFO-21: 43.8;hTERT-HME1: 72.9;OE19: 61.8;RPTEC TERT1: 61.4" "Low region specificity" "Detected in all" "HPA013398, HPA013431" Enhanced Enhanced "Plasma membrane" NA NA 7400000 "Plasma membrane" "HPA013398: AB_1844861, HPA013431: AB_1844862" "unprognostic (2.66e-1)" "unprognostic (5.65e-3)" "unprognostic (4.92e-3)" "unprognostic (8.67e-2)" "unprognostic (2.41e-1)" "unprognostic (5.02e-3)" "unprognostic (4.17e-2)" "unprognostic (1.87e-1)" "unprognostic (5.09e-2)" "unprognostic (2.10e-3)" "prognostic unfavorable (1.28e-4)" "unprognostic (4.82e-2)" "prognostic favorable (8.48e-6)" "unprognostic (2.23e-1)" "unprognostic (2.02e-2)" "unprognostic (7.20e-2)" "unprognostic (3.30e-2)" 20.3 1.1 4.0 7.1 7.4 83.0 16.2 2.4 6.8 7.0 8.5 2.3 0.9 4.2 3.4 4.2 25.0 4.6 11.7 20.5 5.2 5.2 19.8 1.6 46.0 5.7 6.6 5.6 2.8 14.7 6.5 5.8 33.7 10.4 18.8 7.4 2.6 50.8 3.6 14.2 4.1 9.3 5.3 4.0 11.0 23.4 1.8 5.0 2.0 45.3 13.6 7.4 2.8 5.9 0.1 0.0 51.3 0.1 0.0 0.0 0.5 51.5 9.8 0.1 0.1 0.1 0.2 0.0 0.6 0.0 1.5 1.4 52.8 71.5 0.0 43.8 1.8 0.0 20.4 0.0 37.7 2.3 0.2 0.4 4.6 21.1 3.1 6.1 0.6 0.0 0.3 33.4 0.5 72.9 7.6 14.9 1.2 0.1 0.0 0.2 2.0 0.2 0.0 1.6 61.8 7.2 0.0 0.1 0.0 61.4 5.9 0.0 0.0 30.4 7.5 2.1 25.3 1.3 0.6 18.9 0.1 6.8 0.0 11.6 0.4 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 51.3 0.0 0.1 0.0 0.0 0.5 4.0 7.4 2.4 6.8 5.2 5.2 6.6 5.6 10.4 5.0 547.9 38.9 0.0 51.1 22.0 0.0 6.4 58.6 36.1 144.5 36.6 0.0 172.1 14.9 468.5 0.9 32.1 19.7 0.0 274.5 87.0 24.3 117.9 4.7 0.4 16.1 0.0 5.2 20.3 0.0 0.0 2.8 1.7 5.0 36.1 30.9 0.8 473.1 58.5 0.4 1.1 0.3 0.0 9.5 1.2 0.7 5.8 52.5 0.5 28.7 32.0 AP2M1 "AP50, CLAPM1, mu2" ENSG00000161203 "Adaptor related protein complex 2 mu 1 subunit" Q96CW1 3 184174689-184184091 "Plasma proteins, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036849, HPA069870" Uncertain Supported "Plasma membrane" NA NA 340000 "Plasma membrane" "HPA036849: AB_10672101, HPA069870: AB_2686217" "unprognostic (1.16e-1)" "unprognostic (1.35e-2)" "unprognostic (5.28e-3)" "unprognostic (4.96e-3)" "unprognostic (1.79e-1)" "unprognostic (2.88e-2)" "prognostic unfavorable (9.12e-4)" "unprognostic (3.80e-3)" "unprognostic (2.09e-1)" "unprognostic (5.53e-2)" "unprognostic (4.11e-2)" "unprognostic (9.18e-2)" "prognostic unfavorable (7.45e-6)" "unprognostic (2.61e-2)" "unprognostic (4.09e-2)" "unprognostic (1.60e-2)" "unprognostic (1.28e-1)" 37.6 78.2 58.6 38.3 78.2 47.7 32.5 64.2 111.9 52.4 42.7 33.5 35.4 40.7 46.7 27.0 54.9 39.1 41.2 86.8 62.5 64.6 39.7 36.8 35.8 35.2 57.5 83.0 49.8 26.0 53.6 48.2 59.0 79.8 40.0 35.6 44.4 40.2 61.3 33.9 38.1 36.1 60.3 41.5 34.1 32.9 27.8 32.1 30.5 35.3 34.5 37.1 49.5 38.8 26.4 59.3 51.4 62.6 34.9 39.5 77.6 48.6 37.4 32.2 36.2 51.8 54.5 33.3 82.0 47.8 92.7 65.3 40.2 35.7 22.3 100.3 122.6 60.8 55.3 43.5 55.4 76.9 45.8 54.3 57.6 43.0 35.6 61.2 28.3 36.7 69.2 31.5 58.7 37.7 84.0 68.9 29.8 27.6 43.9 86.8 111.4 36.4 16.8 78.5 43.8 56.2 33.9 41.2 44.2 57.5 44.4 34.3 25.0 64.4 81.1 38.1 52.6 108.6 34.6 73.8 58.9 47.8 57.5 108.0 39.6 34.6 49.9 111.0 41.8 38.3 37.5 62.6 51.4 32.5 52.7 32.0 26.4 30.3 31.1 59.3 25.5 26.1 26.7 28.5 34.9 42.2 29.7 39.5 77.6 58.6 78.2 64.2 111.9 62.5 64.6 57.5 83.0 79.8 32.1 50.6 49.0 96.0 145.4 110.9 179.9 166.5 81.5 20.1 39.8 108.2 66.8 350.0 318.3 216.7 238.9 157.2 189.4 116.8 141.3 275.4 160.1 132.3 147.6 66.5 475.3 262.2 135.2 174.3 117.8 263.1 152.5 165.2 189.0 547.4 101.7 147.8 177.5 138.2 201.9 236.1 93.7 194.1 212.7 73.4 100.5 110.7 429.5 123.6 136.9 178.1 APBB1 "Fe65, RIR" ENSG00000166313 "Amyloid beta precursor protein binding family B member 1" O00213 11 6395124-6419414 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, DNA damage, Transcription, Transcription regulation" "Activator, Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 84.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 34.4" "Lineage enriched" "Detected in many" 5 "T-cells: 34.4" "Cell line enhanced" "Detected in many" "SCLC-21H: 28.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038521, HPA038522" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA038521: AB_2676058, HPA038522: AB_2676059" "unprognostic (4.76e-2)" "unprognostic (1.98e-1)" "unprognostic (4.46e-3)" "unprognostic (1.97e-2)" "unprognostic (6.84e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.44e-4)" "unprognostic (7.30e-2)" "unprognostic (3.22e-3)" "unprognostic (2.36e-1)" "prognostic favorable (1.86e-5)" "unprognostic (2.21e-1)" "prognostic favorable (7.44e-13)" "unprognostic (1.32e-2)" "unprognostic (2.71e-2)" "unprognostic (1.91e-1)" "unprognostic (1.09e-2)" 7.9 14.0 26.0 6.9 26.0 1.9 5.5 54.3 84.6 11.5 9.6 31.1 3.7 4.5 15.7 3.2 9.2 19.7 7.0 21.8 29.5 23.9 9.2 2.3 9.4 7.5 27.0 30.7 21.3 9.5 14.8 15.7 5.4 25.8 10.9 3.3 5.5 8.0 16.5 21.5 4.6 5.2 19.5 36.4 5.9 5.7 7.2 24.7 6.0 7.7 2.5 6.6 7.7 5.8 6.3 0.6 3.0 0.6 5.5 34.4 11.3 0.0 5.9 20.7 9.2 11.2 11.6 0.0 9.7 16.9 16.9 21.3 10.7 4.1 0.0 1.5 17.7 15.2 0.2 18.0 3.0 8.1 10.8 13.6 0.1 3.8 0.3 8.1 0.0 4.1 10.4 0.7 7.9 1.2 14.5 20.9 0.5 0.4 0.3 6.2 0.2 0.2 0.0 7.4 0.3 6.4 0.1 0.8 0.0 0.7 0.0 28.5 16.1 1.4 1.2 6.4 6.6 0.8 1.3 9.2 1.7 10.5 11.2 2.0 5.6 2.6 0.8 8.7 0.0 5.8 3.0 0.6 0.1 9.1 0.5 9.8 2.6 12.7 11.7 0.6 6.3 34.4 20.0 0.5 5.5 0.2 0.1 17.0 11.3 26.0 26.0 54.3 49.3 29.5 23.9 27.0 30.7 25.8 24.7 17.9 4.8 3.2 10.7 4.4 36.4 40.0 10.2 26.8 9.1 5.2 21.6 0.4 21.6 14.5 4.3 13.7 0.5 0.0 3.6 0.6 12.5 8.9 1.1 3.0 1.1 38.1 18.6 19.0 2.8 9.2 8.9 0.8 8.5 3.6 0.7 23.8 7.3 1.1 18.0 19.2 16.8 6.5 18.7 4.2 6.6 2.5 0.7 21.7 0.8 4.4 APMAP "BSCv, C20orf3" ENSG00000101474 "Adipocyte plasma membrane associated protein" Q9HDC9 20 24962925-24992979 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 93.8;liver: 100.5" "Cell type enhanced" "Detected in all" 11 "Cytotrophoblasts: 255.8;Hepatocytes: 247.3;Syncytiotrophoblasts: 628.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "granulocytes: 93.8;NK-cells: 43.2;T-cells: 53.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012863, HPA064700" Uncertain Approved "Plasma membrane" NA NA 80000000 "Plasma membrane" "HPA012863: AB_1845683, HPA064700: AB_2685328" "unprognostic (4.07e-3)" "unprognostic (2.50e-2)" "unprognostic (1.20e-1)" "unprognostic (8.16e-2)" "unprognostic (6.79e-2)" "unprognostic (2.14e-2)" "unprognostic (1.10e-2)" "unprognostic (4.09e-2)" "unprognostic (3.10e-2)" "unprognostic (1.19e-2)" "unprognostic (6.46e-2)" "unprognostic (1.54e-1)" "unprognostic (7.99e-3)" "unprognostic (8.26e-2)" "unprognostic (1.67e-1)" "unprognostic (1.23e-1)" "unprognostic (3.51e-2)" 43.5 13.0 14.8 12.4 16.1 44.5 23.1 47.3 22.7 11.7 12.3 15.7 17.9 8.9 14.8 31.8 7.5 13.0 13.4 10.2 18.2 20.9 12.9 100.5 14.4 15.9 15.4 17.2 12.3 12.2 18.9 20.2 28.3 17.0 12.5 12.4 11.6 10.6 18.7 9.8 14.0 9.3 13.8 13.7 16.9 10.2 19.9 15.4 10.6 57.9 5.7 9.2 13.0 10.6 5.2 13.9 93.8 13.9 43.2 53.4 40.1 22.9 39.8 20.5 30.7 39.9 21.8 20.8 30.0 32.9 29.0 30.1 23.5 40.8 9.5 35.1 36.0 53.0 42.4 18.7 34.9 34.1 12.7 14.6 10.5 14.4 47.7 31.4 20.5 25.3 29.5 49.5 34.0 24.5 40.0 41.2 15.7 12.4 42.9 28.1 34.5 14.1 23.1 12.9 36.7 36.3 11.7 68.1 19.8 30.9 21.1 33.6 13.0 30.9 53.5 33.2 22.3 19.0 17.2 36.1 34.9 31.3 29.5 44.7 24.4 27.0 10.5 18.4 31.2 33.1 7.4 13.9 26.1 53.4 13.4 33.0 5.1 15.1 38.8 13.9 5.2 11.9 30.9 93.8 43.2 9.0 6.8 9.9 40.1 14.8 16.1 47.3 22.7 18.2 20.9 15.4 17.2 17.0 15.4 17.9 28.3 27.4 38.9 21.6 49.0 14.5 45.9 24.1 21.6 47.1 9.8 255.8 14.9 60.3 22.9 34.6 17.0 23.3 39.8 32.6 32.9 31.8 34.7 247.3 84.5 15.9 17.2 38.6 45.7 27.7 60.1 81.5 43.9 161.5 17.3 35.4 35.7 19.9 77.1 13.0 18.3 38.8 34.0 52.1 79.8 17.6 628.2 145.4 24.7 24.2 APOD ENSG00000189058 "Apolipoprotein D" P05090 3 195568702-195584205 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "breast: 840.7" "Group enriched" "Detected in many" 5 "Leydig cells: 1923.5;Melanocytes: 975.2;Peritubular cells: 934.8" "Cancer enhanced" "Detected in all" "melanoma: 925.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "memory B-cell: 6.7" "Lineage enriched" "Detected in single" 10 "B-cells: 6.7" "Group enriched" "Detected in some" 7 "ASC diff: 239.5;ASC TERT1: 129.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040520 Enhanced Approved "Plasma membrane" "Secreted to blood" NA NA 98900000000 220000000000 "Plasma membrane" "HPA040520: AB_2677020" "prognostic favorable (5.51e-4)" "unprognostic (7.62e-3)" "unprognostic (7.85e-3)" "unprognostic (3.34e-3)" "unprognostic (2.20e-1)" "unprognostic (1.02e-2)" "unprognostic (3.09e-2)" "unprognostic (2.06e-3)" "unprognostic (1.26e-1)" "unprognostic (3.45e-1)" "unprognostic (3.38e-1)" "unprognostic (3.19e-1)" "unprognostic (6.90e-3)" "prognostic unfavorable (6.02e-4)" "unprognostic (1.38e-1)" "prognostic unfavorable (4.12e-4)" "unprognostic (1.71e-3)" 134.4 15.2 39.7 5.7 39.9 3.4 840.7 14.7 66.1 75.0 16.4 79.7 10.9 12.9 36.6 30.0 46.1 42.9 36.4 124.7 45.5 29.2 8.5 3.5 11.8 6.5 96.9 28.2 19.4 28.3 9.0 14.3 59.6 50.9 39.7 13.1 99.1 152.5 35.1 110.4 66.0 7.2 30.4 81.6 3.6 28.7 32.0 56.5 0.0 87.7 42.2 6.6 62.1 95.7 6.7 0.1 0.4 0.6 0.0 0.1 0.1 0.0 0.1 0.0 0.0 239.5 129.1 0.3 2.0 0.5 0.0 0.0 13.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 6.5 1.4 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.4 2.0 0.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 25.9 0.4 0.1 0.0 0.1 0.1 0.0 6.7 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.1 39.7 39.9 14.7 39.5 45.5 29.2 96.9 28.2 50.9 56.5 0.0 8.3 0.0 14.6 128.8 0.0 31.1 0.0 40.2 104.6 5.2 0.0 4.1 0.0 0.2 9.1 55.0 0.0 0.0 0.0 5.0 271.0 22.1 0.0 0.0 12.4 0.0 44.5 30.1 0.3 22.5 1923.5 6.2 975.2 1.8 0.9 0.0 1.9 0.0 934.8 0.1 0.0 19.4 80.9 3.8 3.8 89.6 4.9 0.0 0.6 37.7 AQP1 "CHIP28, CO" ENSG00000240583 "Aquaporin 1 (Colton blood group)" P29972 7 30911694-30925516 "Blood group antigen proteins, Predicted membrane proteins, Transporters" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 156.5" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 218.3;Cholangiocytes: 377.0;Endothelial cells: 221.7;Proximal tubular cells: 281.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 20.9;HeLa: 7.0;SH-SY5Y: 7.8;U-2 OS: 9.8;WM-115: 37.8" "CAB001707, HPA019206" Enhanced Supported "Plasma membrane" NA NA 250000 "Plasma membrane" "CAB001707: , HPA019206: AB_1844965" "unprognostic (4.18e-2)" "unprognostic (7.82e-3)" "unprognostic (1.10e-2)" "unprognostic (1.08e-1)" "unprognostic (1.02e-1)" "prognostic favorable (6.52e-4)" "unprognostic (1.95e-3)" "unprognostic (1.66e-1)" "unprognostic (3.00e-2)" "unprognostic (3.80e-2)" "unprognostic (4.16e-1)" "unprognostic (2.05e-2)" "prognostic favorable (1.32e-8)" "unprognostic (3.43e-2)" "unprognostic (1.61e-1)" "unprognostic (2.09e-1)" "unprognostic (7.21e-2)" 68.2 8.0 9.9 8.7 17.1 9.4 51.9 10.7 13.0 46.5 18.1 62.1 7.7 10.8 28.0 20.8 58.8 29.0 36.3 46.7 18.1 15.4 156.5 4.2 103.2 9.1 36.9 17.8 16.4 49.9 12.9 4.0 9.1 63.2 32.4 10.6 8.3 19.8 22.7 35.2 24.8 18.2 41.2 56.4 2.9 18.2 15.0 17.8 1.9 21.3 33.5 12.5 36.0 76.7 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.1 0.6 0.4 1.8 0.4 1.2 0.4 0.0 0.0 0.2 0.3 0.0 20.9 1.1 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.2 7.0 0.0 0.4 0.1 0.0 3.3 0.0 0.1 0.0 0.0 2.9 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.3 0.6 0.0 0.0 5.2 0.1 0.7 0.0 0.2 7.8 1.2 0.6 0.0 3.9 0.1 0.1 0.0 0.0 9.8 0.8 0.3 0.5 0.3 0.0 0.1 0.0 37.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 9.9 17.1 10.7 13.0 18.1 15.4 36.9 17.8 63.2 17.8 166.7 218.3 2.9 1.1 81.4 1.1 57.7 377.0 6.7 6.8 29.6 7.9 1.9 24.9 35.6 1.9 221.7 4.2 0.0 2.1 3.0 91.5 1.0 1.1 1.3 3.3 0.0 7.0 154.1 1.8 1.6 1.1 9.8 84.4 2.8 18.2 0.3 2.8 19.2 3.2 281.0 0.2 12.9 92.0 0.3 1.3 68.8 6.1 0.0 71.0 1.0 AQP5 ENSG00000161798 "Aquaporin 5" P55064 12 49961870-49965681 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "salivary gland: 217.9;testis: 76.2" "Group enriched" "Detected in many" 8 "Early spermatids: 1235.0;Late spermatids: 3096.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 87.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 22 "OE19: 70.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065008 Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA065008: AB_2685401" "unprognostic (4.67e-3)" "unprognostic (5.00e-2)" "unprognostic (3.30e-1)" "unprognostic (6.00e-3)" "unprognostic (1.92e-3)" "prognostic favorable (1.75e-5)" "unprognostic (4.13e-3)" "unprognostic (1.02e-2)" "unprognostic (9.39e-2)" "unprognostic (3.70e-3)" "unprognostic (2.88e-3)" "unprognostic (2.46e-3)" "unprognostic (1.69e-4)" "unprognostic (2.53e-1)" "unprognostic (5.28e-2)" "unprognostic (2.51e-3)" "unprognostic (9.11e-3)" 0.2 0.1 0.4 0.2 1.1 0.0 3.8 0.4 0.3 3.0 0.3 0.4 0.3 3.2 0.6 0.8 3.8 0.1 15.6 1.0 0.3 0.3 0.2 0.2 2.3 0.2 0.7 0.2 0.2 0.8 0.1 0.4 0.2 0.3 0.5 0.0 0.4 217.9 0.6 0.9 23.5 0.3 0.6 0.2 0.2 12.0 76.2 0.3 0.2 0.3 2.8 11.5 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 70.7 0.0 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.4 0.3 0.3 0.3 0.7 0.2 0.3 0.3 53.6 1.9 0.0 0.4 1.1 0.5 0.3 0.0 8.1 37.5 7.0 0.0 0.0 0.0 0.0 1235.0 0.0 0.0 0.0 0.2 0.0 0.4 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3096.0 26.4 0.0 280.0 0.0 0.0 45.4 4.3 0.0 18.0 0.0 1.4 19.4 0.3 76.9 15.2 0.6 0.0 0.0 0.0 0.7 ARHGAP19 "FLJ00194, MGC14258" ENSG00000213390 "Rho GTPase activating protein 19" Q14CB8 10 97222173-97292673 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 30.4" "Cell type enhanced" "Detected in many" 4 "Ito cells: 12.3;Spermatocytes: 11.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA035777, HPA043231" Uncertain Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA035777: AB_2674777, HPA043231: AB_10796791" "unprognostic (5.88e-2)" "unprognostic (2.39e-2)" "unprognostic (2.47e-2)" "unprognostic (1.91e-2)" "unprognostic (1.68e-1)" "unprognostic (8.79e-3)" "unprognostic (1.60e-3)" "unprognostic (2.00e-2)" "unprognostic (9.89e-2)" "unprognostic (1.97e-2)" "unprognostic (6.76e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (7.47e-5)" "unprognostic (1.12e-2)" "unprognostic (1.56e-1)" "unprognostic (2.23e-2)" "unprognostic (4.29e-2)" 5.6 3.7 5.6 8.8 7.6 18.3 8.6 7.2 5.3 7.4 5.1 11.7 3.2 4.1 6.9 3.4 6.1 6.0 4.0 4.9 5.7 4.6 4.6 3.2 5.5 14.1 10.9 3.6 11.4 3.4 8.0 7.3 6.0 7.4 5.8 5.3 7.3 6.4 3.7 4.0 6.0 6.6 5.3 14.2 12.0 4.3 20.1 7.0 30.4 4.4 5.5 14.3 6.7 5.9 5.5 5.3 15.5 7.3 4.1 6.0 5.1 8.1 2.6 14.6 25.6 0.9 3.9 4.5 4.0 4.1 6.5 4.6 5.2 7.3 18.2 3.4 2.7 3.8 5.5 12.2 5.0 8.2 9.0 6.7 11.9 3.3 3.5 0.9 18.3 12.8 2.0 1.7 4.5 10.4 2.1 8.8 25.9 11.7 9.6 5.6 4.0 16.6 3.9 7.9 5.2 2.4 20.0 12.5 5.1 1.9 3.6 1.1 6.8 3.0 1.5 6.7 5.6 9.1 9.6 4.1 2.6 3.1 4.1 10.4 8.6 8.8 24.6 3.3 21.7 2.9 15.3 7.3 10.2 5.2 6.6 4.9 5.5 5.1 4.8 5.3 5.5 6.0 5.3 15.5 4.1 5.7 3.0 5.9 5.1 5.6 7.6 7.2 5.3 5.7 4.6 10.9 3.6 7.4 7.0 3.0 2.7 3.0 1.2 0.8 2.1 1.2 5.1 5.3 0.0 0.0 0.0 1.1 0.0 1.1 5.9 3.7 1.7 0.0 1.4 3.0 1.8 2.3 4.7 2.6 2.9 6.4 0.0 12.3 8.5 4.9 3.1 4.0 1.7 1.0 1.9 1.6 0.9 3.5 3.9 0.6 1.2 0.0 1.9 11.4 9.6 2.0 0.8 2.5 3.1 1.0 ARHGEF15 "ARGEF15, FLJ13791, KIAA0915, MGC44868, Vsm-RhoGEF" ENSG00000198844 "Rho guanine nucleotide exchange factor 15" O94989 17 8310241-8322516 "Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 47.3" "Group enriched" "Detected in some" 5 "Endothelial cells: 35.8;Ito cells: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 46 "HUVEC TERT2: 23.4;TIME: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA044443, HPA063495" Supported "Plasma membrane" NA NA "Plasma membrane" "HPA044443: AB_10960424, HPA063495: AB_2685023" "unprognostic (3.02e-1)" "unprognostic (2.97e-1)" "unprognostic (1.18e-2)" "unprognostic (7.09e-3)" "unprognostic (3.82e-1)" "unprognostic (7.29e-4)" "unprognostic (1.43e-2)" "unprognostic (1.84e-1)" "unprognostic (1.42e-1)" "unprognostic (3.40e-1)" "unprognostic (1.06e-2)" "unprognostic (1.45e-1)" "unprognostic (2.23e-3)" "unprognostic (4.88e-2)" "unprognostic (1.33e-1)" "unprognostic (1.89e-1)" "unprognostic (9.56e-3)" 47.3 3.6 1.5 4.6 2.6 0.3 24.7 0.9 2.8 9.6 5.7 2.0 3.3 3.1 19.9 4.9 5.0 5.9 7.5 18.5 3.8 1.4 9.7 4.2 19.4 3.0 2.2 1.5 6.8 2.8 4.2 3.0 14.1 3.1 8.7 2.1 10.7 3.4 5.1 15.0 4.9 4.1 7.0 1.7 6.9 4.4 2.7 1.1 0.6 8.7 8.4 2.9 9.4 32.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.6 0.9 2.8 3.8 1.4 2.2 1.5 3.1 1.1 0.0 4.8 0.5 0.2 2.5 0.8 6.2 5.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.1 35.8 0.0 0.0 0.0 0.1 0.6 0.3 0.0 0.0 0.1 0.0 0.0 34.4 2.4 3.0 0.0 0.0 6.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.9 0.1 0.7 0.0 0.3 ASB5 ENSG00000164122 "Ankyrin repeat and SOCS box containing 5" Q8WWX0 4 176213673-176277571 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 133.4" "Cell type enriched" "Detected in some" 5 "Late spermatids: 229.8" "Cancer enhanced" "Detected in some" "prostate cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "LHCN-M2: 165.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028870 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA028870: AB_10611679" "unprognostic (1.76e-1)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.90e-1)" "unprognostic (7.38e-2)" "unprognostic (1.32e-1)" "unprognostic (1.06e-2)" "unprognostic (4.28e-2)" "unprognostic (1.65e-1)" "unprognostic (6.80e-3)" 2.3 0.0 0.3 0.3 0.2 0.0 0.0 0.2 0.2 0.3 3.5 0.0 0.0 0.1 0.2 6.3 7.9 0.0 0.4 1.3 0.2 0.2 0.3 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 9.6 1.3 0.0 8.0 0.1 133.4 0.0 0.5 23.5 1.0 0.0 2.0 2.2 0.0 0.0 2.3 31.4 2.2 15.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.0 0.0 3.6 7.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 165.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 229.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.0 0.0 ATP1B3 "CD298, FLJ29027" ENSG00000069849 "ATPase Na+/K+ transporting subunit beta 3" P54709 3 141876124-141926514 "CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 712.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020697, HPA048963" Enhanced Supported "Plasma membrane" NA NA 100000 "Plasma membrane" "CAB020697: , HPA048963: AB_2680574" "unprognostic (2.31e-1)" "unprognostic (1.11e-3)" "unprognostic (2.75e-1)" "prognostic favorable (5.19e-5)" "unprognostic (2.60e-2)" "unprognostic (3.31e-2)" "prognostic unfavorable (6.32e-6)" "unprognostic (8.11e-3)" "unprognostic (6.99e-2)" "unprognostic (5.37e-3)" "unprognostic (1.48e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.29e-5)" "unprognostic (5.14e-2)" "unprognostic (2.04e-1)" "unprognostic (7.19e-3)" "unprognostic (6.15e-2)" 50.5 79.9 12.7 26.3 23.3 17.5 105.9 25.7 35.1 17.7 48.2 9.1 16.8 37.3 17.9 14.6 36.9 20.0 47.8 44.0 16.0 18.9 24.9 7.7 44.9 43.4 21.3 12.8 34.7 11.5 6.3 33.8 32.6 43.3 20.5 58.1 23.9 18.4 24.8 7.4 85.4 57.3 24.3 28.4 16.5 13.5 21.1 13.6 14.5 15.6 41.4 18.4 21.9 31.5 10.4 26.8 13.6 60.9 7.8 20.0 22.5 46.4 28.9 27.2 25.5 73.0 21.3 62.3 54.5 49.6 39.7 45.0 44.9 23.4 37.9 49.3 41.4 57.5 102.0 26.9 26.0 45.2 20.6 34.2 33.1 32.5 29.1 28.9 27.2 26.0 22.5 62.3 31.1 30.1 28.4 42.3 26.6 22.7 33.7 40.6 21.1 27.6 45.6 37.8 64.7 13.9 38.0 20.4 38.6 33.3 35.9 22.4 15.3 71.2 33.1 73.1 49.4 25.2 33.2 29.4 34.9 13.4 52.1 31.7 25.1 32.3 61.1 45.5 29.6 28.6 13.6 27.1 8.9 19.2 44.5 14.1 10.4 15.6 20.0 26.8 7.5 9.2 16.7 1.9 7.8 60.9 16.4 16.9 22.5 12.7 23.3 25.7 35.1 16.0 18.9 21.3 12.8 43.3 13.6 53.6 46.5 109.5 333.7 437.8 35.4 16.7 20.4 10.7 43.3 209.3 23.6 255.9 34.9 71.5 391.5 178.3 384.3 140.2 52.8 199.5 109.5 121.1 129.2 6.0 276.1 23.8 53.9 79.8 137.2 712.2 78.6 209.3 210.9 518.4 67.0 42.5 54.6 123.0 64.3 29.8 25.4 122.9 189.2 42.4 191.3 362.3 327.4 66.0 109.6 362.4 ATP2B1 PMCA1 ENSG00000070961 "ATPase plasma membrane Ca2+ transporting 1" P20020 12 89588049-89709300 "Enzymes, Plasma proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calmodulin-binding, Translocase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 53.8" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 311.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 59.7;LHCN-M2: 92.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005605, HPA011166, HPA012945" Enhanced Supported Supported "Plasma membrane" NA NA "Plasma membrane" "CAB005605: AB_2061563, HPA011166: AB_1855484, HPA012945: AB_1855483" "unprognostic (6.78e-2)" "unprognostic (5.27e-2)" "unprognostic (1.57e-2)" "unprognostic (8.23e-2)" "unprognostic (1.72e-1)" "unprognostic (6.44e-2)" "prognostic unfavorable (7.74e-4)" "unprognostic (2.77e-2)" "unprognostic (2.46e-2)" "unprognostic (7.82e-2)" "unprognostic (5.98e-2)" "unprognostic (2.68e-1)" "unprognostic (4.60e-2)" "unprognostic (1.92e-2)" "unprognostic (2.31e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-2)" 8.7 5.1 23.4 12.5 53.8 40.5 8.8 30.9 44.1 9.0 14.0 4.1 4.0 17.8 8.2 5.8 6.5 8.4 11.3 5.2 29.0 11.8 7.4 10.0 9.2 11.8 7.8 31.5 7.6 7.4 13.7 8.7 11.7 9.2 6.4 14.8 2.9 5.6 6.9 10.9 11.3 12.8 8.7 6.1 12.7 12.4 9.8 16.4 5.7 6.3 6.0 12.3 9.9 7.4 27.1 16.2 41.5 25.6 8.4 16.3 6.2 4.2 21.5 8.5 4.1 12.4 19.7 3.9 13.0 42.9 12.6 20.2 8.6 3.9 8.4 0.9 18.1 14.6 3.8 7.4 3.6 35.5 2.9 8.7 3.0 7.6 7.5 40.3 12.5 5.0 16.3 6.9 39.5 59.7 14.9 3.2 3.2 4.9 3.1 92.7 6.7 3.9 5.4 6.6 5.9 10.3 5.6 27.4 3.5 12.0 19.8 8.0 4.4 15.1 4.3 3.6 18.0 6.3 1.4 2.2 34.5 5.6 12.6 14.2 2.3 3.6 9.0 15.6 3.5 7.6 2.7 13.0 6.7 7.1 13.6 9.0 27.1 12.4 9.0 16.2 27.0 4.6 5.7 41.5 8.4 25.6 2.9 16.3 6.2 23.4 53.8 30.9 44.1 29.0 11.8 7.8 31.5 9.2 16.4 41.7 42.4 79.2 52.7 179.2 311.6 18.9 45.9 29.4 36.4 50.6 145.3 117.8 1.7 21.2 1.8 49.1 113.3 0.0 24.6 36.9 79.9 37.8 30.1 35.8 157.7 286.0 87.9 47.3 100.2 6.0 27.0 213.2 52.3 116.4 24.1 78.6 21.7 48.2 30.1 23.1 99.9 32.3 51.5 12.9 122.1 178.9 191.3 55.4 45.3 59.3 ATP2B4 "ATP2B2, MXRA1, PMCA4" ENSG00000058668 "ATPase plasma membrane Ca2+ transporting 4" P23634 1 203626561-203744081 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calmodulin-binding, Translocase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 153.7;Suprabasal keratinocytes: 132.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 59.5;fHDF/TERT166: 45.1;SuSa: 49.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016118, HPA040431" Enhanced Supported "Plasma membrane" NA NA 21000 "Plasma membrane" "CAB016118: AB_2061729, HPA040431: AB_2676980" "unprognostic (7.43e-2)" "unprognostic (1.58e-1)" "unprognostic (1.60e-2)" "unprognostic (8.17e-2)" "unprognostic (2.53e-2)" "unprognostic (9.23e-3)" "unprognostic (8.68e-2)" "unprognostic (3.81e-2)" "unprognostic (9.74e-2)" "unprognostic (1.70e-1)" "unprognostic (1.64e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (1.21e-4)" "unprognostic (3.52e-3)" "unprognostic (2.61e-2)" "unprognostic (1.30e-1)" "unprognostic (2.56e-3)" 23.0 14.0 24.8 10.8 14.2 5.9 11.6 9.4 23.6 32.6 44.2 7.5 12.9 5.3 69.6 13.1 20.4 27.0 13.9 24.0 13.1 8.7 5.0 14.2 16.1 5.3 6.4 19.2 21.9 6.4 8.0 4.8 16.2 9.3 17.0 13.4 11.6 7.5 31.5 5.4 22.0 13.2 74.2 5.7 4.8 16.4 13.1 7.5 9.0 8.3 8.4 7.7 32.8 14.2 1.0 4.2 4.5 2.2 4.2 10.4 2.6 9.2 1.7 3.4 3.2 26.0 38.8 18.0 41.8 59.5 7.1 6.1 0.8 4.7 2.1 6.1 45.1 9.5 9.0 4.9 5.8 7.5 26.5 1.7 6.2 8.3 0.5 9.3 8.8 11.0 28.1 5.7 22.8 3.5 17.3 13.5 12.3 2.7 4.2 5.2 0.5 8.9 2.9 2.0 1.7 5.2 4.7 2.5 3.3 2.4 0.8 1.0 1.4 14.7 2.2 6.6 49.6 1.9 4.3 11.8 17.3 2.5 29.0 10.0 2.8 4.2 1.1 17.3 6.4 5.1 3.0 2.2 0.0 10.4 1.5 7.9 1.0 6.6 8.3 2.4 0.3 1.6 4.2 4.5 4.2 2.2 4.2 6.3 2.6 24.8 14.2 9.4 23.6 13.1 8.7 6.4 19.2 9.3 7.5 83.4 62.7 10.4 15.6 86.3 2.8 64.1 7.6 34.8 40.9 17.4 2.0 22.3 0.0 31.1 4.3 39.1 3.9 23.3 13.2 13.3 48.3 9.5 9.3 15.7 31.0 111.2 23.0 54.6 14.6 1.3 40.6 13.2 25.3 7.2 1.9 153.7 25.2 11.9 35.7 5.0 6.9 19.4 82.4 22.3 2.1 132.0 21.7 45.7 2.6 43.3 B3GALT2 beta3Gal-T2 ENSG00000162630 "Beta-1,3-galactosyltransferase 2" O43825 1 193179045-193186654 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.9;gallbladder: 19.0;heart muscle: 25.1" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 47.7;Cardiomyocytes: 27.8;Cholangiocytes: 15.3;Leydig cells: 29.4;Peritubular cells: 19.8" "Cancer enhanced" "Detected in some" "glioma: 2.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 11.9" "Lineage enriched" "Detected in single" 57 "T-cells: 11.9" "Group enriched" "Detected in some" 4 "AF22: 16.4;ASC TERT1: 7.5;LHCN-M2: 11.1;WM-115: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078659 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA078659: AB_2686887" "unprognostic (1.83e-2)" "unprognostic (3.81e-2)" "unprognostic (1.91e-2)" "unprognostic (1.17e-1)" "unprognostic (3.67e-1)" "unprognostic (1.58e-3)" "unprognostic (2.34e-3)" "unprognostic (2.43e-3)" "unprognostic (1.63e-1)" "unprognostic (2.44e-1)" "unprognostic (6.14e-4)" "unprognostic (4.41e-2)" "unprognostic (8.10e-3)" "unprognostic (2.72e-1)" "unprognostic (1.36e-1)" "unprognostic (1.89e-1)" "unprognostic (4.56e-3)" 0.7 2.0 11.3 1.3 8.9 0.7 0.9 1.4 32.9 0.8 1.7 1.2 0.9 1.6 0.6 1.8 1.2 0.7 19.0 25.1 10.1 7.9 1.7 0.8 2.6 0.7 5.7 19.1 13.8 0.8 0.4 0.9 0.9 5.0 6.5 2.0 0.3 0.5 7.1 0.6 0.7 4.1 0.8 6.5 1.4 2.1 1.4 4.7 0.0 1.8 0.0 1.6 2.0 0.7 0.0 0.2 0.1 0.0 0.0 11.9 0.3 0.0 0.0 16.4 0.0 0.4 7.5 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 1.4 1.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.2 0.0 11.9 0.0 2.7 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 2.3 0.3 11.3 8.9 1.4 32.9 10.1 7.9 5.7 19.1 5.0 4.7 0.0 0.3 0.0 0.0 0.2 47.7 27.8 15.3 4.0 0.0 1.8 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.3 2.3 0.0 0.2 7.9 2.9 1.3 0.3 0.0 29.4 0.1 0.0 0.0 0.3 1.7 0.4 0.0 19.8 0.0 5.8 0.0 0.4 0.0 0.0 0.3 0.0 5.1 0.4 0.0 BACE1 BACE ENSG00000186318 "Beta-secretase 1" P56817 11 117285207-117316259 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "brain: 53.0;pancreas: 161.1" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 111.9;Early spermatids: 89.1;Late spermatids: 222.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 38.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB016358 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "CAB016358: AB_626716" "unprognostic (7.96e-3)" "unprognostic (8.05e-2)" "unprognostic (3.55e-2)" "unprognostic (3.05e-3)" "unprognostic (8.94e-2)" "unprognostic (3.39e-1)" "unprognostic (1.03e-1)" "unprognostic (2.60e-1)" "unprognostic (4.54e-2)" "unprognostic (8.04e-2)" "unprognostic (8.09e-2)" "unprognostic (1.09e-1)" "unprognostic (1.12e-1)" "unprognostic (1.35e-2)" "unprognostic (1.16e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (6.76e-4)" 6.5 7.1 12.1 3.8 18.8 2.2 5.5 9.6 22.4 9.8 4.6 42.5 2.7 3.4 9.3 5.6 7.6 8.6 9.1 5.9 16.9 12.4 6.8 12.1 7.3 2.8 28.8 15.0 11.4 161.1 12.8 4.2 6.3 26.4 6.5 4.7 6.9 5.3 9.9 6.2 7.2 3.6 11.7 53.0 5.7 4.9 4.1 21.4 0.0 6.3 2.3 2.8 6.7 5.5 4.0 2.2 0.7 3.2 2.2 6.7 1.1 3.9 4.7 9.7 14.8 32.2 34.7 0.4 21.3 18.6 10.4 8.5 3.6 6.3 0.8 5.2 38.6 7.8 6.9 10.3 6.1 8.5 2.3 5.5 2.4 7.9 4.3 15.9 0.8 0.5 30.0 9.6 13.2 12.9 25.7 8.9 1.4 0.8 0.4 19.0 14.3 0.6 1.9 6.3 4.1 10.4 1.8 4.4 0.8 4.4 2.2 12.6 14.1 7.9 1.0 2.3 8.9 10.2 2.7 12.2 18.7 2.0 19.5 6.8 0.3 0.3 0.4 8.8 1.2 13.0 0.6 2.0 0.7 2.0 3.2 5.2 4.0 6.7 5.3 2.2 1.8 3.1 2.7 0.0 2.2 1.3 1.3 6.3 1.1 12.1 18.8 9.6 21.7 16.9 12.4 28.8 15.0 26.4 21.4 17.9 8.5 0.0 3.8 4.1 53.4 8.1 17.8 4.0 20.5 5.2 111.9 0.8 5.0 4.7 89.1 5.2 1.5 0.0 17.3 0.9 11.5 2.8 2.3 31.6 7.9 54.0 20.8 6.7 12.6 222.6 17.8 5.8 3.3 1.8 2.4 16.6 5.8 4.0 20.8 5.4 48.1 6.5 6.6 3.2 1.7 3.0 0.7 1.0 2.7 2.5 BASP1 "CAP-23, CAP23, NAP-22, NAP22" ENSG00000176788 "Brain abundant membrane attached signal protein 1" P80723 5 17065598-17276843 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 107.3;epididymis: 126.9" "Cell type enhanced" "Detected in many" 10 "monocytes: 416.6;Muller glia cells: 714.2;Syncytiotrophoblasts: 617.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 42.4" "Lineage enriched" "Detected in many" 17 "granulocytes: 42.4" "Cell line enhanced" "Detected in many" "GAMG: 63.6;HeLa: 111.9;SiHa: 107.5" "Low region specificity" "Detected in many" "HPA045218, HPA050333" Enhanced Enhanced "Plasma membrane" NA NA 85000000 "Plasma membrane" "HPA045218: AB_2679263, HPA050333: AB_2681090" "unprognostic (3.35e-2)" "unprognostic (3.13e-2)" "unprognostic (1.04e-1)" "unprognostic (1.32e-1)" "unprognostic (2.78e-1)" "prognostic unfavorable (5.63e-4)" "unprognostic (2.40e-1)" "unprognostic (1.02e-2)" "unprognostic (2.39e-1)" "unprognostic (1.89e-1)" "unprognostic (2.52e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (5.25e-11)" "unprognostic (1.95e-3)" "unprognostic (1.04e-1)" "unprognostic (3.61e-2)" "unprognostic (1.70e-1)" 9.2 6.7 64.3 28.4 37.4 31.1 4.8 37.2 107.3 16.2 5.2 4.0 15.1 3.8 15.5 126.9 4.0 3.6 12.7 4.4 65.0 55.8 4.2 7.7 9.1 30.2 30.1 56.6 11.7 2.5 3.6 6.4 36.4 21.9 32.2 5.5 7.9 3.8 11.5 1.6 6.0 5.7 14.2 11.0 21.9 9.2 2.2 4.3 3.7 3.6 1.3 35.4 17.6 13.0 2.5 1.6 42.4 1.1 0.6 0.1 0.2 0.0 16.7 20.9 0.0 10.0 10.7 29.9 20.9 6.9 17.6 18.7 0.8 0.0 6.5 2.9 14.9 63.6 1.3 13.3 14.6 22.9 2.6 7.5 0.0 111.9 0.0 22.4 12.9 0.1 18.4 18.2 19.9 16.8 22.6 19.0 0.0 0.0 0.0 18.7 24.0 0.0 11.8 15.4 0.0 5.1 0.0 0.0 3.6 6.3 4.1 13.4 2.8 107.5 9.9 0.0 48.5 0.0 13.4 24.2 23.3 0.0 1.9 3.3 0.2 0.0 3.5 23.5 16.0 3.0 6.2 1.1 7.8 0.0 0.4 0.0 1.8 0.0 0.0 1.6 2.5 0.0 0.0 42.4 0.6 0.6 0.1 0.1 0.2 64.3 37.4 37.2 107.3 65.0 55.8 30.1 56.6 21.9 4.3 8.9 7.4 119.4 82.9 191.9 32.5 1.2 0.0 54.9 18.2 8.7 11.8 112.9 0.0 0.6 0.4 8.9 0.0 23.3 3.0 281.6 123.4 116.0 26.5 0.9 53.1 230.4 0.0 41.7 176.3 0.0 0.6 106.8 27.0 416.6 0.3 714.2 1.2 0.0 0.0 0.0 54.1 0.0 24.5 0.0 1.5 51.4 617.6 1.0 0.6 11.2 BIN2 BRAP-1 ENSG00000110934 "Bridging integrator 2" 12 51281038-51324668 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 85.3;bone marrow: 38.0;lymphoid tissue: 24.8" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 77.7;Extravillous trophoblasts: 144.3;Syncytiotrophoblasts: 132.6;T-cells: 174.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 23.8;HMC-1: 40.6;Karpas-707: 17.7;NB-4: 40.4;RPMI-8226: 15.8;THP-1: 34.2;U-937: 22.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA038666, HPA038667" Enhanced Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA038666: AB_2676139, HPA038667: AB_2676140" "unprognostic (8.44e-3)" "prognostic favorable (1.33e-4)" "unprognostic (2.48e-1)" "prognostic favorable (6.34e-4)" "unprognostic (4.63e-1)" "unprognostic (2.00e-3)" "unprognostic (1.21e-1)" "unprognostic (3.59e-2)" "unprognostic (3.72e-2)" "unprognostic (7.47e-2)" "unprognostic (5.71e-2)" "unprognostic (3.29e-1)" "unprognostic (1.65e-3)" "unprognostic (4.03e-1)" "unprognostic (3.96e-2)" "unprognostic (1.24e-1)" "unprognostic (2.22e-1)" 4.6 1.8 3.5 12.3 4.7 38.0 1.7 1.8 2.0 2.3 3.3 3.6 0.7 2.2 1.4 2.8 2.2 1.4 3.6 2.2 3.1 2.1 2.5 3.1 7.7 23.9 4.4 0.9 1.8 2.3 0.0 1.7 8.4 3.2 1.8 3.6 1.5 4.7 0.6 1.9 2.0 3.3 2.3 4.1 18.3 2.6 3.5 3.9 24.8 1.9 0.7 17.5 4.4 1.9 10.5 17.1 85.3 59.9 35.8 47.7 61.4 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 23.8 0.0 0.0 0.0 9.9 40.6 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 17.7 0.0 0.1 6.9 40.4 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 34.2 0.0 0.0 0.0 0.0 0.0 9.5 0.0 2.3 0.0 22.4 0.0 85.3 30.9 37.4 47.7 49.0 38.5 8.1 32.4 39.8 17.1 10.5 25.3 33.5 61.0 35.8 59.9 6.3 40.9 61.4 3.5 4.7 1.8 2.0 3.1 2.1 4.4 0.9 3.2 3.9 3.0 27.8 26.9 0.1 0.6 0.0 0.6 2.5 6.7 4.5 1.8 0.0 77.7 14.9 0.0 19.8 1.0 1.2 0.0 0.0 144.3 1.9 0.1 53.3 0.9 50.9 0.0 1.2 8.6 57.8 18.7 0.6 49.5 1.7 10.0 9.1 0.0 0.0 3.5 0.4 0.7 0.0 0.0 0.7 32.5 7.7 0.5 132.6 174.0 6.9 0.0 BTN2A1 "BT2.1, BTF1, BTN2.1" ENSG00000112763 "Butyrophilin subfamily 2 member A1" Q7KYR7 6 26457904-26476621 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA019208 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA019208: AB_1845492" "unprognostic (1.86e-1)" "unprognostic (3.48e-1)" "unprognostic (1.20e-1)" "unprognostic (2.87e-1)" "unprognostic (2.29e-1)" "unprognostic (6.17e-2)" "unprognostic (5.74e-3)" "unprognostic (1.22e-2)" "unprognostic (1.03e-1)" "unprognostic (3.26e-2)" "unprognostic (6.90e-3)" "unprognostic (5.14e-2)" "prognostic unfavorable (5.90e-5)" "unprognostic (1.97e-1)" "unprognostic (4.89e-2)" "unprognostic (7.92e-2)" "prognostic favorable (4.52e-5)" 15.3 16.7 10.8 16.3 13.7 18.5 17.2 42.2 16.2 14.8 15.8 13.2 17.4 12.2 18.8 15.0 11.5 14.9 12.7 15.6 11.2 14.6 13.1 8.5 17.2 16.3 14.4 10.2 15.8 8.9 7.7 16.9 23.2 16.1 16.5 14.6 12.0 11.1 19.3 12.1 9.5 13.9 21.1 15.6 23.5 12.4 13.0 15.0 11.3 10.8 7.3 14.4 21.4 13.4 4.8 4.7 28.8 4.8 4.8 8.1 3.4 7.4 6.8 13.4 8.3 6.0 4.9 0.6 16.3 13.8 20.1 18.4 6.0 5.0 6.1 22.6 11.6 26.5 3.4 10.6 4.2 19.3 8.8 10.4 3.7 7.3 7.4 9.4 5.2 9.8 6.8 4.0 22.4 7.3 11.9 7.2 12.1 5.8 9.7 17.2 3.2 9.2 8.7 4.6 2.1 5.5 7.6 13.2 6.4 7.5 3.7 14.0 7.7 5.2 6.7 11.6 8.7 2.2 4.6 9.5 15.1 8.1 13.1 18.3 7.9 18.2 5.1 6.0 10.4 23.8 16.7 4.8 15.5 6.5 2.7 5.9 4.8 5.4 7.1 4.3 3.9 5.0 6.4 28.8 4.8 4.1 4.7 8.1 3.4 10.8 13.7 42.2 16.2 11.2 14.6 14.4 10.2 16.1 15.0 14.9 14.3 13.4 6.9 7.1 9.0 16.8 10.2 32.1 10.3 8.7 5.9 5.1 3.3 9.6 2.6 19.4 10.6 0.0 11.3 9.3 14.7 9.5 23.2 5.8 10.2 3.2 8.6 19.0 18.7 4.1 11.8 17.0 10.1 16.2 13.7 6.4 12.3 11.2 12.0 4.7 2.2 38.8 21.7 8.8 11.7 7.0 9.8 21.7 12.1 11.1 C14orf37 UT2 ENSG00000139971 "Chromosome 14 open reading frame 37" Q86TY3 14 57999735-58298139 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.5" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 32.1;Club cells: 20.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 11.2;AN3-CA: 7.0;fHDF/TERT166: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001580, HPA001789" Enhanced Approved "Plasma membrane" NA NA 270000 "Plasma membrane" "HPA001580: AB_2666366, HPA001789: AB_1078328" "unprognostic (2.56e-2)" "unprognostic (2.04e-2)" "unprognostic (1.20e-3)" "unprognostic (8.56e-2)" "unprognostic (1.15e-1)" "unprognostic (6.97e-3)" "unprognostic (1.94e-1)" "unprognostic (7.84e-3)" "unprognostic (2.66e-1)" "unprognostic (2.32e-1)" "unprognostic (2.42e-1)" "unprognostic (1.01e-1)" "unprognostic (3.87e-8)" "unprognostic (5.22e-6)" "unprognostic (4.93e-2)" "unprognostic (8.74e-4)" "unprognostic (3.01e-4)" 2.8 5.3 11.4 1.5 11.7 1.8 2.4 10.1 14.0 4.1 2.3 3.9 1.1 1.6 6.7 4.0 1.9 4.7 3.9 6.3 8.6 4.6 16.5 2.2 1.8 1.1 5.1 7.8 9.3 2.4 9.2 5.8 1.4 21.5 4.0 2.7 3.9 2.0 3.3 1.2 2.5 1.8 5.0 3.3 1.3 3.0 5.1 5.0 0.0 3.4 0.3 0.9 2.6 3.0 0.3 0.6 0.5 0.3 0.1 0.0 0.0 0.0 0.0 11.2 7.0 5.5 2.3 0.0 2.2 1.7 0.4 0.3 0.5 0.1 0.0 0.7 12.2 1.4 0.1 3.5 0.0 0.5 0.1 1.1 0.0 0.0 0.5 0.2 0.0 5.6 2.4 0.2 0.2 0.2 3.1 0.5 0.9 0.1 0.3 1.4 0.3 0.0 0.0 5.2 0.0 2.3 1.6 0.3 2.7 4.5 0.5 1.3 0.1 0.1 0.0 0.3 3.3 0.3 0.2 0.1 1.7 4.2 0.6 2.9 0.4 0.3 0.0 3.5 0.3 1.2 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.4 0.1 0.0 0.6 0.0 0.0 11.4 11.7 10.1 14.0 8.6 4.6 5.1 7.8 21.5 5.0 3.0 6.5 0.0 7.4 1.3 3.5 0.0 0.0 32.1 20.5 0.0 0.0 0.2 0.0 0.0 1.7 3.0 0.0 0.0 0.0 0.3 4.5 1.3 4.7 2.0 0.1 0.0 0.0 3.1 2.6 0.0 9.2 1.1 3.3 0.0 2.3 9.4 0.0 0.0 9.9 0.0 2.7 0.0 1.4 2.3 2.3 1.8 0.2 1.3 0.3 5.4 C19orf48 "BC006151, MGC13170" ENSG00000167747 "Chromosome 19 open reading frame 48" Q6RUI8 19 50797704-50804929 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA042000 Uncertain Approved "Plasma membrane" NA Yes "Plasma membrane" "HPA042000: AB_10797377" "unprognostic (2.25e-1)" "unprognostic (2.82e-2)" "unprognostic (5.39e-2)" "unprognostic (7.92e-2)" "unprognostic (2.86e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (8.80e-5)" "unprognostic (6.59e-3)" "unprognostic (1.84e-3)" "unprognostic (2.84e-1)" "unprognostic (1.14e-2)" "unprognostic (2.97e-1)" "unprognostic (6.84e-3)" "unprognostic (1.29e-1)" "unprognostic (3.67e-2)" "unprognostic (1.40e-1)" "unprognostic (1.16e-1)" 5.0 9.7 6.5 11.0 6.2 20.7 9.6 7.0 8.9 7.2 9.3 7.0 4.1 6.8 7.8 6.9 13.2 13.5 9.5 4.1 4.0 3.4 7.4 12.0 8.0 22.2 6.8 8.7 13.0 40.7 3.2 4.0 7.5 5.2 32.1 5.8 6.9 8.3 5.6 6.4 15.9 6.4 6.7 5.1 8.8 7.0 19.8 5.0 23.6 17.9 9.1 12.5 5.1 7.3 29.0 20.8 2.8 8.7 12.4 21.6 9.9 21.4 34.1 16.1 10.1 3.1 9.6 14.9 19.4 13.3 28.7 28.7 41.1 20.0 36.8 9.0 7.5 11.1 15.3 26.8 27.3 9.9 11.5 64.7 24.5 14.5 23.9 8.7 25.6 12.4 15.6 28.4 29.9 32.6 7.0 15.3 36.3 26.8 18.4 13.3 18.5 34.3 31.0 12.9 26.4 43.7 25.8 26.3 34.8 9.3 35.9 26.6 12.8 19.4 25.3 26.4 6.1 14.9 25.2 7.2 13.3 24.6 8.1 26.3 10.8 12.2 30.3 8.1 23.3 17.8 1.0 6.0 2.8 9.9 8.7 14.0 29.0 14.1 11.2 11.8 27.3 21.6 16.1 0.4 12.4 6.3 20.8 14.5 9.9 6.5 6.2 7.0 8.9 4.0 3.4 6.8 8.7 5.2 5.0 3.0 6.9 49.4 35.3 51.9 8.7 4.7 12.7 1.4 6.8 17.4 5.9 84.7 28.2 25.6 6.7 15.8 10.0 23.3 94.0 106.2 23.6 54.8 8.1 11.5 36.1 0.0 23.0 6.7 8.8 12.6 16.4 21.5 16.9 39.7 66.4 9.7 47.0 14.0 7.1 15.2 7.0 6.5 21.7 27.2 39.4 60.1 51.8 15.0 100.4 27.5 C1orf54 FLJ23221 ENSG00000118292 "Chromosome 1 open reading frame 54" Q8WWF1 1 150268200-150280916 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 98.9;Leydig cells: 88.1;Macrophages: 71.5;Peritubular cells: 97.9;Smooth muscle cells: 69.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "myeloid DC: 36.2" "Lineage enriched" "Detected in many" 5 "dendritic cells: 36.2" "Cell line enhanced" "Detected in many" "AF22: 20.9;AN3-CA: 31.6;ASC diff: 22.4;ASC TERT1: 37.5;HSkMC: 30.3;HUVEC TERT2: 29.2" "Low region specificity" "Detected in all" "HPA026518, HPA043874" Approved Approved "Plasma membrane" "Secreted to blood" NA NA "Plasma membrane" "HPA026518: AB_1845647, HPA043874: AB_2732511" "unprognostic (4.64e-3)" "unprognostic (6.81e-3)" "unprognostic (4.01e-3)" "unprognostic (5.69e-3)" "unprognostic (2.22e-1)" "unprognostic (1.72e-1)" "unprognostic (1.51e-2)" "unprognostic (1.88e-1)" "unprognostic (1.26e-1)" "unprognostic (1.33e-1)" "unprognostic (3.45e-1)" "unprognostic (3.21e-1)" "prognostic unfavorable (2.43e-4)" "unprognostic (3.16e-2)" "unprognostic (8.06e-2)" "unprognostic (1.33e-2)" "unprognostic (4.48e-2)" 16.0 8.8 16.4 19.0 19.3 4.5 13.8 5.8 10.5 11.9 14.0 4.5 19.1 5.8 19.8 21.1 11.0 17.1 21.6 13.8 13.7 13.7 12.7 12.0 11.8 21.5 21.8 8.3 8.3 6.8 2.0 6.7 24.4 14.0 15.3 11.1 10.9 9.8 30.4 13.4 4.5 8.1 24.1 20.4 27.3 8.3 5.7 14.8 4.9 8.3 17.1 11.2 22.0 14.3 0.3 36.2 0.4 7.7 0.2 1.5 2.2 0.5 0.1 20.9 31.6 22.4 37.5 0.6 3.4 5.0 0.9 3.0 0.2 0.6 0.2 1.1 3.0 0.4 0.9 0.0 0.1 1.1 0.3 3.7 0.6 0.5 0.3 4.6 1.1 0.8 30.3 1.5 6.3 0.5 3.7 29.2 0.5 0.4 4.1 3.2 1.2 0.2 7.2 1.7 0.0 1.1 5.2 0.5 0.4 0.3 1.6 0.4 0.4 0.4 0.2 2.3 4.2 0.4 15.8 0.2 7.5 0.6 0.2 0.3 1.7 1.4 0.3 16.6 0.9 0.2 0.0 7.7 0.3 0.2 6.8 0.9 0.3 1.5 0.6 36.2 0.3 1.5 0.8 0.4 0.2 1.9 0.7 0.6 2.2 16.4 19.3 5.8 10.5 13.7 13.7 21.8 8.3 14.0 14.8 3.0 5.0 2.4 2.0 5.7 0.8 6.2 2.5 0.0 2.3 21.0 0.0 1.0 64.6 0.5 7.4 64.6 2.1 0.0 2.0 0.7 22.1 1.8 1.1 0.8 45.5 0.0 1.2 49.1 98.9 15.7 88.1 71.5 11.8 20.8 1.1 11.1 1.5 0.8 97.9 2.6 1.3 32.3 69.0 16.6 1.3 4.4 3.0 2.5 1.2 5.5 CA14 ENSG00000118298 "Carbonic anhydrase 14" Q9ULX7 1 150257159-150265078 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.9;retina: 29.4;seminal vesicle: 16.5;skeletal muscle: 24.1" "Group enriched" "Detected in some" 16 "Cardiomyocytes: 44.5;Melanocytes: 50.6;Muller glia cells: 123.0" "Group enriched" "Detected in many" 7 "glioma: 4.9;melanoma: 23.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "AF22: 28.7;AN3-CA: 17.0;NTERA-2: 22.3;SK-MEL-30: 57.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008482 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA008482: AB_1078395" "unprognostic (3.06e-2)" "unprognostic (1.67e-1)" "unprognostic (2.10e-2)" "unprognostic (3.25e-2)" "prognostic favorable (8.47e-4)" "unprognostic (7.28e-2)" "unprognostic (4.48e-2)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (2.47e-1)" "unprognostic (5.46e-2)" "unprognostic (1.73e-1)" "unprognostic (5.89e-3)" "unprognostic (1.91e-1)" "unprognostic (1.49e-1)" "unprognostic (1.22e-1)" "unprognostic (5.80e-2)" 0.1 0.3 4.6 0.2 5.2 0.9 0.3 1.4 6.8 0.1 1.7 10.8 0.1 0.3 0.1 0.5 1.6 1.3 0.7 4.4 6.4 4.1 0.3 6.3 0.2 0.2 11.3 3.2 1.4 0.3 0.8 0.1 0.3 4.4 3.2 0.7 29.4 0.6 16.5 24.1 3.7 0.6 0.5 20.9 0.3 0.8 0.5 2.7 0.1 0.9 0.1 0.1 0.2 0.1 2.8 2.2 2.1 2.0 0.2 1.6 0.2 0.2 0.0 28.7 17.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.1 22.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.1 57.1 4.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 1.3 0.1 0.1 0.1 0.0 0.0 0.9 1.3 1.6 2.0 0.6 2.0 1.0 1.2 0.2 2.8 1.2 1.3 2.1 0.2 0.5 2.2 0.0 0.2 4.6 5.2 1.4 4.7 6.4 4.1 11.3 3.2 4.4 2.7 3.0 0.3 0.0 0.2 1.9 1.4 44.5 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.1 0.0 3.8 0.1 0.0 0.0 0.0 0.3 0.0 0.9 0.0 50.6 0.0 0.0 123.0 1.2 0.0 3.2 0.0 4.5 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.4 CA9 "CAIX, MN" ENSG00000107159 "Carbonic anhydrase 9" Q16790 9 35673856-35681159 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "gallbladder: 70.4;pancreas: 47.4;stomach 1: 70.8" "Cell type enhanced" "Detected in some" 25 "Cholangiocytes: 53.5;Early spermatids: 178.0;Exocrine glandular cells: 46.4;Pancreatic endocrine cells: 33.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 10 "cerebellum: 7.3" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 40.0;HDLM-2: 20.8;hTERT-RPE1: 25.5;U-87 MG: 83.9" "Region enriched" "Detected in some" 4 "cerebellum: 13.8" "Low region specificity" "Detected in some" "CAB005100, CAB017107, HPA055207" Enhanced Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "CAB005100: AB_2066539, CAB017107: , HPA055207: AB_2682738" "unprognostic (8.01e-3)" "unprognostic (1.34e-2)" "unprognostic (2.28e-1)" "unprognostic (2.00e-2)" "unprognostic (1.59e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.71e-5)" "unprognostic (1.47e-2)" "unprognostic (3.90e-2)" "unprognostic (1.29e-1)" "unprognostic (6.24e-3)" "unprognostic (1.13e-1)" "prognostic unfavorable (2.22e-7)" "unprognostic (7.29e-2)" "prognostic favorable (9.50e-4)" "unprognostic (2.97e-3)" "unprognostic (8.67e-2)" 1.0 0.1 0.0 0.1 0.3 0.0 0.0 7.3 0.7 0.5 7.2 0.1 0.2 6.7 0.1 1.5 0.3 0.1 70.4 0.7 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.7 47.4 0.0 0.2 0.7 0.4 0.2 0.0 0.1 0.0 0.0 0.0 2.6 8.0 0.0 0.4 0.0 70.8 1.4 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 1.1 0.0 0.0 0.4 0.1 0.0 40.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.2 0.3 20.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 25.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 1.0 0.0 0.0 0.0 83.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.3 7.3 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 3.9 0.0 0.3 53.5 0.0 0.0 0.0 0.0 0.0 0.0 27.8 178.0 0.0 0.0 0.0 46.4 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 12.2 1.4 0.0 0.0 1.0 0.1 1.5 33.9 0.0 0.7 0.0 0.0 0.0 0.4 0.9 2.7 2.8 0.2 0.0 0.2 0.3 CALCRL "CGRPR, CRLR" ENSG00000064989 "Calcitonin receptor like receptor" Q16602 2 187343129-187448460 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 91.0" "Group enriched" "Detected in many" 9 "Endothelial cells: 183.3;Ito cells: 192.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 3.3;myeloid DC: 11.2;plasmacytoid DC: 3.3" "Group enriched" "Detected in many" 6 "dendritic cells: 11.2;monocytes: 3.3" "Cell line enriched" "Detected in some" 4 "HUVEC TERT2: 62.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008070, HPA046515" Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA008070: AB_1845912, HPA046515: AB_2679681" "unprognostic (7.06e-2)" "unprognostic (5.71e-2)" "unprognostic (1.59e-1)" "unprognostic (2.13e-1)" "unprognostic (3.44e-3)" "unprognostic (7.60e-3)" "unprognostic (9.25e-3)" "unprognostic (4.14e-2)" "unprognostic (7.71e-3)" "unprognostic (3.32e-1)" "unprognostic (3.77e-1)" "unprognostic (3.44e-1)" "unprognostic (1.51e-3)" "unprognostic (1.90e-2)" "unprognostic (2.02e-1)" "unprognostic (1.30e-1)" "unprognostic (2.50e-2)" 42.4 5.2 4.9 6.4 3.8 0.2 19.6 7.3 9.4 21.2 12.6 2.6 4.0 3.1 17.9 6.8 16.3 6.5 13.4 15.1 4.5 3.8 16.5 12.5 91.0 16.9 4.7 3.5 15.2 3.7 8.2 5.3 6.4 7.5 10.7 5.3 7.5 8.4 4.4 5.0 4.2 5.6 14.5 18.1 9.1 5.0 7.9 2.8 2.3 16.9 11.8 4.7 10.6 14.0 0.2 11.2 0.1 3.3 1.2 1.1 1.1 0.0 0.0 3.2 0.0 2.3 0.6 0.0 0.2 0.4 0.0 0.4 0.0 0.3 0.0 0.8 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.2 0.5 0.0 0.0 1.8 0.0 0.0 1.6 0.1 0.1 0.7 0.2 62.5 0.0 0.0 0.8 0.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.1 0.1 14.7 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 9.0 0.2 0.0 0.0 0.1 2.3 0.0 0.2 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.6 0.0 0.2 0.0 0.0 11.2 0.0 1.1 0.2 0.1 1.2 1.2 3.3 0.0 1.1 4.9 3.8 7.3 3.7 4.5 3.8 4.7 3.5 7.5 2.8 0.0 14.0 0.8 2.3 8.2 0.1 7.0 2.5 2.7 4.5 0.0 0.0 0.3 3.3 0.1 0.5 183.3 0.0 0.0 0.4 0.1 5.4 1.7 4.7 2.1 0.9 0.0 0.0 192.8 14.2 0.4 7.2 7.7 10.1 20.8 0.0 0.0 0.1 0.0 2.5 12.3 0.0 6.5 6.6 1.2 0.4 5.9 0.2 0.0 0.0 1.2 CASKIN2 "ANKS5B, FLJ21609, KIAA1139" ENSG00000177303 "CASK interacting protein 2" Q8WXE0 17 75500261-75515583 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 35.0;Ito cells: 55.9;Muller glia cells: 29.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071906, HPA075184" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA071906: AB_2732191, HPA075184: AB_2732281" "unprognostic (1.60e-1)" "unprognostic (4.54e-2)" "unprognostic (9.12e-3)" "unprognostic (5.27e-3)" "unprognostic (9.32e-2)" "unprognostic (5.78e-2)" "unprognostic (2.87e-2)" "unprognostic (4.10e-2)" "unprognostic (7.67e-2)" "unprognostic (1.33e-1)" "prognostic favorable (2.47e-5)" "unprognostic (1.82e-2)" "prognostic favorable (4.83e-8)" "unprognostic (1.43e-1)" "unprognostic (1.52e-1)" "unprognostic (1.39e-1)" "unprognostic (4.95e-2)" 25.4 13.4 10.7 6.2 13.7 0.8 16.4 8.6 15.1 11.6 8.7 18.4 9.3 10.8 15.5 7.3 11.1 13.3 13.7 16.8 10.9 7.6 14.9 10.1 24.6 5.7 11.2 7.9 13.5 10.9 10.6 8.5 14.4 11.5 9.2 3.9 18.1 12.5 11.6 13.3 8.6 8.3 13.0 9.5 27.1 9.2 5.9 12.6 0.6 13.8 7.5 3.0 9.1 11.9 0.1 0.9 0.1 0.3 0.2 0.6 0.0 8.9 11.8 7.1 10.0 4.7 2.9 7.9 4.5 6.0 11.0 7.2 12.8 3.7 0.2 5.2 5.2 7.3 8.2 5.7 5.2 2.7 3.1 7.5 6.3 10.9 5.1 5.5 0.3 8.9 2.5 7.3 5.7 4.1 3.7 11.1 9.1 4.5 1.1 3.4 20.8 16.0 0.5 5.2 6.9 12.2 8.6 15.2 1.4 7.2 9.1 7.3 7.2 9.5 13.0 7.8 6.4 9.6 2.7 9.4 11.4 10.4 5.5 5.9 1.0 3.8 1.0 3.9 0.2 7.8 0.0 0.3 0.0 0.6 0.1 0.1 0.1 0.3 0.6 0.2 0.1 0.3 0.4 0.1 0.2 0.2 0.9 0.4 0.0 10.7 13.7 8.6 15.1 10.9 7.6 11.2 7.9 11.5 12.6 3.0 2.1 1.4 1.7 7.1 5.8 9.8 2.5 1.4 1.2 8.7 9.8 1.9 3.3 4.4 0.4 35.0 6.8 0.0 4.6 1.6 3.0 2.0 0.0 5.8 2.2 3.2 7.5 55.9 4.0 1.5 7.5 1.1 1.7 3.6 4.0 29.4 5.0 5.8 10.6 2.8 5.8 0.0 5.1 1.7 3.8 6.0 1.8 0.0 4.3 1.6 CAVIN3 "cavin-3, HSRBC, MGC20400, PRKCDBP, SRBC" ENSG00000170955 "Caveolae associated protein 3" Q969G5 11 6318946-6320647 "Predicted intracellular proteins" "Biological rhythms" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 73.7" "Cell type enhanced" "Detected in many" 18 "Exocrine glandular cells: 224.8;Extravillous trophoblasts: 73.0;monocytes: 53.3;Pancreatic endocrine cells: 141.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 8.1;myeloid DC: 22.4" "Group enriched" "Detected in many" 5 "dendritic cells: 22.4;monocytes: 8.1" "Cell line enhanced" "Detected in many" "A-431: 30.2;BJ: 29.1;HaCaT: 23.3;NTERA-2: 19.3;TIME: 34.5;U-87 MG: 32.7;WM-115: 34.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055136, HPA073327" Supported Approved "Plasma membrane" NA NA "Plasma membrane" "HPA055136: AB_2682711, HPA073327: AB_2686595" "unprognostic (7.92e-2)" "prognostic unfavorable (3.75e-5)" "unprognostic (3.12e-2)" "unprognostic (2.30e-1)" "unprognostic (4.69e-2)" "unprognostic (2.69e-1)" "unprognostic (2.24e-2)" "unprognostic (1.19e-3)" "unprognostic (2.49e-2)" "unprognostic (6.03e-3)" "unprognostic (3.37e-1)" "unprognostic (6.66e-2)" "prognostic unfavorable (5.21e-6)" "unprognostic (3.85e-2)" "unprognostic (1.70e-1)" "unprognostic (1.62e-1)" "unprognostic (1.96e-2)" 30.2 5.1 0.9 14.2 1.6 0.8 12.6 0.8 2.9 38.3 16.1 1.8 14.2 5.8 31.6 32.2 20.3 13.4 15.3 16.8 0.9 1.0 8.6 2.6 9.8 6.8 2.2 3.5 14.0 5.6 1.0 1.7 22.0 2.8 20.9 2.3 11.1 5.0 11.0 12.1 6.8 7.9 34.7 1.3 9.8 11.3 73.7 0.4 0.7 5.5 14.5 4.3 26.5 16.5 0.0 22.4 0.1 8.1 0.1 3.1 2.7 30.2 2.8 0.0 0.1 1.2 5.2 0.0 29.1 9.0 4.0 4.1 0.0 0.0 0.0 9.7 4.1 0.4 23.3 0.0 1.8 0.5 7.6 0.0 0.0 3.0 0.0 3.1 0.0 0.1 3.4 2.4 1.5 1.2 0.0 7.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 19.3 0.1 0.5 0.0 0.0 0.0 3.5 0.0 0.0 0.0 10.4 0.0 6.3 0.1 0.0 0.1 34.5 0.0 0.1 11.3 0.1 0.0 0.2 0.0 32.7 0.0 34.7 0.0 8.1 0.0 0.0 0.5 0.0 0.0 0.4 0.0 22.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 3.1 2.7 0.9 1.6 0.8 2.9 0.9 1.0 2.2 3.5 2.8 0.4 11.9 5.8 0.0 0.0 0.0 0.0 0.0 0.0 18.7 14.8 15.7 0.0 3.0 33.2 6.0 0.0 0.0 0.0 0.0 224.8 73.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 53.3 0.0 0.0 141.7 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 CBWD1 ENSG00000172785 "COBW domain containing 1" Q9BRT8 9 121038-179147 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 54.7" "HPA042759, HPA042813" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (3.75e-2)" "unprognostic (3.47e-2)" "unprognostic (5.23e-2)" "unprognostic (4.15e-2)" "unprognostic (1.39e-1)" "unprognostic (2.67e-2)" "unprognostic (3.91e-2)" "unprognostic (3.72e-1)" "unprognostic (4.15e-2)" "unprognostic (2.07e-3)" "unprognostic (1.82e-1)" "unprognostic (4.68e-2)" "unprognostic (5.80e-7)" "unprognostic (7.19e-2)" "unprognostic (1.04e-1)" "unprognostic (8.94e-2)" "unprognostic (4.98e-3)" 6.3 14.1 5.5 5.3 6.7 3.8 7.2 5.5 4.5 4.9 5.5 4.6 4.5 8.3 10.4 5.0 3.5 7.0 4.9 6.9 16.3 10.1 5.7 4.1 5.9 5.5 10.5 7.5 7.6 8.3 7.2 5.7 8.6 4.5 7.5 7.1 4.1 4.2 4.8 5.6 6.1 6.3 10.0 7.3 6.9 5.1 8.2 28.0 7.0 28.2 4.5 7.6 15.6 12.7 4.8 7.0 3.7 9.2 8.4 15.6 6.7 4.4 9.4 7.2 7.0 4.9 11.7 8.8 2.4 5.7 2.2 3.4 6.4 10.2 20.0 11.9 0.1 11.4 21.5 10.0 33.8 5.3 7.4 3.1 2.2 18.5 6.1 10.0 6.0 3.9 25.9 7.7 15.3 7.3 54.7 7.0 11.2 10.5 14.1 10.7 22.3 12.2 36.3 12.7 7.7 13.8 5.1 5.1 18.1 10.9 32.4 10.4 5.0 7.1 6.4 5.8 3.1 4.2 13.4 12.4 18.1 5.8 1.2 25.3 7.0 4.2 28.2 6.8 8.2 7.6 6.7 28.0 5.6 6.7 7.3 3.8 4.5 21.3 7.4 6.6 15.6 50.6 47.9 33.7 27.4 42.4 48.0 46.0 25.5 38.8 59.1 33.2 102.1 83.3 29.9 60.1 37.4 22.4 21.9 0.0 103.4 31.0 20.3 19.4 30.2 16.0 28.7 36.5 30.0 18.4 26.3 13.0 16.7 36.5 30.4 85.6 35.3 24.9 55.6 28.1 12.4 58.7 53.6 32.3 38.2 33.7 19.8 44.3 104.4 16.0 55.5 21.8 CBWD2 ENSG00000136682 "COBW domain containing 2" Q8IUF1 2 113437691-113496189 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.4" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 97.9;monocytes: 81.2;Suprabasal keratinocytes: 104.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042759, HPA042813" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (4.67e-2)" "unprognostic (2.17e-1)" "unprognostic (4.14e-1)" "prognostic unfavorable (3.22e-5)" "unprognostic (7.69e-2)" "unprognostic (2.17e-1)" "unprognostic (2.16e-3)" "unprognostic (1.31e-3)" "unprognostic (3.69e-2)" "unprognostic (1.72e-2)" "unprognostic (5.85e-2)" "unprognostic (1.39e-1)" "unprognostic (8.50e-2)" "unprognostic (1.90e-1)" "unprognostic (4.90e-2)" "unprognostic (3.21e-1)" "unprognostic (7.57e-3)" 2.0 5.7 3.2 2.6 6.0 0.3 4.3 7.0 4.1 5.6 3.6 0.9 4.1 4.9 5.9 2.1 2.5 9.1 3.1 4.5 8.9 6.6 1.8 1.3 3.2 3.0 3.6 7.7 5.3 3.4 4.1 3.6 4.3 5.0 15.0 1.7 2.2 5.0 1.6 2.3 3.3 1.2 6.2 2.5 4.2 2.5 7.8 26.5 13.8 27.4 7.5 10.4 17.5 8.0 4.8 5.4 6.1 14.1 6.5 10.1 6.3 4.0 5.0 6.5 8.2 5.0 10.6 19.3 6.6 22.7 6.8 5.6 7.0 6.7 3.6 15.0 8.8 8.7 15.3 4.7 3.7 4.2 6.1 4.3 7.2 4.3 9.5 8.9 5.7 5.0 11.6 7.2 8.6 11.7 12.5 6.4 15.4 10.7 5.6 14.1 27.8 13.1 13.0 14.8 4.3 16.3 2.4 2.7 18.9 7.7 10.8 10.6 4.2 5.9 2.5 6.0 4.5 18.7 5.6 6.9 23.0 9.9 4.2 27.4 13.8 5.2 27.1 5.6 7.3 7.9 6.1 26.5 7.8 6.8 6.2 7.5 7.5 21.2 6.5 10.4 17.5 8.9 15.6 26.1 9.5 97.9 11.0 42.0 15.3 37.5 18.2 14.0 15.7 14.3 33.2 23.7 12.9 14.6 8.4 0.0 12.5 11.1 14.6 8.9 15.1 10.6 8.4 12.7 2.4 6.7 8.8 11.8 10.0 23.9 25.3 81.2 8.2 9.5 12.7 12.9 16.3 23.0 12.3 0.0 15.5 16.8 11.1 104.9 21.6 10.9 14.4 9.7 CBWD3 bA561O23.1 ENSG00000196873 "COBW domain containing 3" Q5JTY5 9 68232003-68300015 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "blood: 34.4" "Low cell type specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042759, HPA042813" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (1.72e-2)" "unprognostic (2.15e-1)" "unprognostic (1.95e-1)" "unprognostic (9.71e-3)" "unprognostic (9.99e-2)" "unprognostic (6.38e-2)" "unprognostic (3.44e-2)" "unprognostic (1.79e-2)" "unprognostic (3.54e-2)" "unprognostic (1.81e-1)" "unprognostic (1.05e-2)" "unprognostic (2.05e-2)" "unprognostic (1.05e-3)" "unprognostic (3.77e-2)" "unprognostic (1.67e-1)" "unprognostic (4.43e-3)" "unprognostic (5.16e-4)" 3.8 6.0 4.4 6.6 4.9 4.0 6.5 5.7 5.1 2.7 4.7 4.2 2.9 2.1 5.4 3.0 1.8 2.9 4.8 4.4 7.7 11.1 2.9 5.7 4.5 3.6 10.7 4.2 5.0 5.5 4.1 3.2 3.7 3.6 5.2 4.9 7.6 2.8 3.9 5.0 6.3 3.2 5.1 4.3 4.5 3.5 20.3 24.4 34.4 33.9 5.7 14.0 19.9 21.3 15.9 7.8 12.1 5.8 1.9 10.3 10.7 4.2 4.5 5.3 4.4 21.0 24.7 10.4 7.7 21.0 26.2 14.3 21.0 12.4 38.0 9.2 9.5 36.2 21.0 7.4 17.9 11.9 4.8 6.5 8.2 10.8 9.0 10.5 28.3 17.3 20.2 6.6 13.7 20.9 23.9 11.4 25.5 26.7 9.5 24.3 26.9 5.1 9.2 12.1 7.8 17.6 10.6 13.1 15.1 7.6 20.8 5.0 7.0 17.9 11.5 20.5 11.9 47.4 30.3 21.0 26.5 12.6 9.1 33.9 24.8 11.6 27.2 10.0 20.3 10.8 11.9 24.4 18.4 11.7 10.9 34.4 5.7 19.0 18.3 14.0 19.9 23.8 25.9 16.0 14.0 12.9 27.1 24.2 7.6 40.2 34.2 10.4 27.5 11.9 1.7 5.1 3.3 7.5 11.7 0.0 10.0 6.7 4.7 7.5 11.6 7.3 4.6 11.1 4.1 7.4 13.0 1.7 4.6 8.7 5.0 22.6 6.5 4.3 6.9 14.0 2.8 5.0 34.5 6.5 5.3 10.1 5.0 18.7 12.9 10.2 8.1 9.5 CBWD5 ENSG00000147996 "COBW domain containing 5" Q5RIA9 9 65668805-65734041 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042759, HPA042813" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (1.34e-1)" "unprognostic (3.62e-2)" "unprognostic (8.18e-2)" "unprognostic (4.23e-3)" "unprognostic (5.25e-3)" "unprognostic (1.02e-3)" "unprognostic (5.32e-3)" "unprognostic (9.24e-2)" "unprognostic (2.07e-1)" "unprognostic (1.54e-2)" "unprognostic (1.11e-2)" "unprognostic (6.46e-3)" "unprognostic (1.03e-1)" "unprognostic (4.61e-3)" "unprognostic (1.17e-1)" "unprognostic (5.68e-2)" "unprognostic (3.87e-1)" 4.1 6.0 5.2 3.7 6.8 2.5 9.2 8.2 3.7 2.8 3.3 5.4 1.7 4.8 3.3 1.7 2.2 2.4 6.2 6.0 7.6 17.9 1.9 2.6 4.8 2.1 6.6 2.9 4.0 2.9 4.3 5.5 2.2 3.8 2.1 2.8 4.4 2.5 2.6 5.7 2.2 2.1 5.1 4.4 5.4 1.5 5.5 11.7 7.7 14.0 2.5 5.5 9.3 15.0 16.2 5.8 7.4 8.9 4.1 7.0 10.7 7.2 8.5 8.7 2.1 13.9 20.5 6.9 6.2 12.2 11.1 26.3 8.5 16.1 3.3 6.3 5.7 26.2 36.4 6.7 12.9 3.7 7.2 9.9 7.8 6.3 10.7 15.3 7.9 8.1 15.3 8.6 18.2 6.4 13.7 7.1 26.0 17.5 11.2 8.0 20.5 13.5 9.9 7.7 7.8 8.7 6.8 3.1 10.7 31.8 8.6 4.3 3.8 14.2 11.7 12.2 5.0 13.4 4.9 16.1 14.9 14.5 1.6 11.6 7.7 3.4 14.0 3.7 5.5 5.5 4.7 11.7 2.9 5.1 4.1 7.1 2.5 8.5 4.9 4.1 9.3 38.7 47.5 48.4 29.8 57.9 38.4 30.2 33.1 36.1 52.4 19.2 64.8 36.3 18.3 30.3 7.7 18.2 41.3 23.3 34.0 18.7 12.4 16.5 9.3 42.4 14.1 33.4 16.1 15.4 24.3 4.1 19.5 26.9 28.7 55.1 26.5 9.8 28.6 45.6 16.3 31.8 56.7 6.5 25.0 26.5 16.8 74.8 42.2 19.8 27.6 26.5 CBWD6 CBWD7 ENSG00000215126 "COBW domain containing 6" Q4V339 9 41131306-41199261 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "blood: 9.3;liver: 6.1" "Cell type enhanced" "Detected in many" 11 "Basal keratinocytes: 34.9;Melanocytes: 13.5;Suprabasal keratinocytes: 37.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 12.5;PC-3: 19.4" "HPA042759, HPA042813" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (9.48e-2)" "unprognostic (6.02e-2)" "unprognostic (1.62e-2)" "unprognostic (1.91e-2)" "unprognostic (1.30e-2)" "unprognostic (6.28e-2)" "unprognostic (5.92e-2)" "unprognostic (3.71e-2)" "unprognostic (2.07e-2)" "unprognostic (1.12e-1)" "unprognostic (4.24e-2)" "unprognostic (1.09e-1)" "unprognostic (2.28e-4)" "unprognostic (5.65e-2)" "unprognostic (1.65e-1)" "unprognostic (1.01e-2)" "unprognostic (9.94e-4)" 0.1 5.2 2.2 0.4 2.4 2.0 2.8 1.0 2.0 0.2 0.3 1.2 0.1 0.0 0.2 0.0 1.6 1.3 2.8 1.5 2.1 6.1 0.1 0.0 1.2 0.2 1.3 0.0 0.5 0.0 0.6 0.0 2.8 2.5 4.3 0.4 0.9 0.0 1.2 0.3 0.2 0.1 0.3 0.2 0.2 0.1 4.8 4.0 2.5 9.3 0.6 4.3 2.8 1.4 0.3 0.6 0.3 0.7 1.9 1.2 7.9 8.9 9.2 0.0 3.0 0.9 1.9 0.4 6.4 0.4 1.3 11.7 0.2 0.3 1.9 7.5 0.5 4.2 2.1 0.0 2.3 0.7 0.2 1.1 6.1 7.6 0.7 7.0 0.6 1.0 1.1 12.5 1.2 3.4 0.6 1.9 3.2 19.4 0.8 7.8 2.6 8.2 0.5 0.9 1.0 1.9 0.7 0.9 1.8 0.6 1.2 11.7 0.1 0.9 0.4 0.8 3.5 0.6 10.3 1.2 0.8 0.9 1.6 5.9 2.5 0.8 6.8 1.4 4.8 4.3 3.5 3.3 1.8 3.0 3.4 0.9 0.6 9.3 4.0 1.8 2.8 3.0 6.2 0.0 0.0 34.9 0.0 0.0 0.0 2.7 4.5 5.2 0.0 4.4 3.3 3.7 0.0 0.0 0.0 0.0 4.3 5.7 3.1 0.0 8.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 4.0 13.5 2.8 0.0 0.0 4.1 0.0 0.0 7.2 0.0 0.0 2.6 0.0 0.0 37.5 5.3 0.0 0.0 0.0 CCNYL1 FLJ40432 ENSG00000163249 "Cyclin Y like 1" Q8N7R7 2 207711540-207761839 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Paneth cells: 67.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 41.9" HPA046825 Approved Approved "Plasma membrane" Yes No "Plasma membrane" "HPA046825: AB_10963934" "unprognostic (2.59e-2)" "unprognostic (1.23e-1)" "unprognostic (1.03e-2)" "unprognostic (1.20e-3)" "unprognostic (1.78e-1)" "unprognostic (1.59e-1)" "unprognostic (1.31e-3)" "unprognostic (5.48e-2)" "unprognostic (1.65e-1)" "unprognostic (1.41e-2)" "unprognostic (7.12e-3)" "unprognostic (7.99e-2)" "unprognostic (3.92e-2)" "unprognostic (8.08e-2)" "unprognostic (7.91e-2)" "unprognostic (2.37e-2)" "unprognostic (1.96e-3)" 17.5 8.0 9.8 12.2 10.7 10.6 14.5 4.8 12.8 12.6 18.1 11.2 11.5 13.3 8.8 8.2 24.6 8.0 10.0 11.7 8.0 7.2 15.9 18.4 14.5 11.9 9.1 10.1 6.3 21.6 6.9 8.3 16.8 9.3 7.9 16.4 7.9 12.1 10.0 10.1 5.8 16.3 10.8 11.7 12.1 14.8 18.3 8.1 10.9 14.4 6.6 13.9 10.8 13.9 4.1 1.8 4.6 3.8 1.9 2.7 0.9 11.8 5.1 6.9 9.9 9.4 10.6 41.9 7.3 12.4 7.6 8.3 23.0 11.2 4.5 7.0 13.3 18.5 8.3 8.2 13.5 7.4 1.6 6.2 6.0 5.9 19.3 8.8 5.6 7.2 5.0 5.6 9.3 10.7 6.8 24.5 5.4 2.9 4.8 10.0 6.0 4.9 5.0 13.7 5.1 5.7 4.2 6.9 3.6 8.1 8.9 1.6 5.4 9.0 3.8 11.0 17.5 3.5 14.2 13.0 8.6 8.7 10.8 4.9 2.7 3.7 6.9 9.7 6.4 7.3 1.7 3.8 1.5 1.1 1.9 1.4 1.2 1.9 1.9 1.8 4.1 1.5 2.7 4.6 1.9 1.7 1.7 1.3 0.9 9.8 10.7 4.8 12.8 8.0 7.2 9.1 10.1 9.3 8.1 3.0 15.5 8.5 12.6 10.9 5.7 7.0 2.5 1.4 6.8 22.7 9.8 11.1 1.7 5.7 7.7 11.7 30.0 0.0 12.6 29.2 8.9 12.4 5.7 13.2 14.5 4.8 9.2 21.5 16.1 7.4 2.6 14.3 8.5 20.8 7.5 9.7 10.6 67.0 3.5 9.8 12.9 0.0 9.2 17.0 7.8 9.3 6.4 7.2 6.0 16.0 CCR3 "CC-CKR-3, CD193, CKR3, CMKBR3" ENSG00000183625 "C-C motif chemokine receptor 3" P51677 3 46163604-46266706 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "blood: 175.9" "Cell type enhanced" "Detected in some" 17 "granulocytes: 1.1;Melanocytes: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 22 "basophil: 175.9;eosinophil: 152.0" "Lineage enriched" "Detected in many" 92 "granulocytes: 175.9" "Cell line enriched" "Detected in some" 9 "RPMI-8226: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "CAB003795, HPA069514" Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "CAB003795: AB_562259, HPA069514: " "unprognostic (1.56e-2)" "unprognostic (6.65e-3)" "unprognostic (1.01e-1)" "unprognostic (3.98e-2)" "unprognostic (1.41e-1)" "unprognostic (3.25e-3)" "unprognostic (3.11e-7)" "unprognostic (4.36e-2)" "unprognostic (3.35e-2)" "unprognostic (3.43e-2)" "unprognostic (4.81e-2)" "unprognostic (3.94e-2)" "unprognostic (3.17e-6)" "unprognostic (1.35e-2)" "unprognostic (1.72e-2)" "unprognostic (2.41e-1)" "unprognostic (9.81e-2)" 0.6 0.2 0.3 2.9 1.1 0.4 0.3 0.2 0.8 0.3 1.3 0.2 0.2 2.9 0.8 0.2 0.4 0.5 1.3 0.3 0.2 0.2 0.5 1.2 5.8 0.6 0.3 0.2 0.2 0.3 0.0 0.3 7.0 0.7 1.0 1.4 0.9 2.4 0.2 3.2 3.6 5.1 1.6 0.5 2.7 2.2 0.4 0.2 0.6 1.8 2.8 0.6 4.0 0.3 0.0 0.2 175.9 0.0 0.0 1.9 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 2.3 0.0 0.7 0.0 0.8 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.1 0.3 0.1 0.0 0.0 0.2 0.0 25.5 0.0 2.1 0.1 0.0 0.0 0.7 0.0 0.8 0.0 0.6 0.0 0.1 0.2 0.0 0.1 2.8 2.2 0.0 0.0 0.5 0.0 175.9 0.0 152.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.2 1.9 0.3 0.3 1.1 0.2 0.8 0.2 0.2 0.3 0.2 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 CCR4 "CC-CKR-4, CD194, ChemR13, CKR4, CMKBR4, k5-5" ENSG00000183813 "C-C motif chemokine receptor 4" P51679 3 32951574-32956349 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 28.9;lymphoid tissue: 57.1" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 1.4;granulocytes: 2.3;Horizontal cells: 4.8;T-cells: 2.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "T-reg: 28.9" "Lineage enriched" "Detected in single" 48 "T-cells: 28.9" "Cell line enriched" "Detected in some" 17 "HDLM-2: 67.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA031613 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA031613: AB_10601096" "unprognostic (4.63e-3)" "unprognostic (8.70e-3)" "unprognostic (2.82e-3)" "unprognostic (2.64e-3)" "unprognostic (1.18e-1)" "unprognostic (4.59e-7)" "unprognostic (3.02e-1)" "unprognostic (5.05e-3)" "unprognostic (1.53e-2)" "unprognostic (1.69e-2)" "unprognostic (1.75e-1)" "unprognostic (2.17e-1)" "unprognostic (9.88e-3)" "unprognostic (2.04e-1)" "unprognostic (5.53e-4)" "unprognostic (1.54e-1)" "unprognostic (1.40e-1)" 1.5 0.6 0.3 12.6 0.4 1.5 1.1 0.3 0.3 1.1 1.1 0.1 0.7 0.4 1.0 0.6 1.6 0.8 3.8 0.8 0.3 0.3 1.8 0.9 6.0 24.1 0.3 0.0 0.5 0.5 0.5 0.5 0.1 0.1 1.5 1.2 0.8 4.3 0.2 1.8 2.2 5.0 0.4 0.4 10.2 1.3 2.7 0.0 57.1 1.3 2.8 29.7 8.6 1.1 0.2 0.2 0.5 0.1 0.1 28.9 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 67.1 0.0 4.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.9 1.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.1 0.2 0.1 0.2 0.1 6.0 1.8 0.0 0.2 0.1 0.1 0.5 0.1 0.1 0.2 28.9 0.8 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.0 0.1 0.0 0.0 1.1 0.0 0.5 0.3 0.1 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.5 2.3 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 1.0 0.1 0.0 2.2 0.0 0.4 CD163 "M130, MM130, SCARI1" ENSG00000177575 "CD163 molecule" Q86VB7 12 7470813-7503893 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Acute phase, Inflammatory response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 113.6" "Cell type enriched" "Detected in many" 7 "Kupffer cells: 1509.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "classical monocyte: 28.2;myeloid DC: 25.3" "Group enriched" "Detected in many" 40 "dendritic cells: 25.3;monocytes: 28.2" "Cell line enhanced" "Detected in some" "ASC diff: 1.8;CACO-2: 1.7;GAMG: 5.4;HSkMC: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "CAB002432, HPA046404, HPA051974" Enhanced Supported "Plasma membrane" "Secreted to blood" NA NA 903000000 1600000000 "Plasma membrane" "CAB002432: AB_563510, HPA046404: AB_2679655, HPA051974: AB_2681678" "unprognostic (1.13e-1)" "unprognostic (2.13e-1)" "unprognostic (5.02e-3)" "unprognostic (2.72e-1)" "unprognostic (6.17e-3)" "unprognostic (2.09e-1)" "unprognostic (1.02e-1)" "unprognostic (1.21e-1)" "unprognostic (2.78e-1)" "prognostic unfavorable (7.27e-4)" "unprognostic (1.04e-1)" "unprognostic (6.50e-2)" "unprognostic (1.84e-2)" "unprognostic (8.77e-2)" "unprognostic (4.95e-2)" "unprognostic (1.61e-1)" "unprognostic (1.20e-2)" 66.7 23.8 2.1 44.6 7.2 4.1 23.2 2.8 4.9 11.3 25.3 1.6 1.4 3.5 7.2 16.8 11.3 20.1 13.2 15.7 2.8 1.8 43.9 38.9 81.0 99.8 6.9 0.5 10.3 6.7 3.1 11.7 31.9 9.9 6.8 6.5 9.8 8.6 2.2 15.2 4.0 12.5 37.2 5.7 113.6 10.2 19.6 4.3 3.4 15.5 2.9 3.5 20.1 8.3 0.0 25.3 0.6 28.2 0.0 0.0 6.3 0.0 0.0 0.0 0.0 1.8 1.0 0.4 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 5.4 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.5 0.3 5.3 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.5 0.1 0.0 0.1 0.9 0.1 0.0 0.0 0.2 0.5 0.1 0.1 0.0 0.5 0.0 0.3 0.0 0.9 0.3 0.2 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.5 28.2 0.1 0.0 2.5 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 6.3 2.1 7.2 2.8 2.4 2.8 1.8 6.9 0.5 9.9 4.3 3.0 8.8 9.3 0.2 1.3 0.0 3.4 10.2 2.7 9.1 0.0 2.0 1.3 0.0 0.0 2.5 1.9 0.0 0.0 0.0 1.5 1.6 0.1 4.7 5.9 221.9 0.0 0.0 28.3 1509.4 3.9 4.6 104.2 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.0 0.1 116.4 0.3 3.9 1.7 0.9 2.5 5.0 0.0 0.0 CD200R1 "CD200R, HCRTR2, MOX2R, OX2R" ENSG00000163606 "CD200 receptor 1" Q8TD46 3 112921209-112975122 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 46.7;lymphoid tissue: 21.2" "Cell type enhanced" "Detected in some" 11 "Erythroid cells: 23.3;granulocytes: 14.0;Hofbauer cells: 24.1;Ito cells: 19.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 46.7;eosinophil: 12.7" "Lineage enriched" "Detected in many" 8 "granulocytes: 46.7" "Cell line enriched" "Detected in some" 8 "HEL: 25.6" HPA068512 Supported "Plasma membrane" "Intracellular and membrane" NA NA 1500000 "Plasma membrane" "HPA068512: AB_2732784" "unprognostic (1.49e-2)" "unprognostic (1.06e-2)" "unprognostic (2.55e-1)" "unprognostic (1.97e-2)" "unprognostic (1.53e-1)" "unprognostic (1.24e-2)" "unprognostic (1.13e-1)" "unprognostic (2.06e-3)" "unprognostic (8.30e-2)" "unprognostic (1.85e-1)" "unprognostic (7.98e-2)" "unprognostic (2.46e-1)" "unprognostic (1.08e-5)" "unprognostic (1.77e-1)" "unprognostic (7.84e-3)" "unprognostic (1.25e-1)" "unprognostic (5.12e-3)" 3.6 1.6 1.0 9.5 1.4 1.8 3.8 0.8 1.4 5.0 3.5 0.3 1.5 2.0 3.9 5.4 7.5 1.3 2.7 5.8 1.0 1.2 1.4 3.4 4.3 9.0 1.0 0.0 1.0 1.1 0.5 1.0 7.8 0.4 4.2 3.5 2.4 2.5 1.6 0.9 3.4 3.3 1.7 0.9 21.2 1.7 2.5 0.5 15.8 2.0 3.9 17.0 3.8 2.0 2.3 5.8 46.7 0.8 0.6 3.7 1.3 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.2 25.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 1.2 0.0 46.7 0.8 12.7 1.0 0.4 1.8 2.3 3.7 2.1 5.8 1.2 3.6 1.7 0.2 0.6 0.1 0.1 1.0 1.3 1.0 1.4 0.8 1.4 1.0 1.2 1.0 0.0 0.4 0.5 0.0 1.4 2.9 0.1 1.6 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 23.3 0.0 0.1 1.3 0.0 14.0 0.0 24.1 0.0 0.0 19.6 4.7 0.0 0.0 3.6 5.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.6 0.6 7.5 0.0 0.1 CD300LB "CLM7, TREM5" ENSG00000178789 "CD300 molecule like family member b" A8K4G0 17 74521174-74531474 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 20.7;blood: 30.7;bone marrow: 8.8;lymphoid tissue: 10.9" "Group enriched" "Detected in some" 8 "Hofbauer cells: 6.5;Kupffer cells: 10.1;Macrophages: 10.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "eosinophil: 30.7" "Group enriched" "Detected in many" 52 "dendritic cells: 10.5;granulocytes: 30.7;monocytes: 13.0" "Group enriched" "Detected in some" 6 "HL-60: 4.6;NB-4: 6.0;THP-1: 4.7;U-937: 2.8" HPA060449 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA060449: " "unprognostic (1.39e-1)" "unprognostic (2.44e-2)" "unprognostic (1.37e-1)" "unprognostic (4.39e-2)" "unprognostic (3.59e-2)" "unprognostic (1.15e-1)" "unprognostic (6.41e-2)" "unprognostic (7.69e-2)" "unprognostic (2.05e-1)" "unprognostic (2.95e-2)" "unprognostic (6.24e-2)" "unprognostic (3.32e-1)" "unprognostic (2.49e-4)" "unprognostic (2.92e-2)" "unprognostic (1.79e-2)" "unprognostic (7.08e-2)" "unprognostic (4.01e-2)" 20.7 0.9 0.2 10.9 0.5 8.8 2.0 0.4 0.5 0.6 0.8 0.3 0.1 0.7 0.7 1.0 1.1 1.2 2.8 1.6 1.5 0.4 1.2 1.0 4.4 6.5 1.2 0.1 2.0 2.3 0.0 0.7 1.1 1.0 0.8 1.1 1.6 1.2 0.1 0.3 0.4 2.0 2.2 0.6 6.6 0.7 0.7 0.1 0.9 0.6 0.1 2.2 2.6 0.7 0.0 10.5 30.7 13.0 0.3 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.4 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 2.8 0.0 0.6 13.0 30.7 0.0 5.6 0.1 0.0 0.0 0.0 10.5 0.0 0.0 0.1 13.8 0.3 0.7 6.6 0.0 4.2 0.2 0.5 0.4 0.5 1.5 0.4 1.2 0.1 1.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.5 0.0 0.0 0.6 10.1 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CD38 ENSG00000004468 "CD38 molecule" P28907 4 15778275-15853230 "Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins" "Hydrolase, Receptor, Transferase" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 94.9;seminal vesicle: 104.1" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 49.5;Erythroid cells: 46.7;granulocytes: 39.1;Kupffer cells: 31.1;T-cells: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 15.3" "Group enriched" "Detected in all" 4 "B-cells: 9.0;dendritic cells: 5.1;NK-cells: 15.3" "Cell line enhanced" "Detected in some" "Daudi: 50.8;Karpas-707: 14.2;MOLT-4: 12.8;REH: 10.3;U-266/70: 11.0;U-698: 9.6" "Low region specificity" "Detected in all" "CAB002493, HPA022132, CAB025255, HPA052381" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB002493: AB_563556, CAB025255: , HPA022132: AB_1846300, HPA052381: AB_2681807" "unprognostic (1.27e-2)" "unprognostic (8.06e-3)" "unprognostic (1.06e-2)" "prognostic favorable (9.68e-4)" "unprognostic (1.13e-1)" "unprognostic (1.82e-3)" "unprognostic (2.74e-1)" "unprognostic (8.51e-2)" "unprognostic (5.87e-2)" "unprognostic (6.15e-6)" "unprognostic (5.23e-1)" "unprognostic (4.34e-1)" "unprognostic (6.63e-6)" "unprognostic (1.79e-1)" "unprognostic (5.74e-2)" "unprognostic (2.12e-2)" "unprognostic (2.13e-1)" 4.1 3.3 3.8 17.6 8.5 9.3 2.6 0.7 12.0 1.0 3.2 10.4 14.6 4.3 0.7 0.9 2.3 2.4 1.5 5.0 4.0 4.2 1.2 5.4 4.7 16.1 4.9 3.1 0.6 0.7 0.0 2.5 0.6 3.1 10.8 2.7 4.4 2.8 104.1 14.2 0.5 6.2 0.9 1.8 20.6 2.0 0.7 2.5 94.9 2.8 2.0 13.2 7.6 0.9 9.0 5.1 1.3 2.2 15.3 2.3 3.7 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 50.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.1 14.2 0.0 0.0 12.8 3.1 0.0 0.0 0.0 10.3 0.0 8.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.0 2.2 0.2 0.0 0.0 0.0 0.0 11.0 0.1 9.6 0.1 2.4 0.1 0.0 1.7 0.0 1.1 2.2 0.3 9.0 1.4 1.2 4.1 6.6 2.3 1.8 1.3 15.3 1.4 5.1 2.1 3.7 3.8 8.5 0.7 6.2 4.0 4.2 4.9 3.1 3.1 2.5 3.0 10.8 23.4 0.4 0.0 0.0 0.8 0.0 49.5 18.2 0.0 9.8 0.2 0.0 0.0 1.6 0.1 0.0 46.7 0.0 0.0 0.5 10.7 39.1 1.3 4.6 0.0 0.0 3.1 31.1 0.0 0.0 10.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 2.2 1.4 0.0 0.5 30.5 0.7 0.1 CD4 ENSG00000010610 "CD4 molecule" P01730 12 6786858-6820808 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 111.5;parathyroid gland: 78.4" "Cell type enhanced" "Detected in many" 19 "Hofbauer cells: 121.3;Ito cells: 382.4;Kupffer cells: 192.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 17 "classical monocyte: 42.2;intermediate monocyte: 42.5;memory CD4 T-cell: 29.1;myeloid DC: 29.3;naive CD4 T-cell: 24.8;non-classical monocyte: 33.3;plasmacytoid DC: 46.7;T-reg: 26.4" "Group enriched" "Detected in many" 20 "dendritic cells: 46.7;monocytes: 42.5;T-cells: 29.1" "Group enriched" "Detected in some" 6 "HEL: 34.3;HL-60: 13.8;NB-4: 19.7;THP-1: 39.0;U-937: 36.7" "Region enriched" "Detected in single" 15 "basal ganglia: 41.4" "Not detected" "Not detected" "CAB000011, HPA004252, HPA004472, CAB068180" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB000011: AB_442062, CAB068180: AB_2665653, HPA004252: AB_1078466, HPA004472: AB_1078465" "unprognostic (1.39e-2)" "unprognostic (1.12e-2)" "unprognostic (2.75e-2)" "prognostic favorable (2.16e-4)" "unprognostic (7.76e-2)" "unprognostic (4.82e-3)" "unprognostic (3.70e-2)" "unprognostic (2.74e-2)" "unprognostic (7.04e-2)" "unprognostic (2.40e-1)" "unprognostic (1.13e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (7.45e-4)" "unprognostic (1.06e-1)" "unprognostic (4.65e-3)" "unprognostic (9.08e-3)" "unprognostic (2.95e-1)" 13.8 5.4 6.1 16.0 5.8 4.4 5.6 1.2 4.3 4.5 5.1 8.6 1.8 3.6 3.5 8.3 3.0 5.5 7.3 5.4 4.9 4.4 6.1 32.2 24.0 30.8 6.3 3.1 3.0 3.1 78.4 3.4 10.9 6.2 4.1 6.5 5.7 5.4 3.9 1.9 3.5 9.5 5.2 10.2 49.1 3.9 2.8 5.7 111.5 3.9 4.1 18.6 8.6 3.2 0.1 46.7 1.9 42.5 0.3 29.1 33.6 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 34.3 0.0 0.2 3.8 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 19.7 0.3 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.7 0.0 0.1 42.2 0.3 0.3 42.5 1.1 0.0 29.1 0.1 29.3 0.1 24.8 0.1 1.9 0.3 33.3 46.7 26.4 33.6 6.1 5.8 1.2 4.3 4.9 4.4 6.3 3.1 6.2 5.7 0.0 6.9 8.2 0.2 3.1 1.5 1.6 15.3 26.8 3.4 3.5 0.0 0.8 5.0 0.0 0.0 2.8 0.0 0.0 0.3 0.9 5.4 0.1 7.0 7.8 121.3 4.8 0.0 382.4 192.9 0.0 15.5 72.7 5.0 39.7 0.0 14.3 0.0 0.0 14.2 1.1 0.1 12.9 4.2 0.0 0.1 1.9 1.0 28.4 0.0 0.3 CD46 "MCP, MGC26544, MIC10, TLX, TRA2.10" ENSG00000117335 "CD46 molecule" P15529 1 207752057-207795513 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins" "Complement pathway, Fertilization, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Cancer-related genes, Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 41.7;eosinophil: 63.7;neutrophil: 69.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 69.8" "Low cell line specificity" "Detected in all" "CAB010401, HPA016903" Enhanced Approved "Plasma membrane" NA NA 1000000 "Plasma membrane" "CAB010401: AB_2291289, HPA016903: AB_1846309" "unprognostic (1.42e-2)" "prognostic unfavorable (8.54e-5)" "unprognostic (3.94e-2)" "unprognostic (2.14e-2)" "unprognostic (3.28e-2)" "unprognostic (6.30e-2)" "unprognostic (1.91e-2)" "unprognostic (1.82e-1)" "unprognostic (1.25e-1)" "unprognostic (2.74e-1)" "unprognostic (8.79e-2)" "unprognostic (2.50e-1)" "unprognostic (6.78e-3)" "prognostic favorable (2.38e-4)" "unprognostic (1.76e-1)" "unprognostic (8.23e-2)" "unprognostic (1.49e-2)" 38.0 78.0 13.0 22.9 20.5 18.5 57.0 12.9 17.8 27.5 35.4 25.3 64.3 32.9 39.7 32.6 43.2 30.4 25.2 20.6 16.1 15.5 50.8 57.8 43.6 25.0 21.4 13.2 27.6 47.9 86.6 32.7 119.6 29.1 47.0 28.5 26.7 68.4 60.5 18.8 18.4 39.8 25.0 21.8 26.9 33.9 16.5 20.7 20.3 25.3 21.8 30.3 37.2 27.0 7.7 8.1 69.8 14.1 7.5 13.5 14.9 26.7 15.1 14.2 6.5 44.8 44.4 21.6 20.1 29.2 13.3 18.0 14.8 71.2 4.1 20.5 20.0 18.3 36.3 10.6 27.6 20.3 20.5 15.1 8.9 16.6 26.6 28.5 19.3 31.0 38.1 41.1 20.0 15.8 31.4 37.1 16.3 18.6 17.9 20.4 12.6 9.2 17.0 16.2 16.0 15.1 6.2 22.6 25.2 54.3 53.0 14.4 9.8 25.4 57.2 33.0 29.6 45.0 16.6 31.8 14.3 12.7 30.0 22.8 24.1 29.0 12.4 20.9 12.8 13.4 41.7 13.5 63.7 9.2 14.0 12.5 7.7 11.7 10.1 8.1 6.0 13.5 11.2 69.8 7.5 14.1 4.2 10.1 14.9 13.0 20.5 12.9 17.8 16.1 15.5 21.4 13.2 29.1 20.7 187.6 224.8 34.3 81.1 47.1 61.8 56.5 86.6 227.5 213.9 137.9 62.8 190.0 13.3 67.0 176.4 91.0 82.1 0.0 68.5 62.2 54.2 160.9 108.9 100.2 53.0 38.1 69.8 78.5 81.8 23.7 43.7 72.9 59.1 50.5 91.2 28.9 65.3 92.2 41.4 61.7 79.1 51.8 66.9 13.8 23.3 40.1 287.4 51.1 85.2 127.3 CD81 "TAPA-1, TAPA1, TSPAN28" ENSG00000110651 "CD81 molecule" P60033 11 2376177-2397419 "CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Muller glia cells: 752.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 41.4;naive B-cell: 37.6" "Lineage enriched" "Detected in all" 4 "B-cells: 41.4" "Cell line enhanced" "Detected in many" "ASC diff: 236.1;ASC TERT1: 134.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002507, HPA007234" Supported Supported "Plasma membrane" NA NA 1900000 "Plasma membrane" "CAB002507: AB_563639, HPA007234: AB_1846333" "unprognostic (2.96e-1)" "unprognostic (3.40e-1)" "prognostic unfavorable (7.56e-4)" "unprognostic (1.84e-2)" "prognostic unfavorable (8.21e-5)" "unprognostic (6.03e-2)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (2.09e-1)" "unprognostic (1.24e-1)" "prognostic favorable (3.86e-4)" "unprognostic (3.07e-3)" "unprognostic (2.08e-1)" "unprognostic (3.55e-2)" "unprognostic (1.67e-1)" "unprognostic (2.06e-1)" "unprognostic (2.06e-1)" 102.5 43.7 52.8 40.1 57.0 9.6 79.3 31.7 63.2 124.7 88.9 75.8 261.4 21.1 143.5 141.5 56.8 123.1 86.8 101.2 46.6 52.8 65.5 123.9 107.4 82.4 70.4 51.3 77.9 62.4 41.4 42.9 61.2 63.0 89.3 34.0 46.6 59.7 263.3 22.6 59.6 39.7 138.9 59.3 64.5 52.1 57.6 53.3 25.3 66.3 38.5 37.9 93.5 80.2 41.4 2.1 5.7 1.8 3.5 9.9 2.7 25.0 26.1 20.9 31.9 236.1 134.3 17.5 47.4 105.1 38.4 38.8 24.4 0.1 21.4 17.1 132.9 24.5 33.0 12.9 33.7 15.8 10.1 39.7 3.2 9.9 0.0 78.1 13.9 28.2 97.5 48.3 15.6 23.8 59.6 36.7 15.6 14.6 37.6 53.6 19.2 11.7 17.7 25.1 22.9 21.1 24.2 10.5 13.6 41.2 16.9 22.6 25.0 15.1 39.8 28.6 17.5 13.2 25.4 48.8 19.6 14.4 36.6 16.2 27.9 6.3 39.1 28.4 8.3 33.4 0.2 0.9 5.7 6.0 1.4 9.9 41.4 4.3 9.4 0.6 37.6 2.6 5.0 0.3 3.5 1.8 2.1 3.0 2.7 52.8 57.0 31.7 63.2 46.6 52.8 70.4 51.3 63.0 53.3 226.3 220.8 55.9 245.9 159.7 80.4 246.3 147.7 72.3 130.8 197.1 25.5 19.0 29.9 103.9 13.1 213.4 6.4 46.7 46.5 23.9 217.2 129.6 79.7 450.6 229.2 139.8 69.1 262.8 169.7 26.3 360.5 166.2 143.4 23.4 40.0 752.2 58.2 11.5 236.2 26.2 63.6 116.4 236.9 12.0 13.4 144.2 16.8 56.5 36.6 204.6 CD86 "B7-2, B7.2, CD28LG2" ENSG00000114013 "CD86 molecule" P42081 3 122055366-122121139 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.0;brain: 26.1" "Cell type enriched" "Detected in many" 5 "monocytes: 760.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "classical monocyte: 25.6;intermediate monocyte: 26.4;memory B-cell: 13.6;myeloid DC: 25.9;naive B-cell: 8.0;non-classical monocyte: 27.0" "Group enriched" "Detected in many" 17 "B-cells: 13.6;dendritic cells: 25.9;monocytes: 27.0" "Cell line enriched" "Detected in some" 7 "HDLM-2: 80.7" "Low region specificity" "Detected in all" "CAB004319, HPA026802" Approved Supported "Plasma membrane" NA NA 220000 "Plasma membrane" "CAB004319: AB_627200, HPA026802: " "unprognostic (1.81e-1)" "unprognostic (3.78e-3)" "unprognostic (3.04e-2)" "unprognostic (3.52e-2)" "unprognostic (1.36e-1)" "unprognostic (2.79e-1)" "unprognostic (1.15e-1)" "unprognostic (8.56e-2)" "unprognostic (7.72e-3)" "unprognostic (1.21e-1)" "unprognostic (1.28e-1)" "unprognostic (1.98e-1)" "prognostic unfavorable (9.83e-5)" "unprognostic (9.72e-2)" "unprognostic (1.70e-2)" "unprognostic (9.78e-2)" "unprognostic (8.67e-2)" 10.5 4.7 7.1 23.6 9.5 6.0 3.6 1.5 6.3 2.9 4.3 9.8 0.6 2.5 2.6 5.2 2.8 3.3 10.4 3.5 7.3 6.0 4.0 7.8 13.0 17.8 11.7 3.0 2.5 2.3 2.1 2.6 10.3 8.1 3.1 5.6 3.0 3.6 1.8 1.3 2.4 6.9 5.1 26.1 22.5 3.4 2.4 10.3 7.7 2.3 2.1 15.0 9.2 2.2 13.6 25.9 0.3 27.0 1.2 0.4 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 4.3 0.1 9.6 0.0 0.2 0.0 0.0 25.6 0.2 0.0 26.4 0.0 13.6 0.1 0.1 25.9 8.0 0.0 0.0 0.3 1.2 27.0 2.6 0.4 9.3 7.1 9.5 1.5 6.3 7.3 6.0 11.7 3.0 8.1 10.3 0.0 10.6 25.1 0.0 3.2 0.0 0.2 0.0 0.0 4.5 1.8 0.0 1.6 0.0 0.2 3.0 0.2 0.0 0.0 2.9 0.5 1.7 0.3 2.3 0.8 106.9 0.0 0.0 1.8 111.1 1.3 0.0 155.5 6.8 760.2 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.1 3.4 1.6 0.0 0.0 0.3 CD8A CD8 ENSG00000153563 "CD8a molecule" P01732 2 86784610-86808396 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 14 "blood: 82.2;lymphoid tissue: 262.3" "Cell type enriched" "Detected in some" 11 "T-cells: 65.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 13 "MAIT T-cell: 36.7;memory CD8 T-cell: 82.2;naive CD8 T-cell: 77.8" "Lineage enriched" "Detected in many" 20 "T-cells: 82.2" "Cell line enhanced" "Detected in some" "JURKAT: 5.0;MOLT-4: 17.5;RPMI-8226: 4.0" "Low region specificity" "Detected in many" "CAB000012, HPA037756, CAB075722" Enhanced Supported "Plasma membrane" "Intracellular and membrane" NA NA 500000 "Plasma membrane" "CAB000012: AB_2075537, CAB075722: AB_2665709, HPA037756: AB_2675648" "unprognostic (1.29e-3)" "prognostic favorable (4.54e-4)" "unprognostic (9.26e-3)" "prognostic favorable (6.15e-6)" "unprognostic (7.28e-2)" "unprognostic (2.79e-3)" "unprognostic (1.03e-2)" "unprognostic (2.00e-2)" "unprognostic (1.35e-2)" "unprognostic (4.50e-3)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (1.91e-5)" "unprognostic (1.36e-1)" "unprognostic (1.48e-1)" "unprognostic (6.74e-2)" "unprognostic (1.56e-2)" 2.4 1.4 1.4 7.4 2.8 6.8 1.5 1.4 1.2 2.1 5.3 0.8 0.8 4.2 1.5 2.1 2.0 2.1 4.5 1.6 1.2 1.6 1.3 2.1 6.0 23.8 1.0 0.5 1.7 1.2 0.0 0.9 0.6 0.7 2.3 1.9 1.8 3.0 1.1 0.8 0.7 12.2 0.7 1.7 46.4 5.4 1.0 0.5 262.3 2.2 1.6 8.1 3.8 1.9 0.0 0.1 0.6 0.1 4.0 82.2 17.4 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.4 0.0 1.8 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.0 0.0 0.3 0.0 0.8 17.5 1.1 0.6 0.2 0.3 0.1 0.9 4.0 0.0 0.4 0.9 2.4 0.2 0.1 0.0 0.0 0.4 0.5 0.0 0.0 0.6 0.1 0.0 0.1 0.3 0.9 0.0 0.0 0.1 0.1 0.1 0.0 4.8 0.0 36.7 0.0 0.3 82.2 0.0 0.0 0.3 77.8 0.6 4.0 0.1 0.1 0.1 17.4 1.4 2.8 1.4 1.2 1.2 1.6 1.0 0.5 0.7 0.5 0.0 5.8 1.5 0.2 1.8 0.1 2.9 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.5 0.2 2.3 0.8 0.1 0.0 0.0 5.5 1.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.9 0.5 0.4 1.6 0.1 65.4 0.0 0.1 CD8B CD8B1 ENSG00000172116 "CD8b molecule" P10966 2 86815339-86861924 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 132.1;lymphoid tissue: 61.5" "Cell type enriched" "Detected in some" 7 "T-cells: 61.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory CD8 T-cell: 73.5;naive CD8 T-cell: 132.1" "Lineage enriched" "Detected in many" 40 "T-cells: 132.1" "Cell line enriched" "Detected in some" 55 "RPMI-8226: 158.6" "CAB004353, HPA029164" Enhanced Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "CAB004353: AB_627211, HPA029164: AB_2672936" "unprognostic (1.83e-3)" "unprognostic (1.98e-3)" "unprognostic (2.22e-2)" "prognostic favorable (7.88e-7)" "unprognostic (6.23e-2)" "unprognostic (7.05e-3)" "unprognostic (1.11e-2)" "unprognostic (2.59e-2)" "unprognostic (5.50e-3)" "unprognostic (5.91e-2)" "unprognostic (9.25e-2)" "unprognostic (4.60e-1)" "prognostic unfavorable (7.11e-6)" "unprognostic (7.84e-2)" "unprognostic (3.00e-1)" "unprognostic (1.86e-2)" "unprognostic (4.33e-2)" 1.2 0.7 1.0 5.3 1.0 3.9 1.0 1.3 1.3 21.2 1.1 1.0 1.0 2.5 1.2 1.0 1.0 1.1 1.8 1.0 1.0 1.8 1.0 1.0 2.7 14.4 1.7 1.0 1.3 1.0 6.4 7.4 1.0 2.2 1.3 1.3 1.0 1.0 1.0 1.0 0.9 11.4 1.0 1.5 12.7 2.3 1.0 1.0 61.5 1.5 1.0 8.1 1.8 1.3 0.1 0.1 3.2 0.1 0.1 132.1 36.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 158.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 3.2 0.1 0.0 2.0 0.1 10.0 0.0 0.2 73.5 0.0 0.1 0.5 132.1 0.7 0.1 0.1 0.1 0.2 36.3 1.0 1.0 1.3 1.3 1.0 1.8 1.7 1.0 2.2 1.0 6.0 8.5 0.8 1.7 3.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.7 0.6 0.0 0.2 0.1 0.0 0.0 0.6 1.0 0.0 0.0 1.3 5.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 2.5 0.0 61.8 1.2 0.1 CD9 "BA2, MIC3, MRP-1, P24, TSPAN29" ENSG00000010278 "CD9 molecule" P21926 12 6199715-6238271 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Fertilization" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Urothelial cells: 2399.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 21 "basophil: 137.8;eosinophil: 98.3" "Lineage enriched" "Detected in many" 24 "granulocytes: 137.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 129.4;RT4: 95.9;TIME: 191.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB002490 Supported Supported "Plasma membrane" NA NA 68000000 "Plasma membrane" "CAB002490: AB_563643" "unprognostic (1.38e-1)" "unprognostic (6.36e-3)" "unprognostic (8.27e-3)" "unprognostic (6.98e-3)" "unprognostic (3.89e-1)" "unprognostic (2.81e-1)" "unprognostic (1.32e-1)" "unprognostic (2.08e-2)" "unprognostic (2.90e-1)" "unprognostic (2.60e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (2.30e-1)" "prognostic favorable (6.49e-5)" "unprognostic (6.10e-2)" "unprognostic (1.77e-1)" "prognostic favorable (8.93e-5)" "unprognostic (9.26e-2)" 38.1 44.5 20.0 24.1 36.2 3.1 48.2 6.8 29.6 55.0 68.3 63.1 151.6 19.5 36.2 43.4 139.8 38.4 23.2 39.2 30.3 15.6 39.9 12.2 61.1 8.2 43.3 23.3 14.1 23.3 89.5 15.2 13.0 28.7 77.9 73.5 25.5 91.6 180.4 11.3 60.1 29.6 62.2 48.9 12.2 27.7 10.4 47.7 6.0 63.6 112.3 85.8 54.5 76.0 1.9 0.9 137.8 5.6 0.2 1.1 5.6 34.3 15.1 0.3 9.3 14.8 15.3 13.1 20.4 40.7 7.0 10.7 11.1 129.4 0.1 5.1 4.3 20.8 75.4 7.9 40.7 5.4 1.7 5.5 0.1 11.5 2.4 6.4 0.1 43.3 0.0 30.3 12.8 11.0 19.7 83.6 2.5 1.6 0.1 4.4 49.2 0.1 3.7 11.7 41.8 15.2 0.3 24.9 43.8 68.4 95.9 0.0 2.9 20.3 16.8 17.5 71.5 7.8 3.5 191.3 0.7 19.1 0.7 2.4 0.1 0.1 5.2 11.9 0.0 18.8 137.8 5.6 98.3 0.1 1.8 0.2 0.5 0.1 0.1 0.9 1.9 0.4 1.1 2.6 0.2 0.0 0.3 0.0 5.6 20.0 36.2 6.8 29.6 30.3 15.6 43.3 23.3 28.7 47.7 738.4 321.6 28.1 1345.7 921.9 3.7 14.2 76.5 519.3 651.7 1020.6 0.0 8.4 116.0 478.4 2.3 477.7 411.2 0.0 155.9 225.1 473.0 1465.7 638.5 36.4 653.0 0.0 166.1 406.4 33.8 7.3 29.7 438.3 892.5 256.1 636.4 386.7 257.1 669.9 66.4 14.0 13.1 653.2 455.3 7.0 76.5 1118.7 45.2 23.0 620.5 2399.6 CD99L2 "CD99B, MIC2L1" ENSG00000102181 "CD99 molecule like 2" Q8TCZ2 X 150766337-150898816 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 72.2" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 49.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038782, HPA038783, HPA061400" Enhanced Supported "Plasma membrane" NA NA 790000 "Plasma membrane" "HPA038782: AB_10795139, HPA038783: AB_10794734, HPA061400: AB_2732660" "unprognostic (2.10e-2)" "unprognostic (2.62e-3)" "unprognostic (3.12e-3)" "unprognostic (6.03e-3)" "unprognostic (1.22e-1)" "unprognostic (2.66e-1)" "unprognostic (5.56e-2)" "prognostic favorable (4.96e-4)" "unprognostic (1.10e-1)" "unprognostic (1.28e-1)" "prognostic favorable (2.74e-5)" "unprognostic (5.50e-2)" "unprognostic (5.13e-2)" "unprognostic (1.35e-1)" "unprognostic (6.74e-2)" "unprognostic (9.23e-2)" "prognostic unfavorable (8.74e-4)" 27.1 16.5 23.3 9.2 30.1 4.5 17.8 27.5 56.7 19.2 12.6 21.0 5.5 6.7 17.6 16.5 9.7 17.6 12.4 32.1 26.3 32.0 14.0 17.0 14.9 9.6 30.5 26.6 26.0 8.4 9.7 8.7 21.5 43.1 13.9 7.4 11.9 8.3 22.0 72.2 6.7 8.0 20.8 31.9 12.5 8.0 7.6 13.3 3.0 7.3 6.9 7.0 10.7 7.7 7.2 10.7 9.4 15.1 8.8 8.9 8.4 2.3 23.0 8.7 10.8 46.3 29.0 2.6 19.0 22.3 9.6 13.8 1.6 2.9 8.3 46.1 33.0 7.2 3.7 11.9 12.9 8.0 19.4 9.3 3.6 5.5 2.3 12.5 6.0 6.9 27.3 4.2 7.1 13.5 15.0 11.2 6.6 2.4 22.0 12.0 4.9 5.3 8.8 3.6 1.9 12.5 5.3 7.1 11.4 9.4 1.5 11.6 5.9 7.4 6.4 8.5 6.7 1.8 10.4 13.2 14.2 4.4 18.4 13.6 18.7 30.9 8.1 17.8 12.1 10.7 9.4 11.2 7.6 8.8 9.9 7.8 6.4 8.2 8.9 10.7 7.2 8.3 8.5 2.8 8.8 15.1 7.8 5.9 8.4 23.3 30.1 27.5 55.2 26.3 32.0 30.5 26.6 43.1 13.3 14.9 8.5 4.5 2.7 2.7 23.3 35.5 12.7 1.4 7.9 12.2 17.7 8.7 5.0 4.0 0.3 11.4 3.4 0.0 4.5 3.8 12.3 3.3 7.0 22.1 9.1 49.3 8.1 14.7 16.2 1.5 19.2 4.7 10.1 9.0 2.4 16.9 3.8 2.9 28.3 9.7 15.5 0.0 9.0 1.5 5.1 1.1 11.3 4.4 3.0 1.1 CDH13 CDHH ENSG00000140945 "Cadherin 13" P55290 16 82626803-83800640 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 62.8;Cardiomyocytes: 75.0;Early spermatids: 34.7;Endothelial cells: 34.3;Ito cells: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.2" "Group enriched" "Detected in many" 5 "granulocytes: 2.9;monocytes: 7.2" "Cell line enhanced" "Detected in many" "LHCN-M2: 48.1;U-138 MG: 62.1;U-87 MG: 54.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001380, CAB025863" Enhanced Supported "Plasma membrane" "Intracellular and membrane" NA NA 230000000 "Plasma membrane" "CAB025863: , HPA001380: AB_1078371" "unprognostic (2.50e-2)" "unprognostic (2.75e-2)" "unprognostic (5.61e-2)" "unprognostic (4.06e-1)" "unprognostic (4.88e-2)" "unprognostic (3.30e-3)" "unprognostic (3.01e-1)" "unprognostic (5.76e-2)" "unprognostic (3.49e-2)" "unprognostic (3.34e-1)" "unprognostic (2.21e-1)" "unprognostic (3.26e-1)" "prognostic unfavorable (1.73e-6)" "unprognostic (5.16e-3)" "unprognostic (2.01e-1)" "unprognostic (1.25e-1)" "unprognostic (1.21e-1)" 14.0 2.3 13.9 2.7 14.8 0.7 7.6 0.6 32.5 32.7 3.6 2.0 2.8 1.3 36.1 8.9 6.4 6.1 3.6 34.6 5.2 9.9 3.7 1.4 10.8 1.2 4.2 13.3 3.2 0.8 1.1 0.7 4.0 3.8 2.8 4.2 0.9 4.0 5.0 37.2 14.3 1.8 19.5 3.4 1.6 1.7 3.6 1.6 0.0 4.1 21.3 2.7 4.6 14.6 1.0 0.9 2.9 7.2 0.1 0.1 0.3 2.2 0.0 0.8 0.1 14.2 13.7 0.0 10.1 11.2 11.8 5.1 0.0 0.0 0.0 1.9 29.5 5.7 19.1 0.2 15.1 17.7 0.0 0.1 0.0 7.5 0.0 8.2 0.1 0.1 1.7 13.1 23.6 28.9 18.5 5.8 0.0 0.0 0.1 48.1 0.1 0.0 0.1 2.3 0.0 4.2 0.0 12.7 0.1 10.1 0.1 0.0 0.0 18.1 0.1 0.0 23.9 0.2 0.0 9.3 62.1 5.1 0.4 9.2 0.0 0.0 0.0 54.1 0.1 15.2 2.9 1.0 2.4 0.1 3.8 0.1 0.9 0.1 0.0 0.9 1.0 0.1 0.1 2.0 0.1 7.2 0.6 0.1 0.3 13.9 14.8 0.6 32.5 5.2 9.9 4.2 13.3 3.8 1.6 0.0 0.3 0.0 24.0 62.8 1.5 75.0 0.0 0.0 3.4 3.5 0.0 0.1 6.6 0.3 34.7 34.3 0.0 0.0 0.0 0.1 8.9 3.6 0.0 0.0 0.5 4.8 1.7 41.1 1.3 31.3 0.3 1.0 8.5 0.0 1.3 0.3 0.1 0.8 0.0 0.0 0.3 0.0 31.6 0.5 0.2 16.4 0.1 0.7 0.0 4.8 CDH4 ENSG00000179242 "Cadherin 4" P55283 20 61252426-61940617 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4;lymphoid tissue: 10.2;skeletal muscle: 9.8" "Group enriched" "Detected in some" 6 "Horizontal cells: 15.9;Muller glia cells: 21.8" "Group enriched" "Detected in many" 6 "glioma: 6.9;renal cancer: 3.4;thyroid cancer: 2.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 2.4" "Lineage enriched" "Detected in single" 25 "T-cells: 2.4" "Cell line enhanced" "Detected in some" "AF22: 8.1;hTERT-HME1: 10.7;U-2 OS: 14.5;U-251 MG: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015613 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA015613: AB_2732414" "unprognostic (1.64e-1)" "unprognostic (1.19e-2)" "unprognostic (3.39e-4)" "unprognostic (2.16e-1)" "unprognostic (2.59e-2)" "unprognostic (1.08e-1)" "unprognostic (5.64e-2)" "unprognostic (1.34e-1)" "unprognostic (1.01e-1)" "unprognostic (1.27e-1)" "unprognostic (1.85e-1)" "unprognostic (6.72e-2)" "unprognostic (6.08e-3)" "unprognostic (1.75e-1)" "unprognostic (1.27e-1)" "unprognostic (2.64e-2)" "unprognostic (6.78e-2)" 1.0 1.2 17.4 0.7 15.8 0.9 0.9 1.3 13.6 0.9 0.7 4.0 0.0 0.8 0.9 0.7 1.4 2.6 0.9 1.0 10.2 6.9 0.8 0.9 1.0 0.9 2.8 11.8 6.2 2.0 0.7 0.5 0.9 3.3 0.8 0.7 0.6 1.5 3.6 9.8 2.7 0.8 0.7 1.6 10.2 0.8 1.9 3.1 0.0 1.7 0.0 0.7 0.8 0.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.9 8.1 0.0 0.1 0.6 0.1 2.2 0.0 4.1 0.4 0.2 0.0 0.0 0.2 2.7 2.6 2.9 0.0 4.4 1.7 0.2 0.0 0.0 0.1 0.1 5.6 0.0 0.1 0.8 1.1 0.8 10.7 2.2 0.8 0.3 0.0 0.0 1.6 0.3 0.1 0.0 0.9 0.0 0.0 0.0 0.0 1.1 2.6 0.0 0.8 1.9 0.0 0.1 0.1 1.3 0.0 0.0 0.0 0.0 14.5 0.1 25.3 4.7 0.1 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.4 0.0 17.4 15.8 1.3 13.6 10.2 6.9 2.8 11.8 3.3 3.1 3.0 0.0 0.0 0.5 0.2 1.2 1.2 0.0 0.0 1.2 0.0 2.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 21.8 0.2 0.0 0.4 0.0 1.8 0.0 0.5 0.1 1.7 0.3 0.0 0.0 0.0 0.1 CDH8 ENSG00000150394 "Cadherin 8" P55286 16 61647242-62037035 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 29.6;seminal vesicle: 9.5" "Group enriched" "Detected in some" 4 "Bipolar cells: 10.1;Ciliated cells: 4.0;Early spermatids: 3.8;Spermatogonia: 2.6" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "AF22: 7.0;fHDF/TERT166: 6.1;HaCaT: 13.9;LHCN-M2: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014908, HPA076441" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA014908: AB_1845908, HPA076441: " "unprognostic (1.91e-1)" "unprognostic (2.41e-1)" "unprognostic (4.02e-2)" "unprognostic (7.70e-2)" "unprognostic (1.96e-1)" "unprognostic (3.26e-2)" "unprognostic (1.83e-1)" "unprognostic (8.71e-2)" "unprognostic (3.66e-2)" "unprognostic (5.41e-2)" "unprognostic (2.85e-1)" "unprognostic (6.59e-2)" "unprognostic (2.91e-4)" "unprognostic (6.02e-2)" "unprognostic (4.06e-1)" "unprognostic (2.26e-1)" "unprognostic (1.06e-1)" 0.9 0.9 13.0 0.7 20.4 0.7 1.2 0.5 29.6 1.4 0.8 5.5 0.0 1.2 0.9 1.1 1.0 0.7 1.1 1.1 10.4 7.7 0.8 0.7 0.9 0.7 9.3 12.2 3.7 0.7 0.8 0.9 1.3 12.8 1.4 0.9 0.0 1.4 9.5 1.4 0.9 1.0 1.4 7.7 0.8 0.8 1.2 5.6 0.0 1.0 0.0 0.8 1.7 0.3 0.0 0.0 1.0 0.2 0.1 0.1 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 6.1 0.0 13.9 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.3 0.0 16.8 0.0 0.0 0.0 1.3 0.0 1.3 0.0 0.0 1.0 0.0 1.8 0.1 0.1 0.0 0.0 0.0 2.2 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.1 0.0 13.0 20.4 0.5 17.8 10.4 7.7 9.3 12.2 12.8 5.6 0.0 0.3 0.0 0.7 0.1 10.1 1.1 0.0 4.0 1.2 0.0 0.0 0.9 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.2 0.0 0.4 1.2 2.6 0.1 0.2 0.0 0.0 0.6 CDRT15 ENSG00000223510 "CMT1A duplicated region transcript 15" Q96T59 17 14235673-14236862 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 5.1;testis: 19.0" "Group enriched" "Detected in some" 16 "Early spermatids: 60.5;Late spermatids: 42.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEK 293: 6.9" HPA055952 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA055952: AB_2682983" "unprognostic (3.27e-2)" "unprognostic (1.77e-2)" "unprognostic (8.61e-2)" "unprognostic (9.33e-2)" "unprognostic (5.15e-3)" "unprognostic (2.90e-1)" "unprognostic (6.16e-3)" "unprognostic (1.98e-1)" "unprognostic (1.15e-3)" "unprognostic (2.66e-1)" "unprognostic (2.55e-1)" "unprognostic (1.99e-1)" "unprognostic (5.30e-7)" "unprognostic (1.55e-1)" "unprognostic (1.52e-1)" "unprognostic (6.81e-2)" "unprognostic (2.38e-2)" 0.1 0.3 0.0 1.5 0.0 0.5 0.1 0.3 0.1 0.2 0.2 0.9 0.1 0.0 0.4 0.2 0.4 0.2 0.1 0.1 0.1 0.5 0.2 3.8 0.1 0.4 0.2 0.0 0.1 0.0 0.2 0.0 0.9 0.0 0.1 5.1 1.0 0.0 0.3 1.1 0.4 19.0 0.5 0.0 0.2 0.2 0.2 0.3 0.5 0.1 0.0 2.0 0.0 1.3 2.3 1.6 3.7 0.0 0.0 0.9 1.4 0.0 0.0 0.1 4.4 0.6 3.7 0.9 0.0 0.5 1.7 0.0 0.0 0.0 3.7 6.9 2.1 3.8 3.1 0.0 1.7 2.7 0.0 0.0 0.0 0.0 1.4 0.0 1.8 1.7 0.8 0.0 0.9 1.8 2.7 1.5 2.6 2.3 1.4 0.7 1.5 0.0 1.9 1.8 3.3 0.4 1.0 0.6 5.2 0.8 0.9 2.0 6.0 0.8 1.4 1.6 1.2 1.4 1.7 0.9 2.8 4.3 0.0 0.1 0.5 0.4 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.5 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 CEACAM5 "CD66e, CEA" ENSG00000105388 "Carcinoembryonic antigen related cell adhesion molecule 5" P06731 19 41708585-41729798 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell adhesion" "Cancer-related genes, Oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.5;intestine: 118.2;lymphoid tissue: 100.6" "Cell type enhanced" "Detected in some" 19 "Enterocytes: 233.4;Mucus-secreting cells: 290.9;Paneth cells: 482.9;Undifferentiated cells: 102.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 1007.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "OE19: 35.9" "CAB000021, CAB000022, HPA011041, HPA019758" Enhanced Supported "Plasma membrane" "Intracellular and membrane" NA NA 19000000 "Plasma membrane" "CAB000021: , CAB000022: AB_2335697, HPA011041: AB_1078481, HPA019758: AB_1846326" "unprognostic (1.54e-2)" "unprognostic (7.59e-2)" "unprognostic (5.49e-3)" "unprognostic (1.80e-1)" "unprognostic (1.38e-2)" "unprognostic (2.22e-1)" "unprognostic (3.49e-1)" "unprognostic (2.11e-1)" "unprognostic (2.19e-2)" "unprognostic (2.89e-1)" "unprognostic (8.67e-9)" "unprognostic (2.92e-1)" "unprognostic (2.71e-2)" "unprognostic (6.31e-2)" "unprognostic (1.85e-1)" 0.1 0.1 0.1 78.8 0.1 0.0 0.1 0.1 0.2 12.5 117.1 0.2 0.1 2.5 0.9 0.1 103.5 0.3 1.2 0.1 0.1 0.1 0.1 0.1 3.3 0.1 0.1 0.1 0.2 0.2 0.0 0.2 0.5 0.1 0.3 118.2 0.2 6.8 0.1 0.1 0.6 12.8 3.3 0.1 0.1 20.1 0.2 0.1 0.6 0.2 29.4 100.6 2.0 14.1 0.6 0.6 1.8 0.7 0.6 0.5 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 35.9 0.7 0.1 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 1.2 0.3 0.8 0.3 0.2 0.1 0.5 0.2 0.3 0.6 0.6 0.4 0.5 1.8 0.6 0.7 0.5 0.3 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 29.8 2.6 0.0 0.6 0.0 0.0 0.3 0.0 1.4 5.7 0.0 0.0 0.0 0.0 0.3 0.3 0.0 233.4 0.0 0.8 0.0 0.0 7.8 4.6 0.0 0.0 0.0 63.1 0.0 0.0 0.0 0.0 0.0 5.0 0.0 290.9 0.0 12.4 482.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 102.6 36.7 CHRM3 ENSG00000133019 "Cholinergic receptor muscarinic 3" P20309 1 239386565-239915452 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 39.8" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 17.2;Early spermatids: 14.2;Exocrine glandular cells: 14.9;Paneth cells: 23.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 8.7" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3" "Group enriched" "Detected in many" 18 "monocytes: 1.2;T-cells: 2.3" "Cell line enhanced" "Detected in some" "RPMI-8226: 10.2;SH-SY5Y: 32.5;U-266/70: 13.5;U-266/84: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA024106, HPA048036" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA024106: AB_1854211, HPA048036: AB_2680238" "unprognostic (1.63e-1)" "unprognostic (4.82e-2)" "unprognostic (1.05e-1)" "unprognostic (4.11e-3)" "unprognostic (3.48e-3)" "unprognostic (5.81e-2)" "unprognostic (2.30e-3)" "unprognostic (5.18e-2)" "unprognostic (1.71e-1)" "unprognostic (1.27e-1)" "unprognostic (6.29e-2)" "unprognostic (6.44e-2)" "unprognostic (5.34e-4)" "unprognostic (3.04e-2)" "unprognostic (2.67e-1)" "unprognostic (1.02e-1)" "unprognostic (4.88e-2)" 0.8 0.0 2.1 1.4 1.8 0.0 0.8 0.8 8.7 0.8 5.9 0.8 0.8 0.8 1.4 0.8 6.6 0.3 0.8 0.8 2.5 1.8 0.8 0.8 1.5 0.8 0.8 1.1 4.3 8.7 0.2 0.8 0.8 0.8 3.8 2.2 39.8 13.7 2.5 0.8 0.7 1.2 3.3 0.8 1.0 4.8 1.7 0.8 1.3 1.3 0.8 1.6 7.1 0.8 0.0 0.0 0.0 1.2 0.0 2.3 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.5 0.3 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 3.5 0.3 2.3 1.6 0.0 2.2 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.6 5.6 0.5 0.8 0.0 0.0 2.9 2.7 5.1 0.0 0.7 10.2 0.4 0.5 0.0 32.5 0.0 0.1 0.1 2.7 1.1 0.0 0.0 1.3 0.5 0.1 0.3 13.5 9.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 1.2 0.7 0.0 0.5 0.4 0.0 0.0 2.3 0.7 0.0 0.0 0.7 0.0 0.5 0.2 2.1 1.8 0.8 8.7 2.5 1.8 0.8 1.1 0.8 0.8 0.0 3.0 0.0 1.4 0.0 17.2 0.8 0.0 2.7 1.2 0.0 0.0 2.6 1.7 0.3 14.2 1.1 2.6 0.0 14.9 0.8 0.5 2.3 1.1 0.0 0.4 0.0 3.4 1.3 0.0 2.6 0.0 0.0 6.8 0.0 2.4 0.2 3.7 23.2 0.4 0.7 0.4 0.0 0.3 5.2 2.0 0.0 0.5 0.0 6.6 0.1 CHRNA1 CHRNA ENSG00000138435 "Cholinergic receptor nicotinic alpha 1 subunit" P02708 2 174747592-174787935 "Disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 96.7" "Cell type enhanced" "Detected in some" 11 "Early spermatids: 1.6;Melanocytes: 1.7;T-cells: 1.8" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Region enhanced" "Detected in single" "hippocampal formation: 2.0" "Cell type enriched" "Detected in single" 27 "plasmacytoid DC: 2.6" "Lineage enriched" "Detected in single" 27 "dendritic cells: 2.6" "Group enriched" "Detected in some" 18 "LHCN-M2: 89.4;RH-30: 73.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA071554 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA071554: AB_2686416" "unprognostic (1.49e-1)" "unprognostic (1.97e-1)" "unprognostic (1.22e-3)" "unprognostic (2.28e-2)" "unprognostic (2.96e-1)" "unprognostic (8.55e-3)" "unprognostic (5.34e-2)" "unprognostic (5.29e-3)" "unprognostic (9.59e-2)" "unprognostic (9.64e-2)" "unprognostic (9.66e-2)" "unprognostic (6.37e-2)" "unprognostic (4.18e-4)" "unprognostic (2.04e-1)" "unprognostic (1.31e-1)" "unprognostic (1.86e-1)" "unprognostic (7.18e-2)" 4.5 0.0 0.5 0.5 0.1 0.0 0.6 0.0 0.4 0.7 1.7 0.0 0.1 0.2 0.0 4.6 1.2 0.0 0.0 0.3 2.0 0.1 0.0 0.2 0.7 0.9 0.1 0.0 0.0 0.0 0.0 12.1 0.2 0.0 2.4 1.0 0.0 1.5 0.0 96.7 0.0 0.0 0.0 0.8 0.1 0.0 0.3 0.0 0.5 0.0 4.5 1.3 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 89.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.5 0.1 0.0 0.4 2.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.9 0.3 0.0 1.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 CLDN4 "CPE-R, CPETR, CPETR1, hCPE-R, WBSCR8" ENSG00000189143 "Claudin 4" O14493 7 73799542-73832693 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 141.0" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 2545.0;Glandular cells: 2415.4;Urothelial cells: 7943.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 43.3;BEWO: 51.0;CAPAN-2: 95.4;MCF7: 48.6;OE19: 49.3;PC-3: 62.1;RT4: 42.0;SK-BR-3: 80.9" "Not detected" "Not detected" "Not detected" "Not detected" CAB002610 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB002610: " "unprognostic (1.14e-1)" "unprognostic (2.79e-2)" "unprognostic (2.25e-1)" "unprognostic (1.23e-2)" "unprognostic (1.56e-2)" "unprognostic (1.84e-1)" "unprognostic (1.60e-2)" "unprognostic (7.09e-2)" "unprognostic (3.07e-1)" "prognostic unfavorable (3.28e-4)" "unprognostic (2.16e-3)" "unprognostic (5.11e-1)" "prognostic favorable (3.46e-10)" "unprognostic (5.77e-2)" "unprognostic (1.37e-1)" "unprognostic (9.38e-2)" "unprognostic (4.63e-2)" 0.7 0.2 0.4 17.1 0.4 0.0 17.1 0.4 0.5 17.5 53.7 0.7 23.2 25.0 5.1 15.9 62.3 15.4 15.4 0.5 0.4 0.3 30.2 2.0 28.8 0.4 0.4 0.4 5.5 32.4 2.7 3.5 78.1 1.3 31.8 24.7 0.7 52.0 25.7 0.6 35.3 93.3 2.7 0.4 0.4 2.7 2.5 0.4 3.8 141.0 60.9 55.7 38.5 21.0 0.1 0.1 0.2 0.1 0.1 0.6 0.0 43.3 0.5 0.0 0.2 0.0 0.0 51.0 0.4 0.0 0.0 0.0 22.7 95.4 0.0 3.5 0.0 0.3 24.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 15.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 48.6 0.0 0.2 0.0 49.3 62.1 0.0 0.8 1.0 11.6 42.0 10.1 0.2 0.0 80.9 0.1 2.9 31.6 0.1 0.0 0.1 1.8 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.6 0.2 0.1 0.0 0.1 0.0 0.0 0.4 0.4 0.4 0.5 0.4 0.3 0.4 0.4 1.3 0.4 256.1 182.2 2.2 2545.0 14.3 0.2 0.6 242.0 323.9 224.1 207.6 0.0 586.9 11.6 821.2 0.0 2.9 1686.2 0.0 388.8 629.5 21.8 2415.4 27.6 0.8 67.0 0.0 648.6 0.0 0.3 0.0 2.3 10.6 13.5 27.1 955.9 0.9 781.5 1557.1 0.0 10.2 0.0 0.0 2.1 0.0 0.2 47.2 799.6 1.7 627.6 7943.2 CLEC2A "INPE5792, KACL, PILAR, UNQ5792" ENSG00000188393 "C-type lectin domain family 2 member A" Q6UVW9 12 9898673-9932381 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skin 1: 37.0" "Group enriched" "Detected in some" 199 "Basal keratinocytes: 16.7;Suprabasal keratinocytes: 32.4" "Cancer enhanced" "Detected in some" "cervical cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "fHDF/TERT166: 13.5;U-937: 33.7" "HPA048530, HPA072407" Approved Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA048530: AB_2680429, HPA072407: AB_2686518" "unprognostic (3.10e-1)" "unprognostic (5.29e-2)" "unprognostic (2.23e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.3 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 0.1 CMTM7 "CKLFSF7, FLJ30992" ENSG00000153551 "CKLF like MARVEL transmembrane domain containing 7" Q96FZ5 3 32391671-32483067 "Predicted membrane proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 104.7;Kupffer cells: 102.2;Macrophages: 86.9;monocytes: 120.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 39.8;hTERT-RPE1: 41.0" "Low region specificity" "Detected in all" HPA077409 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA077409: AB_2686838" "unprognostic (2.27e-3)" "unprognostic (3.16e-2)" "unprognostic (3.98e-2)" "unprognostic (1.15e-1)" "unprognostic (5.42e-2)" "unprognostic (3.16e-2)" "prognostic unfavorable (3.21e-4)" "unprognostic (3.03e-2)" "unprognostic (3.92e-2)" "unprognostic (2.60e-1)" "unprognostic (6.55e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (1.00e-6)" "unprognostic (5.86e-2)" "unprognostic (2.51e-1)" "unprognostic (3.79e-1)" "unprognostic (3.12e-2)" 14.5 6.5 3.3 18.9 5.7 23.8 43.1 4.5 2.2 10.0 6.2 4.3 11.0 3.1 7.7 12.3 4.8 24.5 14.6 8.3 2.8 2.8 14.8 5.9 25.1 47.5 5.9 1.0 9.3 27.6 0.9 2.8 11.4 4.7 12.8 5.9 6.1 8.7 17.6 4.0 6.4 10.9 7.0 10.3 32.4 8.2 5.8 4.6 45.9 24.5 3.3 23.1 16.5 12.4 10.0 24.8 24.4 47.0 4.9 36.2 22.1 0.1 4.5 9.8 11.9 9.2 9.1 27.9 4.4 5.3 8.0 7.4 5.0 39.8 0.0 13.8 5.3 9.9 5.0 12.1 20.5 7.1 0.0 9.6 5.3 0.0 11.6 37.6 1.3 8.5 9.6 2.7 8.2 13.1 41.0 18.0 0.0 4.4 12.0 5.9 0.1 0.0 12.3 11.8 2.0 20.9 25.6 3.7 24.4 11.3 8.8 0.5 10.2 0.6 0.7 22.8 4.4 6.2 13.8 10.3 7.6 7.6 8.3 15.4 3.4 1.2 0.0 2.7 16.7 15.9 5.5 47.0 24.4 5.3 44.1 3.2 10.0 17.9 10.9 24.8 7.0 19.5 13.5 18.0 4.9 37.2 10.5 36.2 22.1 3.3 5.7 4.5 2.2 2.8 2.8 5.9 1.0 4.7 4.6 23.8 14.7 40.7 17.6 8.8 0.2 1.5 15.3 14.7 23.9 17.4 0.0 19.8 0.0 83.6 0.1 15.7 1.3 23.3 13.6 6.7 16.0 11.2 28.9 1.0 104.7 1.6 16.6 18.4 102.2 1.0 1.4 86.9 23.6 120.0 3.4 1.3 59.3 8.6 1.1 24.0 0.2 6.5 14.5 1.2 7.2 4.8 5.7 43.6 3.0 10.2 CNP ENSG00000173786 "2',3'-cyclic nucleotide 3' phosphodiesterase" P09543 17 41966741-41977731 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 211.7" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 49.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002672, HPA023266, HPA023278, HPA023280, HPA023338" Enhanced Supported Supported "Plasma membrane" NA NA 730000 "Plasma membrane" "CAB002672: , HPA023266: AB_1847058, HPA023278: AB_1847060, HPA023280: AB_1847061, HPA023338: AB_1847062" "unprognostic (2.17e-1)" "unprognostic (4.48e-2)" "unprognostic (3.85e-3)" "unprognostic (1.41e-1)" "unprognostic (3.09e-1)" "unprognostic (9.71e-2)" "unprognostic (2.58e-3)" "unprognostic (2.08e-1)" "unprognostic (2.23e-1)" "unprognostic (1.62e-1)" "unprognostic (5.76e-3)" "unprognostic (1.87e-1)" "unprognostic (2.99e-3)" "unprognostic (1.60e-1)" "unprognostic (1.55e-1)" "unprognostic (8.86e-2)" "unprognostic (1.10e-3)" 9.1 8.9 51.4 9.5 72.8 6.7 8.1 13.4 125.3 10.3 7.5 211.7 2.3 7.1 8.0 12.7 15.0 9.3 10.8 7.6 78.4 40.7 14.7 9.6 6.7 10.5 86.7 49.0 11.2 9.2 5.8 4.4 7.8 66.7 11.7 6.4 3.6 15.1 13.2 7.6 11.1 6.4 10.1 160.2 7.1 7.4 4.6 63.5 2.1 7.2 2.2 11.2 9.8 5.7 9.9 49.1 7.3 13.1 7.3 7.5 9.1 13.9 23.9 22.7 27.9 19.4 18.3 9.7 17.5 26.9 45.5 51.4 18.7 12.8 14.9 14.1 22.8 23.4 24.1 15.3 11.6 15.8 14.7 19.3 14.4 16.4 32.4 20.9 14.0 13.1 30.1 8.3 24.9 6.1 16.5 20.7 14.9 10.2 12.1 15.8 8.9 35.9 12.7 5.3 7.6 17.0 22.4 33.3 14.5 12.1 14.3 13.3 18.0 22.2 33.4 38.9 11.6 14.9 21.0 20.8 17.7 19.5 24.1 20.6 13.7 15.6 11.8 17.6 10.9 69.2 4.9 12.1 7.3 7.5 13.1 5.9 9.9 6.5 6.0 11.1 7.0 5.9 6.9 2.6 7.3 10.3 49.1 7.2 9.1 51.4 72.8 13.4 93.8 78.4 40.7 86.7 49.0 66.7 63.5 14.9 10.1 20.1 16.4 14.8 20.3 11.3 20.4 13.4 22.7 33.2 5.9 26.2 106.1 40.0 1.0 17.9 18.3 0.0 37.1 41.6 27.2 18.5 9.2 25.9 34.6 47.7 18.9 18.4 13.2 2.8 35.9 14.9 52.3 31.5 12.9 73.9 30.9 17.3 33.9 48.5 23.1 32.3 36.5 3.9 13.0 16.6 10.9 18.7 18.8 16.6 CPZ ENSG00000109625 "Carboxypeptidase Z" Q66K79 4 8592660-8619759 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 63.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 29.5;BJ: 17.0;BJ hTERT+: 22.9;hTERT-RPE1: 13.7;RH-30: 25.1;U-2197: 18.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA078608 Approved "Plasma membrane" "Secreted to extracellular matrix" NA NA "Plasma membrane" "HPA078608: " "unprognostic (2.58e-1)" "unprognostic (7.16e-2)" "unprognostic (4.83e-2)" "unprognostic (1.42e-1)" "unprognostic (7.77e-2)" "unprognostic (2.20e-2)" "unprognostic (2.98e-1)" "unprognostic (7.77e-2)" "unprognostic (2.30e-1)" "unprognostic (1.95e-2)" "unprognostic (1.41e-1)" "unprognostic (1.59e-1)" "unprognostic (7.23e-8)" "unprognostic (4.30e-3)" "unprognostic (3.58e-2)" "unprognostic (6.13e-4)" "unprognostic (5.51e-2)" 4.3 0.9 0.3 2.8 1.1 0.0 5.4 1.1 1.6 15.7 1.8 1.5 27.1 0.1 7.9 24.1 3.0 7.4 12.9 2.4 0.4 0.3 1.5 0.8 2.9 0.7 1.5 0.4 63.2 1.1 0.3 2.3 18.9 2.3 4.1 0.5 4.4 0.8 20.6 0.3 5.5 1.2 10.3 1.3 0.7 1.7 4.4 0.1 1.6 3.5 0.1 2.2 9.8 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.1 0.0 0.7 2.2 0.2 29.5 17.0 22.9 6.4 2.6 0.7 0.3 0.0 1.6 9.3 0.1 0.0 0.0 0.0 2.4 0.0 1.2 0.0 0.1 0.3 2.0 0.0 0.0 4.2 0.0 0.0 0.0 13.7 0.0 0.0 0.4 0.0 0.4 2.5 0.0 0.0 3.9 0.1 9.3 0.0 25.1 0.0 0.0 0.5 0.0 0.0 0.6 0.2 0.0 3.8 0.1 0.0 0.0 0.9 1.2 18.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 1.1 1.6 0.4 0.3 1.5 0.4 2.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CRK ENSG00000167193 "CRK proto-oncogene, adaptor protein" P46108 17 1420689-1463162 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010485, HPA068087" Approved Approved "Plasma membrane" NA NA 390000 "Plasma membrane" "CAB010485: AB_2085043, HPA068087: AB_2685950" "unprognostic (6.82e-3)" "unprognostic (1.94e-1)" "unprognostic (8.70e-3)" "unprognostic (5.34e-2)" "unprognostic (2.43e-1)" "unprognostic (3.32e-2)" "unprognostic (2.48e-1)" "unprognostic (1.67e-2)" "unprognostic (6.65e-2)" "unprognostic (1.88e-1)" "unprognostic (2.65e-1)" "unprognostic (5.35e-2)" "unprognostic (1.96e-1)" "unprognostic (1.67e-1)" "unprognostic (3.77e-1)" "unprognostic (1.56e-1)" "unprognostic (3.93e-2)" 37.1 22.1 23.3 15.9 23.7 4.2 40.0 25.1 23.4 23.3 27.2 21.2 31.5 21.4 26.0 27.5 25.9 19.0 27.5 22.0 23.0 21.6 26.0 40.5 25.6 14.6 25.3 18.4 21.4 22.1 22.6 11.8 33.6 24.2 22.4 28.6 18.0 21.2 27.3 27.8 18.1 26.9 29.3 24.0 17.6 21.6 17.9 26.4 13.6 32.5 20.2 15.8 28.8 40.7 5.5 4.7 16.3 4.6 3.0 4.2 1.7 15.1 23.7 17.7 18.8 29.9 25.2 16.5 26.3 22.2 20.8 19.4 30.5 9.0 7.4 13.2 30.1 14.5 23.5 23.4 19.0 30.7 3.7 16.0 8.2 15.5 16.7 27.8 3.5 7.3 24.4 22.5 21.5 27.2 16.0 25.5 7.0 13.7 7.0 29.0 15.3 3.7 4.0 16.0 16.9 11.9 8.0 8.9 6.7 27.3 16.4 6.5 17.2 25.0 15.6 17.9 17.4 15.3 5.9 27.1 21.0 12.0 22.1 25.8 3.3 5.1 4.6 17.7 6.9 22.8 5.4 4.4 5.4 3.6 4.6 3.6 4.1 3.8 3.1 4.7 5.5 2.9 4.2 16.3 3.0 4.6 4.4 2.6 1.7 23.3 23.7 25.1 22.3 23.0 21.6 25.3 18.4 24.2 26.4 62.5 51.7 22.8 58.7 132.8 40.3 28.2 50.9 33.5 30.7 31.4 25.5 52.9 34.9 58.9 3.3 65.0 75.5 0.0 56.8 51.0 50.5 60.3 7.0 58.9 38.4 50.9 47.8 90.2 42.1 4.2 40.6 35.6 50.6 43.3 51.7 40.4 59.0 54.7 41.4 30.5 36.0 45.3 60.8 22.7 53.5 146.7 71.1 17.3 46.2 81.9 CRYBG3 DKFZp667G2110 ENSG00000080200 "Crystallin beta-gamma domain containing 3" Q68DQ2 3 97822040-97944963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 113.3;Early spermatids: 95.6;Late spermatids: 103.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 1.9;classical monocyte: 3.0;intermediate monocyte: 1.8;myeloid DC: 2.6;non-classical monocyte: 1.9;plasmacytoid DC: 7.1" "Group enriched" "Detected in many" 6 "dendritic cells: 7.1;granulocytes: 1.9;monocytes: 3.0" "Cell line enhanced" "Detected in many" "SCLC-21H: 28.3" "Low region specificity" "Detected in many" HPA075635 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA075635: " "unprognostic (1.88e-1)" "unprognostic (7.62e-3)" "unprognostic (2.54e-1)" "unprognostic (4.56e-2)" "unprognostic (7.60e-2)" "unprognostic (2.70e-2)" "unprognostic (2.45e-2)" "unprognostic (7.10e-2)" "unprognostic (3.41e-3)" "unprognostic (6.59e-2)" "unprognostic (2.80e-2)" "unprognostic (7.86e-2)" "prognostic favorable (7.07e-4)" "unprognostic (1.78e-2)" "unprognostic (1.58e-1)" "unprognostic (1.14e-2)" "unprognostic (6.38e-3)" 19.9 5.1 6.4 13.4 20.9 1.9 13.1 1.6 13.0 14.6 19.2 8.2 12.1 6.0 10.4 7.4 13.9 9.0 8.6 14.9 9.1 5.3 8.2 5.3 11.3 6.5 28.4 5.1 8.7 8.5 10.2 7.4 15.8 15.0 12.9 11.9 4.7 10.6 9.0 21.5 19.5 8.4 10.1 20.3 7.8 11.1 19.2 20.5 2.0 39.7 12.3 7.0 11.2 16.9 0.5 7.1 1.9 3.0 0.1 0.6 0.5 11.4 4.3 2.5 3.0 8.0 8.6 4.5 4.1 3.6 3.0 4.5 0.3 3.8 0.1 1.4 6.9 4.6 7.4 4.9 3.4 5.7 14.0 2.7 2.8 1.9 1.4 4.2 4.2 0.7 5.6 3.5 3.7 4.2 4.8 5.7 0.9 0.2 2.2 5.1 0.1 1.5 0.4 2.2 3.3 4.0 0.0 8.8 1.4 4.3 7.6 28.3 2.0 8.6 3.3 2.8 1.7 3.0 4.6 7.7 6.5 5.0 3.7 4.9 3.6 0.1 2.6 6.8 2.5 4.1 1.9 3.0 0.1 0.3 1.8 0.5 0.2 0.6 0.4 2.6 0.5 0.2 0.4 0.0 0.1 1.9 7.1 0.1 0.5 6.4 20.9 1.6 13.0 9.1 5.3 28.4 5.1 15.0 20.5 29.8 18.7 0.0 5.9 4.5 113.3 36.3 2.5 36.1 27.3 17.4 5.9 2.9 1.7 7.7 95.6 22.6 3.2 0.0 11.4 8.6 6.2 6.7 0.0 5.0 6.0 12.7 12.2 15.4 14.3 103.5 7.8 11.0 8.5 13.6 8.9 36.4 13.1 10.4 4.2 1.7 7.3 38.8 8.2 40.4 6.8 5.4 1.9 0.0 4.4 6.4 CTNNB1 "armadillo, beta-catenin, CTNNB" ENSG00000168036 "Catenin beta 1" P35222 3 41194741-41260096 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation, Wnt signaling pathway" Activator "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Syncytiotrophoblasts: 451.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000108, CAB001950, HPA029159, HPA029160" Supported Enhanced "Plasma membrane" NA NA 1000000 "Plasma membrane" "CAB000108: , CAB001950: , HPA029159: AB_10599619, HPA029160: AB_10600996" "unprognostic (2.47e-1)" "unprognostic (3.48e-2)" "prognostic favorable (7.54e-4)" "unprognostic (1.61e-1)" "unprognostic (9.55e-2)" "unprognostic (1.05e-2)" "unprognostic (3.20e-3)" "unprognostic (2.79e-1)" "unprognostic (1.57e-1)" "unprognostic (1.80e-2)" "unprognostic (1.88e-2)" "unprognostic (9.05e-2)" "unprognostic (1.97e-3)" "unprognostic (1.82e-2)" "unprognostic (1.17e-1)" "unprognostic (2.61e-1)" "unprognostic (9.79e-2)" 52.9 54.5 38.8 33.5 45.9 46.3 70.5 78.8 59.3 71.7 49.6 57.3 34.2 48.7 79.2 42.5 46.3 49.8 45.0 42.1 38.6 41.5 46.9 53.2 53.6 31.6 37.0 47.0 84.2 38.6 59.2 44.0 82.6 41.5 50.8 50.1 75.9 53.9 49.7 31.2 44.7 70.4 66.5 39.4 41.0 37.3 29.0 39.3 40.1 62.3 44.5 36.6 46.9 54.2 10.1 13.5 7.5 14.5 11.1 13.5 4.8 22.5 30.0 63.3 35.4 34.1 28.0 48.6 25.4 36.1 42.5 42.3 20.7 32.2 18.5 23.2 44.9 19.1 16.9 45.8 73.4 45.6 17.1 31.2 29.8 39.9 73.8 25.5 16.9 14.4 40.8 33.3 50.8 30.9 34.8 37.3 8.9 21.1 11.5 47.1 22.8 11.8 9.1 57.6 30.1 23.3 8.9 41.2 12.3 26.3 70.4 15.1 25.6 42.1 21.5 113.0 78.5 35.2 35.2 48.1 32.0 24.5 20.5 37.2 7.2 11.1 19.7 32.8 21.3 53.4 4.3 8.1 6.9 11.2 14.5 13.5 9.6 10.5 12.1 13.5 10.1 10.7 10.8 7.5 11.1 13.7 11.7 12.6 4.8 38.8 45.9 78.8 59.3 38.6 41.5 37.0 47.0 41.5 39.3 128.1 177.9 34.4 112.8 189.7 38.8 66.6 99.3 119.1 161.5 59.3 31.4 274.7 29.9 114.0 5.5 164.1 147.7 46.7 68.4 90.6 121.0 101.1 113.2 146.9 108.7 12.7 90.0 114.2 130.0 5.0 55.3 139.8 192.3 115.4 132.0 103.7 102.3 182.4 81.7 57.4 56.6 45.3 106.2 71.5 40.7 152.9 451.2 62.8 118.4 109.3 CTNND1 "CTNND, KIAA0384, p120, p120cas, p120ctn" ENSG00000198561 "Catenin delta 1" O60716 11 57753243-57819546 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway" "Cancer-related genes, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 12.5;non-classical monocyte: 11.9" "Group enriched" "Detected in many" 8 "dendritic cells: 10.2;monocytes: 12.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB003837, HPA015954, HPA015955" Enhanced Enhanced "Plasma membrane" NA NA 15000 "Plasma membrane" "CAB003837: AB_562066, HPA015954: AB_2669326, HPA015955: AB_1846068" "unprognostic (1.06e-2)" "unprognostic (1.60e-2)" "unprognostic (5.17e-3)" "unprognostic (4.87e-2)" "unprognostic (7.81e-2)" "unprognostic (2.30e-1)" "unprognostic (2.98e-2)" "unprognostic (3.52e-3)" "unprognostic (4.17e-1)" "unprognostic (2.89e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (2.75e-1)" "prognostic favorable (3.54e-4)" "unprognostic (7.17e-2)" "unprognostic (4.09e-2)" "unprognostic (3.34e-1)" "unprognostic (7.33e-2)" 39.7 19.9 15.1 20.4 17.0 3.2 31.4 15.0 20.5 28.8 41.9 25.7 49.2 37.5 32.7 32.7 76.3 22.9 28.8 18.2 15.6 10.3 30.6 31.2 34.0 11.6 14.4 12.8 23.3 50.4 41.9 34.5 49.8 16.4 29.7 39.8 34.4 46.4 39.1 11.8 48.7 82.0 22.8 17.2 25.9 39.4 27.8 14.7 7.1 38.4 34.9 45.6 32.3 38.9 1.4 10.2 0.4 12.5 0.4 0.5 2.3 37.3 28.1 25.1 16.7 13.5 18.6 35.6 17.1 19.4 15.5 14.9 21.7 41.5 0.7 30.3 21.3 14.8 49.1 20.2 26.0 20.0 0.4 6.6 9.3 11.0 24.6 14.1 1.9 14.7 20.4 31.5 19.7 20.2 25.3 47.3 0.6 13.9 0.4 17.2 12.1 0.7 3.5 17.8 25.4 15.1 0.7 21.1 0.8 23.3 39.9 2.3 11.2 24.3 33.3 25.3 43.9 34.9 2.5 40.0 15.0 12.9 14.7 9.7 1.3 0.8 1.1 14.0 1.2 26.4 0.0 6.9 0.2 0.2 12.5 0.5 1.0 0.1 0.4 10.2 1.4 0.2 0.3 0.4 0.4 11.9 3.1 0.2 2.3 15.1 17.0 15.0 20.5 15.6 10.3 14.4 12.8 16.4 14.7 137.0 81.3 9.5 80.1 104.1 22.4 14.9 145.2 44.2 68.2 134.3 37.3 80.9 11.6 90.0 11.2 89.8 213.8 0.0 84.6 65.9 33.0 98.5 32.3 112.4 38.4 14.3 82.8 94.5 50.5 7.8 26.2 39.5 45.5 20.8 134.3 40.4 110.3 157.3 36.0 43.0 26.8 25.8 28.8 32.2 19.2 175.3 76.0 8.7 98.8 174.5 CX3CL1 "ABCD-3, C3Xkine, CXC3, CXC3C, fractalkine, neurotactin, NTN, SCYD1" ENSG00000006210 "C-X3-C motif chemokine ligand 1" P78423 16 57372458-57385048 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Chemotaxis" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 39.3;Endothelial cells: 39.1;Glandular cells: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "EFO-21: 13.7;HDLM-2: 37.3;Hep G2: 27.8;RPTEC TERT1: 16.6;SK-BR-3: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026192, HPA040361" Approved Supported "Plasma membrane" "Secreted to blood" NA NA 1870000 "Plasma membrane" "CAB026192: , HPA040361: AB_10796453" "unprognostic (6.89e-3)" "prognostic favorable (9.46e-4)" "unprognostic (1.52e-2)" "unprognostic (3.20e-2)" "unprognostic (1.73e-1)" "unprognostic (1.82e-1)" "unprognostic (7.12e-2)" "unprognostic (2.08e-3)" "unprognostic (4.49e-2)" "unprognostic (3.70e-1)" "unprognostic (2.59e-2)" "unprognostic (2.06e-2)" "prognostic favorable (8.52e-7)" "unprognostic (5.19e-2)" "unprognostic (2.72e-1)" "unprognostic (1.11e-2)" "unprognostic (9.33e-2)" 24.3 3.6 13.4 4.7 26.6 0.7 42.5 3.8 45.1 12.4 5.9 6.9 8.7 4.2 12.1 7.0 10.7 11.7 14.9 12.0 16.4 13.8 14.5 11.2 35.3 6.0 9.2 18.0 5.2 9.6 3.8 4.5 3.4 11.7 22.3 4.5 12.2 39.9 34.4 9.2 9.9 5.0 21.7 6.6 1.5 5.0 3.8 3.9 0.8 12.0 5.7 4.9 19.7 6.7 1.0 0.8 2.1 0.7 0.8 0.6 0.2 0.0 0.3 3.6 3.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 13.7 0.0 1.9 0.1 0.0 0.0 0.0 37.3 0.2 0.0 0.0 27.8 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.5 0.0 16.6 0.1 0.1 3.2 0.0 9.7 0.8 2.4 0.0 0.1 0.0 0.1 2.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.6 1.4 0.7 0.5 0.6 0.4 0.3 0.6 0.4 0.3 0.2 1.0 0.4 0.6 2.1 0.8 0.4 0.8 0.2 0.2 13.4 26.6 3.8 37.3 16.4 13.8 9.2 18.0 11.7 3.9 3.0 5.8 0.0 39.3 3.9 5.4 7.0 25.5 10.7 25.0 3.5 3.9 0.0 0.0 25.9 0.3 39.1 0.2 0.0 1.6 0.0 3.3 28.6 1.1 10.0 0.0 4.8 1.7 3.1 0.6 0.0 4.4 0.0 0.0 1.0 0.0 0.8 6.6 0.0 26.2 10.2 1.7 12.9 14.4 0.1 0.1 2.3 0.2 0.0 0.7 24.6 CX3CR1 "CCRL1, CMKBRL1, CMKDR1, GPR13, V28" ENSG00000168329 "C-X3-C motif chemokine receptor 1" P49238 3 39263494-39281735 "Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Host-virus interaction" "G-protein coupled receptor, Receptor, Transducer" "Age-related macular degeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 69.2;brain: 51.6" "Cell type enhanced" "Detected in some" 17 "Kupffer cells: 14.4;Macrophages: 26.4;Sertoli cells: 6.5;T-cells: 15.2" "Cancer enhanced" "Detected in many" "glioma: 21.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 69.2" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 20 "RPMI-8226: 114.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032478, HPA046587" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "CAB032478: AB_638830, HPA046587: AB_2679708" "unprognostic (2.00e-1)" "unprognostic (5.12e-2)" "unprognostic (2.65e-1)" "unprognostic (2.42e-2)" "unprognostic (6.52e-2)" "unprognostic (3.01e-3)" "unprognostic (2.64e-1)" "unprognostic (1.16e-2)" "unprognostic (3.98e-2)" "unprognostic (1.57e-3)" "unprognostic (1.13e-2)" "unprognostic (1.04e-1)" "unprognostic (3.05e-2)" "unprognostic (1.36e-2)" "unprognostic (8.59e-2)" "unprognostic (7.71e-3)" "unprognostic (1.12e-1)" 2.3 3.8 14.9 6.0 17.3 0.9 4.8 2.5 34.1 2.7 1.2 51.6 0.0 1.2 2.7 4.2 1.4 5.9 2.5 2.2 12.4 11.9 2.5 1.9 9.0 1.8 21.8 7.4 1.8 1.8 5.2 2.5 4.3 21.8 3.7 1.2 3.5 6.4 7.0 5.2 2.4 1.2 3.3 33.5 10.3 1.5 1.8 16.3 0.8 2.4 0.7 4.7 2.8 1.3 0.1 15.7 3.5 69.2 6.5 46.5 29.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 114.8 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 5.6 0.0 1.2 15.9 0.2 46.5 43.3 0.5 0.1 10.4 25.2 15.7 0.1 3.7 22.7 3.5 6.5 69.2 1.1 0.2 29.8 14.9 17.3 2.5 19.9 12.4 11.9 21.8 7.4 21.8 16.3 0.0 0.3 0.0 0.0 0.5 0.0 0.4 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.7 0.0 3.5 0.0 0.0 0.6 14.4 0.0 0.3 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 6.5 0.0 0.7 0.2 0.5 0.0 15.2 0.0 0.0 CYBRD1 "CYB561A2, DCYTB, FLJ23462, FRRS3" ENSG00000071967 "Cytochrome b reductase 1" Q53TN4 2 171522247-171558133 "Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 205.4;Leydig cells: 187.0;Peritubular cells: 208.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 12.0;intermediate monocyte: 12.4;myeloid DC: 11.7;neutrophil: 6.7;non-classical monocyte: 9.4" "Group enriched" "Detected in many" 4 "dendritic cells: 11.7;granulocytes: 6.7;monocytes: 12.4" "Cell line enhanced" "Detected in many" "ASC diff: 144.2;ASC TERT1: 62.7;BJ hTERT+: 54.3;HSkMC: 44.4;hTERT-RPE1: 37.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014757 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA014757: AB_1847374" "unprognostic (1.35e-1)" "unprognostic (1.57e-1)" "unprognostic (2.89e-2)" "unprognostic (4.87e-2)" "unprognostic (2.97e-2)" "unprognostic (3.11e-2)" "unprognostic (2.86e-1)" "unprognostic (5.44e-3)" "unprognostic (8.90e-3)" "unprognostic (3.57e-3)" "unprognostic (1.74e-1)" "unprognostic (1.71e-1)" "unprognostic (1.02e-3)" "unprognostic (1.93e-2)" "unprognostic (8.48e-2)" "unprognostic (2.77e-2)" "unprognostic (1.51e-2)" 75.2 26.0 10.1 9.3 13.2 4.0 78.9 6.1 8.0 44.5 56.3 14.7 16.3 49.5 44.3 28.5 29.6 26.1 38.8 43.1 12.1 5.5 8.6 6.2 35.6 10.6 11.0 11.2 49.5 5.4 2.0 9.5 9.5 11.4 41.7 10.2 32.0 21.5 21.1 17.5 26.7 111.3 41.1 12.8 7.3 18.1 20.1 11.7 2.1 103.8 23.9 10.0 43.8 56.0 0.0 11.7 6.7 12.4 2.5 1.2 4.4 3.2 2.4 1.3 2.6 144.2 62.7 0.2 11.8 54.3 6.2 7.8 0.1 4.5 0.0 2.0 27.7 6.3 1.6 1.1 0.9 7.3 2.4 0.3 2.7 3.7 0.0 30.3 2.8 0.2 44.4 9.2 9.6 1.8 37.0 3.9 1.6 0.9 0.0 16.9 0.0 0.9 2.6 0.7 0.0 0.6 0.3 17.0 0.1 0.9 0.1 0.1 0.6 13.7 0.0 7.3 0.5 4.8 1.7 7.8 13.9 2.0 12.9 5.0 0.0 0.0 0.0 6.6 2.4 7.4 0.0 12.0 0.5 1.2 12.4 0.2 0.0 0.2 0.1 11.7 0.0 0.0 0.0 6.7 2.5 9.4 0.5 0.0 4.4 10.1 13.2 6.1 8.0 12.1 5.5 11.0 11.2 11.4 11.7 205.4 82.9 0.0 33.8 107.6 0.0 17.1 28.1 8.1 48.9 24.4 0.0 1.6 0.0 1.0 0.9 40.3 13.6 46.7 5.8 1.3 122.8 21.6 2.3 2.1 39.6 0.0 0.0 57.7 57.5 2.1 187.0 28.5 42.2 12.6 3.8 29.3 1.3 8.6 208.2 0.3 1.8 19.4 57.5 0.9 1.3 52.6 1.1 2.5 4.8 13.8 DCHS1 "CDH25, CDHR6, FIB1, FLJ11790, KIAA1773, PCDH16" ENSG00000166341 "Dachsous cadherin-related 1" Q96JQ0 11 6621323-6655854 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 22 "Endothelial cells: 12.7;Fibroblasts: 17.1;Ito cells: 63.3;Melanocytes: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 19.2;HUVEC TERT2: 26.7;REH: 12.9;SH-SY5Y: 18.7;TIME: 11.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA017970, HPA050246" Approved Approved "Plasma membrane" NA NA 75000 "Plasma membrane" "HPA017970: AB_2669718, HPA050246: AB_2681062" "unprognostic (2.42e-1)" "unprognostic (1.13e-1)" "unprognostic (8.93e-2)" "unprognostic (3.52e-2)" "unprognostic (1.83e-1)" "unprognostic (1.38e-3)" "unprognostic (2.52e-2)" "unprognostic (4.55e-3)" "unprognostic (2.63e-2)" "unprognostic (2.93e-2)" "unprognostic (5.96e-2)" "unprognostic (6.87e-2)" "prognostic unfavorable (9.32e-4)" "unprognostic (5.62e-2)" "unprognostic (2.28e-1)" "unprognostic (1.60e-2)" "unprognostic (1.24e-3)" 9.0 2.0 4.1 7.7 4.7 0.5 6.8 5.2 4.4 26.1 12.9 4.4 9.0 3.8 23.9 4.7 5.0 10.4 9.1 8.0 4.0 4.5 3.4 5.6 7.7 3.9 2.5 3.4 13.7 3.3 1.6 2.7 9.7 3.3 12.0 3.4 9.7 3.3 12.0 3.5 3.4 6.0 16.0 1.6 10.2 6.8 2.6 2.5 5.8 3.3 2.6 2.6 10.9 11.9 0.0 1.4 0.1 0.0 0.0 0.9 0.4 0.0 0.0 19.2 0.1 0.0 0.0 0.1 0.6 4.9 3.1 3.5 0.1 0.0 0.1 2.9 5.5 0.2 0.0 1.5 0.0 2.1 0.0 0.5 0.4 0.0 0.0 0.2 0.1 0.0 0.6 0.1 1.4 0.0 0.0 26.7 0.0 0.1 0.0 1.1 0.0 0.6 0.3 2.8 0.0 0.0 12.9 0.0 0.0 0.0 0.0 1.4 18.7 0.0 0.1 0.1 2.1 0.0 0.7 11.4 0.0 5.9 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.8 0.9 0.1 0.0 0.0 1.4 0.0 0.4 4.1 4.7 5.2 4.4 4.0 4.5 2.5 3.4 3.3 2.5 0.0 0.3 0.0 0.2 2.6 0.4 2.8 5.1 0.0 0.0 0.0 0.0 0.2 0.0 0.8 2.2 12.7 0.0 0.0 0.3 0.3 17.1 0.2 0.0 0.0 1.8 0.0 0.0 63.3 6.0 2.9 1.1 0.4 15.1 0.0 0.7 0.5 0.2 0.0 1.8 0.0 0.3 0.0 2.2 2.7 0.5 1.5 0.2 0.0 1.0 0.0 DENND6B "AFI1B, FAM116B, MGC33692" ENSG00000205593 "DENN domain containing 6B" Q8NEG7 22 50309030-50327060 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 24.7" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 47.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 8.3;RPMI-8226: 12.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018934, HPA021653, HPA029570" Uncertain Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA018934: AB_1848365, HPA021653: AB_1848366, HPA029570: AB_10602131" "unprognostic (2.50e-2)" "unprognostic (2.55e-2)" "prognostic unfavorable (1.41e-4)" "prognostic favorable (5.93e-5)" "unprognostic (9.39e-2)" "unprognostic (3.17e-1)" "unprognostic (1.89e-3)" "unprognostic (1.16e-1)" "unprognostic (5.10e-2)" "unprognostic (4.50e-2)" "unprognostic (1.19e-2)" "unprognostic (1.18e-1)" "unprognostic (8.92e-2)" "unprognostic (1.10e-1)" "unprognostic (4.15e-1)" "unprognostic (1.56e-1)" "unprognostic (1.31e-2)" 2.7 5.5 11.6 4.3 17.0 2.0 3.2 21.1 22.8 5.7 2.8 7.5 5.5 2.5 5.2 5.3 3.4 24.7 6.2 2.3 8.4 10.2 5.7 1.3 7.3 5.2 4.9 14.4 4.3 6.4 6.8 15.1 2.3 10.4 4.7 2.3 4.1 5.9 7.4 1.1 5.0 3.0 3.6 3.2 4.4 4.2 9.0 4.5 0.0 6.0 1.0 3.5 4.4 2.7 0.7 1.8 0.5 3.9 1.0 0.7 0.9 0.6 2.3 5.0 5.4 1.2 4.8 0.0 1.0 2.4 0.6 0.4 0.1 3.5 8.3 2.1 2.3 0.3 4.2 0.1 0.1 0.2 2.0 1.2 1.4 4.0 0.2 1.1 0.2 3.7 4.1 5.3 0.1 0.7 4.9 1.0 0.1 1.8 1.5 1.2 3.6 0.0 0.8 0.3 2.5 0.2 1.2 0.0 12.0 6.2 2.0 2.1 4.0 2.7 3.4 0.4 0.2 5.5 1.2 1.1 0.9 0.8 0.8 0.1 1.3 0.3 1.2 2.2 0.9 1.0 0.5 2.6 0.1 0.4 3.2 0.6 0.6 0.6 0.7 1.8 0.7 0.6 0.7 0.5 1.0 3.9 1.4 0.6 0.9 11.6 17.0 21.1 22.8 8.4 10.2 4.9 14.4 10.4 4.5 3.0 2.6 18.2 2.8 1.0 4.9 1.1 7.6 30.8 7.9 5.2 21.6 0.2 3.3 4.8 20.6 3.4 4.9 23.3 1.6 0.6 4.0 3.3 5.7 0.8 12.8 1.6 9.8 3.7 21.8 47.0 2.3 13.7 5.0 26.2 3.4 6.4 2.6 2.3 2.5 14.1 15.4 0.0 1.2 23.6 17.9 0.5 0.8 7.2 3.3 2.3 DHDDS "DS, FLJ13102, HDS, RP59" ENSG00000117682 "Dehydrodolichyl diphosphate synthase subunit" Q86SQ9 1 26432282-26471294 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism" Transferase "Disease mutation, Epilepsy, Mental retardation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 241.5;Rod photoreceptor cells: 101.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026721, HPA026727" Uncertain Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA026721: AB_1847643, HPA026727: AB_1847644" "unprognostic (1.11e-2)" "unprognostic (5.43e-2)" "unprognostic (5.12e-2)" "unprognostic (9.81e-2)" "unprognostic (6.71e-2)" "unprognostic (7.23e-2)" "unprognostic (1.32e-3)" "unprognostic (3.81e-3)" "unprognostic (2.40e-1)" "unprognostic (5.42e-2)" "unprognostic (4.51e-2)" "unprognostic (3.40e-2)" "prognostic favorable (4.08e-7)" "unprognostic (9.42e-2)" "unprognostic (2.85e-1)" "unprognostic (2.22e-1)" "unprognostic (2.95e-1)" 31.8 14.4 11.2 10.8 15.9 6.4 15.0 45.9 18.8 10.4 23.1 12.5 8.3 12.2 15.4 21.9 18.9 9.2 10.9 14.8 9.7 10.7 16.2 15.3 9.5 10.3 12.1 15.8 9.8 14.7 23.2 15.5 13.1 20.6 9.6 23.9 22.0 56.9 9.1 10.3 13.1 12.2 11.3 7.6 10.5 14.2 12.9 8.9 9.7 12.1 11.1 16.9 10.6 9.8 11.1 11.2 11.8 19.5 8.1 11.6 8.2 14.9 12.2 8.1 11.1 16.8 14.1 14.0 25.6 16.0 19.8 19.8 18.8 16.5 16.9 15.7 23.9 14.5 10.9 10.9 20.0 19.0 10.3 5.8 16.8 30.3 13.8 15.8 18.3 24.8 19.3 11.9 27.3 15.4 13.3 24.9 11.1 12.0 18.6 18.1 10.2 9.3 7.7 12.8 21.0 16.4 11.2 14.4 14.4 10.7 14.1 11.4 9.1 17.2 19.0 11.3 11.7 14.3 10.3 31.7 13.8 13.4 25.9 14.6 22.7 30.4 18.2 21.7 23.0 13.4 6.5 13.4 7.1 11.6 19.5 8.4 11.1 7.7 7.5 11.2 9.3 6.5 9.0 11.8 8.1 18.0 9.1 7.3 8.2 11.2 15.9 45.9 18.8 9.7 10.7 12.1 15.8 20.6 8.9 8.9 5.6 17.5 7.9 4.0 31.4 13.7 12.7 8.1 10.3 14.0 241.5 15.5 10.0 17.0 55.9 9.0 44.5 0.0 12.6 19.4 8.2 11.0 18.5 11.5 21.3 14.3 20.1 11.1 7.3 16.4 9.8 9.7 10.1 48.7 32.2 15.3 14.8 42.1 7.1 20.3 101.1 0.0 10.3 9.3 13.5 4.4 21.3 10.0 14.0 11.1 DIAPH1 "DFNA1, hDIA1, LFHL1" ENSG00000131504 "Diaphanous related formin 1" O60610 5 141515016-141619055 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" Hearing Actin-binding "Cancer-related genes, Deafness, Disease mutation, Epilepsy, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 79.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 106.8" "Low region specificity" "Detected in all" "HPA004916, HPA076913" Approved Approved "Plasma membrane" NA NA 10000000 "Plasma membrane" "HPA004916: AB_1847668, HPA076913: " "unprognostic (6.79e-2)" "unprognostic (2.99e-1)" "unprognostic (2.12e-3)" "unprognostic (3.73e-2)" "unprognostic (4.18e-2)" "unprognostic (1.54e-1)" "unprognostic (2.08e-1)" "unprognostic (4.54e-3)" "unprognostic (2.03e-1)" "unprognostic (1.27e-2)" "prognostic unfavorable (7.81e-5)" "unprognostic (2.88e-3)" "prognostic favorable (1.29e-5)" "unprognostic (1.64e-2)" "unprognostic (1.84e-2)" "unprognostic (7.00e-2)" "unprognostic (1.65e-1)" 14.5 10.0 5.2 22.3 10.4 27.9 10.6 8.8 7.8 11.6 17.1 3.9 11.4 14.2 9.9 16.8 26.5 9.1 15.7 21.3 5.1 6.3 30.1 48.7 22.4 21.7 3.8 4.3 9.7 20.2 17.6 22.1 28.2 7.2 7.8 11.0 8.8 18.0 13.8 79.8 19.1 24.1 9.6 3.4 20.2 15.5 12.1 2.9 44.2 14.9 23.8 34.1 12.3 13.3 5.9 8.6 19.2 9.3 8.2 22.7 9.3 25.7 16.7 9.7 12.8 7.8 10.5 13.4 10.6 11.3 12.4 13.0 57.1 24.7 28.8 16.3 15.6 19.7 28.8 21.6 36.1 15.7 15.5 12.0 49.8 22.1 18.6 7.4 34.6 106.8 6.7 19.2 17.8 18.0 5.7 16.2 44.1 17.5 20.3 12.2 25.2 38.4 45.2 9.6 13.6 11.1 43.2 16.0 15.9 23.8 28.5 12.9 6.9 26.3 35.0 10.5 9.1 14.6 16.8 9.4 17.5 9.3 9.6 21.5 10.2 16.2 20.0 9.5 27.8 10.8 12.7 8.6 19.2 22.7 9.2 15.2 5.9 14.4 17.6 8.6 5.0 10.5 17.3 9.4 8.2 9.3 6.6 11.9 9.3 5.2 10.4 8.8 7.8 5.1 6.3 3.8 4.3 7.2 2.9 44.7 41.4 32.0 39.1 46.8 17.7 17.9 22.9 24.1 60.3 41.8 51.1 15.3 5.0 57.1 16.9 35.0 40.0 0.0 84.2 26.5 20.2 67.6 45.1 77.8 16.2 6.4 5.2 9.2 34.1 6.8 10.9 53.5 18.6 17.2 18.0 10.9 93.8 28.1 10.3 13.0 72.6 12.9 19.6 15.4 23.7 52.1 43.6 55.8 23.9 92.4 DNAJB13 "RSPH16A, TSARG6" ENSG00000187726 "DnaJ heat shock protein family (Hsp40) member B13" P59910 11 73950319-73970366 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" Chaperone "Ciliopathy, Disease mutation, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "fallopian tube: 30.4;testis: 10.8" "Group enriched" "Detected in some" 6 "Ciliated cells: 66.9;Early spermatids: 65.2;Late spermatids: 44.5" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 8.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA052465, HPA061330" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA052465: AB_2681842, HPA061330: AB_2732659" "unprognostic (1.07e-1)" "unprognostic (3.23e-2)" "unprognostic (3.27e-3)" "unprognostic (1.56e-2)" "unprognostic (1.03e-1)" "unprognostic (1.20e-4)" "unprognostic (1.30e-2)" "unprognostic (1.72e-4)" "unprognostic (5.00e-2)" "unprognostic (4.73e-2)" "unprognostic (6.30e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (2.10e-6)" "unprognostic (3.32e-2)" "unprognostic (1.41e-1)" "unprognostic (9.44e-2)" "unprognostic (2.40e-2)" 0.0 0.0 1.2 0.4 1.4 2.1 0.0 0.0 0.1 4.7 0.0 0.1 1.0 3.2 0.0 30.4 1.1 0.0 1.6 1.5 0.6 0.0 1.9 1.0 0.0 0.0 0.3 0.0 0.5 0.1 0.3 0.0 0.4 1.6 0.0 0.2 1.4 0.0 0.2 0.5 0.0 10.8 0.1 0.0 0.0 0.0 1.6 3.4 3.1 0.8 0.6 1.7 0.4 0.4 0.9 1.4 1.7 0.1 0.4 0.8 0.3 0.0 0.4 0.1 1.8 0.7 1.8 4.0 0.7 0.8 1.3 0.3 0.0 0.1 5.1 0.8 2.1 1.9 0.7 0.0 1.1 1.6 0.0 0.8 0.4 0.0 1.1 0.0 2.6 0.7 5.2 1.0 0.8 1.3 1.8 0.6 0.5 2.9 0.8 2.8 1.8 8.3 1.6 0.8 2.1 1.0 4.3 0.4 0.9 0.8 1.5 0.3 0.6 1.3 1.9 0.7 4.3 3.5 3.5 0.6 0.5 0.5 3.1 0.8 1.1 1.2 0.2 0.4 1.6 1.2 0.7 0.7 1.5 1.0 1.7 1.4 0.6 0.3 3.4 1.1 0.4 3.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 66.9 3.4 1.8 0.0 0.0 0.0 1.1 65.2 0.0 0.0 0.0 0.0 0.1 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.5 1.1 0.0 1.7 0.0 0.0 0.2 0.1 0.0 1.1 0.1 0.5 0.0 0.0 9.7 0.9 0.0 0.0 0.0 0.0 0.6 DUS1L "DUS1, PP3111" ENSG00000169718 "Dihydrouridine synthase 1 like" Q6P1R4 17 82057506-82065887 "Predicted intracellular proteins" "tRNA processing" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 101.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023384 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA023384: AB_1847879" "unprognostic (4.42e-2)" "unprognostic (2.19e-2)" "unprognostic (4.30e-2)" "unprognostic (3.03e-2)" "unprognostic (1.73e-3)" "unprognostic (1.84e-1)" "unprognostic (4.01e-2)" "unprognostic (5.17e-2)" "unprognostic (1.10e-1)" "unprognostic (4.16e-3)" "unprognostic (5.23e-3)" "unprognostic (3.13e-1)" "prognostic unfavorable (5.89e-5)" "unprognostic (4.17e-2)" "unprognostic (8.57e-2)" "unprognostic (3.47e-1)" "unprognostic (1.70e-3)" 21.4 17.5 12.4 29.1 16.5 37.1 20.2 21.4 20.3 17.7 29.5 14.1 26.8 30.8 18.1 23.4 26.0 18.5 27.9 23.8 13.0 10.9 19.8 54.6 21.5 31.2 18.9 16.0 20.1 59.6 15.2 23.5 16.5 12.9 26.9 14.8 16.0 45.4 18.9 44.1 40.8 28.0 19.6 10.5 30.9 28.9 23.7 12.4 28.0 22.8 26.2 30.4 17.0 18.5 5.0 10.6 6.3 6.0 7.9 9.8 2.9 36.1 23.4 8.1 9.6 6.4 6.5 26.1 12.8 5.8 12.5 8.9 21.3 16.3 29.7 15.0 7.1 8.5 24.4 10.0 13.1 5.0 11.7 61.0 18.8 32.5 36.9 14.4 29.1 23.4 9.7 16.6 8.2 10.4 5.9 14.0 26.8 32.4 15.0 6.3 56.7 40.3 25.1 9.8 17.9 34.1 30.9 9.6 31.9 9.2 23.9 43.4 27.3 9.8 41.1 26.2 8.1 24.0 28.0 10.6 20.3 20.6 17.3 32.2 37.6 10.4 24.0 12.8 21.8 13.9 4.2 5.0 6.3 6.0 5.1 8.7 5.0 6.1 7.0 4.8 5.0 9.8 8.1 1.7 7.9 6.0 10.6 9.8 2.9 12.4 16.5 21.4 20.3 13.0 10.9 18.9 16.0 12.9 12.4 26.8 15.5 15.7 16.5 19.6 29.0 16.2 30.6 10.7 11.4 10.4 27.5 14.3 6.6 10.9 65.7 16.2 40.4 0.0 32.9 16.0 11.3 33.5 3.5 72.7 18.4 17.5 41.5 12.9 19.6 101.1 13.3 17.2 10.1 13.6 53.1 17.1 30.1 25.9 12.7 20.2 46.0 12.9 13.7 20.7 9.8 24.8 13.0 12.8 54.9 32.6 EFNB1 "CFNS, Elk-L, EPLG2, LERK2" ENSG00000090776 "Ephrin B1" P98172 X 68828997-68842147 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Cancer-related genes, Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 104.2;Ito cells: 108.6;Suprabasal keratinocytes: 105.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 7.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 35.3;hTCEpi: 27.6;PC-3: 26.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB031489, HPA067188" Uncertain Supported "Plasma membrane" NA NA 790000 "Plasma membrane" "CAB031489: AB_631414, HPA067188: AB_2685799" "unprognostic (2.00e-1)" "unprognostic (1.33e-2)" "unprognostic (1.77e-2)" "prognostic unfavorable (3.32e-5)" "unprognostic (1.04e-1)" "unprognostic (2.48e-2)" "unprognostic (8.05e-3)" "unprognostic (2.15e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (3.94e-2)" "prognostic unfavorable (4.29e-4)" "unprognostic (1.29e-1)" "unprognostic (2.17e-3)" "unprognostic (2.76e-2)" "unprognostic (8.03e-2)" "unprognostic (1.72e-3)" "unprognostic (1.86e-2)" 36.5 13.2 5.0 11.5 4.5 1.3 26.5 2.3 4.7 19.5 21.1 4.7 13.1 14.0 15.2 14.9 17.4 15.2 33.7 16.0 3.6 2.7 25.5 15.3 23.0 5.2 4.7 3.5 21.6 4.5 15.0 6.4 34.3 3.9 15.9 10.1 14.9 7.0 13.2 9.1 26.4 24.0 12.3 2.6 15.3 13.3 7.4 4.2 4.8 11.9 22.0 11.2 16.7 14.8 0.5 7.1 0.6 3.4 1.3 1.0 1.0 3.6 1.9 15.5 5.7 8.3 5.1 8.2 3.2 3.5 1.4 1.0 1.7 6.9 0.9 21.2 1.2 1.8 19.8 14.7 35.3 0.8 1.5 3.7 0.9 0.8 3.0 7.6 0.7 7.9 9.5 27.6 3.5 15.9 1.3 10.8 1.9 1.0 0.0 1.2 3.0 1.5 0.7 10.7 22.8 26.1 6.6 1.6 5.9 5.9 13.1 5.8 2.8 2.4 0.7 0.9 12.4 0.6 1.3 18.1 2.7 3.3 7.2 1.2 0.0 0.8 0.9 1.3 4.0 1.7 0.0 1.3 0.6 1.0 3.4 0.6 0.5 0.9 0.9 7.1 0.4 0.8 0.4 0.3 1.3 2.1 1.0 0.4 1.0 5.0 4.5 2.3 4.7 3.6 2.7 4.7 3.5 3.9 4.2 3.0 1.4 5.2 58.4 104.2 2.1 8.1 22.9 0.0 7.9 21.0 0.0 9.2 0.0 17.1 0.3 33.4 38.3 0.0 13.8 68.8 20.1 10.6 4.6 3.8 10.6 1.6 8.1 108.6 9.1 0.9 25.3 7.5 20.3 3.6 26.2 14.6 28.9 46.1 7.8 6.3 1.3 12.9 11.8 1.0 3.0 105.3 9.4 4.9 22.1 71.6 EHD1 "FLJ42622, FLJ44618, H-PAST, HPAST1, PAST1" ENSG00000110047 "EH domain containing 1" Q9H4M9 11 64851642-64888296 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 10 "Early spermatids: 850.4;Late spermatids: 1539.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049890, HPA049986, HPA066751, HPA067747" Approved Supported "Plasma membrane" NA NA 19000000 "Plasma membrane" "HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713, HPA067747: AB_2685896" "unprognostic (1.51e-1)" "unprognostic (3.21e-1)" "unprognostic (6.35e-3)" "unprognostic (2.43e-1)" "unprognostic (1.62e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (2.81e-5)" "unprognostic (1.46e-3)" "unprognostic (9.10e-3)" "unprognostic (9.44e-2)" "unprognostic (2.11e-2)" "unprognostic (1.79e-1)" "unprognostic (1.27e-1)" "unprognostic (6.37e-2)" "unprognostic (9.88e-2)" "unprognostic (2.74e-1)" "unprognostic (2.59e-2)" 17.5 10.4 7.3 33.3 7.4 57.5 12.3 27.2 11.3 11.1 13.5 18.2 8.0 14.7 13.1 10.8 15.5 12.5 15.2 11.3 8.2 9.4 14.5 9.3 18.7 41.1 13.8 5.9 10.0 5.2 5.1 3.4 34.8 16.7 9.0 6.6 8.0 11.9 10.0 13.2 14.1 22.9 12.4 13.1 43.1 12.7 65.8 10.4 21.3 12.3 13.6 33.6 13.5 10.3 10.6 3.5 38.0 13.1 10.2 17.2 10.2 26.8 18.7 6.7 7.4 8.2 13.4 3.9 27.4 24.9 23.3 13.6 24.2 16.9 35.4 9.8 32.7 19.9 22.0 7.0 27.6 9.0 22.1 3.9 23.5 9.8 12.2 9.8 7.6 6.4 6.0 5.9 35.9 11.3 10.6 22.9 7.0 9.6 62.9 17.6 14.3 15.2 12.6 4.5 6.8 24.5 6.1 21.6 12.3 22.0 9.0 4.8 4.3 15.3 28.2 12.4 8.0 38.3 5.4 32.2 10.4 9.2 27.4 13.1 25.9 11.4 27.1 27.0 10.0 5.6 6.7 5.0 38.0 16.9 6.7 17.2 10.6 11.9 14.6 2.9 8.2 7.2 9.8 23.6 10.2 13.1 3.5 12.9 10.2 7.3 7.4 27.2 11.3 8.2 9.4 13.8 5.9 16.7 10.4 71.5 40.7 35.7 42.8 59.8 2.6 25.4 12.7 9.4 14.8 14.0 2.0 72.8 6.6 29.4 850.4 27.9 40.2 0.0 35.6 19.3 36.8 19.1 92.3 7.8 27.3 4.8 6.3 9.8 34.3 1539.3 27.9 44.1 25.3 33.3 22.2 4.8 64.9 24.6 25.5 32.3 2.8 77.6 60.8 21.2 24.7 43.0 114.5 67.3 18.3 38.9 EHD2 PAST2 ENSG00000024422 "EH domain containing 2" Q9NZN4 19 47713343-47743134 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Leydig cells: 91.7;Peritubular cells: 100.8;Sertoli cells: 232.8;Smooth muscle cells: 117.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 59.6;ASC TERT1: 45.4;fHDF/TERT166: 46.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047394, HPA049890, HPA049986, HPA066751" Approved Supported "Plasma membrane" NA NA 580000 "Plasma membrane" "HPA047394: AB_2680026, HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713" "unprognostic (1.50e-1)" "unprognostic (2.11e-2)" "unprognostic (3.16e-3)" "unprognostic (1.54e-1)" "unprognostic (3.33e-2)" "unprognostic (5.42e-3)" "unprognostic (3.36e-2)" "unprognostic (1.33e-2)" "unprognostic (2.70e-3)" "prognostic unfavorable (8.75e-4)" "unprognostic (5.49e-3)" "unprognostic (9.50e-2)" "prognostic unfavorable (3.98e-4)" "unprognostic (6.59e-3)" "unprognostic (6.48e-2)" "unprognostic (1.82e-2)" "unprognostic (3.06e-3)" 82.2 17.8 6.7 14.5 6.1 0.6 62.0 4.3 7.5 35.2 29.1 5.0 10.0 6.7 40.2 21.2 33.0 20.7 34.3 19.3 5.4 2.9 8.3 4.5 28.1 13.5 5.4 3.4 34.0 11.1 3.1 3.8 22.8 6.4 28.2 7.3 11.6 9.7 25.1 17.3 15.3 14.3 40.7 4.5 19.0 17.5 12.9 5.7 1.8 15.0 24.6 8.3 35.0 52.6 0.6 0.4 2.4 0.6 0.2 0.5 0.9 11.3 26.6 0.0 0.3 59.6 45.4 0.0 44.4 21.0 16.1 13.1 1.7 5.7 0.0 0.0 46.9 3.8 14.4 0.2 23.1 9.8 0.0 0.1 1.5 15.5 0.1 37.7 0.0 3.1 43.9 20.4 13.5 13.3 21.4 31.0 0.1 4.7 0.0 16.9 2.0 2.3 0.1 0.3 1.6 4.8 0.2 1.8 0.0 12.8 0.5 0.0 0.1 38.9 1.5 1.1 3.7 3.7 0.7 35.3 24.2 5.4 21.2 9.5 0.0 0.0 0.0 22.5 0.6 5.1 1.0 0.4 0.6 0.3 0.3 0.3 0.5 0.3 0.4 0.1 0.6 0.5 0.5 2.4 0.2 0.6 0.4 0.3 0.9 6.7 6.1 4.3 7.5 5.4 2.9 5.4 3.4 6.4 5.7 56.6 22.3 0.0 24.5 18.0 3.2 7.3 12.7 1.4 17.0 5.2 0.0 0.9 0.0 17.5 0.6 58.5 0.0 0.0 11.9 1.3 39.2 11.6 2.3 2.1 1.7 0.0 0.0 42.4 1.0 1.9 91.7 3.2 8.5 1.0 0.0 1.7 25.4 0.0 100.8 0.0 0.8 232.8 117.3 0.7 3.4 11.8 1.3 0.0 0.0 26.5 EHD3 PAST3 ENSG00000013016 "EH domain containing 3" Q9NZN3 2 31234337-31269447 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.4;esophagus: 29.1" "Cell type enriched" "Detected in many" 5 "Ito cells: 172.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory B-cell: 17.8;naive B-cell: 4.4" "Lineage enriched" "Detected in many" 9 "B-cells: 17.8" "Cell line enhanced" "Detected in many" "BJ: 25.6;BJ hTERT+: 63.5;HEL: 24.6;U-266/70: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049890, HPA049986, HPA066751" Approved Approved "Plasma membrane" NA NA 41000000 "Plasma membrane" "HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713" "unprognostic (3.44e-1)" "unprognostic (8.88e-2)" "unprognostic (2.21e-1)" "unprognostic (3.79e-2)" "unprognostic (3.70e-2)" "unprognostic (1.89e-1)" "unprognostic (5.49e-2)" "unprognostic (1.21e-1)" "unprognostic (3.74e-2)" "unprognostic (9.72e-2)" "unprognostic (9.92e-3)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (4.88e-3)" "unprognostic (9.41e-2)" "unprognostic (4.79e-3)" "unprognostic (4.92e-3)" 2.7 7.1 15.0 5.6 16.3 2.0 3.3 10.6 37.4 5.6 2.2 7.3 0.0 1.9 3.9 3.4 29.1 4.9 3.6 14.8 16.7 8.9 15.0 10.8 4.8 6.3 9.6 21.6 2.9 1.4 8.7 6.0 11.3 13.3 5.7 2.1 2.8 4.8 4.9 2.3 3.0 2.9 4.8 9.4 5.8 1.9 1.6 6.6 1.2 2.5 1.5 10.4 7.8 4.2 17.8 0.4 1.0 1.9 0.6 1.7 7.8 0.5 2.7 1.5 1.3 2.5 3.9 0.2 25.6 63.5 2.5 2.3 0.0 0.3 0.2 0.9 8.4 2.2 0.2 0.0 1.7 1.8 1.0 2.3 24.6 0.1 0.0 8.8 0.0 0.0 6.2 0.7 2.4 1.0 6.7 0.0 0.0 0.0 0.1 1.8 4.0 0.3 0.0 5.8 0.0 1.3 0.8 0.1 0.5 1.9 2.9 0.7 3.9 0.2 0.4 0.0 4.9 0.3 0.0 0.0 1.9 1.8 0.1 2.0 15.9 2.0 0.0 4.9 0.0 4.0 0.4 0.4 0.3 1.7 0.8 0.9 17.8 0.9 1.1 0.4 4.4 0.8 0.4 1.0 0.6 1.9 0.0 0.4 7.8 15.0 16.3 10.6 32.7 16.7 8.9 9.6 21.6 13.3 6.6 0.0 0.0 23.6 1.4 0.7 9.2 18.9 2.5 0.0 1.2 0.0 0.0 3.5 0.0 0.3 0.0 5.2 0.0 0.0 0.2 7.3 2.3 0.8 0.0 0.8 1.4 0.0 1.7 172.5 21.8 0.0 1.1 0.2 0.0 1.0 0.0 8.1 0.2 0.0 2.8 0.2 5.4 19.4 3.3 0.2 2.1 0.6 36.7 2.5 0.0 3.2 EHD4 PAST4 ENSG00000103966 "EH domain containing 4" Q9H223 15 41895939-41972578 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 159.2;Urothelial cells: 196.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 34.2;TIME: 56.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049890, HPA049986, HPA052729, HPA066751" Approved Approved "Plasma membrane" NA NA 410000 "Plasma membrane" "HPA049890: AB_2680936, HPA049986: AB_2680983, HPA052729: AB_2681928, HPA066751: AB_2685713" "unprognostic (1.45e-1)" "unprognostic (1.37e-1)" "unprognostic (4.34e-3)" "unprognostic (3.36e-2)" "unprognostic (3.46e-2)" "unprognostic (4.48e-3)" "unprognostic (1.52e-1)" "unprognostic (3.36e-3)" "unprognostic (2.25e-1)" "unprognostic (3.74e-1)" "unprognostic (6.93e-2)" "unprognostic (2.35e-1)" "unprognostic (5.05e-2)" "unprognostic (3.49e-2)" "unprognostic (3.19e-2)" "unprognostic (8.27e-2)" "unprognostic (2.72e-1)" 26.1 5.0 3.3 12.9 5.0 8.0 17.9 1.9 5.6 11.4 11.4 4.7 11.3 4.7 20.8 16.4 18.1 10.5 17.4 35.4 4.3 2.6 14.5 22.8 19.9 24.3 7.2 2.0 14.1 14.1 13.9 6.5 14.4 7.5 14.1 9.3 17.4 11.1 12.0 10.5 16.1 16.0 11.6 7.1 11.1 10.0 7.5 4.3 5.3 19.1 9.0 13.7 14.4 10.1 2.6 13.3 7.7 12.7 3.6 6.8 6.2 9.0 3.1 3.1 3.1 1.5 2.2 2.7 4.8 10.3 8.6 12.2 13.3 5.2 1.9 13.1 6.1 17.2 9.2 4.5 10.6 6.4 11.3 3.8 2.7 4.7 2.2 3.8 1.2 8.1 1.8 4.2 8.7 9.7 3.3 34.2 2.8 2.9 2.1 6.9 3.8 1.3 1.4 2.3 8.9 11.0 0.0 8.1 2.9 7.8 18.5 5.1 2.1 3.5 7.7 5.5 3.1 7.5 1.8 56.2 2.7 5.3 10.1 23.5 6.0 9.6 3.9 3.4 3.0 23.5 0.9 12.7 7.7 3.8 11.2 5.8 2.0 6.0 4.8 13.3 2.6 2.6 3.7 2.1 3.6 4.4 2.2 6.8 6.2 3.3 5.0 1.9 5.6 4.3 2.6 7.2 2.0 7.5 4.3 6.0 46.5 24.5 159.2 72.5 5.0 32.5 17.8 40.2 56.9 41.8 29.5 8.6 6.6 63.9 12.4 61.2 81.9 0.0 54.9 17.5 15.6 38.0 61.1 7.7 74.1 1.6 21.7 51.5 26.4 26.1 6.9 48.1 18.6 75.7 16.5 47.6 58.7 45.6 4.6 3.1 21.5 12.9 18.4 4.2 8.8 69.8 14.5 13.8 23.0 196.5 ELN "SVAS, WBS, WS" ENSG00000049540 Elastin P15502 7 74027789-74069907 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Fibroblasts: 53.4;Ito cells: 49.1;Leydig cells: 102.4;Peritubular cells: 139.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 16.9;BJ: 23.4;fHDF/TERT166: 33.6;U-2197: 133.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "CAB010750, HPA018111, HPA056941" Supported Approved "Plasma membrane" "Secreted to extracellular matrix" NA NA 2900000 "Plasma membrane" "CAB010750: AB_476930, HPA018111: AB_1848109, HPA056941: AB_2683280" "unprognostic (1.51e-2)" "unprognostic (4.86e-2)" "unprognostic (2.50e-2)" "unprognostic (1.11e-1)" "unprognostic (1.57e-2)" "unprognostic (2.72e-2)" "unprognostic (3.70e-3)" "unprognostic (1.23e-1)" "unprognostic (3.33e-2)" "unprognostic (2.00e-3)" "unprognostic (2.88e-1)" "unprognostic (1.09e-1)" "unprognostic (2.18e-3)" "unprognostic (1.79e-2)" "unprognostic (3.90e-2)" "prognostic unfavorable (6.29e-4)" "unprognostic (1.62e-3)" 35.0 8.8 4.3 14.9 3.6 0.0 24.8 27.8 5.8 23.3 12.1 12.9 9.1 3.2 22.3 26.0 30.1 17.1 30.8 41.5 5.4 3.0 8.3 3.7 49.7 7.5 4.4 9.2 10.6 35.3 0.7 6.1 22.5 13.7 25.1 4.6 34.3 16.8 14.5 6.0 23.6 9.2 34.7 9.9 10.7 16.0 8.1 6.4 0.9 11.9 10.3 4.4 34.0 21.7 0.4 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.3 0.1 0.0 16.9 0.1 0.1 23.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 33.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 1.3 0.1 0.1 0.0 9.0 0.1 0.0 0.0 4.6 11.0 0.0 0.2 0.0 1.7 0.1 0.0 0.0 0.0 0.0 133.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 4.3 3.6 27.8 5.8 5.4 3.0 4.4 9.2 13.7 6.4 0.0 8.3 0.0 13.2 9.7 0.9 8.9 2.5 4.0 5.7 7.0 2.0 0.1 0.0 0.2 2.5 26.4 0.0 0.0 3.5 0.2 53.4 1.2 0.0 2.1 0.4 6.4 1.7 49.1 0.3 4.2 102.4 1.0 13.5 0.0 1.3 17.8 1.5 0.0 139.3 0.0 0.7 0.0 31.5 0.9 1.1 9.5 0.1 0.0 0.0 0.8 ENC1 "ENC-1, KLHL37, NRPB, PIG10, TP53I10" ENSG00000171617 "Ectodermal-neural cortex 1" O14682 5 74627406-74641424 "Cancer-related genes, Predicted intracellular proteins" "Actin-binding, Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 106.8" "Cell type enhanced" "Detected in many" 5 "Ductal cells: 54.5;Ito cells: 49.7;Pancreatic endocrine cells: 54.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 7 "amygdala: 39.7;basal ganglia: 42.7;cerebral cortex: 86.4;hippocampal formation: 44.1;olfactory region: 43.9" "Group enriched" "Detected in many" 6 "classical monocyte: 5.4;eosinophil: 3.4;gdT-cell: 2.3;intermediate monocyte: 4.8;memory CD8 T-cell: 3.0;myeloid DC: 2.4;naive CD8 T-cell: 2.5;neutrophil: 1.4;NK-cell: 2.8;non-classical monocyte: 1.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA078061 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA078061: " "prognostic unfavorable (3.88e-4)" "unprognostic (4.90e-2)" "unprognostic (1.13e-1)" "unprognostic (3.00e-3)" "unprognostic (1.05e-1)" "unprognostic (2.22e-3)" "unprognostic (1.36e-1)" "unprognostic (9.74e-2)" "unprognostic (1.24e-1)" "unprognostic (2.59e-1)" "unprognostic (4.98e-2)" "unprognostic (8.08e-2)" "prognostic unfavorable (2.95e-5)" "unprognostic (9.69e-2)" "unprognostic (3.08e-1)" "unprognostic (2.88e-1)" "unprognostic (5.65e-2)" 2.2 1.1 39.7 4.7 42.7 5.4 1.8 1.3 106.8 4.2 5.2 2.4 2.1 6.4 2.9 1.6 2.5 1.3 7.5 3.2 44.1 7.7 2.2 6.4 4.8 2.2 4.6 43.9 6.0 12.3 1.0 2.4 4.2 4.9 4.3 8.1 0.8 5.4 7.4 1.7 1.7 8.1 3.0 2.3 4.0 9.8 4.5 1.5 0.5 1.3 0.3 2.0 6.5 1.3 0.4 2.4 3.4 5.4 2.8 3.0 1.4 11.8 14.7 14.6 6.9 6.3 1.5 31.5 7.9 9.0 9.1 6.7 23.6 19.9 0.0 9.9 6.8 14.9 9.6 0.2 15.3 19.8 0.2 1.1 13.0 2.8 10.3 0.6 1.2 0.1 2.4 1.0 24.1 2.3 31.0 7.4 3.0 2.8 7.6 23.7 2.8 1.2 1.7 15.3 10.9 13.2 1.4 9.6 1.2 4.9 9.0 19.7 8.0 1.3 6.5 0.7 18.8 3.1 1.6 17.6 15.4 25.8 9.1 25.5 0.1 0.0 0.2 17.8 1.1 23.5 0.0 5.4 3.4 2.3 4.8 0.0 0.1 0.5 3.0 2.4 0.4 0.2 2.5 1.4 2.8 1.3 0.0 0.0 1.4 39.7 42.7 1.3 86.4 44.1 7.7 4.6 43.9 4.9 1.5 0.0 13.4 5.7 13.3 2.3 0.4 1.1 17.8 5.3 7.9 10.4 2.0 12.1 3.3 54.5 16.1 6.0 12.3 0.0 27.4 3.5 12.2 16.4 20.8 16.3 21.6 0.0 14.9 49.7 10.4 13.6 34.8 5.3 0.0 1.8 18.9 0.5 54.2 10.5 31.5 3.3 1.1 6.5 8.2 0.6 0.4 1.0 2.2 4.4 26.4 13.6 ENOX1 "cCNOX, CNOX, FLJ10094, PIG38" ENSG00000120658 "Ecto-NOX disulfide-thiol exchanger 1" Q8TC92 13 43213518-43786908 "Predicted intracellular proteins" "Biological rhythms, Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 16 "Early spermatids: 179.3;Late spermatids: 183.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 12.8;RH-30: 17.8;TIME: 12.8;U-2197: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038355 Approved Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA038355: AB_10673171" "unprognostic (9.64e-2)" "unprognostic (3.38e-3)" "unprognostic (1.64e-1)" "unprognostic (1.20e-3)" "unprognostic (1.06e-1)" "unprognostic (2.69e-1)" "unprognostic (2.88e-1)" "unprognostic (6.72e-3)" "unprognostic (2.60e-1)" "unprognostic (2.29e-3)" "unprognostic (1.32e-1)" "unprognostic (9.93e-2)" "unprognostic (1.32e-3)" "unprognostic (1.07e-2)" "unprognostic (1.48e-1)" "unprognostic (2.08e-3)" "unprognostic (1.42e-2)" 5.7 2.2 10.7 4.5 14.8 0.8 2.8 2.1 17.0 5.2 8.5 15.0 0.2 1.3 7.2 2.0 2.1 4.7 3.1 8.3 10.3 6.0 6.1 1.0 1.9 3.5 9.4 10.6 11.2 2.5 0.7 2.3 7.8 15.6 5.6 3.1 3.2 1.3 6.9 11.0 1.4 2.2 8.8 7.7 1.5 3.5 14.5 15.0 0.1 1.4 0.3 2.6 4.8 3.7 0.2 2.3 0.9 0.3 0.3 0.2 0.1 0.1 0.2 2.5 0.0 2.6 10.0 0.5 1.2 2.8 4.2 4.0 1.7 0.3 0.0 0.1 3.6 0.4 0.1 0.5 0.3 1.8 2.9 4.1 0.5 2.9 0.0 1.6 0.1 0.6 9.6 0.9 12.8 6.5 0.7 0.3 2.0 0.0 0.6 2.6 0.2 4.1 0.1 2.8 0.0 1.1 0.0 17.8 0.0 2.2 0.5 8.7 3.4 1.5 2.6 0.6 2.0 0.5 0.0 12.8 1.4 0.4 13.2 1.4 0.0 0.0 0.1 6.2 0.0 9.3 0.9 0.1 0.3 0.1 0.1 0.2 0.2 0.1 0.1 2.3 0.1 0.2 0.1 0.3 0.3 0.3 0.3 0.2 0.1 10.7 14.8 2.1 17.0 10.3 6.0 9.4 10.6 15.6 15.0 3.0 0.0 0.0 1.3 0.6 3.6 1.4 0.0 9.4 4.5 0.0 0.0 0.1 5.0 0.5 179.3 0.0 0.0 0.0 0.3 0.0 1.9 1.6 0.0 0.0 0.2 1.6 0.0 0.0 0.0 183.1 11.2 0.6 0.0 0.0 0.0 0.1 0.1 0.0 4.2 0.1 0.4 6.5 1.2 3.0 7.6 0.3 0.2 0.0 0.0 0.5 EPB41L1 "4.1N, KIAA0338" ENSG00000088367 "Erythrocyte membrane protein band 4.1 like 1" Q9H4G0 20 36091504-36232799 "Disease related genes, Predicted intracellular proteins" Actin-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 147.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 3.9" "Lineage enriched" "Detected in single" 15 "dendritic cells: 3.9" "Cell line enhanced" "Detected in many" "A549: 39.5;HaCaT: 58.2;OE19: 45.7;SK-BR-3: 45.6" "Low region specificity" "Detected in all" "HPA054104, HPA056817" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA054104: AB_2682380, HPA056817: AB_2683244" "unprognostic (2.01e-2)" "unprognostic (7.77e-2)" "unprognostic (1.76e-2)" "prognostic unfavorable (6.46e-5)" "unprognostic (1.19e-1)" "unprognostic (2.31e-1)" "unprognostic (1.23e-1)" "unprognostic (1.56e-2)" "unprognostic (3.87e-1)" "unprognostic (5.83e-3)" "prognostic unfavorable (9.30e-4)" "unprognostic (1.78e-1)" "prognostic favorable (4.39e-10)" "unprognostic (1.25e-1)" "unprognostic (1.71e-1)" "unprognostic (2.47e-1)" "unprognostic (2.26e-2)" 23.1 57.8 36.0 3.5 39.5 0.3 10.9 21.5 56.8 18.4 14.0 28.8 7.3 6.2 13.1 14.7 21.5 21.4 18.3 9.4 31.2 34.6 30.5 3.9 13.5 1.9 35.2 39.4 20.2 13.2 16.8 8.7 9.8 45.2 12.9 9.8 9.4 23.9 20.8 4.8 6.5 7.4 12.7 22.3 3.6 27.9 8.2 23.7 0.0 11.4 4.6 6.1 14.9 11.1 0.2 3.9 0.0 0.0 0.0 0.2 0.0 12.6 39.5 14.2 5.2 9.2 5.8 13.3 4.1 9.1 8.6 6.9 26.1 22.8 0.7 6.8 12.6 17.7 58.2 6.5 4.7 6.5 0.1 3.7 0.1 13.2 25.4 2.8 0.0 4.8 5.0 2.3 8.0 0.6 11.1 2.1 3.1 0.6 10.1 7.4 8.1 0.4 0.2 5.4 45.7 12.3 0.6 3.9 15.6 7.4 20.4 5.0 6.1 18.2 45.6 1.6 11.3 11.2 0.5 1.7 10.3 11.2 5.2 0.9 13.3 4.5 0.1 17.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 36.0 39.5 21.5 56.8 31.2 34.6 35.2 39.4 45.2 23.7 14.9 16.6 0.0 5.2 2.6 31.6 7.9 28.1 26.8 17.0 45.4 147.3 1.3 16.6 19.2 2.3 6.8 8.8 0.0 9.5 0.4 6.4 3.9 49.8 0.4 5.7 30.2 14.9 9.2 1.6 2.0 14.7 1.8 3.3 0.0 5.5 22.2 22.2 16.5 39.6 24.9 8.0 32.3 7.5 4.1 3.6 1.5 0.9 0.0 10.6 14.4 EPB41L5 "BE37, FLJ12957, KIAA1548, YMO1, YRT" ENSG00000115109 "Erythrocyte membrane protein band 4.1 like 5" Q9HCM4 2 120013005-120179119 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Alveolar cells type 1: 202.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 25.1;MCF7: 37.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037563, HPA037564" Uncertain Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA037563: AB_2675546, HPA037564: AB_2675547" "unprognostic (1.27e-2)" "unprognostic (2.15e-1)" "unprognostic (2.56e-2)" "unprognostic (2.31e-1)" "unprognostic (3.33e-2)" "unprognostic (1.47e-2)" "unprognostic (1.53e-1)" "unprognostic (9.06e-3)" "unprognostic (5.93e-2)" "unprognostic (8.76e-2)" "unprognostic (2.20e-2)" "unprognostic (9.51e-2)" "prognostic favorable (2.28e-6)" "unprognostic (1.99e-1)" "unprognostic (3.88e-1)" "unprognostic (9.59e-2)" "unprognostic (2.61e-1)" 4.6 5.0 7.4 6.0 11.6 1.1 13.3 19.4 12.6 7.4 8.6 6.9 4.3 10.6 7.2 4.9 7.0 10.2 6.2 4.9 8.5 7.4 25.6 42.3 36.3 3.8 7.6 6.5 9.4 20.3 13.0 15.8 7.5 12.2 9.9 7.0 7.1 10.8 6.6 8.6 6.6 9.5 7.5 14.8 2.2 7.0 22.0 6.1 2.9 25.2 6.4 5.0 5.3 8.4 4.7 0.4 1.8 1.4 1.5 3.2 1.4 8.0 2.7 11.2 8.6 7.8 5.7 9.7 1.7 1.7 3.6 3.3 25.1 5.4 0.1 6.1 2.1 4.6 5.5 15.0 6.8 5.4 1.6 4.6 2.3 1.3 14.0 9.1 1.0 2.5 5.1 13.0 6.8 4.9 3.2 10.2 4.8 5.4 0.6 7.2 37.6 1.9 3.5 10.0 3.7 2.6 0.0 3.3 2.2 11.4 7.8 5.8 11.1 7.6 13.5 3.7 16.0 6.5 1.9 8.4 0.3 5.4 5.7 1.7 0.8 1.5 4.2 0.9 0.0 2.1 0.3 1.4 1.5 1.1 0.3 0.3 4.7 1.2 1.1 0.4 3.6 3.2 2.4 1.8 1.5 0.9 0.0 0.5 1.4 7.4 11.6 19.4 12.6 8.5 7.4 7.6 6.5 12.2 6.1 202.5 30.3 2.9 19.7 21.8 31.4 12.0 15.3 20.1 25.0 31.4 23.6 11.9 18.3 15.8 22.4 5.8 17.7 0.0 19.5 10.0 13.3 24.0 0.0 47.8 2.7 7.9 14.9 16.5 1.9 16.2 8.3 3.3 13.5 1.0 10.2 18.1 20.4 17.3 8.9 23.7 33.6 19.4 7.7 33.8 43.9 19.1 22.1 2.5 9.7 30.4 EPCAM "17-1A, 323/A3, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC31, TACST-1, TACSTD1, TROP1" ENSG00000119888 "Epithelial cell adhesion molecule" P16422 2 47345158-47387601 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Tumor antigen" "Cancer-related genes, Disease mutation, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 303.2" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 1952.6;Mucus-secreting cells: 1256.8;Paneth cells: 2168.3;Undifferentiated cells: 1330.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.9" "Cell line enhanced" "Detected in many" "A-431: 55.5;CACO-2: 71.9;CAPAN-2: 101.2;OE19: 96.3;RPTEC TERT1: 43.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB003809, HPA026761, CAB030012, CAB055098, HPA067463" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB003809: AB_562285, CAB030012: AB_756075, CAB055098: AB_2335685, HPA026761: AB_1848198, HPA067463: AB_2685846" "unprognostic (6.79e-2)" "unprognostic (2.28e-1)" "unprognostic (1.59e-2)" "unprognostic (1.16e-2)" "unprognostic (1.61e-1)" "unprognostic (3.49e-2)" "unprognostic (2.01e-1)" "unprognostic (3.61e-2)" "unprognostic (3.40e-1)" "prognostic favorable (3.30e-4)" "unprognostic (5.27e-2)" "unprognostic (3.28e-2)" "prognostic favorable (1.04e-6)" "unprognostic (6.38e-3)" "unprognostic (1.28e-1)" "unprognostic (6.45e-3)" "unprognostic (6.08e-2)" 0.4 2.1 1.8 49.8 3.0 0.2 8.9 0.6 1.0 10.8 155.8 0.7 31.5 66.8 4.4 35.2 2.8 10.2 41.6 0.4 1.7 2.7 60.2 1.2 22.6 0.4 1.2 0.4 3.8 54.1 19.8 38.7 2.2 0.9 9.0 70.5 0.7 47.2 25.0 0.5 2.0 303.2 1.7 1.4 0.5 15.3 5.5 0.9 1.7 83.6 4.2 4.1 4.1 2.1 0.2 1.9 0.4 0.2 0.0 0.0 0.6 55.5 0.6 0.0 0.1 0.0 0.0 35.2 0.0 0.0 0.0 0.0 71.9 101.2 0.0 15.6 0.1 0.0 26.2 0.5 6.6 0.2 0.0 6.4 0.0 0.3 28.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 16.6 0.0 0.0 28.3 0.0 2.6 18.2 96.3 3.6 0.0 0.0 14.1 43.2 24.5 39.1 0.3 0.4 20.7 0.0 15.5 17.4 0.1 0.0 0.0 0.7 0.2 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 1.9 0.0 0.6 1.8 3.0 0.6 1.0 1.7 2.7 1.2 0.4 0.9 0.9 288.8 113.7 7.2 161.4 8.2 0.1 1.7 236.9 180.7 188.8 425.7 0.0 14.0 64.6 814.0 5.0 2.3 1952.6 0.0 356.0 2.6 1.9 182.8 33.3 0.4 2.4 0.0 478.4 0.0 0.0 3.2 19.0 5.0 33.7 19.8 1256.8 11.8 505.0 2168.3 17.7 160.0 0.7 12.9 0.4 67.3 135.0 9.2 5.0 2.5 1330.8 202.8 EZR VIL2 ENSG00000092820 Ezrin P15311 6 158765741-158819412 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell shape" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 1685.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004035, HPA021616, CAB047324, CAB075739" Enhanced Enhanced "Plasma membrane" NA NA 75000000 "Plasma membrane" "CAB004035: AB_2100309, CAB047324: , CAB075739: AB_2665745, HPA021616: AB_1848342" "unprognostic (4.79e-3)" "unprognostic (1.48e-1)" "unprognostic (1.97e-2)" "unprognostic (2.50e-1)" "unprognostic (1.07e-1)" "unprognostic (1.31e-3)" "unprognostic (1.76e-2)" "unprognostic (2.41e-1)" "unprognostic (1.32e-1)" "unprognostic (7.53e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (5.59e-2)" "prognostic favorable (9.56e-8)" "unprognostic (1.16e-1)" "unprognostic (1.32e-1)" "unprognostic (1.34e-2)" "unprognostic (9.00e-2)" 22.8 56.4 30.9 31.2 31.4 24.7 13.3 4.0 21.5 18.0 45.5 28.2 35.2 33.8 9.8 25.8 71.8 25.1 30.2 34.3 37.6 13.9 53.5 16.2 44.3 36.7 14.8 19.0 20.7 33.0 77.1 14.6 125.1 23.5 21.7 22.8 37.0 27.4 32.0 13.6 47.5 87.9 22.8 12.8 26.0 55.4 21.4 22.2 41.6 37.1 34.4 75.6 38.2 25.3 81.7 30.0 24.3 31.2 20.7 61.7 41.1 88.1 48.2 11.9 17.1 1.3 1.4 69.7 27.7 9.1 31.3 26.4 56.4 48.9 88.8 27.5 31.6 15.0 67.6 23.5 30.9 36.4 31.0 15.2 1.8 29.2 24.9 31.8 21.9 13.7 2.3 24.0 29.4 28.6 26.8 20.5 12.3 17.5 43.5 18.1 23.2 31.1 26.5 19.9 24.1 16.1 23.4 5.6 20.2 64.3 26.8 21.7 17.7 48.5 69.9 5.2 57.0 17.0 29.0 26.4 10.1 32.5 13.9 42.6 30.0 27.3 76.1 6.3 11.3 12.0 24.3 14.0 16.4 34.8 31.2 41.0 81.7 36.7 42.9 30.0 67.5 19.9 26.5 6.1 20.7 30.6 14.0 61.7 41.1 30.9 31.4 4.0 21.5 37.6 13.9 14.8 19.0 23.5 22.2 884.4 543.1 187.4 615.4 546.1 5.3 247.6 119.8 1685.0 977.1 148.3 0.0 366.9 82.9 222.1 7.9 84.3 679.2 46.7 221.5 488.7 135.0 354.7 114.5 30.6 98.9 0.0 153.2 31.3 77.1 21.1 125.4 213.0 305.4 115.4 206.3 31.3 408.3 238.4 276.5 168.7 4.0 245.8 120.5 46.2 56.6 635.1 1039.8 112.2 143.1 1039.6 F2RL1 "GPR11, PAR2" ENSG00000164251 "F2R like trypsin receptor 1" P55085 5 76818933-76835315 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Immunity, Inflammatory response, Innate immunity" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 64.1" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 97.5;Enterocytes: 75.9;Suprabasal keratinocytes: 147.0;Urothelial cells: 93.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "pons and medulla: 7.8" "Cell type enriched" "Detected in many" 4 "neutrophil: 24.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 24.9" "Cell line enhanced" "Detected in many" "PC-3: 34.7;RPTEC TERT1: 57.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB012989, HPA014091" Approved Approved "Plasma membrane" NA Yes "Plasma membrane" "CAB012989: AB_2533199, HPA014091: AB_2668939" "unprognostic (1.29e-2)" "unprognostic (4.05e-2)" "prognostic favorable (3.88e-4)" "unprognostic (1.98e-2)" "unprognostic (8.22e-2)" "prognostic unfavorable (5.88e-4)" "unprognostic (1.36e-1)" "prognostic unfavorable (8.92e-4)" "unprognostic (6.13e-2)" "unprognostic (4.07e-1)" "unprognostic (2.16e-3)" "unprognostic (1.52e-2)" "prognostic favorable (5.86e-7)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (3.76e-2)" "unprognostic (9.73e-2)" 0.6 1.1 1.0 7.2 1.4 0.1 2.9 0.4 0.8 2.4 34.0 1.1 25.3 17.4 1.0 2.2 6.4 2.9 13.6 3.6 1.1 0.9 28.9 7.4 2.8 3.7 0.8 0.4 1.2 16.6 1.3 3.2 2.8 7.8 6.0 21.4 1.1 7.1 23.7 0.3 24.8 64.1 0.7 1.5 3.5 16.8 0.8 0.5 0.6 9.6 5.8 3.1 5.3 3.9 0.3 2.7 24.9 5.7 0.3 2.3 2.0 8.7 14.4 1.2 0.0 0.4 1.1 9.3 0.4 4.8 0.2 0.7 12.4 22.6 0.0 19.5 1.0 22.3 15.0 7.6 6.7 0.4 0.0 7.1 0.2 0.3 8.8 3.1 0.0 0.0 1.6 19.2 2.2 14.4 2.3 23.9 2.2 0.1 0.0 0.0 4.7 1.0 0.0 1.6 4.9 34.7 0.0 0.0 0.2 57.6 16.2 0.6 0.1 3.4 3.5 0.0 14.5 1.5 0.0 15.7 0.0 9.1 0.0 0.0 1.3 0.2 0.0 5.1 0.0 0.4 4.6 5.7 1.0 0.3 1.9 1.2 0.3 2.3 1.2 2.7 0.1 2.2 1.3 24.9 0.3 0.3 0.3 0.6 2.0 1.0 1.4 0.4 0.8 1.1 0.9 0.8 0.4 7.8 0.5 8.9 3.0 2.0 18.2 97.5 0.0 0.3 35.7 18.7 11.4 29.6 0.0 4.8 1.7 20.1 0.0 0.6 75.9 0.0 13.1 6.2 3.7 19.6 2.3 8.5 0.7 0.0 12.6 1.8 2.4 0.0 0.0 1.1 1.7 0.0 43.8 0.0 29.3 35.1 0.0 20.2 1.6 0.0 1.0 0.0 1.4 147.0 1.7 0.0 39.6 93.4 F2RL3 PAR4 ENSG00000127533 "F2R like thrombin or trypsin receptor 3" Q96RI0 19 16888860-16892606 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood coagulation, Hemostasis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 69.4;breast: 30.7;lung: 33.0" "Group enriched" "Detected in some" 5 "Endothelial cells: 5.8;granulocytes: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 7 "HEL: 24.9;HMC-1: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031401, HPA042340" Supported "Plasma membrane" NA NA "Plasma membrane" "HPA031401: , HPA042340: " "unprognostic (6.17e-2)" "unprognostic (1.08e-1)" "unprognostic (2.64e-2)" "unprognostic (3.83e-1)" "unprognostic (3.27e-1)" "unprognostic (8.31e-3)" "unprognostic (2.97e-1)" "unprognostic (3.28e-2)" "unprognostic (6.52e-2)" "unprognostic (2.60e-1)" "unprognostic (6.30e-2)" "unprognostic (3.00e-3)" "prognostic favorable (6.25e-4)" "unprognostic (2.37e-2)" "unprognostic (1.43e-1)" "unprognostic (3.53e-1)" "unprognostic (2.11e-2)" 69.4 3.3 0.2 2.6 0.4 1.3 30.7 0.2 0.6 1.3 16.9 0.4 0.5 1.9 1.3 1.9 4.3 1.0 4.5 9.7 0.5 0.2 5.0 0.8 33.0 2.6 0.2 0.3 3.9 12.3 0.5 2.3 1.1 1.4 1.4 1.5 1.3 1.0 0.8 6.5 2.2 4.4 1.1 0.2 3.0 5.4 2.5 0.2 0.3 27.1 2.3 1.5 3.4 1.9 5.3 4.3 5.8 2.5 3.9 3.3 3.2 0.2 0.2 0.7 0.3 0.1 0.2 0.7 0.4 0.1 0.2 0.1 0.4 0.7 0.5 0.5 0.2 0.3 0.7 0.1 0.2 0.2 0.3 0.4 24.9 0.9 0.4 0.2 0.3 10.0 0.0 0.1 0.3 0.2 0.3 0.8 0.5 2.0 1.0 0.1 0.3 0.3 2.4 0.3 0.3 0.2 0.2 0.2 0.8 0.2 0.5 0.4 0.2 0.2 0.2 0.1 0.6 0.5 1.7 1.0 0.6 0.5 0.3 0.3 0.5 0.3 0.5 0.2 0.4 0.4 5.8 2.5 1.6 2.2 1.4 2.1 3.9 2.4 1.9 0.8 5.3 3.3 3.1 5.3 3.9 1.8 4.3 1.7 3.2 0.2 0.4 0.2 0.6 0.5 0.2 0.2 0.3 1.4 0.2 0.0 0.6 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.5 0.0 0.5 0.3 6.9 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.5 0.0 0.0 0.3 FBLN2 ENSG00000163520 "Fibulin 2" P98095 3 13549131-13638422 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 80.5" "Group enriched" "Detected in many" 6 "Fibroblasts: 266.2;Leydig cells: 158.2;Peritubular cells: 213.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 9.2;naive CD8 T-cell: 5.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 75.4;fHDF/TERT166: 49.5;HMC-1: 60.2;HSkMC: 43.7;U-2197: 26.7" "Region enriched" "Detected in some" 7 "olfactory region: 15.4" "Low region specificity" "Detected in all" "HPA001934, CAB018622" Enhanced Supported "Plasma membrane" "Secreted to extracellular matrix" NA NA 28000000 "Plasma membrane" "CAB018622: AB_2294196, HPA001934: AB_1078827" "unprognostic (1.19e-1)" "unprognostic (7.76e-2)" "unprognostic (3.21e-1)" "prognostic unfavorable (9.48e-4)" "unprognostic (2.82e-2)" "unprognostic (1.05e-1)" "prognostic favorable (3.17e-4)" "unprognostic (8.02e-2)" "unprognostic (1.72e-1)" "unprognostic (1.70e-2)" "unprognostic (2.57e-1)" "unprognostic (4.66e-2)" "unprognostic (2.13e-2)" "unprognostic (1.89e-2)" "unprognostic (2.82e-2)" "unprognostic (2.61e-2)" "unprognostic (1.41e-1)" 58.5 2.7 1.8 8.0 2.2 0.1 34.3 0.8 3.2 21.4 11.5 1.3 9.5 2.1 11.6 23.6 32.7 7.2 21.9 80.5 1.6 1.7 2.1 1.2 7.8 5.1 2.4 1.4 6.3 3.2 1.1 0.9 31.8 2.3 22.1 4.2 7.9 10.8 3.3 20.1 20.8 6.1 42.9 1.5 2.3 6.9 41.8 0.5 4.8 20.7 23.8 8.5 34.2 36.3 2.2 9.2 0.0 0.0 0.4 5.4 1.1 0.0 0.2 9.8 0.0 75.4 10.2 4.5 23.5 18.8 23.6 15.6 1.5 0.0 0.0 1.1 49.5 0.0 0.0 0.0 0.1 4.4 0.0 0.0 18.6 0.4 0.0 5.1 0.0 60.2 43.7 0.3 3.7 0.0 0.0 0.0 1.6 0.1 0.1 0.1 0.0 0.9 0.1 2.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.4 0.0 17.3 0.0 2.7 0.0 0.0 0.0 0.0 0.0 26.7 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 1.7 0.0 0.3 9.2 2.2 0.0 5.4 0.0 0.4 0.0 0.7 0.0 1.1 1.8 2.2 0.8 3.2 1.6 1.7 2.4 1.4 2.3 0.5 0.0 1.0 0.0 0.7 27.4 0.0 7.3 0.0 0.0 3.4 7.0 2.0 6.6 0.0 0.0 3.4 29.2 0.0 0.0 0.2 4.5 266.2 1.0 24.1 0.2 3.2 0.0 0.0 25.8 0.3 6.5 158.2 2.1 37.1 0.0 0.0 1.3 0.2 0.0 213.6 0.0 0.2 12.9 19.6 2.6 8.8 25.2 5.1 0.0 0.0 0.9 FBLN5 "ARMD3, DANCE, EVEC, UP50" ENSG00000140092 "Fibulin 5" Q9UBX5 14 91869412-91947987 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Age-related macular degeneration, Charcot-Marie-Tooth disease, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Leydig cells: 580.2;Peritubular cells: 747.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.5" "Group enriched" "Detected in many" 19 "granulocytes: 8.5;T-cells: 2.8" "Cell line enhanced" "Detected in some" "ASC diff: 87.8;ASC TERT1: 45.9;BJ: 41.1;BJ hTERT+: 38.5;fHDF/TERT166: 73.5;HSkMC: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000848, HPA000868, CAB025843" Supported Supported "Plasma membrane" "Secreted to extracellular matrix" NA NA 4500000 "Plasma membrane" "CAB025843: , HPA000848: AB_1078620, HPA000868: AB_1078619" "unprognostic (5.53e-3)" "unprognostic (1.14e-1)" "unprognostic (7.78e-2)" "unprognostic (9.29e-2)" "unprognostic (5.55e-3)" "unprognostic (4.73e-2)" "prognostic favorable (6.75e-4)" "unprognostic (5.21e-3)" "unprognostic (4.76e-2)" "unprognostic (1.25e-2)" "unprognostic (3.74e-2)" "unprognostic (1.90e-1)" "unprognostic (7.26e-2)" "unprognostic (1.56e-3)" "unprognostic (1.73e-1)" "unprognostic (5.18e-2)" "unprognostic (3.17e-3)" 48.3 23.5 3.4 11.5 9.5 1.8 49.5 2.2 5.6 52.4 26.6 5.3 20.3 6.0 51.7 36.0 22.6 32.2 97.4 54.5 2.5 2.6 38.9 12.1 50.5 8.6 7.0 4.1 36.5 14.6 7.6 3.9 21.0 9.4 41.2 6.4 40.6 18.3 23.8 24.7 17.5 12.8 51.8 6.8 48.2 18.8 43.9 2.1 1.2 30.3 15.1 9.4 56.4 51.1 0.2 0.1 8.5 0.3 0.0 2.8 0.6 0.0 0.2 0.0 0.0 87.8 45.9 4.6 41.1 38.5 1.1 0.8 0.7 0.0 0.0 0.8 73.5 0.1 0.0 1.8 0.1 0.2 0.0 0.4 0.0 0.8 0.0 14.6 0.0 0.0 42.1 0.0 0.7 2.7 0.5 1.9 0.0 0.0 0.0 4.7 0.1 0.0 0.1 0.1 0.0 0.1 0.0 5.8 0.0 0.2 0.0 0.0 0.0 2.3 0.1 0.5 1.3 0.5 0.0 0.3 0.6 1.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.2 3.5 1.2 0.2 0.7 0.1 0.5 0.1 0.0 0.2 1.7 2.8 4.1 0.0 0.3 0.1 0.1 0.6 3.4 9.5 2.2 5.6 2.5 2.6 7.0 4.1 9.4 2.1 77.4 13.3 0.0 2.5 8.1 0.0 4.5 0.0 17.4 12.5 5.2 0.0 1.9 5.0 3.7 4.7 9.2 0.0 0.0 4.3 1.4 129.7 1.2 2.3 0.5 7.7 0.0 0.0 46.6 1.9 12.1 580.2 2.5 20.3 1.0 0.0 0.0 2.7 0.0 747.1 24.2 0.0 6.5 15.0 2.1 2.0 7.5 3.1 6.9 0.0 0.7 FCAR CD89 ENSG00000186431 "Fc fragment of IgA receptor" P24071 19 54874248-54890472 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "IgA-binding protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.1;lung: 19.5;lymphoid tissue: 15.9" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 3.7;Cardiomyocytes: 1.4;Ciliated cells: 1.4;Kupffer cells: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "classical monocyte: 2.6;neutrophil: 6.1" "Group enriched" "Detected in many" 44 "granulocytes: 6.1;monocytes: 2.6" "Cell line enhanced" "Detected in single" "THP-1: 1.7" "Low region specificity" "Detected in all" HPA014050 Approved Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA014050: AB_1846338" "unprognostic (1.46e-1)" "unprognostic (5.74e-2)" "unprognostic (1.30e-1)" "unprognostic (4.71e-3)" "unprognostic (3.46e-1)" "unprognostic (2.02e-1)" "unprognostic (7.99e-2)" "unprognostic (1.54e-2)" "unprognostic (1.59e-2)" "unprognostic (4.70e-2)" "unprognostic (1.41e-2)" "unprognostic (7.05e-2)" "unprognostic (4.19e-6)" "unprognostic (9.23e-2)" "unprognostic (8.10e-3)" "unprognostic (8.04e-3)" "unprognostic (9.81e-2)" 4.0 0.6 0.4 1.5 4.4 28.1 0.8 0.1 1.0 0.6 0.6 0.7 0.0 0.6 0.6 0.6 0.6 3.8 0.6 8.2 2.0 0.4 0.6 1.8 19.5 15.9 1.2 0.0 2.2 0.6 0.6 0.3 1.5 4.3 0.6 0.6 0.9 0.6 0.6 0.6 0.6 0.6 0.7 2.7 14.9 0.9 2.1 0.0 1.0 0.6 0.3 0.6 4.4 4.8 0.0 0.0 6.1 2.6 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.1 0.0 0.0 0.7 0.4 4.4 0.1 1.0 2.0 0.4 1.2 0.0 4.3 0.0 0.0 3.7 0.0 0.2 0.1 0.1 1.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.3 1.1 0.0 1.0 0.0 0.0 0.0 5.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.1 FFAR4 "GPR120, GPR129, O3FAR1, PGR4" ENSG00000186188 "Free fatty acid receptor 4" Q5NUL3 10 93566665-93604480 "G-protein coupled receptors, Predicted membrane proteins" "Differentiation, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 15.8;lung: 11.7;pituitary gland: 39.2" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 18.7;Intestinal endocrine cells: 20.1;Mucus-secreting cells: 63.6" "Cancer enhanced" "Detected in some" "colorectal cancer: 4.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 3.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "OE19: 16.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA042563 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA042563: AB_10794762" "unprognostic (1.96e-1)" "unprognostic (1.06e-2)" "unprognostic (1.14e-2)" "unprognostic (4.21e-2)" "unprognostic (2.12e-1)" "unprognostic (4.98e-4)" "unprognostic (1.41e-3)" "unprognostic (1.20e-2)" "unprognostic (2.34e-2)" "unprognostic (7.87e-2)" "unprognostic (9.51e-2)" "unprognostic (1.49e-1)" "unprognostic (3.85e-2)" "unprognostic (5.32e-2)" "unprognostic (2.71e-1)" "unprognostic (1.02e-1)" "unprognostic (1.49e-1)" 5.2 0.6 1.8 2.8 1.7 0.2 1.9 0.1 2.6 0.2 11.3 1.1 0.0 0.7 0.1 0.1 0.4 1.4 2.6 1.2 0.9 1.6 0.3 0.6 11.7 1.3 0.6 1.0 0.3 1.1 0.1 39.2 0.4 0.8 0.2 15.8 0.3 0.9 0.1 0.5 1.3 1.0 0.3 2.6 0.2 0.7 2.0 0.9 0.7 0.2 0.0 0.6 0.3 0.2 0.5 3.4 1.3 3.0 0.7 0.3 0.8 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.4 0.4 0.1 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.1 16.8 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 3.0 0.2 0.3 0.6 0.2 0.4 0.2 0.2 3.4 0.5 0.2 0.3 1.3 0.7 0.4 0.4 0.1 0.8 1.8 1.7 0.1 2.6 0.9 1.6 0.6 1.0 0.8 0.9 0.0 0.3 0.0 0.4 0.0 0.0 0.3 12.7 0.0 1.2 0.0 0.0 0.1 0.0 0.6 18.7 0.1 6.5 0.0 0.0 0.5 0.2 0.3 0.0 0.0 7.8 0.0 20.1 0.0 3.2 12.2 0.6 3.8 1.7 0.0 63.6 0.0 1.4 9.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.2 FGD5 "FLJ00274, FLJ39957, ZFYVE23" ENSG00000154783 "FYVE, RhoGEF and PH domain containing 5" Q6ZNL6 3 14810853-14934565 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Endothelial cells: 35.2;Ito cells: 52.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 41.3;TIME: 33.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA014436, HPA014536, HPA019191" Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA014436: , HPA014536: AB_1848518, HPA019191: AB_1848519" "unprognostic (2.57e-1)" "unprognostic (7.33e-2)" "unprognostic (1.03e-1)" "unprognostic (3.28e-2)" "unprognostic (2.02e-2)" "unprognostic (1.03e-3)" "unprognostic (1.08e-1)" "unprognostic (4.10e-2)" "unprognostic (6.34e-2)" "unprognostic (5.53e-2)" "unprognostic (1.46e-1)" "unprognostic (9.39e-2)" "unprognostic (6.84e-3)" "unprognostic (1.71e-2)" "unprognostic (3.46e-1)" "unprognostic (1.32e-2)" "prognostic favorable (7.50e-4)" 18.9 3.7 2.2 10.7 2.7 0.0 18.9 1.2 4.0 11.0 9.2 1.9 8.3 7.3 17.7 9.5 5.7 8.1 14.3 12.3 2.3 2.2 10.3 2.5 27.3 8.1 2.7 1.9 7.2 6.5 2.8 3.9 14.3 3.1 8.3 3.8 8.4 4.5 4.0 7.9 6.0 8.6 9.6 2.4 29.3 5.2 7.1 1.6 1.0 8.6 8.4 3.6 7.2 20.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 41.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.2 0.0 33.8 0.0 2.9 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.7 1.2 4.0 2.3 2.2 2.7 1.9 3.1 1.6 0.0 5.8 1.3 0.2 2.7 0.0 2.2 2.5 0.0 1.2 0.0 0.0 0.2 1.7 0.0 6.7 35.2 0.0 0.0 0.2 0.1 8.3 0.2 0.0 0.8 8.9 0.0 0.0 52.8 2.8 5.2 10.6 3.4 1.7 0.0 0.0 0.0 2.8 0.0 4.2 6.3 0.0 0.0 2.1 0.2 4.7 1.6 0.5 0.7 0.0 0.3 FILIP1L "DOC-1, GIP130" ENSG00000168386 "Filamin A interacting protein 1 like" Q4L180 3 99830141-100114513 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 302.8;Sertoli cells: 252.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 5.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 27.3;HDLM-2: 25.5;TIME: 47.6" "Region enriched" "Detected in some" 7 "olfactory region: 22.1" "Low region specificity" "Detected in all" HPA043133 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA043133: AB_10793991" "unprognostic (9.14e-2)" "unprognostic (2.16e-1)" "unprognostic (7.73e-2)" "unprognostic (5.25e-2)" "unprognostic (6.68e-2)" "unprognostic (1.06e-2)" "unprognostic (4.40e-2)" "unprognostic (1.29e-1)" "unprognostic (2.08e-2)" "unprognostic (2.18e-1)" "unprognostic (1.02e-1)" "unprognostic (3.32e-1)" "prognostic unfavorable (9.40e-4)" "unprognostic (2.46e-2)" "unprognostic (9.44e-2)" "unprognostic (5.30e-2)" "unprognostic (1.82e-3)" 29.0 7.5 11.7 22.1 2.4 0.0 15.2 1.3 7.4 36.2 28.3 0.9 27.2 6.9 52.5 50.0 25.3 17.8 24.3 23.8 4.0 2.1 12.5 6.7 15.9 10.9 2.9 6.5 65.6 10.3 7.7 3.1 14.6 9.4 36.7 7.7 5.5 6.1 36.8 44.8 9.5 19.2 86.3 2.2 27.1 25.1 19.9 1.3 2.5 11.7 53.4 5.8 49.8 16.2 1.5 4.4 0.5 5.9 1.0 0.4 0.5 18.7 0.0 7.4 0.0 12.2 10.4 0.6 9.6 19.3 16.8 19.1 5.7 0.0 0.0 1.7 27.3 4.4 2.3 0.0 4.7 20.0 25.5 0.2 1.5 0.0 7.5 6.1 0.4 0.0 8.2 1.7 1.9 0.0 10.8 7.5 0.0 1.2 0.1 2.5 0.1 1.6 0.3 0.4 1.0 0.0 0.0 8.7 0.2 11.3 0.3 0.6 1.2 0.1 0.1 0.0 4.1 0.0 3.4 47.6 2.9 0.0 0.6 5.0 1.4 0.0 0.1 2.2 0.1 0.0 0.3 1.0 0.2 0.3 2.2 0.1 1.4 0.4 0.3 4.4 1.5 0.2 0.2 0.5 1.0 5.9 0.8 0.3 0.5 11.7 2.4 1.3 7.4 4.0 2.1 2.9 6.5 9.4 1.3 14.9 17.2 0.0 37.5 24.6 4.0 115.5 33.1 2.7 2.3 5.2 7.9 0.6 1.7 158.4 302.8 69.7 2.9 0.0 97.5 0.6 90.1 2.5 33.5 0.5 3.0 100.1 2.9 44.2 29.2 157.4 76.8 76.0 16.9 28.9 3.0 1.0 44.0 0.0 97.9 0.3 5.9 252.2 159.4 7.1 1.9 19.8 2.6 0.5 0.3 3.7 FKBP2 "FKBP-13, PPIase" ENSG00000173486 "FK506 binding protein 2" P26885 11 64241003-64244132 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 119.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025561, HPA049405" Enhanced Approved "Plasma membrane" "Intracellular and membrane" No No 400000 "Plasma membrane" "CAB025561: , HPA049405: AB_2680749" "unprognostic (4.94e-2)" "unprognostic (1.12e-1)" "unprognostic (5.77e-2)" "unprognostic (2.66e-3)" "unprognostic (7.40e-2)" "unprognostic (1.92e-2)" "unprognostic (8.64e-2)" "unprognostic (1.62e-1)" "unprognostic (3.23e-1)" "unprognostic (5.91e-3)" "unprognostic (5.86e-2)" "unprognostic (7.18e-2)" "unprognostic (1.70e-2)" "unprognostic (1.58e-1)" "unprognostic (5.23e-1)" "unprognostic (2.30e-1)" "unprognostic (3.57e-2)" 18.2 35.8 28.9 20.2 35.5 12.1 20.2 18.8 27.1 31.3 28.0 20.3 87.8 39.0 24.4 102.7 20.8 25.5 30.3 28.0 29.7 35.7 40.3 89.6 18.8 17.0 39.3 24.8 22.1 107.2 34.0 57.2 59.2 29.0 26.1 21.9 19.4 59.3 116.6 11.8 18.5 30.2 19.7 28.5 20.9 31.1 19.8 20.6 12.4 63.2 18.6 18.8 21.3 23.9 21.3 119.6 29.0 25.4 20.0 30.7 15.5 24.2 32.0 17.3 35.0 37.5 21.4 24.6 29.4 29.9 22.3 20.7 31.5 54.7 18.0 46.9 36.1 30.5 31.8 13.7 24.4 10.6 22.3 11.9 19.9 42.6 32.1 49.3 16.5 28.0 24.9 36.4 29.5 32.6 32.2 17.7 16.3 14.9 53.9 26.4 40.1 18.0 26.1 20.2 41.7 28.9 16.1 17.1 65.5 40.3 24.4 24.2 21.1 20.2 57.2 32.4 12.7 22.0 14.3 16.7 26.8 23.9 42.6 15.7 32.8 10.2 14.6 35.9 17.4 30.3 29.0 24.5 3.4 24.1 25.4 30.7 21.3 19.2 23.3 23.2 20.5 13.0 18.1 9.1 20.0 20.8 119.6 7.1 15.5 28.9 35.5 18.8 27.1 29.7 35.7 39.3 24.8 29.0 20.6 137.0 150.2 102.0 207.7 146.1 76.1 98.2 310.8 108.4 116.0 369.9 21.6 256.2 349.8 239.2 83.7 136.1 585.6 23.3 222.4 308.7 201.1 281.8 142.9 635.0 211.8 30.2 328.9 152.9 95.0 70.2 213.2 169.2 285.1 186.7 264.4 122.7 276.9 273.5 239.7 629.6 65.3 181.1 142.1 273.8 237.0 146.9 518.9 105.4 226.6 265.6 FZD1 DKFZp564G072 ENSG00000157240 "Frizzled class receptor 1" Q9UP38 7 91264364-91271326 "Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 61.2" "Cell type enhanced" "Detected in many" 13 "Cholangiocytes: 61.1;Horizontal cells: 133.5;Peritubular cells: 42.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 4.2;non-classical monocyte: 5.4" "Lineage enriched" "Detected in many" 4 "monocytes: 5.4" "Cell line enhanced" "Detected in many" "AF22: 16.6;HSkMC: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013008 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "CAB013008: " "unprognostic (1.46e-1)" "unprognostic (1.70e-1)" "unprognostic (1.15e-1)" "unprognostic (3.16e-2)" "unprognostic (4.51e-3)" "unprognostic (2.09e-1)" "unprognostic (5.29e-3)" "unprognostic (3.70e-2)" "unprognostic (2.36e-2)" "unprognostic (5.48e-3)" "unprognostic (2.14e-1)" "unprognostic (7.39e-3)" "prognostic favorable (8.87e-7)" "unprognostic (1.05e-2)" "unprognostic (4.16e-2)" "unprognostic (5.53e-2)" "unprognostic (4.13e-2)" 5.8 4.6 2.6 4.9 3.5 0.9 10.7 8.2 2.8 17.6 8.5 4.1 9.3 4.9 10.1 9.9 7.8 6.1 11.0 12.3 6.1 1.8 15.3 3.9 10.5 1.4 2.0 3.2 15.0 7.9 2.5 4.6 10.0 5.7 12.3 3.7 11.1 9.2 17.5 3.1 10.7 8.3 7.2 4.6 3.4 4.5 4.4 3.5 1.4 61.2 6.5 2.9 10.4 13.9 0.1 1.3 0.2 5.4 0.0 0.0 0.4 0.5 1.6 16.6 1.7 13.5 11.7 3.0 6.0 3.8 2.2 1.6 0.7 2.8 0.0 1.5 3.8 2.8 3.0 2.5 1.3 1.5 0.0 3.2 0.1 3.2 0.8 1.0 2.7 0.7 22.1 2.4 5.1 1.6 8.5 0.5 1.8 0.9 2.4 6.4 3.9 0.5 0.7 4.2 0.8 2.8 3.3 10.2 0.3 3.5 7.7 2.3 4.3 4.5 3.7 0.9 4.0 1.9 2.4 2.5 9.4 7.1 10.0 2.4 2.2 1.5 0.2 10.1 2.3 10.9 0.0 1.4 0.0 0.0 4.2 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 5.4 0.1 0.0 0.4 2.6 3.5 8.2 2.8 6.1 1.8 2.0 3.2 5.7 3.5 3.0 1.0 1.3 30.9 3.8 0.8 12.1 61.1 0.0 4.5 12.2 2.0 3.0 0.0 4.5 0.2 3.6 4.6 0.0 1.8 1.6 12.0 11.7 12.7 0.5 3.6 133.5 3.4 10.4 14.3 0.4 30.8 11.2 16.9 0.0 3.2 3.7 2.1 3.4 42.5 10.8 3.1 0.0 9.4 0.4 2.0 4.4 1.7 0.5 3.5 5.9 FZD6 Hfz6 ENSG00000164930 "Frizzled class receptor 6" O60353 8 103298433-103332866 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 41.7;Suprabasal keratinocytes: 39.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 7.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 41.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017991 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA017991: AB_1849138" "unprognostic (8.22e-3)" "unprognostic (2.64e-1)" "unprognostic (4.75e-2)" "unprognostic (2.57e-1)" "unprognostic (1.22e-2)" "unprognostic (6.99e-2)" "unprognostic (4.01e-2)" "unprognostic (2.74e-1)" "unprognostic (2.43e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (1.20e-6)" "unprognostic (3.62e-2)" "unprognostic (1.83e-1)" "unprognostic (2.86e-1)" "unprognostic (1.32e-1)" "unprognostic (4.92e-2)" "unprognostic (7.54e-2)" 13.1 9.2 3.4 5.2 3.8 0.5 13.3 4.3 5.9 12.1 10.7 3.5 8.6 4.0 12.0 16.4 17.9 17.8 12.3 9.6 3.7 3.8 17.4 5.8 17.1 4.7 4.2 2.9 11.6 14.4 21.3 27.2 14.1 10.0 12.4 4.9 11.6 15.3 8.8 4.3 16.9 7.7 12.7 4.2 6.1 8.0 7.2 1.5 10.9 21.2 18.7 14.7 15.9 11.3 1.7 1.0 0.2 0.0 7.9 2.2 0.5 19.6 4.0 9.5 0.0 2.2 7.0 5.9 10.5 11.5 9.3 6.1 2.1 15.1 0.0 17.9 9.2 2.9 29.1 5.3 21.7 16.6 4.4 6.5 10.4 4.6 2.6 31.3 0.0 0.0 7.9 41.8 9.9 30.6 22.2 19.1 2.2 1.0 8.6 10.0 8.1 9.2 0.8 2.2 1.4 6.9 0.7 4.5 0.0 19.0 12.4 3.3 2.7 14.6 7.7 19.0 5.3 0.0 3.5 1.5 2.2 11.0 8.4 10.6 2.2 1.1 4.2 6.1 0.0 13.5 0.0 0.0 0.2 0.6 0.0 0.0 0.9 2.1 0.9 1.0 1.7 2.2 1.0 0.0 7.9 0.0 0.2 0.6 0.5 3.4 3.8 4.3 5.9 3.7 3.8 4.2 2.9 10.0 1.5 23.8 16.1 0.8 13.5 41.7 3.7 4.7 7.6 26.8 25.0 12.2 2.0 17.8 0.0 10.9 7.8 28.9 3.2 0.0 7.2 6.6 6.9 11.0 0.0 3.2 2.1 6.4 5.1 11.1 0.6 2.1 1.1 1.7 13.5 1.0 6.9 15.5 8.1 3.5 1.4 8.2 4.4 0.0 4.1 7.2 0.7 39.0 12.2 2.5 5.2 19.2 GAB2 KIAA0571 ENSG00000033327 "GRB2 associated binding protein 2" Q9UQC2 11 78215297-78418348 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 49.1" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 23.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.4;neutrophil: 16.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 16.3" "Cell line enhanced" "Detected in many" "BEWO: 19.8;SH-SY5Y: 31.7" "HPA000271, HPA001368, CAB022159" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB022159: , HPA000271: AB_1078925, HPA001368: AB_2666287" "unprognostic (2.51e-2)" "unprognostic (1.90e-1)" "unprognostic (3.56e-3)" "unprognostic (1.99e-3)" "unprognostic (1.04e-2)" "unprognostic (4.69e-2)" "unprognostic (4.47e-2)" "unprognostic (1.08e-1)" "unprognostic (6.54e-2)" "unprognostic (1.37e-1)" "unprognostic (2.25e-1)" "unprognostic (1.74e-1)" "prognostic favorable (9.32e-5)" "unprognostic (6.95e-2)" "unprognostic (4.35e-1)" "unprognostic (3.99e-2)" "unprognostic (1.67e-2)" 15.5 8.4 31.1 12.0 26.9 32.9 11.6 5.7 21.5 10.2 8.9 49.1 1.6 13.7 16.8 4.6 8.2 13.5 9.1 13.6 30.4 21.3 5.2 4.5 16.1 6.8 31.5 14.8 20.0 5.9 10.4 7.0 14.6 24.7 6.5 10.9 6.6 5.4 7.3 5.2 8.8 10.1 17.1 35.4 11.8 7.4 5.5 26.0 9.4 6.5 3.0 5.6 9.3 12.3 0.5 1.7 16.3 3.4 0.0 0.1 0.7 1.8 1.5 4.5 0.5 6.6 2.8 19.8 2.8 3.4 2.0 1.7 11.7 0.9 0.5 12.6 3.9 0.5 2.9 10.5 0.2 2.6 17.5 1.1 7.0 2.7 2.0 3.3 2.6 1.4 3.1 1.0 7.9 1.2 6.0 11.7 2.1 18.5 0.6 3.4 0.7 1.3 6.6 1.4 4.1 2.1 13.3 4.3 0.2 3.7 6.6 3.8 31.7 0.7 1.4 7.2 6.8 6.6 7.6 9.6 0.9 2.3 7.7 0.6 4.9 0.7 0.3 0.8 4.2 8.4 9.4 2.4 0.7 0.0 1.4 0.0 0.5 0.0 0.0 0.8 0.3 0.0 0.0 16.3 0.0 3.4 1.7 0.1 0.7 31.1 26.9 5.7 19.3 30.4 21.3 31.5 14.8 24.7 26.0 3.0 23.1 4.7 0.6 1.8 4.2 9.3 2.5 2.7 1.2 0.0 0.0 4.4 0.0 2.1 5.6 7.7 8.4 0.0 5.4 12.2 6.3 2.7 5.7 0.8 10.3 15.9 10.3 4.9 18.9 2.6 7.5 10.1 6.8 11.8 3.8 0.5 6.5 0.0 10.3 0.5 2.2 12.9 3.8 2.4 1.8 2.5 18.5 2.5 9.2 1.3 GABRG1 ENSG00000163285 "Gamma-aminobutyric acid type A receptor gamma1 subunit" Q8N1C3 4 46035769-46124081 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 35.7" "Group enriched" "Detected in some" 5 "Early spermatids: 5.9;Muller glia cells: 15.1;Sertoli cells: 6.5" "Cancer enriched" "Detected in single" 8 "glioma: 0.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.3;THP-1: 2.6;U-2 OS: 1.8;U-266/70: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035622, HPA058102" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA035622: AB_10603669, HPA058102: " "unprognostic (2.50e-1)" "unprognostic (2.20e-1)" "unprognostic (6.06e-2)" "unprognostic (1.46e-2)" "unprognostic (7.39e-4)" "unprognostic (1.23e-1)" "unprognostic (1.28e-1)" "unprognostic (1.99e-1)" 1.5 1.5 20.3 1.2 25.9 1.2 1.3 26.4 35.7 1.3 1.3 12.2 0.0 1.4 1.4 1.3 1.3 1.7 1.3 1.2 26.0 14.6 1.4 1.4 1.2 1.3 10.2 14.0 3.9 1.2 1.3 1.6 1.2 17.9 1.2 1.3 0.0 1.2 1.3 1.2 1.2 1.4 1.4 17.8 1.4 1.3 1.8 17.8 0.0 1.5 0.0 1.2 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.3 1.8 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 25.9 26.4 18.5 26.0 14.6 10.2 14.0 17.9 17.8 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 1.8 6.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 GAP43 "B-50, PP46" ENSG00000172020 "Growth associated protein 43" P17677 3 115623324-115721490 "Plasma proteins, Predicted intracellular proteins, Transporters" "Differentiation, Growth regulation, Neurogenesis" "Calmodulin-binding, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "brain: 132.7" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 2.4;Cone photoreceptor cells: 2.0;Fibroblasts: 1.7;Melanocytes: 1.7;Rod photoreceptor cells: 3.1;Smooth muscle cells: 1.9" "Cancer enriched" "Detected in many" 43 "glioma: 245.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "naive CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Cell line enhanced" "Detected in some" "AF22: 16.7;NTERA-2: 35.6;SCLC-21H: 22.9;SH-SY5Y: 17.2;U-87 MG: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004417, HPA013392, HPA015600, CAB078783" Enhanced Supported Enhanced "Plasma membrane" NA NA "Plasma membrane" "CAB004417: AB_627660, CAB078783: AB_2620096, HPA013392: AB_1849468, HPA015600: AB_1849466" "unprognostic (1.24e-1)" "unprognostic (1.31e-1)" "unprognostic (1.15e-2)" "unprognostic (5.72e-5)" "unprognostic (7.44e-3)" "unprognostic (2.19e-2)" "unprognostic (3.97e-3)" "unprognostic (3.15e-3)" "unprognostic (6.08e-4)" "unprognostic (3.33e-1)" "unprognostic (2.17e-2)" "unprognostic (1.62e-1)" "unprognostic (5.35e-8)" "unprognostic (1.15e-1)" "unprognostic (1.09e-1)" "unprognostic (2.78e-2)" "unprognostic (1.29e-3)" 1.8 5.0 48.8 5.2 38.3 1.4 1.9 31.2 132.7 1.6 4.1 4.3 0.0 2.7 1.5 1.5 1.9 1.5 3.8 3.6 29.0 56.6 1.4 1.4 1.5 1.5 30.6 42.2 1.4 1.8 1.4 1.5 2.2 25.7 1.7 4.0 0.8 2.2 1.5 1.4 1.4 4.3 3.6 6.1 1.4 1.5 1.6 5.7 0.0 1.5 0.0 1.6 1.7 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.2 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 17.2 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 48.8 38.3 31.2 75.7 29.0 56.6 30.6 42.2 25.7 5.7 0.0 0.0 0.0 0.0 0.2 2.4 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.7 0.0 0.0 0.8 1.2 0.0 0.0 0.0 3.1 0.0 1.9 0.7 1.5 0.1 0.0 0.0 0.0 0.0 GCSAML-AS1 ENSG00000284824 "GCSAML antisense RNA 1" Q8N628 1 247524679-247532613 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 2.1;hTERT-HME1: 1.0;SK-MEL-30: 1.2" HPA058578 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA058578: AB_2683761" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 GLP2R ENSG00000065325 "Glucagon like peptide 2 receptor" O95838 17 9822206-9892102 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "gallbladder: 32.7" "Cell type enriched" "Detected in some" 6 "Rod photoreceptor cells: 24.5" "Cancer enhanced" "Detected in single" "pancreatic cancer: 1.1" "Group enriched" "Detected in some" 4 "basal ganglia: 2.9;cerebral cortex: 4.1;olfactory region: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HeLa: 42.8" "Group enriched" "Detected in some" 6 "cerebral cortex: 2.1;hippocampal formation: 2.6" "Low region specificity" "Detected in some" "CAB022690, HPA049244" Supported Supported "Plasma membrane" NA NA "Plasma membrane" "CAB022690: , HPA049244: AB_2680690" "unprognostic (2.14e-1)" "unprognostic (2.45e-3)" "unprognostic (2.66e-3)" "unprognostic (2.21e-2)" "unprognostic (3.81e-3)" "unprognostic (2.09e-1)" "unprognostic (1.39e-2)" "unprognostic (5.15e-2)" "unprognostic (7.63e-2)" "unprognostic (7.14e-2)" "unprognostic (2.19e-1)" "unprognostic (6.16e-3)" "unprognostic (3.40e-8)" "unprognostic (9.53e-5)" "unprognostic (5.51e-2)" "unprognostic (3.92e-1)" "unprognostic (6.48e-3)" 7.9 0.7 0.6 2.0 2.9 0.0 2.6 0.3 4.3 6.6 14.5 0.0 1.7 12.4 1.9 0.4 5.3 1.4 32.7 0.9 0.6 0.5 0.4 3.2 1.4 0.7 0.6 1.6 0.8 2.1 0.0 0.3 1.5 0.5 8.4 7.5 0.8 0.4 0.2 0.3 0.3 15.4 15.6 0.6 0.3 4.9 1.1 0.2 0.0 0.5 0.1 0.4 13.5 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 42.8 0.3 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.9 0.3 4.1 0.6 0.5 0.6 1.6 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GNB2 ENSG00000172354 "G protein subunit beta 2" P62879 7 100673531-100679174 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 42.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010032, HPA040736" Approved Supported "Plasma membrane" NA NA 36000000 "Plasma membrane" "CAB010032: AB_2263466, HPA040736: AB_2677106" "unprognostic (1.55e-1)" "unprognostic (5.76e-2)" "unprognostic (1.01e-3)" "unprognostic (2.76e-1)" "unprognostic (1.11e-2)" "unprognostic (1.94e-1)" "unprognostic (3.68e-3)" "unprognostic (3.52e-1)" "unprognostic (6.58e-2)" "unprognostic (2.54e-1)" "unprognostic (9.79e-3)" "unprognostic (1.70e-1)" "unprognostic (3.75e-2)" "unprognostic (1.24e-1)" "unprognostic (3.19e-1)" "unprognostic (5.29e-2)" "unprognostic (2.98e-1)" 49.9 45.9 43.8 41.6 58.4 60.9 88.8 31.7 40.9 40.5 43.1 22.3 39.4 34.8 41.1 39.7 74.6 49.6 44.0 54.0 38.9 36.1 39.1 72.9 49.1 94.9 32.5 42.3 47.5 45.6 33.5 45.9 38.0 35.6 47.7 29.0 28.8 77.8 42.5 39.2 59.9 38.3 39.1 23.6 50.7 42.2 31.9 33.9 43.7 40.9 45.8 35.1 37.8 50.1 6.3 9.9 42.7 14.8 5.2 7.9 4.0 51.8 40.0 33.7 40.9 26.4 31.4 29.2 31.3 43.6 44.9 37.3 30.4 50.1 23.3 34.2 46.2 50.8 36.3 26.6 46.5 15.9 32.4 22.8 17.5 30.7 24.9 44.1 22.8 38.2 40.4 44.4 46.3 37.7 36.5 51.5 19.7 32.6 45.9 40.7 140.1 36.1 64.8 26.2 32.9 43.5 34.1 20.6 37.1 35.8 43.2 35.8 58.0 41.3 68.0 28.8 19.9 29.1 28.3 48.5 48.2 53.4 93.6 39.0 13.3 15.9 34.4 36.5 51.0 66.5 7.8 10.6 23.6 6.5 14.8 6.1 4.8 6.8 5.7 9.9 6.3 4.5 4.7 42.7 5.2 12.2 8.5 7.9 4.0 43.8 58.4 31.7 40.9 38.9 36.1 32.5 42.3 35.6 33.9 53.6 112.8 83.5 121.5 134.9 6.7 29.5 107.0 37.5 28.4 80.3 3.9 158.6 137.6 144.7 22.9 125.4 215.4 46.7 189.3 250.9 125.4 201.1 43.8 58.7 231.1 68.3 173.2 118.4 164.4 15.3 134.0 187.0 133.3 161.5 167.9 119.9 203.3 197.2 122.4 84.0 7.1 64.7 122.6 36.1 47.7 170.3 245.8 92.2 152.9 221.4 GNB4 ENSG00000114450 "G protein subunit beta 4" Q9HAV0 3 179396089-179451590 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" Transducer "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 75.0;Ito cells: 52.2;Kupffer cells: 78.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 41.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018383, CAB018737, HPA040736" Supported Supported "Plasma membrane" NA NA 18000000 "Plasma membrane" "CAB018383: AB_631542, CAB018737: AB_640712, HPA040736: AB_2677106" "unprognostic (2.56e-2)" "unprognostic (1.95e-1)" "unprognostic (1.62e-1)" "unprognostic (1.01e-1)" "unprognostic (5.97e-3)" "unprognostic (2.12e-1)" "unprognostic (1.44e-2)" "unprognostic (8.28e-2)" "unprognostic (1.16e-1)" "unprognostic (3.44e-1)" "unprognostic (1.56e-1)" "unprognostic (2.32e-2)" "prognostic unfavorable (1.39e-6)" "unprognostic (1.90e-3)" "unprognostic (3.13e-2)" "unprognostic (8.90e-2)" "unprognostic (2.80e-3)" 16.6 5.3 11.9 16.7 9.9 20.7 12.4 3.2 16.6 10.4 11.1 13.9 2.2 4.4 11.3 10.7 16.1 10.2 11.9 11.0 9.8 6.2 5.0 6.3 14.3 12.6 10.1 8.0 6.3 3.7 2.1 4.3 16.6 9.9 5.1 7.2 6.6 8.8 3.6 4.3 27.0 7.7 16.9 19.4 14.9 10.6 3.7 9.4 5.6 8.8 9.6 8.6 9.5 11.9 8.2 13.6 7.0 15.3 1.8 0.3 4.2 10.4 4.6 12.6 0.2 8.4 14.4 14.6 14.8 10.1 16.5 19.6 0.1 1.1 19.4 3.4 16.2 16.1 0.2 11.1 13.4 17.6 41.4 8.3 21.9 17.6 0.1 8.2 19.2 5.1 11.8 2.1 13.0 6.6 4.1 18.1 4.3 5.7 0.2 14.7 0.4 9.4 7.8 6.4 0.0 5.5 18.9 16.2 8.1 12.2 0.5 2.0 6.7 11.9 11.3 19.7 8.0 22.3 8.7 14.7 16.2 9.0 4.1 19.7 0.0 0.2 0.2 8.8 17.1 11.2 2.2 11.5 5.4 0.1 15.3 0.1 3.6 0.2 0.1 13.6 8.2 0.2 0.1 7.0 1.8 12.6 6.9 0.3 4.2 11.9 9.9 3.2 14.7 9.8 6.2 10.1 8.0 9.9 9.4 23.8 13.8 11.5 1.7 16.7 1.3 17.0 0.0 13.4 21.6 3.5 5.9 11.9 3.3 1.0 1.1 32.9 0.0 0.0 1.4 16.3 18.6 1.7 10.4 0.9 75.0 1.6 0.0 52.2 78.1 0.9 9.5 47.8 13.5 29.7 0.0 1.4 2.0 0.0 14.9 0.0 3.9 25.8 22.8 2.1 17.5 22.2 3.4 1.3 0.0 1.1 GPC3 "DGSX, OCI-5, SDYS, SGB, SGBS, SGBS1" ENSG00000147257 "Glypican 3" P51654 X 133535745-133985895 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 262.7" "Cell type enhanced" "Detected in many" 10 "Fibroblasts: 127.3;Muller glia cells: 96.7;Syncytiotrophoblasts: 124.3" "Cancer enhanced" "Detected in all" "liver cancer: 269.0" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 4 "naive CD4 T-cell: 5.0;naive CD8 T-cell: 3.5;NK-cell: 1.7" "Group enriched" "Detected in many" 12 "NK-cells: 1.7;T-cells: 5.0" "Group enriched" "Detected in some" 5 "HAP1: 54.2;Hep G2: 214.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA006316 Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA006316: AB_1078994" "unprognostic (2.06e-1)" "unprognostic (2.36e-1)" "unprognostic (9.51e-2)" "unprognostic (4.17e-2)" "unprognostic (1.78e-1)" "unprognostic (1.46e-1)" "unprognostic (6.10e-2)" "unprognostic (1.17e-2)" "unprognostic (2.07e-2)" "unprognostic (3.92e-3)" "unprognostic (6.06e-2)" "unprognostic (1.71e-1)" "unprognostic (3.81e-3)" "prognostic unfavorable (4.83e-4)" "unprognostic (1.43e-1)" "unprognostic (2.21e-1)" "unprognostic (1.60e-1)" 30.1 5.9 0.4 3.6 0.7 0.0 50.2 0.6 0.4 3.3 4.5 0.5 2.2 0.5 2.5 11.7 2.0 3.4 9.2 8.0 0.4 1.1 21.2 1.1 37.0 1.9 1.6 0.4 6.0 4.6 0.3 16.9 262.7 1.6 3.6 1.0 6.3 3.8 2.3 4.1 5.5 1.8 3.3 2.1 0.9 4.0 2.1 0.3 2.3 7.2 11.2 3.0 7.6 8.0 0.0 0.2 0.0 0.0 1.7 5.0 0.6 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 54.2 0.0 0.0 0.0 2.5 0.0 0.1 214.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 14.8 0.7 1.8 4.4 0.0 0.0 0.0 26.0 0.0 2.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.5 0.2 0.0 5.0 3.5 0.0 1.7 0.0 0.0 0.0 0.6 0.4 0.7 0.6 0.4 0.4 1.1 1.6 0.4 1.6 0.3 0.0 1.7 0.0 5.4 9.3 0.2 0.3 0.0 44.2 35.2 5.2 0.0 43.0 16.6 0.3 0.9 0.5 0.3 0.0 1.3 32.7 127.3 0.9 0.0 0.0 24.0 0.0 1.7 2.5 0.0 1.3 9.8 1.4 3.3 0.0 1.5 96.7 2.2 0.2 2.8 26.9 1.9 0.0 5.0 1.6 6.1 3.4 124.3 0.0 2.1 0.5 GPR156 "GABABL, PGR28" ENSG00000175697 "G protein-coupled receptor 156" Q8NFN8 3 120164645-120285094 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 7.7" "Group enriched" "Detected in some" 8 "Early spermatids: 6.5;Late spermatids: 14.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 3.1;PC-3: 3.0;SiHa: 8.1;U-2 OS: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028642, HPA028644" Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA028642: AB_10599711, HPA028644: AB_10600441" "unprognostic (2.85e-3)" "unprognostic (1.02e-1)" "unprognostic (3.53e-3)" "unprognostic (2.02e-3)" "unprognostic (1.07e-1)" "unprognostic (3.79e-1)" "unprognostic (2.62e-4)" "unprognostic (2.03e-1)" "unprognostic (4.54e-4)" "unprognostic (5.03e-2)" "unprognostic (1.57e-1)" "unprognostic (1.10e-1)" "unprognostic (4.03e-5)" "unprognostic (2.43e-2)" "unprognostic (3.43e-2)" "unprognostic (4.91e-3)" "unprognostic (6.71e-2)" 0.9 0.5 0.8 1.6 2.2 0.0 1.0 0.1 1.0 1.4 0.7 0.0 0.0 0.0 1.2 0.0 1.9 3.4 1.3 0.2 0.4 0.3 0.3 0.0 0.2 0.0 0.3 0.0 1.4 0.0 0.0 1.4 1.2 0.7 1.9 0.2 0.4 2.4 1.5 0.1 0.3 0.2 1.6 1.5 0.1 0.3 7.7 1.2 0.0 0.1 0.0 0.4 2.5 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.2 0.8 0.1 0.9 1.3 0.1 0.6 0.0 0.9 3.1 0.7 0.1 0.1 0.1 0.5 0.0 0.0 0.0 2.0 0.0 0.8 0.2 0.0 2.0 0.2 0.5 0.0 0.2 0.0 0.1 0.0 0.3 1.0 0.0 0.0 0.0 1.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 1.0 1.6 8.1 0.0 1.0 0.4 1.1 0.1 0.2 0.2 4.5 0.0 0.3 1.0 0.4 0.1 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 2.2 0.1 1.0 0.4 0.3 0.3 0.0 0.7 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.1 0.0 0.0 0.0 GPR160 "GPCR1, GPCR150" ENSG00000173890 "G protein-coupled receptor 160" Q9UJ42 3 170037929-170085403 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "parathyroid gland: 71.0" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 186.9;Rod photoreceptor cells: 156.5;Undifferentiated cells: 149.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 31.0;SK-BR-3: 24.8;THP-1: 48.9;U-266/70: 54.0;U-266/84: 31.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA006970 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA006970: AB_1849275" "unprognostic (1.70e-1)" "unprognostic (5.08e-3)" "unprognostic (2.96e-2)" "unprognostic (2.39e-3)" "unprognostic (2.20e-1)" "unprognostic (3.01e-1)" "unprognostic (5.21e-2)" "prognostic favorable (1.21e-4)" "unprognostic (5.71e-3)" "unprognostic (1.35e-1)" "unprognostic (4.35e-2)" "unprognostic (1.77e-1)" "prognostic favorable (4.93e-7)" "unprognostic (1.40e-1)" "unprognostic (2.25e-1)" "unprognostic (1.43e-1)" "prognostic favorable (3.61e-4)" 7.0 1.4 3.1 21.7 2.5 23.6 8.2 0.9 1.8 2.6 31.2 1.5 7.9 18.0 1.9 21.5 2.6 1.8 16.2 3.0 1.9 1.7 27.4 2.1 23.2 25.6 2.7 0.4 1.6 14.7 71.0 3.5 2.9 1.8 10.7 18.1 11.8 14.2 4.7 2.0 1.8 43.2 0.9 4.7 17.9 18.0 2.9 2.4 6.6 3.8 1.0 10.7 9.1 6.9 11.2 2.9 10.1 1.1 0.3 3.0 1.2 15.9 0.3 0.0 0.1 0.1 0.1 4.0 0.1 0.1 0.1 0.5 2.9 2.0 7.4 3.4 0.1 1.0 0.1 2.2 0.1 0.2 11.3 4.4 4.8 0.2 6.0 0.0 9.4 6.5 0.0 0.2 0.5 0.6 0.7 0.3 3.5 1.5 19.2 0.1 10.2 0.7 2.0 2.6 9.8 0.6 1.3 0.3 31.0 8.4 22.1 1.6 0.4 0.2 24.8 1.1 2.2 14.5 48.9 0.5 0.0 0.1 1.8 1.2 54.0 31.0 12.9 0.2 10.2 0.7 1.5 1.1 8.1 0.5 0.4 0.9 6.8 0.9 0.4 2.2 11.2 3.0 1.1 10.1 0.3 0.1 2.9 0.3 1.2 3.1 2.5 0.9 1.8 1.9 1.7 2.7 0.4 1.8 2.4 8.9 39.0 27.8 3.1 0.3 7.9 1.0 25.5 18.7 18.2 59.3 37.3 2.6 46.4 10.6 24.4 4.5 103.3 0.0 63.8 15.0 0.4 47.4 1.1 0.5 7.0 14.3 186.9 16.0 9.2 32.2 0.6 10.0 27.0 97.4 129.6 7.7 48.2 137.8 0.4 121.7 156.5 0.0 0.3 6.4 11.9 0.6 22.8 2.5 149.6 25.7 GRID2IP ENSG00000215045 "Grid2 interacting protein" A4D2P6 7 6497462-6551436 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 23.6" "Cell type enhanced" "Detected in single" 12 "Rod photoreceptor cells: 1.2" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 23.6" "Cell type enhanced" "Detected in single" "NK-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "REH: 8.9" "Group enriched" "Detected in some" 5 "cerebellum: 25.2;thalamus: 7.9" "Group enriched" "Detected in all" 5 "cerebellum: 14.3;midbrain: 10.0;pons and medulla: 9.7;thalamus: 14.7" HPA045381 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA045381: AB_10962495" "unprognostic (1.77e-1)" "unprognostic (2.64e-1)" "unprognostic (3.39e-4)" "unprognostic (1.19e-3)" "unprognostic (5.52e-2)" "unprognostic (2.50e-2)" "unprognostic (2.82e-1)" "unprognostic (2.37e-2)" "unprognostic (1.92e-3)" "unprognostic (2.06e-3)" "unprognostic (1.64e-1)" "unprognostic (3.40e-2)" "unprognostic (3.38e-2)" "unprognostic (5.54e-2)" "unprognostic (8.08e-2)" "unprognostic (1.87e-1)" "unprognostic (3.17e-1)" 0.2 1.7 0.8 0.6 3.6 1.1 1.1 23.6 6.6 0.6 1.4 6.5 0.0 1.8 0.4 0.1 1.2 1.1 0.6 0.3 1.6 1.6 0.7 0.3 1.2 0.5 0.7 1.2 0.9 1.8 3.9 3.0 0.2 5.5 2.3 0.7 0.3 2.1 1.6 0.2 3.4 1.6 0.0 1.5 1.4 2.2 1.2 6.8 2.5 1.6 0.0 0.6 0.9 0.8 0.7 0.2 0.0 0.2 1.1 0.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.5 0.0 0.7 0.7 0.0 0.2 0.8 0.0 8.9 0.3 0.2 0.2 0.3 0.1 1.1 0.0 0.8 0.0 0.3 2.0 0.2 0.1 0.0 1.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.6 0.4 0.0 0.0 1.1 0.2 0.2 0.0 0.1 0.8 3.6 23.6 6.6 1.6 1.6 0.7 1.2 5.5 6.8 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.1 GRPR "BB2, BB2R" ENSG00000126010 "Gastrin releasing peptide receptor" P30550 X 16123556-16153021 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 24.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "breast cancer: 6.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.9;non-classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 10 "PC-3: 18.0;T-47d: 22.5;U-138 MG: 30.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA069604 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA069604: AB_2686158" "unprognostic (3.32e-2)" "unprognostic (1.97e-1)" "unprognostic (1.72e-1)" "unprognostic (9.24e-2)" "unprognostic (2.87e-1)" "unprognostic (9.17e-2)" "unprognostic (5.06e-2)" "unprognostic (2.82e-1)" "unprognostic (1.01e-1)" "unprognostic (3.68e-3)" "unprognostic (2.62e-1)" "unprognostic (1.57e-1)" "unprognostic (5.59e-2)" "unprognostic (2.15e-2)" "unprognostic (2.56e-1)" "unprognostic (2.92e-1)" "unprognostic (2.86e-2)" 0.5 0.4 3.4 4.7 2.3 0.2 3.5 0.3 3.5 3.7 1.4 0.0 2.5 0.2 1.0 2.8 7.5 0.3 0.2 0.5 3.5 0.4 0.3 0.3 0.4 0.2 0.3 1.9 0.3 24.5 0.4 0.3 0.2 1.1 0.7 0.6 2.0 0.4 0.4 0.4 0.3 0.5 1.2 0.4 0.3 2.1 0.4 0.0 0.0 0.4 0.0 0.2 0.4 0.4 0.6 0.2 0.4 1.9 0.0 0.1 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.2 0.0 0.5 0.0 2.3 1.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.3 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 22.5 0.0 0.1 30.8 0.3 0.0 0.9 0.1 0.1 0.1 0.0 0.0 0.4 0.0 1.1 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.4 0.0 1.6 0.1 0.0 0.4 3.4 2.3 0.3 3.5 3.5 0.4 0.3 1.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GUCA1A "C6orf131, COD3, CORD14, dJ139D8.6, GCAP, GCAP1, GUCA, GUCA1" ENSG00000048545 "Guanylate cyclase activator 1A" P43080 6 42155406-42180056 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "retina: 91.2;testis: 62.2" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 628.3;Late spermatids: 331.5;Rod photoreceptor cells: 949.8" "Cancer enriched" "Detected in single" 9 "testis cancer: 3.5" "Region enhanced" "Detected in many" "basal ganglia: 10.0" "Cell type enriched" "Detected in single" 84 "plasmacytoid DC: 8.4" "Lineage enriched" "Detected in single" 84 "dendritic cells: 8.4" "Group enriched" "Detected in some" 8 "NTERA-2: 7.2;SH-SY5Y: 9.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005561, HPA075056" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA005561: AB_2667361, HPA075056: " "unprognostic (1.91e-2)" "unprognostic (3.92e-3)" "unprognostic (2.49e-2)" "unprognostic (9.16e-2)" "unprognostic (1.04e-4)" "unprognostic (9.70e-2)" "unprognostic (6.71e-3)" "unprognostic (1.89e-1)" "unprognostic (1.59e-2)" "unprognostic (3.08e-3)" "unprognostic (2.79e-1)" "unprognostic (1.51e-1)" "unprognostic (1.54e-1)" "unprognostic (1.16e-1)" 0.2 0.2 2.7 0.3 10.0 0.2 0.2 0.1 1.6 0.2 0.2 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.2 0.1 1.5 5.4 0.1 0.1 0.2 0.3 1.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.2 0.2 91.2 0.2 0.1 0.1 0.2 0.2 0.3 0.2 0.1 0.1 62.2 0.1 0.1 0.1 0.1 0.5 0.3 0.1 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.1 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 2.7 10.0 0.1 0.8 1.5 5.4 1.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 118.0 0.3 0.0 0.0 0.0 0.0 628.3 0.4 0.0 0.0 108.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 62.0 0.0 0.0 0.0 331.5 1.7 0.0 0.0 9.0 0.0 125.6 0.0 0.0 1.8 0.0 949.8 0.0 0.0 2.8 1.9 0.0 0.2 0.0 0.0 0.0 GYPC "CD236, CD236R, Ge, GPC, GYPD" ENSG00000136732 "Glycophorin C (Gerbich blood group)" P04921 2 126655933-126696670 "Blood group antigen proteins, CD markers, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 18 "Erythroid cells: 1448.3;Hofbauer cells: 391.9" "Cancer enhanced" "Detected in all" "melanoma: 66.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 62.6;K-562: 46.5;SK-MEL-30: 91.9;U-266/70: 51.9" "Low region specificity" "Detected in all" "HPA008965, CAB009445" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB009445: AB_2116251, HPA008965: AB_1078455" "unprognostic (1.63e-2)" "unprognostic (7.14e-3)" "unprognostic (8.39e-2)" "unprognostic (3.31e-3)" "unprognostic (4.19e-2)" "unprognostic (1.69e-2)" "unprognostic (8.82e-2)" "unprognostic (3.52e-1)" "unprognostic (1.19e-1)" "unprognostic (2.21e-1)" "unprognostic (1.25e-1)" "unprognostic (1.11e-1)" "unprognostic (2.05e-2)" "unprognostic (2.73e-2)" "unprognostic (1.51e-1)" "unprognostic (2.29e-1)" "unprognostic (8.00e-3)" 44.5 21.7 3.9 34.5 5.3 95.0 99.8 1.3 4.3 20.7 24.8 5.9 9.8 5.0 20.3 26.0 22.9 18.5 21.4 61.2 4.4 3.4 15.2 6.3 29.5 75.8 8.0 3.7 37.4 18.7 1.7 5.5 17.5 5.6 24.5 5.5 13.8 13.0 15.5 48.9 11.3 15.2 34.8 8.3 41.1 13.5 13.4 4.6 28.5 11.6 29.9 22.5 37.1 38.8 21.2 9.9 4.2 7.7 14.7 41.4 21.8 0.1 0.0 22.5 0.0 16.7 14.6 0.0 3.3 26.0 4.0 12.1 0.0 0.0 0.0 0.0 9.4 15.6 0.0 12.2 0.0 1.3 10.7 0.0 37.8 0.0 0.0 62.6 13.2 0.1 32.9 0.0 3.2 0.0 0.3 0.1 26.2 46.5 31.3 9.8 0.0 0.0 20.9 6.7 0.0 0.0 2.4 1.6 0.0 1.6 0.0 0.0 0.0 0.0 0.0 91.9 3.0 0.0 35.9 9.0 15.4 0.1 1.0 0.1 51.9 33.6 0.0 7.5 19.1 13.9 0.1 5.9 0.4 32.3 7.7 36.4 18.9 29.3 39.1 9.9 21.2 41.4 40.4 4.2 14.7 4.7 5.5 35.1 21.8 3.9 5.3 1.3 4.3 4.4 3.4 8.0 3.7 5.6 4.6 6.0 11.4 163.5 2.9 33.8 0.7 31.5 68.8 2.7 5.7 14.0 2.0 4.8 114.4 182.3 1.2 74.4 0.0 1448.3 4.2 6.4 148.3 3.8 23.0 3.4 391.9 0.0 0.0 252.3 99.7 1.5 80.8 80.7 290.1 117.2 0.0 4.9 8.0 0.0 65.0 3.9 2.3 58.2 117.4 0.3 0.8 23.2 7.6 235.7 0.0 0.9 HRASLS5 HRLP5 ENSG00000168004 "HRAS like suppressor family member 5" Q96KN8 11 63461404-63491194 "Predicted intracellular proteins" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.5;testis: 49.4" "Group enriched" "Detected in some" 43 "Early spermatids: 348.1;Late spermatids: 719.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 65 "basophil: 5.1;eosinophil: 14.5" "Lineage enriched" "Detected in single" 104 "granulocytes: 14.5" "Group enriched" "Detected in some" 4 "HAP1: 15.8;NB-4: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042493 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA042493: AB_10797499" "unprognostic (3.16e-1)" "unprognostic (3.45e-2)" "unprognostic (2.83e-3)" "unprognostic (4.24e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (7.11e-3)" "unprognostic (2.14e-1)" "unprognostic (6.66e-2)" "unprognostic (9.46e-2)" "unprognostic (8.89e-3)" "unprognostic (3.15e-2)" "unprognostic (7.33e-2)" "unprognostic (1.04e-5)" "unprognostic (1.52e-1)" "unprognostic (1.21e-2)" "unprognostic (2.57e-3)" "unprognostic (4.50e-4)" 12.4 0.5 2.2 0.4 2.2 0.3 7.6 0.3 2.3 0.4 0.8 2.5 1.7 0.4 0.7 1.0 1.0 1.1 0.9 1.3 1.3 0.9 0.4 0.3 0.8 0.3 1.2 2.1 1.0 11.0 0.2 0.4 0.2 1.7 0.9 0.4 0.6 0.7 2.5 0.3 0.4 0.5 1.3 3.3 0.3 0.6 49.4 0.9 0.0 0.4 0.3 0.3 0.8 0.4 0.0 0.0 14.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.1 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 5.1 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 2.2 0.3 2.3 1.3 0.9 1.2 2.1 1.7 0.9 3.0 0.6 0.0 1.8 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 348.1 0.1 0.0 0.0 0.3 0.1 2.0 0.5 1.1 0.0 0.1 0.0 0.0 0.0 0.0 719.6 3.1 0.7 0.0 0.0 0.0 2.4 0.1 0.0 4.2 1.1 0.0 6.5 0.3 12.4 4.7 0.0 0.8 0.0 0.0 1.0 HTR1B "5-HT1B, 5-HT1DB, HTR1D2, S12" ENSG00000135312 "5-hydroxytryptamine receptor 1B" P28222 6 77461753-77463773 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.8;placenta: 14.2;stomach 1: 10.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "basal ganglia: 11.8" "Cell type enriched" "Detected in single" 17 "basophil: 1.6" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.6" "Group enriched" "Detected in some" 15 "HUVEC TERT2: 41.8;TIME: 18.4" "Region enriched" "Detected in many" 4 "basal ganglia: 34.5" HPA028808 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA028808: AB_2672782" "unprognostic (3.86e-2)" "unprognostic (3.56e-1)" "unprognostic (7.68e-2)" "unprognostic (2.58e-1)" "unprognostic (1.88e-1)" "unprognostic (1.18e-2)" "unprognostic (2.67e-1)" "unprognostic (2.11e-1)" "unprognostic (8.96e-2)" "unprognostic (4.03e-1)" "unprognostic (1.77e-2)" "unprognostic (1.24e-1)" "unprognostic (1.10e-3)" "unprognostic (3.08e-2)" "unprognostic (2.81e-2)" "unprognostic (1.34e-1)" "unprognostic (1.02e-1)" 2.2 1.5 1.3 1.1 11.8 0.3 2.4 0.4 3.7 2.9 0.6 0.1 0.0 0.6 1.1 1.0 1.4 0.8 2.8 0.4 1.0 2.1 0.9 0.3 1.1 0.3 1.2 0.9 1.1 0.5 0.3 0.5 14.2 3.0 1.6 0.4 0.3 1.3 1.2 0.9 0.5 0.4 4.1 0.6 0.4 10.2 1.5 0.6 0.0 0.5 0.0 0.3 2.6 1.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.9 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.4 1.1 0.8 41.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 11.8 0.4 3.7 1.0 2.1 1.2 0.9 3.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTRA1 "ARMD7, HtrA, IGFBP5-protease, PRSS11" ENSG00000166033 "HtrA serine peptidase 1" Q92743 10 122461525-122514908 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor binding, Hydrolase, Protease, Serine protease" "Age-related macular degeneration, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 14 "Horizontal cells: 591.1;Muller glia cells: 269.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.4;memory CD4 T-cell: 1.6" "Group enriched" "Detected in many" 20 "monocytes: 2.4;T-cells: 1.6" "Cell line enhanced" "Detected in many" "ASC diff: 203.0;ASC TERT1: 75.4;fHDF/TERT166: 68.7;HSkMC: 132.4;LHCN-M2: 100.6;U-87 MG: 83.1" "Low region specificity" "Detected in all" HPA036655 Approved Supported "Plasma membrane" "Secreted to blood" NA NA 24800000 2600000 "Plasma membrane" "HPA036655: AB_10671966" "unprognostic (3.84e-1)" "unprognostic (3.42e-2)" "unprognostic (1.57e-2)" "unprognostic (1.86e-2)" "unprognostic (1.22e-3)" "unprognostic (8.71e-3)" "unprognostic (2.33e-2)" "unprognostic (3.83e-1)" "unprognostic (7.22e-2)" "unprognostic (3.36e-2)" "unprognostic (1.32e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (7.90e-7)" "unprognostic (7.12e-3)" "unprognostic (9.13e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (5.62e-6)" 40.8 21.8 64.5 9.1 79.0 0.5 48.2 16.2 62.8 50.4 19.3 60.8 7.2 5.6 47.6 67.0 15.6 19.5 78.7 28.7 50.8 35.4 34.7 60.4 14.6 9.1 62.7 32.5 111.3 14.5 37.6 26.9 114.1 41.9 19.5 14.0 20.7 19.3 31.5 7.5 29.6 9.3 40.5 46.5 10.5 12.9 9.8 49.5 1.7 13.3 8.5 7.1 41.5 27.3 0.0 0.0 0.0 2.4 0.0 1.6 0.7 0.0 3.5 1.6 0.4 203.0 75.4 0.0 8.7 15.9 3.6 1.9 0.0 0.0 0.0 2.4 68.7 5.6 1.0 0.6 9.9 0.5 0.0 0.4 0.0 5.8 0.0 10.3 0.0 0.0 132.4 36.4 2.1 17.0 41.7 16.7 0.0 0.0 0.1 100.6 1.7 0.0 0.0 1.7 0.0 5.5 0.0 0.1 0.0 23.0 0.1 0.1 0.3 21.9 0.0 9.4 7.8 0.7 0.0 10.9 25.6 0.3 11.5 7.4 0.0 0.0 0.0 83.1 0.0 12.0 0.0 2.4 0.0 0.6 0.0 0.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 64.5 79.0 16.2 54.6 50.8 35.4 62.7 32.5 41.9 49.5 20.8 8.6 0.0 31.0 39.2 55.4 23.4 10.2 14.7 0.0 61.1 51.1 15.8 0.0 2.1 2.5 64.7 0.0 0.0 3.9 127.5 77.4 8.5 1.1 85.6 53.0 591.1 0.0 54.6 17.2 3.1 29.4 7.2 43.9 12.6 0.1 269.0 4.2 0.2 72.9 18.8 110.5 6.5 59.8 0.1 0.2 26.7 73.3 4.5 0.2 12.7 IFIT5 RI58 ENSG00000152778 "Interferon induced protein with tetratricopeptide repeats 5" Q13325 10 89414586-89421001 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 30.6;BJ hTERT+ SV40 Large T+ RasG12V: 36.6" "Low region specificity" "Detected in all" "HPA037957, HPA062180" Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA037957: AB_10672499, HPA062180: AB_2684705" "unprognostic (2.17e-1)" "unprognostic (1.85e-1)" "unprognostic (1.38e-1)" "unprognostic (1.26e-1)" "unprognostic (1.67e-3)" "unprognostic (4.19e-2)" "unprognostic (2.88e-2)" "unprognostic (2.80e-1)" "unprognostic (1.45e-1)" "unprognostic (8.89e-2)" "unprognostic (1.63e-1)" "unprognostic (1.86e-1)" "unprognostic (3.24e-2)" "unprognostic (1.48e-1)" "unprognostic (3.42e-1)" "unprognostic (2.43e-2)" "unprognostic (1.73e-1)" 26.6 14.5 15.6 9.7 14.8 11.5 13.1 16.1 15.2 11.9 10.0 11.4 5.5 8.9 11.7 10.9 12.4 10.9 11.9 13.4 15.6 18.1 13.0 14.2 16.8 11.9 17.6 12.3 16.1 8.8 30.2 12.1 13.1 20.6 12.5 8.9 8.4 11.0 10.3 6.6 5.8 11.7 12.8 16.7 20.1 8.8 7.0 15.4 11.1 15.3 5.5 10.1 13.7 14.0 9.1 5.5 21.2 10.4 3.6 8.0 5.0 9.9 2.7 4.1 14.7 13.5 13.3 0.5 7.2 17.3 30.6 36.6 0.1 4.9 0.4 3.0 10.3 11.3 8.3 5.6 5.5 7.9 4.6 3.2 1.1 2.2 1.6 15.1 0.1 0.9 11.5 2.4 7.0 6.1 8.5 1.6 2.6 0.0 7.8 9.8 1.9 2.8 1.4 0.6 0.0 4.8 2.7 5.2 0.9 8.5 1.2 0.5 3.2 3.8 1.8 16.3 1.4 1.5 1.0 4.0 3.9 2.8 6.6 5.2 1.0 0.1 0.0 6.6 0.9 3.3 8.1 6.3 8.2 6.2 10.0 7.6 9.1 6.9 6.0 5.5 7.4 8.0 6.6 21.2 3.6 10.4 0.4 6.3 5.0 15.6 14.8 16.1 14.0 15.6 18.1 17.6 12.3 20.6 15.4 6.0 15.0 8.5 27.4 7.6 6.9 7.2 15.3 2.7 10.3 8.7 0.0 3.9 10.0 10.9 0.1 21.8 5.1 0.0 7.9 7.3 12.7 19.0 15.0 11.3 9.6 33.4 4.7 7.4 7.6 0.0 19.5 7.0 6.8 7.2 5.0 12.6 10.3 2.9 16.3 13.0 4.5 19.4 14.0 8.8 8.3 3.3 3.8 6.9 2.1 27.1 IFNGR1 "CD119, IFNGR" ENSG00000027697 "Interferon gamma receptor 1" P15260 6 137197484-137219449 "CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 258.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 57.1" "Low region specificity" "Detected in all" "CAB025889, HPA029213, HPA063871" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "CAB025889: , HPA029213: AB_10601023, HPA063871: AB_2685138" "unprognostic (1.73e-1)" "unprognostic (8.86e-2)" "unprognostic (9.85e-3)" "unprognostic (1.71e-1)" "unprognostic (6.55e-2)" "unprognostic (1.25e-1)" "unprognostic (4.05e-1)" "unprognostic (6.97e-2)" "unprognostic (9.86e-2)" "unprognostic (1.57e-2)" "unprognostic (4.09e-2)" "unprognostic (2.85e-1)" "prognostic unfavorable (5.48e-4)" "unprognostic (1.58e-1)" "unprognostic (2.87e-2)" "unprognostic (1.81e-2)" "unprognostic (5.38e-3)" 69.5 22.2 17.4 36.9 23.5 37.7 65.3 8.4 18.5 23.6 27.1 27.8 13.8 28.0 19.2 21.2 23.0 20.3 25.9 53.7 20.6 17.4 19.3 66.4 58.7 86.9 33.8 13.2 19.2 17.5 9.2 12.8 47.0 29.9 20.1 22.8 11.6 24.5 18.0 25.3 24.0 46.7 22.5 45.7 69.1 20.3 14.1 26.3 14.5 22.8 19.7 38.2 25.0 22.3 12.2 39.4 92.3 65.4 5.4 29.7 52.3 4.8 4.7 6.2 8.0 40.8 21.5 5.2 13.9 20.7 9.1 12.3 30.5 9.5 4.8 22.3 8.0 13.2 30.3 5.4 14.1 12.7 10.4 7.5 7.6 5.8 45.1 23.1 23.7 11.4 47.5 57.1 7.6 12.3 8.4 11.4 7.0 6.4 8.3 6.8 5.5 3.8 10.9 5.1 44.4 3.8 11.7 6.5 7.3 15.8 23.0 6.2 9.6 17.2 10.1 12.6 12.3 3.6 15.7 15.8 8.9 6.5 11.5 7.3 6.1 5.7 5.4 4.6 15.8 8.6 16.5 65.4 43.3 14.1 63.0 29.7 10.9 8.0 11.8 39.4 12.2 5.2 5.8 92.3 5.4 44.1 10.1 5.6 52.3 17.4 23.5 8.4 18.5 20.6 17.4 33.8 13.2 29.9 26.3 74.5 64.2 57.6 146.1 113.3 14.2 38.0 33.1 83.0 77.3 26.2 11.8 63.2 6.6 61.6 3.2 106.4 70.3 0.0 88.3 59.0 70.9 89.3 61.2 50.3 132.8 9.5 12.6 63.8 258.9 4.3 40.9 249.4 47.2 88.4 19.2 19.7 74.0 28.1 46.3 15.1 20.6 12.9 65.2 8.4 20.4 99.0 175.5 67.8 27.9 144.7 IFT122 "SPG, WDR10, WDR10p, WDR140" ENSG00000163913 "Intraflagellar transport 122" Q9HBG6 3 129440036-129520507 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "testis: 84.7" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 61.8;Late spermatids: 52.6;Spermatocytes: 117.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041815 Uncertain Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA041815: AB_10804118" "unprognostic (7.16e-2)" "unprognostic (3.71e-3)" "unprognostic (3.67e-1)" "unprognostic (7.61e-3)" "unprognostic (5.29e-2)" "unprognostic (5.33e-3)" "unprognostic (4.68e-2)" "unprognostic (1.82e-1)" "unprognostic (7.90e-2)" "unprognostic (3.30e-1)" "unprognostic (1.67e-2)" "unprognostic (3.50e-2)" "unprognostic (1.09e-2)" "unprognostic (7.67e-2)" "unprognostic (5.33e-1)" "unprognostic (9.91e-2)" "unprognostic (4.20e-3)" 7.4 5.7 11.1 4.9 14.0 6.4 9.1 13.3 13.1 10.2 5.6 7.6 6.4 3.5 10.2 9.6 5.4 18.5 5.0 10.0 7.8 6.4 8.8 6.7 6.7 4.5 4.4 9.2 19.0 9.6 13.1 18.9 7.7 7.2 5.7 5.2 10.5 6.3 6.7 3.7 9.9 4.1 7.6 4.2 3.7 6.7 84.7 5.7 7.6 9.6 2.0 4.2 5.3 6.9 4.7 6.0 8.3 5.7 2.8 5.5 3.8 11.0 16.7 14.5 9.5 21.1 15.0 7.7 5.9 8.9 10.3 10.0 8.0 7.3 7.1 7.0 7.6 10.2 7.1 5.6 5.2 9.4 3.8 6.0 5.4 13.6 6.8 5.8 14.9 5.0 17.5 3.9 7.9 6.2 9.0 13.9 15.2 5.5 15.3 8.3 12.2 12.2 7.7 9.7 8.3 4.8 10.9 5.5 5.1 11.1 2.0 18.4 7.5 16.9 5.7 5.1 5.7 15.5 12.0 6.1 7.3 6.2 9.4 7.0 10.5 7.3 6.2 6.6 7.6 5.5 8.3 5.7 6.6 1.9 3.9 3.3 3.8 3.3 4.5 6.0 4.7 3.7 4.5 2.7 2.8 1.7 1.4 5.5 3.8 11.1 14.0 13.3 13.1 7.8 6.4 4.4 9.2 7.2 5.7 8.9 8.0 2.4 4.9 2.4 9.5 5.6 7.6 13.4 4.5 24.4 35.3 5.6 6.6 4.5 61.8 6.0 5.8 0.0 7.8 5.0 8.8 2.8 4.7 3.9 8.4 4.8 2.9 17.8 6.5 52.6 17.3 2.5 3.3 1.8 9.2 10.8 3.4 3.5 13.1 6.0 19.6 0.0 7.1 117.0 35.3 2.5 2.2 3.2 7.0 2.2 IL12RB1 "CD212, IL12RB" ENSG00000096996 "Interleukin 12 receptor subunit beta 1" P42701 19 18058995-18098944 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.6;lymphoid tissue: 21.4" "Cell type enhanced" "Detected in some" 20 "B-cells: 9.0;Kupffer cells: 10.0;T-cells: 35.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 10.7;HDLM-2: 18.0;Karpas-707: 30.8;U-698: 9.0" "Low region specificity" "Detected in all" HPA074414 Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA074414: AB_2686687" "unprognostic (7.70e-3)" "prognostic favorable (3.41e-4)" "unprognostic (9.08e-3)" "unprognostic (1.18e-4)" "unprognostic (2.91e-1)" "unprognostic (1.33e-3)" "unprognostic (2.27e-1)" "unprognostic (8.99e-2)" "unprognostic (1.65e-2)" "unprognostic (1.35e-1)" "unprognostic (1.51e-1)" "unprognostic (2.94e-1)" "prognostic unfavorable (5.90e-5)" "unprognostic (1.49e-1)" "unprognostic (2.21e-2)" "unprognostic (4.34e-2)" "unprognostic (2.93e-2)" 1.9 1.5 1.3 17.5 2.1 5.6 1.2 0.5 1.0 0.9 3.4 2.4 1.1 2.9 1.0 2.4 1.3 1.5 2.5 1.4 1.3 1.2 1.8 1.8 5.0 16.0 2.0 0.2 1.1 1.3 1.2 1.1 2.4 1.4 1.7 2.0 1.1 6.6 0.2 0.9 1.0 8.0 1.0 2.4 21.4 2.3 0.7 2.2 10.1 1.3 0.7 16.9 3.8 1.0 4.9 5.9 6.2 14.0 16.2 28.6 9.0 0.2 0.1 0.1 0.2 0.0 0.1 0.5 0.1 0.1 0.2 0.6 0.2 1.0 10.7 0.1 0.1 0.3 0.2 0.1 0.0 0.0 18.0 0.2 1.2 0.3 0.2 0.4 0.7 1.7 0.0 0.0 0.3 0.1 0.1 0.0 2.4 0.2 30.8 0.0 0.1 5.1 0.2 0.1 0.0 0.1 3.6 0.1 0.5 0.0 0.0 0.3 0.1 0.2 0.2 0.2 0.1 0.2 5.8 0.2 0.3 0.3 0.1 0.1 3.7 5.5 9.0 0.4 6.2 0.7 3.3 5.1 3.6 22.8 14.0 28.6 4.9 15.5 18.3 5.9 3.7 8.7 15.2 6.2 16.2 13.2 3.5 20.5 9.0 1.3 2.1 0.5 1.0 1.3 1.2 2.0 0.2 1.4 2.2 0.0 4.8 9.0 0.6 0.2 0.0 0.8 2.5 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.4 0.4 0.4 4.6 0.0 5.9 0.0 0.0 0.6 10.0 0.0 0.0 5.8 0.0 6.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.6 0.1 35.2 0.0 1.0 IL12RB2 ENSG00000081985 "Interleukin 12 receptor subunit beta 2" Q99665 1 67307364-67396900 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 18.2;pancreas: 15.0" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 2.9;Hofbauer cells: 2.9;Melanocytes: 1.7;T-cells: 6.4" "Cancer enhanced" "Detected in many" "melanoma: 5.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 18.2" "Group enriched" "Detected in many" 42 "NK-cells: 18.2;T-cells: 6.1" "Cell line enhanced" "Detected in some" "HMC-1: 4.5;SCLC-21H: 8.9;SK-MEL-30: 22.4;THP-1: 13.0" "Region enhanced" "Detected in single" "olfactory region: 1.8" "Low region specificity" "Detected in all" HPA024168 Uncertain Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA024168: AB_1851629" "unprognostic (1.32e-1)" "unprognostic (1.54e-3)" "unprognostic (2.09e-1)" "unprognostic (2.68e-2)" "unprognostic (2.82e-2)" "unprognostic (1.09e-3)" "unprognostic (2.37e-2)" "unprognostic (3.90e-2)" "unprognostic (1.10e-1)" "unprognostic (2.38e-2)" "unprognostic (1.39e-1)" "unprognostic (3.60e-2)" "unprognostic (1.08e-3)" "unprognostic (1.82e-1)" "unprognostic (4.69e-2)" "unprognostic (7.11e-3)" "unprognostic (1.90e-1)" 3.8 1.0 1.8 3.1 3.6 1.5 3.7 0.6 7.7 2.4 1.0 0.0 0.0 0.7 0.8 1.1 3.2 0.9 1.1 5.2 9.6 1.1 1.5 1.4 1.8 4.3 1.0 6.0 0.8 15.0 0.9 0.8 14.1 1.6 1.2 0.9 1.3 7.2 1.7 11.4 2.1 1.4 1.0 1.0 2.5 1.0 2.3 0.0 1.1 1.1 3.2 1.6 1.4 1.2 0.0 0.0 0.2 0.0 18.2 6.1 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.1 2.1 1.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.4 0.0 0.0 22.4 0.0 0.0 13.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 2.7 0.0 1.5 1.0 0.0 0.0 0.0 0.0 0.2 18.2 0.0 0.0 3.9 1.0 1.8 3.6 0.6 7.7 9.6 1.1 1.0 6.0 1.6 0.0 0.0 2.9 0.0 0.2 0.5 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.6 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.4 0.0 0.1 IL7R CD127 ENSG00000168685 "Interleukin 7 receptor" P16871 5 35852695-35879603 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 70.3;intestine: 34.0;lung: 52.6;lymphoid tissue: 133.1" "Group enriched" "Detected in many" 5 "monocytes: 441.0;T-cells: 326.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 19.2;MAIT T-cell: 70.3;memory CD4 T-cell: 39.9;memory CD8 T-cell: 28.0;naive CD4 T-cell: 34.5;naive CD8 T-cell: 22.5;NK-cell: 19.1" "Group enriched" "Detected in many" 33 "NK-cells: 19.1;T-cells: 70.3" "Cell line enhanced" "Detected in many" "BJ: 22.2;BJ hTERT+ SV40 Large T+: 20.1;fHDF/TERT166: 41.6;HBF TERT88: 38.3;REH: 86.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB010215, HPA067550" Supported "Plasma membrane" "Intracellular and membrane" NA NA 180000 "Plasma membrane" "CAB010215: AB_673727, HPA067550: " "unprognostic (2.93e-3)" "unprognostic (3.38e-2)" "unprognostic (3.82e-3)" "unprognostic (5.58e-3)" "unprognostic (3.06e-2)" "unprognostic (1.74e-1)" "unprognostic (2.51e-3)" "unprognostic (5.53e-2)" "unprognostic (1.12e-1)" "unprognostic (9.29e-3)" "unprognostic (1.43e-1)" "unprognostic (2.69e-1)" "unprognostic (1.76e-2)" "unprognostic (5.64e-2)" "unprognostic (3.27e-3)" "unprognostic (2.22e-1)" "unprognostic (1.78e-1)" 6.7 3.6 0.7 34.0 0.7 3.1 4.8 0.5 0.6 4.8 20.6 0.3 0.9 3.5 1.8 2.9 6.6 3.7 8.5 1.9 0.7 0.7 7.0 2.7 52.6 133.1 0.8 0.1 2.5 1.7 0.0 1.5 1.2 0.8 3.3 5.4 1.7 13.2 1.8 0.9 1.8 34.0 1.2 1.5 32.3 7.8 3.0 0.4 130.9 5.1 5.3 42.9 12.6 4.6 0.4 0.3 1.3 0.2 19.1 70.3 12.7 0.1 0.0 0.1 0.1 0.1 0.1 0.2 22.2 11.2 20.1 11.9 0.1 0.1 2.1 0.0 41.6 3.7 3.5 0.0 1.3 38.3 1.8 0.2 0.6 2.4 0.0 0.3 0.2 1.6 0.3 0.0 4.3 0.9 0.5 0.5 0.1 0.1 0.3 15.7 0.0 0.5 0.2 0.1 0.0 1.0 86.5 1.2 0.1 0.0 1.2 0.0 0.0 3.7 0.3 0.0 0.1 0.1 0.0 1.5 7.9 13.4 3.4 2.9 0.2 0.0 2.5 4.0 2.1 6.1 0.5 0.2 0.1 19.2 0.2 70.3 0.2 39.9 28.0 0.1 0.4 34.5 22.5 1.3 19.1 0.2 0.3 6.7 12.7 0.7 0.7 0.5 0.6 0.7 0.7 0.8 0.1 0.8 0.4 14.9 19.4 10.9 1.9 10.3 0.0 3.2 0.0 10.7 4.5 0.0 0.0 0.1 0.0 0.9 0.1 3.6 0.0 23.3 1.6 0.1 7.1 1.1 18.5 4.5 10.4 0.0 0.0 17.8 12.7 0.0 0.0 79.7 20.3 441.0 0.0 0.0 0.2 0.9 0.0 0.6 0.0 0.0 9.0 0.0 0.0 9.2 0.2 326.6 0.0 3.8 ILDR2 C1orf32 ENSG00000143195 "Immunoglobulin like domain containing receptor 2" Q71H61 1 166895711-166975482 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6;testis: 18.0" "Cell type enriched" "Detected in some" 8 "Muller glia cells: 116.0" "Cancer enhanced" "Detected in some" "glioma: 4.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.7;JURKAT: 7.4;MOLT-4: 5.1;U-2 OS: 12.5;U-251 MG: 6.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012545, HPA012815" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA012545: AB_2126894, HPA012815: " "unprognostic (9.14e-2)" "unprognostic (5.05e-2)" "unprognostic (8.27e-2)" "unprognostic (2.16e-1)" "unprognostic (5.89e-2)" "unprognostic (5.33e-2)" "unprognostic (2.89e-5)" "unprognostic (2.09e-1)" "unprognostic (8.55e-2)" "unprognostic (4.51e-2)" "unprognostic (1.52e-1)" "unprognostic (2.58e-1)" "unprognostic (9.17e-2)" "unprognostic (5.87e-3)" "unprognostic (4.92e-2)" "unprognostic (1.64e-1)" "unprognostic (1.36e-1)" 0.8 1.1 9.8 0.9 6.4 1.4 0.5 2.1 14.6 0.7 2.9 3.6 0.1 0.7 0.9 1.4 0.9 0.8 1.3 3.1 7.2 7.7 6.3 1.3 1.4 1.0 2.7 8.0 0.8 0.7 0.5 3.3 0.8 3.1 2.3 1.2 2.8 0.8 2.8 0.8 0.7 0.8 2.0 2.3 0.7 0.7 18.0 3.1 1.9 0.9 0.0 1.1 0.9 0.3 0.0 0.4 0.3 0.0 0.0 0.3 0.5 0.0 0.0 9.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 1.0 1.8 0.3 0.0 0.4 0.0 0.0 0.0 0.0 2.2 1.9 0.0 0.0 0.2 0.0 3.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.1 0.2 0.0 5.1 0.0 3.3 0.1 0.0 0.0 0.3 0.7 0.7 0.2 1.3 0.0 0.0 0.0 0.0 1.0 0.0 0.9 0.0 0.0 12.5 0.0 6.6 2.3 0.0 0.5 1.4 1.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.5 9.8 6.4 2.1 11.4 7.2 7.7 2.7 8.0 3.1 3.1 0.0 0.0 0.0 0.0 0.0 3.9 3.2 0.0 0.0 1.2 0.0 5.9 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.1 0.1 1.6 1.2 0.0 0.0 13.8 0.6 0.0 0.0 1.0 0.0 116.0 0.1 0.0 0.0 4.6 6.5 0.0 0.1 3.3 1.3 0.0 0.2 0.0 0.2 0.0 ITGA2B "CD41, CD41B, GP2B, PPP1R93" ENSG00000005961 "Integrin subunit alpha 2b" P08514 17 44372180-44389505 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.5;epididymis: 25.2;lymphoid tissue: 22.8" "Cell type enhanced" "Detected in some" 11 "Cone photoreceptor cells: 7.9;Early spermatids: 14.4;granulocytes: 18.4;Late spermatids: 20.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 10 "basophil: 28.5" "Lineage enriched" "Detected in single" 54 "granulocytes: 28.5" "Group enriched" "Detected in some" 13 "HEL: 71.0;HMC-1: 121.4" "Low region specificity" "Detected in single" "CAB018611, HPA031168, HPA031169, HPA031170, HPA031171" Enhanced Approved "Plasma membrane" NA NA 1100000000 "Plasma membrane" "CAB018611: AB_2265153, HPA031168: AB_10664706, HPA031169: AB_10669671, HPA031170: AB_10696214, HPA031171: AB_10669773" "unprognostic (6.11e-2)" "unprognostic (3.23e-2)" "unprognostic (1.23e-1)" "unprognostic (4.85e-2)" "unprognostic (1.59e-2)" "unprognostic (3.98e-3)" "unprognostic (4.23e-5)" "unprognostic (1.25e-1)" "unprognostic (1.33e-2)" "unprognostic (7.22e-2)" "unprognostic (2.97e-3)" "unprognostic (1.30e-1)" "unprognostic (8.83e-9)" "unprognostic (7.82e-2)" "unprognostic (1.85e-1)" "unprognostic (1.95e-1)" "unprognostic (2.25e-1)" 0.7 0.2 1.4 0.4 1.0 15.2 0.6 3.8 2.4 1.2 0.9 0.4 0.4 0.1 1.1 25.2 0.7 1.9 1.4 10.6 0.9 1.6 1.0 0.4 6.5 0.5 0.7 0.8 2.1 2.5 0.1 2.5 1.9 1.1 0.6 0.3 0.6 0.4 1.6 0.8 0.1 0.6 0.4 0.8 22.8 0.2 3.0 0.4 0.4 5.2 1.0 0.6 0.7 1.9 0.0 0.5 28.5 0.2 0.0 0.2 11.1 0.0 0.1 0.7 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.4 71.0 0.1 0.7 0.0 0.0 121.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.0 7.3 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.7 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 28.5 0.2 2.1 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.0 0.5 0.0 11.1 1.4 1.0 3.8 2.4 0.9 1.6 0.7 0.8 1.1 0.4 0.0 1.0 0.0 0.5 0.2 4.5 1.2 0.0 0.0 2.3 5.2 7.9 0.5 0.0 0.0 14.4 0.6 0.0 0.0 0.0 1.1 0.8 0.3 18.4 0.0 0.2 3.2 0.0 0.6 0.3 20.0 1.7 0.0 0.0 0.0 0.0 1.9 0.1 0.0 1.8 0.0 3.1 0.0 0.0 0.7 3.4 0.0 0.6 0.0 0.0 0.1 ITGA3 "CD49c, GAP-B3, MSK18, VCA-2, VLA3a" ENSG00000005884 "Integrin subunit alpha 3" P26006 17 50055968-50090481 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, Disease mutation, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 96.5;Exocrine glandular cells: 90.7;Pancreatic endocrine cells: 158.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.1" "Lineage enriched" "Detected in single" 4 "T-cells: 1.1" "Cell line enhanced" "Detected in many" "HBEC3-KT: 74.4;hTERT-RPE1: 68.2;RPTEC TERT1: 65.6;U-87 MG: 111.7;WM-115: 67.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008572, CAB018594" Enhanced Supported "Plasma membrane" NA NA 180000 "Plasma membrane" "CAB018594: AB_668044, HPA008572: AB_2668094" "unprognostic (3.24e-3)" "prognostic unfavorable (6.75e-4)" "unprognostic (9.51e-2)" "unprognostic (3.46e-3)" "unprognostic (3.45e-3)" "prognostic unfavorable (1.36e-4)" "unprognostic (8.28e-3)" "unprognostic (2.76e-3)" "unprognostic (1.26e-3)" "unprognostic (1.82e-2)" "prognostic unfavorable (5.95e-5)" "unprognostic (7.05e-2)" "unprognostic (1.14e-1)" "unprognostic (1.93e-1)" "unprognostic (1.30e-1)" "unprognostic (1.28e-2)" "unprognostic (2.35e-2)" 15.7 15.8 4.1 8.6 5.1 0.1 8.7 7.7 6.5 10.9 20.9 2.3 8.9 17.1 11.6 11.6 12.8 14.5 32.6 8.4 4.2 5.4 36.0 1.7 37.6 3.2 3.2 6.7 10.7 8.0 13.0 11.2 26.4 4.3 12.0 8.9 11.6 10.0 9.7 6.6 17.3 37.3 11.6 3.3 6.5 13.7 3.9 1.5 3.3 36.1 13.3 8.3 19.0 8.1 0.2 0.0 0.0 0.0 0.0 1.1 0.2 20.4 27.1 0.1 0.8 0.5 2.1 4.4 9.6 20.7 14.5 11.1 0.6 31.9 0.0 60.6 6.9 48.4 14.6 0.2 74.4 8.9 2.5 0.4 0.0 6.8 0.1 12.8 0.0 0.6 2.6 36.7 14.5 64.6 68.2 10.6 1.0 0.0 0.3 27.3 5.9 0.0 0.0 0.6 9.2 16.4 0.0 1.4 1.5 65.6 35.7 1.1 0.4 10.4 1.4 24.0 6.9 2.4 0.2 23.0 64.8 20.4 0.6 37.3 0.9 1.5 0.6 111.7 0.2 67.3 0.0 0.0 0.0 0.8 0.0 1.0 0.2 0.1 0.1 0.0 0.2 0.2 0.6 0.0 0.0 0.0 0.0 1.1 0.2 4.1 5.1 7.7 6.5 4.2 5.4 3.2 6.7 4.3 1.5 50.6 29.6 5.7 51.4 50.9 14.4 4.4 33.1 4.0 27.3 73.3 23.6 1.8 0.0 96.5 0.4 11.2 77.3 0.0 90.7 2.6 4.5 26.1 3.5 0.0 1.1 3.2 13.9 4.9 1.5 0.0 1.7 3.8 16.9 7.2 21.8 2.3 158.1 31.7 3.9 2.2 13.1 12.9 18.6 0.2 1.6 20.3 1.5 1.3 29.6 70.4 ITGA4 CD49d ENSG00000115232 "Integrin subunit alpha 4" P13612 2 181457202-181536187 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 38.4;lymphoid tissue: 101.6" "Cell type enhanced" "Detected in many" 11 "B-cells: 42.0;Erythroid cells: 70.0;monocytes: 36.1;T-cells: 59.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 39.1;HEL: 62.0;JURKAT: 32.6;MOLT-4: 72.3" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 26.0" HPA074961 Approved "Plasma membrane" "Intracellular and membrane" NA NA 100000 "Plasma membrane" "HPA074961: AB_2732273" "unprognostic (5.31e-2)" "unprognostic (1.54e-1)" "unprognostic (1.99e-2)" "unprognostic (3.94e-2)" "unprognostic (3.76e-1)" "prognostic favorable (8.29e-4)" "unprognostic (1.27e-1)" "unprognostic (1.11e-2)" "unprognostic (1.76e-1)" "unprognostic (2.67e-2)" "unprognostic (1.85e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (3.08e-5)" "unprognostic (2.26e-2)" "unprognostic (8.64e-3)" "unprognostic (2.49e-1)" "unprognostic (2.57e-2)" 3.8 1.7 1.3 39.7 1.1 19.2 3.2 2.4 1.9 6.7 4.8 0.5 1.1 3.8 3.0 3.1 2.9 2.1 6.9 1.7 2.9 1.3 3.0 2.5 13.6 33.7 1.2 0.5 1.8 1.6 0.0 1.3 7.1 0.9 3.8 4.9 2.9 7.5 2.0 1.0 1.5 11.6 2.4 1.6 36.0 4.4 1.2 0.2 101.6 2.6 1.5 14.3 6.0 4.1 11.0 19.1 38.4 38.3 8.8 15.9 16.2 0.0 0.2 1.0 0.0 9.2 13.9 0.0 9.0 11.3 4.8 10.2 0.0 0.0 7.2 0.0 39.1 4.2 5.3 3.2 0.1 5.8 0.0 0.7 62.0 0.2 0.0 0.9 27.4 1.5 9.9 0.0 0.3 0.0 4.7 0.5 32.6 0.0 10.5 3.0 0.0 72.3 19.2 0.8 0.0 0.0 15.9 4.5 1.0 0.0 0.0 1.6 0.6 0.0 0.0 0.3 0.4 0.0 18.1 4.9 1.5 0.9 0.1 1.8 20.5 15.2 4.1 0.8 13.6 20.8 6.7 16.2 38.4 12.9 38.3 9.7 11.0 14.6 15.9 19.1 10.0 8.5 10.4 2.1 8.8 37.5 5.0 3.7 16.2 1.3 1.1 2.4 1.9 2.9 1.3 1.2 0.5 0.9 0.2 0.0 7.9 42.0 0.2 0.2 2.4 0.8 5.1 1.4 3.4 0.0 5.9 0.1 0.0 0.0 0.0 0.0 0.0 70.0 0.0 0.2 2.9 0.3 17.4 0.0 5.8 0.0 0.0 1.8 21.0 0.0 0.6 22.7 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 1.6 0.4 0.9 0.5 0.3 59.7 0.0 0.2 ITGA8 ENSG00000077943 "Integrin subunit alpha 8" P53708 10 15513949-15720125 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein, Integrin, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 7 "Muller glia cells: 17.3;Sertoli cells: 51.8;Smooth muscle cells: 54.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 7.9;HMC-1: 19.0;HSkMC: 8.4;U-266/70: 3.6;U-266/84: 8.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003432 Approved Approved "Plasma membrane" NA NA 110000 "Plasma membrane" "HPA003432: AB_1851825" "unprognostic (2.15e-1)" "unprognostic (1.22e-3)" "unprognostic (1.05e-2)" "unprognostic (2.03e-1)" "unprognostic (1.25e-2)" "unprognostic (8.44e-4)" "unprognostic (2.23e-1)" "unprognostic (6.13e-3)" "unprognostic (6.82e-2)" "unprognostic (3.80e-1)" "unprognostic (2.54e-2)" "unprognostic (1.27e-1)" "unprognostic (4.10e-3)" "unprognostic (1.39e-1)" "unprognostic (1.71e-1)" "unprognostic (2.26e-1)" "unprognostic (6.03e-2)" 7.1 7.8 2.3 2.4 1.9 0.1 3.1 1.4 3.7 36.1 5.5 1.5 4.1 4.8 17.9 22.8 12.4 7.1 10.7 10.3 3.0 1.6 7.4 0.8 22.1 3.7 1.7 2.6 17.0 0.8 0.7 3.3 0.2 2.9 28.3 4.6 18.8 3.0 22.9 3.3 3.1 4.9 21.2 1.5 17.0 19.4 12.1 1.2 0.0 5.3 5.5 4.3 21.3 10.8 0.2 0.2 0.6 0.4 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 7.9 2.3 0.0 0.0 0.0 0.0 19.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 8.6 0.0 0.0 0.1 1.6 0.6 0.0 0.2 0.2 0.4 0.2 0.2 0.3 0.3 0.0 0.2 0.5 0.5 0.5 0.2 0.4 0.2 0.8 0.0 2.3 1.9 1.4 3.7 3.0 1.6 1.7 2.6 2.9 1.2 0.0 2.2 0.0 1.9 0.9 2.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.8 0.0 0.0 0.0 0.0 2.4 1.2 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.9 1.0 1.7 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.2 51.8 54.5 0.0 0.2 1.0 0.0 0.0 0.0 1.4 ITSN1 "ITSN, MGC134948, MGC134949, SH3D1A, SH3P17" ENSG00000205726 "Intersectin 1" Q15811 21 33642400-33899861 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Exocytosis, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Rod photoreceptor cells: 150.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 5.9;eosinophil: 7.2;intermediate monocyte: 4.1;myeloid DC: 1.8;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 7 "dendritic cells: 1.8;granulocytes: 7.2;monocytes: 6.3" "Cell line enhanced" "Detected in all" "BEWO: 43.0;NTERA-2: 38.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018007 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA018007: AB_1851836" "unprognostic (2.12e-1)" "unprognostic (1.51e-1)" "unprognostic (1.62e-1)" "unprognostic (1.21e-1)" "unprognostic (3.91e-1)" "unprognostic (1.81e-1)" "unprognostic (1.10e-1)" "unprognostic (3.94e-2)" "unprognostic (7.33e-3)" "unprognostic (1.31e-2)" "unprognostic (3.23e-1)" "unprognostic (3.25e-2)" "unprognostic (1.16e-2)" "unprognostic (6.78e-3)" "unprognostic (2.37e-1)" "unprognostic (6.02e-2)" "unprognostic (5.64e-2)" 47.4 14.9 24.9 8.9 24.5 5.7 21.7 24.2 24.8 15.5 11.2 10.2 12.3 8.3 17.9 11.8 11.0 13.6 18.5 18.3 24.6 12.1 10.7 23.1 9.5 5.9 12.1 20.4 19.2 4.9 8.4 7.7 22.0 21.1 14.2 10.6 11.4 6.9 21.9 18.0 11.0 9.0 17.4 11.1 13.4 10.3 11.2 15.0 2.4 9.3 4.0 3.9 13.1 12.5 0.0 1.8 7.2 6.3 0.1 0.7 1.1 12.8 5.4 26.1 8.6 12.3 11.8 43.0 13.0 12.6 7.7 7.4 20.4 9.9 3.0 10.6 15.6 16.0 5.0 15.5 9.0 8.3 1.2 6.8 3.7 11.2 9.5 9.3 2.6 3.7 11.6 8.2 14.4 8.0 8.8 20.3 3.5 4.8 2.1 12.3 2.9 3.6 3.5 38.7 4.5 4.1 4.7 12.5 6.2 11.5 5.3 4.9 5.4 18.7 3.9 4.7 17.4 4.8 2.6 18.2 8.6 11.7 6.7 4.5 2.6 7.2 2.8 7.8 8.2 9.5 0.0 5.9 7.2 0.4 4.1 0.5 0.0 0.7 0.2 1.8 0.0 0.3 0.1 0.3 0.1 6.3 0.4 0.0 1.1 24.9 24.5 24.2 24.8 24.6 12.1 12.1 20.4 21.1 15.0 23.8 15.2 5.8 17.3 16.1 68.6 68.0 20.4 20.1 12.5 10.4 86.4 19.3 0.0 18.1 5.9 22.4 16.9 70.0 10.9 21.5 25.7 14.8 2.3 43.3 44.1 62.0 8.7 28.8 27.1 6.5 23.0 11.3 10.1 11.8 5.7 43.1 25.1 9.1 67.1 13.6 150.8 12.9 23.6 20.0 46.4 10.3 13.0 3.2 9.6 16.1 IYD "C6orf71, DEHAL1, dJ422F24.1" ENSG00000009765 "Iodotyrosine deiodinase" Q6PHW0 6 150368892-150405969 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Oxidoreductase "Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "thyroid gland: 212.3" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 8.5;Cholangiocytes: 20.4;Club cells: 12.5;Enterocytes: 25.8;Hepatocytes: 18.3;Mucus-secreting cells: 15.4;Paneth cells: 17.3;Proximal tubular cells: 33.8;Undifferentiated cells: 10.3" "Cancer enriched" "Detected in many" 20 "thyroid cancer: 80.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "CACO-2: 3.0;OE19: 6.8;SK-BR-3: 7.4" "Group enriched" "Detected in some" 13 "hippocampal formation: 8.1;thalamus: 2.6" "Low region specificity" "Detected in many" HPA059627 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA059627: AB_2684086" "unprognostic (3.73e-4)" "unprognostic (2.93e-2)" "unprognostic (5.97e-2)" "unprognostic (1.95e-2)" "unprognostic (1.55e-1)" "unprognostic (2.98e-2)" "prognostic favorable (6.22e-4)" "unprognostic (1.11e-1)" "unprognostic (3.80e-2)" "unprognostic (1.17e-1)" "unprognostic (7.41e-2)" "unprognostic (1.02e-1)" "unprognostic (3.07e-9)" "unprognostic (9.79e-3)" "unprognostic (2.04e-1)" "unprognostic (2.03e-2)" "unprognostic (2.18e-2)" 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 8.2 0.1 0.1 3.6 0.1 0.3 0.1 0.1 6.7 0.1 0.1 0.1 5.4 6.8 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.5 0.1 1.2 0.0 0.3 0.0 0.1 0.2 13.5 0.0 0.1 0.1 0.3 0.1 0.0 0.0 212.3 0.0 0.1 0.1 0.1 1.4 1.0 5.9 1.3 2.3 0.7 2.3 0.1 0.0 0.2 0.3 0.1 0.8 0.4 0.0 0.0 0.0 0.0 3.0 0.5 0.2 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 0.2 0.4 0.8 0.3 0.0 0.1 0.7 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.3 0.6 0.0 0.4 0.0 0.3 0.3 6.8 0.2 0.3 0.2 0.2 0.0 0.7 0.3 0.2 0.0 7.4 0.0 0.1 0.7 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.0 0.1 0.4 0.2 0.1 3.3 1.3 0.7 0.7 1.1 0.5 0.6 0.6 0.5 0.1 1.4 0.6 0.7 5.9 2.3 0.5 1.0 0.5 2.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.0 3.0 8.5 0.0 0.5 0.1 0.0 0.5 20.4 1.4 12.5 0.0 0.0 0.0 1.7 0.1 0.0 0.0 25.8 0.0 0.2 0.0 0.0 1.0 1.1 18.3 0.1 0.0 3.5 1.3 0.0 0.0 0.0 0.5 0.0 0.0 15.4 0.0 0.2 17.3 0.0 33.8 1.1 0.0 0.0 0.0 0.2 0.4 0.2 0.0 10.3 0.7 KANK1 "ANKRD15, KANK, KIAA0172" ENSG00000107104 "KN motif and ankyrin repeat domains 1" Q14678 9 470291-746106 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 178.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 7.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 35.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005539, HPA056090" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA005539: AB_1078164, HPA056090: AB_2683034" "unprognostic (6.59e-2)" "unprognostic (3.33e-2)" "unprognostic (1.06e-3)" "unprognostic (1.30e-1)" "unprognostic (2.69e-1)" "unprognostic (7.53e-2)" "unprognostic (3.33e-1)" "unprognostic (1.23e-2)" "unprognostic (4.91e-2)" "unprognostic (3.05e-2)" "unprognostic (2.84e-2)" "unprognostic (1.24e-1)" "unprognostic (3.07e-2)" "unprognostic (2.72e-1)" "unprognostic (3.06e-2)" "unprognostic (1.82e-1)" "unprognostic (1.61e-1)" 28.9 5.3 23.9 8.7 23.2 1.4 15.5 17.7 18.2 18.2 17.4 28.5 7.6 8.8 26.5 10.3 33.7 12.7 13.2 46.5 21.9 10.4 19.8 39.4 10.0 6.9 21.4 14.8 16.9 17.0 9.5 14.7 18.2 16.5 23.4 11.2 14.8 17.9 24.4 24.2 20.0 9.2 27.6 21.3 3.9 10.7 12.1 23.5 2.8 16.2 8.2 8.8 28.9 26.3 1.5 7.1 0.0 0.2 0.2 4.4 1.0 2.1 4.4 1.5 27.2 22.6 8.6 7.5 13.9 9.7 1.1 1.4 11.1 0.9 16.9 3.4 17.1 2.6 4.5 5.8 11.3 2.0 8.1 3.1 0.0 6.4 35.0 3.2 4.0 0.0 4.9 15.9 1.2 13.7 5.0 11.7 0.5 0.8 21.3 8.7 5.2 1.6 17.1 1.9 3.2 3.4 0.6 3.0 3.1 9.2 13.4 0.6 0.0 1.3 4.1 18.4 13.2 2.7 3.2 17.2 3.2 1.2 4.0 6.3 3.7 21.9 0.0 2.1 7.7 5.9 0.0 0.2 0.0 0.2 0.2 0.0 1.5 2.3 0.8 0.7 1.2 4.4 1.4 0.0 0.2 0.0 7.1 3.0 1.0 23.9 23.2 17.7 17.6 21.9 10.4 21.4 14.8 16.5 23.5 11.9 32.2 2.2 72.1 20.5 22.8 86.0 25.5 6.7 6.8 17.4 39.3 71.9 6.6 10.2 85.1 17.5 9.5 23.3 6.9 5.7 13.2 37.8 1.1 61.8 11.9 0.0 17.2 17.2 4.7 178.6 30.0 3.3 21.9 0.0 11.2 7.5 11.3 10.2 19.4 12.6 20.9 25.8 23.4 16.2 23.9 22.5 55.4 3.2 20.9 53.1 KANK3 "ANKRD47, FLJ46061" ENSG00000186994 "KN motif and ankyrin repeat domains 3" Q6NY19 19 8322584-8343262 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Endothelial cells: 58.3;Ito cells: 34.4;Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 1.0;NK-cells: 3.6;T-cells: 3.5" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 9.3;TIME: 16.8;U-266/70: 6.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "olfactory region: 34.0" HPA051153 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA051153: AB_2681365" "unprognostic (1.56e-1)" "unprognostic (1.63e-4)" "unprognostic (1.54e-2)" "unprognostic (8.95e-3)" "unprognostic (1.07e-1)" "unprognostic (2.84e-3)" "unprognostic (1.82e-3)" "unprognostic (3.26e-2)" "unprognostic (1.19e-1)" "unprognostic (1.39e-2)" "unprognostic (1.34e-2)" "unprognostic (4.77e-1)" "prognostic favorable (1.69e-5)" "unprognostic (5.03e-2)" "unprognostic (1.67e-1)" "unprognostic (2.86e-1)" "unprognostic (3.24e-1)" 23.3 3.6 5.2 3.8 4.8 1.2 13.2 2.7 6.5 3.8 5.6 1.6 2.9 4.0 5.4 6.2 4.7 5.2 3.4 9.6 6.2 2.9 7.7 2.3 19.0 6.3 4.4 1.6 3.1 3.1 1.6 3.5 18.3 4.8 3.3 1.2 6.4 3.4 2.8 15.5 3.5 4.0 3.5 2.8 21.0 3.1 2.5 5.0 0.3 7.9 3.0 1.6 2.5 6.7 0.5 0.3 1.0 0.3 3.6 3.5 0.7 0.1 0.7 0.3 0.6 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.8 0.2 0.0 2.7 0.0 0.1 0.1 0.6 2.9 0.0 0.8 1.6 0.4 0.4 0.5 0.1 0.2 1.5 0.0 0.9 0.0 0.0 0.0 9.3 0.7 0.0 0.4 0.0 0.5 0.0 0.5 0.6 0.6 0.3 1.5 0.0 0.8 0.1 0.2 0.0 0.1 0.0 0.8 0.1 0.0 0.6 0.0 16.8 0.1 1.6 0.4 0.1 6.9 0.2 0.3 0.2 0.1 0.2 0.8 0.3 0.1 3.5 0.1 1.6 0.3 1.9 0.6 0.1 0.5 0.8 1.3 1.0 3.6 0.1 0.3 1.3 0.7 5.2 4.8 2.7 6.5 6.2 2.9 4.4 1.6 4.8 5.0 6.0 5.6 0.0 0.2 2.3 0.2 0.8 0.0 0.0 0.0 0.0 3.9 0.3 5.0 0.2 4.0 58.3 0.0 0.0 1.6 0.2 1.7 0.8 0.0 0.8 0.4 0.0 0.0 34.4 1.6 4.1 0.6 0.7 5.0 0.0 0.0 0.2 0.4 0.0 0.4 0.3 0.7 19.4 2.5 1.1 3.1 1.1 0.2 2.5 0.0 0.5 KCNH8 "elk3, Kv12.1" ENSG00000183960 "Potassium voltage-gated channel subfamily H member 8" Q96L42 3 19148454-19535646 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 31.3;pituitary gland: 16.1" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 4.7;Early spermatids: 2.7;Intestinal endocrine cells: 3.5;Melanocytes: 3.3;Muller glia cells: 3.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 2.1;naive B-cell: 4.5" "Lineage enriched" "Detected in single" 5 "B-cells: 4.5" "Cell line enhanced" "Detected in some" "HAP1: 2.1;OE19: 4.0;SH-SY5Y: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA016586, HPA077537, HPA077773" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA016586: AB_1852127, HPA077537: , HPA077773: " "unprognostic (6.68e-3)" "unprognostic (1.68e-1)" "unprognostic (2.99e-2)" "unprognostic (8.56e-6)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.88e-1)" "unprognostic (9.13e-3)" "unprognostic (4.86e-2)" "unprognostic (1.69e-1)" "unprognostic (5.04e-3)" "unprognostic (2.90e-2)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (3.89e-2)" "unprognostic (8.71e-5)" "unprognostic (1.72e-1)" 0.6 7.0 8.4 1.6 22.0 1.4 2.4 1.3 11.4 1.3 1.9 31.3 0.0 2.2 1.2 1.2 0.7 1.4 2.2 1.0 11.8 5.7 0.7 0.7 0.8 3.2 16.4 10.2 0.7 2.7 0.8 16.1 0.6 15.0 2.2 2.5 0.1 3.3 1.4 0.6 1.9 1.8 1.1 9.9 2.6 5.9 4.0 18.1 0.0 1.1 0.0 3.2 0.9 0.5 4.5 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.8 4.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 9.4 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 4.5 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 8.4 22.0 1.3 11.4 11.8 5.7 16.4 10.2 15.0 18.1 0.0 0.0 0.0 1.6 0.5 4.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.7 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.1 0.0 3.5 0.0 0.0 1.1 0.0 0.0 3.3 0.0 1.7 3.7 0.6 0.0 0.0 0.0 0.9 0.0 0.2 0.7 1.9 0.0 0.1 0.0 0.2 0.2 KCNK7 K2p7.1 ENSG00000173338 "Potassium two pore domain channel subfamily K member 7" Q9Y2U2 11 65592855-65595996 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skin 1: 35.0;tongue: 20.7" "Cell type enriched" "Detected in some" 5 "Suprabasal keratinocytes: 90.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.4" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 12 "basophil: 4.8;naive B-cell: 2.9;neutrophil: 3.6" "Group enriched" "Detected in many" 12 "B-cells: 2.9;granulocytes: 4.8" "Cell line enhanced" "Detected in many" "SCLC-21H: 12.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA077577 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA077577: AB_2686845" "unprognostic (1.12e-2)" "unprognostic (1.21e-1)" "unprognostic (6.08e-2)" "unprognostic (5.71e-2)" "unprognostic (8.59e-2)" "unprognostic (1.34e-1)" "unprognostic (1.68e-3)" "unprognostic (8.53e-2)" "unprognostic (1.69e-1)" "unprognostic (2.87e-1)" "unprognostic (6.90e-2)" "unprognostic (4.88e-2)" "unprognostic (1.49e-2)" "unprognostic (2.65e-1)" "unprognostic (3.57e-1)" "unprognostic (1.16e-1)" "unprognostic (8.11e-2)" 0.6 0.6 0.8 0.3 0.7 3.9 2.6 1.6 2.1 1.4 0.5 0.8 0.3 0.4 0.4 0.3 10.8 0.6 0.3 0.5 0.8 0.4 0.3 0.3 0.3 0.3 0.6 1.1 0.6 0.3 0.1 0.3 0.5 0.4 0.3 0.1 0.3 0.8 0.4 1.8 35.0 0.5 0.3 0.7 0.5 0.3 0.3 0.5 0.7 0.3 20.7 5.7 0.3 3.4 2.9 0.0 4.8 0.2 0.2 0.3 0.1 0.5 2.3 0.1 0.7 0.0 0.0 0.2 0.3 0.0 0.5 0.1 0.3 1.7 0.8 0.7 0.2 0.4 3.8 0.0 0.0 0.0 0.8 2.6 0.8 1.2 1.0 0.0 0.0 0.6 0.1 0.0 0.2 0.0 0.4 0.0 1.6 1.4 2.2 0.7 1.7 0.9 0.7 1.0 1.0 2.2 1.6 0.0 0.4 1.0 0.2 12.4 2.8 0.5 0.7 1.2 0.1 0.7 2.2 0.0 0.6 1.9 1.9 0.1 2.0 1.3 0.5 1.4 1.1 1.0 4.8 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 2.9 0.1 0.0 3.6 0.2 0.2 0.0 0.0 0.1 0.8 0.7 1.6 2.1 0.8 0.4 0.6 1.1 0.4 0.5 0.0 0.3 0.0 0.4 16.9 2.3 0.1 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.5 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.4 0.0 1.2 0.0 1.5 1.3 0.6 0.0 3.3 0.0 0.3 0.2 0.1 2.8 0.0 0.0 0.8 6.5 1.9 0.1 0.5 90.7 0.0 0.0 0.5 1.0 KCNK9 "K2p9.1, TASK-3, TASK3" ENSG00000169427 "Potassium two pore domain channel subfamily K member 9" Q9NPC2 8 139600838-139703056 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "adrenal gland: 9.4;brain: 15.4" "Cell type enhanced" "Detected in some" 18 "Collecting duct cells: 1.8;Distal tubular cells: 1.7;Exocrine glandular cells: 2.2;Late spermatids: 4.6" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 15.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "PC-3: 6.6;SCLC-21H: 2.9;SH-SY5Y: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075842 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA075842: " "unprognostic (1.84e-2)" "unprognostic (2.57e-1)" "unprognostic (1.58e-1)" "unprognostic (8.96e-8)" "unprognostic (1.91e-1)" "unprognostic (8.17e-3)" "unprognostic (2.19e-3)" "unprognostic (1.65e-1)" "unprognostic (3.87e-1)" "unprognostic (1.69e-1)" "unprognostic (1.00e-2)" "unprognostic (3.21e-1)" "unprognostic (5.12e-6)" "unprognostic (2.94e-2)" "unprognostic (1.64e-1)" "unprognostic (9.99e-3)" "unprognostic (1.76e-1)" 0.2 9.4 0.5 0.5 1.0 0.1 0.1 15.4 7.7 1.3 0.5 0.0 0.0 0.1 0.3 0.1 0.2 0.3 0.1 0.2 1.6 1.4 0.1 0.1 0.1 0.1 0.7 1.7 0.1 0.1 0.1 1.1 0.2 6.6 0.1 0.2 0.2 0.1 0.1 1.4 0.1 0.1 0.6 0.6 0.1 0.3 0.5 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 6.6 0.0 0.0 0.0 0.0 0.0 2.9 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 1.0 15.4 3.7 1.6 1.4 0.7 1.7 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.2 1.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 KCNU1 "KCa5.1, Kcnma3, KCNMC1, Slo3" ENSG00000215262 "Potassium calcium-activated channel subfamily U member 1" A8MYU2 8 36784324-36936128 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 15.8" "Group enriched" "Detected in some" 54 "Early spermatids: 49.4;Late spermatids: 18.0" "Cancer enhanced" "Detected in single" "liver cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HDLM-2: 13.1" "Not detected" "Not detected" HPA063317 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA063317: " "unprognostic (2.42e-3)" "unprognostic (4.26e-2)" "unprognostic (2.07e-1)" "unprognostic (4.76e-3)" "unprognostic (7.57e-2)" "unprognostic (1.12e-1)" "unprognostic (1.11e-1)" "unprognostic (2.71e-1)" "unprognostic (1.98e-1)" "unprognostic (7.73e-2)" "unprognostic (1.24e-2)" 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 13.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.3 0.2 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.1 KDR "CD309, FLK1, VEGFR, VEGFR2" ENSG00000128052 "Kinase insert domain receptor" P35968 4 55078259-55125595 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins" "Angiogenesis, Differentiation, Host-virus interaction" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Endothelial cells: 100.3;Ito cells: 200.7;Muller glia cells: 229.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HUVEC TERT2: 32.5;TIME: 36.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB004028 Enhanced Supported "Plasma membrane" "Intracellular and membrane" NA NA 7400000 "Plasma membrane" "CAB004028: AB_2212507" "unprognostic (1.61e-1)" "unprognostic (2.03e-1)" "unprognostic (9.65e-2)" "unprognostic (1.97e-1)" "unprognostic (9.63e-2)" "unprognostic (1.22e-2)" "unprognostic (1.78e-3)" "unprognostic (2.59e-2)" "unprognostic (1.19e-2)" "unprognostic (1.10e-1)" "unprognostic (8.79e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (7.26e-4)" "unprognostic (4.00e-2)" "unprognostic (2.30e-1)" "unprognostic (3.22e-1)" "unprognostic (1.86e-1)" 19.7 6.2 1.8 4.4 3.1 0.4 20.5 1.1 2.2 11.4 6.0 1.8 11.5 2.3 28.8 10.2 5.2 9.5 6.2 12.1 2.3 1.7 7.8 10.4 13.2 14.1 3.1 2.9 6.0 8.1 8.0 6.8 34.5 3.9 9.5 1.4 27.6 7.1 10.3 5.3 3.0 3.8 7.7 2.6 4.4 4.2 5.3 1.2 0.5 20.0 5.3 3.0 4.4 12.0 0.1 0.1 0.7 0.0 0.2 0.2 0.1 0.0 0.0 1.7 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 3.8 0.0 0.0 0.3 0.0 0.0 0.2 0.2 32.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 1.8 3.1 1.1 2.2 2.3 1.7 3.1 2.9 3.9 1.2 0.0 8.2 7.5 0.4 2.3 7.4 4.8 0.0 6.7 30.7 0.0 0.0 0.1 0.0 0.5 0.8 100.3 0.0 0.0 0.0 0.1 1.9 0.4 2.3 1.3 0.4 0.0 0.0 200.7 14.5 0.6 0.0 1.0 6.8 0.0 0.0 229.2 0.3 0.0 0.4 0.0 6.0 0.0 1.4 0.2 0.2 2.4 0.1 0.0 0.0 0.4 KIAA1324 "EIG121, maba1" ENSG00000116299 KIAA1324 Q6UXG2 1 109113679-109206781 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 79.8;salivary gland: 169.4" "Cell type enhanced" "Detected in many" 9 "Glandular cells: 98.1;Intestinal endocrine cells: 156.4;Mucus-secreting cells: 151.0;Undifferentiated cells: 73.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 7 "neutrophil: 33.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 33.8" "Cell line enhanced" "Detected in some" "MCF7: 14.5;SCLC-21H: 9.3;SK-BR-3: 11.3;T-47d: 38.6;U-87 MG: 7.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA029869, HPA070749" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA029869: AB_10794320, HPA070749: AB_2686304" "unprognostic (2.10e-1)" "unprognostic (1.42e-2)" "unprognostic (1.99e-2)" "prognostic favorable (2.14e-7)" "unprognostic (4.18e-3)" "unprognostic (5.63e-2)" "unprognostic (1.96e-3)" "prognostic favorable (5.69e-5)" "unprognostic (2.79e-2)" "prognostic favorable (2.16e-4)" "unprognostic (3.50e-3)" "unprognostic (1.01e-1)" "unprognostic (2.22e-16)" "unprognostic (2.46e-1)" "unprognostic (1.75e-1)" "unprognostic (5.64e-2)" "unprognostic (8.02e-2)" 0.7 0.9 3.7 3.6 7.9 0.0 16.4 0.7 5.6 23.9 11.8 0.4 0.0 14.6 5.5 5.7 1.3 7.8 19.1 0.6 3.3 2.3 0.6 0.6 2.2 0.7 1.0 2.7 1.2 79.8 6.1 46.6 0.0 1.1 15.8 10.0 0.0 169.4 0.0 0.6 2.5 16.5 0.2 0.9 0.9 27.3 9.4 1.1 0.0 3.9 5.2 11.5 0.9 0.6 0.2 0.0 33.8 0.0 0.2 4.6 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.4 0.1 0.0 0.1 0.0 0.0 0.2 0.5 0.8 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.3 14.5 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.5 0.2 0.0 9.3 0.2 0.0 11.3 0.0 0.0 38.6 0.0 0.2 0.0 1.4 0.0 0.1 0.8 2.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 2.2 0.0 3.9 0.2 3.9 1.7 0.0 0.0 1.8 0.7 33.8 0.2 0.0 0.0 4.6 1.0 3.7 7.9 0.7 5.6 3.3 2.3 1.0 2.7 1.1 1.1 14.9 43.1 0.0 6.2 0.5 5.1 1.5 0.0 34.8 62.6 0.0 3.9 0.5 0.0 0.9 32.7 0.5 13.1 0.0 33.1 0.6 1.6 98.1 22.1 0.0 0.9 1.6 156.4 1.3 1.6 12.3 4.0 2.3 3.3 0.0 151.0 1.4 16.5 24.6 2.1 0.0 2.6 0.0 1.4 13.7 1.7 1.4 0.5 4.4 73.4 8.3 KIT "C-Kit, CD117, PBT, SCFR" ENSG00000157404 "KIT proto-oncogene receptor tyrosine kinase" P10721 4 54657918-54740715 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 65.5" "Group enriched" "Detected in many" 10 "granulocytes: 496.5;Melanocytes: 200.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 12.7;eosinophil: 10.0;NK-cell: 9.7" "Group enriched" "Detected in many" 6 "granulocytes: 12.7;NK-cells: 9.7" "Group enriched" "Detected in some" 13 "HEL: 48.8;HMC-1: 102.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003288, HPA004471, CAB068253, CAB072867, HPA073252" Enhanced Supported Supported "Plasma membrane" NA NA 48000000 "Plasma membrane" "CAB003288: AB_2335702, CAB068253: AB_2665717, CAB072867: AB_2665718, HPA004471: AB_1078431, HPA073252: AB_2686589" "unprognostic (1.55e-2)" "unprognostic (1.91e-1)" "unprognostic (4.04e-2)" "unprognostic (8.19e-2)" "unprognostic (3.96e-2)" "unprognostic (2.18e-2)" "unprognostic (2.33e-2)" "unprognostic (1.97e-2)" "unprognostic (3.60e-2)" "unprognostic (1.64e-1)" "unprognostic (2.20e-1)" "unprognostic (1.92e-2)" "prognostic favorable (5.63e-4)" "unprognostic (1.34e-3)" "unprognostic (1.87e-1)" "unprognostic (1.29e-2)" "unprognostic (2.30e-1)" 8.1 1.6 9.5 6.6 11.8 3.7 65.5 18.3 12.0 12.1 10.3 6.5 10.2 5.8 8.9 4.2 9.9 2.5 15.5 2.4 36.0 4.4 9.4 1.1 13.8 3.8 3.6 6.0 28.5 2.1 1.3 2.3 6.2 5.7 9.6 10.4 20.7 12.9 6.9 1.3 14.6 8.9 10.2 3.9 3.2 12.8 4.0 4.5 0.4 28.9 4.3 4.9 9.8 12.5 0.0 1.8 12.7 0.9 9.7 1.9 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.6 0.9 2.6 3.2 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.5 0.0 2.2 0.0 1.2 48.8 0.0 0.0 0.0 0.0 102.6 0.0 0.0 0.0 0.0 0.0 5.7 0.8 0.6 0.1 0.0 0.0 0.2 0.4 1.4 0.0 0.0 0.1 0.0 0.0 0.0 4.8 1.2 0.4 0.0 0.0 0.0 3.0 0.0 0.5 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 12.7 0.0 10.0 0.1 0.0 1.9 0.0 0.3 0.7 1.8 0.0 0.0 0.0 0.8 9.7 0.9 0.0 0.0 0.1 9.5 11.8 18.3 12.0 36.0 4.4 3.6 6.0 5.7 4.5 6.0 34.8 1.4 1.1 12.7 0.0 0.4 5.1 0.0 5.7 3.5 0.0 0.0 3.3 0.8 0.0 2.4 0.0 0.0 0.0 0.1 1.3 0.5 496.5 0.0 0.3 0.0 5.2 1.8 0.3 0.0 1.1 3.1 200.8 0.0 0.3 2.4 0.0 0.0 0.0 0.6 0.3 0.0 0.5 0.0 8.2 3.3 0.2 2.2 0.3 0.3 KLHDC7B MGC16635 ENSG00000130487 "Kelch domain containing 7B" Q96G42 22 50548033-50551022 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 8.4;parathyroid gland: 12.5" "Cell type enriched" "Detected in some" 5 "monocytes: 30.7" "Cancer enhanced" "Detected in many" "cervical cancer: 42.3;urothelial cancer: 40.7" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 4 "HMC-1: 47.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA000518, HPA076540" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA000518: AB_1079213, HPA076540: " "prognostic favorable (1.30e-4)" "unprognostic (3.18e-2)" "unprognostic (2.74e-2)" "unprognostic (2.21e-1)" "unprognostic (3.96e-2)" "unprognostic (6.04e-3)" "unprognostic (3.91e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-2)" "unprognostic (7.13e-2)" "unprognostic (3.33e-3)" "unprognostic (2.48e-1)" "unprognostic (2.09e-3)" "unprognostic (2.89e-1)" "unprognostic (4.69e-2)" "unprognostic (3.49e-1)" "unprognostic (1.02e-1)" 0.4 0.4 0.3 3.9 1.2 1.2 0.7 0.3 1.5 1.3 0.3 0.3 0.3 0.3 0.3 0.3 0.7 0.2 0.3 0.3 0.3 0.1 8.4 1.1 1.1 4.0 0.3 0.3 0.8 0.3 12.5 2.2 0.3 0.9 0.7 0.0 0.8 3.0 0.3 0.3 0.3 2.0 0.3 0.3 5.4 0.5 0.3 0.3 6.5 2.9 0.3 1.7 3.0 0.3 3.8 2.0 2.4 4.0 1.4 5.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.1 47.5 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 2.4 2.2 0.2 4.5 4.0 3.3 3.8 4.7 5.7 2.0 3.1 5.2 4.3 0.4 1.4 2.8 0.7 4.1 2.5 0.3 1.2 0.3 1.5 0.3 0.1 0.3 0.3 0.9 0.3 0.0 1.1 3.7 0.0 0.1 0.0 0.5 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 5.7 0.0 1.6 0.0 0.0 0.0 4.7 0.0 0.0 1.7 0.0 30.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 4.4 0.0 0.1 KLRC1 "CD159a, NKG2, NKG2-A, NKG2-B" ENSG00000134545 "Killer cell lectin like receptor C1" P26715 12 10442264-10454685 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 64.3;lymphoid tissue: 22.1" "Cell type enriched" "Detected in some" 22 "T-cells: 112.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "gdT-cell: 45.7;NK-cell: 64.3" "Group enriched" "Detected in many" 42 "NK-cells: 64.3;T-cells: 45.7" "Cell line enhanced" "Detected in some" "HeLa: 9.3;Karpas-707: 3.8;SuSa: 3.7" HPA058052 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA058052: AB_2683589" "unprognostic (8.17e-3)" "unprognostic (2.13e-2)" "unprognostic (1.48e-2)" "unprognostic (4.58e-7)" "unprognostic (3.57e-1)" "unprognostic (1.17e-2)" "unprognostic (1.05e-1)" "unprognostic (3.68e-2)" "unprognostic (3.73e-4)" "unprognostic (4.13e-2)" "unprognostic (6.49e-2)" "unprognostic (2.54e-1)" "unprognostic (1.18e-4)" "unprognostic (1.88e-1)" "unprognostic (3.23e-1)" "unprognostic (2.45e-1)" "unprognostic (1.92e-3)" 2.4 0.5 1.2 5.8 1.4 5.6 2.3 1.0 2.7 1.7 3.3 0.7 1.2 1.5 5.5 3.9 1.7 2.5 2.4 2.6 1.6 1.3 1.9 2.0 5.9 10.3 2.3 0.6 1.2 1.4 0.3 1.3 3.6 1.5 1.9 2.5 2.0 3.1 0.3 0.5 1.0 5.0 2.1 2.6 22.1 5.2 1.4 0.5 3.5 1.9 3.0 2.9 2.9 1.8 0.1 0.0 1.2 0.1 64.3 45.7 5.1 0.4 1.6 0.1 0.1 0.5 0.4 0.8 0.0 0.0 0.8 1.7 0.0 1.3 0.2 0.1 0.4 3.3 0.3 0.6 2.8 1.1 0.9 0.4 2.1 9.3 0.0 0.1 0.6 0.4 1.0 0.0 0.3 0.0 0.0 0.8 0.7 1.3 3.8 0.8 0.0 0.2 2.8 0.0 0.1 0.0 0.9 0.2 0.3 0.2 0.0 0.5 0.1 0.8 0.0 0.3 3.7 0.3 0.0 2.6 0.4 0.0 0.0 0.3 0.0 0.0 0.7 2.1 0.8 0.0 0.2 0.0 0.0 45.7 0.0 5.8 0.1 0.0 7.9 0.0 0.0 0.0 6.9 1.2 64.3 0.1 0.0 0.0 5.1 1.2 1.4 1.0 0.9 1.6 1.3 2.3 0.6 1.5 0.5 0.0 1.1 0.0 0.2 0.1 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.8 0.1 1.6 1.7 1.3 3.2 0.0 0.6 0.0 5.0 0.0 1.9 0.0 0.0 0.3 1.1 0.6 1.5 0.0 0.3 0.5 0.2 0.1 0.1 112.3 0.0 0.4 KLRC2 "CD159c, NKG2-C" ENSG00000205809 "Killer cell lectin like receptor C2" P26717 12 10426854-10442300 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.8;brain: 16.2" "Group enriched" "Detected in some" 20 "Intestinal endocrine cells: 9.2;T-cells: 36.2" "Cancer enriched" "Detected in single" 8 "glioma: 3.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "gdT-cell: 10.7;NK-cell: 32.8" "Group enriched" "Detected in many" 92 "NK-cells: 32.8;T-cells: 10.7" "Cell line enhanced" "Detected in some" "GAMG: 17.9;HEL: 5.3;HeLa: 16.4;HSkMC: 4.0" HPA058052 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA058052: AB_2683589" "unprognostic (9.05e-4)" "unprognostic (2.54e-2)" "unprognostic (3.77e-2)" "unprognostic (2.51e-3)" "unprognostic (2.83e-1)" "unprognostic (9.49e-4)" "unprognostic (1.27e-1)" "unprognostic (8.74e-2)" "unprognostic (2.88e-1)" "unprognostic (4.00e-3)" "unprognostic (2.88e-2)" "unprognostic (9.16e-3)" "unprognostic (1.55e-9)" "unprognostic (8.10e-2)" "unprognostic (2.34e-1)" "unprognostic (8.93e-2)" "unprognostic (5.31e-3)" 0.5 0.2 8.2 0.6 4.6 2.8 1.1 1.2 16.2 0.4 1.9 2.3 0.1 1.0 1.4 1.0 0.8 0.6 1.7 0.2 6.1 5.4 0.1 1.1 1.4 1.5 6.2 2.6 1.5 0.1 0.0 0.1 0.6 3.7 0.3 1.3 0.1 0.5 0.3 0.1 0.2 1.8 0.1 4.1 8.1 3.2 0.5 1.7 2.2 0.2 0.1 2.0 1.2 0.1 0.0 0.0 0.2 0.0 32.8 10.7 1.7 0.0 0.8 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 17.9 0.0 0.0 2.0 0.0 0.0 0.0 5.3 16.4 0.3 0.0 0.5 0.0 4.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.1 1.1 0.1 0.4 0.0 0.0 0.0 0.0 0.5 2.7 0.1 0.1 0.0 0.0 0.0 10.7 0.0 0.2 0.0 0.0 4.7 0.0 0.0 0.0 3.7 0.2 32.8 0.0 0.0 0.0 1.7 8.2 4.6 1.2 3.6 6.1 5.4 6.2 2.6 3.7 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.2 0.0 0.0 KLRF1 "CLEC5C, NKp80" ENSG00000150045 "Killer cell lectin like receptor F1" Q9NZS2 12 9827481-9845007 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 95.2;lymphoid tissue: 24.7" "Cell type enriched" "Detected in many" 10 "T-cells: 119.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 6 "NK-cell: 95.2" "Lineage enriched" "Detected in many" 6 "NK-cells: 95.2" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.3;CAPAN-2: 1.9;HAP1: 3.0;U-937: 9.5" "Low region specificity" "Detected in some" HPA054038 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA054038: " "unprognostic (2.96e-1)" "unprognostic (8.59e-2)" "unprognostic (3.18e-2)" "unprognostic (2.95e-1)" "unprognostic (3.26e-1)" "unprognostic (1.69e-4)" "unprognostic (6.06e-2)" "unprognostic (3.68e-2)" "unprognostic (9.95e-3)" "unprognostic (3.00e-1)" "unprognostic (2.90e-1)" "unprognostic (4.43e-2)" "unprognostic (6.53e-2)" "unprognostic (4.64e-2)" "unprognostic (1.12e-1)" "unprognostic (2.15e-1)" "unprognostic (8.89e-3)" 3.3 0.7 0.9 3.0 1.2 8.8 1.4 0.6 0.8 1.0 0.6 0.3 0.1 0.0 0.7 3.3 0.8 1.1 0.9 1.0 1.0 0.8 0.8 5.8 10.0 4.0 0.9 0.7 0.7 1.1 0.0 0.9 1.7 0.4 1.5 0.5 0.9 1.5 0.8 1.3 0.8 1.0 0.5 1.0 24.7 0.7 1.0 0.4 2.0 0.8 0.5 2.8 1.0 0.7 0.4 0.3 0.9 0.2 95.2 14.9 11.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 3.3 0.0 0.2 0.0 1.9 0.0 0.3 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 1.1 0.1 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 9.5 1.4 0.0 0.1 0.1 11.6 0.2 14.9 0.4 0.6 5.5 0.2 0.1 0.2 5.8 0.9 95.2 0.1 0.3 0.1 11.1 0.9 1.2 0.6 0.8 1.0 0.8 0.9 0.7 0.4 0.4 0.0 2.1 0.0 1.1 1.3 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.8 8.3 0.2 0.4 1.2 0.0 0.0 0.2 0.5 0.7 0.6 1.1 0.9 1.2 0.0 0.0 8.0 10.1 0.9 0.0 1.4 11.8 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.1 0.1 1.5 1.0 0.5 119.3 0.2 2.1 KLRK1 "CD314, D12S2489E, KLR, NKG2-D, NKG2D" ENSG00000213809 "Killer cell lectin like receptor K1" P26718 12 10372353-10391874 "Cancer-related genes, CD markers, Predicted membrane proteins, Transporters" "Adaptive immunity, Differentiation, Immunity, Innate immunity" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 50.8;lymphoid tissue: 30.7" "Cell type enriched" "Detected in some" 9 "T-cells: 20.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 39 "gdT-cell: 49.4;MAIT T-cell: 18.5;memory CD8 T-cell: 44.0;naive CD8 T-cell: 44.3;NK-cell: 50.8" "Group enriched" "Detected in many" 47 "NK-cells: 50.8;T-cells: 49.4" "Cell line enriched" "Detected in some" 8 "U-698: 36.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB021896, HPA068877" Enhanced Supported "Plasma membrane" NA NA 33000 "Plasma membrane" "CAB021896: , HPA068877: AB_2686052" "unprognostic (3.34e-4)" "unprognostic (2.65e-4)" "unprognostic (3.25e-1)" "unprognostic (2.59e-2)" "unprognostic (1.53e-1)" "unprognostic (1.01e-5)" "unprognostic (5.61e-4)" "unprognostic (1.00e-3)" "unprognostic (1.33e-1)" "unprognostic (9.22e-2)" "unprognostic (1.28e-2)" "unprognostic (2.10e-2)" "unprognostic (6.56e-10)" "unprognostic (1.24e-2)" "unprognostic (6.32e-2)" "unprognostic (7.59e-2)" "unprognostic (7.08e-10)" 4.1 0.9 1.3 18.3 1.1 10.6 2.1 0.4 0.8 2.8 4.5 1.2 0.6 2.0 2.4 2.7 3.1 2.0 7.7 1.3 1.3 1.1 2.4 3.6 13.6 22.2 2.1 0.1 1.5 3.3 0.0 1.2 1.6 1.2 2.2 2.1 2.4 7.0 0.6 0.5 1.1 13.1 1.3 2.1 30.7 3.3 1.9 0.6 6.0 2.9 2.8 11.4 11.3 2.5 1.0 0.2 0.8 0.1 50.8 49.4 16.7 0.2 0.0 0.4 1.9 0.1 4.7 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.1 0.1 0.0 0.4 0.7 0.0 0.2 0.0 0.2 0.1 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 1.2 0.1 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 36.9 0.1 0.0 0.2 0.0 0.0 0.0 49.4 0.1 18.5 0.8 0.3 44.0 0.1 1.0 0.4 44.3 0.8 50.8 0.1 0.2 0.1 16.7 1.3 1.1 0.4 0.8 1.3 1.1 2.1 0.1 1.2 0.6 0.0 2.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 20.3 0.0 0.0 LAIR1 CD305 ENSG00000167613 "Leukocyte associated immunoglobulin like receptor 1" Q6GTX8 19 54351384-54370558 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 39.0" "Cell type enhanced" "Detected in many" 12 "granulocytes: 103.2;Hofbauer cells: 178.5;Kupffer cells: 84.4;Macrophages: 142.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HMC-1: 6.6;Karpas-707: 17.1;THP-1: 19.4" HPA011155 Enhanced Supported "Plasma membrane" NA NA 130000 "Plasma membrane" "HPA011155: AB_1852685" "unprognostic (1.91e-1)" "unprognostic (1.12e-2)" "unprognostic (2.81e-2)" "unprognostic (1.25e-2)" "unprognostic (2.03e-2)" "unprognostic (4.38e-2)" "unprognostic (2.16e-2)" "unprognostic (1.74e-1)" "unprognostic (5.00e-2)" "unprognostic (2.24e-1)" "unprognostic (2.21e-1)" "unprognostic (7.11e-2)" "prognostic unfavorable (5.01e-5)" "unprognostic (1.72e-1)" "unprognostic (2.72e-3)" "unprognostic (3.52e-2)" "unprognostic (5.22e-2)" 12.7 7.0 4.5 10.9 9.9 13.5 6.9 0.5 4.5 2.7 5.1 6.7 0.2 2.7 2.2 6.8 2.5 3.6 4.4 3.9 5.2 4.2 3.8 2.9 16.5 33.1 10.2 1.9 2.0 2.4 1.4 2.8 7.0 7.0 3.0 2.0 3.1 3.9 2.2 2.3 2.3 7.6 7.8 11.9 28.6 2.9 3.1 7.4 39.0 2.0 0.5 6.1 3.7 1.7 6.0 10.3 12.4 8.8 5.8 8.0 5.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 2.8 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 17.1 0.0 0.0 2.2 1.5 0.0 0.0 0.0 2.2 0.1 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 19.4 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 2.7 0.2 12.4 4.2 10.0 8.0 8.3 4.6 2.3 2.4 4.3 0.1 6.0 3.8 4.9 0.6 5.8 8.8 10.3 1.6 5.7 4.5 9.9 0.5 4.5 5.2 4.2 10.2 1.9 7.0 7.4 14.9 34.1 29.8 0.5 0.6 5.5 1.3 0.0 20.1 20.5 0.0 35.3 4.4 0.0 0.0 15.9 0.7 0.0 0.0 0.0 4.1 1.9 0.5 103.2 0.8 178.5 1.6 0.0 4.3 84.4 20.4 0.3 142.0 0.0 1.0 0.0 1.1 0.1 0.0 0.0 0.1 14.8 0.0 0.9 1.4 1.0 1.0 8.4 33.0 0.0 0.8 LAT2 "HSPC046, LAB, NTAL, WBSCR15, WBSCR5, WSCR5" ENSG00000086730 "Linker for activation of T cells family member 2" Q9GZY6 7 74199652-74229834 "Disease related genes, Predicted intracellular proteins" "Adaptive immunity, Immunity, Mast cell degranulation" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 98.4;lymphoid tissue: 36.7" "Cell type enhanced" "Detected in many" 12 "B-cells: 89.1;granulocytes: 165.4;Hofbauer cells: 75.1;Kupffer cells: 75.9;Macrophages: 83.0;monocytes: 54.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 98.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "NB-4: 46.6;REH: 53.0;RPMI-8226: 19.0;THP-1: 48.0;U-937: 46.8" "Low region specificity" "Detected in all" HPA003462 Enhanced Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA003462: AB_1079238" "unprognostic (1.24e-2)" "unprognostic (1.14e-2)" "unprognostic (1.32e-2)" "unprognostic (3.55e-3)" "unprognostic (1.09e-1)" "unprognostic (3.30e-3)" "unprognostic (2.79e-2)" "unprognostic (1.33e-1)" "unprognostic (9.27e-2)" "unprognostic (1.19e-1)" "unprognostic (6.34e-3)" "unprognostic (6.91e-2)" "prognostic unfavorable (4.10e-4)" "unprognostic (1.80e-1)" "prognostic unfavorable (6.10e-4)" "unprognostic (7.44e-2)" "unprognostic (2.03e-1)" 4.6 3.7 10.3 21.4 19.3 32.8 2.5 2.7 9.6 2.8 3.9 11.6 0.5 3.3 2.5 2.4 2.5 3.8 5.9 2.4 8.8 6.5 3.0 3.8 11.6 29.3 21.9 2.5 1.4 2.8 1.0 2.8 4.4 15.7 4.5 4.7 2.3 3.6 2.2 2.7 1.8 9.9 5.0 19.3 36.7 3.6 1.6 17.6 3.2 2.4 1.0 32.7 5.8 4.6 26.8 32.5 98.4 39.5 10.0 1.3 24.7 0.4 0.2 0.2 0.8 0.0 0.0 0.3 0.3 0.3 0.2 0.2 0.5 8.1 5.3 0.1 0.1 1.6 0.2 0.0 0.3 0.1 8.5 0.3 2.1 0.3 0.3 0.0 15.5 15.6 0.1 0.2 0.5 0.1 0.3 0.0 0.2 0.3 2.4 0.2 0.3 0.3 46.6 0.2 1.3 0.5 53.0 0.2 19.0 0.0 0.4 0.2 0.2 0.1 0.3 0.2 0.2 0.2 48.0 0.6 0.6 5.6 0.2 0.4 0.2 1.5 8.3 2.7 46.8 0.3 98.4 39.5 5.9 1.3 22.3 0.1 24.4 0.3 0.1 32.5 26.8 0.1 0.4 69.1 10.0 12.4 1.2 0.6 24.7 10.3 19.3 2.7 9.6 8.8 6.5 21.9 2.5 15.7 17.6 3.0 23.9 89.1 0.6 3.1 0.0 0.8 7.6 10.7 5.7 3.5 0.0 0.5 0.0 0.0 2.3 1.0 0.0 0.0 0.2 0.9 1.4 1.0 165.4 3.2 75.1 0.0 7.5 4.9 75.9 1.9 0.0 83.0 1.7 54.1 0.2 0.3 0.6 0.0 0.7 0.0 1.3 0.0 0.7 0.4 1.1 2.3 1.0 51.6 0.4 0.5 LGALS4 GAL4 ENSG00000171747 "Galectin 4" P56470 19 38801671-38813364 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "gallbladder: 157.1;intestine: 326.8;lymphoid tissue: 83.5" "Cell type enhanced" "Detected in many" 14 "Enterocytes: 3138.6;Mucus-secreting cells: 3717.7;Paneth cells: 2896.2;Undifferentiated cells: 2134.6" "Group enriched" "Detected in many" 21 "colorectal cancer: 450.7;liver cancer: 133.6;pancreatic cancer: 213.7;stomach cancer: 190.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 8 "basophil: 1.7" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.7" "Cell line enriched" "Detected in single" 239 "OE19: 123.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB025653, HPA031184, HPA031185, HPA031186" Enhanced Uncertain "Plasma membrane" NA NA 92000 "Plasma membrane" "CAB025653: , HPA031184: AB_2673776, HPA031185: AB_2673777, HPA031186: AB_2673778" "unprognostic (1.11e-1)" "unprognostic (1.12e-1)" "unprognostic (2.57e-3)" "unprognostic (7.88e-2)" "unprognostic (1.12e-1)" "unprognostic (1.61e-2)" "unprognostic (5.01e-2)" "unprognostic (5.34e-2)" "unprognostic (1.54e-1)" "unprognostic (7.58e-2)" "unprognostic (3.80e-2)" "unprognostic (1.48e-2)" "prognostic unfavorable (2.28e-4)" "unprognostic (1.69e-1)" "unprognostic (3.38e-1)" "unprognostic (9.71e-2)" "prognostic favorable (3.21e-4)" 0.3 0.2 0.2 83.5 0.2 0.0 0.3 0.3 0.2 0.3 190.6 0.3 0.3 65.5 0.3 0.5 0.6 0.5 157.1 0.2 0.2 0.2 0.4 20.3 1.5 0.2 0.2 0.2 0.3 8.3 0.0 0.2 0.2 0.2 0.8 75.8 0.3 0.3 0.4 0.3 0.3 326.8 4.9 0.2 0.6 10.5 0.2 0.2 0.3 0.4 0.3 0.2 2.7 0.3 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 123.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 3.0 6.2 9.0 1.9 1.0 0.8 0.8 820.4 0.0 1.2 0.0 0.0 0.6 0.0 145.0 0.1 0.1 3138.6 0.0 92.9 0.6 0.2 1.5 50.5 28.7 0.1 1.6 624.2 2.5 2.1 0.0 0.0 0.0 0.0 4.6 3717.7 0.9 292.6 2896.2 0.4 1.6 1.8 0.0 0.3 0.0 0.2 2.4 0.5 0.7 2134.6 28.2 LGALS8 PCTA-1 ENSG00000116977 "Galectin 8" O00214 1 236518000-236552981 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 244.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 38.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012734, HPA030491" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA012734: AB_2668720, HPA030491: AB_10602345" "unprognostic (2.03e-2)" "unprognostic (1.54e-1)" "unprognostic (2.38e-2)" "unprognostic (3.80e-3)" "unprognostic (2.02e-3)" "unprognostic (4.71e-3)" "unprognostic (3.93e-2)" "prognostic favorable (9.40e-4)" "unprognostic (9.96e-2)" "unprognostic (1.41e-1)" "unprognostic (2.12e-1)" "unprognostic (1.78e-3)" "prognostic unfavorable (4.93e-7)" "unprognostic (1.41e-1)" "unprognostic (1.57e-1)" "unprognostic (3.15e-2)" "unprognostic (8.21e-2)" 27.8 14.0 15.0 17.0 30.5 28.9 18.6 21.7 22.6 14.1 14.8 9.5 10.7 15.5 13.6 19.2 18.5 12.4 17.2 36.0 16.2 14.8 18.5 34.1 21.0 28.2 13.7 17.0 18.3 18.8 22.5 22.7 43.1 25.2 19.8 14.9 10.0 22.4 17.5 7.7 25.3 18.1 15.3 18.1 41.3 13.6 39.9 14.6 19.9 16.8 13.0 16.4 20.7 14.6 4.4 12.7 38.5 14.2 5.3 8.9 9.3 17.7 9.3 1.3 7.0 16.6 14.1 20.6 13.2 15.1 16.5 19.2 12.6 21.7 0.5 12.9 10.9 9.7 19.9 3.7 18.9 15.5 10.3 2.8 12.0 8.1 22.4 20.9 15.9 28.4 13.0 15.1 14.8 5.0 15.9 18.2 9.2 14.2 9.0 11.9 10.9 7.5 3.1 4.8 1.5 7.0 9.1 0.3 1.1 11.7 28.9 4.5 9.3 8.5 28.0 4.7 0.8 20.8 12.6 13.3 0.3 8.2 9.9 16.5 3.4 2.6 0.4 17.1 22.3 10.5 38.5 14.2 7.2 5.4 12.9 7.4 4.4 7.8 5.8 12.7 2.9 5.2 5.4 6.7 5.3 8.7 5.8 8.9 9.3 15.0 30.5 21.7 22.6 16.2 14.8 13.7 17.0 25.2 14.6 71.5 57.4 15.2 26.4 28.8 24.1 47.0 28.1 68.3 67.1 14.0 23.6 53.8 5.0 47.7 244.5 34.9 23.1 0.0 34.4 48.3 22.6 20.5 104.2 22.4 48.8 36.5 17.4 38.6 85.5 157.7 21.9 34.0 6.8 4.6 17.8 6.5 38.3 26.2 13.1 10.3 18.2 25.8 20.0 24.6 8.7 32.4 147.4 34.6 14.5 18.7 LINGO1 "FLJ14594, LERN1, LRRN6A" ENSG00000169783 "Leucine rich repeat and Ig domain containing 1" Q96FE5 15 77613027-77820900 "Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 67.2" "Cell type enhanced" "Detected in some" 22 "Horizontal cells: 125.5;Muller glia cells: 49.3;Sertoli cells: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 13.2;AN3-CA: 11.0;HAP1: 16.7;HEK 293: 11.7;NTERA-2: 31.4;SuSa: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074653 Enhanced Supported "Plasma membrane" NA NA 8400 "Plasma membrane" "HPA074653: AB_2686706" "unprognostic (1.06e-1)" "unprognostic (7.07e-2)" "unprognostic (2.16e-2)" "unprognostic (1.48e-2)" "unprognostic (3.09e-1)" "unprognostic (2.20e-1)" "unprognostic (2.84e-2)" "unprognostic (3.77e-2)" "unprognostic (3.40e-1)" "unprognostic (1.10e-1)" "unprognostic (7.36e-2)" "unprognostic (2.74e-2)" "prognostic unfavorable (3.23e-7)" "unprognostic (2.07e-1)" "unprognostic (7.06e-2)" "unprognostic (2.85e-1)" "unprognostic (2.59e-2)" 3.0 1.6 27.4 1.7 21.8 0.8 1.3 9.1 67.2 3.8 2.0 5.9 0.0 2.0 3.3 2.7 1.4 3.1 2.5 9.7 29.8 12.2 2.2 1.1 1.1 1.3 10.3 21.8 1.7 2.7 1.1 0.5 6.1 6.8 1.7 1.5 1.8 3.4 2.5 1.0 3.0 1.5 4.5 6.8 3.3 2.0 3.7 3.9 0.0 1.7 0.0 1.1 3.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 13.2 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.2 0.0 16.7 0.0 0.0 0.0 11.7 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 7.2 0.0 0.0 31.4 0.7 0.0 0.0 0.0 0.2 0.0 0.0 2.4 0.7 0.0 1.3 2.8 13.1 0.2 0.2 1.1 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.4 21.8 9.1 47.5 29.8 12.2 10.3 21.8 6.8 3.9 0.0 0.0 0.0 0.1 0.2 14.5 6.1 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.5 8.3 0.9 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.2 125.5 0.0 3.7 0.0 13.7 0.3 0.0 3.3 0.0 0.0 49.3 0.3 8.6 0.4 0.0 15.9 25.8 5.7 0.1 2.5 0.1 0.2 0.0 0.0 0.0 LIPJ "bA425M17.2, LIPL1" ENSG00000204022 "Lipase family member J" Q5W064 10 88586753-88606976 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 11.5" "Cell type enriched" "Detected in some" 6 "Early spermatids: 32.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 2.7;NB-4: 1.0;SK-MEL-30: 2.4;U-2197: 1.0" HPA048594 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA048594: AB_2680456" "unprognostic (4.79e-3)" "unprognostic (6.77e-2)" "unprognostic (4.80e-2)" "unprognostic (2.36e-1)" "unprognostic (2.70e-2)" "unprognostic (9.33e-2)" "unprognostic (2.90e-3)" "unprognostic (7.50e-2)" "unprognostic (1.65e-1)" "unprognostic (1.09e-1)" "unprognostic (4.73e-2)" "unprognostic (1.73e-2)" "unprognostic (6.21e-4)" "unprognostic (9.87e-2)" "unprognostic (9.57e-2)" "unprognostic (1.85e-1)" "unprognostic (1.88e-1)" 0.2 0.0 0.3 0.0 0.3 0.0 0.2 1.0 0.3 0.1 0.0 0.4 0.2 1.6 0.0 1.1 0.1 0.1 0.4 0.5 0.2 0.7 0.0 0.3 0.0 0.1 0.6 0.0 0.1 0.0 0.3 0.2 0.6 0.0 0.4 0.1 0.1 0.3 0.1 0.1 0.3 11.5 0.9 0.4 0.5 0.1 0.7 0.0 1.0 0.1 0.5 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.4 0.0 0.0 0.8 0.0 0.1 0.7 1.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 LOXHD1 "DFNB77, FLJ32670, LH2D1" ENSG00000167210 "Lipoxygenase homology domains 1" Q8IVV2 18 46476972-46657220 "Disease related genes, Predicted intracellular proteins" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 15.5;epididymis: 9.7;testis: 22.0" "Group enriched" "Detected in some" 84 "Early spermatids: 168.6;Late spermatids: 330.2" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Group enriched" "Detected in some" 5 "basal ganglia: 2.4;cerebral cortex: 1.9;thalamus: 1.1" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "THP-1: 3.5;WM-115: 1.4" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 5 "olfactory region: 1.0" HPA077128 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA077128: " "unprognostic (6.95e-2)" "unprognostic (1.88e-2)" "unprognostic (4.81e-3)" "unprognostic (2.65e-1)" "unprognostic (1.30e-2)" "unprognostic (7.75e-4)" "unprognostic (9.53e-2)" "unprognostic (7.91e-2)" "unprognostic (7.61e-2)" "unprognostic (9.44e-2)" "unprognostic (1.26e-2)" "unprognostic (1.93e-2)" "unprognostic (7.43e-3)" "unprognostic (6.48e-5)" "unprognostic (2.30e-1)" "unprognostic (8.10e-3)" "unprognostic (1.66e-3)" 1.7 0.0 0.4 0.0 2.4 2.7 0.4 0.1 1.9 0.0 0.1 0.2 15.5 0.0 0.0 9.7 0.1 1.7 0.1 0.5 0.2 0.1 0.5 0.0 0.8 0.0 0.0 0.0 0.1 0.1 0.4 4.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.2 0.1 0.0 0.0 0.7 0.1 22.0 1.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.9 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.4 2.4 0.1 1.9 0.2 0.1 0.0 0.0 0.0 1.1 3.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 2.7 0.0 0.0 0.0 0.0 1.7 0.0 168.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 330.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.8 1.5 0.0 0.0 0.0 0.0 0.0 LPAR3 "Edg-7, EDG7, HOFNH30, LP-A3, LPA3, RP4-678I3" ENSG00000171517 "Lysophosphatidic acid receptor 3" Q9UBY5 1 84811602-84893213 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 32.0" "Cell type enhanced" "Detected in some" 10 "Basal glandular cells: 13.1;Cardiomyocytes: 24.9;Ciliated cells: 25.4;Glandular cells: 15.0;Urothelial cells: 10.8" "Cancer enhanced" "Detected in many" "ovarian cancer: 24.7" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 13.3;HBEC3-KT: 16.3;hTCEpi: 17.6;NTERA-2: 14.8;PC-3: 16.6;SK-MEL-30: 15.6" "Region enhanced" "Detected in some" "olfactory region: 3.5" "Low region specificity" "Detected in some" HPA013421 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA013421: AB_1847990" "unprognostic (2.85e-2)" "unprognostic (1.67e-1)" "unprognostic (2.66e-1)" "unprognostic (4.42e-1)" "unprognostic (2.72e-2)" "unprognostic (6.46e-3)" "unprognostic (1.15e-1)" "unprognostic (1.29e-2)" "unprognostic (1.20e-1)" "prognostic favorable (4.31e-5)" "unprognostic (1.11e-2)" "unprognostic (7.52e-2)" "unprognostic (1.13e-4)" "unprognostic (4.11e-2)" "unprognostic (1.19e-1)" "unprognostic (4.27e-2)" "unprognostic (5.43e-2)" 0.0 1.2 2.4 0.5 1.9 0.3 0.7 0.2 3.5 8.8 0.4 2.2 2.9 0.1 2.4 11.8 7.2 32.0 0.5 12.4 3.7 0.9 0.0 0.1 4.2 0.1 0.1 2.6 5.1 8.6 0.3 0.4 1.1 6.8 11.5 0.5 0.7 5.0 4.7 0.3 4.0 0.5 0.5 0.3 0.1 0.2 14.7 0.2 0.7 0.2 3.3 4.3 4.8 6.9 0.6 0.4 1.1 0.1 1.8 0.5 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.5 0.2 1.2 1.1 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.2 13.3 16.3 1.0 0.1 2.7 0.0 0.0 0.0 0.4 0.0 0.0 0.1 17.6 4.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 16.6 0.0 0.0 0.0 0.0 3.8 0.9 0.7 0.0 0.3 15.6 1.0 0.0 1.3 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.1 0.2 0.3 0.0 0.2 0.4 0.5 0.5 0.3 0.6 0.4 0.3 1.1 1.8 0.1 0.4 0.1 0.1 2.4 1.9 0.2 3.5 3.7 0.9 0.1 2.6 6.8 0.2 0.0 0.3 0.0 13.1 3.1 0.0 24.9 0.0 25.4 7.9 0.0 0.0 0.4 0.0 0.0 2.4 0.0 0.0 0.0 1.1 0.0 0.2 15.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.1 0.6 0.6 1.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.4 0.2 4.4 8.0 0.1 0.0 0.0 10.8 LRRC69 ENSG00000214954 "Leucine rich repeat containing 69" Q6ZNQ3 8 91101832-91219236 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 6.6" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 38.9;Late spermatids: 11.9" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEK 293: 6.8;SuSa: 6.1;U-266/70: 17.7;U-266/84: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046337 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA046337: AB_2679626" "unprognostic (1.63e-2)" "unprognostic (1.02e-1)" "unprognostic (4.69e-1)" "unprognostic (3.28e-1)" "unprognostic (2.78e-1)" "unprognostic (3.17e-1)" "unprognostic (3.51e-2)" "unprognostic (3.50e-2)" "unprognostic (2.49e-2)" "unprognostic (1.47e-1)" "unprognostic (9.18e-2)" "unprognostic (1.88e-1)" "unprognostic (3.09e-6)" "unprognostic (6.91e-2)" "unprognostic (1.60e-1)" "unprognostic (1.43e-1)" "unprognostic (8.68e-5)" 0.8 0.9 0.2 1.5 0.2 0.0 1.0 0.0 0.1 0.7 0.5 0.1 0.5 1.9 0.7 0.4 0.5 1.1 0.1 0.1 0.9 0.7 0.7 1.9 0.3 0.4 0.7 0.3 0.6 0.5 1.0 1.5 1.1 0.3 0.6 3.5 0.6 1.4 0.3 1.2 0.6 6.6 1.3 1.1 1.0 0.8 1.9 2.0 1.5 1.1 0.4 2.3 0.1 0.6 0.7 0.2 0.5 0.7 1.5 1.2 0.4 0.1 0.3 0.3 1.1 0.9 1.0 0.5 0.2 0.1 0.6 0.7 1.2 0.3 0.3 6.8 1.5 1.8 0.5 0.2 0.5 1.1 0.4 1.1 0.4 0.8 0.4 0.1 1.2 1.1 0.6 0.4 0.2 0.3 0.5 0.7 1.1 0.4 0.8 0.0 0.7 0.2 0.7 0.0 0.2 0.0 0.4 1.0 6.1 1.6 1.2 0.2 0.3 0.7 0.2 0.9 17.7 9.8 4.0 0.1 2.2 0.9 1.3 0.6 1.5 1.5 1.1 1.5 1.2 1.6 0.6 0.1 1.9 2.3 1.2 0.1 0.4 0.6 2.0 2.1 0.1 0.0 0.6 0.8 2.4 4.1 1.8 2.4 0.0 6.7 1.2 3.5 3.9 1.9 3.3 1.3 38.9 2.1 0.5 0.0 1.0 1.5 2.2 3.1 0.0 0.8 0.8 0.0 2.4 3.7 2.1 11.9 2.6 1.7 6.8 4.6 1.4 1.1 1.5 0.9 1.1 0.2 3.2 0.0 2.1 2.3 2.5 4.5 0.8 0.0 1.4 2.0 LSR "ILDR3, LISCH7" ENSG00000105699 "Lipolysis stimulated lipoprotein receptor" Q86X29 19 35248330-35267964 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 106.3;pancreas: 98.6" "Cell type enhanced" "Detected in many" 5 "Ductal cells: 229.3;Exocrine glandular cells: 243.9;Pancreatic endocrine cells: 273.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 88.1;CACO-2: 38.6;CAPAN-2: 41.0;HaCaT: 37.0;OE19: 53.1;RT4: 35.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007270, HPA075309" Approved Supported "Plasma membrane" NA NA 2100000 "Plasma membrane" "HPA007270: AB_1079253, HPA075309: " "unprognostic (3.90e-1)" "unprognostic (1.12e-1)" "unprognostic (2.34e-2)" "unprognostic (2.67e-3)" "unprognostic (2.28e-2)" "unprognostic (6.07e-3)" "unprognostic (1.55e-1)" "unprognostic (9.84e-2)" "unprognostic (2.17e-1)" "unprognostic (2.70e-2)" "unprognostic (2.23e-2)" "unprognostic (3.42e-2)" "prognostic favorable (8.09e-4)" "unprognostic (1.64e-1)" "unprognostic (1.84e-1)" "unprognostic (2.99e-2)" "unprognostic (1.54e-2)" 5.0 11.2 2.9 20.9 4.0 0.9 12.4 2.0 4.5 8.7 32.8 4.0 24.4 29.5 6.5 21.4 20.3 10.6 58.2 2.6 3.4 3.1 15.7 106.3 21.1 17.0 4.1 2.6 4.8 98.6 6.2 13.4 36.6 7.1 11.2 15.4 40.9 26.2 33.8 1.9 16.8 39.5 1.8 3.8 9.1 46.7 21.0 1.9 3.4 24.0 20.1 20.9 9.9 9.5 5.3 0.3 5.9 0.2 6.1 7.1 3.2 88.1 1.4 0.1 0.1 0.2 0.1 16.0 0.2 0.3 0.4 0.3 38.6 41.0 3.5 13.6 0.2 1.3 37.0 8.2 13.5 0.0 5.3 14.9 0.0 1.2 17.0 0.3 0.0 0.1 0.2 15.1 0.3 4.5 0.1 0.1 0.1 13.9 3.1 0.2 31.3 0.1 0.1 12.7 53.1 0.5 0.7 0.1 9.5 8.5 35.7 7.0 0.2 7.4 24.1 6.6 4.2 20.6 0.4 0.0 0.7 8.4 0.5 0.4 5.0 8.9 8.0 0.6 0.1 2.2 5.9 0.2 0.2 3.3 0.0 3.3 5.3 7.1 6.7 0.1 4.1 5.5 6.0 0.1 6.1 0.0 0.3 4.8 3.2 2.9 4.0 2.0 4.5 3.4 3.1 4.1 2.6 7.1 1.9 14.9 17.1 13.9 106.8 45.9 1.4 3.2 79.0 12.0 27.3 34.9 15.7 183.2 10.0 229.3 8.5 29.2 159.2 0.0 243.9 80.3 15.6 94.1 31.1 77.6 19.8 0.0 54.2 17.2 1.5 2.1 6.1 3.7 13.5 11.8 103.4 9.1 273.3 171.7 3.2 20.3 11.0 0.0 24.6 5.4 13.4 45.2 207.4 8.6 101.9 201.4 MAP4K1 HPK1 ENSG00000104814 "Mitogen-activated protein kinase kinase kinase kinase 1" Q92918 19 38587641-38618882 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 16.2;intestine: 16.9;lymphoid tissue: 39.2" "Cell type enhanced" "Detected in many" 14 "B-cells: 29.0;Rod photoreceptor cells: 58.2;T-cells: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 20.8;HDLM-2: 20.6;Karpas-707: 21.4;REH: 11.4;RPMI-8226: 12.9;U-266/70: 16.9;U-266/84: 16.6;U-698: 26.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA007419, CAB007754" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "CAB007754: AB_562299, HPA007419: AB_1853778" "unprognostic (1.99e-3)" "prognostic favorable (6.17e-5)" "unprognostic (9.50e-3)" "unprognostic (3.27e-1)" "unprognostic (6.03e-2)" "prognostic favorable (3.26e-4)" "unprognostic (4.88e-3)" "unprognostic (5.32e-3)" "unprognostic (2.79e-1)" "unprognostic (2.51e-1)" "unprognostic (3.92e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (7.99e-10)" "unprognostic (1.72e-1)" "unprognostic (1.83e-1)" "unprognostic (3.18e-2)" "unprognostic (1.50e-2)" 1.6 0.9 1.2 31.4 2.3 6.3 1.1 1.0 1.2 1.0 3.1 1.7 0.1 2.1 0.9 1.4 2.6 1.2 2.9 0.9 1.1 1.4 2.2 1.6 3.9 23.0 2.3 0.7 0.8 1.2 0.2 1.2 1.4 2.1 1.6 1.9 2.0 4.4 0.8 0.5 1.2 16.9 0.7 3.4 34.4 2.3 0.9 1.3 19.1 1.9 1.4 39.2 3.1 1.3 16.2 15.9 1.3 6.2 3.7 14.6 7.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 20.6 0.1 4.4 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.1 21.4 0.0 0.1 4.9 5.2 0.6 0.1 0.0 11.4 0.0 12.9 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 4.7 0.0 0.0 0.1 0.0 0.0 16.9 16.6 26.2 0.0 5.9 0.0 1.3 3.2 1.2 13.4 6.2 12.4 16.2 11.2 14.0 15.9 10.7 6.2 8.7 0.3 3.7 3.4 14.0 14.6 7.3 1.2 2.3 1.0 1.2 1.1 1.4 2.3 0.7 2.1 1.3 3.0 8.2 29.0 0.1 2.1 6.1 0.6 0.0 0.0 1.2 0.0 11.8 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.2 1.0 0.3 15.1 0.0 2.5 1.6 0.0 1.3 7.1 0.0 0.0 11.7 3.3 2.8 0.0 6.7 0.0 0.0 0.0 0.2 58.2 0.0 0.4 0.6 4.3 0.9 0.1 33.2 0.2 0.1 MAP6 "FLJ41346, KIAA1878, MAP6-N, STOP" ENSG00000171533 "Microtubule associated protein 6" Q96JE9 11 75586918-75669120 "Predicted intracellular proteins" Transport Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.9" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 77.0;Cone photoreceptor cells: 149.2;Horizontal cells: 47.7" "Cancer enhanced" "Detected in many" "glioma: 9.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 2.4" "Lineage enriched" "Detected in single" 24 "B-cells: 2.4" "Group enriched" "Detected in some" 6 "AF22: 19.5;CACO-2: 19.0;HDLM-2: 10.6;SCLC-21H: 32.4;SH-SY5Y: 16.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015442, CAB022600, HPA039061, HPA039062" Enhanced Uncertain "Plasma membrane" NA NA "Plasma membrane" "CAB015442: AB_2140997, CAB022600: , HPA039061: AB_2676325, HPA039062: AB_2676326" "unprognostic (3.04e-2)" "unprognostic (6.18e-2)" "unprognostic (3.15e-2)" "unprognostic (9.07e-2)" "unprognostic (7.54e-2)" "unprognostic (4.49e-2)" "unprognostic (8.29e-2)" "unprognostic (2.51e-2)" "unprognostic (5.99e-2)" "unprognostic (7.99e-2)" "prognostic favorable (3.41e-4)" "prognostic favorable (9.15e-4)" "unprognostic (2.43e-2)" "unprognostic (3.96e-3)" "unprognostic (8.09e-3)" "unprognostic (1.77e-1)" "unprognostic (2.03e-1)" 3.0 16.6 23.7 2.1 26.4 0.6 2.6 14.9 35.9 6.9 6.4 10.0 6.1 1.9 10.0 18.6 4.2 34.6 5.8 5.4 21.3 26.6 7.3 1.3 6.5 1.1 17.0 19.9 7.1 3.4 28.7 24.9 1.8 33.2 12.9 3.6 7.5 2.9 18.7 1.1 2.4 2.0 11.5 13.7 1.7 3.6 12.4 9.9 0.0 6.2 0.0 1.0 2.6 3.1 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 19.5 0.0 0.0 0.0 0.0 1.9 0.1 0.1 0.0 19.0 0.0 0.3 0.7 3.1 0.6 0.0 1.7 0.2 0.0 10.6 0.2 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.2 0.0 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 32.4 16.4 2.3 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.7 26.4 14.9 29.1 21.3 26.6 17.0 19.9 33.2 9.9 3.0 3.0 0.0 1.3 0.7 77.0 7.6 2.5 28.1 4.5 10.4 149.2 0.1 1.7 0.1 21.3 0.7 0.0 0.0 0.2 0.0 0.8 1.6 0.0 0.4 0.1 47.7 12.6 0.6 0.0 31.1 6.9 0.0 5.0 0.0 0.0 16.8 0.3 0.0 17.3 0.8 8.8 0.0 2.3 20.6 1.9 0.4 0.0 0.0 0.0 0.5 MAPK8IP1 "IB1, JIP-1, JIP1, PRKM8IP" ENSG00000121653 "Mitogen-activated protein kinase 8 interacting protein 1" Q9UQF2 11 45885651-45906465 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 73.5" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 38.7;Horizontal cells: 63.5;Intestinal endocrine cells: 38.7" "Cancer enhanced" "Detected in all" "glioma: 51.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 39.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058921, HPA070332, HPA079657" Approved Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA058921: AB_2683854, HPA070332: AB_2686254, HPA079657: " "unprognostic (3.96e-2)" "unprognostic (8.73e-2)" "unprognostic (1.08e-1)" "unprognostic (6.88e-2)" "unprognostic (5.59e-2)" "unprognostic (2.82e-1)" "unprognostic (8.25e-3)" "unprognostic (3.42e-3)" "unprognostic (1.27e-2)" "unprognostic (9.54e-2)" "unprognostic (3.22e-3)" "unprognostic (2.20e-2)" "prognostic favorable (1.23e-11)" "unprognostic (7.19e-2)" "unprognostic (4.01e-2)" "unprognostic (4.46e-2)" "unprognostic (1.80e-3)" 3.0 12.8 33.3 2.1 29.6 1.4 2.7 24.9 73.5 3.1 1.9 4.6 0.1 1.6 4.9 3.1 2.1 6.6 3.0 2.9 38.1 22.3 5.1 2.7 2.6 1.0 28.0 18.9 4.4 26.4 14.7 24.8 1.6 23.5 4.9 1.5 4.5 4.8 5.0 1.7 1.7 2.0 4.4 44.4 1.7 3.8 10.8 4.8 0.0 3.9 0.5 0.9 2.0 0.4 0.4 0.4 2.1 0.9 2.6 0.2 0.0 0.0 3.6 4.8 13.3 1.8 0.9 0.1 2.6 2.3 5.1 3.7 3.1 0.5 0.2 1.3 2.9 8.7 2.9 5.1 2.4 2.3 1.9 6.6 0.0 4.5 2.0 1.6 0.3 2.3 1.3 0.5 3.3 0.7 3.4 1.1 0.5 5.5 0.8 1.4 1.9 0.2 0.3 12.7 1.6 5.3 0.3 7.9 0.1 2.3 0.1 39.4 14.7 4.2 3.5 4.8 1.9 5.6 0.2 1.0 6.5 10.0 9.7 4.6 0.5 0.6 0.2 4.1 0.1 1.9 2.1 0.9 0.0 0.2 0.2 0.1 0.2 0.0 0.1 0.0 0.4 0.1 0.2 1.8 2.6 0.0 0.4 0.1 0.0 33.3 29.6 24.9 41.7 38.1 22.3 28.0 18.9 23.5 4.8 6.0 2.6 0.0 5.9 2.2 33.1 1.1 5.1 2.7 3.4 10.4 21.6 1.2 11.6 5.6 38.7 2.2 1.3 0.0 24.7 0.4 3.9 7.7 0.0 4.0 0.4 63.5 38.7 0.0 0.6 29.6 5.8 1.7 3.3 2.8 1.1 30.4 17.1 0.0 6.0 7.0 15.7 0.0 5.8 12.5 5.5 0.9 4.8 1.0 0.9 5.4 MAT2B "MATIIbeta, SDR23E1" ENSG00000038274 "Methionine adenosyltransferase 2B" Q9NZL9 5 163503114-163519336 "Predicted intracellular proteins" "One-carbon metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037721, HPA037722" Uncertain Approved "Plasma membrane" NA NA 1000000 "Plasma membrane" "HPA037721: AB_10672389, HPA037722: AB_10671718" "unprognostic (1.22e-2)" "unprognostic (2.80e-2)" "unprognostic (1.80e-3)" "unprognostic (1.64e-1)" "unprognostic (5.06e-1)" "unprognostic (2.12e-1)" "unprognostic (1.20e-1)" "unprognostic (1.77e-1)" "unprognostic (9.72e-2)" "unprognostic (1.68e-1)" "unprognostic (5.19e-3)" "unprognostic (3.57e-2)" "prognostic favorable (4.51e-7)" "unprognostic (1.06e-1)" "unprognostic (1.09e-2)" "unprognostic (2.16e-2)" "unprognostic (1.37e-3)" 25.1 32.5 25.2 29.1 28.6 12.1 23.9 37.1 39.6 25.3 41.6 20.1 25.1 38.9 28.0 29.0 27.9 31.9 20.4 41.8 24.2 28.6 48.4 37.2 26.6 41.7 24.7 24.9 35.9 16.4 25.7 17.1 23.9 27.6 30.7 31.4 24.3 28.6 26.8 28.7 20.9 57.2 21.3 21.4 45.5 24.9 18.1 17.7 50.8 53.3 20.1 41.0 32.5 32.9 60.4 34.5 82.4 46.0 62.4 86.8 98.8 19.5 17.0 29.9 16.2 22.2 22.1 17.9 17.5 19.9 20.1 29.5 11.9 37.2 20.9 36.8 19.0 29.5 16.1 24.8 36.3 26.7 68.8 20.5 19.0 19.9 17.7 29.2 19.9 12.9 18.3 30.0 25.6 19.9 24.4 43.5 22.2 15.1 26.4 24.6 11.5 27.4 24.0 11.3 12.4 11.6 31.6 14.5 34.4 32.9 21.3 11.8 17.2 23.3 15.7 25.3 13.7 21.9 26.9 35.0 22.0 14.3 14.6 30.2 22.5 21.7 19.1 16.0 36.5 14.8 82.4 38.3 75.6 58.7 44.6 64.3 60.4 64.8 63.2 34.5 56.6 66.2 63.6 58.8 62.4 46.0 27.8 86.8 98.8 25.2 28.6 37.1 39.6 24.2 28.6 24.7 24.9 27.6 17.7 44.7 37.1 50.2 31.8 37.9 20.3 51.5 35.7 54.9 26.1 41.8 7.9 48.4 53.0 29.8 30.6 40.9 34.6 93.5 23.0 24.4 26.9 37.0 26.7 47.9 41.2 17.5 14.5 33.7 74.1 10.9 31.9 43.7 40.5 50.5 44.3 33.3 25.6 24.6 29.4 77.8 15.0 45.3 29.9 21.6 29.8 31.7 31.5 64.2 48.1 35.5 MBP ENSG00000197971 "Myelin basic protein" P02686 18 76978827-77133683 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Autoimmune encephalomyelitis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 43 "brain: 1297.7" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 9 "glioma: 47.5;melanoma: 20.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 29.0;SK-MEL-30: 60.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002300, HPA049222, HPA064368" Enhanced Supported Approved "Plasma membrane" NA NA "Plasma membrane" "CAB002300: AB_563893, HPA049222: AB_2680679, HPA064368: AB_2685247" "unprognostic (9.36e-2)" "unprognostic (7.60e-2)" "unprognostic (1.28e-2)" "unprognostic (1.22e-1)" "unprognostic (6.93e-2)" "unprognostic (2.81e-1)" "unprognostic (1.14e-1)" "unprognostic (3.31e-1)" "unprognostic (9.87e-2)" "unprognostic (2.90e-2)" "unprognostic (5.25e-2)" "unprognostic (1.95e-1)" "prognostic favorable (4.48e-12)" "unprognostic (2.90e-1)" "unprognostic (5.99e-2)" "unprognostic (1.33e-1)" "unprognostic (6.03e-2)" 4.0 3.4 271.6 6.1 244.9 10.1 4.5 28.7 418.9 5.6 5.5 487.7 0.0 5.9 4.4 3.6 6.4 9.0 5.7 6.8 355.0 247.6 6.2 5.9 6.2 7.1 645.5 43.4 3.7 6.8 16.4 0.7 2.7 242.9 4.5 5.6 0.4 5.0 4.9 29.9 7.9 6.2 3.8 1297.7 7.6 5.1 2.9 224.3 0.0 6.8 0.0 7.7 6.0 0.6 3.4 6.8 23.7 4.7 15.4 17.1 5.6 7.5 6.6 0.0 0.2 11.2 16.7 2.6 0.2 0.2 0.2 0.1 0.9 11.8 4.7 1.3 0.5 0.0 15.0 1.1 6.6 0.2 18.2 1.6 3.0 1.1 1.5 7.0 29.0 20.2 2.4 5.6 6.0 9.3 5.0 1.9 11.4 0.0 1.0 0.0 0.9 1.1 14.9 0.6 4.5 5.3 0.4 0.1 10.5 10.6 10.3 0.5 0.1 0.9 0.0 60.4 1.9 0.2 17.8 0.0 0.0 0.1 0.0 0.8 0.0 0.1 5.0 1.8 18.3 0.7 11.0 4.7 17.8 13.2 4.6 8.0 3.4 9.4 17.1 5.3 3.3 5.7 10.5 23.7 15.4 4.4 6.8 7.9 5.6 271.6 244.9 28.7 127.7 355.0 247.6 645.5 43.4 242.9 224.3 44.7 33.2 33.8 46.5 105.6 50.2 38.2 38.2 56.2 44.3 97.7 2.0 0.6 34.9 38.1 4.8 9.9 40.8 46.7 31.6 0.6 21.8 82.0 69.4 25.5 41.0 1.6 47.8 11.1 60.5 4.5 26.2 83.3 87.7 24.4 45.4 26.0 43.3 23.0 13.4 28.1 6.2 0.0 6.6 4.8 0.7 135.3 0.6 123.7 33.3 87.7 MC5R ENSG00000176136 "Melanocortin 5 receptor" P33032 18 13824149-13827323 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 7.9;esophagus: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HDLM-2: 2.1;OE19: 1.6;SiHa: 1.7;U-138 MG: 6.2;U-2 OS: 1.4;U-2197: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA042365, HPA058088" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA042365: AB_2677961, HPA058088: " "unprognostic (1.57e-2)" "unprognostic (1.37e-1)" "unprognostic (8.77e-2)" "unprognostic (7.10e-2)" "unprognostic (2.64e-2)" "unprognostic (1.30e-2)" "unprognostic (9.04e-3)" "unprognostic (1.54e-1)" 0.3 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.5 0.0 0.0 0.0 0.0 7.9 2.7 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.1 1.6 0.0 0.2 0.0 0.4 0.1 1.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.5 0.0 0.0 6.2 1.4 1.2 0.4 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MCAM "CD146, MUC18" ENSG00000076706 "Melanoma cell adhesion molecule" P43121 11 119308529-119321521 "CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 16 "Endothelial cells: 83.4;Muller glia cells: 87.4;Sertoli cells: 316.9;Smooth muscle cells: 214.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 4 "HUVEC TERT2: 128.2;TIME: 125.2;WM-115: 99.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002147, HPA008848" Enhanced Approved "Plasma membrane" NA NA 2600000000 "Plasma membrane" "CAB002147: AB_563499, HPA008848: AB_1078445" "unprognostic (6.45e-2)" "prognostic unfavorable (7.61e-4)" "unprognostic (7.03e-2)" "unprognostic (1.22e-2)" "unprognostic (6.67e-2)" "unprognostic (2.34e-1)" "unprognostic (2.23e-2)" "unprognostic (8.42e-2)" "unprognostic (2.09e-2)" "unprognostic (1.45e-1)" "unprognostic (1.58e-1)" "unprognostic (9.39e-2)" "prognostic unfavorable (5.14e-4)" "unprognostic (8.75e-3)" "unprognostic (7.84e-2)" "unprognostic (2.31e-1)" "unprognostic (2.79e-3)" 88.2 8.9 6.4 18.5 10.3 0.4 86.1 17.7 13.4 22.3 33.2 13.3 11.7 8.3 40.1 32.5 27.6 29.3 50.9 32.0 7.1 8.2 7.5 3.8 23.8 13.0 7.4 8.1 23.6 6.2 54.5 3.9 47.4 11.1 22.9 9.7 25.0 9.4 44.9 21.1 10.5 15.6 67.1 6.5 9.6 25.0 18.4 5.4 2.2 13.1 15.7 4.8 55.0 24.3 0.8 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.5 0.5 0.0 2.5 0.0 2.6 0.3 0.0 3.4 1.5 1.9 0.1 0.1 10.9 1.2 5.2 0.3 4.4 0.9 1.7 6.2 1.5 0.1 12.3 2.2 6.0 0.0 0.0 1.8 0.0 4.7 2.2 0.1 128.2 0.8 4.1 0.1 0.7 0.0 0.1 1.0 2.2 0.0 0.5 0.1 17.1 3.6 3.1 0.0 1.4 0.4 9.8 0.2 28.2 5.6 0.5 0.1 125.2 0.3 18.4 0.0 9.9 0.2 0.2 0.0 5.0 0.0 99.5 0.0 0.0 0.0 0.0 0.0 2.2 0.8 0.6 1.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 6.4 10.3 17.7 13.4 7.1 8.2 7.4 8.1 11.1 5.4 0.0 2.9 0.8 0.5 4.1 1.3 57.3 12.7 1.4 1.2 0.0 21.6 0.3 0.0 14.3 1.6 83.4 0.0 0.0 0.3 34.2 4.4 1.1 0.0 0.0 0.7 0.0 0.0 74.9 1.6 0.6 0.9 2.7 20.3 1.0 0.0 87.4 2.5 0.0 23.7 0.0 2.1 316.9 214.2 2.2 1.2 2.9 0.3 0.7 0.0 0.7 MCEMP1 "C19orf59, MGC132456" ENSG00000183019 "Mast cell expressed membrane protein 1" Q8IX19 19 7676628-7679826 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 36.5;bone marrow: 30.9;lung: 66.4;lymphoid tissue: 24.2" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 34.6;Club cells: 20.5;Hofbauer cells: 30.0;Kupffer cells: 41.3;Macrophages: 51.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "midbrain: 2.9" "Group enriched" "Detected in some" 5 "classical monocyte: 36.5;neutrophil: 16.6" "Group enriched" "Detected in many" 5 "granulocytes: 16.6;monocytes: 36.5" "Group enriched" "Detected in some" 6 "THP-1: 19.2;U-937: 59.8" HPA014731 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA014731: AB_1845619" "unprognostic (4.84e-2)" "unprognostic (9.81e-4)" "unprognostic (2.41e-1)" "unprognostic (4.36e-2)" "unprognostic (8.85e-3)" "unprognostic (2.62e-3)" "unprognostic (5.57e-3)" "unprognostic (1.42e-1)" "unprognostic (2.19e-1)" "unprognostic (4.36e-2)" "unprognostic (1.77e-2)" "unprognostic (3.50e-1)" "unprognostic (2.69e-5)" "unprognostic (1.15e-2)" "unprognostic (7.37e-2)" "unprognostic (1.93e-2)" "unprognostic (7.95e-2)" 2.2 0.3 0.3 10.0 0.5 30.9 0.5 0.4 0.9 0.1 0.3 0.0 0.0 0.1 0.1 0.2 0.3 1.2 0.2 4.8 0.2 0.2 0.6 1.3 66.4 11.8 2.9 0.0 0.4 0.4 0.0 0.1 0.8 0.6 0.4 0.0 0.1 0.6 0.0 0.2 0.1 0.3 2.4 0.9 24.2 0.6 0.7 0.3 0.3 0.7 0.0 0.1 0.5 2.9 0.0 5.3 16.6 36.5 0.2 0.1 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.8 0.0 0.0 36.5 0.9 0.1 2.1 0.0 0.0 0.1 0.0 5.3 0.0 0.0 0.1 16.6 0.2 0.1 0.3 0.1 11.6 0.3 0.5 0.4 0.9 0.2 0.2 2.9 0.0 0.6 0.3 17.9 34.6 1.4 0.0 0.0 0.0 0.3 0.0 9.4 20.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 7.0 0.0 30.0 0.0 0.0 0.0 41.3 0.0 0.0 51.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 MMP25 "MMP20, MMPL1, MT6-MMP" ENSG00000008516 "Matrix metallopeptidase 25" Q9NPA2 16 3046681-3060726 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.6;bone marrow: 25.6;lymphoid tissue: 54.1" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 10.7;Kupffer cells: 5.9;monocytes: 23.4" "Cancer enhanced" "Detected in many" "testis cancer: 7.1" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 6 "basophil: 10.2;eosinophil: 6.0;neutrophil: 17.6" "Lineage enriched" "Detected in many" 10 "granulocytes: 17.6" "Cell line enriched" "Detected in some" 12 "HMC-1: 50.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB025177, HPA055640" Uncertain Supported "Plasma membrane" "Secreted to blood" NA NA "Plasma membrane" "CAB025177: , HPA055640: " "unprognostic (4.51e-3)" "unprognostic (9.28e-3)" "unprognostic (7.57e-2)" "unprognostic (2.95e-3)" "unprognostic (2.26e-1)" "prognostic favorable (1.09e-5)" "unprognostic (1.36e-1)" "unprognostic (7.39e-3)" "unprognostic (7.63e-3)" "unprognostic (2.29e-2)" "unprognostic (1.51e-1)" "unprognostic (2.53e-2)" "unprognostic (2.37e-3)" "unprognostic (1.17e-2)" "unprognostic (8.30e-2)" "unprognostic (4.01e-1)" "unprognostic (2.02e-1)" 4.0 0.3 0.6 12.3 0.4 25.6 0.8 0.5 0.6 0.8 1.1 0.2 0.0 1.0 0.4 0.5 0.8 3.8 1.1 2.8 0.5 0.4 0.7 2.5 10.7 54.1 1.8 0.0 0.6 0.8 0.0 0.5 2.0 1.1 0.6 1.0 1.0 0.9 0.0 2.4 0.6 1.8 0.5 0.4 43.9 1.1 0.7 0.5 4.1 0.7 0.9 4.2 1.5 2.5 0.0 0.3 17.6 0.2 1.7 0.5 0.1 0.2 0.1 0.7 1.5 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.3 0.6 0.3 0.0 0.0 4.0 0.8 0.1 0.1 0.0 0.0 0.1 50.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.3 0.0 0.5 0.2 3.0 1.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.3 3.6 0.1 0.1 0.4 0.1 0.0 1.2 0.1 0.1 0.0 1.0 0.1 10.2 0.2 6.0 0.3 0.0 0.5 0.0 0.2 0.2 0.0 0.0 0.3 0.2 17.6 1.7 0.0 0.3 0.3 0.1 0.6 0.4 0.5 0.6 0.5 0.4 1.8 0.0 1.1 0.5 3.0 10.7 0.0 0.2 0.3 0.6 0.4 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.5 0.1 0.2 0.5 1.1 0.0 0.1 0.0 0.0 0.0 5.9 0.0 0.0 2.0 0.0 23.4 0.0 0.1 1.1 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.0 3.1 0.1 0.1 MR1 HLALS ENSG00000153029 "Major histocompatibility complex, class I-related" Q95460 1 181033425-181061938 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048304 Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA048304: AB_2680347" "unprognostic (6.89e-2)" "unprognostic (1.54e-1)" "unprognostic (1.31e-2)" "unprognostic (1.96e-1)" "unprognostic (8.66e-3)" "unprognostic (4.37e-2)" "unprognostic (1.96e-1)" "unprognostic (1.36e-2)" "unprognostic (2.03e-1)" "unprognostic (1.18e-1)" "unprognostic (3.49e-2)" "unprognostic (6.41e-2)" "unprognostic (1.05e-2)" "unprognostic (7.40e-3)" "unprognostic (4.69e-2)" "unprognostic (2.39e-1)" "unprognostic (1.07e-2)" 10.5 13.8 5.3 10.2 7.1 7.7 8.3 1.7 5.5 8.6 8.2 5.3 6.8 5.3 10.4 10.9 12.6 8.6 13.2 8.9 5.2 3.1 10.5 10.7 16.6 16.2 5.9 5.0 13.9 5.1 12.4 17.6 11.5 5.1 13.2 6.3 12.3 8.1 8.6 3.8 10.1 7.8 9.6 6.1 14.9 6.7 5.5 6.2 23.2 13.6 7.1 18.4 16.4 9.6 12.9 15.6 24.0 22.2 14.9 14.3 11.1 3.7 2.6 0.1 2.2 16.0 19.5 6.8 7.4 20.4 6.2 10.6 1.0 15.2 4.5 15.5 13.3 4.9 9.9 0.3 8.7 5.4 13.7 2.4 6.6 3.0 4.5 5.4 5.3 19.9 12.7 24.3 9.2 10.0 11.6 0.6 8.5 12.2 12.4 12.0 4.1 5.6 3.8 0.0 0.0 0.4 6.4 0.1 12.6 6.7 11.0 0.1 0.2 3.9 7.2 5.2 3.1 7.6 11.5 3.8 6.1 0.8 10.6 3.6 20.6 6.9 8.5 5.7 7.2 0.6 24.0 17.9 18.1 14.3 22.2 12.7 12.1 13.0 12.7 15.6 12.9 9.7 14.3 13.4 14.9 18.7 8.4 13.6 11.1 5.3 7.1 1.7 5.5 5.2 3.1 5.9 5.0 5.1 6.2 17.9 25.9 17.9 7.5 4.4 0.8 3.9 10.2 10.7 11.4 14.0 0.0 13.9 5.0 7.7 0.2 4.4 1.4 23.3 5.6 7.4 9.3 6.2 16.2 9.0 24.5 0.0 2.4 1.8 22.5 0.0 10.0 17.1 6.8 25.2 3.2 4.5 6.1 5.5 11.3 2.1 0.4 0.0 6.6 0.3 1.1 4.6 20.5 15.2 4.0 12.7 MS4A1 "B1, Bp35, CD20, MS4A2" ENSG00000156738 "Membrane spanning 4-domains A1" P11836 11 60455752-60470760 "CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "B-cell activation" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 77.7;intestine: 46.1;lymphoid tissue: 134.1" "Cell type enriched" "Detected in some" 61 "B-cells: 527.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 105 "memory B-cell: 77.7;naive B-cell: 77.7" "Lineage enriched" "Detected in single" 105 "B-cells: 77.7" "Group enriched" "Detected in some" 25 "Daudi: 122.9;U-698: 61.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000015, HPA014341, HPA014391" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB000015: AB_2282030, HPA014341: AB_1846265, HPA014391: AB_1846264" "prognostic favorable (4.34e-5)" "unprognostic (4.45e-4)" "unprognostic (1.19e-4)" "unprognostic (2.04e-3)" "unprognostic (1.06e-1)" "unprognostic (5.53e-7)" "unprognostic (2.46e-3)" "unprognostic (1.85e-3)" "unprognostic (3.06e-2)" "unprognostic (2.89e-4)" "unprognostic (6.96e-2)" "unprognostic (2.84e-2)" "unprognostic (3.96e-5)" "unprognostic (2.23e-1)" "unprognostic (8.04e-2)" "unprognostic (1.44e-1)" "unprognostic (1.30e-1)" 1.6 0.3 0.3 79.0 0.3 3.6 0.6 0.3 0.3 0.5 2.0 0.0 0.0 0.2 0.4 0.5 7.0 0.4 1.3 0.7 0.3 0.3 2.0 0.9 2.7 81.2 0.3 0.1 0.3 0.4 0.0 0.4 0.4 0.1 1.1 1.7 0.6 14.5 0.2 0.3 0.3 46.1 0.1 0.4 90.7 2.6 0.6 0.0 15.7 2.5 2.7 134.1 6.4 0.8 77.7 0.0 0.2 0.0 0.7 0.6 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 122.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 77.7 0.3 0.6 0.0 77.7 0.0 0.2 0.2 0.7 0.0 0.0 0.0 3.5 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.1 0.0 0.0 6.7 527.8 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.6 1.8 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.7 0.0 0.0 MSN ENSG00000147065 Moesin P26038 X 65588377-65741931 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000263, CAB010898, HPA011135, HPA011227, CAB047336, CAB047337, CAB047338" Enhanced Enhanced "Plasma membrane" NA NA 340000000 "Plasma membrane" "CAB010898: AB_260635, CAB047336: , CAB047337: , CAB047338: , HPA000263: AB_1856043, HPA011135: AB_1854053, HPA011227: AB_1854054" "unprognostic (1.03e-1)" "unprognostic (7.89e-2)" "unprognostic (7.64e-2)" "unprognostic (5.38e-2)" "unprognostic (4.08e-3)" "unprognostic (3.51e-2)" "unprognostic (1.11e-2)" "unprognostic (1.44e-2)" "unprognostic (3.35e-2)" "unprognostic (1.70e-2)" "unprognostic (9.04e-3)" "unprognostic (1.32e-1)" "prognostic unfavorable (1.60e-5)" "unprognostic (5.68e-3)" "unprognostic (7.75e-2)" "unprognostic (7.21e-2)" "unprognostic (6.81e-2)" 36.3 17.6 10.2 40.7 14.4 38.5 98.2 8.6 18.6 25.1 21.3 19.2 7.6 6.5 33.4 14.2 15.7 21.8 20.2 53.8 11.5 10.4 25.6 29.5 102.8 85.0 17.5 5.4 28.8 19.4 5.7 10.2 24.2 30.0 23.1 13.0 16.6 16.3 21.9 13.6 19.5 18.3 41.4 21.8 31.6 17.3 9.0 12.9 18.7 26.2 17.6 38.1 22.7 28.9 16.0 36.4 54.1 69.0 28.0 37.1 81.8 28.3 21.7 21.3 17.6 25.6 33.9 0.1 71.8 46.5 39.8 30.9 0.0 5.0 23.7 64.2 63.5 21.1 19.5 22.5 51.2 52.0 44.0 6.2 65.9 37.7 0.0 24.2 80.0 106.7 25.3 11.0 73.2 64.8 38.6 87.9 33.2 31.9 74.1 63.0 0.0 47.3 60.0 26.4 0.0 41.4 24.8 38.3 18.1 42.6 0.0 0.1 0.0 57.7 0.4 22.8 25.1 0.2 43.6 139.1 45.4 28.8 61.0 47.5 26.9 40.7 25.8 33.2 101.6 50.5 30.8 44.4 30.0 37.1 58.9 27.9 16.0 20.4 29.1 36.4 13.9 14.0 21.3 54.1 28.0 69.0 5.2 15.5 81.8 10.2 14.4 8.6 18.6 11.5 10.4 17.5 5.4 30.0 12.9 166.7 148.6 101.2 51.9 182.5 0.5 23.6 10.2 32.1 70.5 64.6 3.9 5.0 24.9 169.4 1.1 154.5 2.6 23.3 146.5 11.7 88.8 25.9 158.4 46.9 150.1 4.8 0.0 91.4 236.8 3.0 68.1 215.1 65.8 158.7 2.3 38.6 229.7 3.1 102.9 81.2 1.8 71.1 127.7 1.9 3.6 130.7 3.5 174.0 1.8 47.2 MTM1 ENSG00000171100 "Myotubularin 1" Q13496 X 150568619-150673322 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Protein transport, Transport" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010008, HPA010665" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA010008: AB_1079426, HPA010665: AB_1079425" "unprognostic (3.66e-3)" "unprognostic (8.43e-3)" "unprognostic (3.52e-3)" "unprognostic (2.13e-1)" "unprognostic (1.08e-1)" "unprognostic (6.45e-2)" "unprognostic (4.98e-2)" "unprognostic (1.22e-1)" "unprognostic (4.74e-1)" "unprognostic (2.35e-2)" "unprognostic (1.08e-1)" "unprognostic (4.59e-2)" "prognostic favorable (7.40e-7)" "unprognostic (4.46e-2)" "unprognostic (1.25e-1)" "unprognostic (4.99e-2)" "unprognostic (2.46e-1)" 10.7 17.9 15.0 10.2 16.4 11.1 9.2 10.6 10.8 9.1 21.5 12.5 12.7 12.8 10.9 10.9 11.1 11.1 8.0 9.0 14.3 12.0 17.9 19.9 12.2 12.4 17.3 9.3 13.8 7.5 21.4 11.9 21.5 12.9 9.5 21.6 8.3 10.2 12.9 11.2 10.2 21.0 8.0 17.2 15.3 8.6 12.1 16.4 14.5 12.7 8.3 13.9 8.5 9.1 6.9 7.9 18.4 7.2 10.1 7.7 4.6 8.5 3.9 5.5 2.0 5.1 5.0 3.5 4.1 5.6 4.7 5.2 3.0 4.8 13.8 7.3 5.2 14.8 6.1 4.0 7.9 5.8 3.7 3.5 3.7 3.7 9.1 3.8 15.3 12.6 3.0 9.5 3.8 8.1 4.7 6.1 6.0 2.4 12.8 5.7 2.9 4.2 15.9 2.8 8.5 5.1 5.1 3.1 2.7 8.1 4.8 1.4 1.5 3.5 7.4 5.2 8.1 2.6 22.3 5.3 3.2 1.9 8.1 4.2 2.6 5.9 13.1 4.0 9.4 5.1 17.6 6.3 18.4 1.5 7.2 4.9 5.5 6.8 5.2 7.9 6.9 6.5 3.9 8.5 10.1 6.2 5.1 7.7 4.6 15.0 16.4 10.6 10.8 14.3 12.0 17.3 9.3 12.9 16.4 8.9 18.3 3.7 5.8 13.5 0.0 12.3 2.5 9.4 5.7 3.5 0.0 1.9 1.7 2.8 27.7 7.8 12.8 0.0 3.8 2.2 4.2 4.9 8.1 10.5 7.2 0.0 9.2 17.2 13.4 15.8 5.8 11.0 5.0 6.4 18.9 0.0 3.6 7.0 12.0 10.8 0.0 0.0 2.7 4.4 2.5 16.7 6.1 7.5 10.3 8.1 MUC1 "ADMCKD, ADMCKD1, CD227, MCD, MCKD, MCKD1, PEM, PUM" ENSG00000185499 "Mucin 1, cell surface associated" P15941 1 155185824-155192916 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 168.1;kidney: 158.5;lung: 143.5" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 1308.2;Collecting duct cells: 465.9;Exocrine glandular cells: 994.6;Pancreatic endocrine cells: 807.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "T-reg: 4.0" "Group enriched" "Detected in many" 10 "granulocytes: 1.3;T-cells: 4.0" "Group enriched" "Detected in many" 6 "CAPAN-2: 139.4;OE19: 65.3;RPTEC TERT1: 107.0;T-47d: 47.0" "CAB000036, CAB001986, HPA004179, HPA007235, HPA008855" Enhanced Supported "Plasma membrane" "Secreted in other tissues" NA NA 4900000 "Plasma membrane" "CAB000036: AB_2148557, CAB001986: , HPA004179: AB_1846282, HPA007235: AB_1846281, HPA008855: AB_1846283" "unprognostic (4.74e-2)" "unprognostic (2.84e-2)" "unprognostic (2.19e-1)" "unprognostic (8.01e-2)" "unprognostic (1.32e-2)" "unprognostic (1.70e-1)" "unprognostic (2.61e-3)" "unprognostic (6.34e-2)" "unprognostic (1.43e-1)" "unprognostic (3.23e-1)" "prognostic unfavorable (4.60e-4)" "unprognostic (4.75e-1)" "unprognostic (2.05e-2)" "unprognostic (1.13e-1)" "unprognostic (8.12e-2)" "unprognostic (1.42e-1)" "unprognostic (1.21e-1)" 1.5 0.7 0.8 12.6 1.2 0.9 12.6 0.4 0.7 31.6 15.9 1.2 2.4 2.9 10.5 9.8 51.8 18.7 168.1 0.8 0.5 0.3 158.5 2.0 143.5 0.3 0.5 0.3 14.9 74.2 0.0 4.7 15.5 2.1 6.1 16.1 0.8 17.0 5.9 0.8 1.8 3.6 2.8 0.7 0.6 105.0 4.3 0.5 0.7 15.7 10.5 47.8 12.3 5.2 0.0 0.2 1.3 0.1 0.0 4.0 0.2 1.8 0.9 0.6 0.5 0.4 0.5 0.2 0.6 1.4 0.7 1.9 0.0 139.4 0.0 10.1 1.1 0.3 2.8 0.1 0.0 0.2 1.2 0.1 0.2 11.8 0.0 0.3 0.0 4.4 1.2 0.2 0.3 0.2 1.5 0.2 0.2 1.0 1.9 0.5 14.2 0.1 0.1 0.4 65.3 0.2 0.2 0.0 3.4 107.0 0.1 0.6 0.2 3.3 5.9 0.1 0.5 47.0 0.6 0.2 0.4 0.8 1.3 0.1 2.1 1.1 0.0 0.7 0.1 0.1 1.3 0.1 0.0 0.0 0.0 0.8 0.0 2.3 0.4 0.2 0.0 0.3 0.7 0.0 0.0 0.0 0.0 4.0 0.2 0.8 1.2 0.4 0.7 0.5 0.3 0.5 0.3 2.1 0.5 402.0 1308.2 0.9 16.1 0.6 1.0 0.4 384.7 92.3 252.5 465.9 3.9 0.1 29.9 144.7 27.3 3.5 49.2 0.0 994.6 1.2 3.1 11.6 45.2 0.5 0.2 1.6 29.4 1.3 3.4 68.9 2.3 2.6 5.0 42.3 249.7 1.1 807.2 66.2 1.4 0.9 0.2 0.0 1.9 6.2 0.8 1.0 0.2 0.0 132.5 164.3 MYL4 "ALC1, AMLC, GT1, PRO1957" ENSG00000198336 "Myosin light chain 4" P12829 17 47200446-47223679 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Atrial fibrillation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 68 "heart muscle: 712.3" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 2384.1" "Group enriched" "Detected in some" 7 "testis cancer: 2.4;thyroid cancer: 11.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 5.2" "Lineage enriched" "Detected in single" 11 "dendritic cells: 5.2" "Cell line enriched" "Detected in some" 4 "HEL: 109.9" "Group enriched" "Detected in many" 6 "amygdala: 25.9;cerebral cortex: 83.3;hippocampal formation: 27.8" "Not detected" "Not detected" "HPA046859, HPA051884, HPA063034" Enhanced Approved "Plasma membrane" NA NA 140000 "Plasma membrane" "HPA046859: AB_2679842, HPA051884: AB_2681651, HPA063034: AB_2684927" "unprognostic (2.43e-2)" "unprognostic (9.57e-2)" "unprognostic (2.25e-1)" "unprognostic (5.51e-2)" "unprognostic (2.33e-1)" "unprognostic (4.12e-3)" "unprognostic (5.06e-3)" "unprognostic (1.34e-1)" "unprognostic (1.13e-1)" "unprognostic (6.52e-2)" "unprognostic (2.10e-2)" "unprognostic (7.37e-2)" "unprognostic (1.00e-6)" "unprognostic (1.92e-4)" "unprognostic (2.54e-1)" "unprognostic (6.51e-3)" "unprognostic (1.50e-1)" 0.1 0.0 0.0 0.1 0.0 10.4 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 712.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.7 0.0 0.0 0.7 0.1 0.0 0.0 0.8 3.3 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.2 0.7 0.0 0.1 0.6 4.6 0.1 0.1 0.2 0.2 5.2 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 109.9 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.2 0.3 26.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 5.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 3.0 0.0 0.0 0.0 0.7 4.5 2384.1 0.0 0.0 0.0 0.0 60.9 0.4 0.0 0.0 16.3 3.0 0.3 443.9 0.0 2.6 2.1 0.0 0.0 0.0 1.8 1.6 0.0 1.3 0.0 42.1 3.1 0.0 11.8 0.0 0.0 4.9 0.1 0.0 1.4 0.0 17.0 0.0 2.0 1.5 0.4 0.6 1.1 0.0 0.0 0.0 MYO1B myr1 ENSG00000128641 "Myosin IB" O43795 2 191245185-191425389 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 92.7" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 306.7;Hepatocytes: 373.0;Sertoli cells: 200.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 1.7;naive B-cell: 2.7;naive CD4 T-cell: 1.2" "Group enriched" "Detected in many" 4 "B-cells: 2.7;T-cells: 1.2" "Cell line enhanced" "Detected in many" "hTERT-HME1: 75.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013607, HPA060144" Approved Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA013607: AB_1854251, HPA060144: AB_2684211" "unprognostic (4.11e-3)" "unprognostic (7.36e-3)" "unprognostic (1.21e-1)" "unprognostic (4.83e-3)" "unprognostic (2.78e-1)" "unprognostic (1.59e-3)" "unprognostic (1.09e-2)" "unprognostic (1.15e-2)" "unprognostic (3.25e-3)" "unprognostic (5.85e-2)" "unprognostic (4.55e-1)" "unprognostic (9.31e-2)" "prognostic unfavorable (2.36e-5)" "unprognostic (2.22e-2)" "unprognostic (1.79e-1)" "unprognostic (1.47e-1)" "unprognostic (6.55e-2)" 18.8 2.5 3.3 5.9 4.3 0.2 21.8 1.4 4.7 8.2 8.0 2.1 21.6 4.2 11.8 8.2 9.0 4.9 8.9 11.6 3.6 3.1 12.2 92.7 34.5 6.6 3.6 2.3 7.8 34.3 15.0 3.1 15.7 4.4 8.5 7.4 5.8 7.5 18.6 9.3 7.5 5.4 6.7 2.7 6.6 5.0 3.6 2.0 3.6 9.3 10.4 4.8 10.3 9.9 2.7 0.4 0.0 0.0 0.0 1.2 0.0 20.3 10.5 17.2 5.1 4.7 20.4 15.5 38.9 19.3 27.0 26.9 12.9 1.8 0.0 6.5 44.7 10.9 45.2 5.6 33.5 34.0 0.0 4.9 0.0 4.9 16.4 11.1 0.4 0.1 8.2 23.2 28.1 75.9 10.0 4.9 8.7 0.0 0.0 24.8 8.6 7.7 2.4 11.2 1.3 16.7 10.0 10.9 1.5 10.6 8.6 8.7 22.8 13.1 2.3 11.7 15.3 2.1 0.6 5.9 25.9 12.9 15.6 4.5 0.2 0.0 0.2 15.7 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.3 4.3 1.4 4.7 3.6 3.1 3.6 2.3 4.4 2.0 306.7 93.9 10.0 37.0 68.2 1.1 4.8 48.4 32.1 87.6 66.3 0.0 4.5 0.0 92.7 2.8 24.0 13.9 0.0 38.3 21.2 34.0 35.8 3.5 373.0 3.5 0.0 56.1 3.7 8.6 3.2 4.6 4.7 25.3 1.8 23.5 69.7 41.1 49.5 8.5 1.3 1.5 200.5 74.6 1.4 18.9 24.6 2.9 4.3 30.4 41.7 MYO5B KIAA1119 ENSG00000167306 "Myosin VB" Q9ULV0 18 49822813-50195093 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 92.2" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 114.3;Pancreatic endocrine cells: 76.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 21.0;HaCaT: 33.2;RH-30: 51.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA040593, HPA040902, HPA069773" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA040593: AB_10795525, HPA040902: AB_10796230, HPA069773: AB_2686194" "unprognostic (2.51e-1)" "unprognostic (2.15e-2)" "unprognostic (2.12e-2)" "unprognostic (6.17e-3)" "unprognostic (2.14e-1)" "unprognostic (8.84e-3)" "unprognostic (1.32e-1)" "unprognostic (2.59e-1)" "unprognostic (4.13e-2)" "unprognostic (3.46e-1)" "prognostic unfavorable (2.26e-5)" "unprognostic (4.48e-2)" "prognostic favorable (1.45e-11)" "unprognostic (2.17e-3)" "unprognostic (1.50e-1)" "unprognostic (6.56e-2)" "unprognostic (3.28e-1)" 2.0 1.2 1.1 12.7 1.3 0.0 5.2 0.4 2.5 7.5 56.9 1.0 13.7 23.5 1.8 10.4 20.3 4.6 20.6 2.0 1.8 1.2 19.1 13.9 9.4 0.6 0.7 1.5 1.7 16.4 9.3 10.5 13.5 2.1 6.0 17.5 8.4 21.6 8.7 0.6 14.5 92.2 0.8 0.7 0.9 13.1 5.5 0.3 2.4 16.3 14.9 17.4 4.0 11.8 1.0 0.1 0.0 0.0 2.4 0.6 0.0 21.0 5.7 0.1 0.1 0.0 0.0 11.5 0.1 0.8 0.4 0.0 14.9 9.0 0.0 5.3 0.0 1.7 33.2 7.5 9.0 0.4 0.0 2.3 0.0 2.5 10.5 0.0 0.0 0.1 0.0 7.9 0.2 5.5 1.7 0.7 0.1 0.1 8.3 0.9 8.1 0.0 0.0 1.5 12.3 2.3 0.0 51.4 3.5 19.0 4.3 11.4 0.2 8.0 9.5 0.0 3.0 5.6 0.0 0.5 0.0 11.6 0.1 2.2 5.6 3.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 1.0 0.4 0.1 0.0 0.0 0.2 0.4 0.0 2.4 0.0 0.1 0.1 0.0 1.1 1.3 0.4 2.5 1.8 1.2 0.7 1.5 2.1 0.3 50.6 12.0 0.8 8.3 0.3 8.2 1.9 15.3 24.1 19.4 7.0 9.8 3.2 5.0 40.6 14.7 0.6 114.3 0.0 41.1 1.1 0.5 42.9 0.0 15.3 0.7 0.0 6.4 0.0 0.3 1.5 0.9 0.9 3.3 3.6 33.5 29.9 76.1 53.7 0.7 13.0 29.0 0.0 0.2 9.5 3.8 5.6 3.9 0.0 38.0 58.3 MYO9A "FLJ11061, FLJ13244, MGC71859" ENSG00000066933 "Myosin IXA" B2RTY4 15 71822289-72118577 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, GTPase activation, Motor protein, Myosin" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Rod photoreceptor cells: 446.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039812, HPA040071" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA039812: AB_10961421, HPA040071: AB_10961117" "unprognostic (7.53e-2)" "unprognostic (2.40e-1)" "unprognostic (1.96e-1)" "unprognostic (2.42e-3)" "unprognostic (1.63e-1)" "unprognostic (8.69e-3)" "unprognostic (3.77e-2)" "unprognostic (3.56e-2)" "unprognostic (1.26e-1)" "unprognostic (5.50e-2)" "unprognostic (1.32e-1)" "unprognostic (1.34e-1)" "prognostic favorable (2.14e-4)" "unprognostic (3.44e-1)" "unprognostic (4.41e-1)" "unprognostic (1.25e-1)" "unprognostic (4.23e-2)" 10.5 6.0 13.8 9.6 17.9 6.1 14.8 18.3 16.4 13.3 11.1 7.5 10.6 3.4 15.0 11.0 11.2 10.8 7.5 9.3 9.5 9.3 19.6 5.5 12.2 8.4 9.1 12.0 17.5 5.0 15.9 14.7 10.5 14.6 11.9 9.2 9.1 8.3 11.3 12.9 12.0 8.0 14.4 9.0 10.0 9.7 35.6 11.2 9.1 18.4 6.6 8.8 11.9 13.9 6.1 9.3 5.2 3.4 3.7 7.6 1.3 6.4 9.9 6.5 4.6 10.1 11.9 3.9 6.1 6.7 6.2 6.4 4.8 4.4 28.9 3.6 12.1 8.2 6.1 13.1 7.0 8.3 6.3 7.6 7.3 5.6 2.1 6.4 7.3 5.9 6.7 7.1 7.4 10.6 5.2 7.9 5.2 4.7 6.9 8.4 4.0 4.1 3.0 3.5 2.4 4.0 2.9 12.6 2.8 7.6 9.6 3.7 4.1 7.9 6.9 6.4 8.3 5.4 3.5 10.5 12.5 6.1 20.1 6.9 4.4 10.9 7.8 7.4 6.1 5.5 2.2 2.2 5.2 5.6 2.0 7.6 4.7 5.4 4.6 2.2 6.1 5.7 5.3 0.3 3.7 3.4 9.3 4.5 1.3 13.8 17.9 18.3 16.4 9.5 9.3 9.1 12.0 14.6 11.2 107.2 59.0 9.1 19.4 18.5 49.1 28.5 0.0 33.5 31.8 27.9 51.1 9.2 14.9 5.8 102.4 24.2 12.5 23.3 7.0 9.5 20.2 21.2 9.3 4.5 8.0 50.9 12.1 20.9 36.4 117.2 35.9 10.6 21.9 11.8 10.2 22.7 9.6 14.4 40.3 11.0 446.4 19.4 27.4 104.1 36.6 20.8 10.1 7.7 10.6 14.8 NCKIPSD "AF3P21, DIP1, ORF1, SPIN90, WASLBP, WISH" ENSG00000213672 "NCK interacting protein with SH3 domain" Q9NZQ3 3 48673844-48686364 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "brain: 39.6;parathyroid gland: 123.9" "Cell type enhanced" "Detected in many" 6 "Peritubular cells: 44.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019267, HPA050005" Enhanced "Plasma membrane" NA NA 42000 "Plasma membrane" "CAB019267: , HPA050005: AB_2680988" "unprognostic (1.55e-2)" "unprognostic (2.02e-1)" "unprognostic (2.15e-1)" "unprognostic (1.79e-1)" "unprognostic (9.64e-3)" "unprognostic (5.50e-3)" "prognostic unfavorable (8.57e-4)" "unprognostic (1.76e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (2.40e-2)" "unprognostic (1.23e-1)" "prognostic favorable (1.20e-5)" "unprognostic (1.60e-2)" "unprognostic (1.55e-1)" "unprognostic (3.73e-2)" "unprognostic (2.09e-2)" 11.7 11.9 14.4 4.9 18.5 4.4 7.8 17.9 39.6 7.0 7.9 10.3 3.5 7.3 7.8 8.6 7.8 9.6 9.3 17.8 12.9 16.0 8.7 6.8 7.4 5.9 11.1 17.8 17.7 8.5 123.9 10.0 8.0 16.9 8.1 7.4 9.6 8.9 11.7 6.4 9.8 7.3 8.7 9.2 5.7 6.2 8.4 10.9 2.9 7.7 1.9 5.4 7.7 6.5 4.9 8.5 1.0 5.3 4.8 6.4 4.7 11.8 10.5 10.7 11.0 14.6 8.9 14.9 11.9 13.4 13.3 17.0 15.4 7.3 8.8 6.5 7.0 15.2 8.0 13.6 15.8 7.7 9.8 16.6 15.7 38.9 12.2 12.8 10.6 17.7 8.5 13.8 18.4 11.6 15.1 7.5 11.2 5.3 11.8 10.6 8.7 9.6 9.0 12.4 11.8 18.6 4.9 4.9 14.6 7.2 12.3 11.2 9.1 12.5 11.8 10.0 10.2 10.5 13.0 4.1 11.5 12.9 13.6 15.7 10.6 7.7 9.8 13.1 14.2 17.5 1.0 4.6 0.2 3.5 5.3 2.6 4.9 4.2 4.1 5.8 2.6 6.4 4.1 0.3 4.8 2.8 8.5 4.6 4.7 14.4 18.5 17.9 39.6 12.9 16.0 11.1 17.8 16.9 10.9 0.0 8.6 0.0 3.2 2.3 8.9 7.5 7.6 1.4 1.2 1.8 11.8 8.9 5.0 5.5 1.9 4.0 10.6 0.0 4.0 8.8 5.1 2.4 5.7 5.5 7.7 11.1 8.1 24.5 6.3 1.7 17.0 6.9 1.7 4.6 6.4 3.6 7.3 8.0 44.6 5.7 5.9 12.9 5.6 4.1 17.4 1.5 6.9 2.2 9.0 1.8 NCS1 "FREQ, NCS-1" ENSG00000107130 "Neuronal calcium sensor 1" P62166 9 130172578-130237304 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 76.8" "Cell type enriched" "Detected in many" 5 "Horizontal cells: 106.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.2;MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018587, HPA019713" Enhanced Supported Enhanced "Plasma membrane" NA NA "Plasma membrane" "CAB018587: AB_649907, HPA019713: AB_1854404" "prognostic unfavorable (5.40e-4)" "unprognostic (1.57e-1)" "unprognostic (4.64e-3)" "prognostic unfavorable (8.69e-4)" "unprognostic (1.29e-1)" "unprognostic (9.23e-2)" "prognostic unfavorable (1.11e-4)" "unprognostic (1.61e-3)" "unprognostic (4.27e-1)" "unprognostic (1.21e-2)" "unprognostic (8.45e-2)" "unprognostic (1.58e-1)" "unprognostic (3.71e-3)" "unprognostic (8.59e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (8.25e-4)" "unprognostic (1.65e-1)" 5.8 12.6 76.8 7.9 56.6 4.6 2.8 18.6 66.2 7.7 20.1 6.4 5.0 3.6 12.6 4.1 24.9 13.5 8.7 4.6 74.3 25.7 8.7 1.6 2.5 1.6 20.6 28.1 4.6 3.5 1.5 2.7 1.6 17.7 14.9 6.8 4.2 5.3 41.6 0.9 10.0 4.3 34.3 6.8 1.1 5.1 2.2 7.1 0.0 20.1 0.7 2.7 16.4 4.6 0.0 0.0 0.0 0.0 0.0 1.2 0.1 7.8 16.0 8.3 16.6 5.2 11.7 4.0 20.3 9.4 15.6 10.4 7.6 4.0 0.0 7.4 25.6 18.3 14.2 13.5 17.8 7.0 23.2 4.1 0.0 10.6 8.1 8.0 0.7 9.8 13.6 9.1 17.6 11.2 13.9 14.7 3.1 5.7 0.1 22.5 22.6 1.4 7.8 12.7 4.2 6.7 0.0 26.3 5.4 15.2 5.0 22.0 20.7 12.5 6.0 12.0 6.6 11.1 5.0 11.5 30.3 24.7 24.3 26.0 0.0 0.0 0.0 35.4 2.2 32.6 0.0 0.0 0.0 1.2 0.0 1.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 76.8 56.6 18.6 59.9 74.3 25.7 20.6 28.1 17.7 7.1 0.0 0.0 0.0 8.5 8.7 2.7 3.6 0.0 5.3 7.9 10.4 3.9 0.0 5.0 6.6 0.3 0.0 0.0 0.0 2.5 1.5 7.1 4.5 3.5 0.0 3.6 106.5 1.2 1.3 0.0 0.0 1.1 2.3 5.0 17.2 0.5 18.7 4.9 0.0 1.4 12.4 3.1 0.0 20.2 0.0 0.9 6.0 0.5 0.0 0.0 2.6 NECTIN4 "LNIR, nectin-4, PRR4, PVRL4" ENSG00000143217 "Nectin cell adhesion molecule 4" Q96NY8 1 161070995-161089599 "Disease related genes, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.1;placenta: 46.6;skin 1: 39.3" "Cell type enriched" "Detected in some" 7 "Syncytiotrophoblasts: 321.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "basophil: 1.5;eosinophil: 1.2;neutrophil: 3.6" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.6" "Cell line enhanced" "Detected in some" "BEWO: 28.2;HaCaT: 18.2;MCF7: 11.4;OE19: 11.8;SK-BR-3: 23.7;T-47d: 15.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA010775 Enhanced Supported "Plasma membrane" "Secreted in other tissues" No No 11000 "Plasma membrane" "HPA010775: AB_1079720" "unprognostic (1.09e-3)" "unprognostic (1.52e-1)" "unprognostic (3.51e-1)" "unprognostic (1.11e-2)" "unprognostic (5.69e-3)" "unprognostic (2.09e-2)" "unprognostic (6.69e-3)" "unprognostic (1.02e-1)" "unprognostic (1.69e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-3)" "unprognostic (1.13e-1)" "unprognostic (2.24e-8)" "unprognostic (2.98e-2)" "unprognostic (2.43e-1)" "unprognostic (3.68e-2)" "unprognostic (4.97e-2)" 0.2 0.1 0.1 0.8 0.1 0.1 7.7 0.1 0.1 9.8 0.6 0.1 5.4 0.2 1.5 3.7 40.1 1.4 5.6 0.1 0.1 0.1 1.3 0.2 3.1 0.0 0.1 0.0 0.5 4.4 0.0 0.3 46.6 0.1 7.8 0.7 0.1 13.5 5.5 0.1 39.3 0.4 2.0 0.1 0.1 4.5 0.2 0.0 0.5 0.1 22.7 23.1 12.6 18.5 0.2 0.3 3.6 0.1 0.1 0.2 0.0 5.2 0.1 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.1 0.0 7.1 0.0 0.1 0.0 0.0 18.2 0.0 0.6 0.1 0.0 0.2 0.0 0.4 5.3 0.0 0.0 0.3 0.0 7.2 1.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.1 0.1 23.7 0.0 3.3 15.3 0.0 0.0 0.0 1.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.5 0.1 1.2 0.2 0.0 0.1 0.2 0.2 0.0 0.3 0.2 0.1 0.1 3.6 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 6.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 18.7 14.8 15.7 0.0 24.1 0.0 34.7 0.0 0.0 0.0 0.0 26.2 43.5 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.8 0.0 0.0 47.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 321.3 0.0 0.0 0.0 NID2 ENSG00000087303 "Nidogen 2" Q14112 14 52004803-52069228 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 10.5;Fibroblasts: 9.3;Ito cells: 9.2;Peritubular cells: 8.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 53.2;ASC TERT1: 21.2;BJ: 27.8;BJ hTERT+: 23.7;HHSteC: 29.5;HSkMC: 110.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA052460, HPA058772" Enhanced Enhanced "Plasma membrane" "Secreted to extracellular matrix" NA NA 2500000 "Plasma membrane" "HPA052460: AB_2681840, HPA058772: AB_2683815" "unprognostic (6.51e-2)" "unprognostic (3.55e-3)" "unprognostic (3.73e-2)" "unprognostic (3.25e-2)" "unprognostic (2.04e-1)" "unprognostic (1.94e-1)" "unprognostic (5.37e-2)" "unprognostic (3.05e-3)" "unprognostic (2.52e-3)" "unprognostic (3.07e-2)" "unprognostic (4.85e-2)" "unprognostic (1.43e-1)" "unprognostic (1.48e-3)" "prognostic unfavorable (7.34e-4)" "unprognostic (4.58e-2)" "unprognostic (2.87e-2)" "prognostic unfavorable (2.78e-4)" 15.0 5.1 0.9 5.3 1.8 0.1 7.6 0.9 1.7 12.9 8.5 5.1 9.0 1.0 9.5 7.6 9.8 6.0 10.2 17.5 1.2 0.9 6.4 2.9 5.1 3.0 1.3 1.2 16.8 13.9 10.2 2.4 32.5 2.5 13.4 3.6 17.4 4.3 8.9 3.9 1.8 3.0 11.4 1.5 1.1 6.6 4.4 0.8 0.7 18.8 3.6 2.2 10.7 5.2 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.6 13.9 0.0 53.2 21.2 0.0 27.8 23.7 2.6 2.7 0.0 0.0 0.0 4.1 3.0 0.0 1.9 1.7 0.0 0.7 0.0 0.3 0.0 0.4 0.0 29.5 0.0 0.0 110.2 0.0 10.8 0.0 15.1 1.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.6 0.0 0.9 4.1 0.0 0.0 3.6 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.1 10.1 0.1 6.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 1.8 0.9 1.7 1.2 0.9 1.3 1.2 2.5 0.8 0.0 0.0 0.0 0.2 0.6 1.2 1.7 0.0 0.0 0.0 1.8 0.0 0.7 0.0 0.1 10.5 3.7 1.1 0.0 0.0 1.0 9.3 0.1 1.1 0.0 1.3 0.0 0.0 9.2 0.0 2.5 5.8 0.0 3.3 1.8 2.8 0.0 0.3 0.0 8.1 0.0 0.8 6.5 5.7 0.0 0.0 0.9 0.7 0.0 3.3 0.1 NMUR2 NMU2R ENSG00000132911 "Neuromedin U receptor 2" Q9GZQ4 5 152391532-152433368 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.9;stomach 1: 5.0;testis: 8.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "colorectal cancer: 0.5;endometrial cancer: 0.6;pancreatic cancer: 1.8;stomach cancer: 2.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "EFO-21: 14.8" "Region enhanced" "Detected in single" "hypothalamus: 2.0" "Low region specificity" "Detected in all" "HPA027800, HPA045836" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA027800: , HPA045836: AB_10968856" "unprognostic (1.82e-1)" "unprognostic (3.83e-1)" "unprognostic (2.66e-1)" "unprognostic (9.29e-2)" "unprognostic (5.87e-2)" "unprognostic (6.44e-3)" "unprognostic (3.13e-1)" "unprognostic (6.47e-2)" "unprognostic (5.63e-2)" "unprognostic (8.20e-3)" "unprognostic (8.90e-5)" "unprognostic (1.48e-2)" "unprognostic (9.24e-2)" "unprognostic (9.56e-2)" "unprognostic (2.29e-1)" 0.1 0.5 0.6 0.7 1.0 0.0 0.1 0.2 1.2 0.4 0.2 0.7 1.1 0.6 0.9 0.2 0.4 0.1 0.6 1.4 0.9 2.8 2.0 0.1 2.9 0.1 4.3 0.4 0.1 0.0 0.0 0.7 0.5 1.6 0.2 0.4 0.0 0.0 0.2 0.8 0.0 0.3 0.2 8.9 0.0 5.0 8.0 1.4 0.9 2.5 0.0 0.3 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.7 14.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 1.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.2 1.2 0.9 2.8 4.3 0.4 1.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPTN "GP55, GP65, np55, np65, SDFR1, SDR1" ENSG00000156642 Neuroplastin Q9Y639 15 73560014-73634134 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051497, HPA072453" Approved Approved "Plasma membrane" NA No 21000 "Plasma membrane" "HPA051497: AB_2681507, HPA072453: AB_2686523" "unprognostic (9.30e-3)" "unprognostic (1.70e-1)" "unprognostic (5.01e-2)" "unprognostic (4.14e-1)" "unprognostic (3.11e-2)" "unprognostic (7.42e-3)" "unprognostic (9.74e-2)" "unprognostic (9.67e-2)" "unprognostic (3.63e-2)" "unprognostic (1.68e-1)" "unprognostic (3.57e-2)" "unprognostic (1.93e-1)" "unprognostic (1.60e-3)" "unprognostic (5.55e-2)" "unprognostic (7.41e-2)" "unprognostic (1.70e-1)" "unprognostic (1.17e-1)" 20.8 24.9 49.0 17.8 72.9 6.9 22.5 55.3 84.5 30.3 36.2 11.9 28.1 33.2 52.3 39.9 34.2 35.2 30.5 48.4 43.6 38.3 32.7 18.2 27.2 15.9 30.3 47.8 21.0 23.8 35.9 18.3 30.3 40.0 45.3 36.6 22.7 25.9 54.9 12.1 19.5 39.8 75.3 16.8 16.7 27.1 18.8 20.4 6.3 28.7 18.5 16.6 32.7 25.9 3.0 3.9 19.7 13.3 2.5 4.9 7.3 17.5 31.5 18.2 13.3 37.2 33.6 25.5 40.5 66.5 46.8 41.7 21.4 56.4 10.2 24.2 58.1 58.0 72.9 29.2 33.7 27.0 18.2 19.4 8.1 16.1 19.0 26.4 12.4 22.6 27.4 29.9 30.2 18.3 46.4 24.8 9.2 4.5 11.7 33.4 14.0 5.5 7.6 16.7 22.2 11.3 8.9 20.8 8.6 63.7 26.0 11.1 3.4 39.2 21.9 26.0 47.4 19.8 16.9 27.9 36.4 24.5 20.8 23.5 10.2 19.0 8.8 33.8 19.3 24.8 3.6 10.0 9.5 4.9 13.3 4.0 3.0 2.8 4.4 3.7 2.3 2.9 3.3 19.7 2.5 9.6 3.9 3.0 7.3 49.0 72.9 55.3 84.5 43.6 38.3 30.3 47.8 40.0 20.4 71.5 54.8 7.7 22.7 57.8 76.4 87.0 58.6 87.0 66.0 78.5 47.1 5.7 1.7 17.0 2.8 30.7 78.3 0.0 20.5 7.9 45.4 26.3 26.7 38.2 22.1 36.5 98.8 47.9 71.6 6.6 14.1 37.1 40.5 12.6 77.6 35.4 30.5 49.9 36.0 16.8 47.1 19.4 36.0 8.2 10.4 47.7 5.7 12.5 39.9 25.1 NRAS N-ras ENSG00000213281 "NRAS proto-oncogene, GTPase" P01111 1 114704469-114716894 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010157, HPA049830, CAB079912" Uncertain Supported "Plasma membrane" NA NA 4800000 "Plasma membrane" "CAB010157: AB_632073, CAB079912: AB_2784586, HPA049830: AB_2680903" "unprognostic (4.75e-2)" "unprognostic (2.81e-1)" "unprognostic (1.09e-3)" "unprognostic (2.11e-2)" "unprognostic (8.59e-3)" "unprognostic (1.14e-1)" "prognostic unfavorable (3.03e-7)" "unprognostic (7.76e-3)" "unprognostic (1.57e-2)" "unprognostic (1.01e-3)" "prognostic unfavorable (1.36e-4)" "unprognostic (6.60e-3)" "prognostic unfavorable (7.87e-4)" "unprognostic (2.68e-1)" "unprognostic (1.30e-1)" "unprognostic (1.16e-1)" "unprognostic (3.33e-2)" 18.0 9.7 13.1 16.5 14.4 33.5 12.4 9.7 16.6 10.0 18.4 15.8 3.8 14.4 9.8 6.2 19.7 8.7 11.8 7.1 11.7 13.8 24.0 23.9 13.4 18.7 15.3 9.6 10.3 14.2 8.3 7.6 27.4 19.0 9.2 18.5 8.4 12.4 5.2 7.9 16.1 23.4 9.6 20.9 19.5 14.4 9.8 9.7 45.0 11.1 14.0 19.6 13.2 10.5 11.0 9.9 23.7 15.0 12.1 11.1 10.1 24.7 6.7 18.1 6.8 7.5 16.1 12.9 11.8 13.2 22.2 25.0 13.5 9.3 18.8 15.7 15.9 15.5 7.1 24.1 19.2 31.9 25.6 9.4 12.7 10.2 16.0 14.9 31.6 19.8 14.5 15.6 25.4 18.6 7.0 28.2 14.9 20.2 21.7 19.5 66.1 21.8 12.3 30.7 8.1 4.9 16.7 32.2 11.7 19.6 13.4 11.0 16.5 12.1 10.0 28.4 22.0 8.8 25.7 21.5 12.1 23.2 22.6 24.2 38.4 26.4 22.1 24.2 17.3 43.6 23.7 10.0 9.6 9.8 15.0 8.9 11.0 8.0 9.7 9.9 8.8 8.7 11.1 2.7 12.1 12.7 7.7 10.4 10.1 13.1 14.4 9.7 16.6 11.7 13.8 15.3 9.6 19.0 9.7 14.9 13.9 22.5 24.9 27.2 4.4 4.0 25.5 18.7 12.5 21.0 7.9 18.9 11.6 31.0 2.9 23.3 32.2 0.0 27.3 39.9 16.8 25.2 31.1 24.5 43.1 4.8 23.6 40.5 41.2 4.4 7.5 27.8 21.9 41.5 29.5 7.1 39.8 29.4 6.0 27.8 2.2 6.5 10.8 6.5 14.1 31.7 26.1 20.3 24.7 34.0 NRXN1 "Hs.22998, KIAA0578" ENSG00000179915 "Neurexin 1" "P58400, Q9ULB1" 2 49918505-51225575 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Angiogenesis, Cell adhesion" "Mental retardation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 81.9" "Group enriched" "Detected in some" 4 "Bipolar cells: 70.6;Early spermatids: 130.0;Horizontal cells: 73.1;Late spermatids: 79.3" "Cancer enriched" "Detected in single" 8 "glioma: 3.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "neutrophil: 4.4" "Lineage enriched" "Detected in single" 14 "granulocytes: 4.4" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071400 Supported "Plasma membrane" "Intracellular and membrane" NA NA 620000 "Plasma membrane" "HPA071400: AB_2732180" "unprognostic (7.01e-2)" "unprognostic (9.96e-2)" "unprognostic (7.68e-2)" "unprognostic (1.74e-4)" "unprognostic (2.46e-1)" "unprognostic (8.95e-2)" "unprognostic (2.02e-2)" "unprognostic (1.85e-1)" "unprognostic (8.19e-2)" "unprognostic (6.37e-4)" "unprognostic (2.85e-2)" "unprognostic (6.68e-7)" "unprognostic (3.40e-2)" "unprognostic (1.75e-1)" "unprognostic (5.57e-2)" "unprognostic (1.99e-3)" 2.1 3.2 22.4 2.1 20.3 1.4 1.7 56.5 81.9 2.8 5.1 3.0 0.5 2.1 2.1 3.7 3.0 1.4 2.2 3.8 16.9 13.8 1.5 1.6 1.5 1.4 8.3 25.9 2.1 2.3 1.3 4.8 1.1 12.6 2.5 3.8 2.0 3.5 9.3 1.3 2.0 3.1 2.1 6.5 1.3 2.3 6.5 4.7 0.0 1.4 0.0 1.4 2.0 1.6 0.0 0.0 4.4 0.1 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 29.0 1.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 2.4 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.3 0.0 0.0 0.0 0.0 22.4 20.3 56.5 33.2 16.9 13.8 8.3 25.9 12.6 4.7 0.0 0.0 0.0 0.4 0.0 70.6 15.4 0.0 0.0 0.0 0.0 2.0 0.0 1.7 0.0 130.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 73.1 1.7 5.5 0.0 79.3 2.3 0.2 1.7 0.0 0.0 20.9 0.3 0.0 0.7 0.0 8.0 0.0 0.3 9.9 3.8 0.1 0.2 0.0 0.0 0.0 NTNG1 "KIAA0976, Lmnt1" ENSG00000162631 "Netrin G1" Q9Y2I2 1 107140007-107483458 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.4" "Cell type enhanced" "Detected in some" 16 "Basal glandular cells: 6.0;Bipolar cells: 23.3;Collecting duct cells: 7.0;Early spermatids: 7.6;Leydig cells: 7.5;Sertoli cells: 6.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 4.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 28.6;fHDF/TERT166: 13.9;RPTEC TERT1: 15.6;U-138 MG: 13.1;U-251 MG: 9.4;U-87 MG: 14.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065954 Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA065954: AB_2685585" "unprognostic (1.79e-1)" "unprognostic (4.63e-2)" "unprognostic (1.67e-2)" "unprognostic (9.38e-5)" "unprognostic (1.93e-3)" "unprognostic (9.87e-3)" "unprognostic (3.34e-1)" "unprognostic (8.38e-3)" "unprognostic (1.03e-1)" "unprognostic (2.02e-1)" "unprognostic (5.68e-2)" "unprognostic (2.05e-2)" "unprognostic (3.10e-4)" "unprognostic (2.00e-1)" "unprognostic (1.52e-1)" "unprognostic (1.93e-5)" 4.2 11.0 6.8 1.3 6.4 0.9 1.1 7.3 12.8 7.0 2.9 9.6 0.3 0.8 2.2 0.9 1.2 1.3 2.1 0.9 9.8 16.4 13.0 0.8 9.2 1.7 5.0 5.3 1.9 1.1 0.7 7.4 3.2 10.0 9.0 1.7 6.4 2.8 12.1 1.1 1.9 1.7 7.5 7.4 1.3 1.4 1.7 6.1 0.0 0.8 0.0 2.0 5.3 3.0 4.4 0.8 1.4 0.7 0.8 0.6 0.3 0.0 0.0 1.7 0.0 2.9 28.6 0.0 7.8 1.1 0.7 0.6 0.0 0.0 0.0 0.3 13.9 0.0 0.0 0.0 0.8 1.6 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 8.2 0.2 2.0 1.1 8.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.0 3.6 0.0 1.9 0.0 15.6 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.1 13.1 2.5 4.8 9.4 0.0 0.0 0.0 14.6 0.0 1.4 1.4 0.3 0.4 0.3 0.4 0.5 4.4 0.4 0.3 0.4 1.0 0.6 0.5 0.9 0.8 0.7 0.8 0.4 0.3 6.8 6.4 7.3 12.3 9.8 16.4 5.0 5.3 10.0 6.1 0.0 0.0 0.5 6.0 0.5 23.3 0.8 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 7.6 0.3 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.5 7.5 0.0 1.7 0.0 0.0 0.8 0.2 0.0 0.0 0.0 2.1 6.5 1.4 0.2 0.4 0.5 0.0 0.0 0.0 4.3 NTSR1 NTR ENSG00000101188 "Neurotensin receptor 1" P30989 20 62708837-62762771 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.0;intestine: 15.1" "Cell type enhanced" "Detected in single" 29 "Kupffer cells: 3.2" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "PC-3: 35.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050299 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA050299: " "unprognostic (4.14e-2)" "unprognostic (2.02e-2)" "unprognostic (2.75e-2)" "unprognostic (8.87e-4)" "unprognostic (9.27e-3)" "unprognostic (1.45e-1)" "unprognostic (4.17e-2)" "unprognostic (2.80e-3)" "unprognostic (7.16e-2)" "unprognostic (3.10e-3)" "unprognostic (3.55e-2)" "unprognostic (2.53e-1)" "unprognostic (1.27e-2)" "unprognostic (1.25e-1)" "unprognostic (1.29e-1)" "unprognostic (1.17e-1)" "unprognostic (2.49e-1)" 0.3 0.1 3.7 2.5 3.6 3.8 0.1 0.1 7.0 0.1 15.1 0.0 0.0 0.4 0.2 0.1 0.1 0.1 1.4 0.1 2.0 1.1 0.6 0.2 0.3 0.3 3.3 1.0 0.4 0.1 0.2 0.3 0.2 1.4 0.2 0.5 1.2 0.3 0.1 0.2 0.2 1.5 0.8 0.8 0.6 0.5 0.5 0.0 0.0 0.1 0.3 0.1 0.3 0.1 0.0 0.3 0.0 0.3 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.2 6.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 1.7 0.1 1.6 0.2 0.7 35.8 1.1 0.0 5.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.5 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.7 3.6 0.1 7.0 2.0 1.1 3.3 1.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10P1 "OR10P1P, OR10P2P, OR10P3P, OST701" ENSG00000175398 "Olfactory receptor family 10 subfamily P member 1" Q8NGE3 12 55636860-55637854 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "blood: 2.0;heart muscle: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.0;T-reg: 1.7" "Lineage enriched" "Detected in single" 7 "T-cells: 2.0" "Cell line enhanced" "Detected in single" "THP-1: 2.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA074114 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA074114: " 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2C3 "OR2C4, OR2C5P, OST742" ENSG00000196242 "Olfactory receptor family 2 subfamily C member 3" Q8N628 1 247524677-247536440 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 4.2;testis: 4.6" "Group enriched" "Detected in some" 6 "Early spermatids: 1.6;granulocytes: 1.1;Late spermatids: 2.1;Spermatocytes: 2.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "basophil: 4.2;plasmacytoid DC: 1.3" "Group enriched" "Detected in many" 18 "dendritic cells: 1.3;granulocytes: 4.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.8" HPA058578 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA058578: AB_2683761" "unprognostic (1.96e-1)" "unprognostic (7.29e-2)" "unprognostic (3.45e-2)" "unprognostic (1.03e-1)" 0.2 0.4 0.1 0.0 0.1 0.1 0.2 0.4 0.1 0.9 0.1 0.0 0.2 0.9 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.2 1.3 0.1 0.4 0.7 0.0 0.1 0.0 0.5 0.1 0.1 0.4 0.1 0.1 0.1 4.6 0.1 0.0 0.2 0.1 0.0 1.3 4.2 0.0 0.1 0.1 0.0 0.5 0.3 0.6 0.2 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.3 1.8 0.6 0.2 0.0 1.1 0.3 0.0 0.1 0.0 0.7 0.5 0.1 0.2 0.1 0.1 0.2 0.5 0.5 0.0 0.1 0.0 0.4 0.1 0.5 1.2 0.7 0.1 0.0 0.4 0.2 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.4 0.8 0.3 0.0 0.3 0.5 0.6 0.6 0.3 0.7 0.4 1.2 0.1 0.1 0.0 0.2 0.3 0.5 0.1 0.5 4.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 OR8S1 ENSG00000284723 "Olfactory receptor family 8 subfamily S member 1" Q8NH09 12 48525632-48528103 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "intestine: 1.2;ovary: 1.0" "Cell type enriched" "Detected in single" 7 "Spermatocytes: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;CAPAN-2: 1.6" "Not detected" "Not detected" HPA045595 Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA045595: AB_10964447" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.4 0.0 0.0 0.0 0.0 0.0 OSBPL6 ORP6 ENSG00000079156 "Oxysterol binding protein like 6" Q9BZF3 2 178194481-178402891 "Plasma proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 33.4" "Group enriched" "Detected in many" 4 "Bipolar cells: 59.0;Ciliated cells: 133.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Group enriched" "Detected in many" 8 "granulocytes: 2.2;T-cells: 1.4" "Cell line enhanced" "Detected in many" "HEL: 25.0;hTERT-HME1: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032131 Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA032131: AB_10670963" "unprognostic (6.22e-2)" "unprognostic (1.53e-1)" "unprognostic (2.47e-1)" "unprognostic (5.95e-3)" "unprognostic (5.26e-2)" "unprognostic (1.40e-2)" "unprognostic (7.55e-2)" "unprognostic (4.81e-2)" "unprognostic (3.32e-1)" "unprognostic (1.03e-1)" "unprognostic (3.03e-3)" "unprognostic (3.49e-2)" "unprognostic (1.15e-5)" "unprognostic (1.11e-2)" "unprognostic (1.30e-1)" "unprognostic (3.73e-4)" "unprognostic (4.44e-6)" 2.4 2.8 9.2 1.9 10.5 0.8 3.2 10.2 18.4 1.9 1.7 3.2 0.2 1.6 1.8 1.7 4.1 2.1 2.2 5.9 7.5 6.3 4.5 8.7 6.3 2.0 4.9 8.0 2.8 2.3 1.2 15.1 1.4 11.3 5.3 2.1 2.5 2.9 2.9 33.4 11.6 5.6 2.6 4.3 2.0 1.7 2.4 4.3 0.0 4.1 6.3 1.7 1.5 2.3 0.2 0.1 2.2 0.0 0.2 1.4 0.6 0.0 0.5 4.4 8.9 3.7 4.1 3.4 7.2 3.8 6.4 7.9 0.7 0.1 0.0 0.3 6.6 3.5 0.1 10.3 5.9 10.9 0.1 5.3 25.0 1.6 0.0 2.4 4.0 0.1 2.7 9.4 14.1 27.4 2.3 3.0 3.2 0.4 3.1 8.4 3.5 0.0 0.0 5.3 0.0 5.3 0.0 9.0 1.6 0.4 0.0 3.4 2.0 3.2 0.9 7.1 5.1 1.2 0.0 5.9 7.4 4.6 4.9 8.4 17.0 6.6 0.0 8.8 0.0 3.4 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.6 0.8 0.0 0.2 1.4 0.1 2.2 0.2 0.0 0.1 0.0 0.6 9.2 10.5 10.2 18.4 7.5 6.3 4.9 8.0 11.3 4.3 0.0 4.5 0.0 2.3 11.7 59.0 12.9 7.6 133.8 11.4 0.0 23.6 0.2 1.7 0.6 0.7 1.8 0.3 0.0 0.7 2.5 1.1 1.8 6.9 4.3 2.9 1.6 1.7 0.0 2.2 0.9 0.0 0.9 5.0 0.0 3.8 11.5 0.3 0.0 1.4 5.3 6.6 0.0 5.3 0.0 0.1 18.2 0.1 0.0 0.1 0.5 OTOP2 ENSG00000183034 "Otopetrin 2" Q7RTS6 17 74924275-74933912 "Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 20.4;testis: 5.1" "Cell type enriched" "Detected in some" 48 "Paneth cells: 508.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Lineage enhanced" "Detected in single" "dendritic cells: 1.4" "Cell line enriched" "Detected in single" 47 "HDLM-2: 15.2" "Region enriched" "Detected in single" 13 "olfactory region: 15.6" "Low region specificity" "Detected in all" "HPA024524, HPA053090" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA024524: AB_2671592, HPA053090: AB_2682041" "unprognostic (1.62e-2)" "unprognostic (1.45e-1)" "unprognostic (7.25e-2)" "unprognostic (3.21e-2)" "unprognostic (3.62e-1)" "unprognostic (1.30e-1)" "unprognostic (2.85e-2)" "unprognostic (3.81e-1)" "unprognostic (9.04e-2)" "unprognostic (2.04e-2)" 0.1 0.0 0.1 2.9 0.1 0.0 0.1 0.1 0.1 0.1 20.4 0.1 0.1 0.2 0.5 0.1 1.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 10.9 0.1 0.1 0.1 0.1 0.2 11.3 0.2 0.1 0.1 0.0 5.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.4 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 10.6 0.0 0.0 0.0 0.0 2.7 0.0 0.0 508.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.5 0.0 OXGR1 "aKGR, GPR80, GPR99, P2RY15, P2Y15" ENSG00000165621 "Oxoglutarate receptor 1" Q96P68 13 96985719-96994730 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 7.0" "Cell type enriched" "Detected in some" 11 "Extravillous trophoblasts: 35.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "myeloid DC: 2.9;plasmacytoid DC: 5.2" "Lineage enriched" "Detected in single" 6 "dendritic cells: 5.2" "Cell line enhanced" "Detected in some" "RT4: 7.8;SK-BR-3: 3.6;T-47d: 1.7;U-2 OS: 4.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA067673 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA067673: AB_2685883" "unprognostic (1.83e-1)" "unprognostic (1.01e-2)" "unprognostic (1.33e-1)" "unprognostic (6.97e-4)" "unprognostic (7.23e-2)" "unprognostic (1.52e-1)" "unprognostic (8.38e-2)" "unprognostic (2.16e-1)" "unprognostic (1.16e-1)" "unprognostic (2.22e-2)" "unprognostic (4.14e-2)" "unprognostic (3.88e-2)" "unprognostic (1.89e-1)" "unprognostic (2.75e-1)" "unprognostic (1.54e-1)" "unprognostic (9.68e-2)" 2.1 0.0 0.7 1.7 0.2 0.0 6.7 0.0 2.0 1.6 3.0 0.1 0.6 4.0 3.2 2.5 0.0 0.0 0.8 0.8 7.0 0.0 0.5 0.0 0.7 0.0 0.6 0.0 0.3 1.2 0.5 2.4 4.9 0.3 0.1 4.3 0.5 0.5 1.6 0.3 0.1 0.0 0.8 0.9 1.8 0.9 0.0 5.2 0.1 0.5 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 7.8 0.0 0.2 0.0 3.6 0.0 0.2 1.7 0.0 0.0 0.0 4.1 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.3 0.0 0.5 0.1 0.0 0.1 0.8 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.1 0.0 0.0 5.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 1.1 1.7 0.0 0.2 0.1 0.0 0.0 0.0 35.1 0.1 0.0 0.0 0.0 1.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.0 0.8 0.0 PALM2 ENSG00000243444 "Paralemmin 2" Q8IXS6 9 109640788-109946703 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.9;liver: 19.7" "Cell type enhanced" "Detected in some" 14 "Cardiomyocytes: 5.9;Fibroblasts: 5.4;Hepatocytes: 14.7;Intestinal endocrine cells: 7.9;Smooth muscle cells: 6.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 5.9;RH-30: 20.8" "Low region specificity" "Detected in many" "HPA074153, HPA076866" Approved "Plasma membrane" NA NA "Plasma membrane" "HPA074153: AB_2686669, HPA076866: " "unprognostic (7.68e-2)" "unprognostic (1.21e-1)" "unprognostic (1.44e-2)" "unprognostic (1.17e-3)" "unprognostic (3.14e-3)" "unprognostic (1.11e-1)" "unprognostic (2.51e-2)" "unprognostic (2.77e-2)" "unprognostic (2.36e-2)" "unprognostic (3.35e-1)" "unprognostic (7.62e-2)" "unprognostic (1.09e-1)" "unprognostic (5.59e-2)" "unprognostic (2.50e-2)" "unprognostic (2.02e-1)" "unprognostic (1.74e-6)" "unprognostic (8.39e-2)" 14.8 6.1 8.1 2.0 11.1 1.2 6.7 1.7 17.9 4.3 2.4 9.1 0.0 1.8 4.9 1.7 2.4 3.8 3.0 7.6 6.3 1.8 2.7 19.7 4.8 1.5 5.0 9.7 2.3 2.2 1.4 1.6 3.1 8.4 2.4 2.4 0.0 3.2 1.4 2.5 3.1 2.0 2.2 4.9 1.5 2.2 2.7 8.7 0.0 4.3 0.0 1.4 2.8 2.6 0.5 0.1 1.1 0.2 0.3 0.1 0.0 0.1 0.6 0.5 0.0 0.4 0.9 0.2 0.4 1.2 0.7 1.7 0.3 0.7 0.1 0.1 1.9 4.2 1.8 0.0 0.6 1.3 0.1 1.0 0.0 2.5 0.2 0.0 0.0 0.1 2.0 0.8 5.9 0.9 0.6 0.0 0.0 0.0 0.0 2.5 0.5 0.0 0.0 3.4 0.2 1.3 0.0 20.8 0.4 2.9 0.4 3.9 0.0 5.1 0.2 1.6 0.9 2.0 0.4 0.2 2.1 3.0 0.1 1.7 0.1 0.7 0.1 1.6 0.0 2.4 0.3 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.5 0.1 0.0 1.1 0.3 0.1 0.1 0.0 0.0 8.1 11.1 1.7 12.7 6.3 1.8 5.0 9.7 8.4 8.7 0.0 0.3 0.0 0.5 1.1 0.0 5.9 0.0 2.7 0.0 0.0 0.0 0.2 0.0 0.3 0.4 0.3 0.0 0.0 0.2 1.5 5.4 0.4 0.0 14.7 0.1 0.0 7.9 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.7 0.0 0.0 0.0 6.6 0.2 1.0 2.0 0.2 0.0 0.4 0.1 PANX1 "MRS1, PX1, UNQ2529" ENSG00000110218 "Pannexin 1" Q96RD7 11 94128928-94181972 "Predicted membrane proteins, Transporters" "Calcium transport, Differentiation, Ion transport, Oogenesis, Transport" "Calcium channel, Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 90.6;Suprabasal keratinocytes: 63.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016930 Uncertain Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA016930: AB_1854954" "unprognostic (1.65e-2)" "unprognostic (2.32e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.16e-1)" "unprognostic (7.02e-2)" "unprognostic (6.04e-2)" "prognostic unfavorable (7.09e-5)" "unprognostic (1.79e-1)" "unprognostic (1.43e-1)" "unprognostic (1.00e-3)" "unprognostic (3.26e-1)" "prognostic unfavorable (1.49e-7)" "unprognostic (1.15e-2)" "unprognostic (9.45e-2)" "unprognostic (1.79e-1)" "unprognostic (1.26e-3)" 13.5 9.4 7.9 13.5 14.3 3.8 18.0 7.8 14.8 10.1 11.8 5.6 4.3 6.1 10.8 6.6 9.4 8.7 13.7 13.4 5.6 10.2 8.7 19.4 14.7 6.7 7.4 9.2 9.0 8.5 10.1 7.8 11.0 8.7 9.4 8.6 3.9 9.7 8.6 29.8 11.5 7.4 14.7 5.0 9.6 10.7 12.3 7.4 12.7 10.2 13.9 8.7 13.6 14.1 2.6 5.0 3.6 7.4 4.2 5.1 6.1 11.7 5.0 13.2 8.0 12.3 16.8 8.6 14.7 31.3 12.7 15.6 12.7 18.6 3.7 13.8 14.9 23.3 24.9 10.4 24.3 12.8 16.1 5.4 17.4 5.3 6.5 11.9 8.9 15.6 13.2 17.1 16.5 14.9 8.2 10.5 9.9 11.2 13.7 14.1 3.7 14.8 2.1 10.5 9.5 9.1 17.7 17.6 4.7 8.2 11.7 5.5 16.1 10.3 5.9 7.0 7.0 12.6 4.6 7.6 25.2 13.0 8.2 14.5 2.2 8.5 6.2 10.5 9.3 16.0 3.6 7.4 0.5 4.3 4.2 5.0 2.6 3.5 4.4 5.0 2.4 3.2 3.6 0.5 4.2 2.6 0.8 5.1 6.1 7.9 14.3 7.8 14.8 5.6 10.2 7.4 9.2 8.7 7.4 0.0 8.3 1.9 8.9 90.6 1.2 3.1 0.0 6.7 2.3 1.8 0.0 10.6 0.0 12.9 4.7 3.1 3.3 0.0 15.8 28.0 12.4 6.8 9.2 6.4 16.9 0.0 2.4 2.5 4.4 2.2 4.0 10.1 16.9 3.6 3.3 0.9 18.5 3.4 3.5 1.9 1.3 0.0 14.4 1.0 6.8 63.1 19.9 3.2 2.8 13.1 PANX2 "hPANX2, PX2" ENSG00000073150 "Pannexin 2" Q96RD6 22 50170731-50180294 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.4" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 10.2;Hepatocytes: 6.8;Muller glia cells: 21.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.2" "Group enriched" "Detected in many" 36 "dendritic cells: 1.8;granulocytes: 5.2" "Cell line enhanced" "Detected in many" "EFO-21: 9.1;HDLM-2: 13.9;Hep G2: 16.3;MCF7: 9.0;SCLC-21H: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004624, HPA039117" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA004624: , HPA039117: AB_10805354" "unprognostic (1.00e-1)" "unprognostic (7.25e-2)" "unprognostic (2.72e-2)" "unprognostic (1.05e-1)" "unprognostic (3.01e-3)" "unprognostic (2.11e-2)" "unprognostic (1.03e-1)" "unprognostic (1.48e-1)" "unprognostic (1.56e-1)" "unprognostic (4.43e-2)" "unprognostic (3.08e-1)" "unprognostic (1.23e-1)" "unprognostic (1.65e-9)" "unprognostic (2.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.00e-1)" "unprognostic (4.08e-1)" 1.6 2.6 10.3 2.6 9.2 5.3 1.4 22.4 31.4 1.8 1.1 1.2 10.5 1.1 2.4 2.7 3.8 4.9 2.3 1.1 14.2 8.8 3.4 7.8 2.4 1.2 15.9 7.9 3.5 3.0 1.0 4.1 1.6 23.9 3.8 1.0 1.5 5.5 6.2 1.5 2.6 1.2 1.2 4.5 2.7 1.4 2.6 2.4 0.0 3.8 0.2 1.5 1.8 0.9 0.0 1.8 5.2 0.0 0.0 0.0 0.0 0.8 1.8 0.3 2.0 0.0 0.2 4.3 2.2 2.2 0.5 0.4 0.4 6.9 0.0 9.1 0.2 1.3 0.4 1.1 0.9 0.1 13.9 1.2 0.3 2.9 16.3 0.7 0.1 1.1 0.2 0.9 0.6 0.0 1.0 0.5 0.0 1.1 0.0 0.2 9.0 0.0 0.8 3.4 0.0 3.7 0.8 0.0 3.3 0.0 1.4 8.6 0.8 1.4 0.1 5.2 0.4 0.6 0.6 3.8 0.4 3.7 5.9 4.1 1.6 0.1 0.5 0.2 0.0 6.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 1.8 0.0 0.0 10.3 9.2 22.4 31.4 14.2 8.8 15.9 7.9 23.9 2.4 0.0 1.4 0.0 2.3 0.5 10.2 0.6 2.5 4.0 4.5 0.0 0.0 0.0 5.0 1.7 0.2 0.0 0.0 0.0 2.4 0.1 0.5 4.0 0.0 6.8 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.8 0.0 21.1 2.2 0.0 1.1 1.2 3.6 0.0 0.4 0.0 0.4 0.3 0.0 0.0 0.0 2.8 PARD6G "PAR-6G, PAR6gamma" ENSG00000178184 "Par-6 family cell polarity regulator gamma" Q9BYG4 18 80157232-80247546 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 37.0" "Cell type enhanced" "Detected in many" 13 "Basal keratinocytes: 35.1;Sertoli cells: 19.4;Suprabasal keratinocytes: 55.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 21.6;hTCEpi: 20.1;RT4: 16.1;U-2 OS: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA047017 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA047017: AB_2679904" "unprognostic (1.11e-1)" "unprognostic (4.39e-2)" "unprognostic (9.88e-2)" "unprognostic (4.40e-2)" "unprognostic (2.97e-1)" "unprognostic (5.48e-3)" "prognostic unfavorable (3.19e-4)" "unprognostic (1.80e-1)" "unprognostic (9.96e-2)" "unprognostic (4.27e-2)" "unprognostic (1.17e-1)" "unprognostic (4.09e-2)" "unprognostic (6.86e-3)" "unprognostic (9.65e-2)" "unprognostic (1.01e-1)" "unprognostic (4.85e-1)" "unprognostic (2.72e-1)" 2.9 2.2 3.1 4.0 3.1 0.8 8.8 2.0 4.3 15.1 5.0 3.1 8.2 2.1 9.5 6.1 17.3 6.7 4.5 3.0 4.3 4.1 5.5 3.5 2.6 10.4 2.8 2.4 8.9 3.1 2.1 3.7 5.7 3.7 8.8 2.5 4.0 7.0 6.6 2.0 37.0 2.9 8.2 2.6 2.4 2.5 2.4 1.8 6.9 20.7 14.1 11.2 8.4 10.7 0.5 0.5 2.5 0.4 0.6 1.0 0.1 1.7 2.5 10.5 7.8 0.3 0.4 7.6 1.9 0.4 1.7 0.2 0.7 0.7 0.0 0.8 0.8 3.0 7.7 3.7 11.1 1.7 0.3 3.3 0.1 2.0 5.9 0.5 2.2 21.6 3.4 20.1 0.2 1.1 1.3 0.8 2.4 0.7 0.5 2.5 2.8 2.0 0.2 3.1 0.8 3.0 0.0 6.9 0.8 0.3 16.1 4.4 4.5 2.3 1.3 11.0 5.4 1.5 2.0 0.6 3.5 17.4 1.3 0.9 0.5 0.7 0.1 1.1 0.5 6.4 2.5 0.2 0.4 0.3 0.2 0.2 0.3 0.3 1.0 0.2 0.5 0.4 0.5 1.2 0.6 0.4 0.5 0.1 0.1 3.1 3.1 2.0 4.3 4.3 4.1 2.8 2.4 3.7 1.8 3.0 1.1 0.0 12.6 35.1 1.6 2.2 2.5 1.4 1.2 3.5 0.0 0.5 0.0 0.3 0.4 3.1 0.0 0.0 0.2 4.2 5.6 5.4 0.0 1.6 0.7 0.0 0.0 8.0 1.9 0.4 1.7 1.1 11.8 0.0 0.0 2.0 0.9 0.0 1.8 6.3 2.2 19.4 5.8 0.9 4.1 55.8 0.3 2.2 0.5 10.1 PARP6 pART17 ENSG00000137817 "Poly(ADP-ribose) polymerase family member 6" Q2NL67 15 72241181-72272999 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Late spermatids: 137.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026991 Approved Approved "Plasma membrane" Yes No "Plasma membrane" "HPA026991: AB_1854989" "unprognostic (3.88e-2)" "prognostic favorable (3.17e-5)" "prognostic unfavorable (3.37e-4)" "unprognostic (3.36e-1)" "unprognostic (7.13e-2)" "unprognostic (3.05e-1)" "unprognostic (2.37e-2)" "unprognostic (1.33e-1)" "unprognostic (2.00e-1)" "unprognostic (2.64e-1)" "unprognostic (8.55e-2)" "unprognostic (6.92e-2)" "prognostic unfavorable (8.02e-8)" "unprognostic (6.81e-2)" "unprognostic (1.14e-1)" "unprognostic (1.45e-1)" "unprognostic (4.42e-2)" 13.7 16.6 28.0 12.8 32.4 25.1 26.5 46.6 41.2 15.5 16.2 16.9 18.2 14.1 23.3 23.8 14.0 17.0 20.2 18.4 26.1 22.4 14.3 9.0 15.7 16.8 19.9 21.8 26.3 20.9 20.6 30.8 17.0 19.4 19.3 14.3 14.5 21.3 18.8 23.9 20.3 14.4 19.6 14.2 18.2 18.2 25.1 15.8 9.6 21.7 12.5 15.8 16.3 15.8 4.1 4.0 12.1 5.3 4.3 4.3 2.9 7.3 13.2 13.9 18.1 15.0 12.5 11.3 6.3 9.5 10.4 15.4 8.7 13.3 10.0 3.9 9.5 15.3 9.6 15.3 8.5 6.0 11.9 13.8 14.6 23.1 0.1 12.5 7.5 14.0 16.0 21.0 9.7 26.8 16.4 6.9 16.8 7.4 11.6 8.3 13.3 6.4 13.2 6.4 6.1 0.0 11.9 9.9 7.9 9.6 14.5 39.4 20.9 10.5 8.6 17.1 19.3 10.9 8.7 6.5 13.1 12.0 17.0 9.5 13.1 12.0 10.9 9.4 14.7 9.0 1.7 5.3 12.1 3.8 4.4 2.7 3.3 2.7 4.0 4.0 4.1 4.3 3.2 5.7 4.3 4.9 3.1 4.2 2.9 28.0 32.4 46.6 41.2 26.1 22.4 19.9 21.8 19.4 15.8 20.8 20.5 4.7 8.4 12.8 14.0 14.6 0.0 2.7 15.9 8.7 19.6 5.9 6.6 7.3 49.1 9.8 9.2 0.0 11.2 4.3 9.3 7.6 15.1 4.2 8.1 17.5 16.7 7.4 12.4 137.7 11.5 8.2 15.1 6.4 5.3 7.4 8.1 5.8 9.2 10.3 15.1 6.5 9.5 39.0 8.3 13.8 5.4 7.5 5.6 8.3 PCBD2 "DCOH2, DCOHM" ENSG00000132570 "Pterin-4 alpha-carbinolamine dehydratase 2" Q9H0N5 5 134904906-135007959 "Enzymes, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 47.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036428 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA036428: AB_10670103" "unprognostic (3.70e-2)" "unprognostic (3.53e-2)" "unprognostic (3.54e-3)" "unprognostic (1.36e-2)" "unprognostic (2.92e-1)" "unprognostic (1.98e-1)" "unprognostic (4.22e-1)" "unprognostic (6.43e-2)" "unprognostic (4.49e-1)" "unprognostic (1.01e-1)" "unprognostic (1.22e-1)" "unprognostic (5.18e-2)" "unprognostic (1.87e-3)" "unprognostic (4.57e-2)" "unprognostic (6.34e-2)" "unprognostic (9.32e-3)" "unprognostic (1.50e-1)" 4.9 8.1 5.4 7.0 6.6 6.6 5.3 3.0 4.4 3.9 8.7 6.5 9.4 8.0 6.5 8.4 9.3 4.9 6.9 13.8 5.0 5.3 9.2 9.8 6.5 5.0 5.6 5.2 5.1 12.9 9.6 6.1 4.8 6.8 4.7 6.4 9.6 14.2 7.9 47.0 6.7 12.7 7.6 7.0 5.5 7.1 5.5 5.8 5.3 8.3 13.5 8.1 5.6 5.5 8.2 11.5 7.2 10.1 6.3 6.6 4.3 7.8 7.6 8.1 6.1 5.6 4.8 6.0 6.3 4.9 3.6 3.6 14.2 20.1 9.4 10.6 4.2 7.1 5.3 5.5 6.0 3.3 13.1 3.7 5.3 8.1 8.5 5.4 6.1 3.8 2.6 5.9 3.7 8.7 4.2 4.2 7.3 7.7 14.1 6.3 16.1 6.4 10.4 4.5 10.8 7.4 10.2 7.6 8.3 6.6 6.7 6.1 8.0 9.4 4.9 7.8 7.1 13.7 8.1 4.6 6.9 5.2 6.1 8.0 11.0 15.0 6.4 6.2 7.5 4.5 2.7 10.1 7.2 5.1 6.3 5.0 8.2 6.3 5.3 8.6 8.2 5.4 5.3 3.3 6.3 6.1 11.5 6.6 4.3 5.4 6.6 3.0 4.1 5.0 5.3 5.6 5.2 6.8 5.8 8.9 6.4 4.5 5.6 3.2 12.0 29.7 17.8 10.7 3.4 15.7 11.8 10.5 18.3 14.5 5.4 8.4 17.2 46.7 15.8 21.0 4.9 6.2 5.8 21.7 21.4 22.3 4.1 6.7 5.9 2.5 6.6 9.5 5.0 31.5 8.4 13.5 15.4 3.5 2.1 21.4 46.7 0.0 5.3 5.6 10.4 5.3 8.5 7.5 15.8 7.2 PCDHA1 ENSG00000204970 "Protocadherin alpha 1" Q9Y5I3 5 140786136-141012347 "Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.1;testis: 3.1" "Cell type enhanced" "Detected in some" 24 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.1;Ito cells: 1.3;Sertoli cells: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "T-47d: 14.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035969 Enhanced Approved "Plasma membrane" "Secreted - unknown location" NA NA "Plasma membrane" "HPA035969: AB_10673492" "unprognostic (2.76e-5)" "unprognostic (1.19e-1)" "unprognostic (3.74e-2)" "unprognostic (1.09e-4)" "unprognostic (7.38e-2)" "unprognostic (2.86e-2)" "unprognostic (2.26e-3)" "unprognostic (1.25e-2)" "unprognostic (1.91e-2)" "unprognostic (1.81e-1)" "unprognostic (9.01e-5)" "unprognostic (2.46e-2)" "unprognostic (1.91e-1)" "unprognostic (7.57e-2)" "unprognostic (1.11e-1)" "unprognostic (1.77e-3)" "unprognostic (1.29e-1)" 0.2 1.5 4.6 0.2 4.4 0.1 0.2 3.3 7.1 0.2 0.3 0.7 0.5 0.1 0.2 0.2 0.4 0.1 5.0 3.7 0.6 0.1 0.2 0.3 3.4 0.2 0.2 1.0 1.4 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.6 0.2 3.4 0.2 0.3 3.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.4 1.0 0.0 0.2 1.8 0.3 14.4 0.5 0.0 1.6 1.0 0.7 0.1 0.0 0.1 0.0 0.4 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 PCDHB11 "ME2, PCDH-BETA11" ENSG00000197479 "Protocadherin beta 11" Q9Y5F2 5 141199582-141203779 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 3.0;Bipolar cells: 2.7;Peritubular cells: 3.2;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 8.2;EFO-21: 11.8;U-2 OS: 4.3" HPA045042 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA045042: AB_2679194" "unprognostic (1.32e-1)" "unprognostic (3.47e-2)" "unprognostic (7.21e-2)" "unprognostic (1.76e-1)" "unprognostic (1.18e-1)" "unprognostic (1.56e-1)" "unprognostic (2.82e-2)" "unprognostic (1.42e-1)" "unprognostic (6.78e-2)" "unprognostic (1.29e-2)" "unprognostic (1.07e-1)" "unprognostic (2.89e-1)" "unprognostic (3.87e-3)" "unprognostic (4.96e-2)" "unprognostic (1.37e-2)" "unprognostic (9.79e-2)" "unprognostic (6.47e-3)" 13.6 2.4 2.8 2.0 4.1 1.1 3.4 8.8 5.0 8.6 3.1 1.4 0.0 1.4 4.9 3.4 4.1 3.1 3.1 3.0 1.4 1.8 5.0 1.3 2.9 1.0 1.5 3.7 11.0 12.0 15.8 3.6 2.2 3.0 4.5 1.7 6.8 3.3 3.6 2.0 2.9 1.8 5.1 1.6 2.2 2.9 2.6 1.3 0.0 2.8 2.3 1.1 5.5 4.2 1.2 1.0 2.8 0.9 1.4 0.8 0.1 0.0 0.2 2.5 8.2 0.1 0.3 1.8 0.2 0.8 0.0 0.0 0.0 0.2 0.0 11.8 0.7 0.7 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.2 0.2 0.3 0.3 0.0 0.0 1.0 0.1 0.1 0.1 2.0 0.4 0.2 0.0 0.2 0.3 0.0 0.4 0.0 3.2 0.0 0.1 0.3 3.4 0.5 1.8 0.2 1.1 0.4 1.9 0.0 0.5 0.2 4.3 3.3 0.1 0.1 0.1 0.1 2.2 0.2 2.1 2.2 0.9 0.8 0.8 0.5 0.5 0.6 0.6 0.5 0.3 1.2 0.5 0.7 2.8 1.4 0.4 1.0 0.4 0.1 2.8 4.1 8.8 5.0 1.4 1.8 1.5 3.7 3.0 1.3 3.0 0.3 0.0 0.7 0.0 2.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.9 0.0 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 2.0 0.0 1.7 0.0 0.0 1.7 1.1 0.0 3.2 0.5 0.2 6.5 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.6 PCDHB12 PCDH-BETA12 ENSG00000120328 "Protocadherin beta 12" Q9Y5F1 5 141208697-141212571 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 3.2;Intestinal endocrine cells: 1.7;Melanocytes: 3.3;Peritubular cells: 2.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.8;ASC diff: 4.7;EFO-21: 5.4;RH-30: 5.8;U-2 OS: 4.4;U-2197: 4.4" HPA045042 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA045042: AB_2679194" "unprognostic (1.43e-2)" "unprognostic (3.22e-3)" "unprognostic (4.18e-3)" "unprognostic (8.43e-2)" "unprognostic (3.95e-3)" "unprognostic (7.87e-3)" "unprognostic (1.46e-1)" "unprognostic (2.95e-2)" "unprognostic (3.63e-1)" "unprognostic (9.13e-3)" "unprognostic (4.86e-2)" "unprognostic (2.94e-2)" "unprognostic (4.37e-3)" "unprognostic (3.22e-3)" "unprognostic (4.97e-3)" "unprognostic (3.83e-2)" "unprognostic (6.41e-3)" 4.2 2.5 4.4 1.9 5.0 0.4 3.4 9.1 7.5 5.8 3.3 2.5 1.5 1.3 8.0 3.5 1.8 4.9 3.9 3.9 3.1 2.2 2.6 1.5 3.6 0.9 3.0 6.4 8.3 4.0 3.6 13.9 2.0 3.7 4.5 1.8 3.2 1.9 3.9 1.8 1.6 1.7 6.8 3.9 2.6 2.1 3.1 2.7 0.0 1.9 1.2 0.9 3.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 4.8 4.7 2.7 0.7 0.1 3.4 0.3 0.4 0.0 0.0 0.0 5.4 0.5 2.5 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 1.2 0.0 0.0 1.3 0.4 0.0 0.0 1.2 1.2 0.3 0.0 0.0 0.1 0.0 1.0 0.9 5.8 0.0 0.0 0.0 2.8 1.6 0.0 0.0 1.0 0.4 3.7 0.8 0.3 0.7 4.4 4.4 0.1 0.0 0.0 0.0 2.8 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 5.0 9.1 7.5 3.1 2.2 3.0 6.4 3.7 2.7 0.0 0.6 0.0 0.0 0.3 3.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.3 0.0 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.1 0.0 1.7 0.6 0.0 0.0 1.1 0.0 3.3 0.0 0.0 1.4 0.4 0.0 2.5 0.0 0.3 0.0 0.5 0.9 0.0 0.1 0.0 0.0 0.0 0.0 PCDHGC3 "PC-43, PC43, PCDH-GAMMA-C3, PCDH2" ENSG00000240184 "Protocadherin gamma subfamily C, 3" Q9UN70 5 141475947-141512979 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 99.3" "Group enriched" "Detected in some" 7 "Bipolar cells: 6.9;Horizontal cells: 11.1;Muller glia cells: 4.9" "Group enriched" "Detected in all" 6 "glioma: 55.0;melanoma: 20.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "plasmacytoid DC: 15.2" "Lineage enriched" "Detected in single" 22 "dendritic cells: 15.2" "Cell line enhanced" "Detected in many" "ASC diff: 43.5;ASC TERT1: 41.7;HSkMC: 40.8;U-138 MG: 52.4;WM-115: 78.0" "HPA008755, HPA010580, HPA077289" Approved Approved "Plasma membrane" NA NA 74000 "Plasma membrane" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077289: AB_2686832" "unprognostic (2.52e-1)" "unprognostic (4.83e-3)" "unprognostic (1.17e-1)" "unprognostic (6.76e-2)" "unprognostic (3.76e-1)" "unprognostic (3.44e-2)" "unprognostic (4.30e-1)" "unprognostic (1.87e-1)" "unprognostic (1.70e-1)" "prognostic unfavorable (6.19e-4)" "unprognostic (2.03e-1)" "unprognostic (2.22e-1)" "prognostic unfavorable (8.18e-4)" "unprognostic (3.72e-2)" "unprognostic (5.66e-2)" "unprognostic (9.55e-2)" "prognostic unfavorable (6.00e-4)" 14.9 15.0 52.8 7.0 49.0 0.5 11.2 30.1 99.3 28.0 8.7 38.9 2.4 3.8 20.6 27.6 12.8 15.7 14.6 11.0 40.2 25.2 7.1 8.0 20.9 4.2 32.0 24.9 16.6 4.4 18.8 7.9 17.7 25.8 17.1 10.2 17.3 8.4 20.1 5.8 18.3 5.6 19.8 28.1 5.3 6.6 4.8 24.1 0.9 5.4 6.4 7.1 8.6 11.1 0.6 15.2 0.0 0.0 0.0 0.1 0.0 2.8 1.6 10.8 2.9 43.5 41.7 0.1 14.2 37.9 7.0 7.6 0.0 2.7 9.4 9.2 24.7 26.5 10.3 1.4 4.4 6.7 0.0 4.3 0.0 0.2 0.2 13.4 0.1 0.3 40.8 6.8 10.6 8.7 25.8 4.7 0.0 0.0 0.3 17.7 5.2 0.2 1.0 0.4 0.1 0.0 6.3 21.9 0.0 3.7 3.0 3.5 15.4 3.8 0.1 23.3 4.0 8.8 13.1 5.7 52.4 2.7 10.2 15.3 0.0 0.1 0.1 12.5 0.0 78.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 15.2 0.0 0.0 52.8 49.0 30.1 38.9 40.2 25.2 32.0 24.9 25.8 24.1 0.0 0.0 0.0 0.4 0.2 6.9 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.9 0.6 0.0 0.0 0.2 0.1 0.7 0.3 0.0 0.0 0.2 11.1 0.0 0.6 0.3 0.4 1.1 0.0 0.0 0.0 0.0 4.9 0.5 0.0 0.4 0.0 0.9 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.5 PDE3A CGI-PDE ENSG00000172572 "Phosphodiesterase 3A" Q14432 12 20369245-20684381 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" Hydrolase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 62.2" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 41.0;Cardiomyocytes: 107.8;Horizontal cells: 49.3;Smooth muscle cells: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.9;HEL: 14.6;HeLa: 39.5;HUVEC TERT2: 7.1;SH-SY5Y: 14.8;U-138 MG: 11.4" "Low region specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 35.4" "HPA014492, HPA074258" Approved Approved "Plasma membrane" NA NA 23000 "Plasma membrane" "HPA014492: AB_1855120, HPA074258: " "unprognostic (2.59e-2)" "unprognostic (2.94e-2)" "unprognostic (1.25e-1)" "unprognostic (3.23e-1)" "unprognostic (2.27e-1)" "unprognostic (1.21e-1)" "unprognostic (3.50e-2)" "unprognostic (1.67e-2)" "unprognostic (8.14e-2)" "unprognostic (1.49e-1)" "unprognostic (4.25e-1)" "unprognostic (3.37e-1)" "prognostic unfavorable (1.72e-6)" "unprognostic (5.58e-2)" "unprognostic (5.94e-2)" "unprognostic (4.28e-2)" "unprognostic (2.76e-4)" 7.1 1.0 1.7 4.7 2.0 0.0 3.8 3.5 1.4 7.8 15.9 1.0 2.0 2.1 7.8 3.5 9.1 4.9 5.5 62.2 1.6 1.4 3.7 1.8 3.9 3.3 1.9 1.1 7.1 6.5 1.0 2.8 13.8 2.7 6.3 9.0 12.0 7.8 4.2 2.0 1.4 21.4 6.0 1.8 2.1 5.5 2.3 0.7 0.0 2.8 1.9 0.9 4.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 7.9 0.0 1.8 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 14.6 39.5 0.2 0.6 0.0 0.0 1.8 0.0 0.4 0.1 0.1 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.1 0.0 0.0 0.0 2.2 0.0 0.1 14.8 0.0 0.0 0.0 3.5 0.0 0.0 0.2 11.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.7 2.0 3.5 1.4 1.6 1.4 1.9 1.1 2.7 0.7 0.0 0.0 0.0 0.1 0.2 41.0 107.8 5.1 0.0 1.2 0.0 0.0 0.0 0.0 3.7 0.2 2.2 24.6 0.0 0.4 0.0 3.5 0.5 16.2 0.0 0.5 49.3 4.1 0.6 0.0 0.0 1.4 0.0 1.7 0.0 7.4 2.5 0.5 24.6 0.7 2.6 2.2 6.5 51.8 0.2 0.4 0.3 0.0 0.0 13.9 0.2 PHACTR1 "dJ257A7.2, KIAA1733, RPEL1" ENSG00000112137 "Phosphatase and actin regulator 1" Q9C0D0 6 12716805-13290484 "Predicted intracellular proteins" "Actin-binding, Protein phosphatase inhibitor" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.9;brain: 80.3" "Cell type enhanced" "Detected in many" 7 "B-cells: 134.6;Horizontal cells: 170.0;Kupffer cells: 97.1;Macrophages: 102.6" "Cancer enhanced" "Detected in many" "melanoma: 10.2" "Region enhanced" "Detected in all" "basal ganglia: 80.3" "Group enriched" "Detected in many" 13 "memory B-cell: 7.2;myeloid DC: 7.7;naive B-cell: 20.9;neutrophil: 10.1;plasmacytoid DC: 25.9" "Group enriched" "Detected in many" 17 "B-cells: 20.9;dendritic cells: 25.9;granulocytes: 10.1" "Cell line enhanced" "Detected in many" "HMC-1: 16.7;SK-MEL-30: 15.7;U-266/70: 41.2;U-266/84: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029755, HPA029756, HPA029757" Enhanced Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA029755: AB_10600089, HPA029756: AB_10601852, HPA029757: AB_10669870" "unprognostic (7.86e-2)" "unprognostic (7.49e-2)" "unprognostic (2.74e-2)" "unprognostic (2.80e-1)" "unprognostic (1.59e-1)" "unprognostic (1.29e-1)" "unprognostic (7.72e-2)" "unprognostic (4.80e-2)" "unprognostic (1.10e-1)" "unprognostic (1.22e-1)" "unprognostic (3.67e-4)" "unprognostic (1.53e-1)" "prognostic unfavorable (5.48e-6)" "unprognostic (1.31e-1)" "unprognostic (1.43e-1)" "unprognostic (5.00e-2)" "unprognostic (1.16e-1)" 3.5 1.6 11.6 7.2 80.3 22.6 1.6 4.9 31.4 1.4 1.4 1.3 0.3 2.0 1.3 2.6 1.5 1.9 4.2 9.2 10.9 4.4 3.9 1.9 9.0 8.7 2.7 16.6 1.8 4.2 0.5 6.0 1.7 2.2 1.4 1.5 0.6 1.4 0.7 1.2 2.6 2.9 1.7 2.6 6.5 2.0 2.2 7.2 0.4 1.3 0.0 13.4 3.4 1.4 20.9 25.9 10.1 1.1 0.4 0.2 1.1 0.0 0.1 1.1 0.2 0.0 0.0 3.2 0.3 1.2 1.2 2.1 0.1 0.0 0.2 0.4 0.1 1.6 0.1 0.0 0.0 1.5 4.2 0.3 8.4 0.1 0.1 0.1 7.9 16.7 0.4 0.0 0.0 0.1 0.1 1.5 0.5 3.9 7.1 1.2 0.0 0.1 6.1 1.1 0.0 0.0 4.0 2.2 0.7 1.0 0.1 5.0 1.5 0.0 3.2 15.7 1.6 9.6 1.9 1.7 0.1 0.3 0.0 0.0 41.2 26.8 7.0 0.6 2.3 6.4 0.1 1.1 0.6 0.1 0.9 0.0 7.2 0.1 0.0 7.7 20.9 0.1 0.2 10.1 0.4 0.3 25.9 0.0 1.1 11.6 80.3 4.9 31.4 10.9 4.4 2.7 16.6 2.2 7.2 62.5 37.4 134.6 1.5 3.3 35.3 9.1 2.5 9.4 14.8 59.3 3.9 1.2 26.6 0.6 54.5 8.3 0.4 0.0 2.5 2.0 6.2 0.8 80.7 0.8 76.1 170.0 1.7 15.4 97.1 44.3 4.4 102.6 45.5 18.0 0.1 21.8 1.0 0.0 6.0 0.6 13.0 0.0 4.0 1.2 2.7 2.8 1.6 2.5 0.4 0.7 PI3 "cementoin, ELAFIN, ESI, SKALP, WAP3, WFDC14" ENSG00000124102 "Peptidase inhibitor 3" P19957 20 45174876-45176544 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 157.1;esophagus: 200.8;lymphoid tissue: 173.5;tongue: 468.6" "Cell type enhanced" "Detected in many" 21 "Enterocytes: 69.5;Exocrine glandular cells: 290.8;Pancreatic endocrine cells: 135.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 2666.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 1121 "neutrophil: 157.1" "Lineage enriched" "Detected in single" 1571 "granulocytes: 157.1" "Group enriched" "Detected in some" 5 "EFO-21: 26.6;HaCaT: 32.3;OE19: 29.6;PC-3: 55.0" "CAB009449, HPA017737" Enhanced Approved "Plasma membrane" "Secreted to blood" NA NA 2100000 "Plasma membrane" "CAB009449: AB_2252354, HPA017737: AB_1848107" "prognostic favorable (6.94e-4)" "unprognostic (3.61e-2)" "unprognostic (1.00e-1)" "unprognostic (8.30e-2)" "unprognostic (7.34e-2)" "unprognostic (1.85e-1)" "unprognostic (3.20e-3)" "unprognostic (5.53e-3)" "unprognostic (1.75e-1)" "prognostic unfavorable (3.84e-6)" "prognostic unfavorable (6.89e-4)" "unprognostic (8.54e-3)" "prognostic unfavorable (1.94e-8)" "unprognostic (1.23e-1)" "unprognostic (7.38e-2)" "unprognostic (1.04e-2)" "unprognostic (5.91e-3)" 0.4 0.0 0.2 8.8 0.2 0.0 0.7 0.2 0.2 85.3 9.3 0.2 0.4 0.1 7.7 0.2 200.8 0.3 4.8 0.6 0.2 0.0 0.3 0.6 3.1 0.8 0.2 0.2 0.3 0.4 0.0 0.2 0.6 0.3 1.0 3.7 0.3 35.6 0.4 0.2 6.4 3.2 0.6 0.2 1.4 0.7 5.1 0.2 23.4 0.2 468.6 173.5 1.6 118.7 0.0 0.0 157.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.9 0.6 0.4 26.6 0.0 0.3 32.3 0.0 6.6 0.0 0.3 0.0 0.1 2.0 0.2 0.0 0.2 0.0 0.0 6.3 5.2 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 29.6 55.0 0.0 0.2 0.0 6.3 0.1 0.0 0.0 4.5 0.6 0.0 0.0 0.0 0.0 0.2 0.3 3.2 0.0 0.2 0.1 0.4 0.1 4.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 157.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.2 0.0 11.3 0.5 5.2 0.1 0.0 0.0 7.6 0.0 13.6 17.4 0.0 0.0 0.0 14.9 0.1 0.1 69.5 0.0 290.8 0.0 0.3 25.8 4.6 0.0 0.1 0.0 16.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 9.4 0.0 135.9 29.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.3 0.0 0.0 33.5 18.7 PI4K2A "DKFZP761G1923, PI4KII, PIK42A" ENSG00000155252 "Phosphatidylinositol 4-kinase type 2 alpha" Q9BTU6 10 97640686-97676434 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 32.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB030649, HPA076857" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "CAB030649: , HPA076857: AB_2686817" "unprognostic (1.34e-1)" "unprognostic (3.50e-2)" "prognostic unfavorable (4.21e-5)" "unprognostic (1.80e-2)" "unprognostic (2.12e-1)" "unprognostic (1.75e-2)" "unprognostic (2.84e-3)" "unprognostic (1.60e-2)" "unprognostic (1.39e-3)" "unprognostic (1.38e-2)" "unprognostic (1.02e-2)" "unprognostic (1.65e-1)" "unprognostic (9.92e-2)" "unprognostic (1.27e-1)" "unprognostic (1.80e-1)" "unprognostic (1.45e-1)" "unprognostic (2.90e-1)" 17.2 23.0 13.8 10.7 21.2 22.8 9.5 16.8 33.8 12.0 9.1 16.8 9.5 10.9 12.8 15.5 18.3 8.9 16.1 15.2 14.5 17.9 14.7 17.1 15.0 11.0 15.9 15.7 10.6 9.5 23.2 15.5 19.9 30.7 10.3 10.2 23.8 10.1 12.7 11.3 15.3 9.9 15.0 9.9 14.4 8.8 14.9 7.5 8.2 12.0 8.8 11.8 13.6 11.2 4.1 3.7 1.1 3.4 1.9 4.0 1.6 12.1 9.2 7.6 13.5 16.3 11.8 6.1 12.2 27.0 19.3 20.5 8.3 12.1 4.4 7.2 15.4 14.2 11.8 8.4 24.3 16.1 5.3 7.2 3.9 6.5 7.5 15.7 3.5 5.6 12.4 20.8 20.2 36.0 21.2 9.8 8.7 6.1 7.3 13.3 6.2 7.7 2.7 4.9 6.3 8.7 3.6 7.9 4.3 13.2 11.4 2.6 8.4 10.3 2.6 15.2 11.2 7.2 5.6 10.8 9.2 6.9 10.9 9.4 6.5 7.6 7.2 17.1 2.1 3.0 0.0 3.4 0.0 4.0 2.3 2.8 4.1 1.7 3.4 3.7 1.9 1.4 2.6 1.1 1.9 1.6 1.7 3.1 1.6 13.8 21.2 16.8 33.8 14.5 17.9 15.9 15.7 30.7 7.5 3.0 4.8 4.7 4.1 11.8 12.9 9.8 10.2 1.4 2.3 5.2 11.8 11.6 3.3 4.0 1.9 5.0 8.3 0.0 4.2 5.3 9.4 4.3 1.1 9.3 32.1 11.1 2.9 3.1 11.0 1.7 4.0 17.5 10.1 22.6 2.5 6.9 5.7 0.0 8.5 6.2 14.2 6.5 5.9 9.1 5.6 12.5 22.7 7.0 2.5 7.1 PIGW "FLJ37433, Gwt1" ENSG00000277161 "Phosphatidylinositol glycan anchor biosynthesis class W" Q7Z7B1 17 36535020-36539310 "Disease related genes, Predicted membrane proteins" "GPI-anchor biosynthesis" "Acyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023499 Approved "Plasma membrane" No Yes "Plasma membrane" "HPA023499: " "unprognostic (4.96e-3)" "unprognostic (3.84e-2)" "unprognostic (5.40e-3)" "unprognostic (7.39e-2)" "unprognostic (2.32e-1)" "unprognostic (7.71e-2)" "unprognostic (8.14e-3)" "unprognostic (1.05e-1)" "unprognostic (1.89e-1)" "unprognostic (4.62e-2)" "unprognostic (1.98e-1)" "unprognostic (3.29e-1)" "unprognostic (1.73e-2)" "unprognostic (1.41e-1)" "unprognostic (8.96e-2)" "unprognostic (1.08e-3)" "unprognostic (1.88e-1)" 3.0 2.4 2.5 4.9 2.9 3.0 4.5 1.8 6.4 2.5 3.8 2.4 0.4 3.3 3.2 4.4 5.7 2.0 2.7 3.5 2.3 6.7 12.0 2.9 4.7 3.6 2.2 4.3 4.8 3.3 6.0 2.6 6.3 2.1 4.8 3.7 3.7 2.8 6.5 5.0 3.9 3.1 3.2 4.3 3.3 3.4 2.2 4.0 4.1 8.1 5.5 2.4 1.2 4.4 6.2 1.1 4.9 4.8 5.8 3.3 7.3 9.7 6.8 6.2 2.9 2.6 8.9 8.9 3.9 8.1 6.7 8.5 7.7 11.0 2.7 4.9 8.9 10.4 11.9 5.0 11.1 6.1 12.6 9.5 6.1 6.8 2.3 19.5 10.5 3.0 5.8 8.9 4.0 1.8 4.5 3.6 16.0 7.0 5.6 5.4 9.6 5.8 9.7 4.3 6.6 8.6 16.0 10.8 4.3 9.7 13.5 10.2 12.7 4.7 6.3 6.4 17.0 3.0 6.1 13.9 16.9 13.4 15.7 5.9 18.6 13.2 3.7 9.9 12.5 1.1 2.8 0.5 3.6 4.2 5.6 2.5 4.7 3.6 6.2 4.4 5.8 5.2 0.9 4.8 4.9 2.9 2.4 3.3 3.0 1.9 1.5 7.4 3.1 2.0 1.2 10.2 2.7 3.4 0.0 0.0 5.2 6.6 4.6 0.1 2.8 1.4 0.0 5.5 5.1 3.7 4.9 0.0 5.3 4.0 3.2 1.2 1.3 2.1 0.2 2.6 2.7 0.0 2.8 3.5 5.6 4.7 3.1 2.1 3.8 2.7 0.0 3.1 2.6 7.3 5.9 3.4 4.3 5.0 4.8 PITPNM3 "ACKR6, CORD5, NIR1, RDGBA3" ENSG00000091622 "PITPNM family member 3" Q9BZ71 17 6451264-6556494 "Disease related genes, Predicted intracellular proteins" "Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.0;lymphoid tissue: 43.3;ovary: 24.2" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 16.8;Ito cells: 35.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 58 "neutrophil: 5.8" "Lineage enriched" "Detected in single" 58 "granulocytes: 5.8" "Cell line enhanced" "Detected in some" "HaCaT: 11.3;HeLa: 8.8;hTCEpi: 33.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022432, HPA059005" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA022432: AB_2670936, HPA059005: AB_2683876" "unprognostic (2.97e-2)" "unprognostic (8.60e-3)" "unprognostic (1.45e-2)" "unprognostic (1.52e-1)" "unprognostic (2.69e-2)" "prognostic favorable (3.67e-6)" "unprognostic (1.25e-2)" "unprognostic (6.86e-2)" "unprognostic (3.66e-2)" "unprognostic (3.01e-2)" "unprognostic (2.99e-3)" "unprognostic (3.58e-2)" "unprognostic (2.41e-1)" "unprognostic (9.60e-2)" "unprognostic (1.61e-1)" "unprognostic (3.55e-1)" "unprognostic (2.63e-1)" 1.1 2.4 17.9 1.2 18.8 0.5 1.7 18.7 23.0 2.4 4.5 0.7 3.4 1.5 1.9 3.4 9.4 4.3 3.8 0.8 7.2 5.2 1.5 1.6 3.1 0.6 2.9 11.9 24.2 0.9 1.9 0.7 0.6 2.5 2.7 3.6 2.3 1.9 8.3 1.1 14.3 1.4 3.8 0.9 43.3 3.2 2.4 1.5 0.0 2.4 0.7 2.1 1.3 2.5 0.0 0.0 5.8 0.0 0.0 0.0 0.0 5.6 0.6 0.4 0.2 0.0 0.1 0.4 0.4 0.1 0.5 0.4 0.3 4.0 0.1 2.1 0.1 1.5 11.3 0.2 2.3 0.2 0.2 0.4 0.1 8.8 0.1 0.6 0.2 0.4 0.1 33.0 0.6 1.9 2.7 0.3 0.4 0.1 0.0 0.3 0.5 0.1 0.1 0.6 2.8 1.6 0.2 1.2 0.0 0.8 0.1 0.3 0.3 5.2 2.4 0.1 0.2 0.8 0.0 0.2 0.3 2.1 0.4 1.3 0.3 0.1 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 17.9 18.8 18.7 23.0 7.2 5.2 2.9 11.9 2.5 1.5 3.0 16.8 0.0 1.7 4.5 6.9 2.2 7.6 8.1 9.1 1.8 3.9 0.0 0.0 2.2 3.8 2.7 5.4 0.0 0.5 0.0 0.6 1.5 5.7 0.9 0.1 4.8 1.2 35.0 4.9 1.3 0.6 0.0 0.0 0.0 3.6 0.5 5.9 5.8 0.0 0.0 10.2 0.0 0.5 2.1 1.6 5.1 0.1 0.8 6.0 3.6 PLAUR "CD87, UPAR, URKR" ENSG00000011422 "Plasminogen activator, urokinase receptor" Q03405 19 43646095-43670547 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 118.0;bone marrow: 165.0" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 664.4;Macrophages: 801.6;Urothelial cells: 2343.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 118.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 50.2;U-251 MG: 71.3;U-87 MG: 62.2;WM-115: 60.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA050843, CAB073533" Uncertain Supported "Plasma membrane" "Intracellular and membrane" NA NA 760000 "Plasma membrane" "CAB073533: , HPA050843: AB_2681255" "unprognostic (9.28e-2)" "unprognostic (9.65e-3)" "unprognostic (1.39e-1)" "unprognostic (1.29e-3)" "unprognostic (3.59e-3)" "unprognostic (1.50e-2)" "unprognostic (2.18e-3)" "prognostic unfavorable (2.33e-5)" "unprognostic (8.08e-3)" "unprognostic (4.30e-2)" "unprognostic (2.29e-3)" "unprognostic (5.30e-2)" "prognostic unfavorable (7.83e-9)" "unprognostic (4.99e-2)" "unprognostic (1.66e-1)" "unprognostic (5.45e-2)" "unprognostic (9.33e-2)" 25.2 3.6 3.0 23.6 4.8 165.0 6.3 2.2 6.1 10.7 7.5 4.4 1.8 3.3 9.5 6.0 8.6 10.6 23.0 11.5 4.5 3.2 5.1 6.1 39.4 8.1 6.0 1.1 11.9 4.3 2.5 4.4 12.2 6.9 6.1 6.0 4.6 11.0 3.7 7.9 3.5 7.3 7.2 7.1 12.6 12.0 6.3 6.3 2.5 4.4 7.7 7.0 22.7 14.9 0.2 21.3 118.0 50.5 0.6 0.9 21.0 14.3 5.0 4.5 0.3 4.1 14.6 2.8 30.0 30.5 19.0 23.8 0.4 16.9 0.5 7.6 18.5 11.0 6.1 1.2 7.4 21.2 0.9 0.9 2.7 7.5 0.6 5.2 3.2 34.9 15.0 1.5 50.2 7.5 27.8 20.9 3.3 2.7 0.6 18.2 1.0 3.4 8.6 1.5 25.7 10.8 4.0 3.0 1.0 5.9 0.7 0.2 3.9 13.4 3.1 3.9 2.3 0.6 10.0 21.4 41.9 21.5 19.1 71.3 0.6 1.4 0.1 62.2 5.8 60.6 7.2 48.9 72.4 0.7 41.5 0.8 0.2 0.9 0.6 21.3 0.1 0.3 0.4 118.0 0.6 50.5 6.8 0.3 21.0 3.0 4.8 2.2 6.1 4.5 3.2 6.0 1.1 6.9 6.3 68.5 114.1 4.7 664.4 93.4 0.4 3.5 15.3 20.1 44.3 19.2 0.0 4.1 1.7 219.5 0.8 49.2 68.8 0.0 94.2 28.2 110.9 445.0 294.8 1.3 440.8 9.5 14.3 18.4 142.0 0.9 6.4 801.6 69.2 13.6 15.1 1.2 350.1 4.9 3.9 2.4 0.6 6.5 151.4 0.9 3.2 55.2 11.0 9.6 5.0 2343.3 PLCB1 "KIAA0581, PLC-I, PLC154" ENSG00000182621 "Phospholipase C beta 1" Q9NQ66 20 8077251-8968360 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 56.7" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 29.3;Distal tubular cells: 28.2;Endothelial cells: 30.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 22.0;Hep G2: 33.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004275, CAB005334, HPA034743, HPA057910" Enhanced Approved "Plasma membrane" NA NA 5400 "Plasma membrane" "CAB004275: AB_628118, CAB005334: AB_632196, HPA034743: AB_2674311, HPA057910: AB_2683552" "unprognostic (2.32e-1)" "unprognostic (1.02e-1)" "unprognostic (6.63e-2)" "unprognostic (9.77e-2)" "unprognostic (9.87e-2)" "unprognostic (2.37e-1)" "unprognostic (1.27e-4)" "unprognostic (1.13e-1)" "unprognostic (3.16e-2)" "unprognostic (1.91e-1)" "unprognostic (7.12e-3)" "unprognostic (6.57e-2)" "unprognostic (2.87e-3)" "unprognostic (3.20e-2)" "unprognostic (4.41e-2)" "unprognostic (1.71e-2)" "unprognostic (2.12e-1)" 5.6 7.0 13.8 4.4 27.7 3.4 5.9 7.5 31.1 6.5 9.9 2.1 20.6 5.5 8.0 10.3 4.5 7.4 6.6 8.6 15.7 9.1 10.0 3.1 4.0 1.6 9.3 14.5 3.2 10.8 56.7 4.6 14.2 5.5 10.4 3.6 1.3 19.7 22.2 9.8 2.3 4.5 12.3 4.0 2.9 5.5 2.6 8.0 4.1 3.1 1.9 1.1 8.6 6.3 0.5 0.8 2.8 3.3 2.4 5.2 0.4 0.0 0.6 2.3 0.1 4.3 8.3 3.2 9.8 6.5 2.6 1.6 22.0 2.4 1.0 4.1 1.9 0.1 0.0 1.8 0.0 1.9 0.0 2.1 0.4 1.6 33.1 1.1 0.5 0.3 0.5 0.4 3.5 0.0 3.3 5.2 6.3 3.3 12.9 0.0 2.9 0.5 1.6 7.4 5.1 3.6 7.0 0.0 5.8 2.0 8.1 8.5 3.6 0.0 2.0 0.4 8.9 9.8 3.2 0.9 8.5 3.8 0.6 6.1 9.7 11.2 16.6 4.3 6.1 14.5 0.8 3.3 2.8 3.6 0.7 5.2 0.2 1.0 1.3 0.4 0.5 0.5 1.1 2.1 2.4 0.4 0.8 0.2 0.4 13.8 27.7 7.5 30.8 15.7 9.1 9.3 14.5 5.5 8.0 0.0 4.3 0.8 17.4 1.6 0.8 29.3 5.1 16.0 3.4 15.7 0.0 1.9 28.2 0.9 7.6 30.5 0.3 0.0 11.3 1.9 7.9 21.8 1.1 2.1 0.7 1.6 0.0 21.5 4.6 3.1 3.1 2.5 6.8 1.0 1.9 16.3 2.4 0.0 3.5 7.9 3.7 0.0 13.0 3.1 4.3 1.5 1.5 5.1 1.2 16.2 PLCD3 ENSG00000161714 "Phospholipase C delta 3" Q8N3E9 17 45108967-45133354 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 63.6" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 138.0;Paneth cells: 62.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 40.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025711, HPA053665" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA025711: AB_1855320, HPA053665: AB_2732580" "unprognostic (3.58e-2)" "unprognostic (1.66e-1)" "unprognostic (2.77e-2)" "unprognostic (1.27e-2)" "unprognostic (2.66e-1)" "unprognostic (4.14e-3)" "unprognostic (8.13e-3)" "prognostic unfavorable (2.89e-6)" "unprognostic (2.96e-1)" "unprognostic (9.53e-2)" "unprognostic (1.34e-3)" "unprognostic (6.21e-2)" "unprognostic (3.18e-2)" "unprognostic (2.07e-1)" "unprognostic (1.62e-1)" "prognostic favorable (4.28e-4)" "unprognostic (3.34e-3)" 5.7 12.0 10.1 4.8 16.5 2.4 6.6 12.2 12.9 5.0 24.9 14.0 2.8 2.9 6.3 6.4 8.9 5.8 9.4 13.1 11.6 6.6 3.6 1.2 4.5 1.7 13.9 11.4 9.9 2.7 1.5 3.0 5.7 19.5 5.8 13.7 10.3 4.7 5.7 63.6 9.9 2.8 12.9 15.0 2.0 17.9 5.4 14.6 0.0 2.3 20.1 2.8 17.5 10.5 1.3 0.9 2.9 1.5 1.3 0.9 0.5 8.4 21.1 1.5 3.1 2.3 5.0 10.7 4.6 10.4 4.3 4.1 5.1 15.5 0.3 16.7 10.8 3.5 19.3 2.4 19.9 1.7 4.2 7.9 0.3 22.2 6.6 11.9 0.4 1.2 5.4 8.0 3.9 5.3 11.0 2.6 0.9 1.8 0.6 4.6 13.2 1.3 1.9 1.8 40.6 20.8 3.0 3.5 0.5 13.6 16.9 0.4 2.7 5.0 8.4 4.5 3.4 17.9 0.9 5.3 2.7 14.8 3.5 5.4 0.8 0.9 0.6 4.4 0.5 2.1 2.3 1.5 2.4 0.9 1.5 0.6 1.0 0.7 0.6 0.5 1.3 0.9 0.8 2.9 1.3 0.3 0.9 0.6 0.5 10.1 16.5 12.2 11.5 11.6 6.6 13.9 11.4 19.5 14.6 11.9 2.2 0.0 10.9 6.8 27.2 23.8 12.7 1.4 2.3 7.0 23.6 2.5 1.7 7.0 12.5 9.2 138.0 0.0 2.9 7.2 8.2 9.8 1.1 0.4 1.5 6.4 4.7 8.6 0.3 3.6 18.4 0.3 3.3 1.0 13.0 6.8 18.3 62.6 31.1 1.7 37.9 6.5 4.2 1.9 6.6 5.0 6.1 0.0 26.3 40.1 PLPP1 "LPP1, PAP-2a, PPAP2A" ENSG00000067113 "Phospholipid phosphatase 1" O14494 5 55424854-55535050 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Ito cells: 254.8;Leydig cells: 203.1" "Cancer enhanced" "Detected in all" "prostate cancer: 200.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 93.3;fHDF/TERT166: 28.4;HMC-1: 48.9;HSkMC: 35.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033331, HPA047815" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB033331: AB_2168044, HPA047815: AB_2680164" "unprognostic (1.22e-1)" "unprognostic (1.54e-1)" "unprognostic (1.74e-1)" "unprognostic (1.55e-2)" "unprognostic (2.52e-1)" "unprognostic (1.36e-1)" "prognostic favorable (6.06e-4)" "unprognostic (2.81e-1)" "unprognostic (2.20e-1)" "unprognostic (4.05e-3)" "unprognostic (2.43e-2)" "unprognostic (1.05e-1)" "unprognostic (4.37e-3)" "prognostic unfavorable (5.77e-4)" "unprognostic (3.94e-2)" "unprognostic (1.66e-1)" "unprognostic (3.11e-2)" 56.3 26.7 12.5 14.8 14.6 0.6 57.9 10.6 18.5 34.5 30.9 26.1 18.0 17.3 36.8 26.0 18.4 20.4 61.0 33.7 13.4 10.8 34.5 42.0 15.9 17.3 20.8 10.1 16.5 17.6 16.9 10.1 22.4 21.4 82.0 24.7 29.8 9.8 24.0 18.4 16.6 25.4 39.6 28.2 10.2 21.7 18.1 14.5 4.4 32.7 9.6 10.0 43.1 18.1 5.4 13.6 3.3 0.7 2.7 9.5 1.6 2.0 4.9 1.4 2.9 93.3 10.9 2.0 4.4 12.4 2.4 5.8 3.4 3.6 2.0 4.2 28.4 6.7 1.3 5.1 2.5 2.8 1.3 4.0 0.2 2.1 4.2 14.7 0.5 48.9 35.8 5.3 3.6 2.2 4.9 4.0 1.9 0.0 5.7 4.9 1.2 1.3 1.0 3.3 0.2 4.0 0.4 2.4 0.1 9.3 15.9 1.8 1.2 4.4 0.9 2.6 6.4 3.2 0.3 4.9 0.8 1.5 3.7 3.1 3.5 1.4 2.4 3.3 0.2 4.0 0.0 0.4 3.3 1.5 0.4 1.6 5.4 5.2 3.2 1.9 3.4 9.5 7.5 0.3 2.7 0.7 13.6 2.2 1.6 12.5 14.6 10.6 18.5 13.4 10.8 20.8 10.1 21.4 14.5 6.0 10.3 3.9 48.9 0.0 5.2 0.0 15.3 4.0 10.3 27.9 2.0 2.2 5.0 22.3 30.3 45.0 26.9 0.0 24.7 9.6 32.8 109.6 25.6 50.5 11.0 1.6 1.2 254.8 14.9 19.1 203.1 3.6 0.0 7.2 23.2 14.3 28.1 29.4 83.1 24.5 4.8 58.2 0.0 47.0 18.1 0.0 4.1 4.3 14.9 41.0 PLXNA4 "DKFZp434G0625PRO34003, FAYV2820, KIAA1550, PLXNA4A, PLXNA4B" ENSG00000221866 "Plexin A4" Q9HCM2 7 132123332-132648688 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.2;breast: 34.7" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 9.9;Cardiomyocytes: 9.5;Collecting duct cells: 12.2;Cone photoreceptor cells: 15.7;Early spermatids: 9.9;Leydig cells: 13.0;Muller glia cells: 10.0" "Cancer enhanced" "Detected in many" "glioma: 3.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 6.1" "Lineage enriched" "Detected in many" 5 "dendritic cells: 6.1" "Cell line enhanced" "Detected in some" "ASC diff: 15.0;HMC-1: 10.0;hTERT-RPE1: 12.9;RH-30: 10.7;TIME: 32.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029919, HPA052141, HPA075592" Approved Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA029919: AB_10671093, HPA052141: AB_2681745, HPA075592: AB_2732297" "unprognostic (2.05e-2)" "unprognostic (3.59e-2)" "unprognostic (2.08e-2)" "prognostic unfavorable (1.61e-6)" "unprognostic (5.76e-2)" "unprognostic (1.21e-2)" "unprognostic (1.28e-2)" "unprognostic (2.43e-2)" "unprognostic (2.19e-1)" "unprognostic (7.99e-2)" "unprognostic (7.64e-2)" "unprognostic (1.14e-1)" "unprognostic (1.69e-5)" "unprognostic (1.67e-1)" "unprognostic (2.28e-1)" "unprognostic (5.90e-2)" "unprognostic (1.42e-3)" 23.2 5.1 8.7 3.5 9.0 1.1 34.7 3.9 15.1 16.2 2.0 1.0 0.8 1.5 2.3 1.0 7.7 3.0 4.2 6.9 9.7 7.2 2.0 1.3 1.8 2.5 4.0 6.6 6.2 1.0 1.0 1.6 6.7 6.6 1.4 2.1 0.7 1.2 2.4 1.7 4.1 1.4 5.1 1.5 2.4 2.8 2.4 1.8 0.0 3.3 0.0 1.3 2.1 9.4 0.0 6.1 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.1 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 10.0 0.1 0.0 0.0 0.0 12.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 10.7 1.1 0.0 0.0 0.2 5.6 0.0 0.0 0.0 0.1 0.0 0.0 32.6 3.3 0.1 0.7 0.2 0.0 0.0 0.0 3.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.1 0.0 6.1 0.0 0.0 8.7 9.0 3.9 15.1 9.7 7.2 4.0 6.6 6.6 1.8 0.0 0.0 0.0 0.1 0.6 9.9 9.5 0.0 0.0 0.0 12.2 15.7 0.0 0.0 0.0 9.9 0.7 0.0 0.0 0.0 0.1 5.4 0.2 1.1 0.0 0.1 0.0 1.2 1.8 0.0 5.9 13.0 0.0 6.8 0.0 0.0 10.0 0.4 0.0 6.7 0.3 1.4 0.0 1.4 0.2 0.1 1.1 0.0 0.0 0.0 0.5 PPP1R16A "MGC14333, MYPT3" ENSG00000160972 "Protein phosphatase 1 regulatory subunit 16A" Q96I34 8 144477969-144502121 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 23.3" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 167.9;Proximal tubular cells: 269.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 26.1" "Low region specificity" "Detected in all" HPA023755 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA023755: AB_1854268" "unprognostic (9.63e-2)" "unprognostic (4.51e-2)" "unprognostic (5.45e-3)" "unprognostic (3.11e-1)" "unprognostic (5.60e-2)" "unprognostic (3.75e-2)" "unprognostic (4.64e-3)" "unprognostic (2.65e-1)" "unprognostic (3.68e-2)" "unprognostic (2.20e-2)" "unprognostic (1.52e-2)" "unprognostic (1.35e-1)" "unprognostic (1.05e-1)" "unprognostic (1.29e-2)" "unprognostic (1.03e-1)" "unprognostic (9.45e-2)" "unprognostic (2.79e-2)" 3.0 3.8 6.5 3.1 6.8 2.2 3.0 3.3 4.8 3.0 11.1 3.0 3.0 20.5 3.0 3.0 3.0 6.7 3.0 3.0 6.5 4.6 6.5 5.3 3.0 3.0 3.1 3.0 3.0 5.7 4.0 10.2 3.0 3.0 3.4 1.6 3.0 5.4 4.5 3.4 3.7 23.3 3.0 3.0 3.0 7.8 7.4 3.0 3.0 6.8 3.0 3.0 3.0 3.0 2.5 3.2 0.7 4.1 0.7 3.2 2.1 15.8 12.9 2.1 8.2 0.9 1.5 10.6 4.4 2.8 3.4 2.8 3.4 11.4 2.6 11.6 1.6 3.1 10.5 1.1 3.6 0.5 5.3 6.4 3.1 12.5 3.5 2.6 2.2 4.3 1.5 4.9 4.0 1.1 2.2 2.4 4.4 12.3 3.3 1.2 26.1 7.9 10.4 4.0 8.2 16.4 8.3 1.0 5.2 3.1 5.3 6.8 13.1 8.0 7.4 6.6 0.5 17.5 4.8 4.1 3.9 18.4 10.8 8.3 2.2 2.1 0.9 12.6 4.3 3.5 0.0 2.3 0.0 3.2 3.4 2.8 2.5 2.3 2.9 3.2 0.5 1.7 3.1 0.7 0.7 4.1 1.8 1.7 2.1 6.5 6.8 3.3 4.8 6.5 4.6 3.1 3.0 3.0 3.0 3.0 12.5 7.3 31.2 38.4 23.1 75.5 101.9 32.1 17.0 38.4 13.7 6.0 102.8 26.8 8.2 10.5 167.9 0.0 36.4 19.6 9.1 37.1 3.5 156.2 5.4 28.6 49.5 10.4 7.6 9.5 21.0 12.3 8.5 2.8 69.6 87.7 27.8 95.1 14.5 269.6 48.8 6.5 13.3 58.4 27.0 54.1 5.6 6.2 83.9 21.8 PPP1R9A "FLJ20068, KIAA1222, Neurabin-I" ENSG00000158528 "Protein phosphatase 1 regulatory subunit 9A" Q9ULJ8 7 94907202-95296415 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 109.7;Rod photoreceptor cells: 85.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 5.8;NK-cell: 10.9" "Group enriched" "Detected in many" 6 "granulocytes: 5.8;NK-cells: 10.9" "Cell line enhanced" "Detected in many" "HAP1: 10.5;RH-30: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027726, HPA075591" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA027726: AB_1855653, HPA075591: AB_2732296" "unprognostic (1.05e-1)" "unprognostic (6.59e-2)" "unprognostic (5.90e-2)" "unprognostic (1.63e-2)" "unprognostic (1.35e-1)" "unprognostic (1.12e-1)" "unprognostic (8.62e-2)" "unprognostic (6.19e-2)" "unprognostic (1.45e-1)" "prognostic favorable (7.17e-4)" "unprognostic (2.26e-2)" "unprognostic (1.89e-1)" "prognostic favorable (8.63e-6)" "unprognostic (2.74e-1)" "unprognostic (4.85e-2)" "unprognostic (8.47e-2)" "unprognostic (8.79e-3)" 2.9 11.7 11.0 1.9 23.5 0.8 8.1 10.9 19.7 5.2 8.7 7.4 7.7 3.0 5.4 9.2 3.2 9.6 4.4 8.2 11.5 9.7 8.2 1.1 6.4 0.9 8.1 13.7 5.0 14.3 16.5 15.5 4.5 12.7 4.2 6.8 5.7 14.2 5.3 6.7 1.1 3.0 5.1 9.1 3.2 6.2 10.0 11.2 0.0 10.9 1.3 1.0 4.2 1.4 1.3 0.3 5.8 0.1 10.9 0.2 0.2 0.0 9.4 6.0 6.7 0.0 0.0 4.8 0.4 0.1 0.9 0.7 5.2 3.1 0.0 8.0 0.4 0.6 0.0 10.5 0.0 1.2 0.0 4.0 9.6 3.8 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.7 4.0 0.1 0.0 4.9 4.3 1.7 0.0 10.5 0.0 9.8 7.8 6.4 6.6 0.0 0.8 1.3 3.9 2.0 0.0 0.0 0.1 3.9 0.1 3.4 6.4 9.2 0.0 0.1 0.0 0.7 5.8 0.0 0.5 0.0 0.0 0.2 0.9 0.0 0.0 0.0 1.3 0.0 0.0 0.0 10.9 0.1 0.3 0.0 0.2 11.0 23.5 10.9 18.3 11.5 9.7 8.1 13.7 12.7 11.2 38.7 49.4 0.0 0.8 0.3 51.3 109.7 7.6 33.5 26.1 45.4 53.0 16.9 3.3 20.0 13.6 2.2 8.8 0.0 6.1 2.0 1.4 8.0 5.7 1.3 1.5 1.6 37.3 8.0 0.0 12.2 2.3 0.4 6.8 0.0 13.4 56.5 7.0 10.5 0.7 6.2 85.0 0.0 3.1 18.2 10.2 0.6 27.7 0.0 16.4 1.0 PRRT2 "DKFZp547J199, DSPB3, DYT10, EKD1, FICCA, FLJ25513, ICCA, IFITMD1, PKC" ENSG00000167371 "Proline rich transmembrane protein 2" Q7Z6L0 16 29811382-29815892 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation, Dystonia, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 86.7" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 79.8;Cone photoreceptor cells: 29.5;Leydig cells: 33.4;Peritubular cells: 37.8;Rod photoreceptor cells: 40.1" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "NK-cell: 7.3" "Lineage enriched" "Detected in single" 11 "NK-cells: 7.3" "Cell line enhanced" "Detected in many" "AF22: 19.8;hTERT-RPE1: 12.2;REH: 15.1;U-138 MG: 13.7" "HPA014447, HPA019203, HPA048045" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA014447: AB_1855786, HPA019203: AB_2670097, HPA048045: " "unprognostic (7.60e-3)" "unprognostic (3.00e-1)" "unprognostic (8.32e-3)" "unprognostic (4.34e-2)" "unprognostic (3.72e-2)" "unprognostic (1.19e-3)" "unprognostic (2.85e-1)" "unprognostic (1.23e-1)" "unprognostic (9.30e-2)" "unprognostic (1.93e-1)" "unprognostic (4.45e-2)" "unprognostic (3.26e-2)" "unprognostic (3.43e-8)" "unprognostic (1.22e-1)" "unprognostic (1.17e-1)" "unprognostic (5.12e-2)" "unprognostic (2.44e-2)" 3.7 7.2 27.2 2.8 40.5 0.8 2.1 86.7 53.6 10.1 6.0 6.0 3.1 6.2 20.7 8.3 4.4 10.2 10.3 5.3 18.9 13.0 2.1 0.9 5.7 3.5 5.5 33.2 35.7 2.4 8.6 17.6 7.1 18.0 16.2 2.6 5.2 4.6 14.4 4.3 3.1 6.8 10.3 7.4 1.8 7.3 9.9 10.2 0.0 2.8 0.3 1.6 5.1 10.7 0.2 0.0 0.5 0.2 7.3 0.6 0.3 0.3 1.2 19.8 7.4 1.0 3.7 0.5 2.4 4.0 0.8 0.9 1.1 2.3 0.2 0.4 3.2 0.6 2.0 2.7 0.4 0.3 5.2 1.6 1.3 8.8 0.8 0.2 0.0 0.3 3.4 0.1 1.4 0.1 12.2 1.0 0.6 0.2 1.6 0.6 3.3 0.5 0.6 5.7 0.0 1.0 15.1 1.1 0.4 0.1 0.7 4.3 4.5 0.2 2.9 0.4 3.2 7.3 0.1 1.1 13.7 4.8 0.8 1.3 3.4 0.4 0.1 5.4 0.1 0.5 0.5 0.0 0.1 0.2 0.1 0.3 0.1 0.6 0.4 0.0 0.2 0.4 0.2 0.2 7.3 0.2 0.0 0.1 0.3 27.2 40.5 86.7 53.6 18.9 13.0 5.5 33.2 18.0 10.2 3.0 0.0 0.0 1.3 1.0 79.8 0.8 0.0 6.7 1.2 0.0 29.5 1.5 1.7 1.1 1.7 2.0 9.6 0.0 1.4 0.6 9.3 1.4 0.0 0.0 0.3 19.1 5.8 2.5 0.0 6.3 33.4 0.0 0.0 1.0 2.0 6.5 2.3 10.5 37.8 0.2 40.1 6.5 13.2 2.4 3.2 0.4 2.2 0.0 1.7 1.0 PSCA ENSG00000167653 "Prostate stem cell antigen" O43653 8 142670308-142682724 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 72.6;stomach 1: 230.2;urinary bladder: 112.0" "Cell type enhanced" "Detected in many" 19 "Cholangiocytes: 124.9;Glandular cells: 317.3;Intestinal endocrine cells: 265.2;Urothelial cells: 540.7" "Cancer enriched" "Detected in many" 6 "urothelial cancer: 785.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.6;HeLa: 22.6;OE19: 8.9;RT4: 32.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030783, HPA056418" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA030783: AB_2673611, HPA056418: AB_2683123" "unprognostic (1.21e-3)" "unprognostic (1.76e-3)" "unprognostic (3.20e-1)" "unprognostic (2.24e-1)" "unprognostic (1.77e-2)" "unprognostic (7.57e-2)" "unprognostic (1.93e-2)" "unprognostic (7.81e-3)" "unprognostic (8.25e-3)" "unprognostic (2.13e-1)" "prognostic unfavorable (5.60e-5)" "unprognostic (6.82e-2)" "unprognostic (2.38e-3)" "unprognostic (4.93e-2)" "unprognostic (2.68e-1)" "unprognostic (3.07e-1)" "unprognostic (1.06e-3)" 0.4 0.2 0.0 0.2 0.0 0.2 0.3 0.0 0.2 7.0 2.4 0.7 0.1 0.6 0.3 0.2 72.6 1.1 21.2 0.1 0.0 0.0 2.6 0.1 3.0 0.2 0.0 0.0 0.1 0.3 0.1 0.5 17.2 0.0 30.1 0.7 0.1 11.7 0.6 0.1 0.8 1.5 18.9 0.0 0.2 230.2 0.2 0.0 0.0 0.1 9.3 35.1 112.0 54.5 0.0 0.8 0.0 0.3 0.0 0.0 0.0 5.4 0.3 0.0 0.0 1.1 3.7 5.6 2.5 0.6 1.1 0.9 0.0 11.6 0.0 0.2 0.2 4.2 1.1 0.0 0.2 0.7 0.3 0.0 0.0 22.6 0.0 0.0 0.0 0.8 3.2 4.1 2.4 0.0 0.3 0.0 0.0 0.0 0.0 0.8 3.0 0.8 0.3 0.6 8.9 0.6 0.3 0.0 0.4 0.5 32.2 0.1 0.2 2.7 8.3 1.7 0.2 0.1 0.1 0.5 0.8 0.9 1.5 0.0 1.0 0.0 0.0 1.5 0.4 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.0 0.0 16.8 0.8 0.0 1.0 124.9 115.1 19.4 1.8 0.0 2.1 6.6 0.3 0.2 0.0 0.0 0.0 1.0 1.8 0.3 317.3 0.0 0.0 0.6 0.0 265.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.9 0.0 33.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.6 1.1 23.8 0.0 0.6 540.7 PSD2 "DKFZp761B0514, EFA6C" ENSG00000146005 "Pleckstrin and Sec7 domain containing 2" Q9BQI7 5 139795821-139844466 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "brain: 52.4" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 1.5;Muller glia cells: 2.7;Spermatocytes: 1.4" "Cancer enriched" "Detected in single" 43 "glioma: 19.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 3.6;SCLC-21H: 2.2;SH-SY5Y: 3.6;U-2 OS: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054625 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA054625: " "unprognostic (3.76e-2)" "unprognostic (1.90e-1)" "unprognostic (1.34e-3)" "unprognostic (2.48e-3)" "unprognostic (1.34e-2)" "unprognostic (5.01e-2)" "unprognostic (1.22e-2)" "unprognostic (6.55e-2)" "unprognostic (2.42e-1)" "unprognostic (2.17e-1)" "unprognostic (2.53e-1)" "unprognostic (4.02e-1)" "unprognostic (4.16e-3)" "unprognostic (3.40e-2)" "unprognostic (2.28e-1)" "unprognostic (3.07e-1)" "unprognostic (2.12e-3)" 1.3 1.7 21.1 1.3 28.9 1.3 1.7 12.6 52.4 1.9 1.3 15.2 0.0 1.4 1.4 3.6 1.3 1.6 1.3 1.4 16.1 15.2 1.3 1.3 1.3 1.3 18.9 14.4 1.3 1.6 1.3 0.2 1.3 24.7 1.4 1.3 0.0 3.5 1.7 1.4 1.3 1.3 1.4 12.8 1.4 1.3 2.2 17.0 0.0 1.3 0.0 1.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.1 0.2 0.9 0.1 0.2 0.0 0.0 0.2 0.3 0.9 1.4 0.0 0.2 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.4 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.1 2.2 3.6 0.0 0.7 0.1 0.3 0.0 0.2 0.0 0.2 1.7 0.0 0.0 1.0 0.0 1.5 1.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 28.9 12.6 17.5 16.1 15.2 18.9 14.4 24.7 17.0 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 0.0 PTPRG "PTPG, RPTPG" ENSG00000144724 "Protein tyrosine phosphatase, receptor type G" P23470 3 61561569-62297613 "Enzymes, Plasma proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 91.5;Horizontal cells: 146.2;Ito cells: 89.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 36.2;HSkMC: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000546, HPA064237" Uncertain Approved "Plasma membrane" NA NA 520000000 "Plasma membrane" "HPA000546: , HPA064237: AB_2685221" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (1.31e-2)" "unprognostic (1.93e-1)" "unprognostic (8.73e-2)" "unprognostic (3.26e-1)" "unprognostic (5.38e-2)" "unprognostic (1.18e-2)" "unprognostic (5.84e-2)" "unprognostic (2.28e-1)" "unprognostic (2.86e-1)" "unprognostic (1.14e-1)" "prognostic favorable (3.10e-6)" "unprognostic (9.91e-2)" "unprognostic (3.25e-1)" "unprognostic (1.19e-1)" "unprognostic (2.63e-2)" 22.2 18.0 12.9 10.1 10.7 1.2 26.1 8.1 16.4 17.2 13.9 5.2 12.0 5.6 15.8 19.0 6.4 13.1 15.7 12.4 24.5 9.9 20.2 8.2 38.9 10.2 8.3 10.5 16.6 6.0 58.6 11.9 13.1 15.1 11.3 8.9 23.3 7.9 17.2 19.2 6.6 8.4 17.4 12.7 9.2 8.7 11.4 5.0 0.1 21.7 7.0 3.2 10.0 14.6 1.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.1 11.7 0.0 36.2 18.5 5.7 7.2 11.8 7.7 10.4 5.4 0.2 0.2 4.2 8.5 6.1 0.1 5.6 5.6 12.2 0.6 3.2 0.5 0.0 6.2 12.2 3.0 0.0 26.8 2.3 10.9 13.2 2.5 8.3 0.8 0.0 7.2 6.9 3.1 0.0 0.0 7.2 0.0 0.0 4.7 3.6 0.2 7.9 3.3 0.9 1.9 1.7 0.0 2.8 5.0 0.0 0.1 18.9 10.8 10.3 17.2 6.0 2.3 2.6 0.0 8.2 1.3 13.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 12.9 10.7 8.1 16.4 24.5 9.9 8.3 10.5 15.1 5.0 11.9 25.9 0.8 5.2 8.1 91.5 10.4 7.6 2.7 5.7 21.0 5.9 7.6 5.0 7.9 2.9 41.3 11.0 0.0 1.6 0.6 33.6 7.0 0.0 26.0 15.0 146.2 23.6 89.0 2.2 2.5 61.5 1.8 16.9 1.0 7.6 38.3 4.5 7.0 53.4 13.3 4.8 71.1 52.3 1.0 6.1 4.3 10.5 0.9 11.0 2.2 PTPRM "hR-PTPu, PTPRL1, RPTPU" ENSG00000173482 "Protein tyrosine phosphatase, receptor type M" P28827 18 7566782-8406861 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Endothelial cells: 47.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD8 T-cell: 7.2" "Group enriched" "Detected in many" 50 "dendritic cells: 2.7;T-cells: 7.2" "Cell line enhanced" "Detected in many" "ASC diff: 35.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003891, CAB022442, CAB022443" Supported Approved "Plasma membrane" NA NA 76000000 "Plasma membrane" "CAB022442: , CAB022443: , HPA003891: AB_2667073" "unprognostic (2.59e-1)" "prognostic unfavorable (8.65e-5)" "unprognostic (4.89e-2)" "unprognostic (1.00e-1)" "unprognostic (1.13e-1)" "unprognostic (1.46e-1)" "unprognostic (1.80e-1)" "unprognostic (3.41e-2)" "unprognostic (7.62e-2)" "unprognostic (2.74e-2)" "unprognostic (1.56e-2)" "unprognostic (9.64e-2)" "unprognostic (5.63e-2)" "unprognostic (3.11e-3)" "unprognostic (9.41e-2)" "unprognostic (2.63e-2)" "prognostic favorable (1.07e-4)" 31.4 14.1 9.5 6.3 22.2 0.6 23.6 10.4 17.2 11.0 13.6 6.2 28.1 4.7 15.4 10.9 8.1 13.6 18.1 33.5 10.5 15.0 16.9 6.5 22.0 7.8 8.5 12.0 15.7 7.6 16.3 21.9 18.3 23.2 10.6 6.6 18.3 7.4 21.8 26.0 7.3 8.7 14.1 9.3 12.1 11.0 12.2 9.1 2.9 31.1 7.3 6.3 18.6 25.3 0.0 2.7 0.0 0.0 0.0 7.2 1.4 1.5 11.4 5.5 0.0 35.1 24.4 13.3 14.0 12.3 9.4 14.0 10.4 2.4 0.0 13.8 16.7 0.2 0.1 0.0 4.9 13.1 0.1 2.5 0.0 7.6 5.0 10.0 0.0 0.1 27.6 10.3 5.2 14.9 18.1 9.4 0.0 0.0 4.8 7.5 0.2 4.5 0.1 0.9 3.3 2.5 0.1 4.7 21.1 23.1 19.6 0.5 3.0 0.4 0.0 11.7 9.1 0.0 0.0 9.7 19.4 12.2 9.2 2.4 0.4 0.1 0.0 16.6 0.0 3.6 0.0 0.0 0.0 4.5 0.0 1.8 0.0 6.0 7.2 0.1 0.0 1.7 3.1 0.0 0.0 0.0 2.7 1.0 1.4 9.5 22.2 10.4 17.2 10.5 15.0 8.5 12.0 23.2 9.1 41.7 29.0 0.9 6.8 5.4 24.2 24.1 17.8 22.7 9.1 5.2 2.0 10.4 1.7 15.5 24.0 47.4 0.5 0.0 7.1 2.7 10.2 7.0 2.3 20.2 8.2 0.0 1.7 38.1 8.0 34.9 2.6 5.2 28.7 1.0 1.3 2.8 12.6 0.3 4.9 11.3 1.9 6.5 8.0 3.6 9.8 2.5 10.5 2.5 0.8 5.4 PTX3 "TNFAIP5, TSG-14" ENSG00000163661 "Pentraxin 3" P26022 3 157436789-157443628 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 61.7;skeletal muscle: 67.7;urinary bladder: 77.0" "Cell type enhanced" "Detected in some" 10 "Ductal cells: 6.0;Fibroblasts: 10.1;Macrophages: 5.9;Melanocytes: 13.5" "Cancer enhanced" "Detected in many" "glioma: 22.5" "Group enriched" "Detected in some" 6 "hippocampal formation: 1.1;pons and medulla: 3.6" "Cell type enhanced" "Detected in some" "eosinophil: 3.2" "Group enriched" "Detected in many" 20 "dendritic cells: 1.3;granulocytes: 3.2;monocytes: 1.2" "Cell line enhanced" "Detected in many" "ASC diff: 86.4;ASC TERT1: 125.2;BJ hTERT+: 82.2;HHSteC: 160.8;HSkMC: 167.5;hTEC/SVTERT24-B: 88.5;TIME: 119.2;U-2197: 111.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA069320 Approved Approved "Plasma membrane" "Secreted to blood" NA NA 1090000 310000 "Plasma membrane" "HPA069320: AB_2686118" "unprognostic (1.93e-2)" "unprognostic (4.96e-3)" "unprognostic (1.35e-1)" "prognostic unfavorable (8.35e-9)" "unprognostic (5.79e-3)" "prognostic unfavorable (6.36e-4)" "unprognostic (6.03e-3)" "prognostic unfavorable (8.75e-6)" "unprognostic (2.45e-1)" "unprognostic (6.69e-2)" "unprognostic (7.60e-2)" "unprognostic (2.63e-1)" "unprognostic (2.76e-9)" "unprognostic (6.03e-3)" "unprognostic (5.98e-2)" "unprognostic (2.15e-4)" "unprognostic (1.92e-3)" 61.7 3.4 0.3 16.7 0.2 31.6 35.3 0.2 0.7 0.8 13.2 0.3 0.6 0.5 0.5 0.8 2.0 6.5 3.5 14.7 1.1 0.0 3.0 0.6 22.5 7.0 0.3 0.1 6.8 18.0 0.3 1.0 4.9 3.6 2.5 1.2 5.2 1.8 0.4 67.7 6.0 1.9 6.4 0.9 9.6 4.9 0.9 0.2 0.3 2.7 0.4 0.4 77.0 2.5 0.0 1.3 3.2 1.2 0.0 0.0 0.1 0.0 0.0 52.1 0.0 86.4 125.2 0.0 9.0 82.2 3.9 4.2 0.0 0.5 0.0 32.1 10.6 6.1 0.0 0.0 0.0 7.7 0.0 0.0 0.1 0.0 0.0 160.8 0.1 0.0 167.5 0.0 88.5 30.1 7.7 18.2 0.0 0.0 0.0 26.0 0.0 0.0 0.1 0.7 0.0 0.3 0.0 0.0 0.0 0.3 3.5 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.1 119.2 17.7 0.8 111.1 1.5 0.0 0.0 0.0 3.7 0.4 5.0 0.0 1.2 3.2 0.0 1.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.3 0.2 0.2 0.2 1.1 0.0 0.3 0.1 3.6 0.2 0.0 1.7 0.0 1.1 1.4 0.8 0.4 0.0 0.0 2.3 0.0 0.0 0.1 0.0 6.0 1.9 2.0 0.0 0.0 0.0 0.0 10.1 0.4 0.0 0.0 2.6 0.0 0.0 3.1 4.6 0.8 0.3 5.9 13.5 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.4 0.0 4.2 0.0 0.4 0.9 0.2 0.0 0.0 0.1 PXDC1 C6orf145 ENSG00000168994 "PX domain containing 1" Q5TGL8 6 3722614-3752026 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 79.6" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 93.5;Extravillous trophoblasts: 114.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "memory B-cell: 4.2" "Lineage enriched" "Detected in single" 4 "B-cells: 4.2" "Cell line enhanced" "Detected in many" "HHSteC: 43.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019246 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA019246: AB_2670113" "unprognostic (1.55e-1)" "unprognostic (1.87e-2)" "prognostic unfavorable (3.64e-4)" "prognostic unfavorable (1.14e-4)" "unprognostic (2.82e-2)" "unprognostic (3.80e-2)" "unprognostic (2.95e-1)" "unprognostic (1.48e-1)" "unprognostic (6.73e-2)" "unprognostic (6.08e-2)" "unprognostic (2.32e-1)" "unprognostic (2.13e-1)" "unprognostic (2.01e-2)" "unprognostic (6.17e-3)" "unprognostic (1.10e-1)" "unprognostic (2.97e-1)" "unprognostic (2.84e-1)" 26.3 5.5 5.9 5.9 6.5 0.4 30.6 3.2 6.6 11.1 10.3 6.4 5.3 10.7 10.1 14.4 13.9 8.3 18.5 10.8 6.5 4.4 13.4 79.6 14.2 5.8 7.5 3.1 6.2 10.0 3.4 4.3 32.9 6.2 9.1 3.1 7.5 12.3 8.1 11.9 11.7 16.9 20.6 7.0 6.1 8.9 3.9 6.9 1.0 16.8 11.5 5.8 14.9 21.0 4.2 0.3 0.5 0.0 0.0 0.9 0.3 11.7 5.0 8.2 5.5 26.0 19.7 26.4 21.4 16.5 18.3 14.2 8.3 2.3 0.0 13.9 35.0 13.5 8.8 1.6 5.9 8.7 11.9 1.6 0.0 3.6 7.4 43.5 0.0 0.0 17.8 19.4 11.3 24.4 15.1 20.0 0.8 0.0 1.5 14.3 0.7 0.0 0.1 0.3 2.3 6.0 0.6 4.4 0.4 6.9 9.9 0.9 0.4 14.2 14.6 28.7 11.4 1.2 0.7 20.8 15.5 6.6 6.0 14.5 0.0 0.0 0.0 3.5 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.3 4.2 0.1 0.0 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.3 5.9 6.5 3.2 6.6 6.5 4.4 7.5 3.1 6.2 6.9 44.7 10.4 4.2 93.5 42.8 0.4 6.9 15.3 5.3 12.5 7.0 0.0 26.6 10.0 30.2 0.4 37.0 1.3 0.0 44.5 114.0 36.1 45.1 3.5 57.1 21.2 0.0 0.0 36.2 9.1 0.2 21.0 17.8 23.6 37.9 0.8 14.3 55.0 0.0 17.0 16.8 0.7 0.0 31.6 0.5 3.8 29.0 65.6 2.9 0.0 38.2 RAB43 "ISY1, RAB11B, RAB41" ENSG00000172780 "RAB43, member RAS oncogene family" Q86YS6 3 129087569-129122801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 73.9" "Cell type enhanced" "Detected in single" 13 "Club cells: 1.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.3" "Group enriched" "Detected in all" 5 "granulocytes: 13.3;T-cells: 3.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046840, HPA060085" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA046840: , HPA060085: AB_2684199" "unprognostic (3.01e-1)" "unprognostic (1.14e-2)" "unprognostic (3.08e-1)" "unprognostic (1.01e-1)" "unprognostic (5.08e-2)" "unprognostic (1.91e-1)" "unprognostic (9.36e-2)" "unprognostic (3.17e-2)" "unprognostic (4.16e-1)" "unprognostic (8.68e-2)" "unprognostic (3.14e-1)" "unprognostic (3.08e-1)" "unprognostic (2.46e-2)" "unprognostic (9.32e-2)" "unprognostic (5.82e-3)" "unprognostic (1.42e-1)" "unprognostic (2.71e-2)" 5.4 6.2 3.9 8.0 3.3 14.6 5.3 6.0 3.6 6.4 7.0 3.2 7.2 5.8 5.4 6.8 4.1 5.3 12.0 3.8 2.8 2.0 9.1 73.9 11.4 12.1 2.7 1.6 7.8 7.4 2.5 8.0 4.7 3.7 7.3 1.7 7.7 7.4 4.7 1.9 3.0 5.9 4.9 2.7 9.9 5.7 5.2 2.1 17.3 17.1 2.6 13.6 6.6 6.0 1.3 1.1 13.3 1.6 1.5 3.5 1.3 15.6 4.3 1.0 4.1 2.0 0.9 6.2 5.4 3.6 3.1 2.6 6.7 6.7 0.4 12.6 4.0 4.2 6.6 0.4 6.2 0.7 7.9 4.2 1.0 0.7 8.7 19.4 3.6 9.3 5.3 3.8 1.6 0.4 1.3 6.2 9.4 1.7 7.9 4.3 6.6 3.5 6.9 5.0 3.6 7.0 7.5 2.3 4.5 10.1 13.3 0.3 1.9 2.4 5.0 10.0 1.7 2.1 3.8 8.9 6.9 4.9 5.6 2.0 12.4 6.5 2.4 6.2 0.7 7.4 0.5 1.5 2.6 1.9 1.6 0.9 0.6 1.8 1.5 0.7 1.3 3.5 3.0 13.3 1.5 0.7 1.1 2.7 1.3 3.9 3.3 6.0 3.6 2.8 2.0 2.7 1.6 3.7 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 RABEPK "bA65N13.1, RAB9P40" ENSG00000136933 "Rab9 effector protein with kelch motifs" Q7Z6M1 9 125200542-125234158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 59.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023920, HPA067106" Supported Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA023920: AB_1856023, HPA067106: " "unprognostic (8.72e-2)" "unprognostic (1.29e-1)" "unprognostic (1.76e-2)" "unprognostic (1.58e-1)" "unprognostic (3.24e-2)" "unprognostic (2.70e-2)" "unprognostic (3.47e-2)" "unprognostic (3.47e-2)" "unprognostic (9.74e-2)" "unprognostic (4.92e-2)" "unprognostic (1.27e-1)" "unprognostic (1.92e-1)" "unprognostic (1.52e-3)" "unprognostic (1.09e-1)" "unprognostic (1.63e-1)" "unprognostic (8.25e-2)" "unprognostic (2.69e-1)" 11.9 11.7 14.9 11.5 21.6 8.6 13.7 9.3 21.3 11.0 11.4 12.4 9.0 9.9 18.7 15.3 12.9 13.7 10.6 11.6 13.8 15.1 9.8 49.6 8.6 13.9 16.5 17.7 11.5 10.9 7.7 13.6 10.2 15.0 10.1 13.1 9.5 13.0 12.0 17.4 12.4 8.5 14.3 13.0 8.1 9.0 11.1 12.6 11.6 9.2 10.0 11.4 10.2 10.0 15.9 14.6 19.0 13.5 13.8 28.5 16.0 9.3 22.9 8.7 16.0 14.0 17.1 16.6 13.3 13.1 16.0 12.7 28.1 9.7 29.0 11.7 18.0 15.6 25.8 22.2 16.7 15.5 16.2 18.6 12.4 21.4 41.5 12.7 24.0 9.0 12.5 20.4 23.0 24.4 9.5 16.7 18.1 27.9 8.1 15.0 26.6 16.7 16.4 18.0 38.3 21.2 24.4 16.7 31.8 12.6 7.5 21.0 10.3 13.7 9.1 15.4 9.0 19.1 10.5 14.1 10.5 10.8 25.1 22.9 11.0 24.2 19.6 13.9 15.9 16.1 16.5 13.5 14.9 17.2 10.8 15.9 15.9 25.0 16.8 14.6 13.4 28.5 20.6 19.0 13.8 11.1 14.0 25.3 16.0 14.9 21.6 9.3 21.3 13.8 15.1 16.5 17.7 15.0 12.6 0.0 9.9 9.3 12.6 12.9 11.2 8.1 7.6 6.7 4.5 5.2 7.9 28.7 21.6 12.3 59.9 10.5 7.7 0.0 11.5 25.3 19.1 8.8 4.7 48.8 18.9 12.7 2.4 10.4 8.2 12.6 15.0 8.7 8.5 47.7 10.6 9.2 9.0 0.0 17.7 16.8 16.3 0.0 13.9 7.7 13.0 11.3 10.6 8.7 15.6 11.6 RAI2 ENSG00000131831 "Retinoic acid induced 2" Q9Y5P3 X 17800049-17861337 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Leydig cells: 45.5;Peritubular cells: 66.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "naive CD4 T-cell: 1.5;naive CD8 T-cell: 5.1" "Lineage enriched" "Detected in single" 11 "T-cells: 5.1" "Cell line enriched" "Detected in some" 10 "ASC diff: 49.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051054 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA051054: AB_2681328" "unprognostic (3.45e-2)" "unprognostic (9.61e-2)" "unprognostic (2.41e-1)" "unprognostic (2.03e-2)" "unprognostic (1.98e-1)" "unprognostic (2.49e-2)" "unprognostic (4.10e-2)" "unprognostic (2.51e-2)" "unprognostic (1.44e-1)" "unprognostic (1.49e-1)" "prognostic favorable (2.77e-4)" "unprognostic (1.31e-2)" "prognostic favorable (3.39e-14)" "unprognostic (1.57e-2)" "unprognostic (2.33e-1)" "unprognostic (1.82e-2)" "unprognostic (2.80e-2)" 23.6 9.7 2.5 10.1 4.0 0.0 28.5 4.0 4.9 41.0 13.7 1.7 15.0 3.5 29.6 17.8 12.2 27.9 21.2 16.1 2.4 2.7 9.4 1.9 14.5 12.9 2.4 1.8 32.7 7.7 4.6 11.1 7.1 2.9 28.3 4.5 10.7 6.6 18.7 7.2 8.3 8.8 20.4 2.7 2.4 12.0 16.2 2.1 2.0 15.1 6.3 5.9 24.2 53.6 0.0 0.0 0.0 0.0 0.4 5.1 0.4 0.0 0.0 0.1 0.0 49.6 4.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 2.7 0.0 0.5 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.5 5.1 0.0 0.4 0.0 0.0 0.0 0.4 2.5 4.0 4.0 4.9 2.4 2.7 2.4 1.8 2.9 2.1 11.9 5.0 0.0 8.6 3.7 13.8 11.2 7.6 8.1 1.2 21.0 0.0 0.0 5.0 6.8 0.2 14.6 0.3 0.0 8.8 0.1 13.2 11.3 0.0 0.0 0.4 25.4 26.5 9.8 0.0 1.1 45.5 0.0 5.0 1.0 0.0 13.7 4.1 0.0 66.4 1.6 2.8 0.0 6.2 0.5 1.1 2.5 0.0 0.0 0.0 4.8 RASGRP2 CALDAG-GEFI ENSG00000068831 "RAS guanyl releasing protein 2" Q7LDG7 11 64726911-64745456 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.6;bone marrow: 63.9;lymphoid tissue: 47.6" "Cell type enhanced" "Detected in many" 9 "B-cells: 95.7;Kupffer cells: 67.8;Sertoli cells: 129.4;Smooth muscle cells: 71.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 23.1;HL-60: 41.7;NB-4: 79.1;REH: 23.6;THP-1: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015635, HPA015667" Approved Supported "Plasma membrane" NA NA 1900000 "Plasma membrane" "HPA015635: , HPA015667: AB_1856090" "unprognostic (5.96e-2)" "unprognostic (3.24e-3)" "unprognostic (5.55e-2)" "unprognostic (1.50e-2)" "unprognostic (3.52e-2)" "unprognostic (4.74e-5)" "unprognostic (1.11e-2)" "unprognostic (7.36e-3)" "unprognostic (2.02e-1)" "unprognostic (3.33e-1)" "unprognostic (4.91e-3)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.38e-4)" "unprognostic (1.08e-1)" "unprognostic (5.40e-2)" "unprognostic (1.90e-1)" "unprognostic (1.23e-1)" 7.6 4.2 4.6 26.8 26.4 63.9 4.5 4.3 8.2 5.6 9.9 3.2 4.5 3.6 8.8 4.9 4.5 8.9 4.7 13.7 5.5 4.7 5.5 3.1 8.5 47.6 4.7 5.7 2.7 1.2 0.7 1.5 8.1 4.1 6.9 3.2 5.3 7.4 10.4 5.8 1.5 25.6 8.1 2.7 43.9 5.4 3.1 8.2 9.7 2.9 2.5 30.1 7.0 4.8 51.6 29.1 24.5 32.2 16.7 32.8 22.2 0.0 0.0 0.7 0.0 0.0 0.0 2.0 0.3 0.0 0.3 0.2 0.3 0.0 14.3 0.6 0.0 0.2 0.1 1.2 0.2 0.0 0.0 0.4 23.1 0.0 0.0 0.0 41.7 8.5 0.0 0.0 0.1 0.0 0.0 0.0 5.9 0.9 0.2 0.0 0.3 9.8 79.1 0.6 0.1 0.0 23.6 0.0 1.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.5 0.1 24.8 0.1 0.0 0.5 0.3 0.0 0.1 0.0 13.2 0.0 13.2 0.0 16.5 11.8 19.1 24.4 28.6 13.2 51.6 25.3 19.3 11.6 32.0 32.8 29.0 24.5 16.7 32.2 29.1 29.9 22.2 4.6 26.4 4.3 8.2 5.5 4.7 4.7 5.7 4.1 8.2 3.0 2.6 95.7 0.1 2.1 0.8 46.4 2.5 1.4 0.0 0.0 0.0 1.5 0.0 0.0 5.2 6.8 0.0 0.0 0.0 1.3 4.5 0.1 3.5 0.9 5.7 0.0 0.0 31.3 67.8 11.9 16.7 22.0 0.0 26.2 0.0 0.7 0.0 0.0 44.9 1.0 2.3 129.4 71.9 10.1 28.3 1.1 9.8 47.3 0.2 0.1 RCSD1 "CapZIP, MGC21854, MK2S4" ENSG00000198771 "RCSD domain containing 1" Q6JBY9 1 167630093-167706249 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 56.4;lymphoid tissue: 70.8;skeletal muscle: 52.3" "Cell type enhanced" "Detected in many" 9 "B-cells: 128.0;Kupffer cells: 116.2;monocytes: 64.1;Sertoli cells: 77.6;T-cells: 84.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 48.3;REH: 48.5;RPMI-8226: 33.1;THP-1: 25.5;U-266/70: 32.4;U-698: 31.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016597, HPA073490" Enhanced Approved "Plasma membrane" NA NA 150000 "Plasma membrane" "HPA016597: AB_2669397, HPA073490: " "unprognostic (2.13e-2)" "unprognostic (7.38e-3)" "unprognostic (6.50e-3)" "unprognostic (1.37e-3)" "unprognostic (1.08e-1)" "prognostic favorable (2.97e-4)" "unprognostic (5.51e-2)" "unprognostic (8.90e-3)" "unprognostic (3.65e-1)" "unprognostic (8.48e-2)" "unprognostic (1.01e-1)" "unprognostic (6.33e-2)" "unprognostic (2.53e-3)" "unprognostic (3.19e-1)" "unprognostic (3.58e-2)" "unprognostic (6.94e-2)" "unprognostic (3.97e-2)" 8.5 2.9 3.5 33.3 4.8 19.2 7.3 1.2 3.1 3.0 8.4 3.6 1.3 3.6 2.7 5.4 4.1 3.1 8.8 18.4 3.9 3.6 4.2 3.7 9.0 45.6 5.1 2.2 2.5 1.5 0.8 2.0 7.0 3.1 3.7 5.0 3.1 6.5 2.5 52.3 2.3 20.1 7.4 6.9 40.6 4.9 3.7 3.4 70.8 4.8 12.7 29.2 7.4 4.5 51.0 22.1 56.4 38.2 26.6 27.8 26.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.3 0.0 0.0 0.0 8.3 0.9 0.1 0.0 0.1 0.0 0.0 0.0 19.7 15.5 14.2 6.5 0.0 15.3 11.9 0.4 0.0 0.0 48.5 0.2 33.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 25.5 0.1 0.0 0.1 0.0 0.0 32.4 9.6 31.8 0.0 15.8 0.0 48.4 38.2 56.4 15.2 25.1 18.3 45.6 19.8 18.9 22.1 51.0 17.2 15.9 38.5 26.6 24.1 12.8 27.8 26.3 3.5 4.8 1.2 3.1 3.9 3.6 5.1 2.2 3.1 3.4 3.0 10.7 128.0 1.2 1.0 0.6 40.7 0.0 0.0 5.7 1.8 0.0 0.4 0.0 0.1 0.4 17.9 0.0 0.0 0.0 0.2 3.1 0.7 12.8 1.7 37.5 0.0 0.0 27.0 116.2 1.5 0.9 47.2 5.0 64.1 0.0 0.0 0.1 0.0 0.4 0.3 0.7 77.6 21.5 0.0 0.1 1.5 1.0 84.1 0.0 0.3 RECK "hRECK, ST15" ENSG00000122707 "Reversion inducing cysteine rich protein with kazal motifs" O95980 9 36036433-36124451 "Plasma proteins, Predicted membrane proteins" "Wnt signaling pathway" "Protease inhibitor, Serine protease inhibitor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 55.3;ASC TERT1: 44.3;BJ: 17.2;BJ hTERT+: 24.7;fHDF/TERT166: 15.2;HSkMC: 19.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025109, HPA071729" Supported Supported "Plasma membrane" NA NA 37000000 "Plasma membrane" "CAB025109: , HPA071729: AB_2686438" "unprognostic (3.42e-1)" "unprognostic (4.01e-3)" "unprognostic (5.50e-2)" "unprognostic (5.05e-4)" "unprognostic (8.87e-2)" "unprognostic (8.47e-2)" "unprognostic (2.24e-1)" "unprognostic (2.23e-1)" "unprognostic (3.75e-2)" "unprognostic (1.51e-2)" "unprognostic (9.06e-2)" "unprognostic (8.48e-2)" "unprognostic (7.45e-2)" "prognostic unfavorable (7.31e-4)" "unprognostic (2.68e-2)" "unprognostic (1.50e-2)" "unprognostic (3.60e-2)" 15.9 8.9 6.9 6.3 8.2 1.5 31.7 9.1 7.8 18.9 10.2 8.5 6.2 4.3 18.4 7.5 13.7 12.0 15.6 11.3 8.4 4.9 6.9 6.7 16.7 6.1 8.3 4.9 17.2 3.9 3.7 7.8 12.7 8.3 12.3 7.6 10.5 7.8 8.9 5.7 8.7 7.7 17.3 7.9 8.1 9.8 7.9 8.5 8.4 10.5 9.8 6.2 17.8 16.8 3.5 3.7 1.2 5.5 3.6 8.9 3.1 0.3 0.6 2.1 1.1 55.3 44.3 0.0 17.2 24.7 1.2 3.0 0.0 0.0 0.6 1.6 15.2 1.0 0.1 0.4 0.3 1.7 1.0 0.9 0.6 0.7 0.0 4.4 0.0 3.0 19.7 0.4 1.9 0.7 5.0 3.8 1.3 0.0 0.5 3.2 0.0 1.6 0.2 0.7 0.0 0.5 1.7 1.6 0.0 0.8 0.0 0.2 1.2 0.3 0.2 0.6 2.3 0.0 2.3 11.7 2.4 0.9 1.5 0.9 0.7 0.8 0.7 1.5 2.2 1.5 1.2 3.3 0.9 5.4 3.5 6.1 1.7 7.1 5.7 3.7 3.5 8.9 6.4 0.5 3.6 5.5 2.1 3.2 3.1 6.9 8.2 9.1 7.8 8.4 4.9 8.3 4.9 8.3 8.5 3.0 4.8 7.8 2.6 6.4 14.3 1.6 2.5 4.0 2.3 3.5 13.7 0.7 0.0 5.5 30.6 14.3 0.0 0.0 1.3 6.3 15.6 4.0 9.2 0.8 13.1 7.9 5.8 25.8 8.4 31.4 17.3 7.0 3.3 6.4 1.4 17.7 1.8 0.0 16.6 1.5 7.6 0.0 9.9 25.9 24.0 6.6 0.7 8.5 0.9 1.0 RGS3 "C2PA, FLJ20370, PDZ-RGS3" ENSG00000138835 "Regulator of G protein signaling 3" P49796 9 113444731-113597743 "Plasma proteins, Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 149.4;Proximal tubular cells: 130.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 53.6;HDLM-2: 86.1" "Low region specificity" "Detected in all" HPA044234 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA044234: " "prognostic unfavorable (9.93e-4)" "unprognostic (4.04e-2)" "unprognostic (5.33e-3)" "unprognostic (6.71e-3)" "unprognostic (1.49e-2)" "unprognostic (1.69e-2)" "prognostic unfavorable (6.62e-4)" "unprognostic (6.79e-2)" "unprognostic (9.17e-2)" "unprognostic (2.24e-1)" "unprognostic (8.59e-3)" "unprognostic (3.04e-1)" "unprognostic (2.51e-3)" "unprognostic (1.52e-2)" "unprognostic (1.45e-1)" "unprognostic (8.53e-2)" "unprognostic (2.90e-1)" 25.2 17.8 7.6 10.7 18.3 4.7 34.0 4.2 13.8 9.8 13.0 27.9 5.1 9.9 11.4 8.0 11.3 8.4 25.0 52.2 9.7 10.1 31.9 20.1 24.9 12.5 18.4 8.5 7.2 17.5 6.3 8.1 18.9 18.1 14.5 9.6 12.9 5.6 6.6 24.6 7.0 10.8 17.9 16.8 16.2 12.3 14.8 17.1 4.0 13.2 10.7 8.3 18.3 8.1 1.4 3.8 10.6 4.1 22.4 15.0 7.8 0.9 3.5 8.7 8.0 2.7 4.0 0.6 8.8 53.6 7.2 6.1 8.6 3.2 3.7 6.5 7.1 7.2 2.3 0.1 3.4 4.2 86.1 0.0 0.3 2.9 5.2 5.5 0.0 1.2 7.2 3.6 19.9 2.9 16.0 27.0 0.2 0.0 3.7 13.0 3.9 0.2 0.4 2.2 6.0 2.9 0.2 4.3 0.6 14.8 1.7 6.8 0.9 0.8 6.9 5.2 4.4 4.7 0.8 13.0 24.2 2.6 1.1 16.5 1.8 0.3 0.5 27.9 0.8 11.1 3.4 3.5 2.1 15.0 4.1 10.1 1.4 3.5 12.1 3.8 1.2 1.4 6.6 10.6 22.4 3.1 0.1 2.0 7.8 7.6 18.3 4.2 13.8 9.7 10.1 18.4 8.5 18.1 17.1 14.9 11.5 1.9 9.8 10.6 0.6 39.3 61.1 6.7 6.8 21.0 5.9 4.1 69.6 58.9 34.8 43.8 18.6 0.0 27.0 3.4 35.7 4.0 48.3 27.3 12.9 149.4 0.0 71.8 13.6 11.9 4.4 7.1 52.3 7.2 7.0 2.7 26.2 14.2 13.1 130.2 6.1 6.5 49.5 6.6 1.5 9.9 2.5 20.3 9.0 11.6 RGS9BP "FLJ45744, PERRS, R9AP, RGS9" ENSG00000186326 "Regulator of G protein signaling 9 binding protein" Q6ZS82 19 32675407-32678300 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 38.3;skeletal muscle: 15.8" "Group enriched" "Detected in some" 13 "Bipolar cells: 30.8;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 70.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "pons and medulla: 6.8" "Cell type enhanced" "Detected in some" "gdT-cell: 1.4;memory CD8 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 10.7;HMC-1: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA049791 Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA049791: AB_2680884" "unprognostic (2.82e-2)" "unprognostic (6.99e-3)" "unprognostic (2.44e-3)" "unprognostic (1.20e-7)" "unprognostic (1.49e-1)" "unprognostic (1.21e-2)" "unprognostic (1.17e-2)" "unprognostic (1.32e-1)" "unprognostic (2.80e-1)" "unprognostic (6.71e-2)" "unprognostic (6.74e-2)" "unprognostic (3.89e-2)" "unprognostic (1.63e-3)" "unprognostic (2.29e-1)" "unprognostic (8.22e-2)" "unprognostic (5.23e-2)" "unprognostic (5.34e-2)" 0.4 0.5 0.8 0.3 1.1 0.3 0.4 0.2 0.7 0.3 0.4 1.4 0.2 0.4 0.3 0.6 1.1 0.4 0.3 6.7 1.0 0.8 0.9 0.3 0.9 0.3 1.1 0.3 0.3 0.4 0.4 0.6 0.4 6.8 1.3 0.3 38.3 0.5 0.6 15.8 0.6 0.3 7.4 1.3 0.4 0.4 0.9 0.9 0.1 0.4 4.3 0.3 2.3 1.0 0.0 0.3 0.0 0.9 0.5 1.5 0.0 0.2 0.2 0.0 0.9 0.5 0.2 0.5 0.0 0.5 0.4 0.2 0.2 0.3 0.4 0.5 0.1 0.5 0.1 1.8 0.1 0.1 0.5 0.2 10.7 0.3 0.0 0.2 0.3 2.8 0.0 0.5 0.0 0.4 0.2 0.0 0.1 0.9 1.5 0.2 0.5 0.0 1.7 0.0 0.1 2.0 0.2 0.4 0.2 0.0 0.1 0.4 0.1 0.0 1.1 0.1 0.0 1.1 0.5 0.0 0.5 0.7 0.2 0.3 0.6 0.7 0.1 0.3 0.6 0.8 0.0 0.3 0.0 1.4 0.9 0.0 0.0 0.2 1.5 0.3 0.0 0.0 0.4 0.0 0.5 0.3 0.0 0.0 0.0 0.8 1.1 0.2 0.7 1.0 0.8 1.1 0.3 6.8 0.9 0.0 0.0 0.0 0.1 0.0 30.8 3.9 0.0 0.0 0.0 1.8 53.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.2 1.6 0.0 0.6 0.8 0.9 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.4 70.9 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.2 0.0 RHEX "C1orf186, FLJ16052" ENSG00000263961 "Regulator of hemoglobinization and erythroid cell expansion" Q6ZWK4 1 206052723-206102459 "Predicted membrane proteins" "Differentiation, Erythrocyte maturation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "blood: 117.7" "Cell type enriched" "Detected in some" 14 "granulocytes: 308.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 42.8;ovarian cancer: 41.1" "Cell type enriched" "Detected in some" 51 "basophil: 117.7" "Lineage enriched" "Detected in many" 51 "granulocytes: 117.7" "Cell line enriched" "Detected in some" 5 "HMC-1: 189.5" "Low region specificity" "Detected in all" HPA037859 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA037859: AB_10697084" "unprognostic (9.26e-3)" "unprognostic (1.91e-2)" "unprognostic (9.66e-2)" "unprognostic (1.65e-2)" "unprognostic (2.06e-2)" "unprognostic (5.27e-3)" "unprognostic (9.55e-2)" "unprognostic (3.04e-3)" "unprognostic (2.36e-1)" "unprognostic (1.31e-2)" "unprognostic (1.35e-1)" "unprognostic (7.20e-3)" "unprognostic (1.89e-2)" "unprognostic (3.02e-2)" "unprognostic (1.35e-1)" "unprognostic (3.77e-2)" "unprognostic (2.80e-3)" 4.3 0.0 0.0 3.9 0.0 0.0 1.8 0.0 0.0 13.1 3.1 0.0 12.1 0.9 6.2 8.2 3.4 1.6 16.2 0.4 0.0 6.8 1.8 5.2 4.0 0.0 0.0 0.8 0.0 0.0 0.0 1.2 0.0 9.4 3.3 2.9 0.0 16.9 1.5 0.2 4.0 7.0 0.0 0.4 2.4 1.1 0.0 0.6 0.0 1.7 2.5 4.3 10.0 0.3 2.2 117.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.1 0.0 8.6 189.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 38.1 0.0 0.0 0.0 0.0 0.0 0.2 2.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 117.7 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 19.2 0.0 1.5 1.7 2.9 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 308.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 RHOBTB2 "DBC2, KIAA0717" ENSG00000008853 "Rho related BTB domain containing 2" Q9BYZ6 8 22987417-23020199 "Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 59.6;Alveolar cells type 2: 57.6;Bipolar cells: 30.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 31.8;hTCEpi: 28.3;RT4: 47.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060938 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA060938: AB_2684391" "unprognostic (2.67e-3)" "unprognostic (1.64e-1)" "unprognostic (1.64e-1)" "unprognostic (7.94e-2)" "unprognostic (7.83e-3)" "unprognostic (2.13e-2)" "unprognostic (8.13e-2)" "unprognostic (8.17e-2)" "unprognostic (3.47e-3)" "unprognostic (1.93e-2)" "unprognostic (1.60e-2)" "unprognostic (1.46e-2)" "prognostic favorable (2.98e-4)" "unprognostic (2.01e-1)" "unprognostic (1.09e-1)" "unprognostic (8.89e-3)" "unprognostic (2.43e-1)" 5.9 7.4 14.8 6.4 33.2 2.0 5.3 5.1 36.9 4.4 8.1 7.2 24.4 7.7 6.3 5.2 4.6 6.6 6.0 17.6 14.0 9.1 6.0 1.9 31.0 12.2 9.8 14.4 15.9 7.2 5.8 9.0 10.0 8.0 5.7 2.5 11.2 5.6 22.6 10.9 3.5 19.7 6.1 4.0 10.4 6.9 7.0 6.5 5.5 14.9 2.8 14.5 13.7 3.4 7.8 2.9 4.5 1.6 4.4 2.8 1.1 2.5 4.9 4.0 6.4 4.9 3.4 5.4 3.5 4.6 5.5 4.1 12.7 2.5 31.8 5.3 5.0 7.1 5.0 1.9 19.5 2.6 2.7 1.1 3.4 6.7 3.5 2.3 2.0 7.1 4.4 28.3 5.7 2.9 3.8 3.9 2.3 0.8 3.1 3.6 7.3 1.3 3.2 4.2 7.3 3.5 1.7 6.4 2.1 3.9 47.6 2.6 4.8 2.6 8.1 5.3 3.1 1.5 5.2 4.8 6.9 5.0 12.3 3.9 8.0 7.7 11.4 6.7 2.9 5.3 4.5 1.0 1.3 2.8 1.6 1.9 7.8 0.8 1.3 1.0 7.1 1.1 1.1 0.2 4.4 1.6 2.9 1.4 1.1 14.8 33.2 5.1 36.9 14.0 9.1 9.8 14.4 8.0 6.5 59.6 57.6 5.2 2.3 2.6 30.1 10.1 5.1 4.0 14.8 7.0 3.9 12.8 1.7 1.5 0.5 4.0 0.7 0.0 3.3 6.5 4.6 1.0 4.6 0.8 12.1 15.9 5.8 8.0 2.2 0.2 5.8 4.3 1.7 1.0 3.4 6.0 3.5 0.2 6.0 3.7 5.8 0.0 3.7 0.9 1.7 0.5 4.7 2.2 0.4 0.6 ROBO1 "DUTT1, FLJ21882, SAX3" ENSG00000169855 "Roundabout guidance receptor 1" Q9Y6N7 3 78597240-79767815 "Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 46.4;Urothelial cells: 49.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB013524, HPA052968, HPA074461" Uncertain Enhanced "Plasma membrane" NA NA 6500000 "Plasma membrane" "CAB013524: , HPA052968: AB_2682001, HPA074461: AB_2732256" "unprognostic (2.89e-1)" "unprognostic (6.42e-2)" "unprognostic (2.29e-2)" "unprognostic (1.30e-1)" "unprognostic (4.77e-2)" "unprognostic (1.61e-3)" "prognostic unfavorable (9.88e-4)" "unprognostic (2.44e-1)" "unprognostic (2.92e-2)" "unprognostic (2.00e-1)" "unprognostic (6.40e-2)" "unprognostic (1.42e-1)" "unprognostic (1.65e-1)" "unprognostic (6.77e-2)" "unprognostic (1.91e-1)" "unprognostic (2.39e-2)" "unprognostic (1.16e-2)" 12.5 10.1 15.5 10.7 30.2 0.4 7.3 12.5 22.0 15.9 9.4 14.7 1.6 3.5 10.5 8.2 13.7 5.6 8.6 9.0 12.3 12.4 3.7 4.0 8.3 9.3 14.7 8.9 18.4 2.3 2.1 29.6 8.4 12.2 14.5 6.9 8.5 5.5 13.8 4.5 21.8 5.4 11.4 8.1 9.2 5.0 10.8 15.7 14.0 5.5 8.8 18.8 13.2 14.1 1.0 0.7 0.0 0.4 0.1 3.1 0.1 0.1 11.0 10.5 16.8 14.8 9.7 0.5 8.4 11.3 6.7 5.7 0.2 4.6 0.0 0.0 10.4 5.3 4.4 12.8 8.7 8.5 0.1 16.3 6.4 22.0 17.3 3.5 0.1 1.7 16.1 12.0 25.4 12.1 12.7 6.7 0.0 0.8 20.0 6.9 5.2 0.0 0.0 13.4 3.1 4.0 0.3 11.1 0.1 0.0 3.5 8.2 5.6 18.2 4.1 6.7 10.6 12.9 0.1 0.1 22.5 9.8 13.3 14.3 0.7 0.0 0.0 20.4 0.0 18.6 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.2 0.7 0.3 0.0 3.1 0.0 0.1 0.4 0.0 0.0 0.1 15.5 30.2 12.5 13.6 12.3 12.4 14.7 8.9 12.2 15.7 3.0 11.2 0.0 17.6 29.5 10.2 3.6 0.0 1.4 7.9 7.0 3.9 8.4 0.0 0.5 21.1 4.7 0.3 0.0 0.2 7.3 26.7 15.0 1.1 0.0 1.2 1.6 1.2 15.4 2.5 46.4 18.4 1.3 13.5 2.8 0.1 6.7 0.3 0.3 23.0 0.2 1.0 12.9 11.2 1.6 5.1 29.5 4.7 0.0 0.2 49.2 ROBO4 "ECSM4, FLJ20798, MRB" ENSG00000154133 "Roundabout guidance receptor 4" Q8WZ75 11 124883691-124898500 "Plasma proteins, Predicted membrane proteins" "Angiogenesis, Differentiation" "Developmental protein, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 13 "Endothelial cells: 62.4;Ito cells: 172.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 10 "HUVEC TERT2: 64.9;TIME: 58.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065212 Approved "Plasma membrane" NA NA 340000000 "Plasma membrane" "HPA065212: AB_2685434" "unprognostic (2.86e-1)" "unprognostic (9.35e-2)" "unprognostic (2.67e-1)" "unprognostic (1.07e-1)" "unprognostic (3.82e-2)" "unprognostic (6.97e-2)" "prognostic favorable (4.85e-4)" "unprognostic (7.94e-2)" "unprognostic (2.27e-1)" "unprognostic (1.43e-1)" "unprognostic (1.73e-3)" "unprognostic (2.17e-1)" "unprognostic (1.17e-2)" "prognostic unfavorable (8.73e-4)" "unprognostic (1.55e-1)" "unprognostic (4.63e-1)" "unprognostic (5.15e-2)" 33.3 4.5 4.0 5.6 4.5 0.6 21.6 2.0 5.5 11.1 4.4 4.3 3.7 2.8 10.8 7.8 5.3 7.7 8.5 15.5 4.9 3.0 10.6 6.5 24.9 5.8 4.7 2.8 5.9 3.5 3.8 3.8 23.6 5.5 6.0 1.8 9.2 2.9 4.5 12.5 4.5 4.7 8.4 3.6 33.3 4.3 3.9 3.3 1.0 11.6 9.8 2.5 6.2 5.9 0.0 1.2 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.1 0.3 0.0 0.0 0.0 6.2 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.7 0.1 64.9 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.2 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 4.0 4.5 2.0 5.5 4.9 3.0 4.7 2.8 5.5 3.3 0.0 6.2 2.4 0.6 1.9 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 62.4 0.0 0.0 0.2 0.0 1.1 0.2 2.3 0.6 0.1 0.0 0.0 172.5 9.1 0.9 4.0 2.0 1.7 0.0 0.0 1.4 0.1 0.0 1.1 0.0 3.6 0.0 0.8 0.0 0.1 1.1 0.0 0.0 0.0 0.1 S100A4 "18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98" ENSG00000196154 "S100 calcium binding protein A4" P26447 1 153543613-153550136 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 419.2" "Cell type enhanced" "Detected in many" 11 "Hofbauer cells: 1794.8;Kupffer cells: 3413.1;Macrophages: 4385.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 115.2;ASC diff: 149.4;BJ hTERT+: 287.5;fHDF/TERT166: 205.6;RPMI-8226: 108.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB002618, HPA007973, CAB027387, CAB058698, CAB068227, CAB068228" Enhanced Enhanced "Plasma membrane" NA NA 13000000 "Plasma membrane" "CAB002618: , CAB027387: , CAB058698: AB_2665603, CAB068227: AB_2665602, CAB068228: AB_2665601, HPA007973: AB_1079858" "unprognostic (1.56e-1)" "unprognostic (6.10e-2)" "unprognostic (2.84e-2)" "unprognostic (8.20e-2)" "unprognostic (6.21e-2)" "prognostic favorable (4.03e-5)" "unprognostic (8.35e-2)" "unprognostic (4.81e-2)" "unprognostic (1.50e-1)" "unprognostic (2.20e-1)" "unprognostic (2.78e-2)" "unprognostic (3.39e-2)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.05e-1)" "unprognostic (3.05e-1)" "unprognostic (2.76e-2)" "unprognostic (3.16e-2)" 125.9 10.1 2.6 29.2 8.3 75.2 171.6 2.2 4.6 52.1 33.9 2.7 25.8 7.3 26.8 52.2 58.6 27.9 34.7 59.9 3.0 1.7 27.8 6.1 80.7 53.2 10.8 3.1 12.7 6.7 0.0 3.0 46.9 6.6 49.5 28.0 19.3 29.8 13.4 25.4 44.5 25.5 38.5 8.9 55.9 17.2 18.2 6.2 8.5 23.7 57.5 26.4 34.9 58.2 18.6 213.1 281.6 293.3 17.3 162.7 419.2 0.5 115.2 0.5 3.3 149.4 103.1 0.1 73.0 287.5 1.4 6.5 0.8 8.1 0.0 13.3 205.6 0.1 2.9 0.4 1.0 1.1 16.4 0.0 49.2 25.6 2.5 0.2 4.3 83.3 16.0 1.1 2.8 0.6 0.2 0.1 0.0 0.4 0.1 104.7 0.4 0.1 51.0 0.3 8.4 44.2 2.6 0.1 108.6 4.5 3.1 4.4 0.5 1.3 55.6 0.4 18.7 3.3 61.7 0.1 0.3 0.6 98.1 0.4 3.6 24.5 0.5 0.2 54.8 5.6 49.5 293.3 30.8 141.2 201.4 147.2 18.6 127.2 112.3 213.1 6.2 22.4 66.5 281.6 17.3 253.9 37.4 162.7 419.2 2.6 8.3 2.2 4.6 3.0 1.7 10.8 3.1 6.6 6.2 455.6 554.5 203.3 20.0 686.7 0.6 8.4 30.6 108.4 174.0 847.9 0.0 45.2 94.5 21.8 4.3 34.1 4.4 116.8 21.4 168.0 716.5 10.9 1330.4 13.0 1794.8 42.9 4.6 120.3 3413.1 10.7 218.3 4385.9 1132.0 911.7 7.1 3.9 22.9 14.4 43.2 14.3 2.7 148.8 785.1 1.6 3.6 606.6 44.6 1190.0 8.0 60.2 SCIN KIAA1905 ENSG00000006747 Scinderin Q9Y6U3 7 12570577-12660179 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.3;intestine: 31.7;kidney: 30.3;placenta: 46.0" "Cell type enhanced" "Detected in many" 14 "Collecting duct cells: 317.6;Early spermatids: 90.6;Enterocytes: 121.7;Paneth cells: 111.2" "Cancer enhanced" "Detected in many" "renal cancer: 13.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "RPTEC TERT1: 38.6;SK-BR-3: 41.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA020518, HPA024264" Enhanced Enhanced "Plasma membrane" No No "Plasma membrane" "HPA020518: AB_1856619, HPA024264: AB_1856621" "unprognostic (3.68e-1)" "unprognostic (4.98e-2)" "unprognostic (5.05e-1)" "unprognostic (2.47e-1)" "unprognostic (1.50e-1)" "unprognostic (5.98e-2)" "unprognostic (3.64e-5)" "unprognostic (1.31e-2)" "unprognostic (3.09e-1)" "unprognostic (3.77e-2)" "unprognostic (1.25e-1)" "unprognostic (1.24e-1)" "prognostic favorable (4.26e-8)" "unprognostic (3.87e-1)" "unprognostic (4.99e-2)" "unprognostic (3.13e-2)" "unprognostic (3.18e-1)" 4.1 1.0 14.5 2.3 30.3 1.0 0.9 1.5 13.3 1.2 11.2 7.5 1.0 16.2 1.2 0.7 14.5 3.6 2.0 0.5 11.1 4.2 30.3 0.6 3.4 0.6 22.8 2.3 0.8 0.9 1.1 3.1 46.0 20.0 2.3 10.2 0.6 9.0 1.0 0.6 2.5 31.7 1.0 27.9 0.6 12.2 4.3 23.4 0.0 1.0 2.7 8.2 5.5 1.1 4.5 1.5 3.5 1.5 2.1 1.9 0.8 0.1 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.1 0.5 0.0 0.0 0.2 0.1 0.1 0.5 0.1 0.0 0.1 0.0 0.1 0.1 8.5 0.2 0.2 0.1 0.6 0.1 2.2 1.3 0.1 0.2 0.0 38.6 1.4 1.7 0.0 0.4 41.8 0.0 0.3 4.4 0.3 0.0 0.1 0.3 0.8 0.1 1.4 0.1 0.1 0.0 0.1 0.1 3.5 1.5 1.0 1.7 1.3 1.5 4.5 1.5 1.4 1.0 2.5 1.6 1.9 2.5 2.1 1.4 1.5 1.0 0.8 14.5 30.3 1.5 13.3 11.1 4.2 22.8 2.3 20.0 23.4 0.0 20.5 0.0 1.3 2.5 0.4 0.8 7.6 22.7 6.8 317.6 0.0 14.0 69.6 0.7 90.6 0.7 121.7 0.0 0.2 3.7 1.3 4.5 38.2 0.0 76.4 0.0 8.7 0.0 0.6 64.0 0.3 3.1 10.1 2.8 36.1 0.5 5.2 111.2 1.1 1.8 2.5 0.0 0.0 3.9 5.4 5.6 55.0 0.0 13.5 7.1 SCUBE3 "CEGF3, FLJ34743" ENSG00000146197 "Signal peptide, CUB domain and EGF like domain containing 3" Q8IX30 6 35214419-35253079 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 38.0" "Cell type enhanced" "Detected in many" 8 "Horizontal cells: 9.5;Intestinal endocrine cells: 10.4;Rod photoreceptor cells: 6.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 9.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 10.6;ASC diff: 32.4;ASC TERT1: 43.5;HSkMC: 20.3;hTEC/SVTERT24-B: 12.4;U-138 MG: 12.1;WM-115: 10.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040606 Uncertain Approved "Plasma membrane" "Secreted to blood" NA NA 1890000 110000 "Plasma membrane" "HPA040606: AB_10795383" "unprognostic (1.45e-1)" "unprognostic (1.79e-2)" "unprognostic (2.22e-1)" "unprognostic (2.41e-3)" "unprognostic (1.52e-1)" "unprognostic (1.27e-1)" "unprognostic (4.43e-2)" "unprognostic (5.01e-2)" "unprognostic (2.00e-2)" "unprognostic (7.41e-2)" "unprognostic (1.57e-1)" "unprognostic (2.64e-2)" "unprognostic (4.83e-8)" "unprognostic (1.54e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (1.38e-4)" "unprognostic (3.06e-3)" 1.6 2.6 0.5 1.1 0.4 0.2 0.3 0.3 0.7 1.6 3.3 0.0 2.8 0.2 1.3 7.0 1.5 0.7 0.7 6.4 0.3 0.5 2.3 0.2 1.3 0.2 0.4 0.6 0.9 0.2 0.3 1.6 0.9 0.6 7.0 1.1 6.8 1.1 5.3 0.8 0.7 0.8 13.8 0.6 0.3 1.2 1.7 0.0 0.0 38.0 0.3 0.3 11.4 2.5 1.1 1.6 2.5 0.7 1.1 1.1 0.1 0.0 0.0 10.6 0.1 32.4 43.5 0.1 2.6 1.3 0.0 0.0 0.2 0.0 0.0 0.4 6.2 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 20.3 0.0 12.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.3 0.7 4.4 0.2 0.0 0.6 12.1 0.5 0.0 0.1 0.0 0.0 0.0 1.9 0.0 10.2 1.4 0.7 1.3 1.1 0.5 0.3 0.8 0.7 0.3 0.1 1.1 0.8 0.8 2.5 1.1 0.5 1.6 0.8 0.1 0.5 0.4 0.3 0.7 0.3 0.5 0.4 0.6 0.6 0.0 0.0 1.1 0.0 0.2 0.0 2.5 3.3 0.0 1.4 3.4 1.8 2.0 0.8 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.2 1.0 0.1 1.1 0.0 0.3 9.5 10.4 0.0 1.2 2.2 0.9 0.0 1.7 0.0 0.0 2.0 0.1 0.0 3.5 0.0 6.1 0.0 4.7 0.2 1.9 0.0 0.6 0.0 0.0 0.1 SHANK1 "SPANK-1, SSTRIP, synamon" ENSG00000161681 "SH3 and multiple ankyrin repeat domains 1" Q9Y566 19 50661827-50719450 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 35.7" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 5.3;Cardiomyocytes: 3.0;Cone photoreceptor cells: 2.0;Horizontal cells: 7.9" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 7.5;SH-SY5Y: 3.6;U-138 MG: 4.2;U-2 OS: 10.6;U-87 MG: 4.0;U-937: 4.4" "Low region specificity" "Detected in all" "HPA032129, HPA032130" Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA032129: AB_10602796, HPA032130: AB_2674169" "unprognostic (1.62e-1)" "unprognostic (4.40e-2)" "unprognostic (7.83e-3)" "unprognostic (4.62e-2)" "unprognostic (1.70e-2)" "unprognostic (1.54e-1)" "unprognostic (1.76e-2)" "unprognostic (1.35e-2)" "unprognostic (5.02e-2)" "unprognostic (1.61e-1)" "unprognostic (7.51e-2)" "unprognostic (3.27e-1)" "unprognostic (3.65e-2)" "unprognostic (1.61e-2)" "unprognostic (5.14e-2)" "unprognostic (4.66e-3)" "unprognostic (1.29e-3)" 0.9 2.6 27.9 0.9 10.0 1.2 0.9 13.6 35.7 1.3 0.9 1.1 0.0 0.9 1.3 1.0 0.9 2.2 1.1 0.9 25.6 12.3 0.9 0.8 0.8 0.9 6.0 11.1 0.9 0.9 2.1 2.8 1.0 4.1 1.0 0.8 0.2 0.9 1.0 1.0 1.2 0.9 1.1 2.2 0.9 0.8 1.4 3.5 0.4 0.9 0.0 0.9 0.9 0.0 0.0 0.7 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.2 0.5 0.0 1.3 1.2 0.1 0.1 0.0 0.0 0.0 2.0 0.7 0.1 0.0 0.2 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.1 0.0 0.4 0.4 0.0 0.0 0.1 0.0 0.6 0.9 0.0 0.0 0.7 0.1 0.1 0.8 1.2 0.0 0.1 7.5 0.0 0.8 0.0 0.0 0.0 3.6 0.0 0.0 1.1 0.0 0.0 3.2 2.3 4.2 10.6 0.0 0.0 0.0 0.0 0.0 4.0 4.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.7 0.0 0.0 27.9 10.0 13.6 23.0 25.6 12.3 6.0 11.1 4.1 3.5 0.0 0.0 0.0 0.0 0.0 5.3 3.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 SLC10A5 ENSG00000253598 "Solute carrier family 10 member 5" Q5PT55 8 81693607-81696174 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.1;liver: 10.3" "Cell type enhanced" "Detected in some" 11 "Ciliated cells: 6.7;Enterocytes: 5.2;Intestinal endocrine cells: 3.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA025966 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA025966: AB_1856959" "unprognostic (6.42e-2)" "unprognostic (3.89e-1)" "unprognostic (1.25e-2)" "unprognostic (2.34e-2)" "unprognostic (8.13e-3)" "unprognostic (1.91e-1)" "unprognostic (5.71e-2)" "unprognostic (5.63e-2)" "unprognostic (3.67e-1)" "unprognostic (2.41e-1)" "unprognostic (1.37e-1)" "unprognostic (3.22e-1)" "unprognostic (8.95e-2)" "unprognostic (2.51e-1)" "unprognostic (2.24e-1)" "unprognostic (1.67e-1)" "unprognostic (2.82e-7)" 0.0 0.3 0.9 0.1 2.3 0.0 0.2 5.1 1.8 0.3 2.5 2.9 0.3 0.9 0.2 0.3 1.4 0.1 0.9 2.1 1.8 10.3 0.3 0.0 0.8 0.4 1.0 0.3 1.9 0.0 0.5 3.5 0.3 0.2 0.1 0.4 3.5 0.2 0.3 0.3 3.4 0.0 0.8 0.0 0.3 0.1 0.0 0.5 0.0 0.0 0.3 0.4 0.0 0.7 0.3 0.9 0.9 0.7 1.4 0.7 0.9 0.4 0.3 0.5 0.4 0.5 0.9 1.3 0.2 0.2 0.9 1.1 0.8 1.3 0.7 2.4 1.8 2.6 1.4 0.4 0.1 0.3 0.4 2.2 0.7 1.7 1.5 0.4 0.6 1.6 1.2 1.3 0.7 0.5 1.2 0.4 6.5 0.5 0.3 0.3 0.6 1.2 3.1 2.1 0.9 0.7 0.6 0.3 0.5 1.6 0.6 0.9 1.1 1.5 1.4 1.4 1.5 2.2 0.1 1.1 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 6.7 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 5.2 0.0 1.0 0.1 0.0 0.2 0.0 2.1 0.0 0.0 3.5 0.6 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.5 1.7 0.0 1.8 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.0 0.4 SLC13A3 "NADC3, SDCT2" ENSG00000158296 "Solute carrier family 13 member 3" Q8WWT9 20 46557823-46684467 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "kidney: 128.6" "Cell type enhanced" "Detected in many" 25 "Cytotrophoblasts: 97.7;Proximal tubular cells: 272.5;Syncytiotrophoblasts: 66.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 10.0;EFO-21: 11.4;Hep G2: 32.6;HHSteC: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014333, HPA014353, HPA014736" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA014333: AB_2732407, HPA014353: AB_1856968, HPA014736: AB_1856970" "unprognostic (1.07e-2)" "unprognostic (7.40e-2)" "unprognostic (5.59e-2)" "unprognostic (1.19e-2)" "unprognostic (3.34e-1)" "unprognostic (3.19e-2)" "unprognostic (2.15e-1)" "unprognostic (2.82e-2)" "unprognostic (1.66e-2)" "unprognostic (9.50e-2)" "unprognostic (1.92e-2)" "unprognostic (1.03e-1)" "unprognostic (8.94e-2)" "unprognostic (3.87e-1)" "unprognostic (1.17e-1)" "unprognostic (1.87e-1)" "unprognostic (2.05e-2)" 0.7 0.9 2.6 0.5 6.2 0.4 0.9 2.5 3.6 0.9 0.5 15.1 0.0 0.4 0.9 0.7 0.6 1.1 0.9 0.6 3.4 3.1 128.6 7.0 0.8 0.5 9.3 2.1 1.8 3.0 0.4 0.6 12.9 6.5 2.3 0.5 8.1 1.7 0.6 0.6 1.0 0.4 0.9 7.8 0.5 1.7 2.7 5.6 0.0 0.8 0.0 0.6 1.0 0.4 0.6 2.4 2.7 0.4 0.7 0.9 0.0 0.0 0.0 0.9 3.3 5.1 4.8 10.0 2.1 1.2 1.1 0.9 0.0 0.0 0.1 11.4 0.1 0.0 1.2 0.0 1.5 2.7 0.0 0.3 3.9 0.2 32.6 11.4 0.0 2.9 6.5 4.5 6.6 3.3 3.2 0.0 0.0 8.7 0.2 0.0 0.3 0.0 0.4 6.1 0.2 0.0 0.1 0.0 0.0 0.7 0.2 0.4 0.1 0.0 2.4 0.5 0.6 1.7 0.1 0.1 0.1 2.4 5.2 0.0 0.3 0.6 0.0 0.4 0.0 0.2 2.7 0.4 0.3 0.9 0.2 0.2 0.4 0.3 0.3 0.1 0.6 0.6 0.6 1.3 0.7 0.3 2.4 0.3 0.0 2.6 6.2 2.5 3.6 3.4 3.1 9.3 2.1 6.5 5.6 0.0 2.1 0.0 1.1 1.1 0.7 0.5 0.0 5.3 0.0 7.0 0.0 97.7 13.3 0.1 17.2 0.2 0.0 0.0 0.8 4.5 1.1 3.2 0.0 11.6 8.1 0.0 0.0 0.0 0.8 22.8 2.8 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.4 272.5 0.2 0.0 0.3 1.1 0.9 0.5 66.4 0.0 0.0 0.5 SLC14A1 "HsT1341, JK, RACH1, RACH2" ENSG00000141469 "Solute carrier family 14 member 1 (Kidd blood group)" Q13336 18 45687025-45752520 "Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 44.5;prostate: 64.7;urinary bladder: 29.6" "Group enriched" "Detected in some" 10 "Basal glandular cells: 246.2;Erythroid cells: 93.5;Glandular cells: 129.8;Urothelial cells: 212.7" "Group enriched" "Detected in many" 5 "glioma: 5.3;prostate cancer: 8.6;urothelial cancer: 16.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 2.4;gdT-cell: 2.0;memory CD4 T-cell: 2.0;memory CD8 T-cell: 2.4;naive CD8 T-cell: 3.4;NK-cell: 1.8;T-reg: 7.2" "Group enriched" "Detected in many" 5 "granulocytes: 2.4;NK-cells: 1.8;T-cells: 7.2" "Group enriched" "Detected in some" 5 "GAMG: 79.4;RT4: 30.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059570, HPA077233" Supported Supported "Plasma membrane" NA NA "Plasma membrane" "HPA059570: AB_2684066, HPA077233: " "unprognostic (2.04e-1)" "unprognostic (2.56e-3)" "unprognostic (5.20e-2)" "unprognostic (1.27e-1)" "unprognostic (6.86e-2)" "unprognostic (1.84e-2)" "unprognostic (1.70e-2)" "unprognostic (7.97e-2)" "unprognostic (8.17e-2)" "unprognostic (9.99e-2)" "unprognostic (2.69e-1)" "unprognostic (1.42e-1)" "unprognostic (3.02e-2)" "unprognostic (2.31e-1)" "unprognostic (1.52e-1)" "unprognostic (9.09e-2)" "unprognostic (6.93e-2)" 2.2 2.1 15.6 1.5 21.5 10.3 2.4 4.6 24.2 2.9 1.6 33.7 0.0 1.9 1.1 1.4 1.1 1.0 8.7 8.2 33.7 11.7 10.1 1.5 4.1 2.4 28.0 23.4 1.0 1.5 1.2 0.4 2.0 44.5 64.7 1.8 0.0 2.6 3.2 3.4 1.7 2.1 3.9 34.9 2.6 2.0 1.0 44.0 0.0 3.6 0.0 2.6 29.6 3.0 0.7 0.3 2.4 0.1 1.8 7.2 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 79.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.0 1.1 0.0 0.0 0.7 0.3 0.3 0.1 0.1 2.4 2.0 0.0 0.1 0.6 2.0 2.4 0.0 0.7 0.5 3.4 0.4 1.8 0.0 0.3 7.2 1.1 15.6 21.5 4.6 24.2 33.7 11.7 28.0 23.4 44.5 44.0 0.0 1.1 1.3 246.2 0.2 0.3 6.7 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.7 0.0 93.5 0.2 0.0 0.1 129.8 0.0 0.0 0.1 0.0 0.0 17.8 1.2 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 5.7 0.0 212.7 SLC16A2 "AHDS, DXS128, MCT7, MCT8, MRX22, XPCT" ENSG00000147100 "Solute carrier family 16 member 2" P36021 X 74421461-74533917 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 43.6" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 50.8;Peritubular cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "BJ: 34.4;GAMG: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072719 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA072719: AB_2686552" "prognostic unfavorable (8.88e-5)" "unprognostic (2.48e-1)" "unprognostic (1.99e-1)" "unprognostic (2.90e-3)" "unprognostic (1.49e-1)" "unprognostic (1.58e-2)" "unprognostic (1.58e-3)" "unprognostic (2.47e-2)" "unprognostic (1.48e-1)" "unprognostic (2.54e-1)" "unprognostic (5.67e-2)" "unprognostic (3.51e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (2.15e-2)" "unprognostic (1.89e-1)" "unprognostic (6.89e-3)" "prognostic unfavorable (3.16e-4)" 13.5 24.4 10.9 5.4 12.2 0.7 4.9 5.9 14.3 9.9 5.5 8.4 1.8 4.1 9.4 2.7 5.2 6.7 10.5 10.7 8.0 5.9 9.4 43.6 6.0 1.6 4.2 8.0 14.7 6.6 12.7 12.6 10.0 8.2 9.2 2.6 11.1 5.8 7.0 3.5 2.2 3.0 7.6 4.1 1.9 4.2 1.8 5.1 6.4 13.6 4.3 3.0 5.0 5.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 3.2 4.0 2.9 16.6 7.9 4.2 0.0 34.4 10.6 14.0 8.0 0.0 0.3 0.0 0.5 13.3 27.0 0.6 0.4 14.6 8.2 2.3 1.3 0.0 0.0 0.0 0.6 0.0 0.0 6.2 3.5 7.2 8.5 5.3 0.0 0.0 0.0 0.0 3.2 0.0 0.2 1.0 11.0 0.0 3.0 6.6 7.9 0.0 6.9 0.0 0.7 5.1 3.8 19.3 0.1 1.0 0.2 0.4 0.0 13.6 3.6 14.9 17.1 0.0 0.0 0.0 15.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 10.9 12.2 5.9 14.3 8.0 5.9 4.2 8.0 8.2 5.1 0.0 1.1 0.0 3.2 0.7 4.5 3.5 5.1 4.0 3.4 3.5 0.0 4.2 3.3 3.7 0.0 2.7 0.0 0.0 2.1 2.7 4.8 3.2 2.3 50.8 0.8 3.2 8.1 2.5 1.5 0.0 14.1 0.0 3.3 1.0 0.0 6.1 3.1 0.0 19.4 5.4 1.1 12.9 5.6 0.1 0.0 1.1 1.7 0.0 0.0 4.8 SLC19A1 "FOLT, RFC1" ENSG00000173638 "Solute carrier family 19 member 1" P41440 21 45493572-45544411 "Cancer-related genes, Predicted membrane proteins, Transporters" "Antiport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 37.6" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 133.1;Syncytiotrophoblasts: 303.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 37.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 37.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024802 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA024802: AB_10602892" "unprognostic (4.31e-3)" "prognostic unfavorable (4.15e-4)" "unprognostic (5.23e-2)" "unprognostic (2.02e-1)" "unprognostic (3.11e-1)" "unprognostic (3.04e-2)" "unprognostic (7.34e-2)" "unprognostic (2.87e-3)" "unprognostic (4.04e-2)" "unprognostic (4.09e-2)" "unprognostic (2.85e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (1.07e-10)" "unprognostic (1.44e-1)" "unprognostic (2.31e-1)" "unprognostic (7.97e-5)" "unprognostic (3.10e-1)" 9.0 7.8 7.1 8.2 13.5 10.5 12.5 9.6 8.9 5.0 9.7 6.0 9.4 31.2 4.3 4.6 2.3 4.6 3.5 3.2 7.1 6.1 4.7 14.1 13.9 14.1 8.7 4.4 8.1 5.4 1.8 3.5 32.9 11.5 4.7 2.0 17.8 6.0 3.5 3.5 6.1 16.5 2.3 5.9 11.7 5.7 3.4 3.4 11.8 9.6 2.8 4.1 3.1 3.1 0.9 4.9 37.6 6.4 0.4 1.1 2.4 10.6 9.7 1.9 7.9 0.6 0.8 15.9 5.0 0.8 4.6 2.9 22.4 9.9 9.9 9.9 1.2 3.9 5.5 3.9 3.6 1.1 9.1 19.3 20.8 5.2 15.5 2.7 13.5 3.2 1.0 2.8 4.9 1.6 1.3 3.8 10.6 24.8 4.3 1.6 11.9 18.3 12.6 11.4 4.7 11.3 25.0 2.2 28.7 2.1 6.4 11.8 10.4 5.6 9.3 4.3 2.7 7.0 16.0 4.6 6.0 7.5 1.6 8.1 1.8 6.6 9.0 2.7 22.1 4.8 0.6 6.4 8.5 0.3 6.0 1.1 0.9 0.5 0.7 4.9 0.3 0.8 0.5 37.6 0.4 3.7 1.5 1.0 2.4 7.1 13.5 9.6 8.9 7.1 6.1 8.7 4.4 11.5 3.4 44.7 4.6 0.8 1.7 2.2 18.0 2.4 2.5 1.4 10.3 0.0 0.0 133.1 0.0 7.8 3.3 2.8 9.3 0.0 4.2 16.2 2.9 3.6 1.1 10.9 24.0 7.9 0.0 1.8 11.6 3.2 6.1 5.9 3.3 0.0 3.1 8.6 6.8 5.3 10.6 1.9 3.6 0.0 3.8 1.2 4.1 1.4 303.1 2.2 7.6 0.9 SLC1A5 "AAAT, ASCT2, M7V1, RDRC" ENSG00000105281 "Solute carrier family 1 member 5" Q15758 19 46774883-46788594 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Host-virus interaction, Symport, Transport" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 134.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 34.6" "Group enriched" "Detected in many" 4 "dendritic cells: 34.6;monocytes: 22.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA035239, HPA035240" Enhanced Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA035239: AB_10670587, HPA035240: AB_10604092" "unprognostic (8.26e-3)" "unprognostic (6.38e-2)" "unprognostic (7.24e-2)" "unprognostic (7.94e-2)" "unprognostic (2.32e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.66e-8)" "unprognostic (2.08e-1)" "unprognostic (1.06e-2)" "unprognostic (9.82e-2)" "unprognostic (9.40e-3)" "unprognostic (9.57e-3)" "prognostic unfavorable (1.18e-7)" "unprognostic (1.28e-2)" "unprognostic (6.30e-2)" "unprognostic (1.06e-2)" "unprognostic (9.83e-2)" 39.3 5.7 3.4 16.0 5.4 16.2 45.0 0.9 3.0 20.7 15.8 5.0 50.4 4.9 14.3 33.7 33.9 18.1 31.2 10.0 4.5 2.2 23.7 4.1 23.4 17.7 8.2 0.9 33.3 24.6 0.2 9.1 25.8 4.9 35.2 13.8 5.2 99.0 55.7 6.9 18.6 12.1 23.1 5.3 19.8 17.9 21.7 6.1 14.9 6.5 28.4 25.9 48.3 44.9 7.0 34.6 0.9 22.4 6.9 5.6 7.4 23.8 44.1 10.6 16.0 27.7 23.6 25.1 34.1 39.0 25.6 37.2 40.0 27.0 26.2 16.7 84.6 14.7 38.5 30.9 40.5 19.1 17.3 28.0 43.4 16.9 37.5 71.7 30.2 25.6 38.3 101.3 30.0 76.2 8.6 13.6 35.0 45.8 69.4 13.6 40.6 13.8 81.3 18.5 85.5 19.4 15.7 12.0 37.2 14.3 52.2 16.4 12.0 16.8 46.0 36.5 8.6 26.5 39.9 10.1 15.4 24.7 12.0 27.7 43.1 41.6 21.8 29.0 37.7 37.7 0.0 11.5 0.9 5.3 19.9 4.4 7.0 3.1 3.7 17.8 2.5 0.7 2.3 0.3 6.9 22.4 34.6 5.6 7.4 3.4 5.4 0.9 3.0 4.5 2.2 8.2 0.9 4.9 6.1 0.0 15.9 11.9 134.3 51.3 0.1 19.9 20.4 4.0 7.9 0.0 0.0 80.4 3.3 26.8 14.6 17.1 22.0 93.5 55.3 97.4 44.3 44.4 28.8 0.5 33.9 0.0 10.3 26.4 16.8 10.3 17.5 27.3 18.6 10.8 88.4 0.6 35.9 74.6 18.4 23.9 0.8 6.5 22.6 4.4 4.3 24.7 20.4 20.8 50.3 96.8 SLC24A4 NCKX4 ENSG00000140090 "Solute carrier family 24 member 4" Q8NFF2 14 92322581-92501483 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Olfaction, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport" "Amelogenesis imperfecta, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.6;brain: 28.1" "Group enriched" "Detected in some" 8 "Bipolar cells: 223.9;Cone photoreceptor cells: 188.5" "Group enriched" "Detected in some" 5 "glioma: 0.5;melanoma: 0.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 7.9;intermediate monocyte: 11.6;non-classical monocyte: 9.4" "Lineage enriched" "Detected in many" 5 "monocytes: 11.6" "Cell line enhanced" "Detected in some" "Daudi: 2.7;SCLC-21H: 5.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063206 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA063206: " "unprognostic (1.53e-1)" "unprognostic (1.41e-1)" "unprognostic (2.22e-1)" "unprognostic (1.18e-1)" "unprognostic (1.06e-1)" "unprognostic (3.43e-3)" "unprognostic (1.34e-1)" "unprognostic (2.04e-3)" "unprognostic (3.40e-2)" "unprognostic (1.32e-1)" "unprognostic (2.48e-3)" "unprognostic (3.21e-1)" "unprognostic (1.48e-3)" "unprognostic (1.25e-1)" "unprognostic (1.08e-1)" "unprognostic (1.90e-2)" "unprognostic (1.58e-2)" 1.8 1.0 4.9 3.8 6.0 8.6 0.6 1.1 11.7 0.8 0.9 9.6 6.3 0.9 0.6 0.7 0.8 0.8 1.9 0.9 4.7 3.2 0.5 0.7 2.3 2.7 10.8 4.7 1.0 0.6 0.5 1.8 1.2 28.1 0.7 1.0 4.6 0.7 1.2 2.4 0.8 1.2 1.4 14.2 5.0 0.9 2.9 5.7 0.0 0.6 0.0 1.4 1.5 0.8 0.1 2.3 1.3 11.6 0.2 0.2 2.0 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.6 2.7 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.7 0.4 0.4 0.2 0.0 0.2 0.3 0.0 0.2 0.3 0.0 0.2 0.0 0.2 0.1 0.6 0.0 0.4 0.0 0.3 1.1 0.0 0.3 0.1 0.1 0.3 0.0 0.3 5.2 0.0 0.2 0.2 0.5 0.1 0.3 1.2 0.6 0.2 1.5 0.3 0.1 0.4 0.1 0.1 0.2 0.3 0.3 0.2 7.9 0.0 0.0 11.6 0.2 0.0 0.0 0.0 2.3 0.1 0.0 0.0 1.3 0.2 9.4 0.4 0.0 2.0 4.9 6.0 1.1 7.3 4.7 3.2 10.8 4.7 28.1 5.7 0.0 3.4 0.0 0.1 0.0 223.9 1.2 0.0 1.4 0.0 0.0 188.5 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 3.5 0.0 0.0 1.8 26.6 4.6 0.3 4.0 0.0 0.0 0.0 2.1 0.1 0.0 0.4 0.0 8.2 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 SLC2A1 "CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR" ENSG00000117394 "Solute carrier family 2 member 1" P11166 1 42925375-42959176 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Cancer-related genes, Cataract, Disease mutation, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "placenta: 194.0" "Cell type enhanced" "Detected in many" 20 "Cytotrophoblasts: 686.5;Extravillous trophoblasts: 412.9;Syncytiotrophoblasts: 2076.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 44.8;CACO-2: 72.7;Hep G2: 49.6" "Low region specificity" "Detected in all" "CAB002759, HPA031345, HPA058494" Enhanced Supported Enhanced "Plasma membrane" No No 36000000 "Plasma membrane" "CAB002759: , HPA031345: AB_2673835, HPA058494: AB_2683734" "unprognostic (3.60e-2)" "unprognostic (5.85e-3)" "unprognostic (7.59e-2)" "unprognostic (1.31e-2)" "unprognostic (4.10e-3)" "unprognostic (3.22e-2)" "prognostic unfavorable (3.65e-8)" "prognostic unfavorable (1.09e-4)" "unprognostic (1.10e-1)" "unprognostic (4.84e-2)" "prognostic unfavorable (4.39e-5)" "unprognostic (1.87e-1)" "prognostic unfavorable (4.55e-9)" "unprognostic (1.11e-1)" "unprognostic (9.49e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (4.05e-4)" 4.2 3.7 12.4 3.9 16.9 45.2 4.1 6.7 15.5 15.2 4.8 15.1 4.3 2.4 7.6 3.4 28.8 8.5 8.6 5.0 15.4 13.7 7.6 2.1 2.4 5.3 18.2 5.0 3.4 3.7 7.3 2.9 194.0 15.5 5.2 3.3 44.2 8.4 7.9 1.8 42.1 2.9 2.5 17.8 3.4 5.5 2.5 12.5 1.8 4.0 11.5 12.0 22.2 24.5 8.4 14.7 1.3 0.2 3.0 7.5 2.7 10.7 15.6 12.8 3.2 1.5 0.5 44.8 7.1 15.4 8.8 12.9 72.7 30.1 4.1 21.2 2.1 6.2 10.1 2.8 16.5 3.9 2.4 2.6 6.7 9.0 49.6 4.5 3.6 1.9 1.9 12.7 5.5 5.9 26.0 1.4 3.5 15.0 0.9 3.9 19.2 1.7 2.5 8.2 5.3 3.9 1.6 4.1 5.7 8.0 5.2 6.8 4.8 8.3 26.3 3.1 19.2 1.1 4.6 3.2 8.0 5.8 1.4 16.0 0.7 1.5 2.5 15.8 2.6 6.5 0.3 0.2 1.3 7.5 0.2 6.9 8.4 4.1 5.1 2.9 7.3 3.2 4.7 1.0 3.0 0.1 14.7 4.7 2.7 12.4 16.9 6.7 15.5 15.4 13.7 18.2 5.0 15.5 12.5 0.0 2.6 23.8 35.5 254.3 8.1 23.0 25.5 28.1 9.1 26.2 62.8 686.5 5.0 47.8 4.0 9.9 16.8 303.7 10.3 412.9 42.1 25.5 5.8 1.3 74.8 4.8 17.6 0.6 1.3 0.0 7.2 3.2 20.3 61.3 13.7 394.9 72.4 18.7 13.8 1.6 31.1 0.0 20.2 0.0 1.7 208.3 2076.2 17.3 9.0 98.7 SLC2A14 "GLUT14, SLC2A3P3" ENSG00000173262 "Solute carrier family 2 member 14" Q8TDB8 12 7812512-7891148 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis, Sugar transport, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 52.4" "Cell type enriched" "Detected in many" 7 "Spermatocytes: 60.6" "Cancer enriched" "Detected in single" 35 "testis cancer: 7.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 6.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.9" "Cell line enhanced" "Detected in some" "BEWO: 12.6;CACO-2: 20.4;Hep G2: 5.3;SuSa: 25.2" HPA006539 Supported Approved "Plasma membrane" NA NA "Plasma membrane" "HPA006539: AB_1078984" "unprognostic (2.52e-1)" "unprognostic (4.74e-3)" "unprognostic (1.79e-1)" "unprognostic (1.29e-1)" "unprognostic (3.35e-2)" "unprognostic (1.82e-3)" "unprognostic (8.62e-2)" "unprognostic (7.15e-2)" "unprognostic (1.89e-1)" "unprognostic (9.91e-3)" "unprognostic (1.23e-1)" "unprognostic (1.27e-1)" "unprognostic (8.46e-4)" "unprognostic (3.92e-2)" "unprognostic (3.41e-1)" "unprognostic (3.26e-2)" "unprognostic (1.22e-2)" 0.4 3.1 0.1 0.1 0.6 3.0 0.4 0.1 0.2 0.4 0.4 0.3 0.1 0.0 0.3 0.8 0.8 0.1 0.3 0.1 0.2 0.3 0.1 2.0 0.2 0.2 0.1 0.1 2.7 7.4 0.0 0.6 0.5 0.3 0.6 0.2 0.1 0.1 0.1 0.1 0.1 0.7 0.2 0.1 0.1 0.0 52.4 0.2 0.1 0.1 0.1 0.1 0.6 0.1 0.6 0.4 6.9 0.7 1.3 1.7 0.2 0.0 0.3 0.3 0.2 0.2 0.6 12.6 0.0 0.0 0.0 0.2 20.4 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 2.1 0.5 5.3 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.9 0.1 0.0 0.1 0.1 0.1 2.3 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.4 0.0 25.2 0.0 1.3 0.3 0.1 0.5 0.3 0.1 0.1 0.1 0.2 0.3 0.0 0.3 5.5 0.7 1.8 1.0 0.2 1.2 0.5 1.0 0.8 0.4 0.6 0.7 0.9 6.9 1.3 0.2 0.3 1.7 0.2 0.1 0.6 0.1 0.2 0.2 0.3 0.1 0.1 0.3 0.2 0.0 0.6 0.0 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.0 3.7 2.3 0.0 0.0 1.3 0.9 1.9 0.0 9.2 0.4 0.2 0.0 0.0 8.0 4.4 0.9 0.3 3.1 1.7 0.0 0.0 0.0 0.5 5.8 2.5 0.0 0.4 0.0 4.2 60.6 2.7 0.1 0.3 3.2 0.0 0.0 SLC2A2 GLUT2 ENSG00000163581 "Solute carrier family 2 member 2" P11168 3 170996348-171026750 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "intestine: 77.4;liver: 172.8" "Cell type enriched" "Detected in some" 5 "Hepatocytes: 433.3" "Cancer enriched" "Detected in some" 12 "liver cancer: 105.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 68 "CACO-2: 7.3;Hep G2: 24.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB010444, HPA028997" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB010444: AB_641068, HPA028997: AB_2672860" "unprognostic (9.56e-2)" "unprognostic (1.24e-1)" "prognostic favorable (2.63e-5)" "unprognostic (3.10e-1)" "unprognostic (1.02e-1)" "unprognostic (2.95e-2)" "unprognostic (6.31e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 27.9 0.0 0.0 10.8 0.1 0.2 0.1 0.1 3.8 0.1 0.1 0.1 15.3 172.8 0.1 0.0 0.1 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 77.4 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 24.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.6 0.0 0.0 0.0 0.0 0.0 1.7 0.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 433.3 0.0 0.0 0.0 6.7 8.9 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 49.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 SLC2A3 GLUT3 ENSG00000059804 "Solute carrier family 2 member 3" P11169 12 7919230-7936275 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 166.3" "Cell type enhanced" "Detected in many" 7 "granulocytes: 462.0" "Cancer enriched" "Detected in all" 7 "testis cancer: 107.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 30.2;neutrophil: 55.6" "Lineage enriched" "Detected in all" 9 "granulocytes: 55.6" "Group enriched" "Detected in many" 5 "BEWO: 143.6;CACO-2: 154.0;SuSa: 113.9" "CAB002763, HPA006539" Approved Approved "Plasma membrane" NA NA 33000000 "Plasma membrane" "CAB002763: , HPA006539: AB_1078984" "unprognostic (9.20e-2)" "unprognostic (9.63e-3)" "prognostic unfavorable (8.58e-4)" "unprognostic (2.65e-1)" "unprognostic (5.29e-3)" "unprognostic (2.16e-3)" "unprognostic (1.12e-1)" "unprognostic (8.27e-2)" "unprognostic (2.35e-1)" "unprognostic (3.83e-2)" "unprognostic (8.47e-3)" "unprognostic (5.40e-2)" "prognostic unfavorable (6.36e-8)" "prognostic unfavorable (2.89e-5)" "unprognostic (1.70e-1)" "unprognostic (1.14e-2)" "unprognostic (2.91e-3)" 48.8 10.0 9.5 25.2 10.5 166.3 26.4 13.1 24.3 9.4 10.0 6.8 1.8 4.2 10.3 8.2 13.2 8.0 25.6 22.8 10.8 13.6 10.3 14.1 32.4 12.8 13.3 3.3 18.8 6.1 6.9 10.9 43.9 13.7 15.0 6.9 14.8 3.8 3.9 13.6 7.4 5.8 18.7 15.4 16.4 7.0 10.6 12.5 3.3 15.7 7.0 13.6 51.8 10.5 1.8 2.4 55.6 4.6 3.6 6.4 3.5 0.0 0.7 6.6 2.5 2.4 8.5 143.6 2.3 2.5 2.3 5.4 154.0 1.0 0.1 0.0 1.6 3.2 0.0 0.2 0.3 4.2 4.5 0.1 8.9 0.6 20.2 6.7 3.2 13.0 3.5 0.2 6.1 2.8 5.4 2.1 0.7 4.1 2.1 2.1 0.0 0.2 3.4 29.1 0.1 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 3.0 113.9 0.0 0.4 2.1 2.9 1.5 5.6 0.2 0.0 6.2 0.4 8.5 1.5 1.5 30.2 4.6 7.0 6.4 0.5 5.3 1.8 4.4 4.9 2.4 1.7 2.8 3.8 55.6 3.6 0.2 0.1 5.8 3.5 9.5 10.5 13.1 13.3 10.8 13.6 13.3 3.3 13.7 12.5 134.0 147.7 116.7 2.9 115.1 27.9 8.4 7.6 18.7 48.9 3.5 58.9 41.5 0.0 0.2 2.4 227.7 0.0 0.0 0.0 218.4 149.1 3.8 462.0 1.0 97.9 4.8 1.2 85.3 85.8 1.9 9.5 229.2 173.7 1.0 0.0 19.2 0.8 0.2 7.4 1.2 68.8 116.4 236.4 1.4 0.6 71.6 93.1 133.8 0.0 2.8 SLC35F5 FLJ22004 ENSG00000115084 "Solute carrier family 35 member F5" Q8WV83 2 113705011-113756823 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034828, HPA049229" Uncertain Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA034828: AB_2674350, HPA049229: AB_2680682" "unprognostic (1.59e-2)" "prognostic unfavorable (2.60e-4)" "unprognostic (8.37e-2)" "unprognostic (3.87e-3)" "unprognostic (5.62e-2)" "unprognostic (4.73e-3)" "unprognostic (3.94e-2)" "unprognostic (5.68e-2)" "unprognostic (1.19e-1)" "unprognostic (1.63e-2)" "unprognostic (1.93e-2)" "unprognostic (1.77e-1)" "prognostic favorable (1.71e-5)" "unprognostic (1.64e-1)" "unprognostic (1.84e-1)" "unprognostic (2.33e-1)" "unprognostic (4.83e-2)" 20.0 46.8 7.9 11.7 9.2 3.6 13.8 10.6 9.0 16.9 18.1 15.0 18.9 14.5 14.2 12.6 20.4 10.7 14.9 20.0 8.2 7.9 44.7 29.5 15.0 12.7 10.4 5.0 19.1 23.6 21.6 20.6 24.6 11.7 16.1 16.5 14.1 23.4 16.9 20.0 15.1 32.4 13.1 9.6 12.6 13.7 12.6 10.3 9.2 33.1 14.6 16.7 14.1 16.7 3.4 6.8 5.8 9.1 6.2 4.3 3.2 9.9 9.4 5.1 2.8 47.8 33.3 15.2 16.5 17.4 10.6 15.8 18.7 18.4 9.3 21.3 21.2 27.1 9.2 9.1 8.6 14.7 3.7 3.7 6.5 6.5 16.5 16.4 9.4 17.7 28.8 11.5 13.5 19.2 16.9 11.2 2.5 8.3 9.1 22.5 6.9 2.8 4.8 5.0 11.7 7.7 3.9 10.3 5.9 37.4 13.5 1.6 3.8 12.2 13.2 9.2 10.2 10.4 5.4 10.0 16.8 8.9 8.7 5.2 6.1 8.1 6.3 13.0 5.3 10.9 5.8 5.4 3.7 2.9 8.0 3.8 3.3 2.6 3.1 6.8 3.4 2.9 2.1 4.3 6.2 9.1 3.0 4.3 3.2 7.9 9.2 10.6 9.0 8.2 7.9 10.4 5.0 11.7 10.3 20.8 16.6 2.4 27.7 22.6 10.8 21.0 22.9 20.1 28.4 69.8 21.6 39.1 10.0 25.8 21.3 12.6 39.7 0.0 25.0 60.1 22.6 31.6 24.2 22.1 24.5 4.8 13.9 10.4 14.3 11.0 11.5 11.2 8.5 19.0 23.1 20.9 21.3 26.6 13.1 35.7 17.6 0.0 12.2 42.6 11.7 29.6 55.5 10.4 21.3 29.8 SLC35G2 "DKFZp564K2464, MGC3295, TMEM22" ENSG00000168917 "Solute carrier family 35 member G2" Q8TBE7 3 136818647-136855892 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 36.2;Endothelial cells: 26.0;Ito cells: 26.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "gdT-cell: 1.6;memory CD8 T-cell: 3.5;naive CD8 T-cell: 2.4" "Lineage enriched" "Detected in single" 16 "T-cells: 3.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 34.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052054, HPA064728" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA052054: AB_2681709, HPA064728: AB_2685336" "unprognostic (1.04e-1)" "unprognostic (1.46e-2)" "unprognostic (6.91e-4)" "unprognostic (2.56e-4)" "unprognostic (5.34e-2)" "unprognostic (6.73e-2)" "unprognostic (1.16e-5)" "unprognostic (1.83e-3)" "unprognostic (1.12e-1)" "unprognostic (6.39e-2)" "unprognostic (1.49e-2)" "unprognostic (3.32e-1)" "prognostic unfavorable (1.16e-7)" "unprognostic (1.00e-2)" "unprognostic (1.69e-1)" "unprognostic (1.07e-2)" "unprognostic (2.30e-2)" 20.2 24.6 10.6 3.7 12.0 1.3 18.3 16.6 17.4 8.1 3.6 6.4 6.6 2.2 6.7 8.1 4.1 5.0 8.7 7.6 11.6 15.2 4.3 7.1 6.0 3.3 10.9 10.5 5.3 13.3 6.7 15.9 11.7 11.3 4.8 3.8 3.2 2.7 4.8 2.8 3.0 2.4 8.5 12.4 3.1 3.1 17.2 4.9 0.9 8.8 2.1 2.5 8.2 9.3 0.2 0.0 0.0 0.1 0.0 3.5 0.3 1.7 4.9 5.0 2.2 10.1 8.2 0.0 7.8 34.1 11.7 17.7 4.6 2.6 0.0 6.0 8.0 18.7 0.6 5.9 0.3 10.9 0.0 1.6 1.4 6.0 2.8 12.9 0.0 0.0 11.6 0.9 10.2 2.8 8.6 8.7 3.1 0.8 0.0 14.9 0.0 2.1 1.5 1.1 0.0 3.7 1.8 3.3 0.0 10.0 0.4 8.3 5.5 6.3 0.0 10.7 1.8 0.0 0.8 5.9 8.7 2.2 3.8 8.4 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.5 0.0 0.1 3.5 0.0 0.2 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.3 10.6 12.0 16.6 17.0 11.6 15.2 10.9 10.5 11.3 4.9 11.9 6.5 2.7 3.7 3.0 5.4 2.0 0.0 1.4 10.3 1.8 11.8 1.0 1.7 2.7 36.2 26.0 0.5 0.0 9.3 1.1 11.0 3.3 2.3 1.8 0.6 6.4 4.1 26.4 1.0 19.8 9.2 3.5 3.3 3.6 0.6 6.8 9.1 0.0 2.8 0.4 4.7 6.5 7.2 22.7 9.4 2.6 1.8 4.8 0.6 1.8 SLC41A3 FLJ20473 ENSG00000114544 "Solute carrier family 41 member 3" Q96GZ6 3 126006355-126101561 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045847 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA045847: AB_2679472" "unprognostic (1.77e-1)" "unprognostic (3.35e-2)" "unprognostic (1.11e-1)" "unprognostic (3.37e-2)" "unprognostic (7.68e-3)" "unprognostic (2.20e-1)" "prognostic unfavorable (1.49e-7)" "unprognostic (1.36e-1)" "unprognostic (3.23e-2)" "unprognostic (2.82e-3)" "unprognostic (5.74e-2)" "unprognostic (3.57e-1)" "prognostic favorable (6.04e-7)" "unprognostic (1.26e-1)" "unprognostic (5.88e-2)" "unprognostic (2.85e-1)" "unprognostic (7.54e-2)" 11.2 20.2 21.3 10.7 20.7 5.3 22.2 29.8 43.4 18.6 10.6 12.6 12.1 10.1 21.1 32.9 10.8 24.0 16.3 17.1 17.9 20.6 14.0 8.5 9.5 14.3 17.1 16.5 31.2 17.6 19.7 16.9 10.9 21.4 12.5 10.9 18.6 16.7 14.5 25.5 10.7 8.9 17.1 11.7 8.8 10.7 30.5 6.0 27.7 18.0 11.5 10.4 12.3 11.9 9.0 8.6 9.3 8.2 13.0 18.8 5.6 17.7 7.3 12.1 10.2 34.5 20.3 18.3 10.2 17.7 14.2 16.8 9.7 16.2 13.0 19.3 20.1 15.4 14.0 4.4 17.7 12.4 12.6 13.9 7.1 13.8 14.0 28.6 12.8 7.9 19.7 21.7 8.5 17.6 20.9 19.5 16.1 5.9 10.9 18.6 9.5 14.1 10.5 9.2 23.6 11.5 7.5 12.5 17.6 16.9 13.2 9.4 10.2 15.7 5.1 43.1 11.9 5.1 17.3 13.4 13.2 10.2 20.1 11.4 8.3 6.7 6.3 12.0 5.7 12.1 9.3 5.7 3.9 11.2 8.2 9.1 9.0 10.6 11.5 8.6 8.4 9.2 8.7 1.2 13.0 5.1 8.4 18.8 5.6 21.3 20.7 29.8 43.4 17.9 20.6 17.1 16.5 21.4 6.0 14.9 10.4 8.0 20.1 12.2 12.9 12.9 25.5 6.7 14.8 21.0 3.9 30.6 3.3 30.8 27.0 24.2 6.8 0.0 21.8 27.8 22.2 13.0 5.7 5.8 14.0 27.0 20.3 27.0 8.9 12.0 34.8 9.4 13.5 14.4 12.7 23.0 21.6 3.5 51.6 10.9 10.8 25.8 19.6 12.6 38.4 13.4 21.2 17.5 16.6 16.8 SLC45A4 KIAA1126 ENSG00000022567 "Solute carrier family 45 member 4" Q5BKX6 8 141207166-141308305 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 32.9;Collecting duct cells: 47.1;Cone photoreceptor cells: 51.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "eosinophil: 9.4;neutrophil: 8.6" "Lineage enriched" "Detected in single" 19 "granulocytes: 9.4" "Cell line enhanced" "Detected in many" "HMC-1: 15.6;OE19: 23.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023154 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA023154: AB_2191204" "unprognostic (7.79e-3)" "unprognostic (1.06e-1)" "unprognostic (4.30e-2)" "unprognostic (1.44e-1)" "unprognostic (6.06e-2)" "unprognostic (3.96e-2)" "unprognostic (1.26e-1)" "unprognostic (4.49e-3)" "unprognostic (1.02e-1)" "unprognostic (5.31e-2)" "unprognostic (2.12e-1)" "unprognostic (1.84e-1)" "prognostic favorable (1.73e-6)" "unprognostic (8.79e-3)" "unprognostic (1.13e-1)" "unprognostic (1.77e-2)" "unprognostic (2.40e-2)" 5.6 3.9 6.9 7.6 7.0 10.2 4.3 10.0 19.1 14.2 6.6 2.7 8.5 5.4 6.7 8.9 5.0 11.6 6.9 9.3 8.2 5.9 12.2 1.6 10.1 7.6 5.1 8.4 5.0 14.2 5.4 20.6 17.8 11.5 9.5 3.9 11.4 15.6 16.3 6.4 7.4 6.0 4.3 3.0 6.8 24.4 28.5 2.9 6.6 8.7 1.8 6.4 7.8 4.4 0.0 0.4 9.4 0.1 0.2 0.5 0.1 3.7 8.6 3.1 4.9 0.2 0.2 13.8 2.1 1.3 1.9 1.5 5.4 10.0 0.8 9.4 0.8 2.7 3.1 1.7 1.0 0.9 5.9 2.5 2.4 2.5 0.0 1.5 0.9 15.6 0.7 1.4 1.5 0.8 0.4 1.3 4.0 4.6 0.6 0.5 9.2 8.4 1.9 4.1 23.2 3.5 2.6 0.2 2.4 6.8 6.8 4.9 3.9 2.3 0.8 3.6 2.2 1.6 5.6 0.7 0.0 2.1 3.3 4.1 3.1 9.9 1.0 1.9 3.7 3.6 1.3 0.1 9.4 0.2 0.1 0.2 0.0 0.2 0.5 0.1 0.0 0.2 0.2 8.6 0.2 0.1 0.4 0.2 0.1 6.9 7.0 10.0 19.1 8.2 5.9 5.1 8.4 11.5 2.9 8.9 10.1 0.0 5.7 2.4 32.9 11.1 10.2 17.4 6.8 47.1 51.1 7.1 0.0 6.2 9.5 1.4 9.5 0.0 2.4 0.6 2.0 6.0 1.1 0.0 5.6 3.2 2.4 0.6 2.7 4.1 2.0 2.7 3.3 0.0 6.3 2.8 5.6 5.8 2.1 3.3 9.3 0.0 2.1 4.2 1.9 2.0 13.6 1.5 3.3 9.5 SLC4A8 NBC3 ENSG00000050438 "Solute carrier family 4 member 8" Q2Y0W8 12 51391317-51515763 "Predicted membrane proteins" "Anion exchange, Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6;pituitary gland: 20.0;testis: 15.3" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 85.2;Cone photoreceptor cells: 168.9;Horizontal cells: 109.7;Spermatocytes: 91.6" "Group enriched" "Detected in some" 6 "breast cancer: 1.7;glioma: 2.7;testis cancer: 4.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 17.6;HMC-1: 12.4;SCLC-21H: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077895 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA077895: " "unprognostic (4.01e-1)" "unprognostic (8.15e-2)" "unprognostic (2.49e-2)" "unprognostic (6.39e-2)" "unprognostic (1.29e-1)" "unprognostic (1.96e-2)" "unprognostic (3.46e-2)" "unprognostic (7.72e-4)" "unprognostic (3.13e-2)" "unprognostic (7.03e-3)" "unprognostic (1.07e-4)" "unprognostic (1.70e-1)" "unprognostic (9.60e-6)" "unprognostic (1.35e-1)" "unprognostic (2.57e-1)" "unprognostic (3.21e-2)" "unprognostic (2.47e-1)" 1.0 6.5 5.8 2.2 13.3 1.7 3.1 9.2 22.9 2.7 1.1 9.8 0.0 1.4 1.2 5.4 0.7 3.7 1.1 1.0 10.9 5.6 3.2 0.8 2.8 3.0 6.0 9.3 7.3 2.4 1.0 20.0 1.0 28.6 1.4 1.4 2.2 1.5 1.7 0.8 1.0 2.0 1.1 4.7 2.2 3.0 15.3 5.1 0.0 0.8 0.0 2.7 1.0 0.7 1.1 2.6 3.4 3.1 1.7 1.7 0.7 0.2 0.8 9.9 0.1 0.4 0.5 17.6 2.7 4.5 4.4 2.8 5.8 0.2 3.6 0.4 3.6 2.4 0.1 3.9 0.2 4.1 0.7 0.5 1.8 0.3 0.0 0.0 0.6 12.4 0.1 0.2 2.2 0.5 2.6 5.1 1.6 0.1 6.4 2.2 2.1 5.2 1.1 4.3 1.1 2.9 0.1 0.0 0.0 0.5 0.1 13.2 8.9 1.0 1.4 0.0 3.2 1.6 0.4 4.7 2.8 1.5 0.2 3.4 3.2 1.0 0.2 3.9 0.5 0.4 1.3 2.1 3.4 1.7 1.4 0.4 0.6 0.6 1.6 2.6 1.1 0.6 1.0 2.3 1.7 3.1 1.0 0.3 0.7 5.8 13.3 9.2 22.9 10.9 5.6 6.0 9.3 28.6 5.1 0.0 8.3 0.5 0.6 0.0 85.2 1.7 0.0 38.8 9.1 1.8 168.9 1.0 6.6 0.1 48.8 1.1 0.3 0.0 1.2 4.3 0.5 1.0 7.0 0.0 2.1 109.7 5.8 0.6 1.2 22.8 2.6 3.3 1.7 0.0 0.2 13.6 0.1 2.9 3.5 0.8 18.4 0.0 0.8 91.6 6.4 0.1 0.3 2.5 0.0 1.0 SLC5A3 "SMIT, SMIT1" ENSG00000198743 "Solute carrier family 5 member 3" P53794 21 34073570-34106262 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 46.0" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 130.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029791 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA029791: AB_10601892" "unprognostic (9.70e-2)" "unprognostic (4.99e-2)" "unprognostic (2.23e-1)" "unprognostic (7.57e-2)" "unprognostic (1.07e-1)" "unprognostic (4.54e-2)" "unprognostic (4.48e-3)" "unprognostic (1.63e-1)" "unprognostic (3.02e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (1.98e-5)" "unprognostic (1.30e-1)" "prognostic unfavorable (4.72e-4)" "unprognostic (1.82e-1)" "unprognostic (1.82e-1)" "unprognostic (2.21e-1)" "unprognostic (8.60e-2)" 10.1 9.5 10.5 7.3 11.0 3.6 26.6 8.0 10.1 6.5 7.6 4.6 9.4 5.0 11.3 9.1 7.5 8.5 4.9 6.8 11.6 6.8 46.0 9.5 8.5 7.6 11.7 4.7 9.0 5.8 6.3 6.6 15.8 13.6 7.0 8.8 11.3 6.4 6.9 7.8 10.1 7.4 5.9 14.7 4.9 7.8 10.6 9.0 5.9 42.7 4.4 8.0 6.5 22.1 0.8 2.3 0.7 1.0 1.0 2.6 0.7 6.3 5.7 11.9 8.4 10.0 8.2 5.7 7.2 22.1 4.5 6.9 9.4 13.9 10.2 5.9 14.6 8.5 3.3 14.4 4.1 7.7 10.6 3.7 10.6 5.3 3.1 2.6 4.5 4.5 3.9 10.7 12.3 4.9 13.9 2.7 8.5 10.4 2.4 11.6 4.3 4.8 3.7 6.0 2.4 5.6 4.9 2.1 4.6 17.8 8.9 6.2 2.9 15.0 4.0 3.4 7.4 2.4 4.8 2.6 8.9 6.9 16.9 2.9 12.7 10.9 7.7 17.9 6.6 5.9 0.0 1.0 0.2 2.6 0.9 2.1 0.8 1.4 1.7 0.9 0.8 1.9 2.6 0.7 1.0 0.4 2.3 0.4 0.7 10.5 11.0 8.0 10.1 11.6 6.8 11.7 4.7 13.6 9.0 14.9 12.2 8.0 40.9 0.0 28.5 7.6 12.7 16.0 23.9 130.9 19.6 21.2 18.3 3.4 8.6 4.5 28.0 0.0 4.5 15.7 10.7 71.1 41.4 15.3 12.8 35.0 47.1 6.7 12.1 5.2 6.1 9.8 0.0 24.4 48.3 6.0 5.8 46.0 19.4 6.5 20.8 12.9 2.2 12.1 18.9 0.0 23.6 17.3 26.6 32.3 SLC5A6 SMVT ENSG00000138074 "Solute carrier family 5 member 6" Q9Y289 2 27199587-27212958 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 64.0;placenta: 51.7" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 98.8;Extravillous trophoblasts: 89.2;monocytes: 78.5;Syncytiotrophoblasts: 190.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 69.3;SK-BR-3: 74.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036958 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA036958: AB_10672343" "unprognostic (5.85e-2)" "unprognostic (8.32e-3)" "unprognostic (1.38e-1)" "unprognostic (2.61e-3)" "unprognostic (9.38e-2)" "unprognostic (7.14e-2)" "unprognostic (3.20e-3)" "unprognostic (7.92e-2)" "unprognostic (6.96e-2)" "unprognostic (9.80e-2)" "unprognostic (2.05e-2)" "unprognostic (7.46e-2)" "prognostic unfavorable (3.60e-7)" "unprognostic (2.40e-3)" "unprognostic (1.20e-2)" "unprognostic (4.56e-3)" "unprognostic (4.18e-2)" 20.9 4.6 5.0 7.6 8.5 8.5 15.9 7.9 8.1 4.0 6.4 5.6 6.4 10.9 7.4 36.7 5.5 5.9 6.3 3.5 5.3 5.7 5.9 64.0 6.0 6.4 7.0 8.1 5.6 6.0 4.5 4.2 51.7 7.1 4.8 6.6 5.6 6.7 10.6 7.9 4.6 7.6 4.9 4.4 4.8 4.8 17.5 6.1 5.8 5.1 4.3 13.0 4.6 10.1 6.8 10.0 2.0 9.0 6.3 10.4 5.8 16.7 17.4 11.1 14.6 10.3 3.7 69.3 6.1 4.1 9.3 6.4 25.6 6.0 11.6 9.3 3.3 10.1 9.4 23.7 7.0 6.5 9.0 13.9 20.6 7.4 39.2 12.2 26.4 10.8 12.9 6.0 11.4 8.9 2.6 8.3 9.5 30.1 4.8 5.9 34.4 8.9 12.9 32.0 19.4 6.4 15.1 13.1 16.8 5.3 16.1 9.4 13.9 6.6 74.6 8.8 11.3 16.6 5.7 3.8 10.3 14.1 6.2 16.3 8.0 18.3 18.5 5.6 18.6 14.4 0.1 6.5 2.0 8.5 7.3 10.4 6.8 8.3 8.2 9.7 6.7 8.5 10.1 0.3 6.3 9.0 10.0 8.2 5.8 5.0 8.5 7.9 8.1 5.3 5.7 7.0 8.1 7.1 6.1 0.0 4.1 13.4 6.8 7.1 4.5 5.9 7.6 4.0 2.3 7.0 3.9 98.8 1.7 9.6 11.6 3.8 6.0 0.0 7.0 89.2 5.4 7.1 0.0 36.0 19.5 11.1 5.2 7.4 10.0 25.3 6.6 6.5 0.0 78.5 6.8 3.9 6.2 2.9 13.1 3.6 3.4 12.9 5.9 31.1 18.5 5.5 190.6 7.5 13.3 6.4 SLC9A1 "APNH, NHE1, PPP1R143" ENSG00000090020 "Solute carrier family 9 member A1" P19634 1 27098815-27166981 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" Calmodulin-binding "Deafness, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 60.7" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022371, HPA048532, HPA052891" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB022371: , HPA048532: AB_2680431, HPA052891: AB_2681981" "unprognostic (6.18e-2)" "unprognostic (1.59e-1)" "unprognostic (2.21e-1)" "unprognostic (8.48e-2)" "prognostic unfavorable (7.47e-4)" "unprognostic (2.70e-2)" "unprognostic (4.33e-3)" "unprognostic (3.18e-2)" "unprognostic (9.74e-2)" "prognostic unfavorable (7.10e-4)" "unprognostic (3.44e-2)" "unprognostic (6.95e-2)" "unprognostic (2.05e-2)" "unprognostic (1.27e-2)" "unprognostic (1.60e-1)" "unprognostic (3.34e-1)" "unprognostic (1.16e-2)" 7.1 11.3 7.5 9.9 10.1 7.3 8.4 11.7 18.9 8.7 14.0 5.0 26.9 20.7 10.6 6.8 10.3 7.1 24.4 13.4 4.6 5.3 7.3 2.4 11.2 5.8 5.0 6.7 6.9 6.4 13.4 8.0 42.5 14.8 8.5 10.2 10.1 60.7 55.4 3.8 9.2 24.7 8.1 3.9 10.5 45.6 8.3 4.9 6.0 8.0 6.5 9.0 18.8 8.4 0.9 0.6 5.5 1.5 0.4 4.2 1.8 13.7 4.7 4.5 4.5 10.2 7.4 27.6 11.3 17.3 9.9 10.8 5.7 9.0 6.2 9.7 14.7 4.8 17.2 4.4 28.0 6.2 7.4 4.1 9.5 3.1 2.4 31.1 5.5 7.2 9.2 13.6 16.7 23.3 7.2 16.4 4.4 2.6 6.1 14.5 8.2 2.8 2.9 6.2 17.0 9.8 5.1 4.0 2.9 5.2 20.8 5.2 1.6 9.5 13.0 5.7 4.8 6.0 3.5 17.6 10.6 4.2 9.8 6.2 5.5 3.5 1.8 11.3 6.2 6.1 0.1 1.5 1.5 1.9 0.9 4.2 0.2 2.2 2.0 0.6 0.9 1.4 1.7 5.5 0.4 1.5 0.1 0.8 1.8 7.5 10.1 11.7 18.9 4.6 5.3 5.0 6.7 14.8 4.9 6.0 17.9 5.2 16.2 27.7 6.3 11.3 10.2 0.0 3.4 10.4 0.0 30.0 0.0 8.5 26.9 7.1 52.0 0.0 10.9 16.2 11.0 8.8 26.5 1.0 11.5 19.1 12.0 8.0 4.9 9.7 8.6 6.6 6.8 1.8 12.3 10.8 19.4 22.0 12.4 1.3 3.6 6.5 8.7 1.4 3.4 22.0 44.3 6.7 14.3 16.3 SLC9A3 NHE3 ENSG00000066230 "Solute carrier family 9 member A3" P48764 5 470458-524332 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 65.8;intestine: 85.1;kidney: 43.6" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 1: 14.9;Club cells: 10.3;Collecting duct cells: 15.7;Proximal tubular cells: 38.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 28.2" "Region enriched" "Detected in single" 14 "cerebellum: 4.6" "Not detected" "Not detected" "HPA036493, HPA036669" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA036493: AB_10673353, HPA036669: AB_10670843" "unprognostic (1.27e-1)" "unprognostic (4.88e-1)" "unprognostic (9.35e-3)" "unprognostic (1.11e-1)" "unprognostic (2.37e-1)" "unprognostic (3.35e-1)" "unprognostic (2.51e-1)" "unprognostic (9.40e-2)" "prognostic unfavorable (8.49e-4)" "unprognostic (5.18e-2)" "unprognostic (1.29e-1)" "unprognostic (3.69e-2)" "unprognostic (3.84e-1)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" "unprognostic (1.24e-2)" "unprognostic (1.32e-1)" 0.6 0.6 0.5 16.2 1.0 0.0 0.6 4.2 0.9 0.9 27.5 0.7 1.1 12.7 0.9 3.4 2.4 0.8 65.8 0.6 0.6 0.6 43.6 0.5 0.5 0.9 0.9 0.7 0.8 1.1 0.6 0.9 0.5 1.2 1.4 2.3 1.2 2.1 0.8 0.7 4.2 85.1 1.1 0.6 0.5 22.7 1.1 0.5 0.6 0.7 2.4 2.7 0.8 2.0 1.9 2.0 0.2 1.2 3.5 6.8 2.9 4.2 3.8 7.0 7.4 1.7 2.0 5.5 4.2 2.5 5.2 3.3 9.3 4.9 10.2 5.5 1.9 3.8 7.0 3.9 2.5 2.5 28.2 7.3 4.6 16.5 3.4 2.6 3.4 5.9 2.7 5.2 2.3 3.5 2.6 1.5 4.2 6.1 5.4 1.8 6.6 3.7 16.7 2.6 12.2 6.3 5.6 6.6 5.3 1.8 3.6 7.9 3.3 12.6 3.5 2.6 3.2 8.0 2.7 1.9 6.0 5.3 4.1 2.7 9.1 3.6 5.8 3.8 15.3 3.8 0.0 1.2 0.1 4.3 0.5 3.8 1.6 5.6 4.1 1.4 1.9 6.8 5.2 0.2 3.5 0.4 2.0 4.2 2.9 0.5 1.0 4.2 0.9 0.6 0.6 0.9 0.7 1.2 0.5 14.9 4.3 0.0 0.0 0.0 0.0 0.6 0.0 5.3 10.3 15.7 0.0 0.0 5.0 7.5 0.0 0.0 1.0 0.0 7.7 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 8.2 0.0 0.0 6.5 0.0 0.0 38.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC9A3R2 "E3KARP, NHERF-2, SIP-1, TKA-1" ENSG00000065054 "SLC9A3 regulator 2" Q15599 16 2025356-2039026 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 275.4;Hepatocytes: 196.4;Ito cells: 306.3;Pancreatic endocrine cells: 190.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 3.6;intermediate monocyte: 2.7;myeloid DC: 6.8;plasmacytoid DC: 5.0" "Group enriched" "Detected in many" 5 "dendritic cells: 6.8;monocytes: 3.6" "Cell line enhanced" "Detected in many" "A549: 38.1;MCF7: 60.8;PC-3: 57.3;SK-BR-3: 38.5;U-251 MG: 38.3;WM-115: 41.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001672, HPA066520" Enhanced Supported "Plasma membrane" NA NA 120000 "Plasma membrane" "HPA001672: AB_1080017, HPA066520: AB_2732748" "unprognostic (6.99e-2)" "unprognostic (4.56e-2)" "unprognostic (2.06e-2)" "prognostic favorable (1.03e-4)" "unprognostic (1.41e-2)" "unprognostic (1.54e-1)" "unprognostic (2.94e-3)" "unprognostic (9.17e-2)" "unprognostic (1.68e-2)" "unprognostic (1.56e-2)" "unprognostic (2.17e-2)" "unprognostic (1.70e-2)" "unprognostic (2.20e-2)" "unprognostic (6.20e-3)" "unprognostic (9.10e-2)" "unprognostic (2.40e-1)" "unprognostic (2.80e-2)" 51.5 19.4 20.0 10.0 25.4 1.1 41.0 15.5 26.6 29.7 13.1 15.2 13.5 13.5 28.7 10.3 16.1 20.9 30.4 65.1 18.4 15.7 40.7 80.9 51.2 11.1 21.0 15.9 18.3 14.0 5.3 17.4 25.1 17.8 25.5 6.5 37.5 76.3 22.9 60.9 7.1 15.7 9.9 12.2 39.0 35.0 8.8 13.5 2.5 32.7 21.5 12.3 13.3 25.0 0.1 6.8 0.0 3.6 0.1 0.9 1.0 6.3 38.1 1.0 7.9 1.3 1.8 1.1 27.8 16.8 14.0 4.6 5.0 8.5 0.0 13.2 11.9 1.8 6.2 3.0 2.7 1.5 0.0 9.1 0.6 16.4 12.1 9.3 0.1 2.8 1.9 2.8 4.1 1.2 6.6 13.9 2.9 4.6 0.5 0.9 60.8 0.1 7.0 1.5 15.2 57.3 5.4 1.6 10.0 3.1 0.6 7.3 6.8 1.9 38.5 2.5 1.0 31.2 3.3 35.5 4.4 6.4 0.4 38.3 1.0 0.8 0.1 0.5 0.7 41.1 0.0 3.6 0.0 0.9 2.7 0.3 0.0 0.2 0.2 6.8 0.1 0.9 0.9 0.0 0.1 0.9 5.0 0.2 1.0 20.0 25.4 15.5 26.6 18.4 15.7 21.0 15.9 17.8 13.5 3.0 13.8 20.1 19.8 13.5 1.5 21.0 66.2 6.7 5.7 12.2 0.0 0.8 5.0 30.7 12.9 275.4 5.7 0.0 7.5 0.7 37.7 42.0 0.0 196.4 2.2 3.2 20.6 306.3 28.2 22.9 75.9 9.5 32.1 1.8 66.3 11.2 190.9 5.8 41.8 12.2 4.4 25.8 53.1 1.7 7.7 9.9 0.8 6.9 14.3 41.9 SLCO1A2 "OATP, OATP-A, OATP1A2, SLC21A3" ENSG00000084453 "Solute carrier organic anion transporter family member 1A2" P46721 12 21264600-21419594 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.9;liver: 11.2;retina: 14.2;salivary gland: 14.5" "Cell type enriched" "Detected in some" 9 "Alveolar cells type 1: 32.8" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NTERA-2: 13.3;RPMI-8226: 9.2;SuSa: 14.2;U-266/70: 19.8;U-266/84: 8.0" "Low region specificity" "Detected in all" HPA071152 Supported "Plasma membrane" No No "Plasma membrane" "HPA071152: AB_2686350" "unprognostic (5.43e-3)" "unprognostic (2.33e-1)" "unprognostic (1.28e-1)" "unprognostic (8.59e-2)" "unprognostic (1.08e-1)" "unprognostic (6.36e-2)" "unprognostic (7.63e-2)" "unprognostic (1.53e-1)" "unprognostic (3.82e-2)" "unprognostic (1.54e-2)" "unprognostic (1.51e-1)" "unprognostic (8.82e-2)" "unprognostic (1.66e-4)" "unprognostic (2.52e-2)" "unprognostic (3.20e-1)" "unprognostic (1.24e-1)" 0.2 0.1 3.3 0.0 3.4 0.0 3.6 3.4 17.9 0.1 0.1 1.9 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.9 4.1 2.5 1.1 11.2 2.7 0.6 3.0 4.0 0.2 2.3 0.5 0.5 1.2 9.7 0.7 0.0 14.2 14.5 0.0 0.4 0.4 0.2 0.0 2.9 0.4 0.4 1.6 1.4 0.0 0.3 0.0 0.3 0.4 0.1 1.3 0.7 4.3 0.4 1.1 2.3 0.2 2.0 0.5 0.8 0.2 0.0 0.0 2.7 0.0 0.0 0.0 0.0 2.9 1.7 0.1 2.1 0.1 0.0 0.2 0.2 0.1 0.4 0.5 0.7 0.0 0.4 1.1 0.0 0.3 0.2 0.0 1.3 0.1 0.1 1.2 0.1 0.4 3.4 1.4 0.0 2.0 0.3 0.1 13.3 1.5 0.1 0.1 0.2 9.2 0.0 2.0 1.8 2.3 0.0 0.2 0.2 14.2 2.6 0.7 0.0 0.0 1.4 0.6 0.3 19.8 8.0 0.1 0.2 0.2 0.1 0.6 0.4 0.3 1.4 0.3 2.3 1.3 2.2 1.5 0.1 1.0 2.1 1.6 4.3 1.1 0.1 0.7 1.8 0.2 3.3 3.4 3.4 5.0 4.1 2.5 3.0 4.0 9.7 1.4 32.8 1.9 0.0 0.0 0.0 0.0 0.4 0.0 2.7 0.0 1.8 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.1 0.0 0.0 0.0 SLCO1B3 "OATP1B3, OATP8, SLC21A8" ENSG00000111700 "Solute carrier organic anion transporter family member 1B3" Q9NPD5 12 20810702-20916911 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "liver: 88.1" "Cell type enriched" "Detected in some" 20 "Hepatocytes: 91.8" "Cancer enhanced" "Detected in many" "liver cancer: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 35.8;A549: 9.8;CAPAN-2: 7.1;GAMG: 7.8;HeLa: 8.1;PC-3: 9.8;U-2 OS: 8.5" "HPA004943, HPA050892" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA004943: AB_1854758, HPA050892: AB_2681265" "unprognostic (5.36e-2)" "unprognostic (1.25e-1)" "unprognostic (6.95e-2)" "unprognostic (1.63e-2)" "unprognostic (1.89e-2)" "unprognostic (7.09e-2)" "unprognostic (3.08e-2)" "unprognostic (1.54e-2)" "unprognostic (7.37e-2)" "unprognostic (1.50e-1)" "unprognostic (6.61e-3)" "unprognostic (2.36e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 4.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 88.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.8 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 7.1 0.0 2.5 0.0 7.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 8.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 91.8 0.0 0.0 0.0 0.6 1.9 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 SLIT1 "MEGF4, SLIL1, Slit-1, slit1, SLIT3" ENSG00000187122 "Slit guidance ligand 1" O75093 10 96998038-97185920 "Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 44.3" "Group enriched" "Detected in some" 6 "Early spermatids: 27.2;Late spermatids: 15.4" "Group enriched" "Detected in many" 10 "glioma: 9.2;prostate cancer: 2.2;thyroid cancer: 10.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 1.6;plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 10 "JURKAT: 12.4;MOLT-4: 41.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA006879 Approved "Plasma membrane" "Secreted in brain" NA NA "Plasma membrane" "HPA006879: AB_1078197" "unprognostic (2.72e-1)" "unprognostic (2.25e-2)" "unprognostic (5.67e-3)" "unprognostic (1.43e-5)" "unprognostic (8.40e-2)" "unprognostic (2.60e-3)" "unprognostic (4.57e-2)" "unprognostic (1.81e-2)" "unprognostic (3.53e-1)" "unprognostic (6.06e-2)" "unprognostic (2.28e-3)" "unprognostic (1.46e-1)" "unprognostic (1.08e-5)" "unprognostic (1.66e-1)" "unprognostic (2.18e-1)" "unprognostic (1.21e-1)" "unprognostic (4.39e-3)" 1.2 0.8 13.4 0.9 16.1 0.9 0.8 0.4 44.3 0.8 0.9 0.5 0.0 0.9 0.8 0.7 0.8 1.0 0.8 0.8 13.9 10.5 0.8 0.7 1.0 0.9 4.6 13.2 0.8 1.4 0.8 8.0 0.8 2.2 1.1 0.8 0.3 0.8 0.7 0.9 0.8 0.9 0.8 1.4 0.9 1.1 2.0 0.3 3.3 3.6 0.0 0.9 0.8 0.0 0.0 1.6 0.4 0.7 0.0 0.0 0.2 0.0 0.0 2.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.3 0.0 0.1 41.4 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 1.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.4 1.6 0.0 0.2 13.4 16.1 0.4 24.8 13.9 10.5 4.6 13.2 2.2 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 27.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 1.7 0.0 0.3 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 3.4 1.4 0.0 0.0 0.0 0.0 0.1 SLITRK6 FLJ22774 ENSG00000184564 "SLIT and NTRK like family member 6" Q9H5Y7 13 85792787-85806683 "Disease related genes, Predicted membrane proteins" "Hearing, Sensory transduction, Vision" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 24.2;salivary gland: 22.8;smooth muscle: 22.4;urinary bladder: 27.8" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 14.0;Ciliated cells: 69.6;Club cells: 25.0" "Cancer enhanced" "Detected in many" "breast cancer: 21.1" "Group enriched" "Detected in many" 4 "basal ganglia: 11.1;cerebellum: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 13.5;OE19: 10.9;RT4: 46.2;WM-115: 10.9" "Region enhanced" "Detected in many" "thalamus: 24.7" "Low region specificity" "Detected in many" "HPA014491, HPA014513" Uncertain Supported "Plasma membrane" NA NA 9500 "Plasma membrane" "HPA014491: AB_10601603, HPA014513: AB_2669026" "unprognostic (6.14e-2)" "unprognostic (5.21e-3)" "unprognostic (1.40e-1)" "unprognostic (2.66e-2)" "unprognostic (2.46e-2)" "prognostic unfavorable (8.52e-4)" "unprognostic (6.10e-2)" "unprognostic (1.72e-2)" "unprognostic (1.69e-1)" "unprognostic (4.82e-2)" "unprognostic (7.60e-2)" "unprognostic (7.92e-2)" "unprognostic (3.31e-5)" "unprognostic (5.60e-2)" "unprognostic (1.81e-1)" "unprognostic (1.83e-1)" "unprognostic (2.51e-2)" 0.4 0.3 0.3 2.7 11.1 0.0 2.9 4.9 0.3 1.0 4.5 0.0 0.2 2.8 0.7 3.4 3.6 0.3 1.1 1.9 0.3 1.3 0.3 1.1 3.1 0.0 0.6 0.0 0.3 0.4 0.0 0.4 4.1 0.8 24.2 5.8 1.7 22.8 1.8 0.3 4.5 7.2 22.4 0.4 0.2 1.2 0.5 1.8 0.0 0.6 3.4 0.7 27.8 5.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.2 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 13.5 0.0 1.6 1.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 10.9 0.9 0.1 0.0 0.0 0.0 46.2 0.4 0.5 0.2 0.0 0.0 0.8 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 10.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 11.1 4.9 0.3 0.3 1.3 0.6 0.0 0.8 1.8 0.0 2.6 0.0 4.8 3.4 14.0 0.3 0.0 69.6 25.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.0 8.9 0.0 0.0 0.0 0.4 1.1 1.1 0.0 0.4 0.0 1.4 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.0 3.1 SMOC1 ENSG00000198732 "SPARC related modular calcium binding 1" Q9H4F8 14 69854131-70032366 "Disease related genes, Predicted secreted proteins" Differentiation "Developmental protein" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.2;liver: 48.0" "Group enriched" "Detected in many" 4 "Hepatocytes: 78.8;Peritubular cells: 125.2;Syncytiotrophoblasts: 33.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 4.9" "Lineage enriched" "Detected in single" 50 "dendritic cells: 4.9" "Cell line enhanced" "Detected in some" "AF22: 19.8;HeLa: 54.5;HSkMC: 16.0;SiHa: 32.1;SK-BR-3: 14.1;U-266/70: 20.3;U-87 MG: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004153, CAB034427" Approved Approved "Plasma membrane" "Secreted to extracellular matrix" NA NA 27000 "Plasma membrane" "CAB034427: AB_2193382, HPA004153: AB_1080035" "unprognostic (3.31e-1)" "unprognostic (2.17e-3)" "unprognostic (8.17e-2)" "unprognostic (1.96e-2)" "unprognostic (1.89e-2)" "unprognostic (4.04e-1)" "unprognostic (6.75e-3)" "unprognostic (2.09e-3)" "unprognostic (4.76e-2)" "unprognostic (2.80e-2)" "unprognostic (5.10e-2)" "unprognostic (5.63e-2)" "unprognostic (4.09e-2)" "unprognostic (3.92e-1)" "unprognostic (2.57e-1)" "unprognostic (1.34e-1)" "unprognostic (1.87e-1)" 7.4 10.7 23.0 1.4 10.8 1.1 2.9 5.2 62.2 8.6 2.2 32.0 19.4 3.0 2.2 10.3 1.3 7.1 1.5 4.7 22.6 16.2 2.1 48.0 1.4 1.8 23.8 8.5 1.8 26.4 1.1 2.4 9.0 21.7 42.9 2.0 14.7 3.6 35.8 8.7 1.2 2.3 1.9 15.0 19.5 3.5 24.7 16.9 0.0 2.9 0.6 1.5 1.7 3.6 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 19.8 0.0 4.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 7.7 0.0 54.5 8.0 0.0 0.0 0.0 16.0 4.6 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.8 0.1 32.1 14.1 0.0 0.1 0.0 0.0 0.1 0.1 1.4 0.0 0.0 20.3 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 23.0 10.8 5.2 11.2 22.6 16.2 23.8 8.5 21.7 16.9 0.0 0.0 0.9 0.0 0.2 1.5 1.7 10.2 1.4 0.0 0.0 15.7 18.5 0.0 0.2 4.1 1.3 0.0 0.0 1.9 0.8 4.2 0.0 0.0 78.8 2.5 0.0 15.0 2.5 2.7 13.2 7.2 0.0 0.0 0.0 0.0 0.2 5.8 0.0 125.2 0.0 0.2 0.0 0.7 1.5 3.3 0.4 33.6 0.0 0.0 0.0 SMPX "DFN6, DFNX4" ENSG00000091482 "Small muscle protein, X-linked" Q9UHP9 X 21705972-21758163 "Disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 23 "heart muscle: 108.8;skeletal muscle: 155.8;tongue: 74.5" "Cell type enriched" "Detected in single" 2069 "Cardiomyocytes: 810.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "GAMG: 22.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA077360 Approved "Plasma membrane" NA NA 45000 "Plasma membrane" "HPA077360: AB_2732342" "unprognostic (7.29e-2)" "unprognostic (1.78e-1)" "unprognostic (2.63e-1)" "unprognostic (1.28e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.04e-5)" "unprognostic (1.39e-2)" "unprognostic (7.46e-2)" "unprognostic (5.27e-1)" "unprognostic (1.96e-2)" "unprognostic (3.97e-2)" "unprognostic (3.58e-2)" "unprognostic (2.67e-2)" "unprognostic (2.82e-1)" "unprognostic (8.38e-2)" 1.4 0.0 0.1 0.6 0.1 0.0 0.2 0.6 0.9 0.1 4.0 0.0 0.0 0.1 0.1 4.7 4.0 0.1 0.1 108.8 0.1 0.2 0.0 0.2 0.0 0.1 0.7 0.3 0.2 0.1 0.0 0.0 0.0 0.0 1.6 0.5 0.0 3.6 0.1 155.8 0.0 0.9 1.8 0.1 0.0 1.5 0.1 0.0 0.0 1.0 74.5 4.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.2 0.0 0.0 0.0 0.4 3.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.9 0.1 0.2 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 810.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 SNAP23 "HsT17016, SNAP23A, SNAP23B" ENSG00000092531 "Synaptosome associated protein 23" O00161 15 42491233-42545356 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 273.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 102.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001214, CAB037083, CAB037317" Approved Supported "Plasma membrane" NA NA 12000000 "Plasma membrane" "CAB037083: AB_477494, CAB037317: AB_261925, HPA001214: AB_1080037" "unprognostic (1.77e-1)" "unprognostic (1.37e-1)" "unprognostic (1.18e-1)" "unprognostic (3.76e-3)" "unprognostic (2.42e-2)" "unprognostic (1.65e-1)" "unprognostic (9.67e-3)" "unprognostic (1.60e-1)" "unprognostic (2.60e-1)" "unprognostic (2.93e-1)" "unprognostic (7.31e-2)" "unprognostic (1.36e-1)" "unprognostic (2.04e-2)" "unprognostic (1.59e-1)" "unprognostic (8.95e-2)" "unprognostic (1.10e-1)" "unprognostic (3.93e-2)" 29.9 24.0 15.2 28.4 20.5 14.3 28.6 11.1 17.5 20.8 30.8 21.6 27.7 23.0 38.9 18.6 20.3 21.3 18.7 24.6 16.6 11.7 22.8 23.0 28.0 35.4 27.3 10.5 24.6 19.8 10.4 17.7 81.6 18.9 24.1 24.5 16.3 37.0 25.8 32.8 15.3 40.8 22.8 23.4 41.6 22.1 25.1 21.3 20.1 20.3 18.1 35.1 25.5 53.7 17.2 22.9 102.0 36.3 10.3 11.5 23.0 17.5 7.9 15.0 14.6 24.7 19.5 23.1 22.1 16.7 13.1 15.9 25.7 6.9 8.5 29.2 13.6 14.4 15.0 16.6 12.9 18.6 14.4 9.6 40.6 8.6 24.1 17.9 16.3 39.1 15.5 10.2 11.7 20.1 18.7 50.2 19.6 30.4 8.8 17.8 6.0 19.4 16.9 12.7 25.3 6.1 35.7 8.9 14.0 18.4 15.9 2.4 9.6 15.9 14.6 14.0 23.9 21.0 23.5 39.4 13.3 18.1 15.9 21.8 19.1 33.8 45.5 16.0 33.2 17.1 30.2 24.7 102.0 8.4 36.3 9.8 17.2 8.9 8.2 22.9 15.4 11.5 8.8 56.2 10.3 34.4 9.5 9.8 23.0 15.2 20.5 11.1 17.5 16.6 11.7 27.3 10.5 18.9 21.3 104.2 26.2 49.8 68.2 45.1 7.4 14.3 22.9 41.5 19.4 19.2 19.6 58.5 48.0 63.9 163.9 67.1 52.1 0.0 45.9 88.6 49.1 68.2 79.9 24.3 76.0 4.8 14.3 67.5 97.9 273.8 36.2 83.7 42.2 120.8 68.8 14.6 83.4 48.0 57.0 61.4 19.1 51.8 45.7 15.6 6.5 33.6 119.1 47.7 32.9 54.8 SPN "CD43, GPL115, LSN" ENSG00000197471 Sialophorin P16150 16 29662979-29670876 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 52.1;bone marrow: 33.1;lung: 25.0;lymphoid tissue: 79.7" "Group enriched" "Detected in many" 4 "Alveolar cells type 2: 22.9;Erythroid cells: 23.3;granulocytes: 42.7;Hofbauer cells: 27.4;Kupffer cells: 21.5;Macrophages: 52.4;T-cells: 85.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 52.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 56.1;HL-60: 49.8;HMC-1: 28.1;K-562: 17.4;MOLT-4: 19.3;REH: 17.4;THP-1: 27.0;U-937: 35.5" "CAB002666, HPA055244" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "CAB002666: , HPA055244: AB_2682756" "prognostic favorable (1.40e-4)" "unprognostic (1.63e-3)" "unprognostic (3.14e-2)" "prognostic favorable (3.08e-5)" "unprognostic (2.68e-2)" "unprognostic (2.49e-3)" "unprognostic (4.02e-2)" "unprognostic (4.17e-2)" "prognostic favorable (1.88e-4)" "unprognostic (1.70e-1)" "unprognostic (4.67e-2)" "unprognostic (2.68e-1)" "unprognostic (2.61e-2)" "unprognostic (4.52e-2)" "unprognostic (4.14e-2)" "unprognostic (5.85e-2)" "unprognostic (4.72e-2)" 5.7 1.0 1.2 12.9 2.7 33.1 1.6 0.7 1.5 1.3 2.8 2.6 0.0 2.3 1.5 0.6 1.9 1.7 2.8 3.9 1.2 1.4 1.8 1.9 25.0 18.3 3.7 0.2 1.0 1.6 0.2 1.0 0.8 2.3 1.6 2.6 1.6 5.0 0.6 0.8 1.6 6.8 1.0 4.6 15.9 2.0 0.6 1.9 79.7 1.6 1.7 17.4 2.6 1.4 1.0 8.8 3.5 52.1 17.5 26.5 10.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.1 0.0 0.4 0.0 49.8 28.1 0.0 0.0 0.0 0.0 0.0 0.0 10.9 17.4 13.7 0.1 0.0 19.3 12.5 0.0 0.0 0.0 17.4 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.1 0.0 0.0 0.0 0.0 0.1 1.0 7.3 0.0 35.5 0.0 2.4 5.5 3.5 26.5 24.3 14.5 1.0 10.7 18.1 8.8 0.3 7.6 13.2 0.9 17.5 52.1 7.0 9.1 10.7 1.2 2.7 0.7 1.5 1.2 1.4 3.7 0.2 2.3 1.9 8.9 22.9 9.3 0.5 1.9 0.6 5.1 0.0 2.7 4.5 1.8 0.0 0.2 0.0 0.0 0.0 0.7 0.0 23.3 0.0 0.3 2.6 0.4 42.7 0.9 27.4 1.6 0.0 4.3 21.5 0.0 0.0 52.4 1.7 1.8 0.0 0.4 0.0 0.0 0.0 0.3 1.9 0.0 1.7 0.2 0.6 1.8 0.2 85.3 0.0 0.7 SRPRB "APMCF1, SR-beta" ENSG00000144867 "SRP receptor beta subunit" Q9Y5M8 3 133784033-133825772 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 104.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011173 Approved Approved "Plasma membrane" NA NA 54000 "Plasma membrane" "HPA011173: AB_1857484" "unprognostic (5.44e-2)" "unprognostic (1.32e-1)" "unprognostic (6.40e-2)" "unprognostic (1.58e-2)" "unprognostic (2.61e-1)" "unprognostic (2.02e-2)" "prognostic unfavorable (3.12e-5)" "unprognostic (1.99e-1)" "unprognostic (3.60e-2)" "unprognostic (6.07e-3)" "unprognostic (8.45e-2)" "unprognostic (1.31e-2)" "unprognostic (3.79e-2)" "unprognostic (5.08e-2)" "unprognostic (7.37e-2)" "unprognostic (6.47e-2)" "unprognostic (2.26e-2)" 10.4 15.7 8.7 10.2 9.3 5.8 12.5 5.2 10.2 14.4 11.3 5.1 33.2 8.9 8.0 25.6 16.8 9.1 11.0 10.9 9.0 10.7 17.2 56.3 9.2 17.3 10.4 7.7 8.9 104.0 11.7 15.6 7.7 8.8 9.5 13.4 7.6 53.3 29.9 10.6 8.6 7.4 10.3 7.4 9.5 12.5 14.7 5.4 6.3 16.5 10.2 13.7 8.7 10.4 15.4 20.0 3.8 15.2 14.3 29.0 18.0 12.1 9.9 6.3 20.0 26.3 18.3 11.8 25.8 13.5 14.4 12.5 18.0 9.5 23.1 38.2 19.7 14.5 17.8 19.6 13.9 13.7 15.6 15.7 20.7 9.8 17.0 32.0 32.3 16.8 16.5 23.5 13.1 38.8 8.0 12.2 11.8 17.5 26.9 15.4 17.7 11.1 15.4 11.9 32.4 17.1 13.5 11.7 49.3 17.3 8.4 20.8 8.6 19.8 18.4 7.2 5.0 20.9 15.0 12.1 14.2 8.4 22.3 13.8 34.7 34.5 34.9 12.7 21.5 15.8 3.8 11.6 1.4 21.4 15.2 29.0 15.4 18.3 19.0 13.2 13.4 18.0 21.2 0.8 14.3 9.9 20.0 10.6 18.0 8.7 9.3 5.2 10.2 9.0 10.7 10.4 7.7 8.8 5.4 14.9 22.3 15.6 21.0 33.5 6.2 22.2 43.3 20.1 19.4 34.9 11.8 58.0 10.0 42.5 49.3 24.9 15.5 0.0 58.0 60.5 38.5 38.7 32.3 77.2 46.0 6.4 30.9 17.8 19.9 31.5 29.7 19.3 33.7 10.0 36.2 15.6 40.9 21.0 26.2 24.9 8.8 12.9 23.7 52.8 41.9 27.6 43.3 20.8 32.9 21.4 SSTR1 ENSG00000139874 "Somatostatin receptor 1" P30872 14 38207999-38213067 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 15.0;intestine: 14.3;stomach 1: 22.8" "Group enriched" "Detected in some" 5 "Cholangiocytes: 5.1;Enterocytes: 9.0;Hepatocytes: 6.4;Intestinal endocrine cells: 17.4;Ito cells: 9.8;Mucus-secreting cells: 8.0;Paneth cells: 8.7;Undifferentiated cells: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 47.9;BJ hTERT+: 13.3;BJ hTERT+ SV40 Large T+: 8.8;fHDF/TERT166: 28.3;HeLa: 10.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003207, HPA031506" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA003207: , HPA031506: AB_2673913" "unprognostic (1.40e-1)" "unprognostic (1.37e-1)" "unprognostic (3.36e-1)" "unprognostic (2.50e-3)" "unprognostic (4.34e-2)" "unprognostic (9.90e-2)" "unprognostic (3.66e-3)" "unprognostic (1.91e-1)" "unprognostic (6.16e-3)" "unprognostic (3.20e-2)" "unprognostic (1.72e-2)" "unprognostic (9.19e-2)" "prognostic favorable (4.28e-4)" "unprognostic (2.17e-1)" "unprognostic (1.67e-1)" "unprognostic (4.71e-2)" "unprognostic (3.28e-2)" 0.7 0.4 6.8 0.6 6.9 0.0 0.6 0.5 15.0 0.9 3.7 0.6 0.1 14.3 1.0 0.6 0.4 0.7 0.5 0.8 4.3 10.4 2.2 6.7 5.5 0.1 6.8 4.0 0.6 3.8 0.1 1.4 2.8 2.8 1.2 2.5 0.2 0.2 0.5 0.7 0.4 8.2 0.6 1.3 0.7 22.8 0.1 0.7 0.1 0.3 0.1 0.1 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 47.9 13.3 8.8 0.7 0.5 0.0 0.0 0.0 28.3 0.0 0.1 0.0 0.0 6.4 0.0 0.0 0.0 10.9 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 3.8 0.1 0.0 0.0 0.0 1.9 0.0 1.4 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 6.9 0.5 15.0 4.3 10.4 6.8 4.0 2.8 0.7 0.0 0.0 0.0 0.0 0.2 0.6 0.6 5.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.8 9.0 0.0 0.7 0.0 0.6 0.1 0.0 6.4 0.0 0.0 17.4 9.8 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.3 8.7 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 6.0 0.0 SSTR5 ENSG00000162009 "Somatostatin receptor 5" P35346 16 1078781-1080142 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 8.2;lymphoid tissue: 5.2;pituitary gland: 9.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "Hep G2: 9.4;PC-3: 35.0" "Group enriched" "Detected in some" 5 "basal ganglia: 4.2;hypothalamus: 2.7" "Low region specificity" "Detected in all" HPA066503 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA066503: AB_2685679" "unprognostic (2.16e-2)" "unprognostic (7.31e-2)" "unprognostic (3.69e-2)" "unprognostic (2.39e-2)" "unprognostic (2.14e-1)" "unprognostic (9.89e-3)" "unprognostic (1.72e-2)" "unprognostic (1.72e-2)" "unprognostic (2.06e-1)" "unprognostic (2.05e-1)" "unprognostic (4.09e-2)" 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.4 0.4 0.0 0.7 0.6 0.9 0.5 0.0 8.2 2.9 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 9.0 0.0 0.0 1.1 0.0 0.0 1.1 0.9 0.1 0.1 0.8 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 5.2 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 35.0 0.0 1.3 0.3 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STAMBPL1 "ALMalpha, AMSH-FP, AMSH-LP, bA399O19.2, FLJ31524, KIAA1373" ENSG00000138134 "STAM binding protein like 1" Q96FJ0 10 88879734-88975153 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 18.6" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 37.8;Spermatocytes: 27.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040202 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA040202: AB_10805708" "unprognostic (2.73e-1)" "unprognostic (1.95e-1)" "unprognostic (7.56e-2)" "unprognostic (4.25e-2)" "unprognostic (6.46e-2)" "unprognostic (6.27e-2)" "unprognostic (1.68e-2)" "unprognostic (1.05e-2)" "unprognostic (4.67e-2)" "unprognostic (8.20e-2)" "unprognostic (2.78e-1)" "unprognostic (6.57e-2)" "prognostic unfavorable (1.08e-5)" "unprognostic (4.41e-2)" "unprognostic (4.06e-2)" "unprognostic (1.50e-1)" "unprognostic (4.40e-3)" 3.9 15.9 3.7 6.8 5.1 2.8 2.1 12.4 8.9 2.0 5.8 3.4 1.5 4.5 2.7 1.5 2.7 1.2 2.9 4.8 3.3 3.4 1.5 1.7 2.9 11.3 2.6 14.8 8.5 1.8 2.2 6.6 1.5 4.1 1.9 8.0 1.5 1.5 1.5 1.5 3.4 6.1 1.8 3.1 6.0 3.1 18.6 3.2 1.5 1.5 1.5 9.5 3.9 2.7 10.5 15.2 4.3 0.6 13.1 14.7 4.5 6.8 8.1 0.5 0.3 8.1 15.6 0.0 14.4 14.2 9.3 8.3 0.3 13.1 8.4 1.0 7.8 6.2 3.4 2.0 2.9 9.4 7.4 5.1 2.1 5.8 0.4 5.5 9.2 3.0 5.5 0.7 15.5 4.9 10.6 0.2 10.1 0.0 3.8 24.9 1.4 15.3 10.9 3.0 6.5 6.3 1.5 6.1 1.8 3.5 2.6 4.7 5.6 1.8 0.6 16.4 2.0 1.0 1.9 2.1 8.3 6.0 9.9 9.0 8.9 8.4 7.8 9.1 9.4 7.8 4.3 0.6 4.2 6.3 0.6 8.2 10.5 9.2 7.9 0.9 7.0 9.9 5.9 0.9 13.1 0.3 15.2 14.7 4.5 3.7 5.1 12.4 8.9 3.3 3.4 2.6 14.8 4.1 3.2 0.0 5.0 9.3 4.1 8.5 3.7 5.0 0.0 8.1 0.0 5.2 0.0 0.1 0.0 0.8 37.8 2.2 7.4 0.0 1.6 0.1 5.1 1.5 4.7 1.9 3.0 6.4 8.7 1.8 1.0 13.9 6.6 3.5 0.0 1.0 8.1 10.6 1.2 0.0 1.4 0.5 0.2 0.0 6.7 27.6 2.4 9.9 0.1 14.9 13.3 1.6 STARD4 ENSG00000164211 "StAR related lipid transfer domain containing 4" Q96DR4 5 111496033-111512590 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046177, HPA048081" Approved Approved "Plasma membrane" NA Yes "Plasma membrane" "HPA046177: AB_2679570, HPA048081: AB_2680253" "unprognostic (1.13e-1)" "unprognostic (7.07e-3)" "unprognostic (1.53e-2)" "unprognostic (1.64e-1)" "unprognostic (1.01e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (4.80e-5)" "unprognostic (1.31e-1)" "unprognostic (1.11e-1)" "unprognostic (4.26e-1)" "unprognostic (6.27e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (5.89e-5)" "unprognostic (2.00e-1)" "unprognostic (3.82e-3)" "unprognostic (4.01e-3)" "prognostic unfavorable (2.84e-4)" 5.2 12.4 9.7 11.2 27.3 12.6 3.2 20.7 17.5 8.5 11.0 6.8 5.5 30.0 6.4 12.9 8.4 4.6 7.6 11.0 12.5 12.5 8.2 25.3 22.0 8.8 10.5 7.3 6.6 4.7 17.2 10.8 27.8 25.5 16.5 13.1 7.1 5.9 8.0 1.6 2.6 29.9 5.4 17.0 8.8 13.2 5.1 16.3 5.1 7.7 5.7 7.4 5.2 8.8 2.8 2.8 11.0 3.1 2.9 4.2 2.1 6.8 3.4 16.7 10.0 15.0 30.1 5.7 7.0 16.0 10.6 31.6 12.6 20.5 8.2 2.9 4.5 31.0 3.0 8.4 24.4 10.1 7.8 3.6 6.3 10.9 7.6 16.7 3.1 4.0 16.0 16.8 22.4 16.7 12.4 19.4 8.0 3.5 15.9 7.1 1.3 7.7 5.7 5.7 0.2 1.8 1.8 18.6 7.5 15.4 2.2 9.5 37.1 0.0 4.2 6.3 11.6 5.5 10.1 28.7 8.9 8.1 5.9 2.9 5.5 5.0 7.3 8.5 11.8 4.5 11.0 2.1 1.5 4.2 3.1 2.2 2.8 2.0 3.0 2.8 2.7 2.1 3.1 0.0 2.9 2.2 1.9 1.2 2.1 9.7 27.3 20.7 17.5 12.5 12.5 10.5 7.3 25.5 16.3 23.8 33.3 11.0 1.2 0.9 9.5 17.7 12.7 1.4 4.5 8.7 7.9 13.3 1.7 6.8 6.1 14.6 33.7 0.0 8.1 5.1 5.1 3.1 31.2 16.4 16.3 6.4 20.5 4.9 18.3 7.0 6.6 18.3 3.3 6.4 21.7 6.0 7.4 17.5 7.4 5.3 7.3 19.4 8.7 7.7 9.7 2.3 11.8 8.6 15.5 2.8 STOML3 "Epb7.2l, SRO" ENSG00000133115 "Stomatin like 3" Q8TAV4 13 38965925-38991066 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.7;epididymis: 8.1;fallopian tube: 31.7;lung: 9.2" "Cell type enriched" "Detected in some" 24 "Ciliated cells: 133.8" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 39 "AF22: 19.0" "Region enriched" "Detected in some" 6 "olfactory region: 29.0" "Low region specificity" "Detected in all" "HPA012892, HPA071011" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA012892: AB_1857610, HPA071011: AB_2732169" "unprognostic (2.64e-1)" "unprognostic (1.91e-2)" "prognostic favorable (1.49e-4)" "unprognostic (1.82e-1)" "unprognostic (1.17e-1)" "unprognostic (4.24e-2)" "unprognostic (1.19e-1)" "unprognostic (2.14e-1)" "unprognostic (2.14e-1)" "unprognostic (1.07e-2)" "unprognostic (1.35e-2)" "unprognostic (3.07e-2)" "unprognostic (1.74e-1)" "unprognostic (1.22e-1)" 0.1 0.1 2.9 0.1 3.8 0.1 0.2 0.0 0.2 1.7 0.2 6.6 0.0 0.2 1.1 8.1 0.1 31.7 0.1 0.1 4.4 4.1 0.1 0.1 9.2 0.1 0.0 0.0 7.6 0.1 0.1 0.0 0.3 9.7 0.2 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.6 2.1 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.8 0.0 0.2 4.4 4.1 0.0 0.0 9.7 2.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 133.8 5.7 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 STX18 Ufe1 ENSG00000168818 "Syntaxin 18" Q9P2W9 4 4415742-4542346 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 98.6" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "endometrial cancer: 43.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003019 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA003019: AB_1857622" "unprognostic (2.33e-1)" "unprognostic (1.65e-1)" "prognostic favorable (2.84e-4)" "prognostic favorable (6.33e-8)" "unprognostic (4.21e-1)" "unprognostic (6.77e-2)" "unprognostic (6.17e-3)" "unprognostic (2.95e-2)" "unprognostic (7.53e-2)" "unprognostic (3.22e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-2)" "prognostic favorable (7.03e-4)" "unprognostic (1.92e-2)" "unprognostic (1.55e-1)" "unprognostic (7.44e-2)" "prognostic favorable (4.69e-4)" 14.0 17.6 12.4 16.0 18.4 9.2 11.0 11.2 15.9 98.6 19.7 19.5 12.2 15.0 46.5 11.9 11.5 38.9 16.1 11.0 11.3 14.2 24.2 14.0 9.8 10.4 14.5 12.3 12.4 18.5 12.2 24.1 17.5 17.3 12.3 11.9 12.7 12.2 14.7 19.0 11.0 19.6 13.5 14.8 14.2 15.0 28.5 10.3 18.1 10.1 9.8 15.0 11.8 12.3 11.2 25.5 7.1 13.0 10.8 13.4 9.3 14.3 9.3 11.1 11.3 9.6 14.0 14.9 16.5 15.2 15.8 13.2 19.6 20.9 19.1 39.8 15.3 14.4 7.8 19.6 9.7 15.6 8.0 9.8 12.0 12.3 23.7 14.3 20.8 10.1 13.1 8.5 13.4 9.8 8.9 13.3 15.4 11.5 17.0 11.2 7.6 18.8 14.8 14.7 11.9 19.4 17.0 8.3 15.2 16.3 8.7 14.1 12.5 12.4 8.3 14.4 10.0 12.2 10.1 15.1 9.6 10.5 8.7 17.7 12.2 18.5 22.0 11.7 16.0 11.9 4.8 10.6 7.1 10.9 10.4 13.4 11.2 10.1 9.9 16.0 9.3 8.5 9.8 2.1 10.8 13.0 25.5 9.1 9.3 12.4 18.4 11.2 15.9 11.3 14.2 14.5 12.3 17.3 10.3 29.8 7.0 10.4 7.5 7.0 20.2 18.3 10.2 34.8 25.0 19.2 19.6 25.1 59.7 27.4 58.7 11.9 28.7 0.0 24.4 16.2 18.5 12.5 8.1 8.3 24.9 9.5 4.7 6.7 14.5 62.0 13.0 16.9 13.5 30.7 19.0 22.5 28.8 24.6 13.8 18.3 16.1 6.5 11.3 58.5 33.4 8.4 26.5 10.7 17.5 10.5 STX4 "p35-2, STX4A" ENSG00000103496 "Syntaxin 4" Q12846 16 31032889-31042975 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001330 Approved Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA001330: AB_1080167" "unprognostic (2.31e-3)" "prognostic favorable (3.65e-4)" "unprognostic (3.25e-2)" "unprognostic (4.76e-2)" "unprognostic (1.74e-2)" "unprognostic (1.63e-1)" "unprognostic (3.75e-3)" "unprognostic (5.64e-3)" "unprognostic (2.93e-2)" "unprognostic (1.01e-2)" "unprognostic (3.12e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (2.88e-9)" "unprognostic (6.90e-2)" "unprognostic (7.91e-2)" "unprognostic (1.52e-1)" "unprognostic (3.26e-2)" 26.5 28.2 28.6 23.8 29.6 14.1 23.5 24.2 28.0 21.4 24.0 24.4 16.9 28.3 24.1 19.8 26.4 19.6 23.7 24.6 26.7 18.0 21.7 25.2 25.8 22.5 38.1 22.3 22.7 19.3 33.6 14.9 27.0 32.4 19.8 22.0 14.0 21.3 21.8 30.3 32.7 26.7 27.7 26.1 31.4 22.7 10.7 31.5 19.2 21.3 17.3 26.7 25.4 29.4 11.9 14.8 20.6 18.2 18.2 14.9 8.6 18.4 26.4 6.0 13.4 20.2 20.6 12.8 17.1 30.2 18.3 18.9 8.1 20.1 12.5 22.2 30.2 21.1 13.4 5.6 19.8 17.5 22.4 16.9 9.0 18.4 22.0 22.9 10.4 30.3 19.6 13.9 31.6 23.6 22.7 24.2 8.7 10.5 14.6 32.4 28.9 9.8 16.1 12.4 13.8 14.2 8.4 17.9 16.3 18.1 13.7 4.9 9.4 15.1 15.5 6.2 8.3 12.4 13.8 25.9 18.5 8.2 20.8 9.5 15.7 12.7 5.5 27.9 16.8 11.2 14.6 17.7 20.6 14.9 18.2 12.9 9.7 12.5 14.5 14.8 11.9 9.5 12.2 18.5 18.2 15.8 8.6 6.8 8.6 28.6 29.6 24.2 28.0 26.7 18.0 38.1 22.3 32.4 31.5 41.7 20.7 21.5 31.3 57.9 6.7 21.4 45.9 34.8 23.9 21.0 11.8 27.3 24.9 50.0 6.2 41.3 69.9 0.0 59.4 32.0 50.3 41.0 59.9 17.0 84.0 4.8 24.6 29.4 48.2 10.8 35.6 88.9 28.7 62.3 35.0 20.7 57.7 47.2 33.2 45.6 5.9 38.8 44.3 6.5 7.9 57.0 27.7 40.5 40.8 30.1 SUSD2 "BK65A6.2, FLJ22778" ENSG00000099994 "Sushi domain containing 2" Q9UGT4 22 24181259-24189110 "Predicted membrane proteins" Receptor "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 100.1" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 232.3;Alveolar cells type 2: 121.0" "Cancer enhanced" "Detected in all" "testis cancer: 64.5" "Region enhanced" "Detected in many" "pons and medulla: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 31 "SK-BR-3: 138.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA004117 Enhanced Approved "Plasma membrane" NA NA 3600000 "Plasma membrane" "HPA004117: AB_1857674" "unprognostic (5.24e-3)" "unprognostic (1.60e-1)" "unprognostic (1.74e-1)" "unprognostic (7.30e-2)" "unprognostic (1.27e-2)" "unprognostic (5.40e-2)" "unprognostic (5.20e-2)" "unprognostic (1.89e-2)" "unprognostic (5.87e-2)" "unprognostic (1.20e-2)" "unprognostic (9.74e-3)" "unprognostic (8.97e-2)" "prognostic unfavorable (3.29e-5)" "unprognostic (2.72e-2)" "unprognostic (2.82e-2)" "unprognostic (1.88e-2)" "unprognostic (3.33e-3)" 6.0 4.2 0.3 1.4 0.9 0.5 11.3 3.8 1.4 10.5 10.5 2.5 1.3 7.8 7.1 8.3 2.8 6.9 5.3 10.8 0.6 2.9 19.5 1.2 100.1 1.4 0.6 2.6 2.6 2.4 1.3 3.6 3.5 9.6 2.8 1.0 2.2 7.9 4.0 3.0 11.8 32.4 2.4 3.0 1.6 2.5 1.9 0.7 0.1 12.7 5.9 1.5 2.3 4.7 0.7 0.2 0.0 0.0 0.0 0.2 0.0 0.7 1.5 0.0 0.0 3.0 3.9 0.1 0.3 0.0 0.0 0.0 1.1 0.0 0.2 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 1.2 0.0 0.0 3.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.2 2.1 0.1 138.9 0.0 0.6 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 3.8 1.4 0.6 2.9 0.6 2.6 9.6 0.7 232.3 121.0 0.0 0.2 0.2 0.0 2.8 0.0 5.3 33.0 1.8 0.0 14.1 5.0 0.0 0.0 0.3 1.6 0.0 0.0 0.4 3.5 0.8 3.5 0.0 0.9 0.0 1.7 4.3 0.0 0.0 0.6 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 24.9 0.0 0.0 15.1 0.9 0.9 2.4 22.1 0.0 0.0 0.5 SYNGR3 ENSG00000127561 "Synaptogyrin 3" O43761 16 1989660-1994275 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.3" "Cell type enhanced" "Detected in some" 8 "Cardiomyocytes: 3.9;Horizontal cells: 6.4;monocytes: 4.6;Spermatogonia: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 3.7;NK-cells: 4.6;T-cells: 2.7" "Cell line enhanced" "Detected in many" "HDLM-2: 25.7;HMC-1: 16.6;Karpas-707: 14.0;SK-BR-3: 17.5;U-266/70: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034278, HPA042842" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "CAB034278: AB_2200905, HPA042842: AB_2678198" "unprognostic (8.89e-3)" "prognostic favorable (6.92e-4)" "unprognostic (6.07e-3)" "unprognostic (2.94e-3)" "unprognostic (2.92e-2)" "unprognostic (8.06e-3)" "unprognostic (2.52e-1)" "unprognostic (5.70e-2)" "unprognostic (2.84e-2)" "unprognostic (1.06e-1)" "unprognostic (3.69e-3)" "unprognostic (1.05e-1)" "prognostic favorable (7.12e-7)" "unprognostic (1.03e-1)" "unprognostic (1.19e-1)" "unprognostic (2.79e-1)" "unprognostic (8.78e-2)" 1.1 11.1 20.3 3.7 21.8 1.6 1.1 24.2 55.3 1.5 2.3 2.6 0.0 2.2 1.0 1.0 1.3 1.1 1.3 1.4 14.6 40.8 1.7 1.0 1.3 4.0 27.1 20.1 1.5 1.0 9.4 3.1 5.4 28.2 1.3 2.2 0.9 2.1 1.1 0.9 1.1 2.5 1.7 4.4 2.2 2.1 4.2 2.0 0.0 1.0 0.0 4.7 1.4 0.2 3.7 0.7 0.0 0.8 4.6 2.7 0.9 0.4 2.1 2.0 0.2 0.2 0.2 2.4 1.0 1.7 0.8 0.7 3.3 1.6 3.2 0.7 0.7 2.2 1.8 2.2 0.3 0.2 25.7 1.5 0.0 2.8 1.6 1.2 0.0 16.6 0.5 0.1 0.0 0.5 3.9 0.2 1.0 9.2 14.0 0.4 2.4 0.1 0.1 10.3 0.3 0.9 0.0 0.3 2.5 1.3 0.0 4.6 5.8 2.3 17.5 0.2 1.1 2.4 0.2 0.4 0.5 8.1 0.0 0.3 22.1 2.5 3.7 0.3 2.9 0.3 0.0 0.8 0.0 0.9 0.3 2.1 3.2 1.7 2.7 0.7 3.7 2.0 0.8 0.0 4.6 0.7 0.0 1.6 0.9 20.3 21.8 24.2 39.3 14.6 40.8 27.1 20.1 28.2 2.0 0.0 1.1 0.0 0.7 0.2 2.6 3.9 0.0 0.0 0.0 0.0 2.0 0.4 1.7 1.7 0.4 0.3 0.0 0.0 0.4 0.6 0.6 0.8 1.1 0.0 0.2 6.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.6 0.4 0.8 1.2 0.0 0.0 0.0 0.5 0.0 0.2 2.3 8.1 0.3 2.6 2.2 0.0 0.6 TACR2 "NK2R, NKNAR, SKR, TAC2R" ENSG00000075073 "Tachykinin receptor 2" P21452 10 69403903-69416867 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 56.3;smooth muscle: 35.5" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 2.7;Horizontal cells: 6.4;Kupffer cells: 2.2;Leydig cells: 2.6" "Cancer enhanced" "Detected in many" "stomach cancer: 6.7" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "intermediate monocyte: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SK-MEL-30: 8.7;U-87 MG: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA076573 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA076573: AB_2732313" "unprognostic (2.83e-1)" "unprognostic (1.58e-3)" "unprognostic (2.48e-2)" "unprognostic (1.67e-1)" "unprognostic (4.22e-1)" "unprognostic (2.30e-1)" "unprognostic (1.30e-2)" "unprognostic (1.96e-2)" "unprognostic (3.72e-1)" "unprognostic (6.14e-2)" "unprognostic (2.45e-2)" "unprognostic (3.16e-2)" "unprognostic (9.88e-4)" "unprognostic (5.59e-3)" "unprognostic (4.31e-3)" "unprognostic (1.25e-3)" "unprognostic (1.32e-1)" 1.6 0.1 0.5 3.1 0.5 0.1 1.2 0.5 1.1 11.1 56.3 0.2 0.4 4.1 12.3 0.9 19.6 7.2 1.2 1.9 0.5 0.3 0.2 0.5 0.8 0.5 0.2 0.4 2.0 0.8 0.0 0.1 0.1 0.4 14.9 8.2 0.2 0.4 0.9 1.1 0.4 14.2 35.5 0.8 0.5 16.5 0.9 0.5 0.1 0.4 0.8 0.4 19.4 3.1 1.2 2.0 0.5 4.2 0.1 0.8 0.3 2.0 1.2 0.4 0.7 3.1 0.2 0.2 0.5 0.3 0.5 0.7 0.7 0.4 0.2 0.5 0.5 0.7 0.8 0.1 0.1 0.0 0.4 0.5 1.6 0.6 1.9 0.3 0.0 3.1 0.5 0.7 0.0 0.1 0.8 0.2 0.1 0.4 2.5 0.0 0.8 0.1 0.5 0.4 1.7 1.9 0.1 0.0 0.0 0.0 1.0 0.8 0.6 1.3 2.7 8.7 0.4 1.2 0.2 0.8 3.1 0.4 1.3 1.1 1.2 1.3 0.2 5.0 0.3 1.8 0.5 1.5 0.1 0.3 4.2 0.4 1.2 0.8 0.3 2.0 0.6 0.4 0.2 0.2 0.1 1.7 0.3 0.1 0.3 0.5 0.5 0.5 1.1 0.5 0.3 0.2 0.4 0.4 0.5 0.0 0.3 0.0 0.2 0.6 0.2 0.5 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 1.1 6.4 0.0 1.3 2.2 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.3 0.0 1.2 0.2 0.1 0.1 0.0 0.0 0.4 0.4 TASP1 "C20orf13, dJ585I14.2, FLJ20212" ENSG00000089123 "Taspase 1" Q9H6P5 20 13389392-13638940 "Predicted intracellular proteins" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030824, HPA030825" Uncertain Approved "Plasma membrane" No No "Plasma membrane" "HPA030824: AB_10600327, HPA030825: AB_10601575" "unprognostic (1.29e-1)" "unprognostic (1.68e-1)" "unprognostic (8.61e-2)" "unprognostic (1.20e-1)" "unprognostic (2.47e-1)" "unprognostic (6.46e-2)" "unprognostic (3.44e-3)" "unprognostic (9.85e-2)" "unprognostic (9.85e-2)" "unprognostic (6.95e-2)" "unprognostic (1.59e-1)" "unprognostic (3.13e-2)" "unprognostic (2.21e-1)" "unprognostic (1.04e-1)" "unprognostic (2.70e-1)" "prognostic unfavorable (6.78e-4)" "unprognostic (1.67e-2)" 12.1 8.0 6.0 9.1 11.9 6.8 11.4 8.9 15.3 10.7 8.3 6.3 13.4 5.7 21.7 14.2 8.7 13.4 7.2 9.1 6.8 6.4 9.9 7.2 10.5 8.7 4.8 8.1 10.1 11.1 14.6 28.5 10.3 8.2 8.9 9.6 10.8 16.3 11.1 5.0 9.6 9.6 8.4 5.2 9.1 8.9 11.3 4.4 31.3 12.9 9.0 12.2 8.5 11.1 9.7 15.1 3.5 4.8 10.7 15.8 5.6 9.4 5.7 2.4 2.9 2.8 4.3 4.5 3.9 5.6 4.6 5.5 11.6 9.9 4.2 2.7 5.1 5.0 12.7 3.7 13.6 5.5 2.5 4.5 8.6 3.6 14.9 5.7 11.5 3.1 4.9 9.2 4.8 11.4 2.8 4.5 7.7 7.5 0.2 4.0 11.3 21.8 6.4 3.1 8.5 2.6 3.4 9.6 6.5 6.4 7.5 6.2 4.3 6.1 11.8 6.9 3.5 6.2 4.4 4.3 4.4 3.1 4.4 5.5 8.6 11.9 3.0 2.4 2.6 4.1 1.7 3.5 3.5 10.3 4.8 7.3 9.7 10.7 8.1 3.9 8.6 15.8 12.2 1.9 10.7 4.7 15.1 9.8 5.6 6.0 11.9 8.9 15.3 6.8 6.4 4.8 8.1 8.2 4.4 6.0 10.6 9.3 9.6 12.6 12.9 5.2 10.2 24.1 6.8 5.2 9.8 9.8 6.6 9.6 11.6 4.9 3.8 0.0 5.4 10.7 11.8 7.8 15.0 4.9 4.1 11.1 3.5 3.1 1.0 2.7 3.1 4.1 10.1 1.0 9.0 6.3 7.2 10.5 3.2 9.8 15.4 6.5 15.1 23.7 8.1 10.7 5.8 7.9 7.8 5.5 TAZ "BTHS, CMD3A, EFE, EFE2, G4.5, TAZ1, XAP-2" ENSG00000102125 Tafazzin Q16635 X 154411518-154421726 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039557 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA039557: AB_10672899" "unprognostic (1.14e-1)" "prognostic favorable (5.70e-4)" "unprognostic (4.94e-3)" "unprognostic (1.43e-1)" "unprognostic (8.29e-2)" "unprognostic (7.84e-2)" "unprognostic (1.56e-2)" "unprognostic (8.21e-3)" "unprognostic (1.69e-1)" "unprognostic (1.62e-1)" "unprognostic (4.68e-2)" "unprognostic (8.39e-2)" "prognostic unfavorable (1.22e-7)" "unprognostic (4.00e-3)" "unprognostic (4.20e-1)" "unprognostic (1.41e-1)" "unprognostic (3.79e-2)" 11.9 8.7 12.1 15.0 13.6 36.8 11.7 12.4 13.5 10.9 15.4 15.6 12.1 13.9 10.8 13.0 15.1 9.9 14.1 25.9 11.0 8.4 13.3 14.0 14.3 17.3 16.7 9.6 12.6 16.3 10.7 8.9 9.1 13.1 11.1 10.8 12.2 12.7 14.5 27.9 18.6 15.0 11.7 12.8 25.4 12.8 3.4 15.1 17.2 11.8 13.4 14.4 10.8 19.5 16.7 14.7 13.8 10.3 12.3 17.2 7.8 11.0 12.5 4.6 5.1 9.0 5.4 8.8 3.9 7.7 6.0 8.3 4.1 13.8 13.1 21.3 5.7 20.0 16.8 6.5 7.2 4.2 11.2 9.6 2.6 8.0 6.4 10.1 5.0 6.2 5.5 13.2 5.2 11.8 5.6 9.0 16.8 5.2 13.9 5.2 6.7 12.6 15.8 1.3 9.7 13.1 10.5 7.0 17.6 8.2 3.2 5.8 8.2 2.5 7.4 10.7 5.0 4.5 8.9 6.5 4.9 6.3 12.0 5.9 32.4 12.8 27.3 6.0 17.6 5.6 5.7 10.3 13.8 12.1 9.3 11.0 11.3 17.2 15.5 14.7 16.7 14.4 12.5 9.4 12.3 7.4 7.3 12.2 7.8 12.1 13.6 12.4 13.5 11.0 8.4 16.7 9.6 13.1 15.1 6.0 10.2 10.7 6.9 9.6 21.3 18.9 12.7 5.3 13.6 8.7 17.7 4.9 5.0 12.0 0.5 15.0 12.3 0.0 14.5 8.0 9.9 5.6 18.4 7.8 21.2 9.5 5.8 16.0 22.1 1.3 10.6 15.9 13.5 23.4 12.9 15.1 10.8 10.2 8.5 4.4 23.8 12.9 9.2 5.1 0.6 9.8 2.4 23.6 13.6 4.8 TBC1D10A "AC004997.C22.2, EPI64, TBC1D10" ENSG00000099992 "TBC1 domain family member 10A" Q9BXI6 22 30291990-30327046 "Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 126.2;Syncytiotrophoblasts: 97.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA007725, HPA008142, HPA076041" Approved Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA007725: AB_2667907, HPA008142: AB_1080209, HPA076041: AB_2686772" "unprognostic (3.37e-2)" "unprognostic (2.44e-3)" "unprognostic (1.13e-1)" "unprognostic (1.10e-2)" "unprognostic (2.11e-3)" "unprognostic (1.20e-1)" "unprognostic (4.96e-2)" "unprognostic (5.07e-2)" "unprognostic (4.28e-1)" "unprognostic (6.40e-2)" "unprognostic (1.08e-1)" "unprognostic (2.45e-1)" "unprognostic (3.02e-1)" "unprognostic (7.92e-2)" "unprognostic (3.89e-2)" "unprognostic (1.05e-2)" "unprognostic (7.52e-2)" 13.5 10.7 8.4 14.5 13.4 7.8 14.8 10.5 13.6 16.5 12.0 4.6 17.6 9.3 9.7 16.0 31.5 11.6 13.8 6.4 8.4 6.6 16.0 10.8 14.3 15.6 6.0 6.5 16.2 12.7 8.9 13.0 35.7 8.1 13.6 6.1 17.3 15.0 19.4 4.3 27.1 10.4 10.5 7.0 15.8 10.6 17.5 6.1 19.8 14.6 10.2 22.7 12.7 23.2 13.3 22.3 21.0 23.9 12.9 26.1 17.1 11.1 4.5 1.9 5.9 5.6 7.1 14.6 6.6 9.8 7.7 12.4 5.2 4.4 5.6 6.4 11.5 10.7 11.1 2.8 6.2 4.1 4.2 7.5 1.6 3.8 3.7 14.4 2.2 8.0 9.4 10.2 15.4 2.6 8.2 3.5 12.7 2.9 5.5 5.8 13.6 16.1 4.8 1.1 21.6 5.8 7.2 7.9 5.1 7.7 11.2 3.1 2.5 6.6 10.3 15.2 5.4 8.8 1.4 6.4 14.7 6.6 8.0 3.5 5.4 2.3 5.1 10.2 3.4 8.4 17.0 8.9 21.0 16.5 17.1 18.2 8.4 19.3 16.9 12.8 13.3 26.1 21.3 6.0 12.9 23.9 22.3 16.2 17.1 8.4 13.4 10.5 10.5 8.4 6.6 6.0 6.5 8.1 6.1 6.0 4.3 9.8 37.3 43.7 7.4 2.2 10.2 1.4 7.9 5.2 17.7 49.7 19.9 17.7 5.4 13.2 18.4 0.0 9.1 68.0 28.7 20.3 9.2 6.8 22.9 1.6 10.3 11.6 7.2 4.2 20.1 15.4 25.3 126.2 14.0 26.6 14.6 14.8 8.5 18.7 35.6 38.8 20.6 20.0 12.5 32.4 97.3 27.7 10.0 28.5 TEC PSCTK4 ENSG00000135605 "Tec protein tyrosine kinase" P42680 4 48135783-48269864 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 12.7;granulocytes: 18.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 13.3;eosinophil: 11.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 13.3" "Cell line enhanced" "Detected in many" "HEL: 10.6;HMC-1: 16.7;U-266/70: 16.7;U-266/84: 11.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA005733, HPA024657" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA005733: AB_1857878, HPA024657: AB_2671637" "unprognostic (7.19e-2)" "unprognostic (1.44e-1)" "unprognostic (1.41e-2)" "unprognostic (4.07e-3)" "unprognostic (4.21e-2)" "unprognostic (8.57e-2)" "unprognostic (3.14e-1)" "unprognostic (1.67e-1)" "unprognostic (8.36e-2)" "prognostic favorable (7.12e-4)" "unprognostic (7.46e-3)" "unprognostic (7.83e-2)" "unprognostic (1.01e-4)" "unprognostic (4.24e-2)" "unprognostic (2.16e-1)" "unprognostic (7.39e-2)" "unprognostic (4.96e-3)" 3.9 4.5 0.8 7.2 1.1 9.8 5.1 0.6 2.0 3.4 4.8 0.5 8.4 2.8 3.0 21.6 9.5 3.6 2.1 3.3 0.9 0.9 4.0 5.7 6.4 7.0 1.5 0.3 2.9 2.9 2.6 6.4 2.0 3.2 2.0 2.5 3.0 6.8 4.7 2.1 8.1 6.5 3.0 1.2 6.7 2.2 5.5 0.6 4.4 4.4 5.8 11.1 3.2 6.5 0.9 1.3 13.3 0.6 2.9 0.4 0.3 2.3 0.6 0.0 0.0 0.0 0.0 0.1 0.4 1.8 1.1 2.3 0.0 1.8 1.5 1.7 0.0 0.0 0.5 0.9 0.0 1.5 0.1 0.7 10.6 0.8 0.1 0.0 1.7 16.7 0.0 0.2 1.4 0.0 1.1 0.0 0.5 5.8 0.4 3.3 0.8 1.0 3.8 0.3 1.1 0.7 2.4 2.2 0.0 2.8 0.7 0.0 0.2 0.5 0.3 0.4 0.9 0.6 3.4 0.0 0.0 0.0 2.3 0.0 16.7 11.9 2.1 0.0 2.4 0.1 13.3 0.5 11.0 0.1 0.6 0.3 0.9 0.1 0.4 1.3 0.6 0.4 0.4 0.4 2.9 0.1 0.1 0.0 0.3 0.8 1.1 0.6 2.0 0.9 0.9 1.5 0.3 3.2 0.6 6.0 5.0 0.8 1.5 2.3 0.5 1.6 12.7 0.0 4.5 0.0 0.0 1.3 0.0 1.3 3.9 0.6 2.2 0.0 0.9 0.1 0.9 1.1 18.5 3.2 4.0 0.0 2.9 0.0 4.5 1.7 0.0 2.8 1.7 0.0 1.4 5.0 0.9 0.0 0.4 1.8 2.4 6.5 0.7 0.7 1.1 2.6 0.7 2.5 2.0 1.3 TGFBR1 "ACVRLK4, ALK-5, ALK5, ESS1, MSSE, TBR-i, TBRI" ENSG00000106799 "Transforming growth factor beta receptor 1" P36897 9 99104038-99154192 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation, Growth regulation" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Aortic aneurysm, Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 114.1;Late spermatids: 74.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 68.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002441, CAB031481, HPA056473" Uncertain Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "CAB002441: AB_564029, CAB031481: AB_2202455, HPA056473: AB_2683144" "unprognostic (2.58e-3)" "unprognostic (1.20e-2)" "unprognostic (3.64e-3)" "unprognostic (2.80e-1)" "unprognostic (8.63e-2)" "unprognostic (3.36e-2)" "unprognostic (1.97e-2)" "unprognostic (1.32e-3)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (8.21e-3)" "unprognostic (1.82e-1)" "unprognostic (1.18e-1)" "unprognostic (1.01e-3)" "unprognostic (3.40e-2)" "unprognostic (3.19e-2)" "unprognostic (1.14e-2)" 11.1 6.9 10.3 11.5 14.6 20.0 15.4 12.6 11.3 14.4 20.0 11.0 5.5 7.4 18.8 8.0 13.2 10.9 14.9 9.7 7.8 7.5 16.0 9.8 19.2 18.9 15.8 4.3 13.3 8.8 6.5 13.5 50.9 14.1 12.3 9.2 10.4 10.2 12.2 8.4 6.6 11.0 28.6 17.9 13.9 25.5 11.4 12.4 10.8 7.7 8.1 11.5 13.0 10.2 1.6 2.0 13.1 2.4 4.0 8.3 1.9 3.4 5.2 31.4 9.7 7.3 5.4 4.7 11.7 12.9 11.0 12.3 5.2 2.5 7.6 3.6 9.1 8.7 8.1 10.6 9.1 14.8 19.9 3.3 11.4 5.7 4.6 12.1 7.0 27.9 11.2 9.8 17.1 8.1 6.9 1.9 2.9 15.8 3.2 15.0 5.3 1.0 8.0 6.7 3.2 3.1 2.8 68.5 3.2 2.7 0.8 8.5 9.9 9.1 40.7 12.2 13.5 7.5 9.6 3.6 8.2 7.1 35.0 7.1 3.3 3.3 5.2 17.2 12.1 7.0 13.1 2.4 9.1 8.3 1.6 7.2 1.6 3.6 6.1 2.0 1.3 3.5 6.7 4.9 4.0 1.9 1.4 2.2 1.9 10.3 14.6 12.6 11.3 7.8 7.5 15.8 4.3 14.1 12.4 6.0 9.1 9.3 6.5 20.9 7.2 6.3 5.1 1.4 10.3 57.6 0.0 17.0 0.0 14.1 114.1 14.5 3.3 23.3 27.1 5.9 46.2 13.4 29.9 11.5 43.1 0.0 9.2 8.0 20.9 74.1 8.9 36.3 33.7 19.0 6.6 2.9 25.9 3.5 12.7 12.2 1.6 32.3 22.2 8.0 10.5 14.2 16.2 11.5 7.2 8.4 TGFBR2 "MFS2, TBR-ii, TBRII" ENSG00000163513 "Transforming growth factor beta receptor 2" P37173 3 30606502-30694142 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Apoptosis, Differentiation, Growth regulation" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Aortic aneurysm, Cancer-related genes, Craniosynostosis, Disease mutation, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Endothelial cells: 188.8;Ito cells: 564.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 54.5;ASC TERT1: 82.2;HSkMC: 70.9;LHCN-M2: 67.2;TIME: 61.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB073537 Supported "Plasma membrane" NA NA 560000 "Plasma membrane" "CAB073537: " "unprognostic (1.74e-1)" "unprognostic (1.84e-2)" "unprognostic (3.70e-1)" "unprognostic (3.02e-2)" "unprognostic (1.92e-1)" "unprognostic (2.26e-1)" "unprognostic (1.96e-1)" "unprognostic (1.62e-1)" "unprognostic (1.40e-1)" "unprognostic (2.24e-2)" "unprognostic (7.36e-2)" "unprognostic (1.12e-1)" "unprognostic (1.65e-2)" "unprognostic (4.72e-2)" "unprognostic (1.81e-2)" "unprognostic (8.81e-2)" "unprognostic (8.02e-2)" 91.8 24.6 6.7 24.6 10.3 7.3 88.3 3.6 7.3 36.5 42.6 9.8 18.6 13.2 42.6 23.3 36.2 28.4 42.6 73.5 6.9 5.2 32.6 21.9 52.6 75.7 12.6 3.7 22.2 26.0 17.4 10.3 24.2 9.9 35.2 17.5 27.9 22.5 19.5 34.9 17.0 31.3 37.2 12.0 68.7 26.8 15.4 8.2 19.3 40.9 16.8 26.9 48.0 82.0 5.3 6.8 20.0 6.6 1.4 19.7 3.9 2.5 14.7 0.9 0.0 54.5 82.2 2.5 12.8 18.0 4.4 4.4 3.3 13.6 0.3 46.2 17.1 5.2 5.1 0.6 18.7 7.3 1.0 1.3 1.4 1.7 16.5 23.3 2.3 12.1 70.9 16.6 19.0 18.4 20.2 47.6 1.7 0.3 0.0 67.2 0.2 2.3 1.7 0.4 12.8 5.9 2.1 5.9 0.3 23.6 6.0 0.0 0.9 3.8 1.0 3.6 1.2 0.0 2.5 61.6 21.7 5.4 9.8 4.8 0.5 0.0 2.0 13.0 2.5 8.7 6.9 2.9 20.0 3.5 3.0 3.2 4.0 5.4 4.2 2.6 5.3 19.7 9.1 12.6 1.4 6.6 6.8 1.2 3.9 6.7 10.3 3.6 7.3 6.9 5.2 12.6 3.7 9.9 8.2 134.0 83.8 41.5 14.2 33.2 1.9 64.1 48.4 12.0 53.4 26.2 0.0 5.3 3.3 11.4 2.0 188.8 9.7 0.0 13.8 4.3 48.1 7.3 28.9 45.3 27.1 0.0 8.1 564.1 139.2 2.0 30.5 46.1 28.7 1.8 11.9 0.2 25.3 10.8 44.6 5.6 0.9 32.3 36.0 0.3 1.1 26.7 3.1 39.4 13.0 9.0 THBS1 "THBS, THBS-1, TSP, TSP-1, TSP1" ENSG00000137801 "Thrombospondin 1" P07996 15 39581079-39599466 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion, Unfolded protein response" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Fibroblasts: 194.3;granulocytes: 164.5;Smooth muscle cells: 246.9" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basal ganglia: 3.4;pons and medulla: 8.1" "Cell type enhanced" "Detected in some" "eosinophil: 14.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 164.7;HUVEC TERT2: 160.1;LHCN-M2: 119.5;TIME: 233.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB033678, HPA059756" Approved Approved "Plasma membrane" "Secreted to extracellular matrix" NA NA 16000000000 1600000000 "Plasma membrane" "CAB033678: AB_793044, HPA059756: AB_2684121" "unprognostic (1.72e-2)" "unprognostic (9.55e-3)" "unprognostic (7.49e-2)" "unprognostic (3.31e-1)" "unprognostic (4.34e-2)" "unprognostic (1.03e-3)" "unprognostic (3.60e-1)" "unprognostic (1.53e-2)" "unprognostic (1.22e-1)" "unprognostic (2.07e-1)" "unprognostic (6.40e-2)" "unprognostic (9.16e-2)" "prognostic unfavorable (8.47e-5)" "prognostic unfavorable (8.50e-4)" "unprognostic (1.00e-1)" "unprognostic (9.25e-3)" "unprognostic (1.48e-3)" 79.6 15.2 0.9 81.4 3.4 19.3 41.0 0.7 1.3 25.7 42.7 2.5 6.6 5.0 72.8 30.5 22.7 40.8 57.7 49.0 1.0 1.0 23.4 27.2 118.4 38.8 1.1 0.8 60.9 14.0 1.3 7.7 38.1 8.1 31.9 18.3 8.4 38.0 13.2 22.6 9.2 23.0 63.5 4.5 58.0 46.5 27.5 0.2 0.6 14.0 21.4 18.4 111.8 78.9 0.0 0.5 14.1 7.4 7.5 2.6 8.6 11.7 4.0 3.1 1.1 13.3 15.7 0.0 68.0 55.6 18.7 12.3 11.6 8.9 0.0 25.7 164.7 3.6 41.9 0.1 33.2 9.5 3.0 0.0 3.0 2.3 2.9 2.9 0.0 0.9 35.0 2.4 15.5 35.1 73.9 160.1 0.1 0.1 0.1 119.5 0.9 0.0 0.2 0.5 1.1 1.4 0.0 8.3 0.0 28.1 29.9 0.0 0.0 19.3 1.1 1.1 4.1 11.9 0.2 233.4 65.5 15.5 77.1 78.1 0.1 0.1 0.1 2.1 0.0 70.0 0.2 7.4 14.1 0.8 0.8 2.6 0.0 0.4 0.5 0.5 0.0 0.1 0.1 1.4 7.5 0.1 0.3 0.0 8.6 0.9 3.4 0.7 1.0 1.0 1.0 1.1 0.8 8.1 0.2 23.8 25.3 10.7 130.6 85.1 0.0 35.0 25.5 14.7 26.1 66.3 5.9 2.2 0.0 18.5 0.2 39.3 91.3 0.0 111.9 1.8 194.3 54.9 164.5 7.2 5.9 0.0 3.5 67.5 123.1 0.0 1.7 83.3 37.1 3.6 27.1 0.0 117.5 21.5 0.4 50.2 0.8 6.5 246.9 0.2 0.3 44.5 1.7 5.7 29.3 27.8 THEGL ENSG00000249693 "Theg spermatid protein like" P0DJG4 4 56530609-56603507 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 8.9;vagina: 10.7" "Group enriched" "Detected in some" 58 "Early spermatids: 18.2;Late spermatids: 14.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 1.8;HSkMC: 3.7;hTEC/SVTERT24-B: 2.3;K-562: 3.0;SH-SY5Y: 2.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA066627, HPA068093" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA066627: , HPA068093: AB_2685951" "unprognostic (4.33e-2)" "unprognostic (2.88e-3)" "unprognostic (7.97e-2)" "unprognostic (1.19e-1)" "unprognostic (3.69e-2)" "unprognostic (3.26e-1)" "unprognostic (1.90e-2)" "unprognostic (6.55e-2)" "unprognostic (1.61e-1)" "unprognostic (1.37e-1)" "unprognostic (4.70e-2)" "unprognostic (4.49e-2)" "unprognostic (1.73e-1)" "unprognostic (8.41e-2)" 0.1 0.2 0.6 0.1 0.5 0.8 1.9 0.1 1.1 1.7 0.7 0.6 1.0 0.1 0.4 1.3 0.2 0.4 0.8 0.1 0.2 0.4 0.1 0.1 0.1 0.0 0.2 0.3 0.5 0.1 0.0 0.3 0.0 0.8 0.7 0.1 0.2 0.2 0.5 0.1 1.2 0.2 1.8 0.2 0.1 0.3 8.9 0.4 0.0 0.1 0.0 0.1 3.0 10.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 1.1 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.3 3.7 0.0 2.3 0.0 0.5 0.4 0.0 3.0 0.0 0.9 0.0 0.8 0.0 0.2 0.0 0.4 0.4 0.4 0.0 0.0 0.0 0.1 2.0 0.8 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.1 0.3 0.8 0.1 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.1 1.1 0.2 0.4 0.2 0.3 0.8 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 TIMD4 ENSG00000145850 "T cell immunoglobulin and mucin domain containing 4" Q96H15 5 156919282-156963255 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "liver: 32.0;lymphoid tissue: 83.9;testis: 58.9" "Group enriched" "Detected in some" 24 "Early spermatids: 1044.9;Late spermatids: 1409.2" "Cancer enriched" "Detected in some" 10 "renal cancer: 6.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 2.3;memory CD8 T-cell: 4.5;naive CD4 T-cell: 3.0;naive CD8 T-cell: 3.0;T-reg: 6.4" "Lineage enriched" "Detected in single" 14 "T-cells: 6.4" "Group enriched" "Detected in some" 18 "U-266/70: 46.8;U-266/84: 12.7" "HPA015625, CAB026027" Approved Approved "Plasma membrane" NA NA 18000000 "Plasma membrane" "CAB026027: , HPA015625: AB_1858018" "unprognostic (2.92e-1)" "unprognostic (1.06e-2)" "unprognostic (1.73e-1)" "unprognostic (2.31e-1)" "unprognostic (1.80e-1)" "unprognostic (3.01e-2)" "unprognostic (1.10e-1)" "unprognostic (3.11e-1)" "unprognostic (3.42e-1)" "unprognostic (8.42e-2)" "unprognostic (1.10e-1)" "unprognostic (6.90e-2)" "prognostic favorable (3.37e-4)" "unprognostic (1.31e-2)" "unprognostic (4.07e-1)" "unprognostic (3.27e-2)" "unprognostic (2.08e-2)" 6.7 0.4 0.4 3.5 0.4 5.3 0.5 0.4 0.4 0.4 1.3 0.0 0.0 0.0 0.4 1.0 1.5 0.4 0.3 0.8 0.4 0.4 1.7 32.0 0.6 83.9 0.5 0.0 0.4 0.4 0.0 0.4 2.8 0.0 1.1 0.1 0.0 6.5 0.0 0.7 0.4 1.1 0.2 0.5 12.5 0.4 58.9 0.0 21.7 0.8 0.2 8.5 5.3 0.4 0.4 0.0 0.0 0.0 0.0 6.4 1.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 46.8 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 2.3 4.5 0.0 0.0 3.0 3.0 0.0 0.0 0.0 0.0 6.4 1.4 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 5.0 0.0 1044.9 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 34.7 0.0 0.0 0.0 52.0 1409.2 13.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.6 0.0 12.9 0.0 10.9 4.3 0.0 0.2 0.0 0.0 0.0 TMEM229A ENSG00000234224 "Transmembrane protein 229A" B2RXF0 7 124030916-124033023 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.6;intestine: 16.4;testis: 10.6" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 3.3;Cytotrophoblasts: 1.9;Muller glia cells: 1.3" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 44 "SH-SY5Y: 55.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056391 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA056391: AB_2683114" "unprognostic (2.52e-2)" "unprognostic (3.04e-2)" "unprognostic (2.30e-1)" "unprognostic (2.50e-1)" "unprognostic (2.89e-2)" "unprognostic (8.21e-2)" "unprognostic (4.74e-2)" "unprognostic (2.31e-1)" "unprognostic (4.31e-3)" 0.4 1.5 6.9 0.5 7.6 0.4 0.4 1.3 9.0 0.8 0.5 7.6 0.0 16.4 0.7 1.2 0.4 1.7 0.6 0.9 8.0 4.6 0.5 0.4 0.5 0.4 10.6 4.9 1.0 0.4 2.5 1.0 0.6 5.6 0.8 0.6 0.6 0.7 0.5 0.4 0.4 7.7 0.7 7.3 0.6 3.7 10.6 8.7 0.0 0.5 0.0 0.4 1.1 0.1 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.1 0.0 6.9 7.6 1.3 6.1 8.0 4.6 10.6 4.9 5.6 8.7 0.0 0.0 0.0 0.0 0.0 3.3 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.1 TNFRSF8 "CD30, D1S166E, KI-1" ENSG00000120949 "TNF receptor superfamily member 8" P28908 1 12063377-12144207 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.3" "Cell type enhanced" "Detected in some" 14 "Early spermatids: 2.8;Kupffer cells: 6.0;Late spermatids: 7.2" "Cancer enriched" "Detected in some" 12 "testis cancer: 9.3" "Region enriched" "Detected in single" 14 "basal ganglia: 13.1" "Cell type enhanced" "Detected in some" "intermediate monocyte: 21.7;non-classical monocyte: 33.3" "Lineage enriched" "Detected in many" 5 "monocytes: 33.3" "Cell line enriched" "Detected in some" 21 "HDLM-2: 112.6" "Low region specificity" "Detected in many" "CAB000016, HPA014823, HPA032081, HPA032082" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "CAB000016: AB_563546, HPA014823: , HPA032081: AB_2674141, HPA032082: AB_2674142" "unprognostic (1.07e-2)" "unprognostic (2.06e-2)" "unprognostic (2.52e-2)" "unprognostic (5.98e-2)" "unprognostic (2.50e-1)" "unprognostic (1.46e-3)" "unprognostic (2.19e-1)" "unprognostic (3.93e-2)" "unprognostic (1.18e-1)" "unprognostic (9.18e-3)" "unprognostic (1.86e-1)" "unprognostic (2.06e-1)" "unprognostic (3.17e-8)" "unprognostic (3.31e-1)" "unprognostic (8.56e-2)" "unprognostic (2.07e-1)" "unprognostic (2.31e-2)" 10.7 0.2 0.1 7.2 13.1 1.4 5.8 0.2 0.4 1.1 0.8 0.0 1.5 0.2 1.7 1.3 0.9 2.1 1.4 3.8 0.1 0.2 0.9 0.2 3.9 2.9 0.5 0.5 1.2 0.4 0.0 0.1 6.2 0.5 1.0 0.5 0.0 0.7 0.3 3.1 1.6 1.3 1.3 1.4 2.9 6.4 2.5 0.9 3.0 0.7 2.7 5.3 2.6 3.8 0.0 3.2 6.8 33.3 0.0 0.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 112.6 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 5.2 0.3 0.0 0.0 0.3 0.0 4.5 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.3 0.0 21.7 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 6.8 0.0 33.3 0.8 0.3 2.7 0.1 13.1 0.2 0.4 0.1 0.2 0.5 0.5 0.5 0.9 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 1.4 0.0 0.0 1.3 6.0 7.2 0.3 1.9 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.1 0.2 0.0 0.0 0.0 TPRN "C9orf75, DFNB79, FLJ90254" ENSG00000176058 Taperin Q4KMQ1 9 137191617-137204193 "Disease related genes, Predicted intracellular proteins" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.8;pancreas: 45.3" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 109.1;Mucus-secreting cells: 43.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 27.8;T-47d: 26.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 40.9" "HPA020899, HPA076667" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA020899: AB_1845835, HPA076667: " "unprognostic (5.41e-2)" "prognostic favorable (2.13e-4)" "unprognostic (2.94e-1)" "unprognostic (9.28e-2)" "unprognostic (1.68e-1)" "unprognostic (2.61e-2)" "unprognostic (3.59e-3)" "unprognostic (8.20e-2)" "unprognostic (9.96e-2)" "unprognostic (1.21e-1)" "unprognostic (1.89e-2)" "unprognostic (4.77e-2)" "prognostic favorable (5.16e-9)" "unprognostic (1.96e-3)" "unprognostic (6.35e-2)" "unprognostic (1.51e-1)" "unprognostic (5.44e-2)" 3.2 3.8 8.5 5.0 16.8 3.2 3.3 26.1 17.9 3.4 18.5 32.8 2.3 23.6 2.8 1.8 8.2 4.2 4.8 3.6 11.2 7.0 12.1 10.0 5.8 3.0 25.3 7.1 4.7 45.3 2.8 2.7 4.3 11.0 4.4 8.1 13.1 8.7 4.8 5.0 8.0 29.0 2.4 11.9 3.7 10.8 4.7 21.7 0.2 2.5 2.3 3.5 3.8 2.7 1.2 2.3 0.2 2.9 2.9 2.2 0.6 4.5 5.2 1.7 7.9 2.5 2.6 14.1 3.2 2.0 3.3 1.8 17.4 5.6 8.4 4.8 1.6 4.3 14.0 3.6 1.8 0.4 5.3 5.1 3.9 7.8 11.4 3.7 6.0 5.1 2.2 3.5 2.9 2.0 2.1 2.0 3.8 7.1 3.0 0.9 27.8 3.9 13.0 6.3 25.0 6.8 11.8 4.2 12.7 7.3 9.6 11.5 4.2 4.9 23.2 5.7 1.4 26.9 9.5 2.3 6.0 2.8 9.4 6.8 2.5 4.8 4.3 4.3 5.4 3.3 0.0 2.9 0.2 1.3 2.6 0.4 1.1 1.3 1.8 2.1 1.2 0.6 1.2 0.0 2.9 1.5 2.3 2.2 0.6 8.5 16.8 26.1 17.9 11.2 7.0 25.3 7.1 11.0 21.7 17.9 5.6 2.7 1.1 1.5 15.5 7.3 12.7 1.4 1.2 15.7 5.9 4.7 6.6 7.1 2.3 1.9 109.1 23.3 38.5 1.1 1.6 2.8 1.1 14.4 3.1 11.1 8.6 4.3 3.2 3.8 3.1 2.1 5.0 1.8 43.9 10.9 16.4 23.2 4.2 16.6 5.9 6.5 1.7 1.0 5.5 2.5 1.6 0.0 21.2 1.7 TRPV2 "VRL, VRL-1, VRL1" ENSG00000187688 "Transient receptor potential cation channel subfamily V member 2" Q9Y5S1 17 16415542-16437003 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "granulocytes: 48.5;Hofbauer cells: 48.6;monocytes: 52.3" "Cancer enriched" "Detected in all" 8 "melanoma: 59.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 27.1;fHDF/TERT166: 35.4;HMC-1: 29.8;SK-MEL-30: 30.7;TIME: 27.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044993 Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA044993: AB_10960889" "unprognostic (1.57e-1)" "unprognostic (4.34e-3)" "unprognostic (2.05e-2)" "unprognostic (1.58e-2)" "unprognostic (2.85e-2)" "unprognostic (6.16e-3)" "unprognostic (5.25e-2)" "unprognostic (1.25e-1)" "unprognostic (8.40e-3)" "unprognostic (2.43e-1)" "unprognostic (3.11e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.19e-6)" "unprognostic (7.94e-2)" "prognostic unfavorable (5.53e-4)" "unprognostic (8.07e-2)" "unprognostic (1.23e-1)" 25.4 17.6 5.9 14.3 4.9 15.6 11.3 1.9 7.6 6.7 6.0 4.2 0.5 5.4 8.2 6.1 5.7 6.8 6.7 8.9 5.0 8.1 4.4 4.5 25.8 24.9 6.0 4.2 8.9 8.4 7.7 1.8 15.6 8.1 6.3 5.0 4.9 4.4 2.1 3.8 5.0 8.8 9.2 4.1 23.4 5.3 2.8 2.5 23.4 5.7 4.2 18.0 8.1 6.7 9.0 25.9 20.4 22.3 26.5 29.8 17.4 0.1 0.5 0.0 0.0 8.7 27.1 1.6 2.7 3.1 3.0 3.0 0.1 0.1 3.1 0.7 35.4 2.6 0.0 0.0 0.0 1.7 13.7 0.2 3.4 0.0 8.4 10.4 4.7 29.8 12.0 0.0 18.2 0.2 1.4 1.2 4.2 11.6 8.6 14.4 0.1 6.0 6.5 0.0 0.0 0.0 3.6 0.1 1.3 13.5 0.3 0.4 0.0 0.0 0.0 30.7 14.5 0.0 4.1 27.6 0.0 0.1 0.1 0.3 0.0 0.1 1.6 2.8 6.9 4.1 20.4 12.2 15.2 29.8 22.3 25.9 9.0 21.9 27.6 25.9 8.7 12.5 21.7 3.0 26.5 19.8 22.7 21.2 17.4 5.9 4.9 1.9 7.6 5.0 8.1 6.0 4.2 8.1 2.5 0.0 7.7 9.3 0.1 2.5 0.5 1.0 2.5 1.4 1.2 0.0 0.0 1.9 0.0 0.2 0.3 8.7 0.0 0.0 3.1 1.3 8.9 0.0 48.5 0.5 48.6 0.0 0.0 11.1 17.4 0.0 1.7 26.8 27.0 52.3 0.0 0.0 4.0 0.0 4.2 0.0 0.4 25.8 17.3 0.5 0.9 1.5 13.5 29.9 0.0 0.1 TSPO2 "BZRPL1, dJ34B21.2" ENSG00000112212 "Translocator protein 2" Q5TGU0 6 41042554-41044337 "Predicted intracellular proteins, Predicted membrane proteins" Transport Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "bone marrow: 32.4" "Cell type enriched" "Detected in some" 84 "Erythroid cells: 210.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "OE19: 15.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA060691, HPA066996" Approved "Plasma membrane" NA NA "Plasma membrane" "HPA060691: , HPA066996: AB_2685761" "unprognostic (1.89e-3)" "unprognostic (8.35e-3)" "unprognostic (2.57e-3)" "unprognostic (2.29e-2)" "unprognostic (1.63e-1)" "unprognostic (2.66e-2)" "unprognostic (6.61e-3)" "unprognostic (2.29e-1)" "unprognostic (3.37e-1)" "unprognostic (2.89e-1)" "unprognostic (2.71e-1)" "unprognostic (4.92e-2)" "unprognostic (1.86e-2)" "unprognostic (2.70e-2)" "unprognostic (1.16e-1)" "unprognostic (5.37e-2)" "unprognostic (1.76e-2)" 0.1 0.0 0.1 0.1 0.1 32.4 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.8 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.0 1.3 2.5 0.4 0.1 0.1 0.1 0.1 0.4 0.0 0.1 0.9 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 1.3 0.1 3.3 4.5 1.3 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 1.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.3 0.2 0.5 0.0 15.8 0.0 0.4 0.0 0.0 0.3 0.1 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.4 0.2 0.8 0.2 0.2 0.0 0.4 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.3 0.0 0.3 210.2 0.8 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 TTC7B TTC7L1 ENSG00000165914 "Tetratricopeptide repeat domain 7B" Q86TV6 14 90524564-90816479 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 28.6;Sertoli cells: 25.8;Syncytiotrophoblasts: 25.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 7.0;eosinophil: 9.7" "Lineage enriched" "Detected in many" 8 "granulocytes: 9.7" "Cell line enhanced" "Detected in many" "HMC-1: 33.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058363, HPA059577" Enhanced Supported "Plasma membrane" NA NA 11000 "Plasma membrane" "HPA058363: AB_2683692, HPA059577: AB_2684069" "unprognostic (9.37e-2)" "unprognostic (4.20e-2)" "unprognostic (1.01e-2)" "unprognostic (2.41e-2)" "unprognostic (2.58e-1)" "unprognostic (2.67e-4)" "unprognostic (9.42e-2)" "unprognostic (2.17e-1)" "unprognostic (5.38e-2)" "unprognostic (7.60e-2)" "unprognostic (2.75e-3)" "unprognostic (2.87e-2)" "prognostic favorable (3.20e-6)" "unprognostic (2.74e-2)" "unprognostic (7.41e-2)" "unprognostic (4.48e-2)" "unprognostic (1.07e-2)" 16.2 9.0 29.1 6.6 20.1 6.7 7.1 40.6 33.7 10.0 7.9 10.9 5.6 3.8 11.0 5.0 11.8 5.7 7.0 23.8 26.0 15.9 7.7 6.7 8.9 2.8 14.7 18.3 9.9 17.2 6.7 7.0 19.2 20.3 10.1 3.6 8.8 8.6 11.1 37.4 3.2 4.2 13.1 8.8 10.6 6.1 2.7 8.1 0.3 5.9 2.5 2.1 8.1 4.8 0.4 0.7 9.7 0.6 0.5 1.2 0.7 8.5 7.8 9.2 6.7 8.6 10.2 30.3 6.9 6.0 9.3 10.1 2.0 2.3 0.1 11.0 7.8 11.0 0.1 5.9 4.8 9.1 15.5 6.4 19.3 4.0 1.8 8.6 0.4 33.7 7.6 3.3 5.0 6.2 8.6 13.3 7.6 10.7 15.9 8.9 9.1 0.2 7.5 5.2 0.5 6.7 16.7 15.2 2.8 3.0 6.4 14.1 9.7 6.9 2.9 14.7 6.1 4.1 5.9 15.2 9.6 7.6 7.0 11.2 5.4 2.7 0.1 13.8 1.8 9.3 7.0 0.3 9.7 0.2 0.6 0.3 0.3 0.3 0.2 0.4 0.4 0.3 0.2 1.4 0.5 0.2 0.7 1.2 0.7 29.1 20.1 40.6 27.8 26.0 15.9 14.7 18.3 20.3 8.1 3.0 0.6 0.0 1.8 2.5 10.9 18.1 0.0 5.3 0.0 5.2 15.7 11.0 1.7 2.2 3.9 5.8 0.0 0.0 2.0 6.5 4.1 2.6 7.0 8.1 6.9 28.6 1.2 9.2 3.9 1.1 6.4 2.8 11.8 3.6 0.0 5.4 1.2 0.0 6.7 2.8 17.7 25.8 5.2 1.5 1.6 1.8 25.2 0.5 0.0 1.0 TWF2 "A6r, A6RP, PTK9L" ENSG00000247596 "Twinfilin actin binding protein 2" Q6IBS0 3 52228610-52239260 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.7" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 187.1;monocytes: 272.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053874 Uncertain Uncertain "Plasma membrane" NA NA 14000000 "Plasma membrane" "HPA053874: AB_2682287" "unprognostic (4.24e-2)" "unprognostic (8.61e-2)" "unprognostic (2.18e-1)" "unprognostic (2.62e-2)" "unprognostic (2.70e-2)" "unprognostic (3.51e-2)" "unprognostic (5.46e-3)" "unprognostic (2.76e-1)" "unprognostic (6.56e-2)" "unprognostic (1.97e-1)" "unprognostic (2.58e-2)" "unprognostic (5.07e-2)" "unprognostic (4.31e-3)" "unprognostic (4.40e-1)" "unprognostic (1.03e-1)" "unprognostic (1.09e-1)" "unprognostic (7.07e-2)" 25.0 13.0 10.4 21.0 10.9 17.0 22.3 17.5 21.1 13.8 15.2 7.7 10.4 12.1 14.3 13.1 17.2 11.4 18.7 38.8 13.2 9.4 13.9 11.7 16.5 39.4 9.2 13.2 14.4 10.9 5.4 7.5 11.0 9.1 13.4 7.1 10.4 18.2 13.5 81.7 11.9 13.5 13.5 8.4 23.3 13.4 7.9 7.3 34.5 9.4 15.4 19.5 18.7 14.3 32.3 46.8 72.5 50.1 26.9 40.9 38.7 6.6 17.1 6.0 10.4 19.6 24.0 10.7 15.7 25.4 18.8 16.9 8.9 18.3 23.9 10.4 18.4 17.2 11.8 7.5 22.0 4.2 15.1 9.9 24.6 12.8 21.5 16.9 14.8 41.3 22.2 10.6 22.3 7.6 12.8 28.6 15.2 5.7 12.5 14.0 5.8 20.4 34.0 9.3 8.7 48.6 7.9 6.2 25.0 14.8 10.8 4.7 17.9 5.6 23.7 31.1 3.8 5.4 16.1 29.4 18.5 20.1 14.3 13.5 11.2 9.9 11.6 36.4 42.0 22.2 26.8 50.1 39.6 33.7 48.9 30.6 32.3 35.9 35.8 46.8 25.4 28.9 35.6 72.5 26.9 49.5 42.3 40.9 38.7 10.4 10.9 17.5 21.1 13.2 9.4 9.2 13.2 9.1 7.3 6.0 8.5 43.9 25.9 15.2 12.0 25.8 30.6 5.3 4.5 12.2 0.0 35.9 31.5 70.3 2.8 31.5 60.1 0.0 89.7 67.2 36.1 19.7 40.3 8.9 187.1 6.4 21.2 23.4 112.2 2.4 32.5 86.2 32.1 272.3 18.1 14.9 81.2 38.6 31.8 14.6 4.5 51.8 24.5 0.9 23.6 13.4 18.9 73.4 21.1 23.7 TYROBP "DAP12, KARAP, PLO-SL, PLOSL" ENSG00000011600 "TYRO protein tyrosine kinase binding protein" O43914 19 35904401-35908295 "Disease related genes, Predicted membrane proteins" Immunity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 267.2;bone marrow: 125.7;lymphoid tissue: 123.6" "Group enriched" "Detected in many" 4 "Hofbauer cells: 3494.1;Kupffer cells: 3415.8;Macrophages: 2767.6;monocytes: 2409.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 267.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 10 "HMC-1: 118.8;THP-1: 65.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009493, HPA041899" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB009493: AB_638987, HPA041899: AB_10795266" "unprognostic (7.09e-2)" "unprognostic (8.38e-3)" "unprognostic (7.87e-2)" "unprognostic (4.76e-2)" "unprognostic (1.51e-1)" "unprognostic (1.39e-1)" "unprognostic (5.27e-2)" "unprognostic (8.04e-2)" "unprognostic (2.07e-2)" "unprognostic (2.47e-1)" "unprognostic (2.91e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (1.05e-4)" "unprognostic (4.47e-2)" "unprognostic (1.72e-2)" "unprognostic (4.27e-2)" "unprognostic (4.39e-2)" 76.0 21.4 13.3 54.9 20.7 125.7 16.4 2.8 11.3 11.9 14.3 24.0 2.3 17.1 8.1 19.3 7.2 14.0 25.7 17.5 12.9 14.2 17.6 29.8 75.3 80.0 20.8 5.6 11.7 8.7 1.8 9.0 32.0 17.2 14.9 12.3 15.0 12.4 7.2 7.3 6.7 18.9 16.0 36.3 123.6 10.4 7.3 18.6 8.5 6.7 6.6 10.3 22.3 8.4 0.7 79.3 267.2 190.6 62.8 20.3 162.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.1 5.4 118.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 8.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 65.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.8 0.0 32.8 190.6 100.9 20.3 134.4 10.6 0.7 0.4 2.8 79.3 0.3 0.5 2.3 267.2 62.8 130.3 68.5 0.3 162.3 13.3 20.7 2.8 11.3 12.9 14.2 20.8 5.6 17.2 18.6 53.6 239.1 119.8 2.3 49.0 0.0 5.3 56.0 37.5 79.6 19.2 0.0 18.6 1.7 0.8 2.5 35.9 0.7 0.0 4.8 19.4 38.6 1.2 723.1 19.1 3494.1 0.0 0.0 89.6 3415.8 4.7 8.6 2767.6 54.0 2409.4 0.0 0.5 1.2 0.2 1.1 6.8 1.1 77.6 17.2 0.7 2.8 39.0 32.5 348.1 0.1 1.0 UBASH3B "KIAA1959, STS-1, TULA-2, TULA2" ENSG00000154127 "Ubiquitin associated and SH3 domain containing B" Q8TF42 11 122655675-122814473 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.5;lymphoid tissue: 27.7" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 29.2;Extravillous trophoblasts: 45.7;Hofbauer cells: 34.3;Kupffer cells: 31.7;Syncytiotrophoblasts: 39.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebellum: 32.5;pons and medulla: 21.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 42.6;HMC-1: 32.5;hTEC/SVTERT24-B: 26.5;REH: 25.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038605, HPA038607" Approved Approved "Plasma membrane" NA NA 2200000 "Plasma membrane" "HPA038605: AB_10669648, HPA038607: AB_2676112" "unprognostic (4.94e-2)" "unprognostic (6.03e-3)" "unprognostic (1.34e-1)" "unprognostic (2.98e-1)" "unprognostic (2.02e-1)" "unprognostic (1.49e-1)" "unprognostic (9.09e-2)" "unprognostic (4.67e-3)" "unprognostic (1.21e-1)" "unprognostic (1.95e-1)" "unprognostic (1.46e-3)" "unprognostic (6.20e-2)" "unprognostic (9.02e-3)" "unprognostic (1.54e-1)" "unprognostic (3.22e-2)" "unprognostic (2.72e-3)" "unprognostic (1.53e-1)" 4.3 1.3 2.8 5.5 4.0 7.2 1.5 32.5 4.9 4.0 1.5 0.7 0.0 1.7 1.3 0.3 1.8 1.1 2.4 1.3 3.4 3.5 1.5 1.7 5.5 10.9 5.1 1.9 0.8 1.2 0.6 0.9 16.8 21.2 1.3 1.8 0.9 1.3 0.9 1.8 4.1 2.4 2.3 2.1 27.7 1.7 2.1 0.2 23.9 2.9 1.7 3.8 3.4 1.3 1.0 1.7 9.8 11.0 6.5 4.9 1.8 4.5 11.1 2.0 2.7 0.9 1.6 10.6 16.2 9.0 6.6 5.1 4.4 2.4 1.8 1.3 8.6 6.3 2.2 0.0 5.8 10.5 0.0 0.3 42.6 0.3 3.7 2.5 5.1 32.5 1.4 0.3 26.5 9.8 7.2 4.4 1.9 0.0 0.0 6.4 0.1 6.3 3.3 0.9 4.6 2.6 25.4 1.2 0.2 10.4 3.8 4.6 0.1 4.3 0.3 3.6 4.4 0.0 1.4 11.4 8.6 4.6 5.0 6.7 0.4 0.0 5.4 4.5 7.3 15.5 0.0 1.3 9.8 2.0 6.5 2.2 0.3 2.6 1.8 1.7 1.0 3.0 1.6 2.8 6.5 11.0 0.2 4.9 1.8 2.8 4.0 32.5 4.9 3.4 3.5 5.1 1.9 21.2 0.2 0.0 6.6 0.0 3.5 6.4 0.6 1.2 0.0 0.0 1.2 3.5 0.0 29.2 0.0 9.2 1.9 4.2 0.4 0.0 8.3 45.7 4.2 2.9 12.7 0.0 34.3 11.1 0.0 4.9 31.7 2.8 0.0 19.6 1.7 0.0 0.0 0.5 16.9 0.0 0.4 0.0 1.1 0.0 4.2 0.0 0.5 5.3 39.8 7.2 0.3 2.7 VANGL1 STB2 ENSG00000173218 "VANGL planar cell polarity protein 1" Q8TAA9 1 115641953-115698224 "Disease related genes, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 37.3;Ito cells: 31.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.9" "Group enriched" "Detected in many" 7 "dendritic cells: 3.5;NK-cells: 8.9;T-cells: 4.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA025235, CAB076375" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "CAB076375: AB_2665604, HPA025235: AB_1858718" "unprognostic (1.04e-2)" "unprognostic (2.04e-2)" "prognostic favorable (7.53e-4)" "unprognostic (9.94e-2)" "unprognostic (1.71e-2)" "unprognostic (5.18e-2)" "unprognostic (2.18e-3)" "unprognostic (5.11e-3)" "unprognostic (2.11e-1)" "unprognostic (6.43e-3)" "prognostic unfavorable (7.89e-4)" "unprognostic (1.88e-2)" "unprognostic (1.74e-2)" "unprognostic (7.71e-3)" "unprognostic (1.21e-1)" "unprognostic (4.50e-3)" "unprognostic (9.06e-3)" 7.0 8.6 2.2 5.8 3.1 2.0 16.4 1.2 2.5 14.0 9.3 5.3 8.3 4.0 13.2 8.8 14.4 13.7 5.3 12.7 3.2 2.3 11.8 7.1 12.1 7.4 2.1 1.9 8.9 11.5 5.5 2.2 5.3 2.4 9.4 7.1 6.6 9.5 11.0 2.1 9.8 6.6 15.9 2.0 4.7 6.6 7.9 2.6 18.0 11.8 10.0 10.0 10.2 9.4 0.3 3.5 0.0 0.8 8.9 4.3 1.4 21.5 9.2 3.0 4.0 11.2 10.1 6.0 8.4 6.1 11.0 8.8 5.3 10.8 0.0 14.5 9.7 10.4 27.3 5.0 14.9 7.3 25.2 6.1 12.0 8.5 4.3 4.1 3.5 5.2 5.3 10.5 7.8 8.4 5.8 10.9 20.6 7.2 6.7 11.0 28.8 17.6 1.4 7.5 12.6 8.8 0.0 8.7 6.2 5.1 14.5 2.7 3.6 15.1 10.0 7.2 5.9 5.1 3.9 11.6 7.6 12.0 16.5 15.2 0.9 1.0 0.0 10.2 6.3 18.5 0.0 0.8 0.0 3.0 0.5 0.8 0.3 1.9 2.9 3.5 0.0 0.7 3.3 0.0 8.9 0.8 3.0 4.3 1.4 2.2 3.1 1.2 2.5 3.2 2.3 2.1 1.9 2.4 2.6 3.0 2.7 1.9 6.3 6.5 4.0 6.3 2.5 6.7 1.2 8.7 37.3 3.7 0.0 14.9 4.6 7.7 7.7 0.0 12.1 5.8 6.4 7.0 0.0 2.4 3.8 0.0 6.4 31.9 1.5 1.9 5.5 1.8 0.0 19.0 7.9 4.2 16.1 5.8 7.8 5.7 0.7 6.5 5.7 1.0 9.4 5.6 0.3 1.8 8.3 6.5 VIL1 "D2S1471, VIL" ENSG00000127831 "Villin 1" P09327 2 218419092-218453295 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Actin capping, Actin-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 129.3" "Group enriched" "Detected in many" 5 "Enterocytes: 321.8;Intestinal endocrine cells: 109.0;Mucus-secreting cells: 120.3;Paneth cells: 175.6;Undifferentiated cells: 122.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 56.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "neutrophil: 2.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.5" "Group enriched" "Detected in some" 91 "CACO-2: 121.2;Hep G2: 56.9;OE19: 50.8" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB002452, HPA006884, HPA006885" Enhanced Enhanced "Plasma membrane" NA NA 41000000 "Plasma membrane" "CAB002452: AB_564052, HPA006884: AB_1080566, HPA006885: AB_1080564" "unprognostic (1.28e-1)" "unprognostic (1.91e-2)" "unprognostic (1.61e-2)" "unprognostic (1.09e-1)" "unprognostic (1.83e-1)" "unprognostic (3.36e-1)" "unprognostic (3.03e-1)" "unprognostic (5.90e-2)" "unprognostic (2.44e-2)" "unprognostic (7.06e-2)" "unprognostic (4.14e-1)" "unprognostic (1.03e-1)" "unprognostic (2.25e-3)" "unprognostic (3.90e-1)" "unprognostic (2.58e-1)" "unprognostic (4.79e-2)" "unprognostic (4.65e-2)" 0.3 0.2 0.6 5.7 0.8 0.0 0.3 0.7 0.4 0.3 36.6 0.3 0.3 68.9 0.3 1.2 0.3 0.2 22.6 0.3 0.5 0.5 4.6 6.1 0.3 0.3 0.5 0.3 0.3 7.2 0.0 0.4 0.3 0.3 0.3 32.6 0.3 0.5 0.3 0.3 0.3 129.3 1.2 0.5 0.4 0.9 0.6 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.4 2.5 0.1 0.1 0.1 7.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 121.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 50.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.5 0.1 0.0 0.4 0.0 7.8 0.6 0.8 0.7 0.4 0.5 0.5 0.5 0.3 0.3 0.3 0.0 0.0 0.0 0.2 0.7 2.2 0.4 17.8 0.0 0.0 0.0 2.0 0.2 3.3 6.7 1.5 0.0 321.8 0.0 37.7 0.1 0.6 0.3 9.2 28.8 0.1 1.6 109.0 1.3 2.6 0.0 0.0 1.0 0.0 0.0 120.3 0.8 15.1 175.6 0.0 26.6 1.2 0.0 0.8 0.7 0.9 0.6 0.2 1.0 122.8 0.4 ZBTB8OS ARCH ENSG00000176261 "Zinc finger and BTB domain containing 8 opposite strand" Q8IWT0 1 32600172-32650903 "Predicted intracellular proteins" "tRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046315 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA046315: AB_2679623" "unprognostic (3.41e-2)" "unprognostic (1.39e-2)" "unprognostic (1.08e-1)" "unprognostic (9.08e-2)" "unprognostic (1.82e-1)" "unprognostic (8.14e-2)" "prognostic unfavorable (4.25e-4)" "unprognostic (9.63e-2)" "prognostic unfavorable (8.56e-4)" "unprognostic (5.18e-2)" "unprognostic (3.84e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (7.11e-8)" "unprognostic (1.94e-2)" "unprognostic (2.79e-1)" "unprognostic (1.68e-1)" "unprognostic (1.42e-1)" 16.1 18.8 20.9 21.2 22.3 14.5 16.7 21.7 21.1 13.1 25.6 11.9 21.4 24.9 13.9 29.5 20.6 15.5 12.2 20.7 16.9 15.8 23.2 26.6 15.5 25.9 23.5 18.6 10.4 20.3 9.2 36.6 13.6 20.9 15.9 26.8 15.3 19.0 18.5 29.5 13.4 28.6 16.2 18.0 22.3 20.6 11.1 23.0 8.4 18.7 20.3 32.5 14.8 13.5 36.0 26.1 33.8 35.4 22.4 40.1 18.0 18.4 10.7 9.5 16.1 16.8 15.4 13.1 21.0 21.2 16.8 17.1 25.2 20.7 20.6 19.4 15.3 18.6 13.9 16.6 16.4 22.5 27.4 15.3 16.7 22.2 41.9 13.9 23.9 15.5 15.3 18.0 14.7 17.8 10.5 18.2 25.3 16.4 28.0 21.4 14.5 18.2 14.0 29.6 28.8 16.6 14.7 20.6 20.0 19.9 22.0 19.3 14.9 17.0 17.1 26.3 27.1 11.7 19.9 12.9 23.4 14.2 18.8 26.1 42.6 41.7 58.0 16.8 29.9 23.1 15.8 29.2 33.8 24.4 33.9 23.5 36.0 27.0 28.9 20.4 23.1 22.5 24.2 32.5 22.4 35.4 26.1 40.1 18.0 20.9 22.3 21.7 21.1 16.9 15.8 23.5 18.6 20.9 23.0 20.8 53.8 37.9 26.7 15.2 44.5 57.6 33.1 40.2 31.8 36.6 41.2 44.3 76.3 54.3 27.3 35.0 79.9 23.3 46.1 51.1 32.5 30.0 41.7 75.0 66.3 15.9 36.1 34.4 66.8 24.3 33.9 58.6 49.0 83.8 44.2 24.2 63.5 46.3 43.5 103.7 51.5 32.3 36.3 42.1 29.1 13.7 54.5 49.8 48.8 32.5 ZDHHC2 "DHHC2, ZNF372" ENSG00000104219 "Zinc finger DHHC-type containing 2" Q9UIJ5 8 17156029-17224799 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 72.6;Rod photoreceptor cells: 80.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023331, HPA023334" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA023331: AB_2671165, HPA023334: " "unprognostic (8.92e-2)" "unprognostic (4.23e-1)" "unprognostic (1.80e-2)" "unprognostic (2.53e-1)" "unprognostic (6.89e-2)" "unprognostic (2.25e-1)" "unprognostic (6.12e-2)" "unprognostic (1.78e-2)" "unprognostic (1.04e-1)" "unprognostic (2.37e-2)" "unprognostic (2.16e-1)" "unprognostic (1.58e-1)" "prognostic favorable (3.24e-4)" "unprognostic (5.00e-2)" "unprognostic (3.87e-1)" "unprognostic (2.87e-2)" "unprognostic (5.10e-2)" 10.1 22.5 14.8 9.4 14.5 24.4 14.8 22.8 12.2 12.9 13.4 17.5 17.4 9.3 7.0 10.5 5.3 12.8 6.4 10.1 13.0 14.0 24.2 7.5 12.7 10.3 13.6 10.9 13.0 27.0 19.2 20.2 6.1 14.7 12.0 10.3 21.2 15.9 13.7 15.9 3.4 9.1 8.8 25.9 11.2 14.1 14.2 14.5 13.8 32.3 10.4 10.2 17.3 8.7 5.3 4.6 4.9 2.7 4.4 7.0 1.5 0.9 5.2 10.2 2.1 9.0 16.1 6.0 17.6 21.4 10.0 11.9 1.6 14.7 10.6 6.9 15.3 25.2 0.6 13.7 8.7 18.6 6.9 6.9 9.6 7.6 2.1 9.0 10.1 1.1 6.7 1.4 12.5 11.4 23.1 16.4 12.7 1.1 28.6 12.0 0.2 7.4 6.1 6.5 7.8 8.1 7.4 10.2 3.9 18.1 11.3 5.5 3.6 7.5 0.0 1.6 15.9 0.4 4.6 13.5 5.1 15.6 11.2 17.5 5.7 21.3 12.5 14.1 9.3 2.3 2.6 2.6 4.9 4.1 2.7 7.0 5.3 5.1 4.9 2.2 4.6 4.7 5.0 1.8 4.4 1.6 4.6 2.6 1.5 14.8 14.5 22.8 12.2 13.0 14.0 13.6 10.9 14.7 14.5 41.7 20.1 11.5 11.9 2.7 37.3 11.3 10.2 6.7 14.8 48.8 72.6 0.5 18.3 19.5 6.7 9.0 6.3 0.0 29.1 0.9 7.4 32.3 8.1 7.3 11.7 11.1 18.9 5.5 21.8 8.2 4.6 15.5 21.9 4.6 15.0 23.4 34.3 10.5 2.8 19.8 80.1 12.9 7.6 5.5 2.5 2.4 0.3 13.4 13.7 23.7 ZDHHC22 C14orf59 ENSG00000177108 "Zinc finger DHHC-type containing 22" Q8N966 14 77131270-77142734 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 52.3" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 9.9;Cone photoreceptor cells: 3.9;Late spermatids: 3.3" "Cancer enriched" "Detected in single" 40 "glioma: 7.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 5.3;NTERA-2: 5.6;RH-30: 9.4;SCLC-21H: 10.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049471, HPA072213" Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA049471: AB_2732553, HPA072213: AB_2686496" "unprognostic (1.02e-1)" "unprognostic (3.42e-1)" "unprognostic (1.22e-4)" "unprognostic (1.66e-1)" "unprognostic (8.86e-2)" "unprognostic (2.68e-1)" "unprognostic (3.41e-1)" "unprognostic (1.87e-1)" "unprognostic (6.94e-4)" "unprognostic (3.05e-1)" "unprognostic (6.30e-2)" "unprognostic (1.16e-1)" "unprognostic (4.02e-1)" "unprognostic (1.95e-1)" "unprognostic (4.79e-1)" 1.1 1.5 11.2 1.1 12.6 1.1 1.1 8.4 52.3 1.1 1.2 6.7 0.0 1.1 1.1 1.4 1.3 1.2 1.1 1.2 14.5 18.4 1.1 1.1 1.1 1.1 10.7 19.5 1.1 1.1 1.1 3.1 1.1 9.2 1.1 1.3 0.5 1.1 1.1 1.3 1.1 1.1 1.2 3.6 1.1 1.3 1.4 5.1 0.0 1.3 0.0 1.1 1.4 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 5.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 5.6 0.0 0.7 0.0 9.4 0.0 0.0 0.0 10.4 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 11.2 12.6 8.4 29.5 14.5 18.4 10.7 19.5 9.2 5.1 0.0 0.0 0.0 0.0 0.0 9.9 0.3 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 ZNF227 ENSG00000131115 "Zinc finger protein 227" Q86WZ6 19 44207547-44237268 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030573 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA030573: AB_10610702" "unprognostic (3.01e-2)" "unprognostic (1.79e-2)" "unprognostic (7.14e-2)" "unprognostic (2.77e-2)" "unprognostic (4.74e-2)" "unprognostic (1.66e-2)" "unprognostic (8.05e-2)" "unprognostic (7.89e-2)" "unprognostic (1.52e-2)" "unprognostic (1.08e-1)" "unprognostic (5.68e-3)" "unprognostic (1.94e-1)" "unprognostic (4.88e-2)" "unprognostic (1.27e-1)" "unprognostic (2.21e-2)" "unprognostic (9.91e-2)" "prognostic favorable (2.64e-4)" 10.4 11.5 13.6 8.3 13.3 6.3 12.7 24.7 14.4 12.9 10.3 13.0 8.7 8.0 15.4 12.1 10.1 12.6 9.0 8.9 12.3 11.7 10.0 11.0 9.4 14.0 13.5 12.5 17.6 9.9 18.5 28.0 11.4 15.7 13.3 9.0 9.6 9.3 11.2 10.0 9.6 8.9 12.8 15.3 13.4 12.6 10.7 17.6 20.8 12.7 4.3 16.2 12.3 13.2 12.1 5.8 13.0 4.5 10.6 13.1 4.9 5.3 7.6 9.1 11.3 7.4 6.5 4.3 5.2 7.5 5.1 9.9 3.7 4.2 9.3 8.1 4.8 6.1 3.1 10.3 5.5 6.9 12.1 13.0 16.2 8.1 4.5 5.3 14.1 7.2 5.9 6.2 5.0 9.4 8.4 7.5 10.9 1.6 0.2 5.4 2.8 13.2 3.7 14.6 5.5 4.0 7.9 9.2 7.9 5.2 9.7 15.5 15.9 11.7 5.3 4.1 9.3 4.4 7.6 6.4 5.6 9.3 4.2 6.6 21.8 28.8 20.4 3.7 5.9 7.5 13.0 4.5 8.6 10.7 3.2 11.7 11.4 10.0 10.3 5.4 12.1 13.1 11.1 4.1 10.6 2.9 5.8 11.8 4.9 13.6 13.3 24.7 14.4 12.3 11.7 13.5 12.5 15.7 17.6 0.0 1.0 5.1 3.8 2.7 6.0 6.2 2.5 1.4 6.8 5.2 2.0 4.6 3.3 3.4 18.5 8.1 2.1 0.0 3.6 3.8 3.6 7.0 1.1 3.9 3.7 7.9 2.4 9.2 5.7 16.6 5.2 3.5 1.7 4.6 4.9 5.2 4.7 3.5 5.3 2.4 4.5 6.5 4.7 4.4 6.9 3.3 1.8 6.4 4.2 2.5 ZNF706 HSPC038 ENSG00000120963 "Zinc finger protein 706" Q9Y5V0 8 101177878-101206193 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 852.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042793 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042793: AB_10795710" "unprognostic (2.05e-2)" "unprognostic (3.29e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (3.12e-5)" "unprognostic (1.60e-1)" "unprognostic (1.26e-1)" "unprognostic (2.48e-3)" "unprognostic (5.22e-2)" "unprognostic (3.19e-2)" "unprognostic (1.21e-2)" "unprognostic (1.35e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (5.90e-11)" "unprognostic (9.65e-2)" "unprognostic (1.59e-1)" "unprognostic (3.57e-1)" "unprognostic (2.17e-2)" 28.0 24.6 38.4 34.5 40.8 26.3 39.4 35.5 39.0 21.8 35.9 34.5 21.5 37.1 23.0 38.5 42.4 20.5 29.9 27.8 37.0 25.4 23.4 34.6 34.1 45.5 32.8 40.0 23.9 82.3 26.9 28.9 30.1 29.3 21.6 36.1 20.9 29.4 21.2 31.6 53.6 50.4 25.7 32.6 30.1 34.5 31.1 32.1 21.2 25.1 33.6 39.4 23.9 28.7 63.6 85.4 32.4 73.1 19.3 46.4 38.1 39.8 23.0 40.3 12.8 14.5 16.8 25.8 16.7 21.5 17.3 18.5 16.4 24.7 24.2 29.1 19.8 35.3 21.9 23.0 22.5 20.0 17.9 20.0 24.2 14.2 31.4 19.2 18.0 23.6 14.5 35.3 16.3 35.6 23.9 29.3 24.6 26.2 47.3 15.3 28.1 37.7 49.8 12.2 81.1 57.0 15.9 13.5 49.5 22.8 20.7 26.8 12.0 11.7 19.4 71.4 36.0 20.3 19.2 19.4 9.5 19.5 25.1 17.2 40.2 38.5 38.9 25.6 39.8 43.8 32.4 45.9 24.9 23.7 71.9 24.3 63.6 33.1 30.1 42.3 49.0 37.5 35.8 6.2 19.3 73.1 85.4 46.4 38.1 38.4 40.8 35.5 39.0 37.0 25.4 32.8 40.0 29.3 32.1 56.6 37.1 175.0 195.4 408.4 54.6 67.0 112.1 75.0 69.4 75.0 17.7 165.7 152.5 226.9 436.3 144.3 251.1 116.8 226.4 308.8 110.7 186.3 119.0 105.2 242.6 81.0 254.7 69.3 125.8 852.0 80.6 213.1 195.7 341.8 228.1 114.7 312.8 245.4 81.7 155.6 49.2 103.5 156.4 70.2 63.6 452.8 161.7 105.8 130.7 254.7